data_1gks_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gks _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.2 mt -53.0 -59.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.534 0.734 . . . . 0.0 109.544 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -52.17 -49.07 64.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 112.435 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.1 -50.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.556 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -138.98 -17.09 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.99 36.1 3.77 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 120.075 1.307 . . . . 0.0 111.34 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -136.77 150.51 48.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.611 1.564 . . . . 0.0 108.013 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.18 109.59 5.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.653 1.181 . . . . 0.0 109.274 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.33 153.68 31.56 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 CA-C-N 120.105 1.073 . . . . 0.0 111.82 -9.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.45 124.85 24.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 109.667 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.03 -48.1 81.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.418 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -39.59 -56.86 1.59 Allowed 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.447 1.899 . . . . 0.0 112.253 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -43.52 -31.61 0.76 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.408 1.483 . . . . 0.0 113.375 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.2 m -104.28 -56.53 2.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.897 0.479 . . . . 0.0 111.277 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -68.62 -28.55 67.01 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.4 -39.24 93.98 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.95 0.795 . . . . 0.0 110.318 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ttm105 -95.32 -28.71 14.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.414 1.086 . . . . 0.0 111.978 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.6 6.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.81 133.18 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.69 31.24 7.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.628 1.171 . . . . 0.0 111.636 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.4 76.25 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.659 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.91 136.5 72.91 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 118.511 1.156 . . . . 0.0 108.402 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.86 120.15 7.71 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.339 2.026 . . . . 0.0 108.596 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.49 167.96 16.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.65 158.75 33.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.547 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.39 49.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.375 1.47 . . . . 0.0 111.9 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.23 62.17 19.47 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.651 1.58 . . . . 0.0 109.036 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -44.1 -41.41 12.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.238 3.292 . . . . 0.0 113.779 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -49.51 -41.11 40.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.514 1.125 . . . . 0.0 111.315 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.3 -24.89 67.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.671 0.788 . . . . 0.0 111.956 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -104.95 -30.87 9.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.316 1.046 . . . . 0.0 112.353 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.59 -49.9 1.56 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.627 1.571 . . . . 0.0 112.795 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -27.68 60.56 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -76.74 151.0 82.25 Favored Pre-proline 0 CA--C 1.534 0.333 0 O-C-N 121.64 -0.663 . . . . 0.0 110.03 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.08 85.83 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 107.982 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.45 -25.55 25.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.56 1.944 . . . . 0.0 113.304 -171.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.3 m -48.17 113.82 0.82 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.495 1.118 . . . . 0.0 110.651 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.81 -46.14 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.373 1.069 . . . . 0.0 110.512 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -58.19 -24.64 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.779 1.232 . . . . 0.0 112.852 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -90.06 -53.0 4.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.3 mt -47.85 -42.01 25.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.298 1.039 . . . . 0.0 111.861 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.44 -34.64 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.755 -0.591 . . . . 0.0 111.289 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -64.52 -50.12 68.62 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 119.375 0.988 . . . . 0.0 108.653 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -51.13 -46.1 61.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.673 0.789 . . . . 0.0 109.844 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -50.56 71.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.825 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.02 -45.42 92.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.294 -0.879 . . . . 0.0 111.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -32.67 67.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.877 0.871 . . . . 0.0 112.227 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.56 160.19 28.93 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -157.61 122.01 4.29 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.974 -0.721 . . . . 0.0 109.263 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.08 9.34 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.02 53.86 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.003 0.521 . . . . 0.0 111.807 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.4 ttp -65.89 115.89 27.25 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.733 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.13 164.84 23.73 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.369 2.046 . . . . 0.0 110.947 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.33 134.68 50.69 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -97.03 -15.06 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -47.79 100.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.671 0.788 . . . . 0.0 112.624 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.05 -37.97 3.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.062 1.315 . . . . 0.0 111.781 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -76.42 -38.92 54.85 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.786 0.793 . . . . 0.0 110.134 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.65 136.61 46.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.79 144.83 30.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -32.31 -44.95 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.63 1.972 . . . . 0.0 111.496 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.64 -49.53 76.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.942 0.792 . . . . 0.0 111.561 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -56.1 -56.92 15.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 122.728 1.251 . . . . 0.0 108.626 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.4 mt -48.62 -58.56 4.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.823 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 t -46.09 -53.54 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.426 1.09 . . . . 0.0 110.024 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -59.02 -39.03 80.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.656 0.382 . . . . 0.0 111.192 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.56 71.9 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.47 -49.95 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.601 1.16 . . . . 0.0 109.825 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.07 -39.14 85.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.135 0.88 . . . . 0.0 109.228 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.1 -47.51 85.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mtp -54.03 -59.31 4.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.01 -35.94 64.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 112.634 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -62.9 -10.65 14.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.419 1.008 . . . . 0.0 113.173 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -89.62 -11.61 42.11 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.783 1.174 . . . . 0.0 111.558 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.216 -1.85 . . . . 0.0 111.875 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.96 -57.46 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.699 0.799 . . . . 0.0 110.175 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.71 -49.25 77.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.825 0.85 . . . . 0.0 112.31 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.15 -48.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.084 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.52 -18.19 1.95 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.85 -34.43 38.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.842 1.201 . . . . 0.0 112.364 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 p -73.06 151.32 41.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.419 0.609 . . . . 0.0 110.444 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.68 106.72 6.42 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.872 1.269 . . . . 0.0 108.559 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.16 150.65 36.01 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.351 1.161 . . . . 0.0 111.738 -5.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.06 124.53 22.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.676 1.19 . . . . 0.0 109.142 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -54.43 -46.34 73.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.026 0.83 . . . . 0.0 110.558 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 p -40.4 -52.46 2.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.111 2.165 . . . . 0.0 112.338 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -38.47 -48.2 1.36 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 112.082 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.9 m -93.02 -55.05 3.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.208 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -64.84 -25.95 68.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 120.289 1.404 . . . . 0.0 111.356 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -119.72 -15.05 8.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.963 0.905 . . . . 0.0 112.466 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.74 34.23 44.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.2 t -55.13 132.62 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.34 31.53 7.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.729 1.211 . . . . 0.0 111.911 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.61 22.24 75.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.398 -0.668 . . . . 0.0 113.044 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.15 131.66 80.5 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 118.707 1.253 . . . . 0.0 109.324 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.7 119.57 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.411 2.074 . . . . 0.0 108.211 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.39 179.78 6.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.811 0.815 . . . . 0.0 112.567 -172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.43 159.37 24.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.14 54.11 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.084 1.754 . . . . 0.0 112.238 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.21 58.56 15.4 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.034 0.933 . . . . 0.0 110.96 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -38.48 -48.27 2.51 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.557 3.505 . . . . 0.0 114.152 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -47.77 -40.1 19.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.363 1.465 . . . . 0.0 111.988 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.71 -27.9 58.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.923 0.329 . . . . 0.0 111.455 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.94 -26.14 19.42 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.756 0.822 . . . . 0.0 112.004 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -34.76 -46.81 0.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.493 2.317 . . . . 0.0 114.456 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.05 2.7 35.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -83.37 158.29 63.78 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 118.978 0.808 . . . . 0.0 109.821 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.01 120.88 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.258 2.639 . . . . 0.0 110.833 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -64.36 -39.16 93.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -82.35 133.33 35.22 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 122.067 -0.395 . . . . 0.0 111.115 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -52.98 -40.7 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -54.34 -29.48 48.14 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.024 1.33 . . . . 0.0 112.598 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.28 -52.49 6.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.89 -40.15 60.2 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -60.2 -33.97 55.43 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 CA-C-N 119.528 1.058 . . . . 0.0 110.743 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -62.47 -49.81 73.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 m -52.27 -46.95 66.06 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.453 0.57 . . . . 0.0 109.817 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 m -61.12 -40.35 93.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.491 0.717 . . . . 0.0 111.487 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . 0.286 0.9 OUTLIER -111.02 36.65 3.07 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.37 -44.49 2.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.474 1.91 . . . . 0.0 107.175 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.33 145.63 9.76 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.89 1.71 . . . . 0.0 109.462 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -156.36 132.95 10.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.8 -117.64 11.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.36 1.01 38.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.186 0.994 . . . . 0.0 112.064 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.7 ttp -69.58 122.83 87.03 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.067 0.849 . . . . 0.0 110.308 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.82 152.55 47.23 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.155 1.903 . . . . 0.0 108.86 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.58 119.14 13.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -76.34 1.97 14.75 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -46.37 112.51 0.5 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 110.924 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.37 -30.01 6.73 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.636 0.636 . . . . 0.0 112.149 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -72.7 -46.28 54.51 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.29 124.56 13.78 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.0 155.4 28.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -29.32 -49.81 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.496 1.918 . . . . 0.0 111.852 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -64.7 -41.05 96.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.258 0.936 . . . . 0.0 112.304 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.12 -58.0 8.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 122.437 1.113 . . . . 0.0 108.443 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.3 mt -46.03 -57.9 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 127.047 2.139 . . . . 0.0 110.48 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -39.84 -55.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 110.813 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -60.58 -37.25 80.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.284 1.034 . . . . 0.0 111.816 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.64 32.27 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.74 -0.6 . . . . 0.0 109.442 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.67 -50.85 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.049 0.94 . . . . 0.0 110.785 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.94 -41.65 92.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.847 1.203 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -59.03 -51.52 69.71 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.27 -53.61 48.35 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.33 -38.24 76.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.118 0.567 . . . . 0.0 111.78 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.7 p -63.5 -5.22 3.49 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -87.06 -12.43 47.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.771 1.168 . . . . 0.0 111.093 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.656 -1.64 . . . . 0.0 110.197 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 121.349 0.595 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.02 -58.15 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.2 -50.24 65.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.176 0.99 . . . . 0.0 112.17 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.2 mt -69.21 -48.04 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.468 -174.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -145.32 -12.74 0.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.55 38.85 2.99 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 120.244 1.384 . . . . 0.0 111.257 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.16 153.76 51.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.135 1.374 . . . . 0.0 109.073 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.08 108.63 8.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.495 1.118 . . . . 0.0 110.968 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -57.02 159.27 24.89 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.843 0.98 . . . . 0.0 111.83 -12.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.82 122.66 19.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.484 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -54.72 -47.51 73.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.712 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 p -41.48 -52.47 3.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.339 1.856 . . . . 0.0 112.263 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -48.51 -24.78 1.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.065 1.346 . . . . 0.0 113.874 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -109.03 -54.1 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.743 0.817 . . . . 0.0 110.951 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -69.84 -21.67 63.35 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.25 -58.05 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.366 0.985 . . . . 0.0 109.773 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -26.29 32.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.635 0.374 . . . . 0.0 111.563 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.81 6.15 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.32 144.4 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.47 29.8 7.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.076 0.95 . . . . 0.0 111.491 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.27 79.16 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.05 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.71 132.64 88.96 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.754 1.277 . . . . 0.0 108.409 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.17 119.02 5.93 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.793 2.329 . . . . 0.0 109.398 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -82.55 177.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.9 0.857 . . . . 0.0 111.255 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -82.98 157.53 22.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m120 50.4 41.48 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.94 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.28 52.93 8.64 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.443 1.097 . . . . 0.0 110.24 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -46.88 -39.61 24.63 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.75 2.967 . . . . 0.0 112.643 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -49.66 -40.63 40.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.404 1.081 . . . . 0.0 111.48 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.41 -27.36 60.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.234 0.614 . . . . 0.0 111.199 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.06 -27.24 19.82 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.839 -0.538 . . . . 0.0 111.697 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.2 -50.58 0.73 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.6 1.96 . . . . 0.0 113.503 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.74 -23.43 42.29 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.62 135.5 75.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.647 -0.658 . . . . 0.0 109.423 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.72 113.99 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.295 1.997 . . . . 0.0 111.256 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.61 -32.4 58.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.144 0.978 . . . . 0.0 111.834 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -53.99 101.81 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.457 1.503 . . . . 0.0 111.279 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -45.43 -40.82 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.011 1.324 . . . . 0.0 109.933 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.94 -36.52 5.54 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.963 2.105 . . . . 0.0 112.639 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -84.03 -50.14 8.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -52.66 -39.27 61.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.046 0.938 . . . . 0.0 112.019 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 m -60.1 -36.07 65.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.143 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -67.5 -48.76 66.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.677 1.126 . . . . 0.0 108.451 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 m -50.7 -46.42 58.86 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -67.34 -50.89 58.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.649 0.379 . . . . 0.0 111.179 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.0 -44.77 94.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.188 -0.945 . . . . 0.0 111.031 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.32 -35.36 54.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.544 0.738 . . . . 0.0 112.462 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 158.23 24.36 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -164.47 133.53 3.67 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.891 0.846 . . . . 0.0 109.803 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.76 -84.84 0.28 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.96 -6.28 2.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.193 1.797 . . . . 0.0 111.453 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.3 ttp -64.61 124.01 84.83 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.067 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.49 158.68 55.28 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.124 1.883 . . . . 0.0 109.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 147.02 53.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -111.81 -12.75 13.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.098 1.359 . . . . 0.0 111.232 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.75 123.04 6.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.416 1.086 . . . . 0.0 110.136 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.6 -26.07 23.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.387 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -97.74 -54.64 3.05 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.498 1.149 . . . . 0.0 110.361 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.03 125.91 33.12 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.55 51.39 1.06 Allowed 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.719 1.608 . . . . 0.0 111.921 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 52.05 -62.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.928 3.291 . . . . 0.0 113.734 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -50.92 -34.85 30.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.763 1.225 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -53.0 -56.63 14.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.734 1.614 . . . . 0.0 109.143 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.07 -53.32 58.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 125.44 1.496 . . . . 0.0 109.684 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.2 t -43.39 -57.51 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 122.899 0.479 . . . . 0.0 109.875 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -60.72 -43.86 97.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.876 0.471 . . . . 0.0 112.056 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.55 95.6 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.802 -0.561 . . . . 0.0 110.398 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.89 -49.63 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.49 1.516 . . . . 0.0 110.087 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.69 -39.81 89.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -58.22 -53.05 62.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.389 0.54 . . . . 0.0 109.617 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.7 mtp -48.25 -58.58 4.35 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -55.61 -39.86 71.33 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.811 0.844 . . . . 0.0 112.078 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.0 m -67.17 -6.53 18.26 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.506 -0.746 . . . . 0.0 112.006 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -119.14 42.44 2.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.597 1.559 . . . . 0.0 109.635 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.136 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 119.578 -0.249 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.7 mt -53.91 -57.53 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 109.978 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -57.07 -50.34 73.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.236 1.014 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.91 -51.18 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.88 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.996 0.816 . . . . 0.0 112.851 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.76 38.94 1.51 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 157.51 45.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.231 1.813 . . . . 0.0 108.44 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.714 0.805 . . . . 0.0 110.629 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.06 160.35 23.48 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 CA-C-N 119.941 1.015 . . . . 0.0 111.878 -12.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.31 127.45 32.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.706 0.802 . . . . 0.0 109.558 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -57.71 -50.77 72.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.457 0.646 . . . . 0.0 111.199 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -39.42 -56.13 1.64 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.642 1.977 . . . . 0.0 112.986 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.67 -38.0 0.83 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.337 1.455 . . . . 0.0 112.564 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -96.83 -59.25 1.84 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 0.0 110.372 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -60.69 -46.11 91.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -22.18 64.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.862 0.301 . . . . 0.0 111.759 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -114.87 11.99 16.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.209 1.004 . . . . 0.0 111.293 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.71 38.39 29.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.124 0.869 . . . . 0.0 113.63 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.8 t -55.14 132.74 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.52 31.44 7.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 111.883 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.71 22.32 75.12 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.742 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.49 136.25 82.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.253 1.027 . . . . 0.0 108.697 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.22 126.94 21.47 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.346 2.031 . . . . 0.0 109.626 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -94.07 174.47 7.14 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.449 0.643 . . . . 0.0 112.014 -174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.82 162.3 19.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.09 53.6 0.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.758 1.623 . . . . 0.0 112.125 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.79 64.5 22.18 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 124.235 1.014 . . . . 0.0 109.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -41.17 -51.55 3.87 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.024 3.15 . . . . 0.0 114.29 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -44.15 -51.92 7.71 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.144 1.378 . . . . 0.0 110.843 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.55 -45.38 56.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.953 0.901 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -85.6 -30.6 23.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.325 0.65 . . . . 0.0 111.379 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.41 93.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.411 1.084 . . . . 0.0 109.408 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.89 -42.15 97.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.014 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -74.85 162.66 72.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.528 0.731 . . . . 0.0 111.266 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -68.03 84.33 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.36 2.04 . . . . 0.0 107.798 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -48.9 -28.82 4.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.462 1.905 . . . . 0.0 113.247 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.79 106.82 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.748 2.019 . . . . 0.0 110.911 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.0 t -47.75 -44.41 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.248 1.019 . . . . 0.0 110.939 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -53.78 -36.0 61.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.755 1.622 . . . . 0.0 111.842 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.69 -50.7 10.22 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.7 -42.31 45.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.128 0.971 . . . . 0.0 112.408 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.62 -36.11 68.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.818 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -65.46 -49.43 69.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 119.763 1.165 . . . . 0.0 108.581 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 m -52.07 -46.11 65.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.078 0.466 . . . . 0.0 109.812 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -65.19 -49.98 67.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.761 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.53 -45.29 94.82 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.315 -0.866 . . . . 0.0 110.81 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.79 74.91 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.715 0.806 . . . . 0.0 111.819 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 164.95 26.04 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -156.36 106.98 2.39 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.85 -0.794 . . . . 0.0 109.389 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.59 -111.55 3.33 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.79 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.088 0.555 . . . . 0.0 111.117 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -65.0 117.96 44.38 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.323 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.47 157.51 52.8 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.531 2.154 . . . . 0.0 109.644 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 145.68 52.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.456 0.302 . . . . 0.0 110.302 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -110.81 -12.31 14.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.192 1.397 . . . . 0.0 111.349 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -46.51 123.58 5.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.978 1.311 . . . . 0.0 110.548 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.69 -25.38 21.5 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.119 0.866 . . . . 0.0 112.34 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -98.1 -57.1 2.3 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.384 1.092 . . . . 0.0 110.325 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.11 119.61 26.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.46 84.92 4.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 15.32 -59.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 131.389 3.876 . . . . 0.0 115.866 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -48.28 -35.39 12.07 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.2 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -54.99 -59.75 4.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.211 1.405 . . . . 0.0 108.787 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 mt -55.51 -53.84 51.34 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 126.282 1.833 . . . . 0.0 109.858 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.3 t -45.38 -57.03 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.32 0.648 . . . . 0.0 109.422 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -60.3 -41.24 93.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.766 -0.584 . . . . 0.0 111.651 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.36 99.01 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 109.787 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.88 -44.18 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.64 1.176 . . . . 0.0 108.565 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.14 -50.72 68.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -55.26 -51.64 65.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.522 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.7 mtt -47.57 -63.79 0.96 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.113 0.959 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -53.3 -36.05 60.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.069 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.4 m -72.07 34.57 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.656 1.116 . . . . 0.0 113.94 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -134.21 -10.86 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.662 1.585 . . . . 0.0 109.85 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.579 -1.677 . . . . 0.0 110.093 -178.771 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.627 0.251 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.45 -60.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.893 1.677 . . . . 0.0 110.671 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.75 -48.08 73.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.83 0.852 . . . . 0.0 111.589 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.29 -49.98 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.457 1.103 . . . . 0.0 111.021 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.65 33.77 0.27 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.42 37.85 1.75 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 156.04 48.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.287 1.835 . . . . 0.0 107.751 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.42 108.82 6.73 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.859 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.8 155.73 27.72 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.074 1.062 . . . . 0.0 111.581 -9.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.17 128.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.54 0.736 . . . . 0.0 109.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.3 m -58.35 -49.41 77.3 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 0.0 110.117 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -41.18 -55.5 2.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.405 1.882 . . . . 0.0 113.49 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.27 -36.38 3.98 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.941 0.896 . . . . 0.0 112.339 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.41 -57.91 2.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -67.06 -36.12 81.35 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -68.21 -33.84 75.16 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -84.46 -26.8 27.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.112 0.965 . . . . 0.0 111.122 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.18 33.3 57.13 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.62 139.46 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.9 29.43 6.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.126 0.97 . . . . 0.0 111.572 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.22 24.49 76.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.718 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.67 80.41 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.608 1.204 . . . . 0.0 108.275 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.6 122.01 10.61 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.257 1.972 . . . . 0.0 110.051 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -90.56 177.18 6.43 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.606 0.717 . . . . 0.0 111.65 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 156.77 29.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 51.08 35.48 13.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.614 0.766 . . . . 0.0 111.845 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.79 67.27 79.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.06 1.344 . . . . 0.0 110.352 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.18 -50.82 5.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.148 3.232 . . . . 0.0 114.454 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -50.93 -35.21 32.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.946 1.299 . . . . 0.0 112.227 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.37 -27.66 68.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.149 0.431 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -101.53 -35.42 9.16 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.548 1.139 . . . . 0.0 112.097 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.34 -51.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.587 1.555 . . . . 0.0 113.125 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.89 -23.18 45.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -79.53 144.28 60.95 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.38 93.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.72 2.28 . . . . 0.0 108.457 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.56 -21.12 36.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.044 1.337 . . . . 0.0 112.994 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.41 106.93 0.11 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.571 1.948 . . . . 0.0 110.455 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.0 -42.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.937 0.895 . . . . 0.0 110.632 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.82 -31.23 64.52 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.371 1.469 . . . . 0.0 112.36 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.83 -53.49 5.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt -48.62 -45.61 38.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.502 0.721 . . . . 0.0 111.877 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.94 -35.98 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 121.854 -0.529 . . . . 0.0 110.976 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.89 -45.09 75.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 m -53.96 -44.08 70.45 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.3 m -64.55 -50.61 66.62 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.81 0.444 . . . . 0.0 110.49 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.48 -44.97 89.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.411 -0.806 . . . . 0.0 110.924 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.9 68.49 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.799 0.84 . . . . 0.0 112.288 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.09 161.25 26.47 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -159.66 117.31 2.68 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.892 -0.769 . . . . 0.0 109.215 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.18 -117.62 11.63 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.44 54.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.883 0.473 . . . . 0.0 111.447 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -67.98 121.47 79.99 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 118.784 0.72 . . . . 0.0 110.112 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.73 161.29 39.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.629 2.219 . . . . 0.0 110.195 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.02 136.83 57.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.89 -14.05 18.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.121 0.968 . . . . 0.0 113.247 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -49.41 102.83 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.311 0.644 . . . . 0.0 112.142 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.73 -36.24 4.28 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.14 1.352 . . . . 0.0 111.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -79.17 -41.11 29.19 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 117.828 0.814 . . . . 0.0 110.184 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.35 132.76 39.87 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.56 144.94 30.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -28.29 -52.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -62.45 -40.65 97.31 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.674 -0.641 . . . . 0.0 112.033 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.23 -58.91 6.38 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 122.429 1.109 . . . . 0.0 108.199 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -46.09 -56.02 6.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.493 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -41.53 -54.49 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.815 1.246 . . . . 0.0 110.572 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -57.04 -42.53 80.68 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.342 -0.224 . . . . 0.0 111.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.99 81.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.54 -45.47 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.578 0.751 . . . . 0.0 109.344 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -55.1 -51.0 67.77 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.875 0.87 . . . . 0.0 108.824 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -55.87 -52.05 65.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.414 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.6 mtp -49.73 -54.41 19.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.391 0.677 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.19 -36.81 76.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.03 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.6 m -74.41 42.49 0.16 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.468 -0.77 . . . . 0.0 112.766 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -135.93 -7.78 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.77 1.228 . . . . 0.0 110.307 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.22 -1.371 . . . . 0.0 108.999 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.522 0.201 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.7 -59.78 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.632 1.573 . . . . 0.0 109.96 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -58.12 -48.56 79.85 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.135 0.574 . . . . 0.0 111.441 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.6 mt -69.84 -46.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.877 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.69 39.07 0.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.45 39.49 1.16 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -139.16 156.9 46.79 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.458 1.903 . . . . 0.0 107.496 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.51 108.17 6.63 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.814 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.32 154.55 31.27 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 CA-C-N 120.104 1.073 . . . . 0.0 111.827 -9.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.08 121.73 16.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.561 1.145 . . . . 0.0 109.179 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -52.71 -49.71 64.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.206 0.527 . . . . 0.0 110.496 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -43.39 -51.26 6.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.029 1.732 . . . . 0.0 112.77 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -47.39 -34.21 6.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.655 0.782 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 m -96.85 -55.74 2.79 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -66.06 -36.91 84.5 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.99 -43.26 88.27 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -72.55 -30.23 64.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.626 0.77 . . . . 0.0 111.076 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.2 56.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.02 143.15 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.63 30.69 6.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.11 0.964 . . . . 0.0 111.383 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.43 27.56 73.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.622 -0.543 . . . . 0.0 112.494 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.32 131.89 90.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.51 1.155 . . . . 0.0 108.299 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.68 112.52 1.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.756 2.304 . . . . 0.0 109.564 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.54 175.33 9.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.638 1.208 . . . . 0.0 109.896 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.63 140.77 29.11 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 68.29 35.43 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.231 1.013 . . . . 0.0 109.795 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.89 58.23 37.42 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.218 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.79 -47.23 2.72 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.537 3.492 . . . . 0.0 114.315 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -47.53 -40.46 18.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.488 1.515 . . . . 0.0 112.026 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.51 -25.64 54.42 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.954 0.343 . . . . 0.0 111.464 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -92.05 -23.48 19.48 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.605 0.762 . . . . 0.0 111.734 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.71 -46.36 0.43 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.873 2.069 . . . . 0.0 114.155 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -101.07 -3.3 29.54 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -83.74 145.78 48.07 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.849 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.78 118.59 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.993 2.462 . . . . 0.0 111.65 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -62.26 -32.71 73.45 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 103.94 0.13 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.299 2.24 . . . . 0.0 111.507 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.09 -40.09 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.774 -0.579 . . . . 0.0 109.5 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.02 -26.0 34.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.576 1.55 . . . . 0.0 112.428 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.67 -53.42 4.53 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.22 -40.89 48.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.43 -31.52 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.668 -0.645 . . . . 0.0 110.38 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -65.85 -51.02 62.36 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.538 1.063 . . . . 0.0 108.296 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -49.97 -44.92 51.01 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.864 0.866 . . . . 0.0 109.98 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 m -64.54 -52.26 58.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.948 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.51 -41.57 98.92 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.025 -1.047 . . . . 0.0 111.867 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.6 -33.96 31.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.971 0.909 . . . . 0.0 112.283 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 151.56 17.45 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -155.18 136.99 14.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.73 -115.68 7.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.07 -0.46 33.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 ttp -65.43 127.0 92.58 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.891 0.769 . . . . 0.0 110.088 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.84 154.74 67.08 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.708 1.605 . . . . 0.0 109.247 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 121.64 15.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.14 -10.18 57.98 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -53.79 84.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.451 1.101 . . . . 0.0 113.751 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.1 -30.91 5.09 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.452 1.977 . . . . 0.0 111.77 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.49 80.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.022 0.911 . . . . 0.0 109.338 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.8 147.44 51.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -82.75 142.17 31.81 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -34.15 -44.69 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.422 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -46.02 91.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.421 1.01 . . . . 0.0 111.068 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -55.84 -56.34 21.76 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 122.128 0.966 . . . . 0.0 108.394 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.3 mt -48.6 -60.41 2.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.256 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 t -43.85 -56.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.692 1.197 . . . . 0.0 110.063 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.6 -40.74 84.12 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.206 -0.309 . . . . 0.0 111.246 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.69 -55.32 27.89 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -49.83 -47.09 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.138 1.375 . . . . 0.0 110.099 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -53.98 -51.2 64.66 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.714 0.688 . . . . 0.0 109.239 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.56 -49.72 75.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.0 mtp -49.11 -54.78 14.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.827 . . . . 0.0 109.525 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.79 -35.16 77.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.017 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.03 41.42 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.351 -0.843 . . . . 0.0 113.188 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.6 p -138.37 -3.75 1.71 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.475 1.51 . . . . 0.0 110.044 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.713 -1.613 . . . . 0.0 110.271 -174.648 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.98 -53.97 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.423 0.556 . . . . 0.0 109.871 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -66.46 -39.34 88.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.711 0.404 . . . . 0.0 111.36 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -76.87 -50.82 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -138.5 -14.42 1.27 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.19 -37.72 31.49 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.748 1.158 . . . . 0.0 111.786 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -69.02 150.54 47.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 122.359 -0.495 . . . . 0.0 110.303 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.32 114.57 7.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.468 1.107 . . . . 0.0 108.549 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.23 151.49 18.19 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.504 1.216 . . . . 0.0 111.408 -13.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.11 121.75 16.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.796 1.639 . . . . 0.0 109.883 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 m -54.03 -48.68 70.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.417 0.627 . . . . 0.0 110.273 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -41.17 -56.16 2.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.918 2.087 . . . . 0.0 112.373 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -45.54 -33.98 3.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.501 1.12 . . . . 0.0 113.038 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -98.16 -57.66 2.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.054 0.388 . . . . 0.0 110.322 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.08 -16.8 64.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.91 5.87 50.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.783 0.72 . . . . 0.0 109.974 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -128.71 -27.62 2.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.269 1.028 . . . . 0.0 112.232 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.42 27.07 62.17 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 140.05 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.96 29.22 5.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.091 0.956 . . . . 0.0 111.513 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.36 25.5 75.27 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.956 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.34 79.11 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.768 1.284 . . . . 0.0 108.977 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.83 110.36 1.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 N-CA-C 106.742 -2.061 . . . . 0.0 106.742 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -72.93 156.16 39.14 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.94 171.87 8.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.26 33.97 16.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.15 74.47 6.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.622 -170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -37.92 -50.94 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.359 3.373 . . . . 0.0 114.403 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.34 -43.23 15.81 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.194 1.397 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.05 -22.04 66.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.504 0.722 . . . . 0.0 111.95 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -109.37 -29.42 8.46 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.226 1.01 . . . . 0.0 112.584 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.36 -49.92 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.794 1.637 . . . . 0.0 113.11 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.66 -27.29 58.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.721 0.809 . . . . 0.0 113.166 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -79.32 155.41 76.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.492 0.717 . . . . 0.0 110.342 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.29 124.52 15.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.952 1.768 . . . . 0.0 110.284 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 p -66.16 -26.53 67.47 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.632 -0.668 . . . . 0.0 110.32 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -55.22 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.347 1.859 . . . . 0.0 112.395 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.1 t -47.85 -43.44 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.537 1.135 . . . . 0.0 109.689 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -52.7 -28.94 24.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.806 1.642 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.47 -48.63 6.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.388 1.075 . . . . 0.0 109.069 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -49.4 -41.56 39.86 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.603 0.361 . . . . 0.0 111.088 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.94 -35.29 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.566 -0.708 . . . . 0.0 111.019 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -64.25 -48.25 76.48 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.461 1.028 . . . . 0.0 108.466 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -53.64 -44.13 69.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -62.54 -49.35 75.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.575 0.35 . . . . 0.0 110.482 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.95 -46.74 89.51 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.267 -0.896 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 -33.33 74.96 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.664 0.786 . . . . 0.0 112.062 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.27 159.67 31.21 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.07 120.93 2.66 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.784 -0.833 . . . . 0.0 109.248 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.99 -119.97 20.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.51 -17.42 54.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.7 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -68.67 118.55 61.54 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 119.142 0.883 . . . . 0.0 109.424 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 158.69 53.38 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.266 1.978 . . . . 0.0 110.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.82 47.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -97.79 -11.55 23.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.215 1.006 . . . . 0.0 111.922 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -41.6 113.03 0.37 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.262 1.425 . . . . 0.0 112.153 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.43 -21.73 16.29 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.166 0.889 . . . . 0.0 113.089 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -85.17 -48.11 9.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.084 0.942 . . . . 0.0 109.179 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.57 141.14 48.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -83.9 140.8 31.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -29.83 -45.86 0.06 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 126.281 1.832 . . . . 0.0 111.46 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -60.16 -49.49 77.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.946 1.248 . . . . 0.0 111.526 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -53.71 -59.14 4.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.832 1.301 . . . . 0.0 108.995 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.3 mt -49.11 -58.72 4.48 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 126.098 1.759 . . . . 0.0 110.491 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -47.76 -56.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.526 1.13 . . . . 0.0 109.657 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -55.41 -39.05 69.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.079 0.552 . . . . 0.0 111.508 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.94 68.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.744 0.418 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.86 -46.64 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.692 1.197 . . . . 0.0 109.007 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.9 -53.83 43.47 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.91 -50.62 71.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.305 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 ttp -50.45 -59.82 3.63 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.3 mp -55.05 -37.86 67.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.811 -0.556 . . . . 0.0 111.431 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -62.79 -6.69 3.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.661 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.1 p -89.13 -15.25 34.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.57 1.532 . . . . 0.0 111.227 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.193 -1.384 . . . . 0.0 110.289 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.83 -57.95 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -57.42 -44.32 84.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.923 0.889 . . . . 0.0 112.195 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.6 mt -76.44 -49.68 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.199 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -136.63 -17.15 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.2 -33.73 39.3 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 119.965 1.257 . . . . 0.0 112.003 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -73.61 154.13 39.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.36 0.58 . . . . 0.0 110.98 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 110.37 5.86 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.66 1.184 . . . . 0.0 109.436 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.98 151.85 20.56 Favored 'Cis proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.1 1.071 . . . . 0.0 111.784 -11.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.74 123.1 19.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.153 1.381 . . . . 0.0 109.129 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.3 -47.66 75.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.849 0.356 . . . . 0.0 110.483 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 p -39.91 -56.26 1.84 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 126.432 1.893 . . . . 0.0 112.315 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -41.57 -36.32 0.9 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.31 1.444 . . . . 0.0 112.763 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.8 m -101.21 -57.01 2.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.51 0.324 . . . . 0.0 111.459 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -68.36 -33.33 74.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.57 -36.3 73.54 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -82.01 -27.3 33.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.234 1.013 . . . . 0.0 111.587 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.07 32.23 60.81 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.66 141.58 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.8 29.69 6.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.136 0.974 . . . . 0.0 111.424 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 24.54 77.0 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.876 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 134.55 79.56 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.745 1.273 . . . . 0.0 108.203 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.31 124.86 15.58 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.454 2.102 . . . . 0.0 108.75 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.56 172.68 8.34 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 160.3 23.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 35.7 51.67 0.71 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.891 1.676 . . . . 0.0 111.956 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.18 64.12 25.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.886 1.274 . . . . 0.0 110.143 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -39.85 -48.24 3.68 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.247 3.298 . . . . 0.0 114.63 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.08 -34.42 56.46 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.639 0.776 . . . . 0.0 112.213 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -66.96 -25.51 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.871 0.468 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -105.61 -29.61 10.02 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.451 1.1 . . . . 0.0 112.79 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.04 -50.17 0.89 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.687 1.595 . . . . 0.0 113.116 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.88 -19.74 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -80.54 157.32 72.58 Favored Pre-proline 0 CA--C 1.537 0.465 0 O-C-N 121.511 -0.743 . . . . 0.0 110.661 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.23 111.2 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.965 2.443 . . . . 0.0 111.436 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -60.89 -31.76 71.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.91 101.86 0.07 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.301 2.24 . . . . 0.0 111.421 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.62 -40.37 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.676 0.791 . . . . 0.0 110.038 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.11 -33.56 62.94 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.818 1.647 . . . . 0.0 112.029 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.04 -50.35 9.78 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.86 -44.03 39.39 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -57.22 -42.39 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 119.468 1.031 . . . . 0.0 110.449 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.69 -43.52 93.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -55.24 -40.8 71.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.2 0.455 . . . . 0.0 110.408 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -68.22 -55.46 12.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.321 0.649 . . . . 0.0 109.438 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 mt -54.9 -41.14 70.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.411 1.485 . . . . 0.0 111.816 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.69 -34.42 58.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.973 0.909 . . . . 0.0 111.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.58 162.99 35.28 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -167.04 130.04 1.79 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.04 -136.27 50.68 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.36 -25.91 68.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.427 -0.887 . . . . 0.0 111.73 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.2 ttp -64.56 117.42 37.66 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 119.265 0.939 . . . . 0.0 110.73 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.63 156.61 57.35 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.533 2.156 . . . . 0.0 109.538 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.79 114.58 3.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -72.4 -12.7 61.23 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.461 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -37.3 109.78 0.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.328 0.967 . . . . 0.0 112.859 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.77 -19.41 54.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.359 0.981 . . . . 0.0 114.533 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -78.63 -57.58 3.69 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.8 1.3 . . . . 0.0 111.321 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.47 141.28 49.3 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.56 1.144 . . . . 0.0 107.972 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.48 150.08 28.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -27.38 -52.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.807 2.043 . . . . 0.0 111.492 168.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.45 -48.26 80.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.698 0.681 . . . . 0.0 111.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -55.11 -57.15 12.91 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 122.138 0.97 . . . . 0.0 108.938 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.26 -58.83 4.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.722 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.86 -57.5 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 124.052 0.941 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -58.76 -40.91 85.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.118 0.417 . . . . 0.0 111.778 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.18 92.27 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.988 -0.445 . . . . 0.0 109.92 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.88 -46.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.765 0.826 . . . . 0.0 109.133 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -54.54 -48.95 71.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -57.02 -53.88 53.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.517 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 ptm -57.12 -49.71 75.06 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.922 0.783 . . . . 0.0 109.395 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.77 -36.13 73.91 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.07 -1.018 . . . . 0.0 111.399 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t -63.53 -5.65 4.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.121 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -92.2 -12.18 33.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.331 1.423 . . . . 0.0 110.701 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.64 -1.172 . . . . 0.0 110.99 -176.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.03 -60.33 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.269 1.428 . . . . 0.0 110.173 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -56.59 -47.09 80.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.559 0.743 . . . . 0.0 111.439 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.5 -47.01 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.451 0.7 . . . . 0.0 111.793 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -9.69 0.33 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 -28.69 52.06 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.707 1.139 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -76.34 154.49 34.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.445 0.623 . . . . 0.0 110.41 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.23 104.96 4.09 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 108.122 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.46 146.66 32.95 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.499 1.214 . . . . 0.0 111.897 -3.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.92 120.89 14.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.751 1.621 . . . . 0.0 109.56 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 m -54.23 -49.71 68.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.166 0.508 . . . . 0.0 110.116 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -41.0 -55.56 2.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.256 1.822 . . . . 0.0 112.676 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -46.21 -33.72 3.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.241 1.016 . . . . 0.0 113.002 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.4 m -97.3 -56.67 2.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 117.888 0.313 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.9 -45.07 94.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.096 0.862 . . . . 0.0 109.708 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -76.98 -36.23 56.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.29 0.636 . . . . 0.0 111.948 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.89 38.76 5.68 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.84 130.55 17.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.5 31.47 7.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.503 1.121 . . . . 0.0 111.576 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.89 26.38 74.07 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.556 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.69 134.37 71.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.402 1.101 . . . . 0.0 108.573 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -62.6 112.02 1.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.694 2.263 . . . . 0.0 108.85 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -82.64 179.77 7.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.369 1.068 . . . . 0.0 112.35 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.21 159.55 28.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.96 52.19 0.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.984 1.714 . . . . 0.0 112.045 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.67 56.62 15.86 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.942 1.297 . . . . 0.0 111.026 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -41.32 -45.9 5.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.817 3.011 . . . . 0.0 114.967 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.04 -41.11 33.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.687 0.795 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.25 -16.34 61.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 112.336 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.55 -26.19 11.5 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 112.52 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.46 -51.52 0.62 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.437 1.895 . . . . 0.0 113.67 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.87 -17.46 40.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -78.64 151.74 77.36 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 121.462 -0.774 . . . . 0.0 110.639 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 115.28 2.11 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.071 2.514 . . . . 0.0 111.56 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -63.19 -32.23 73.58 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.124 -0.985 . . . . 0.0 110.11 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 104.99 0.17 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.479 2.312 . . . . 0.0 111.753 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -50.06 -43.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.525 0.73 . . . . 0.0 109.638 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -53.64 -30.91 45.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 112.482 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.88 -51.93 6.77 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.0 mt -50.16 -40.1 45.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.812 0.845 . . . . 0.0 112.829 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.63 -39.34 69.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 119.216 0.916 . . . . 0.0 110.375 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -66.19 -46.31 77.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.226 0.921 . . . . 0.0 108.71 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 m -52.64 -45.74 66.8 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.079 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 m -67.84 -48.69 65.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.749 0.42 . . . . 0.0 110.761 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.79 -40.85 96.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.101 -0.999 . . . . 0.0 111.098 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 -32.43 60.78 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.0 111.357 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.81 167.58 37.77 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -160.52 112.54 1.96 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.09 -111.25 2.69 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -35.09 74.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.113 0.565 . . . . 0.0 111.066 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.01 118.3 47.78 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.063 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.16 156.43 55.49 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.551 2.167 . . . . 0.0 109.933 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 115.96 5.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.811 0.444 . . . . 0.0 109.833 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.98 -7.95 57.51 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -55.87 83.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.295 1.038 . . . . 0.0 112.644 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.16 -34.59 2.29 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.76 1.647 . . . . 0.0 111.043 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -84.11 -38.88 20.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.184 0.994 . . . . 0.0 110.984 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.6 129.47 20.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.33 151.62 25.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -29.96 -49.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.69 1.996 . . . . 0.0 112.648 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.55 -35.84 81.21 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.363 0.983 . . . . 0.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.79 -59.01 4.71 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.6 mt -46.33 -57.91 4.19 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.218 2.207 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -36.32 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.533 1.533 . . . . 0.0 110.299 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -60.16 -42.4 94.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.554 0.342 . . . . 0.0 111.606 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -48.49 69.17 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.764 0.426 . . . . 0.0 110.01 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 mt -56.72 -50.21 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.61 1.164 . . . . 0.0 109.203 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -55.83 -52.01 65.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -54.05 -56.26 19.64 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.572 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptm -60.94 -45.14 95.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.869 0.759 . . . . 0.0 109.629 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.04 -36.84 70.96 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.45 -0.781 . . . . 0.0 110.974 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -63.34 -6.52 4.8 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.7 p -90.34 -8.7 50.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.221 1.373 . . . . 0.0 111.047 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.47 -1.729 . . . . 0.0 110.832 -176.645 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -49.25 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.16 -48.51 78.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.903 0.481 . . . . 0.0 111.528 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.1 mt -73.47 -43.67 55.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.999 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.68 -8.24 0.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.75 -32.49 40.84 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.801 1.182 . . . . 0.0 111.321 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -73.47 155.45 39.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.449 0.624 . . . . 0.0 110.722 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.56 110.41 6.26 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.463 1.105 . . . . 0.0 108.966 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.93 153.28 16.95 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.323 1.151 . . . . 0.0 112.04 -11.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -70.24 114.35 8.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.625 1.57 . . . . 0.0 109.037 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.08 -48.4 22.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.662 0.785 . . . . 0.0 110.986 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -41.91 -50.57 4.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.608 1.963 . . . . 0.0 112.808 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -48.71 -32.47 8.48 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.316 0.647 . . . . 0.0 112.604 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.04 -54.99 2.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.903 0.481 . . . . 0.0 110.786 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.62 -32.79 71.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.04 -40.06 87.08 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.18 -28.58 42.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.573 0.749 . . . . 0.0 111.472 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.71 34.81 52.68 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.59 139.1 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.82 29.84 6.37 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.187 0.995 . . . . 0.0 111.593 -177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.62 24.25 76.5 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.764 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 135.31 82.99 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 118.554 1.177 . . . . 0.0 108.23 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.77 123.73 13.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.567 2.178 . . . . 0.0 110.006 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.65 179.03 5.76 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.774 0.797 . . . . 0.0 112.117 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.94 161.84 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.17 54.16 0.74 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.125 1.77 . . . . 0.0 111.662 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 65.03 17.52 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.194 0.998 . . . . 0.0 110.124 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.06 -52.93 2.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.195 3.263 . . . . 0.0 114.381 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -49.48 -35.61 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.7 1.2 . . . . 0.0 112.615 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -65.45 -28.12 69.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.342 0.519 . . . . 0.0 111.245 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -102.32 -36.61 8.4 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.652 1.181 . . . . 0.0 112.43 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.68 -52.02 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.093 1.757 . . . . 0.0 113.082 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.79 -24.92 56.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.55 150.94 79.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 121.525 -0.734 . . . . 0.0 110.202 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.23 87.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.883 2.389 . . . . 0.0 108.207 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -24.59 22.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.366 1.866 . . . . 0.0 113.252 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.33 110.33 0.32 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.358 1.463 . . . . 0.0 110.46 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -47.93 -46.2 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.611 0.764 . . . . 0.0 110.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.91 -29.17 55.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.74 1.216 . . . . 0.0 113.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.67 -51.5 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.1 mt -49.79 -42.46 46.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.234 0.614 . . . . 0.0 112.188 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.25 -33.68 54.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.119 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.34 -49.06 70.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.895 1.225 . . . . 0.0 108.577 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -51.23 -46.47 62.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.57 0.748 . . . . 0.0 110.225 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -63.92 -49.94 70.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.83 -42.56 99.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.852 -1.155 . . . . 0.0 111.157 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.71 -30.53 61.57 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.074 0.95 . . . . 0.0 111.865 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.62 157.11 30.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.08 115.51 3.85 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.131 -0.629 . . . . 0.0 109.506 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.67 -116.58 9.17 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -24.88 58.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.923 0.489 . . . . 0.0 111.472 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.29 119.63 66.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.589 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.66 157.63 51.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.447 2.098 . . . . 0.0 110.276 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.76 120.18 11.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.333 0.653 . . . . 0.0 110.064 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.05 -12.46 58.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -45.48 112.55 0.47 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.73 0.812 . . . . 0.0 111.146 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 -32.39 7.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.457 1.027 . . . . 0.0 112.599 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -88.51 -49.99 6.57 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.404 1.102 . . . . 0.0 110.733 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.83 121.81 34.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -80.49 152.72 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -26.65 -51.57 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.859 2.064 . . . . 0.0 111.564 168.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -63.01 -43.48 98.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.237 0.926 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.27 -56.67 17.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 122.339 1.066 . . . . 0.0 108.369 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.4 mt -47.8 -57.52 5.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -37.81 -55.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.537 1.535 . . . . 0.0 110.135 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.1 mttp -55.65 -42.75 75.48 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.331 0.394 . . . . 0.0 111.628 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.92 -48.5 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 122.729 0.411 . . . . 0.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -37.49 84.07 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.638 1.108 . . . . 0.0 109.11 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -60.43 -47.38 86.34 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.055 0.843 . . . . 0.0 110.147 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.0 mtt -49.54 -65.65 0.53 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.1 mp -49.78 -40.56 41.84 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.067 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -61.24 -8.47 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.2 p -92.92 -11.53 33.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.521 1.51 . . . . 0.0 111.357 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.679 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -57.86 -59.94 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.786 0.834 . . . . 0.0 109.683 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -54.18 -47.42 72.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 0.0 111.801 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.44 -47.55 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.421 0.688 . . . . 0.0 111.502 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -148.61 -15.51 0.32 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.05 3.48 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 120.099 1.318 . . . . 0.0 111.288 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -133.69 149.95 51.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.562 1.545 . . . . 0.0 107.627 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.26 6.08 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.421 1.088 . . . . 0.0 109.377 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.35 152.57 31.78 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.204 1.109 . . . . 0.0 111.808 -8.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.67 126.28 29.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.487 1.115 . . . . 0.0 109.888 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -59.52 -50.17 74.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -37.66 -61.04 0.65 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.024 2.13 . . . . 0.0 113.101 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -38.63 3.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.666 1.187 . . . . 0.0 112.3 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.6 m -91.11 -58.34 2.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 117.665 0.211 . . . . 0.0 110.985 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -67.54 -41.96 83.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.24 -34.6 78.02 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.654 -0.654 . . . . 0.0 110.607 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.15 -24.71 18.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.787 0.835 . . . . 0.0 112.678 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.77 35.12 13.8 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.101 0.858 . . . . 0.0 111.472 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -56.75 131.63 20.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.65 31.24 7.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 111.451 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.48 26.06 74.72 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.632 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.5 134.08 77.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.418 1.109 . . . . 0.0 108.568 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.84 120.29 8.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.479 2.119 . . . . 0.0 109.493 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -88.0 174.14 8.47 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.466 0.65 . . . . 0.0 111.923 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.94 165.56 24.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 45.82 41.23 7.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.549 1.14 . . . . 0.0 111.655 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.1 59.44 10.7 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -47.43 -34.41 19.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.421 3.414 . . . . 0.0 113.713 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -51.67 -38.87 56.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 110.7 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 15.7 4.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.453 0.701 . . . . 0.0 112.113 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -134.66 -40.28 0.79 Allowed 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.011 0.823 . . . . 0.0 111.485 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -40.41 -46.71 2.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.998 1.319 . . . . 0.0 112.505 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.58 -26.41 50.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 113.195 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -75.28 159.33 82.5 Favored Pre-proline 0 CA--C 1.534 0.347 0 O-C-N 121.576 -0.703 . . . . 0.0 109.976 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.07 121.43 10.05 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.839 1.693 . . . . 0.0 109.677 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -64.56 -39.16 93.24 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 109.634 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 m -50.72 102.51 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.142 1.777 . . . . 0.0 112.036 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.7 -40.19 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.302 1.041 . . . . 0.0 109.964 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.73 -35.29 65.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.798 0.839 . . . . 0.0 112.253 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -77.74 -48.2 17.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.01 -43.6 70.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 122.879 0.472 . . . . 0.0 111.612 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.41 -44.29 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.911 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.15 -46.22 79.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.746 1.157 . . . . 0.0 109.652 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -54.23 -37.77 64.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.042 0.383 . . . . 0.0 111.392 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -68.0 -50.39 55.87 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.614 0.766 . . . . 0.0 109.357 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -42.42 94.34 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 120.158 1.345 . . . . 0.0 111.472 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.11 -38.49 78.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.044 0.538 . . . . 0.0 111.981 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.98 155.32 29.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -155.48 135.17 12.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.66 -118.44 13.83 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.59 -3.32 46.59 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.694 0.798 . . . . 0.0 112.242 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.0 ttp -68.1 122.02 82.36 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 119.259 0.936 . . . . 0.0 110.595 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.29 153.12 55.49 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.034 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 112.62 6.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -71.32 -3.07 18.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.26 110.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 0.0 111.072 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.82 -11.27 62.54 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.345 0.974 . . . . 0.0 114.596 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -76.1 -47.94 22.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.044 1.422 . . . . 0.0 109.906 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.64 156.23 46.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.56 140.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -32.83 -44.21 0.1 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.577 1.951 . . . . 0.0 112.436 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.78 -47.8 83.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.811 1.187 . . . . 0.0 111.197 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.4 -56.77 16.96 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 122.902 1.334 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -48.08 -57.27 6.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.857 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.19 -53.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.892 1.277 . . . . 0.0 109.919 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -57.87 -38.91 76.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.498 0.319 . . . . 0.0 111.258 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.13 81.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.915 -0.49 . . . . 0.0 109.896 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.4 mt -66.7 -52.61 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.613 0.765 . . . . 0.0 109.991 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.29 -39.7 76.27 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.234 0.924 . . . . 0.0 109.086 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.14 -52.73 64.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.128 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 ptm -54.44 -43.35 71.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.611 0.641 . . . . 0.0 109.346 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.6 mt -65.15 -35.18 80.28 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.476 -0.765 . . . . 0.0 110.763 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 m -74.83 37.93 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.009 -1.057 . . . . 0.0 112.634 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -148.59 24.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.582 1.153 . . . . 0.0 109.918 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.252 1.232 0 CA-C-O 116.148 -1.882 . . . . 0.0 107.132 -177.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.23 -57.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.842 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -57.64 -52.15 66.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.888 0.475 . . . . 0.0 111.623 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.57 -46.34 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.557 -173.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.57 38.81 0.33 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.298 0.954 . . . . 0.0 113.04 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.75 40.33 1.09 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -137.25 156.94 47.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.436 1.895 . . . . 0.0 107.841 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 106.64 5.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.861 0.864 . . . . 0.0 108.904 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.83 152.85 24.35 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 120.378 1.171 . . . . 0.0 112.142 -7.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.38 123.79 19.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -51.0 62.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.912 0.885 . . . . 0.0 111.439 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 p -40.88 -54.41 2.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.447 1.899 . . . . 0.0 111.872 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.91 -38.74 1.64 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.61 1.164 . . . . 0.0 113.094 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -98.43 -57.15 2.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.964 0.347 . . . . 0.0 111.49 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -73.71 -19.47 60.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -172.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.37 -53.57 18.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.535 1.061 . . . . 0.0 108.989 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -79.98 -31.13 39.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.467 0.307 . . . . 0.0 111.052 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.5 42.85 5.69 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.26 142.81 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.37 28.62 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.066 0.947 . . . . 0.0 111.502 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.95 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.715 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 134.14 87.54 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.738 1.269 . . . . 0.0 108.377 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.78 115.76 3.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.701 2.267 . . . . 0.0 108.258 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -86.16 179.08 7.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.901 0.857 . . . . 0.0 113.215 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.23 159.94 22.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 34.61 52.38 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.545 1.538 . . . . 0.0 112.565 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.9 61.96 31.28 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.317 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.73 -46.76 6.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.045 3.163 . . . . 0.0 114.683 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -49.88 -39.99 41.37 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.822 1.249 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.67 -15.45 61.7 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.873 0.869 . . . . 0.0 112.463 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -110.94 -25.57 9.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.508 1.123 . . . . 0.0 112.294 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.05 -46.26 0.48 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.921 2.088 . . . . 0.0 114.433 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.39 -5.57 32.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -81.48 154.96 71.63 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 121.483 -0.761 . . . . 0.0 110.211 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.52 115.6 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.072 2.515 . . . . 0.0 111.462 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -60.72 -34.03 73.77 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.26 99.96 0.07 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.754 2.022 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.2 t -53.33 -38.44 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.616 -0.677 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.29 -26.2 51.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 112.415 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.13 -50.81 5.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -49.02 -41.01 33.23 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.694 0.798 . . . . 0.0 112.117 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.85 -30.4 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.533 -0.729 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.29 -49.62 68.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -50.99 -46.29 61.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.619 0.767 . . . . 0.0 109.796 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 m -60.68 -51.9 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.05 -45.46 93.46 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.245 -0.909 . . . . 0.0 111.456 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 -32.37 63.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.833 0.853 . . . . 0.0 112.369 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 161.01 27.8 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.45 115.1 2.49 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.962 -0.728 . . . . 0.0 109.163 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.62 -116.95 9.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.25 -24.58 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.371 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.38 121.18 75.57 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.946 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 165.26 29.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.711 2.274 . . . . 0.0 109.781 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.78 134.03 48.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.79 -14.77 20.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.125 0.97 . . . . 0.0 112.326 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.77 101.02 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.269 1.028 . . . . 0.0 112.539 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.48 -37.28 3.77 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.009 1.29 . . . . 0.0 111.481 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -77.02 -36.45 56.25 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-N 117.756 0.778 . . . . 0.0 109.913 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.8 149.11 50.87 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.29 130.45 37.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -31.69 -44.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.029 2.132 . . . . 0.0 112.818 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.46 -48.95 75.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.684 1.129 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.76 -47.93 81.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.012 0.925 . . . . 0.0 108.797 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -51.86 -55.91 17.2 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.037 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -45.2 -57.81 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.211 1.004 . . . . 0.0 109.271 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -56.36 -39.8 73.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 118.483 0.583 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.97 95.01 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.722 -0.611 . . . . 0.0 110.073 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.73 -47.76 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -53.47 -52.46 59.44 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -54.56 -52.15 63.01 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.56 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.19 -50.57 64.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.13 -30.12 71.2 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.945 -0.472 . . . . 0.0 110.997 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.1 m -74.25 40.59 0.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.073 -1.017 . . . . 0.0 112.782 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.5 p -135.43 -10.92 2.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 109.827 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.7 -1.619 . . . . 0.0 110.25 -177.839 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.29 -50.51 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.408 1.083 . . . . 0.0 110.483 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -68.29 -46.39 70.46 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.694 0.397 . . . . 0.0 110.398 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.85 -42.11 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.958 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 32.47 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.24 14.85 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.096 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -97.89 168.8 10.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.644 0.778 . . . . 0.0 111.497 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.5 115.53 25.18 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.0 1.32 . . . . 0.0 107.822 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.51 169.66 35.43 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.609 1.253 . . . . 0.0 110.057 -10.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -78.25 149.68 33.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 m -61.87 -44.54 96.6 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -50.56 -47.41 57.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.086 1.355 . . . . 0.0 111.651 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -42.64 -40.35 2.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.782 0.719 . . . . 0.0 112.167 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.8 m -98.29 -57.93 2.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.468 0.175 . . . . 0.0 111.188 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -62.2 -40.38 95.89 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.47 -29.77 64.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.138 0.426 . . . . 0.0 111.107 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -115.61 17.73 16.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.708 0.803 . . . . 0.0 111.681 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 48.09 40.23 20.55 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 123.899 0.761 . . . . 0.0 113.8 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.94 135.49 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.082 -0.658 . . . . 0.0 109.381 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 31.31 7.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.756 1.223 . . . . 0.0 111.806 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.55 23.38 77.09 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.667 -0.518 . . . . 0.0 112.628 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.73 140.77 75.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.222 1.011 . . . . 0.0 108.791 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -58.27 119.44 6.69 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.489 2.126 . . . . 0.0 107.81 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.52 167.58 19.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.832 1.301 . . . . 0.0 111.26 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mp -77.01 162.26 27.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.873 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.23 53.56 1.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.939 1.296 . . . . 0.0 110.601 -176.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.92 64.93 11.75 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.006 1.723 . . . . 0.0 109.427 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -39.12 -55.46 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.588 3.525 . . . . 0.0 114.358 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -44.71 -45.44 9.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.01 1.324 . . . . 0.0 112.281 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -53.76 -39.16 65.12 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.463 0.705 . . . . 0.0 110.762 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -92.88 -29.9 15.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.846 0.859 . . . . 0.0 111.169 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.19 98.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 109.617 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.99 -41.75 97.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 110.326 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -76.36 164.15 61.69 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.683 1.193 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.0 88.66 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 107.539 -1.754 . . . . 0.0 107.539 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -51.98 -22.2 3.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.293 1.437 . . . . 0.0 112.463 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -56.77 108.3 0.48 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.287 1.035 . . . . 0.0 110.453 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.53 -46.33 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.736 1.214 . . . . 0.0 110.047 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.89 -36.83 3.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.201 2.2 . . . . 0.0 112.335 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.21 -52.74 4.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.298 1.039 . . . . 0.0 109.182 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -44.72 -45.93 10.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.773 0.829 . . . . 0.0 112.634 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.35 -34.31 60.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 O-C-N 121.348 -0.845 . . . . 0.0 111.585 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.2 -47.18 71.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 m -53.5 -46.26 69.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.06 0.544 . . . . 0.0 110.051 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -62.17 -52.02 65.48 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.982 0.513 . . . . 0.0 111.345 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -40.48 84.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.56 -0.713 . . . . 0.0 109.698 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.43 76.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.145 0.578 . . . . 0.0 111.617 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.52 154.99 24.26 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -158.38 125.64 4.98 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.45 -137.67 49.15 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.06 -16.88 64.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.624 -0.788 . . . . 0.0 111.997 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.42 117.28 51.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.652 1.115 . . . . 0.0 109.801 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.32 155.06 64.91 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.441 2.094 . . . . 0.0 109.951 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.11 133.58 55.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.65 6.58 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.951 0.9 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -40.69 108.84 0.1 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.243 1.817 . . . . 0.0 112.688 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.28 -20.27 5.02 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.529 0.585 . . . . 0.0 113.021 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -76.37 -44.3 36.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.72 25.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.73 152.61 33.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -23.16 -52.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.219 2.208 . . . . 0.0 111.692 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -60.54 -56.68 18.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.351 0.523 . . . . 0.0 111.811 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.67 -49.89 69.53 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.411 1.084 . . . . 0.0 109.687 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.0 mt -52.13 -58.6 6.09 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.291 1.436 . . . . 0.0 110.057 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.16 -58.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.753 0.821 . . . . 0.0 109.509 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.08 -26.1 62.12 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.17 1.388 . . . . 0.0 113.068 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 -59.39 2.72 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 mt -51.17 -44.53 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.643 1.177 . . . . 0.0 111.459 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -53.86 -37.85 64.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.865 0.757 . . . . 0.0 110.708 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.95 -44.21 90.16 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.996 0.816 . . . . 0.0 109.664 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.7 mtp -53.55 -58.39 7.34 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.3 -36.79 66.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.688 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -62.49 -10.36 11.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.388 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -89.01 -9.02 52.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.462 1.483 . . . . 0.0 111.158 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 116.554 -1.689 . . . . 0.0 111.033 -176.288 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -50.65 -60.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.51 -52.56 63.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.241 1.416 . . . . 0.0 112.027 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.1 mt -67.84 -47.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.015 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.04 11.94 0.3 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.49 34.55 5.52 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.629 1.104 . . . . 0.0 111.591 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.21 157.64 45.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.486 1.514 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.58 107.75 9.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.207 1.003 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.16 159.17 68.99 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.172 1.097 . . . . 0.0 110.053 -8.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -68.13 118.55 11.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.06 1.344 . . . . 0.0 110.429 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 m -46.49 -48.56 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.981 0.913 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -45.46 -44.73 12.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.979 1.712 . . . . 0.0 112.547 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -53.2 -26.16 16.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.016 0.526 . . . . 0.0 112.255 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -104.02 -58.26 1.91 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.097 0.408 . . . . 0.0 109.941 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -66.89 -35.52 80.2 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.67 -41.67 75.18 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.102 0.865 . . . . 0.0 109.834 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -80.57 -28.7 37.11 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.097 0.559 . . . . 0.0 111.513 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.27 38.71 7.64 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.04 125.53 11.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.51 32.77 9.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.031 0.932 . . . . 0.0 111.128 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.41 76.95 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.941 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.45 113.33 5.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.57 1.185 . . . . 0.0 108.591 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -36.32 116.79 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 125.014 3.809 . . . . 0.0 114.493 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.39 173.69 10.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 111.701 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.58 159.52 32.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 49.43 29.71 2.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.848 0.859 . . . . 0.0 112.119 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.07 61.53 33.43 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.989 0.916 . . . . 0.0 110.954 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -45.35 -42.35 17.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.72 2.947 . . . . 0.0 112.799 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.36 -39.67 32.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 112.198 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -67.97 -25.07 65.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.125 0.57 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -105.52 -23.37 12.81 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.453 1.101 . . . . 0.0 112.893 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -51.25 0.72 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.548 1.939 . . . . 0.0 113.582 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.71 -22.08 43.79 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -77.14 151.69 81.61 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.875 0.87 . . . . 0.0 110.206 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.3 125.28 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.675 1.583 . . . . 0.0 108.768 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -62.58 -29.63 70.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.797 -0.565 . . . . 0.0 110.35 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -56.01 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.986 1.714 . . . . 0.0 111.945 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.09 -42.39 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.304 1.441 . . . . 0.0 109.411 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.41 -37.43 11.42 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.386 2.274 . . . . 0.0 112.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.42 -50.86 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.1 mt -47.71 -42.16 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.88 0.872 . . . . 0.0 112.401 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.94 -32.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.16 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.58 -50.03 68.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -51.26 -47.33 62.49 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.599 0.76 . . . . 0.0 109.908 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.1 m -61.73 -49.54 75.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.74 -45.52 93.59 Favored 'General case' 0 N--CA 1.458 -0.063 0 O-C-N 121.132 -0.98 . . . . 0.0 111.143 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.51 -31.16 65.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.944 0.897 . . . . 0.0 112.289 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.01 160.71 29.53 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -155.51 108.86 2.77 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.964 -0.727 . . . . 0.0 109.327 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.01 -113.95 5.88 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.69 -30.19 64.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.688 0.395 . . . . 0.0 111.0 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.1 ttp -63.62 120.35 62.12 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.913 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.57 156.66 44.94 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.843 2.362 . . . . 0.0 110.01 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.71 135.1 56.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -100.46 -13.89 18.51 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 113.329 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.97 102.79 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 112.148 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.38 -38.97 3.03 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.126 1.346 . . . . 0.0 111.537 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -76.79 -39.74 50.47 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 117.68 0.74 . . . . 0.0 110.112 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.43 130.54 30.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -79.72 146.72 32.23 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -27.93 -53.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.377 170.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -41.94 96.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.134 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.49 -59.58 5.17 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -46.07 -58.66 3.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.495 1.518 . . . . 0.0 111.004 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -39.34 -51.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.812 2.045 . . . . 0.0 111.149 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -58.06 -45.57 86.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.703 0.801 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -47.69 78.15 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.407 -0.808 . . . . 0.0 109.826 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.9 mt -56.98 -52.16 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.876 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.41 -39.98 92.72 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.984 -1.072 . . . . 0.0 109.28 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -57.08 -49.5 75.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.418 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.5 mtt -48.13 -63.62 1.02 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.17 0.986 . . . . 0.0 108.649 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mp -49.83 -41.55 45.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.669 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -62.17 -10.94 11.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 p -90.1 -13.38 35.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.195 1.362 . . . . 0.0 111.207 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.6 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.566 -174.826 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.14 -57.07 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.795 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -56.18 -50.46 71.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.307 1.043 . . . . 0.0 111.651 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.72 -46.9 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.859 -174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.11 36.38 0.29 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 33.17 2.28 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.845 0.748 . . . . 0.0 111.252 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 155.68 48.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.687 1.995 . . . . 0.0 107.189 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.01 108.23 18.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -62.52 166.07 37.45 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.216 1.113 . . . . 0.0 109.341 -11.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -67.54 136.09 53.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 m -49.7 -43.48 47.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 0.687 . . . . 0.0 109.426 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.8 p -47.21 -41.44 18.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.066 1.347 . . . . 0.0 112.561 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.1 m -46.2 -39.16 9.31 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.3 0.64 . . . . 0.0 111.316 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -102.96 -52.33 3.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -72.0 -27.5 62.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.39 -47.08 62.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -68.17 -41.87 80.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.203 1.001 . . . . 0.0 110.367 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 34.81 13.08 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.57 145.55 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.68 32.24 6.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.22 1.008 . . . . 0.0 111.576 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.58 24.43 73.9 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.34 126.62 75.01 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.818 1.309 . . . . 0.0 108.038 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.85 116.51 3.4 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.628 2.219 . . . . 0.0 108.294 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -74.68 -149.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.516 1.127 . . . . 0.0 111.433 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.63 145.78 51.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.496 1.518 . . . . 0.0 107.474 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' OXT' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 49.14 48.13 21.23 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -168.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.42 51.78 1.41 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.341 2.257 . . . . 0.0 111.499 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -47.89 -34.97 23.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.336 3.358 . . . . 0.0 113.807 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -50.33 -40.13 48.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.917 1.287 . . . . 0.0 110.966 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.22 -5.67 52.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -107.96 -44.99 4.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.58 46.03 26.05 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.913 0.863 . . . . 0.0 110.236 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.86 53.11 2.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 0.0 112.216 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -57.04 157.29 11.55 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.33 101.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.73 2.286 . . . . 0.0 111.073 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -59.05 -23.69 62.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.457 1.103 . . . . 0.0 111.989 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -55.07 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.71 1.604 . . . . 0.0 110.721 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -43.59 -41.47 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.279 1.431 . . . . 0.0 109.709 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -42.5 -38.02 1.81 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.345 2.258 . . . . 0.0 112.609 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.13 -50.53 5.79 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.636 0.774 . . . . 0.0 110.17 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -51.09 -40.48 58.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.426 0.69 . . . . 0.0 111.844 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.02 -34.41 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.695 -0.628 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.09 -44.04 81.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.7 m -54.46 -44.99 73.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -67.01 -45.09 78.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.027 0.531 . . . . 0.0 110.889 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 O-C-N 121.259 -0.9 . . . . 0.0 110.68 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.39 51.79 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.416 1.086 . . . . 0.0 112.697 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 161.47 30.57 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -161.57 117.79 2.13 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.083 -0.657 . . . . 0.0 109.319 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.41 -118.06 13.51 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.34 -25.34 51.0 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.209 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.5 ttp -62.22 118.68 42.21 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.178 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.46 160.52 46.58 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.509 2.139 . . . . 0.0 110.065 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.8 116.73 8.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -82.49 -7.46 59.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.676 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -55.9 88.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.931 0.892 . . . . 0.0 112.091 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 -41.9 1.44 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 110.572 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -75.55 -35.27 60.72 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.393 0.677 . . . . 0.0 110.384 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.72 130.72 20.54 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.57 149.66 32.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -32.04 -47.49 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.124 1.77 . . . . 0.0 111.494 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.68 -49.16 77.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.838 0.745 . . . . 0.0 111.66 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.43 -56.34 22.38 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 122.556 1.169 . . . . 0.0 108.791 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -48.68 -60.71 2.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.085 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -43.29 -51.72 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.887 1.675 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -59.21 -33.87 71.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.395 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.14 13.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.781 0.719 . . . . 0.0 109.39 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.4 mt -54.76 -45.77 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.121 0.968 . . . . 0.0 111.279 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.66 -41.39 90.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.036 1.289 . . . . 0.0 110.599 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.63 -54.14 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 ttm -45.75 -55.06 6.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.121 1.368 . . . . 0.0 109.782 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.85 -26.62 58.86 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.239 0.615 . . . . 0.0 112.535 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -79.83 10.49 4.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.83 0.741 . . . . 0.0 112.372 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -177.05 54.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' CD1' ' C ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.73 -55.46 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.24 -48.44 78.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.167 0.987 . . . . 0.0 111.872 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.24 -51.73 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.538 -175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.85 8.69 0.37 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -173.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.39 4.42 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 119.795 1.18 . . . . 0.0 111.253 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -137.82 156.18 48.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.793 1.637 . . . . 0.0 108.155 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.0 110.79 10.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.761 0.825 . . . . 0.0 110.596 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.09 160.77 15.66 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 CA-C-N 119.915 1.005 . . . . 0.0 111.851 -15.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -70.34 114.9 8.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.355 1.062 . . . . 0.0 108.982 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -44.54 -48.27 10.23 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.19 0.996 . . . . 0.0 111.324 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -43.76 -47.93 8.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.374 1.87 . . . . 0.0 112.184 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -49.46 -34.6 17.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 m -96.7 -58.03 2.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.63 0.252 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -67.4 -36.36 81.14 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.26 -41.37 85.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -30.13 56.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.667 0.787 . . . . 0.0 110.572 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.47 40.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.4 136.95 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.02 28.21 5.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.119 0.968 . . . . 0.0 111.471 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 24.76 76.67 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.955 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.76 132.96 47.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.903 1.351 . . . . 0.0 108.422 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -49.48 104.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.958 3.106 . . . . 0.0 110.917 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -75.24 176.23 7.57 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.514 1.149 . . . . 0.0 109.666 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.4 142.43 27.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.14 33.11 12.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.348 0.659 . . . . 0.0 109.461 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.66 55.87 17.72 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.641 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -37.09 -46.57 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.486 3.457 . . . . 0.0 114.242 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -41.47 -45.36 3.17 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.046 1.338 . . . . 0.0 112.738 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -76.84 -25.05 52.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.679 0.672 . . . . 0.0 112.261 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -91.08 -23.49 20.3 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.411 0.684 . . . . 0.0 111.429 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -47.39 0.53 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.32 2.248 . . . . 0.0 114.355 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -91.33 -14.37 30.87 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.428 0.691 . . . . 0.0 112.852 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -78.59 147.58 71.72 Favored Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 123.839 0.856 . . . . 0.0 109.731 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.15 110.3 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.844 1.696 . . . . 0.0 108.573 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.34 -27.47 47.4 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.135 0.574 . . . . 0.0 112.007 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 109.24 0.36 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.844 1.658 . . . . 0.0 111.482 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.3 t -51.95 -42.07 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.86 -20.96 40.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -93.64 -53.85 3.88 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.8 mt -47.65 -41.72 22.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.62 0.768 . . . . 0.0 112.163 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.71 -37.1 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 121.688 -0.632 . . . . 0.0 110.41 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.7 -48.26 75.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -52.3 -46.04 65.78 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.811 0.845 . . . . 0.0 110.4 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -67.82 -40.97 83.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.058 0.543 . . . . 0.0 111.216 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.09 -56.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.37 61.72 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.567 1.147 . . . . 0.0 112.354 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.75 152.76 25.24 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -151.76 142.75 23.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -90.37 0.08 OUTLIER Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.98 16.0 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.365 1.466 . . . . 0.0 112.058 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.0 mtm -67.89 134.78 92.02 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 119.29 0.95 . . . . 0.0 110.847 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.42 78.42 3.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.99 2.46 . . . . 0.0 108.784 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -10.08 106.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 128.315 2.646 . . . . 0.0 112.403 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -76.21 -6.65 52.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -47.29 114.83 0.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.557 0.743 . . . . 0.0 111.272 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.12 -26.95 21.45 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.206 0.908 . . . . 0.0 112.717 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -90.28 -52.44 4.93 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.514 1.157 . . . . 0.0 110.349 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.57 133.79 54.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.06 147.42 31.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -32.23 -45.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.38 1.872 . . . . 0.0 111.546 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.0 -47.18 84.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.211 0.914 . . . . 0.0 111.667 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.94 -58.65 7.23 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 122.577 1.179 . . . . 0.0 108.738 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.8 mt -47.14 -57.37 5.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.406 1.882 . . . . 0.0 110.078 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -46.24 -57.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 124.844 1.257 . . . . 0.0 109.713 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.78 -43.65 81.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.802 0.274 . . . . 0.0 111.441 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.25 72.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.6 mt -57.75 -47.33 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.251 1.42 . . . . 0.0 109.463 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.26 -51.69 65.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -55.95 -50.8 69.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.361 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 79.0 mtp -51.84 -53.46 40.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.291 0.636 . . . . 0.0 109.987 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.78 -37.44 73.71 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.577 0.751 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.3 m -72.67 41.18 0.09 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.3 p -135.64 -16.35 1.78 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.36 1.864 . . . . 0.0 110.014 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.033 -178.126 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 119.969 -0.062 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.33 -59.59 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.296 1.438 . . . . 0.0 109.197 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.32 -51.42 70.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 111.349 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 mm -65.73 -46.02 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.816 0.446 . . . . 0.0 111.065 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.13 44.03 0.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.97 36.67 1.21 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.44 157.27 46.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.732 2.013 . . . . 0.0 107.47 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.92 113.49 6.41 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.802 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.73 152.5 19.71 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 CA-C-N 120.321 1.15 . . . . 0.0 111.065 -13.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.31 125.17 24.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.609 1.164 . . . . 0.0 109.775 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -54.74 -51.05 66.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -39.54 -61.06 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.509 1.923 . . . . 0.0 112.214 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.0 m -41.51 -39.62 1.6 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.441 1.497 . . . . 0.0 113.387 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.46 -56.82 2.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.045 0.45 . . . . 0.0 110.923 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -60.67 -41.18 94.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -48.31 -40.93 26.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.668 0.787 . . . . 0.0 112.109 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -116.43 26.08 10.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.991 0.516 . . . . 0.0 111.863 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.21 43.08 18.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.566 0.603 . . . . 0.0 113.54 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.25 136.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.69 30.36 8.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.549 1.14 . . . . 0.0 111.676 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.0 23.49 74.45 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.6 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.01 142.91 84.88 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 118.459 1.129 . . . . 0.0 109.323 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -59.78 121.53 9.98 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 106.848 -2.02 . . . . 0.0 106.848 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.47 176.76 7.23 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.671 1.7 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.5 tp -97.46 140.46 31.87 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.518 -2.128 . . . . 0.0 107.525 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 64.59 35.98 8.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.353 0.661 . . . . 0.0 109.459 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.62 71.26 81.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.467 1.107 . . . . 0.0 111.233 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -41.0 -57.99 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 124.344 3.363 . . . . 0.0 114.456 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -43.53 -47.92 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.154 1.381 . . . . 0.0 112.164 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.26 -39.56 63.96 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 110.972 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -91.03 -29.89 17.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.318 0.647 . . . . 0.0 111.073 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.0 97.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.359 0.663 . . . . 0.0 109.396 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.56 -41.86 96.05 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -77.29 164.68 57.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.586 1.154 . . . . 0.0 111.085 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -67.82 89.8 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 N-CA-C 107.632 -1.719 . . . . 0.0 107.632 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -21.96 7.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.702 1.201 . . . . 0.0 112.322 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.94 109.5 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.434 1.893 . . . . 0.0 110.932 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.13 -44.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.251 1.02 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.41 -29.09 61.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.009 1.724 . . . . 0.0 112.606 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.81 -55.35 3.89 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 mt -45.61 -44.36 13.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.833 1.253 . . . . 0.0 112.994 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.89 -37.33 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 O-C-N 121.722 -0.611 . . . . 0.0 110.607 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -65.58 -47.24 76.44 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.192 0.905 . . . . 0.0 108.905 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -53.04 -46.6 68.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.386 0.674 . . . . 0.0 110.259 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -64.13 -46.45 84.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.002 0.521 . . . . 0.0 110.356 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -57.06 -54.41 47.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.791 -0.568 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.48 64.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.22 1.008 . . . . 0.0 112.988 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.61 160.27 33.12 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -157.68 126.36 5.65 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.861 -0.787 . . . . 0.0 109.05 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.0 -120.68 22.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.92 -14.44 54.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.746 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.2 ttp -71.69 118.23 64.67 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 119.166 0.894 . . . . 0.0 108.716 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.23 160.56 48.56 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.389 2.059 . . . . 0.0 110.611 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.2 133.14 53.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -101.65 -11.55 19.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.615 0.766 . . . . 0.0 111.363 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -46.37 117.53 1.62 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.364 1.065 . . . . 0.0 111.558 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.52 -25.0 11.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.267 0.937 . . . . 0.0 112.34 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -86.35 -47.38 9.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.86 0.83 . . . . 0.0 108.865 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.08 142.24 41.82 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -80.36 131.03 35.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -28.35 -49.88 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.205 2.202 . . . . 0.0 112.659 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -61.28 -49.04 78.66 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.82 -0.55 . . . . 0.0 111.225 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.35 86.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 123.93 0.892 . . . . 0.0 109.141 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.9 mt -51.63 -58.99 4.79 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.64 -54.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.158 1.383 . . . . 0.0 110.484 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -56.72 -45.55 81.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.139 0.427 . . . . 0.0 111.333 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.34 98.43 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.798 -0.564 . . . . 0.0 110.179 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.2 -55.85 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 109.268 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -59.26 -38.86 81.12 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.643 1.11 . . . . 0.0 109.773 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.53 -49.81 76.34 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttp -53.52 -54.27 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.7 mt -56.36 -38.97 72.13 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.619 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -61.42 -6.5 2.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.882 1.219 . . . . 0.0 113.951 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.0 p -86.75 -5.28 59.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.725 1.148 . . . . 0.0 110.684 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.224 -1.37 . . . . 0.0 110.688 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.39 -55.95 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 109.6 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -56.66 -50.48 71.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.914 0.886 . . . . 0.0 111.607 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.46 -45.29 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.131 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.91 36.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -173.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.04 33.0 2.22 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.98 157.45 46.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.271 2.228 . . . . 0.0 106.408 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.49 113.19 6.62 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.755 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -50.08 153.73 7.78 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 120.522 1.222 . . . . 0.0 110.752 -15.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.2 p -67.01 144.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -56.25 -38.89 71.75 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.076 0.853 . . . . 0.0 108.906 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -56.28 -23.27 35.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 112.8 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.0 m -57.48 -28.32 63.3 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.488 1.04 . . . . 0.0 110.628 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.2 m -122.54 -52.31 1.93 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -70.09 -20.35 63.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.21 -52.12 65.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.818 0.735 . . . . 0.0 109.869 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -91.47 -22.95 20.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 111.339 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 42.15 8.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.35 146.6 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.51 30.17 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.081 0.952 . . . . 0.0 111.417 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.4 79.96 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.027 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.95 135.61 90.31 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.873 1.336 . . . . 0.0 108.272 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -60.31 128.83 27.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.459 2.106 . . . . 0.0 109.915 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -89.02 171.44 9.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.264 1.031 . . . . 0.0 112.937 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.48 156.42 36.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.891 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 52.32 36.56 20.03 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.889 0.876 . . . . 0.0 111.265 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.37 65.52 68.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.842 -175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -39.74 -47.03 3.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 124.324 3.349 . . . . 0.0 114.428 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -51.11 -39.59 56.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.865 1.266 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.49 -21.88 66.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.426 0.69 . . . . 0.0 111.733 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -108.58 -30.73 8.09 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.4 1.08 . . . . 0.0 112.903 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.49 -50.79 1.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.728 1.611 . . . . 0.0 113.048 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 -24.51 50.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.92 143.85 67.14 Favored Pre-proline 0 CA--C 1.535 0.381 0 O-C-N 121.529 -0.732 . . . . 0.0 110.276 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.79 96.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.675 2.25 . . . . 0.0 108.895 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -55.78 -26.88 48.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.815 1.246 . . . . 0.0 112.943 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 m -50.0 104.28 0.07 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.827 1.651 . . . . 0.0 111.48 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.14 -44.07 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.167 1.387 . . . . 0.0 111.54 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.18 -31.86 67.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.183 0.593 . . . . 0.0 112.045 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -81.63 -48.01 12.28 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.67 -41.3 61.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 m -59.94 -34.18 55.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.87 -48.48 81.6 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.531 1.514 . . . . 0.0 109.057 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.69 -42.21 67.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.795 0.838 . . . . 0.0 111.205 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -70.39 -44.57 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.384 0.673 . . . . 0.0 110.334 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -64.18 -50.66 67.25 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 124.795 1.238 . . . . 0.0 109.751 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.12 61.59 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.201 1.001 . . . . 0.0 112.214 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 158.53 31.48 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -157.15 118.34 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.013 -0.698 . . . . 0.0 109.482 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 -117.77 12.28 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.39 -23.13 54.06 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.744 0.418 . . . . 0.0 111.461 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.4 ttp -66.41 118.49 54.04 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.466 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.34 154.38 56.13 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.481 2.121 . . . . 0.0 109.954 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.84 123.36 17.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.827 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -92.28 -11.9 33.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.967 0.803 . . . . 0.0 111.756 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -44.26 116.01 0.94 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.062 0.945 . . . . 0.0 112.037 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -26.36 9.73 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.154 0.883 . . . . 0.0 112.4 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -83.91 -44.75 13.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.23 146.39 37.04 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.55 132.58 34.91 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -31.96 -44.32 0.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.141 1.776 . . . . 0.0 112.64 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -57.02 -44.62 83.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.819 1.191 . . . . 0.0 111.645 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -54.03 -57.76 9.84 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.17 0.986 . . . . 0.0 108.531 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -50.34 -59.12 4.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.0 t -43.38 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.445 1.098 . . . . 0.0 109.687 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.36 -40.79 97.58 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 122.11 -0.369 . . . . 0.0 111.815 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.88 97.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.0 mt -65.22 -48.13 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.105 0.962 . . . . 0.0 109.111 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.27 -51.73 51.5 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.59 -53.73 54.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.107 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ptm -55.66 -47.34 76.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.507 0.594 . . . . 0.0 109.68 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.73 -38.52 90.83 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.832 -0.542 . . . . 0.0 110.449 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.2 m -61.71 -5.4 1.92 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.5 p -88.38 -16.31 33.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.207 1.367 . . . . 0.0 111.19 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.657 -1.64 . . . . 0.0 110.601 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mt -58.23 -49.23 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -68.05 -44.72 75.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.967 0.907 . . . . 0.0 110.743 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.9 mt -69.32 -50.97 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.311 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.2 -9.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -171.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.2 -40.18 42.37 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 119.847 1.203 . . . . 0.0 111.131 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -72.57 158.59 35.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.76 111.88 5.78 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.439 1.096 . . . . 0.0 109.792 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 151.34 12.04 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.249 1.125 . . . . 0.0 110.86 -13.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 p -66.3 134.35 52.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -51.4 -41.41 60.7 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.63 0.729 . . . . 0.0 109.334 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 p -50.93 -37.05 41.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 112.814 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -44.75 -39.28 5.07 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.876 0.762 . . . . 0.0 111.407 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.7 m -107.04 -56.31 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.514 0.725 . . . . 0.0 110.439 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -62.7 -26.83 68.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.46 -1.52 53.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.69 0.677 . . . . 0.0 111.026 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -127.35 -17.69 4.64 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.925 0.89 . . . . 0.0 111.65 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.56 27.17 65.9 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.597 -0.69 . . . . 0.0 111.488 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.87 141.64 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.38 27.76 5.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 111.575 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.47 74.49 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.65 129.2 80.91 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.595 1.198 . . . . 0.0 108.311 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -64.54 123.56 11.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.24 1.96 . . . . 0.0 109.269 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.29 -179.53 5.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.703 0.763 . . . . 0.0 113.053 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.67 159.57 34.16 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 48.06 32.34 2.89 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 112.356 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.16 61.85 59.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.406 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -37.24 -49.11 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.456 3.437 . . . . 0.0 114.01 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.02 -43.78 9.52 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.245 1.418 . . . . 0.0 111.951 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.01 -27.0 67.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.747 0.819 . . . . 0.0 111.924 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -103.62 -18.55 14.69 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.689 1.195 . . . . 0.0 112.429 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -47.05 0.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.407 1.883 . . . . 0.0 114.013 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -9.84 30.16 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -81.27 131.57 58.54 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.62 109.79 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.959 2.439 . . . . 0.0 110.888 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -56.59 -26.26 54.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.764 0.826 . . . . 0.0 112.446 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -49.43 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.31 1.844 . . . . 0.0 111.618 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.0 t -48.47 -38.56 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.67 0.788 . . . . 0.0 110.715 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.01 -44.01 82.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.844 0.458 . . . . 0.0 111.383 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -68.71 -45.96 70.19 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -56.51 -44.51 80.83 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.448 0.299 . . . . 0.0 111.553 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.12 -36.26 77.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -52.66 64.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.951 0.796 . . . . 0.0 109.798 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 m -51.17 -43.26 61.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.908 0.883 . . . . 0.0 111.106 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -69.12 -44.0 73.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.933 0.493 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.26 -52.5 64.47 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.337 -0.852 . . . . 0.0 109.947 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.5 77.91 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.677 0.791 . . . . 0.0 110.905 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.26 87.14 1.43 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.542 1.068 . . . . 0.0 110.867 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -77.79 146.58 35.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.652 1.181 . . . . 0.0 109.82 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.83 -110.85 3.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.24 9.49 28.01 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.684 1.193 . . . . 0.0 111.903 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 42.8 mtm -71.25 137.83 84.25 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 119.172 0.896 . . . . 0.0 111.627 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.52 139.37 69.98 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 N-CA-C 106.961 -1.977 . . . . 0.0 106.961 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 114.99 3.67 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -80.82 -8.74 59.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.846 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -51.7 112.15 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.94 0.791 . . . . 0.0 110.609 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.83 -26.14 10.25 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.945 0.783 . . . . 0.0 111.916 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -74.6 -44.19 51.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.435 1.094 . . . . 0.0 108.696 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.99 157.11 40.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.79 1.236 . . . . 0.0 108.338 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.47 129.82 35.35 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -33.6 -43.81 0.13 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.532 1.933 . . . . 0.0 112.046 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.86 -48.82 80.05 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.401 1.0 . . . . 0.0 111.522 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -48.81 78.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -50.8 -58.73 5.22 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.127 0.489 . . . . 0.0 109.693 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 t -47.36 -56.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.796 1.239 . . . . 0.0 109.823 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -57.12 -40.38 76.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.873 0.469 . . . . 0.0 111.72 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.62 93.98 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.36 -46.77 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -53.78 -51.42 63.48 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -54.17 -54.11 44.27 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.306 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.3 mtp -49.33 -60.03 3.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.407 0.683 . . . . 0.0 109.394 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.13 -39.15 66.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.54 0.736 . . . . 0.0 111.678 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -62.82 -9.01 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.321 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -88.8 -14.1 37.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.17 1.35 . . . . 0.0 110.932 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.122 -175.631 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.526 0.679 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.91 -53.37 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -59.52 -45.43 91.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.905 0.32 . . . . 0.0 111.67 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.76 -52.82 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.375 0.67 . . . . 0.0 112.035 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -133.23 -18.6 2.26 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.4 -32.34 43.03 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.916 1.235 . . . . 0.0 112.845 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 150.45 45.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.583 0.692 . . . . 0.0 110.687 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.73 111.89 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.021 1.329 . . . . 0.0 109.46 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.46 159.14 59.07 Favored 'Cis proline' 0 N--CA 1.453 -0.877 0 CA-C-N 120.343 1.158 . . . . 0.0 109.402 -12.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -65.22 121.04 13.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.394 1.477 . . . . 0.0 110.31 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 m -51.17 -47.02 62.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.011 0.524 . . . . 0.0 110.552 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.8 p -41.44 -52.42 3.6 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 126.582 1.953 . . . . 0.0 112.226 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -47.62 -33.54 6.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.249 1.02 . . . . 0.0 112.552 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.4 m -99.28 -56.0 2.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.049 0.386 . . . . 0.0 110.838 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -70.65 -38.81 73.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.36 -42.98 78.4 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.359 0.981 . . . . 0.0 108.994 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -38.91 79.36 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.212 1.005 . . . . 0.0 111.509 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.54 34.91 8.19 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.813 1.197 . . . . 0.0 110.362 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.98 129.46 17.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 30.96 6.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.481 1.112 . . . . 0.0 111.361 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.99 24.2 77.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.357 -0.69 . . . . 0.0 112.823 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.36 131.58 52.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.548 1.174 . . . . 0.0 108.33 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -60.09 116.95 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.077 2.518 . . . . 0.0 109.226 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -84.54 173.61 10.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.184 0.994 . . . . 0.0 112.631 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.09 161.68 29.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 m120 49.36 32.03 4.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.549 0.74 . . . . 0.0 112.622 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 59.56 38.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.373 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.55 -45.89 3.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.055 3.17 . . . . 0.0 114.468 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.59 -44.48 18.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.663 1.185 . . . . 0.0 111.519 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.09 -18.15 61.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.171 0.989 . . . . 0.0 112.327 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -104.89 -18.22 14.28 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.32 1.048 . . . . 0.0 112.153 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -46.2 0.59 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.391 1.876 . . . . 0.0 114.243 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.41 -14.91 27.9 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.616 0.767 . . . . 0.0 112.991 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -81.31 124.93 80.22 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.09 0.956 . . . . 0.0 109.373 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.31 120.99 8.17 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.571 2.181 . . . . 0.0 111.473 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.73 -31.05 57.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.827 0.851 . . . . 0.0 112.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -48.72 102.17 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.568 1.947 . . . . 0.0 112.855 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.1 -43.06 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.689 0.796 . . . . 0.0 109.404 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.24 -27.35 63.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.444 1.098 . . . . 0.0 112.769 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.85 -54.06 4.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.2 mt -52.92 -40.69 63.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.793 0.837 . . . . 0.0 112.521 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.97 -28.51 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.505 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.74 -47.39 83.77 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.681 1.128 . . . . 0.0 108.867 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 m -54.22 -48.22 71.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 109.892 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -62.02 -45.24 94.46 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.921 -0.487 . . . . 0.0 111.066 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -62.14 -53.44 55.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.197 0.599 . . . . 0.0 110.98 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.89 -21.42 47.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.067 1.347 . . . . 0.0 112.976 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.4 162.63 35.32 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -159.91 114.33 2.29 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -115.33 7.14 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -27.96 60.4 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.49 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 33.3 ttp -62.98 115.45 17.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.688 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.21 130.27 10.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.032 2.488 . . . . 0.0 110.415 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.62 114.69 0.55 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.434 1.494 . . . . 0.0 111.848 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -83.14 -13.63 55.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.483 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -48.99 112.85 0.68 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.89 0.768 . . . . 0.0 111.258 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.08 -32.92 6.56 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.278 0.942 . . . . 0.0 111.651 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -79.15 -44.66 21.51 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.98 135.83 49.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.54 146.88 32.39 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -32.2 -47.89 0.16 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.234 1.814 . . . . 0.0 111.31 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.1 -46.02 92.31 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.673 0.67 . . . . 0.0 111.371 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.24 -58.15 9.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 122.08 0.943 . . . . 0.0 108.632 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.5 mt -45.87 -58.03 3.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.543 1.537 . . . . 0.0 110.416 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.5 t -41.63 -51.67 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 125.158 1.383 . . . . 0.0 111.214 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -57.85 -38.84 76.4 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.572 0.169 . . . . 0.0 111.416 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -48.15 56.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -58.1 -49.08 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.315 0.646 . . . . 0.0 111.114 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.5 -44.19 97.53 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.022 -1.049 . . . . 0.0 109.629 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -56.95 -53.51 57.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.286 0.494 . . . . 0.0 109.68 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttm -48.2 -53.57 16.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.806 1.642 . . . . 0.0 109.907 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.34 -37.87 84.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.233 -0.292 . . . . 0.0 110.489 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 m -73.4 39.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.3 p -129.43 -12.93 4.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.932 1.693 . . . . 0.0 109.559 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.352 -1.308 . . . . 0.0 110.304 -176.282 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.3 mt -52.7 -61.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.427 . . . . 0.0 110.0 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.77 -48.82 77.01 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.288 0.635 . . . . 0.0 112.035 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.69 -44.02 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.153 -173.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 6.14 0.19 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -174.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.04 40.04 2.65 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.827 1.194 . . . . 0.0 111.323 -177.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.94 49.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.527 1.531 . . . . 0.0 108.585 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.25 109.19 8.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.738 0.815 . . . . 0.0 110.158 -177.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.73 156.69 32.27 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.802 0.965 . . . . 0.0 111.462 -12.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.1 123.17 19.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.915 1.286 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -55.79 -49.3 73.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.497 0.665 . . . . 0.0 111.011 -177.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -41.52 -51.1 3.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.282 1.833 . . . . 0.0 112.543 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -44.44 -35.34 2.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.793 1.237 . . . . 0.0 113.345 -178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -102.23 -52.73 3.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.747 0.419 . . . . 0.0 110.729 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -67.12 -25.63 66.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.39 -44.32 97.35 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.3 0.954 . . . . 0.0 110.249 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -30.19 16.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 111.152 178.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.94 40.1 5.01 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -176.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.7 136.22 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.411 0.685 . . . . 0.0 109.36 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.54 32.25 8.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.776 1.23 . . . . 0.0 112.097 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.76 81.18 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.267 -0.74 . . . . 0.0 113.278 178.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.23 130.38 68.7 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.529 1.165 . . . . 0.0 108.61 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.88 119.17 6.16 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.004 1.802 . . . . 0.0 109.402 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.4 158.52 33.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.526 0.679 . . . . 0.0 110.323 -176.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.92 151.08 25.28 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 64.45 34.82 9.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.985 0.914 . . . . 0.0 109.363 -174.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.8 68.46 43.43 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.765 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -38.65 -52.39 2.07 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.291 3.328 . . . . 0.0 114.275 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -48.52 -39.99 25.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.322 1.449 . . . . 0.0 111.812 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.04 -30.85 71.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.808 0.443 . . . . 0.0 111.339 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -101.25 -27.67 13.07 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.783 0.833 . . . . 0.0 112.359 -175.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.55 0.92 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.05 1.74 . . . . 0.0 112.98 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.54 -21.31 38.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -177.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -81.36 156.5 71.24 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.872 0.869 . . . . 0.0 110.268 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.89 109.85 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.008 2.472 . . . . 0.0 111.646 176.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.96 -31.52 72.64 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.031 -1.043 . . . . 0.0 110.423 177.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 105.17 0.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 111.68 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -48.77 -39.7 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.001 0.92 . . . . 0.0 110.599 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.55 -39.67 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.841 1.256 . . . . 0.0 111.648 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.29 -44.18 47.0 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.1 mt -56.11 -49.73 73.06 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.8 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.41 -44.69 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.64 -44.69 85.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.322 0.964 . . . . 0.0 109.596 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -59.58 -33.2 71.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.084 176.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.7 m -72.38 -45.31 60.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.5 0.72 . . . . 0.0 109.751 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -54.65 -52.31 62.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.86 1.209 . . . . 0.0 110.517 174.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.83 82.26 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.358 0.411 . . . . 0.0 111.762 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.21 124.21 3.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -101.12 139.87 36.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.133 1.373 . . . . 0.0 107.748 178.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.06 3.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.39 8.61 43.52 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.088 0.955 . . . . 0.0 112.723 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 37.1 mtm -68.06 148.25 98.37 Favored Pre-proline 0 C--N 1.338 0.091 0 CA-C-N 119.756 1.162 . . . . 0.0 112.261 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.32 140.92 25.16 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 N-CA-C 106.345 -2.214 . . . . 0.0 106.345 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.85 117.66 6.17 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.0 4.07 10.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -50.67 104.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 111.713 177.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -8.43 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.186 0.898 . . . . 0.0 113.214 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -78.75 -42.21 28.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.84 144.91 47.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 174.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.47 143.21 32.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -27.72 -50.31 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.4 2.28 . . . . 0.0 112.295 169.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.77 -49.88 71.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.539 0.609 . . . . 0.0 111.095 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.93 -50.65 72.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.35 1.06 . . . . 0.0 109.377 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -51.29 -56.84 10.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.251 1.42 . . . . 0.0 109.986 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.3 t -52.44 -53.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.175 0.59 . . . . 0.0 109.98 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -56.33 -36.83 69.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.672 0.789 . . . . 0.0 111.529 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.72 38.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.16 -48.72 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 -176.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.28 -42.17 90.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.208 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -61.14 -48.85 79.71 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.557 0.617 . . . . 0.0 110.152 177.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.0 mtp -48.02 -58.05 4.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.016 0.912 . . . . 0.0 109.149 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -56.28 -40.05 73.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.086 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 m -74.17 42.36 0.15 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.122 -0.987 . . . . 0.0 113.583 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.6 p -132.01 -15.62 2.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.441 1.496 . . . . 0.0 109.949 171.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.927 -177.33 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.38 -57.11 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.162 0.985 . . . . 0.0 110.06 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -54.9 -44.68 74.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -74.48 -51.71 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.956 -173.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -16.55 1.83 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.47 -35.06 43.01 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.654 1.115 . . . . 0.0 112.112 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -70.25 147.05 50.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.026 0.53 . . . . 0.0 110.791 -178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.69 109.81 13.3 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.704 1.202 . . . . 0.0 109.349 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.35 161.25 58.86 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.257 1.128 . . . . 0.0 110.371 -8.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -70.73 125.48 26.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.26 1.424 . . . . 0.0 110.934 -177.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 m -56.18 -48.74 75.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.268 0.556 . . . . 0.0 110.389 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 p -38.44 -58.51 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.941 2.096 . . . . 0.0 111.888 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -41.1 -38.74 1.1 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.947 1.299 . . . . 0.0 113.113 -179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.6 m -94.64 -56.07 2.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.828 0.285 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -65.65 -33.48 75.98 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.01 -39.88 83.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 119.752 1.16 . . . . 0.0 109.471 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -76.79 -29.99 56.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.174 0.99 . . . . 0.0 110.712 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.65 31.47 62.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -174.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -58.42 140.2 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.27 29.31 6.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.084 0.954 . . . . 0.0 111.414 -177.317 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 25.62 74.47 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.391 -0.672 . . . . 0.0 112.651 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 135.36 82.75 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.621 1.21 . . . . 0.0 108.622 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -62.9 122.64 11.0 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.389 2.06 . . . . 0.0 109.178 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -87.77 177.48 7.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.795 0.807 . . . . 0.0 111.955 -174.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.15 161.14 31.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.23 51.05 0.78 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.573 1.549 . . . . 0.0 111.786 177.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.41 63.13 27.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.8 1.24 . . . . 0.0 110.275 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -40.19 -46.42 4.14 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.245 3.297 . . . . 0.0 114.523 -176.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.31 -39.93 33.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.92 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.41 -24.45 66.47 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.53 0.732 . . . . 0.0 111.781 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -106.6 -22.3 12.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.69 1.196 . . . . 0.0 112.938 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.33 -49.53 0.71 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.935 1.694 . . . . 0.0 113.484 -178.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.1 -15.27 36.67 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -81.63 153.36 70.59 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 118.944 0.793 . . . . 0.0 110.512 -177.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.24 125.92 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.455 176.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -67.37 -40.18 85.74 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -49.42 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.006 2.522 . . . . 0.0 112.19 178.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.62 -40.1 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.025 0.93 . . . . 0.0 109.703 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.5 -25.39 36.81 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.324 1.85 . . . . 0.0 112.373 176.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -89.83 -51.23 5.6 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -51.35 -38.99 56.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.728 0.811 . . . . 0.0 112.158 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.76 -33.62 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.542 -0.724 . . . . 0.0 110.286 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -65.1 -49.45 69.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.598 1.09 . . . . 0.0 108.424 177.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -53.04 -43.69 66.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.047 0.539 . . . . 0.0 109.831 177.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -67.96 -46.23 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.028 -0.42 . . . . 0.0 110.716 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.7 mt -56.18 -51.09 69.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.673 -0.642 . . . . 0.0 110.083 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.79 -27.81 55.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.598 1.159 . . . . 0.0 113.134 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 163.3 32.92 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -175.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -157.42 119.63 3.82 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.916 -0.755 . . . . 0.0 109.499 -178.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.01 -118.06 12.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.8 -21.21 55.46 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.743 0.417 . . . . 0.0 111.588 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.6 ttp -68.54 118.66 62.19 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 118.942 0.792 . . . . 0.0 110.075 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.57 158.37 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.486 2.124 . . . . 0.0 109.798 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.24 148.01 38.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.92 -9.18 12.47 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.417 1.087 . . . . 0.0 113.14 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -48.13 110.24 0.31 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.084 0.856 . . . . 0.0 111.796 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.38 -31.33 7.55 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.084 0.849 . . . . 0.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -74.33 -46.46 40.72 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.01 129.02 46.05 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.84 145.16 38.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -30.69 -46.19 0.08 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 127.113 2.165 . . . . 0.0 112.153 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.6 -54.51 44.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.475 1.034 . . . . 0.0 110.89 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -51.06 71.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.433 1.093 . . . . 0.0 109.382 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.4 -56.96 9.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.522 1.129 . . . . 0.0 110.103 177.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 t -50.42 -57.35 2.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 123.877 0.871 . . . . 0.0 109.395 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -54.2 -43.58 70.86 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.965 0.348 . . . . 0.0 111.525 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.06 95.36 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.07 -51.52 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.395 0.678 . . . . 0.0 109.886 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.45 -40.11 85.78 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 120.107 1.321 . . . . 0.0 108.878 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -57.2 -51.66 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.464 0.574 . . . . 0.0 109.945 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ptm -56.55 -46.61 80.58 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -35.12 79.45 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.658 -0.651 . . . . 0.0 111.204 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.8 m -62.81 -7.59 5.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.4 p -88.03 -12.19 45.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.867 1.212 . . . . 0.0 111.0 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 116.486 -1.721 . . . . 0.0 111.095 -175.92 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.21 -59.34 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.806 1.243 . . . . 0.0 110.292 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -58.29 -52.1 67.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.06 0.944 . . . . 0.0 111.893 -178.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.16 -44.21 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.292 -173.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 44.03 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 37.16 0.98 Allowed Glycine 0 CA--C 1.524 0.63 0 O-C-N 121.638 -0.664 . . . . 0.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -138.87 157.53 45.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.464 1.906 . . . . 0.0 107.587 177.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.39 107.92 8.64 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.562 0.745 . . . . 0.0 109.755 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.25 158.2 27.59 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 CA-C-N 119.991 1.033 . . . . 0.0 112.314 -9.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.98 117.31 11.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.278 1.031 . . . . 0.0 109.116 178.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m -46.43 -48.62 18.82 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.709 0.804 . . . . 0.0 111.194 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 p -44.45 -46.91 9.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.026 1.73 . . . . 0.0 112.586 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -50.91 -30.29 14.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 m -101.66 -56.37 2.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.895 0.316 . . . . 0.0 110.786 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -71.7 -23.14 61.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -172.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.48 -50.78 62.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.52 1.054 . . . . 0.0 109.024 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.89 35.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.6 44.53 9.3 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -175.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 144.2 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.28 29.91 7.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.965 0.906 . . . . 0.0 111.319 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.87 20.41 79.83 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.109 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 137.61 84.49 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.931 1.365 . . . . 0.0 108.416 176.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.54 128.49 26.1 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.561 2.174 . . . . 0.0 109.842 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.9 174.73 7.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.291 1.043 . . . . 0.0 113.347 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.08 166.71 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 113.497 -1.683 . . . . 0.0 106.853 169.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 48.03 34.77 4.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.558 0.743 . . . . 0.0 111.111 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.34 61.16 16.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.794 -173.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -40.09 -49.22 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.846 3.031 . . . . 0.0 113.729 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.83 -40.93 10.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.396 1.478 . . . . 0.0 112.264 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -63.41 -26.04 68.56 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.859 0.464 . . . . 0.0 111.661 -177.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -106.26 -28.68 10.27 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.257 1.423 . . . . 0.0 111.961 -175.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.24 -46.15 0.5 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.754 2.022 . . . . 0.0 112.86 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.63 30.64 6.11 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.215 1.006 . . . . 0.0 112.888 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -134.69 159.36 72.46 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.549 1.14 . . . . 0.0 108.414 176.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.32 109.15 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.154 2.569 . . . . 0.0 112.77 -177.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.46 -32.4 73.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.211 -0.931 . . . . 0.0 110.276 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -55.92 103.94 0.12 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.479 1.912 . . . . 0.0 112.399 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.42 -39.43 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.72 -24.74 51.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.36 1.064 . . . . 0.0 112.569 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.21 -55.08 3.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.6 mt -47.82 -40.7 21.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.79 -35.02 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.933 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.45 -48.41 75.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.398 0.999 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m -54.98 -41.64 71.44 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.825 0.45 . . . . 0.0 109.799 176.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -67.64 -45.0 76.6 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.07 -0.394 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.09 -51.82 68.12 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.649 -0.657 . . . . 0.0 109.981 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.68 61.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.748 1.219 . . . . 0.0 113.432 -176.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.24 163.9 24.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -158.8 114.76 2.64 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.977 -0.719 . . . . 0.0 109.323 -177.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.42 -116.22 8.19 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.33 -26.17 60.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.88 0.472 . . . . 0.0 111.554 178.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.5 ttp -67.97 116.54 39.67 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.75 -177.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.57 166.2 24.76 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.23 1.953 . . . . 0.0 110.738 176.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.35 133.55 49.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -101.25 -10.43 20.36 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 113.256 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -49.25 110.09 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.549 0.613 . . . . 0.0 111.013 179.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.01 -37.44 3.77 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.725 1.155 . . . . 0.0 111.666 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -43.99 42.91 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 117.994 0.897 . . . . 0.0 108.836 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.84 132.14 41.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 176.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -79.23 150.84 31.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -32.18 -46.65 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.328 1.851 . . . . 0.0 111.715 171.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.81 -44.92 88.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.434 1.015 . . . . 0.0 111.329 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.9 -56.31 23.83 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 122.459 1.123 . . . . 0.0 108.619 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.9 mt -47.63 -58.97 3.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.164 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 t -45.17 -57.39 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 124.515 1.126 . . . . 0.0 109.636 177.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -58.68 -41.71 86.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.349 0.522 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.31 93.84 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.718 -0.614 . . . . 0.0 110.02 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.41 -48.01 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -53.19 -51.47 61.98 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.7 -52.7 61.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.222 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -51.31 -56.52 12.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.69 -37.6 68.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.837 -0.539 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -67.92 -3.34 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 113.461 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.2 p -110.76 15.26 22.02 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 120.19 1.359 . . . . 0.0 111.242 177.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.62 179.613 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.656 0.741 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.67 -57.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.041 0.937 . . . . 0.0 109.747 -177.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -58.03 -46.92 84.53 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.8 mt -71.82 -49.07 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.787 -172.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.92 -13.74 0.93 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -170.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.33 -30.73 36.23 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 120.079 1.309 . . . . 0.0 112.66 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -75.21 156.59 35.64 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.715 0.757 . . . . 0.0 111.161 -177.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.34 111.49 7.1 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.913 1.285 . . . . 0.0 108.954 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.26 150.77 55.54 Favored 'Cis proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.435 1.191 . . . . 0.0 109.645 -11.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.93 118.62 7.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.227 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 m -48.26 -47.04 36.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.476 0.655 . . . . 0.0 110.535 -178.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -45.09 -43.81 9.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.983 1.713 . . . . 0.0 112.557 178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -51.13 -33.06 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.595 0.634 . . . . 0.0 112.025 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.3 m -100.05 -53.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.424 0.289 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.85 -29.3 66.51 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -173.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.73 -42.44 86.27 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.344 0.974 . . . . 0.0 108.855 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -81.76 -27.6 33.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.289 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.84 46.42 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.45 144.69 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 O-C-N 122.09 -0.653 . . . . 0.0 109.289 -176.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.03 29.71 6.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.205 1.002 . . . . 0.0 111.534 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.3 23.04 78.59 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.306 -0.719 . . . . 0.0 112.799 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 131.0 84.37 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.761 1.28 . . . . 0.0 108.028 176.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -61.65 121.72 9.97 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.218 1.945 . . . . 0.0 109.041 -178.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.02 163.2 24.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.435 1.112 . . . . 0.0 111.121 -176.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.79 161.97 29.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 171.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.18 55.0 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 111.19 -178.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.71 64.66 7.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.759 0.824 . . . . 0.0 111.093 -178.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -36.86 -49.79 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.776 3.651 . . . . 0.0 114.523 -178.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.98 -43.01 13.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.128 1.371 . . . . 0.0 111.794 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.7 -24.51 66.26 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.037 0.935 . . . . 0.0 112.008 -177.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -106.01 -19.39 13.74 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.443 1.097 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.43 -49.14 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.524 1.53 . . . . 0.0 113.342 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.11 -14.75 33.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -82.03 131.63 56.16 Favored Pre-proline 0 CA--C 1.535 0.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.856 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.51 113.71 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.913 2.408 . . . . 0.0 111.198 177.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -58.05 -26.56 62.65 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.461 0.704 . . . . 0.0 112.395 -178.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -50.71 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 111.662 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.8 t -41.36 -53.03 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 124.592 1.157 . . . . 0.0 110.619 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.89 -43.26 69.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -61.52 -47.11 87.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.118 0.872 . . . . 0.0 108.782 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.6 -37.51 81.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.383 178.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.03 -43.57 97.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.81 -46.22 91.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.406 1.003 . . . . 0.0 109.724 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -54.3 -45.54 72.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.345 . . . . 0.0 110.454 176.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -67.37 -45.31 76.65 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.922 -0.486 . . . . 0.0 110.531 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 mt -54.11 -54.93 32.73 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.726 -0.609 . . . . 0.0 109.712 177.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.54 74.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.926 0.891 . . . . 0.0 112.613 -177.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.95 164.29 31.28 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 -174.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -157.58 108.79 2.28 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.761 -0.846 . . . . 0.0 109.569 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.54 -115.08 6.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.47 -29.47 64.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.725 0.41 . . . . 0.0 111.052 178.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.4 ttp -65.16 120.05 64.06 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.421 -178.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.78 160.15 44.13 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.442 2.095 . . . . 0.0 110.354 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.68 52.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.6 -10.83 16.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.961 0.904 . . . . 0.0 111.019 177.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.0 123.81 7.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.0 111.037 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -16.36 33.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.186 0.898 . . . . 0.0 112.739 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 mtm105 -97.25 -48.84 5.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.225 1.013 . . . . 0.0 109.223 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 127.14 42.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 65' ' ' GLU . 13.5 m-20 -76.69 83.01 3.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 3.2 -47.91 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 1 C-N-CA 132.522 4.329 . . . . 0.0 117.221 -178.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 63' ' ' ASP . 42.9 mt-10 -50.07 -37.43 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.961 1.255 . . . . 0.0 109.265 173.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.02 -57.68 8.02 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.687 1.995 . . . . 0.0 109.818 173.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.66 -56.41 22.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.749 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.1 t -43.85 -57.14 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.199 1.0 . . . . 0.0 109.725 176.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -56.51 -48.9 76.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.242 1.017 . . . . 0.0 111.094 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.46 77.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.682 -0.636 . . . . 0.0 109.362 -178.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.37 -46.78 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.546 1.138 . . . . 0.0 110.846 -176.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.57 -38.17 80.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.937 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -62.14 -51.35 68.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.173 176.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.0 mtp -44.45 -58.9 2.69 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.088 0.947 . . . . 0.0 109.632 177.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.3 -41.05 83.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.275 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -74.58 42.55 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.4 p -136.46 -13.2 1.78 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.437 1.495 . . . . 0.0 110.096 171.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.268 -178.408 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.84 0.353 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.46 -55.04 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -59.28 -48.53 81.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.249 0.62 . . . . 0.0 111.843 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.95 -49.39 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.175 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -135.06 -17.68 1.84 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.49 -34.52 35.58 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.978 1.263 . . . . 0.0 112.543 -176.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -70.25 151.18 45.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 117.361 0.58 . . . . 0.0 110.424 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.09 111.22 7.89 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 109.133 -179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 151.97 24.81 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.306 1.145 . . . . 0.0 111.449 -11.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.91 124.98 23.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.805 1.242 . . . . 0.0 109.309 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.15 -45.36 79.65 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.393 0.616 . . . . 0.0 110.57 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 p -42.27 -50.51 4.95 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.567 1.947 . . . . 0.0 112.067 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.16 -37.35 2.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.292 1.037 . . . . 0.0 112.5 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -102.14 -57.37 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.637 0.375 . . . . 0.0 111.046 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -67.95 -20.96 65.11 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.43 -2.65 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.164 0.893 . . . . 0.0 110.882 176.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -135.44 -9.6 2.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 35.5 51.88 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.694 -0.629 . . . . 0.0 111.908 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.1 133.47 20.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.31 31.1 8.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.304 1.041 . . . . 0.0 111.462 -177.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.33 23.18 78.36 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.622 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 139.75 80.24 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.334 1.067 . . . . 0.0 109.251 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.09 126.08 18.63 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.373 2.049 . . . . 0.0 109.308 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.66 171.72 9.46 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.182 0.992 . . . . 0.0 112.491 -175.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 161.08 19.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.929 172.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 37.7 52.96 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.136 1.374 . . . . 0.0 112.009 176.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.04 65.41 11.94 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.796 0.838 . . . . 0.0 110.469 -177.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.67 -51.56 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.781 3.654 . . . . 0.0 114.695 -177.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.16 -39.34 28.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.136 0.974 . . . . 0.0 112.196 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.91 -26.8 68.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.564 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -104.24 -29.86 10.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.026 1.33 . . . . 0.0 112.269 -175.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.02 -41.51 1.69 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.957 1.703 . . . . 0.0 113.605 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.59 -22.65 26.13 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.541 0.737 . . . . 0.0 112.317 -176.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -80.93 143.51 53.65 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.022 0.929 . . . . 0.0 110.026 -176.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 85.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.063 2.509 . . . . 0.0 108.267 173.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -23.86 26.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.728 2.011 . . . . 0.0 113.543 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -51.18 112.69 0.77 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.649 1.18 . . . . 0.0 110.683 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -46.64 -44.58 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.524 1.13 . . . . 0.0 110.553 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.79 -31.53 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.236 1.415 . . . . 0.0 113.001 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.44 -52.83 4.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 109.046 177.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 mt -48.36 -41.32 28.31 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 122.824 0.449 . . . . 0.0 111.994 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.14 -37.71 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 121.747 -0.596 . . . . 0.0 110.903 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -65.85 -48.12 72.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 m -53.56 -42.28 67.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.708 0.29 . . . . 0.0 110.299 176.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -67.04 -48.83 67.12 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.282 0.633 . . . . 0.0 111.235 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.8 -43.02 69.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 109.528 -174.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.7 73.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.538 0.735 . . . . 0.0 111.073 178.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 152.3 27.92 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -153.5 149.52 27.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.27 -116.98 8.69 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.29 14.21 22.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.453 1.101 . . . . 0.0 111.495 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.96 127.31 93.32 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.495 -0.753 . . . . 0.0 110.416 -178.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.76 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.492 2.128 . . . . 0.0 109.19 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -25.55 123.29 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.178 2.191 . . . . 0.0 112.11 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.6 6.57 48.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.839 0.456 . . . . 0.0 112.096 -176.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -42.09 109.45 0.13 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.497 1.519 . . . . 0.0 112.695 178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 -14.43 8.03 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.73 0.681 . . . . 0.0 113.449 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 mtm105 -82.05 -46.94 13.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.28 1.04 . . . . 0.0 108.507 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.05 126.27 45.95 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 172.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.22 150.26 33.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -27.24 -49.89 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 126.177 1.791 . . . . 0.0 112.102 170.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.67 -50.35 73.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.115 1.325 . . . . 0.0 111.56 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -54.29 -56.12 21.55 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 122.662 1.22 . . . . 0.0 109.031 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.38 -59.48 3.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -45.05 -53.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 125.394 1.478 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -56.33 -33.94 66.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.048 0.539 . . . . 0.0 112.055 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.68 27.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.747 0.703 . . . . 0.0 109.924 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.61 -49.92 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.825 . . . . 0.0 110.233 -176.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.65 -44.29 73.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.185 0.902 . . . . 0.0 109.777 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.14 -50.51 72.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 ptm -54.5 -44.19 72.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.53 -34.74 77.71 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.627 -0.671 . . . . 0.0 110.696 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -73.92 56.64 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.005 0.922 . . . . 0.0 111.793 179.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.6 p -150.81 -32.71 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.444 2.298 . . . . 0.0 109.598 177.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.523 1.929 . . . . 0.0 110.413 178.885 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.14 -56.4 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.494 1.118 . . . . 0.0 109.826 -178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.47 -48.07 80.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.756 0.822 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 mm -70.42 -48.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.425 0.69 . . . . 0.0 111.146 -174.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 39.79 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -173.122 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.81 38.91 1.17 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -139.07 155.95 47.55 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.502 1.921 . . . . 0.0 107.587 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 105.29 16.85 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 123.715 0.806 . . . . 0.0 111.198 -176.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.54 164.47 61.49 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 CA-C-N 120.286 1.138 . . . . 0.0 110.113 -8.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -67.31 119.11 11.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.543 1.137 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -46.89 -45.46 20.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.895 0.878 . . . . 0.0 111.228 -176.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -46.02 -42.71 13.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.715 1.606 . . . . 0.0 112.311 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -55.94 -16.27 4.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.3 m -115.27 -57.43 2.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.788 175.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -71.14 -22.9 62.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -173.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.54 -48.6 66.51 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.751 1.16 . . . . 0.0 109.615 -178.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -86.54 -25.19 25.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.917 0.887 . . . . 0.0 111.1 178.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.38 41.97 8.85 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.51 140.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.41 28.58 5.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.993 0.917 . . . . 0.0 111.476 -177.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.46 79.62 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.009 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 121.25 43.14 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.823 1.311 . . . . 0.0 108.247 176.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -44.15 114.99 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.869 3.046 . . . . 0.0 113.636 -177.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.81 169.63 17.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.758 0.79 . . . . 0.0 111.759 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 159.72 28.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.31 51.08 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.362 1.465 . . . . 0.0 111.733 178.053 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.96 62.04 31.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.919 0.888 . . . . 0.0 111.055 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -38.17 -45.85 2.15 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 124.33 3.353 . . . . 0.0 114.198 -178.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.42 -43.67 11.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.896 1.278 . . . . 0.0 111.957 178.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -69.3 -25.54 64.28 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.658 0.783 . . . . 0.0 112.074 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -104.26 -18.2 14.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.795 1.238 . . . . 0.0 112.754 -174.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.04 -48.4 0.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.937 2.095 . . . . 0.0 113.969 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -98.65 -4.13 34.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -87.26 128.81 53.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.486 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.95 123.87 13.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.525 2.15 . . . . 0.0 110.967 177.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -64.25 -23.57 67.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.295 0.638 . . . . 0.0 110.668 178.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -49.33 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.856 2.062 . . . . 0.0 112.264 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.44 -41.5 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.316 0.646 . . . . 0.0 109.43 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -50.61 -38.6 46.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.847 1.259 . . . . 0.0 112.262 177.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -79.57 -49.64 11.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.29 -40.66 62.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.913 0.485 . . . . 0.0 111.915 -178.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -61.69 -35.05 65.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.298 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.9 -46.3 78.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 120.204 1.365 . . . . 0.0 108.698 178.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 m -52.89 -45.7 67.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.947 0.404 . . . . 0.0 110.162 175.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -69.5 -44.41 71.14 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.924 -0.485 . . . . 0.0 110.97 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.16 -51.14 70.96 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.283 -0.886 . . . . 0.0 110.347 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.74 59.2 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.36 1.064 . . . . 0.0 112.376 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.14 163.64 28.67 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -176.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -157.06 111.12 2.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.97 -0.723 . . . . 0.0 109.324 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.15 -113.52 5.2 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.65 -30.67 63.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.945 0.498 . . . . 0.0 111.168 177.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.3 ttp -63.07 119.29 50.89 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.255 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.84 160.46 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.365 2.044 . . . . 0.0 110.28 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.57 119.78 12.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -87.22 -4.45 59.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.785 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.83 89.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 179.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.2 2.54 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.889 1.709 . . . . 0.0 110.589 -178.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -87.23 -37.27 17.39 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.258 1.023 . . . . 0.0 111.106 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 126.14 18.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.33 153.57 24.54 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -29.17 -47.53 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.577 1.951 . . . . 0.0 112.047 171.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -62.81 -50.72 69.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.991 1.268 . . . . 0.0 111.665 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -54.96 -55.31 32.16 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.824 1.297 . . . . 0.0 108.955 178.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.4 mt -49.93 -60.46 2.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.151 179.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.4 t -42.09 -56.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 109.765 177.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -56.99 -43.07 81.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.512 0.142 . . . . 0.0 111.22 -178.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.89 53.34 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.9 mt -54.66 -46.62 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.964 1.306 . . . . 0.0 110.135 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -53.51 -52.58 59.14 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -55.94 -50.5 70.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.605 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.5 mtp -50.83 -58.16 6.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.377 0.671 . . . . 0.0 109.731 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.07 -36.73 73.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.884 0.874 . . . . 0.0 111.59 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -74.7 50.92 0.45 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.023 0.829 . . . . 0.0 112.659 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.7 p -149.24 -25.75 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.282 2.233 . . . . 0.0 110.035 174.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.62 -1.657 . . . . 0.0 110.421 179.528 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.08 -53.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -57.47 -42.87 83.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 112.738 -177.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -84.37 -39.93 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.709 -175.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -130.55 -34.73 1.54 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -172.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.73 32.12 4.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.473 1.033 . . . . 0.0 113.343 -172.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -133.7 144.98 49.48 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.12 107.78 19.8 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.929 1.292 . . . . 0.0 110.388 -177.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.57 161.46 66.24 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.327 1.153 . . . . 0.0 109.718 -9.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.23 130.79 45.28 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.514 0.726 . . . . 0.0 110.145 -178.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.9 -41.92 71.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.023 0.829 . . . . 0.0 109.683 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 t -59.25 -8.71 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 m -67.08 -30.42 70.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 120.352 1.433 . . . . 0.0 109.898 175.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.0 m -113.95 -63.75 1.41 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 112.407 -172.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -57.93 -23.36 53.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.006 1.322 . . . . 0.0 113.555 -174.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.18 -25.13 64.19 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.133 -0.355 . . . . 0.0 111.535 178.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -121.11 -12.28 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.251 1.021 . . . . 0.0 112.218 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.3 35.89 51.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.87 145.47 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.19 28.09 6.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.898 0.879 . . . . 0.0 111.466 -177.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.53 21.37 79.56 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.032 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 132.55 87.25 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.855 1.327 . . . . 0.0 108.669 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.07 122.54 10.57 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.469 2.112 . . . . 0.0 108.769 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.23 172.15 10.72 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -170.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.41 158.48 23.63 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.04 50.83 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 0.0 112.078 177.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.15 60.84 24.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.624 1.17 . . . . 0.0 110.885 -178.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.93 -48.46 1.5 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.599 3.533 . . . . 0.0 114.322 -178.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.39 -44.35 8.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.208 1.403 . . . . 0.0 111.838 178.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.69 -26.93 67.26 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.978 0.911 . . . . 0.0 112.014 -177.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -103.19 -15.96 15.86 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.826 1.25 . . . . 0.0 112.452 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.68 -47.07 0.64 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.243 1.817 . . . . 0.0 113.709 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -99.72 -4.29 31.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.836 0.854 . . . . 0.0 113.27 -176.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -88.25 126.92 59.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.812 0.845 . . . . 0.0 109.405 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.33 106.03 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.784 2.323 . . . . 0.0 110.529 177.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.7 -23.05 49.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.767 0.827 . . . . 0.0 112.509 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.81 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.159 2.184 . . . . 0.0 111.031 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -49.69 -41.94 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 110.001 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -53.49 -34.97 60.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.986 1.714 . . . . 0.0 112.194 177.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.84 -52.12 7.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.8 mt -51.76 -37.82 52.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.88 -37.94 69.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.408 1.004 . . . . 0.0 110.149 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.38 -47.05 77.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.667 1.121 . . . . 0.0 108.814 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -52.61 -43.92 65.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.629 0.372 . . . . 0.0 110.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -71.97 -44.6 63.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.887 0.475 . . . . 0.0 111.066 -178.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.2 mt -57.69 -50.24 73.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 121.442 -0.786 . . . . 0.0 109.898 179.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.09 65.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.956 0.902 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 118.61 3.06 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -106.63 135.01 48.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.319 1.048 . . . . 0.0 108.456 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.22 -121.48 26.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.12 -1.56 58.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.473 0.709 . . . . 0.0 112.32 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.0 ttp -65.19 127.59 93.01 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 119.016 0.825 . . . . 0.0 111.082 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 144.44 99.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.0 109.964 173.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.39 121.53 15.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -88.28 -4.93 58.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.432 -178.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -54.55 84.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.433 1.093 . . . . 0.0 113.538 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.56 -36.86 2.46 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.982 2.229 . . . . 0.0 110.419 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -42.24 75.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.642 0.721 . . . . 0.0 109.202 177.128 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.24 129.2 21.9 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -84.06 154.2 23.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -29.85 -49.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.407 1.883 . . . . 0.0 112.011 171.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.01 -45.12 93.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.373 0.988 . . . . 0.0 111.784 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.52 -57.56 12.43 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 122.612 1.196 . . . . 0.0 108.77 177.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.8 mt -47.25 -57.9 4.69 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.906 2.082 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 t -40.38 -54.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 0.0 110.459 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -60.34 -44.52 95.44 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.072 0.232 . . . . 0.0 111.394 -178.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.25 63.97 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.515 -0.74 . . . . 0.0 109.919 -179.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.64 -52.67 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.894 1.278 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -60.6 -42.37 96.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.631 1.105 . . . . 0.0 109.616 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -57.18 -51.96 67.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.644 0.656 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 ttp -54.16 -54.52 38.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -56.3 -37.68 70.21 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.918 -0.489 . . . . 0.0 111.137 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.8 m -63.46 -7.45 6.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.084 -0.96 . . . . 0.0 113.493 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 p -87.6 -11.75 47.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.289 1.404 . . . . 0.0 110.802 175.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.05 -176.067 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.557 0.217 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 mt -62.94 -57.82 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.106 1.762 . . . . 0.0 109.323 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -58.47 -51.09 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.287 1.035 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.38 -48.32 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.926 -174.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.59 39.89 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.049 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.84 36.95 1.48 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 118.867 0.758 . . . . 0.0 111.737 179.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.23 158.74 43.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.02 1.728 . . . . 0.0 108.01 178.025 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.12 107.59 6.81 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.773 -178.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 154.39 29.51 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 120.146 1.088 . . . . 0.0 111.732 -9.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.65 126.14 27.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.2 m -53.03 -48.35 67.66 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.848 0.749 . . . . 0.0 110.607 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -42.6 -49.47 5.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.043 1.737 . . . . 0.0 112.454 178.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.03 -36.18 3.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.168 0.987 . . . . 0.0 112.766 -178.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.2 m -99.88 -54.4 2.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.317 0.247 . . . . 0.0 110.996 -178.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -69.65 -24.23 63.59 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.58 -42.42 82.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.864 0.756 . . . . 0.0 109.475 178.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -89.54 -24.9 21.63 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.207 1.003 . . . . 0.0 112.027 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.8 35.14 40.89 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -174.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.33 145.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -176.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.35 29.3 6.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 111.392 -177.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.84 24.21 76.95 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.868 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 132.9 87.68 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 118.852 1.326 . . . . 0.0 108.346 176.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.42 121.54 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.294 1.996 . . . . 0.0 107.954 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.24 159.89 19.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.159 0.981 . . . . 0.0 112.88 -172.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.52 142.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 69.28 27.08 5.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.079 1.352 . . . . 0.0 111.315 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 70.3 76.32 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.621 1.168 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.27 -52.05 3.08 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.667 3.578 . . . . 0.0 114.23 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -50.46 -34.07 23.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.514 1.526 . . . . 0.0 112.518 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.65 -27.49 66.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.282 0.492 . . . . 0.0 111.181 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -101.05 -24.92 14.22 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 111.864 -176.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.24 -43.73 0.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.793 1.637 . . . . 0.0 112.688 178.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -111.81 36.14 3.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.283 1.033 . . . . 0.0 112.08 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -128.89 155.74 79.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.36 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.8 126.84 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.562 2.175 . . . . 0.0 111.367 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -70.22 -41.65 73.31 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -51.86 102.45 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.532 1.933 . . . . 0.0 112.893 -179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -49.25 -43.17 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.848 0.859 . . . . 0.0 108.912 174.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.44 -34.96 26.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.557 1.943 . . . . 0.0 112.667 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -87.03 -49.68 7.16 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 mt -49.75 -40.59 41.54 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.777 0.431 . . . . 0.0 111.979 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.13 -32.45 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 O-C-N 121.378 -0.826 . . . . 0.0 110.76 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.72 -47.24 79.02 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.773 1.17 . . . . 0.0 108.457 177.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.87 -44.24 70.25 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -66.54 -45.56 79.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.878 0.37 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.65 -49.41 77.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.447 -0.783 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.84 -31.16 61.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.483 1.113 . . . . 0.0 112.798 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.17 164.47 29.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -176.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -158.72 114.05 2.58 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.996 -0.708 . . . . 0.0 109.145 -178.003 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.98 -116.12 7.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 -26.42 60.93 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.968 0.507 . . . . 0.0 111.437 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.3 ttp -67.55 121.12 77.74 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 118.631 0.65 . . . . 0.0 109.847 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.86 160.19 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.49 2.127 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 122.59 17.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -89.15 -9.96 49.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.256 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -54.22 91.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.408 1.004 . . . . 0.0 113.056 -177.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.66 -42.2 1.72 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.463 1.506 . . . . 0.0 110.361 -178.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -39.4 89.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.41 164.94 26.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.09 140.74 40.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.933 0.893 . . . . 0.0 108.961 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ttt-85 -29.24 -50.48 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.289 2.235 . . . . 0.0 113.234 173.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.14 -45.5 84.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.329 0.968 . . . . 0.0 111.366 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.25 -54.5 45.07 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.881 0.848 . . . . 0.0 109.017 177.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.6 mt -47.38 -57.84 4.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.371 1.468 . . . . 0.0 109.867 176.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -43.82 -55.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.622 1.169 . . . . 0.0 109.74 178.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.61 -43.16 89.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.35 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.85 84.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.394 -0.816 . . . . 0.0 109.573 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.35 -42.52 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.902 1.281 . . . . 0.0 109.79 177.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.12 -52.52 64.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.305 0.957 . . . . 0.0 109.032 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -54.25 -54.02 45.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.4 ttm -47.1 -56.16 7.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 110.079 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.15 -33.27 73.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.557 -0.714 . . . . 0.0 112.431 177.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 m -74.66 43.44 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.179 0.9 . . . . 0.0 112.367 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.1 p -135.81 -17.06 1.7 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.196 1.799 . . . . 0.0 109.819 173.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.445 -1.264 . . . . 0.0 109.569 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.26 -58.98 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.12 1.368 . . . . 0.0 110.643 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -56.62 -52.41 64.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 0.0 112.087 -178.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.22 -44.94 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.246 -174.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.82 44.66 0.19 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.57 38.14 0.95 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 176.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.33 159.5 42.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.845 2.058 . . . . 0.0 107.378 177.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.94 113.68 6.41 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.265 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.61 152.05 13.24 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 120.307 1.145 . . . . 0.0 111.33 -15.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.61 116.81 7.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.507 1.123 . . . . 0.0 108.6 177.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -46.68 -48.25 20.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.546 0.738 . . . . 0.0 110.788 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -45.92 -46.35 16.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.212 1.805 . . . . 0.0 112.739 178.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -52.04 -29.66 22.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.143 0.429 . . . . 0.0 112.051 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.83 -56.97 2.24 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.777 0.262 . . . . 0.0 110.644 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -66.92 -32.76 74.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -173.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.81 -43.04 76.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 119.103 0.865 . . . . 0.0 109.139 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.12 -26.6 39.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.625 -177.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.55 50.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -176.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.97 141.01 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.61 29.17 5.29 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 0.0 111.394 -177.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.61 28.41 71.03 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.754 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.09 134.84 84.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.862 1.331 . . . . 0.0 108.368 175.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.91 111.99 1.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.6 2.2 . . . . 0.0 107.984 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -84.87 175.82 8.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.978 0.894 . . . . 0.0 111.425 -174.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.48 154.34 41.61 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 171.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 48.28 32.96 3.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.312 1.845 . . . . 0.0 112.661 178.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.86 59.25 4.11 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 109.666 178.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -47.62 -41.72 30.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.054 3.169 . . . . 0.0 113.053 -174.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -47.75 -37.67 13.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.903 0.881 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.52 -27.71 56.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.198 0.454 . . . . 0.0 111.37 -178.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -92.09 -13.3 31.03 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.57 0.748 . . . . 0.0 111.616 -177.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.72 -45.16 0.36 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.274 1.83 . . . . 0.0 112.899 177.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -113.74 28.6 8.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.121 0.968 . . . . 0.0 112.552 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -115.13 119.61 38.38 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.514 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.69 118.7 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.761 2.307 . . . . 0.0 110.786 177.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 -22.17 66.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.073 0.549 . . . . 0.0 111.343 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.04 103.65 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.087 2.155 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -49.34 -44.23 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.638 0.775 . . . . 0.0 109.706 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.98 -34.0 54.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.172 1.789 . . . . 0.0 112.295 177.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.47 -51.16 8.08 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.1 mt -52.79 -38.81 61.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.702 0.801 . . . . 0.0 112.34 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.61 -38.46 75.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 119.243 0.928 . . . . 0.0 109.984 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.16 -45.52 80.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.708 1.14 . . . . 0.0 108.911 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 m -53.5 -44.97 69.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -70.76 -44.75 66.07 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.103 -0.373 . . . . 0.0 110.8 -178.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -57.53 -52.19 66.43 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 121.393 -0.817 . . . . 0.0 109.999 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.76 65.05 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.943 0.897 . . . . 0.0 111.817 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.29 159.38 34.71 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -175.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -162.16 139.4 8.33 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.78 -138.57 48.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 108.284 -1.926 . . . . 0.0 108.284 -175.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.11 -21.03 66.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.689 -0.755 . . . . 0.0 111.835 176.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.7 ttp -65.49 117.04 36.88 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 119.663 1.12 . . . . 0.0 110.888 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.42 153.64 55.58 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.327 2.018 . . . . 0.0 110.021 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 123.46 16.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.333 0.653 . . . . 0.0 109.947 178.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -90.25 -4.44 57.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.844 0.747 . . . . 0.0 111.992 177.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -44.16 114.33 0.66 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.491 1.116 . . . . 0.0 111.893 176.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.71 -21.2 19.9 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.292 0.948 . . . . 0.0 112.898 178.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -87.71 -44.49 11.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.974 0.909 . . . . 0.0 109.298 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 126.93 45.9 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.64 152.37 28.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -30.55 -46.76 0.08 Allowed 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 126.07 1.748 . . . . 0.0 111.686 170.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.08 -50.49 73.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.583 1.083 . . . . 0.0 111.923 178.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -57.04 -54.93 41.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.096 1.358 . . . . 0.0 109.202 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.6 mt -50.33 -57.55 7.64 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 125.989 1.716 . . . . 0.0 109.711 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.64 -56.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.882 1.273 . . . . 0.0 109.668 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -57.94 -39.23 77.56 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.136 0.575 . . . . 0.0 111.634 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.69 -48.12 64.7 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.539 -0.726 . . . . 0.0 109.777 177.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.37 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.084 1.353 . . . . 0.0 110.768 -176.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.37 -39.54 87.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.949 1.249 . . . . 0.0 109.763 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.53 -59.54 5.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 85.9 mtp -41.33 -64.75 0.51 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.619 1.168 . . . . 0.0 108.709 177.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 mt -46.64 -31.98 3.21 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.845 2.058 . . . . 0.0 113.371 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 m -64.87 -4.86 4.9 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.512 1.051 . . . . 0.0 112.287 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.3 p -154.33 22.85 0.48 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.685 3.994 . . . . 0.0 106.0 -179.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 C-N-CA 128.257 2.623 . . . . 0.0 113.795 -170.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 119.717 -0.182 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.72 -56.48 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 0.0 109.889 -178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -56.95 -47.19 81.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.992 0.917 . . . . 0.0 111.264 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.92 -64.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.357 -175.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -141.5 43.81 1.74 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.77 0.714 . . . . 0.0 111.374 -173.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.69 36.89 1.22 Allowed Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.225 -0.922 . . . . 0.0 112.304 177.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.97 155.43 48.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.31 1.844 . . . . 0.0 107.703 176.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.06 113.28 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.572 -177.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.71 142.91 12.57 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.045 1.052 . . . . 0.0 110.363 -14.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -67.83 128.66 37.33 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.503 -178.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.2 m -54.38 -48.15 71.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.39 0.676 . . . . 0.0 111.149 -175.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -42.47 -54.65 3.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.184 1.793 . . . . 0.0 112.105 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.7 -35.69 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.236 1.414 . . . . 0.0 112.878 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.0 m -100.78 -57.28 2.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.559 0.343 . . . . 0.0 111.414 -178.024 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -70.5 -35.12 73.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -41.59 88.77 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -74.98 -31.33 61.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.291 1.436 . . . . 0.0 111.344 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.62 33.73 51.27 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -175.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.15 143.08 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 122.096 -0.649 . . . . 0.0 109.744 -176.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.47 32.61 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.361 1.064 . . . . 0.0 111.834 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.0 22.3 77.12 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.443 -0.643 . . . . 0.0 113.095 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 136.23 83.27 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.689 1.245 . . . . 0.0 107.745 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.36 123.12 13.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.049 1.833 . . . . 0.0 109.969 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.89 169.45 17.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.267 1.032 . . . . 0.0 110.172 -178.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.87 151.12 19.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.096 179.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.81 37.36 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.49 68.34 31.6 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.517 0.727 . . . . 0.0 111.915 -175.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -38.98 -51.42 2.43 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.653 3.569 . . . . 0.0 114.867 -177.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.98 -40.25 21.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.346 1.059 . . . . 0.0 111.988 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.21 -22.38 66.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.469 0.707 . . . . 0.0 111.884 -177.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -110.15 -30.21 7.85 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.747 1.219 . . . . 0.0 112.607 -175.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.31 -51.03 1.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.68 1.592 . . . . 0.0 113.021 -178.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.22 -26.42 56.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -78.24 142.38 63.33 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.121 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.48 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.179 2.586 . . . . 0.0 108.257 173.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -20.65 55.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.892 1.677 . . . . 0.0 113.639 -170.007 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -50.12 115.83 1.59 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.886 1.274 . . . . 0.0 110.651 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.3 t -48.18 -46.21 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.445 0.698 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.95 -24.31 64.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.853 0.861 . . . . 0.0 113.02 -178.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.29 -54.56 4.13 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 mt -47.84 -43.32 28.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -59.91 -37.05 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 121.915 -0.491 . . . . 0.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.3 -44.42 79.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -47.32 72.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.162 0.506 . . . . 0.0 110.19 174.325 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -62.57 -45.99 90.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.9 mt -58.26 -51.83 68.11 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.59 -0.694 . . . . 0.0 109.226 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.06 79.63 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.093 0.557 . . . . 0.0 112.151 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.94 157.19 32.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 108.299 -1.921 . . . . 0.0 108.299 -174.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -156.38 129.48 7.99 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.816 -0.814 . . . . 0.0 109.034 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 -136.85 50.45 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.24 -23.62 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.811 176.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -65.88 115.5 23.49 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 111.147 -177.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.45 162.32 27.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.655 2.237 . . . . 0.0 111.255 177.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 136.66 43.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.83 -8.02 19.02 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.093 0.957 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -43.42 115.89 0.85 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.321 1.848 . . . . 0.0 111.714 177.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.67 -23.24 9.11 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.912 0.768 . . . . 0.0 112.559 177.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -83.92 -46.83 11.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.924 0.862 . . . . 0.0 108.746 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.29 138.1 37.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.58 25.93 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -173.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 62.19 -41.4 0.16 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.224 2.21 . . . . 0.0 111.979 -173.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -64.81 -36.85 85.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.323 -1.485 . . . . 0.0 110.198 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.92 -58.36 7.21 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 123.229 1.49 . . . . 0.0 108.547 178.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.08 -58.64 6.84 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 126.484 1.914 . . . . 0.0 110.022 178.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -41.94 -54.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.481 0.713 . . . . 0.0 110.451 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -61.71 -40.53 95.38 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.77 71.56 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.554 -0.717 . . . . 0.0 110.082 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.21 -48.04 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.838 2.055 . . . . 0.0 110.38 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.74 -44.17 90.44 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.891 1.223 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -61.77 -52.59 63.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 ttm -46.17 -50.26 15.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 110.513 179.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.84 -35.39 80.95 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.124 -0.36 . . . . 0.0 110.823 178.131 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -74.8 59.14 0.86 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.588 0.755 . . . . 0.0 111.218 178.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 -40.57 0.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.739 2.016 . . . . 0.0 108.979 176.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.344 2.657 . . . . 0.0 111.213 179.441 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mt -70.68 -35.56 61.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -60.56 -45.02 95.47 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.346 -1.471 . . . . 0.0 109.989 176.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 mt -82.4 -28.82 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.548 -0.72 . . . . 0.0 111.545 -177.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -125.97 38.09 4.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.724 1.209 . . . . 0.0 110.707 -174.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.76 46.85 2.08 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 129.488 3.423 . . . . 0.0 112.041 -178.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.259 3.1 p 69.73 -142.11 0.08 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.414 1.885 . . . . 0.0 111.553 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.31 124.56 29.43 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 124.307 1.043 . . . . 0.0 110.863 -172.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -62.56 177.73 9.52 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 119.541 0.872 . . . . 0.0 110.112 -18.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 136.85 33.27 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 m -54.62 -51.62 64.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.306 0.643 . . . . 0.0 110.222 -176.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -40.91 -61.34 0.99 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.518 1.927 . . . . 0.0 112.817 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.72 -35.02 13.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.042 0.937 . . . . 0.0 112.55 -178.267 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.5 m -85.92 -59.9 2.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 118.594 0.634 . . . . 0.0 110.165 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -61.23 -50.81 71.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.643 0.777 . . . . 0.0 113.028 -173.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.86 -39.68 71.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.199 0.454 . . . . 0.0 110.994 -178.463 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -88.23 -2.07 58.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.078 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 35.68 82.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.389 0.995 . . . . 0.0 112.443 -177.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.79 130.75 17.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 O-C-N 121.931 -0.746 . . . . 0.0 109.195 -179.242 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.92 31.41 8.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 111.479 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.67 78.95 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.355 -0.692 . . . . 0.0 112.568 179.749 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.43 137.9 68.71 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.578 1.189 . . . . 0.0 108.53 176.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.72 121.06 9.13 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.239 1.959 . . . . 0.0 109.098 -179.032 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.42 166.56 23.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.404 1.097 . . . . 0.0 112.359 -174.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.3 164.38 26.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.66 53.32 0.46 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.173 1.389 . . . . 0.0 111.735 -178.713 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.67 68.13 19.47 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.702 -176.094 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.89 -48.59 2.78 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.453 3.435 . . . . 0.0 114.44 -177.351 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -50.61 -40.53 52.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.05 -23.85 66.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.339 0.655 . . . . 0.0 111.535 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -105.51 -30.71 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.348 1.059 . . . . 0.0 112.749 -174.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.54 -50.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.784 1.634 . . . . 0.0 112.998 -178.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.9 -22.31 42.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -78.99 158.06 75.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.569 -0.707 . . . . 0.0 110.377 -177.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.52 108.91 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.886 2.391 . . . . 0.0 110.939 176.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.87 -37.02 75.6 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 m -59.69 107.97 0.67 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.752 1.621 . . . . 0.0 111.555 178.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -48.41 -41.92 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.494 1.118 . . . . 0.0 110.405 178.182 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.0 -27.16 17.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.231 1.412 . . . . 0.0 112.869 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.26 -49.57 7.17 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 mt -51.14 -39.44 56.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.875 0.87 . . . . 0.0 112.457 179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.15 -33.16 49.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.652 177.571 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.17 -49.59 71.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.48 1.491 . . . . 0.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -51.83 -47.2 64.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.067 0.947 . . . . 0.0 110.114 175.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -66.87 -42.16 86.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.212 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.99 -56.13 24.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.04 -27.92 57.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.233 1.013 . . . . 0.0 112.869 -176.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 164.69 29.11 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -175.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -157.96 112.15 2.57 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -113.48 5.1 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -178.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.26 -31.33 65.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.969 0.508 . . . . 0.0 111.243 178.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.2 ttp -64.7 118.47 48.54 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.55 -176.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.5 157.5 40.63 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.742 2.295 . . . . 0.0 110.058 179.068 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 139.05 58.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.969 0.508 . . . . 0.0 110.685 178.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -114.53 -0.45 13.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.84 0.856 . . . . 0.0 111.63 175.436 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -46.67 117.86 1.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.232 1.013 . . . . 0.0 111.781 175.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.31 -19.62 21.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.1 0.857 . . . . 0.0 112.548 179.73 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -88.95 -45.18 9.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.489 1.115 . . . . 0.0 108.662 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.5 123.09 42.09 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.95 146.05 48.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -25.65 -52.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.449 2.3 . . . . 0.0 112.01 168.058 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.1 -45.64 84.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.86 0.464 . . . . 0.0 111.788 -178.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.17 -48.51 79.77 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -52.34 -59.48 4.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 t -42.77 -59.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.288 1.035 . . . . 0.0 109.673 177.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -54.99 -42.69 72.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 118.37 0.532 . . . . 0.0 112.335 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.65 -53.67 47.7 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -55.36 -44.14 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.609 1.163 . . . . 0.0 110.262 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -56.02 -55.59 31.01 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 118.784 0.72 . . . . 0.0 109.097 177.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -55.19 -51.28 67.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.297 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 ttm -48.58 -62.14 1.66 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.603 1.161 . . . . 0.0 109.326 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.55 -35.58 68.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.485 0.714 . . . . 0.0 111.661 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 m -62.95 -5.54 3.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.472 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -87.9 -14.67 38.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.484 1.493 . . . . 0.0 111.004 175.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 116.718 -1.61 . . . . 0.0 110.401 -177.883 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.38 -55.93 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.843 0.747 . . . . 0.0 109.842 179.189 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -63.54 -43.01 98.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -178.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.75 -45.17 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 112.091 -172.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -151.41 -10.9 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.78 3.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.026 1.285 . . . . 0.0 111.442 -176.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -136.08 147.16 47.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.256 1.822 . . . . 0.0 106.766 177.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.5 109.23 10.26 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.813 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.24 159.87 30.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 CA-C-N 120.193 1.105 . . . . 0.0 111.85 -8.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -74.18 122.58 22.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.117 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -54.4 -51.6 64.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.548 0.69 . . . . 0.0 110.102 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -39.68 -61.37 0.84 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.006 2.122 . . . . 0.0 112.419 179.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -42.92 -43.49 4.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.002 1.321 . . . . 0.0 113.068 -177.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.31 -55.61 3.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.463 0.305 . . . . 0.0 111.305 -177.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -64.75 -33.97 77.22 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.863 0.865 . . . . 0.0 113.172 -173.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.83 -48.02 82.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.544 0.611 . . . . 0.0 109.355 177.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -73.05 -30.58 63.82 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.229 0.612 . . . . 0.0 111.31 179.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.35 49.45 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -174.664 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.67 141.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.11 31.5 6.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.287 1.035 . . . . 0.0 111.668 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.61 76.38 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.993 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.25 87.58 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.564 1.182 . . . . 0.0 108.674 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -62.75 114.97 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.74 2.293 . . . . 0.0 108.764 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -80.93 174.23 11.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.729 0.776 . . . . 0.0 112.667 -172.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.6 160.64 16.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 170.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.73 51.88 0.96 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.176 1.39 . . . . 0.0 112.419 176.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.33 59.01 19.09 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 123.807 0.843 . . . . 0.0 111.005 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -38.56 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.558 3.505 . . . . 0.0 114.025 -177.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -47.66 -40.8 20.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.402 1.481 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.94 -26.09 53.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.637 -177.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -91.6 -26.08 18.88 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.587 0.755 . . . . 0.0 111.736 -177.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.14 -46.33 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.159 2.184 . . . . 0.0 114.437 -178.129 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -91.91 -15.14 28.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.441 0.697 . . . . 0.0 112.816 -175.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -81.08 148.78 64.92 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.489 0.716 . . . . 0.0 109.655 -177.496 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.34 129.41 28.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.58 2.186 . . . . 0.0 111.157 176.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -67.21 -40.84 86.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.415 0.626 . . . . 0.0 110.348 179.203 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.74 110.32 1.13 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.393 1.477 . . . . 0.0 111.425 -177.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.74 -36.78 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.21 1.004 . . . . 0.0 109.891 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.48 -33.71 63.91 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.356 1.863 . . . . 0.0 111.343 177.49 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -83.4 -50.67 8.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -51.73 -38.12 53.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 118.946 -1.101 . . . . 0.0 110.467 177.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.15 -44.9 83.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.734 1.606 . . . . 0.0 109.409 -179.418 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -58.04 -33.05 68.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 110.468 174.312 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -75.73 -47.47 25.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.179 0.991 . . . . 0.0 110.007 -179.167 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.8 -48.06 73.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 120.598 -1.314 . . . . 0.0 110.099 174.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.32 74.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 112.692 -178.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.9 162.63 29.88 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -175.074 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.1 129.63 4.49 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.769 0.784 . . . . 0.0 109.083 -178.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.89 -120.28 21.78 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -177.696 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.2 -13.92 48.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.916 177.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.0 ttp -66.53 117.16 41.52 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 119.254 0.934 . . . . 0.0 110.38 -178.261 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.27 159.72 38.21 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.346 2.031 . . . . 0.0 111.064 177.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.83 118.58 10.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -82.02 -4.22 56.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.467 1.031 . . . . 0.0 113.205 -179.092 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.57 86.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.292 1.037 . . . . 0.0 112.484 -179.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 128.02 -33.97 3.08 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.548 1.547 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -78.33 -34.76 48.36 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.667 0.734 . . . . 0.0 110.936 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.39 146.01 36.06 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.99 138.94 31.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -30.59 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.274 2.23 . . . . 0.0 113.028 173.111 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.17 -57.64 11.96 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.619 0.645 . . . . 0.0 110.441 177.808 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.49 -53.71 47.56 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.98 0.895 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.5 mt -47.73 -55.27 9.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.85 1.66 . . . . 0.0 110.561 176.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.22 -58.67 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -54.51 -37.36 65.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.117 0.567 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.1 82.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.36 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.54 -47.38 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.507 178.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -45.25 -56.43 4.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.605 1.093 . . . . 0.0 109.751 176.56 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -55.66 -52.66 63.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.917 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 ptm -54.85 -43.62 73.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.533 0.606 . . . . 0.0 110.251 -178.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.3 mt -69.71 -29.78 67.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.625 -0.672 . . . . 0.0 111.057 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 m -73.96 43.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.036 0.834 . . . . 0.0 112.678 179.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -135.89 -13.83 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.783 2.033 . . . . 0.0 109.914 174.155 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.035 -179.109 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.827 0.346 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.81 -40.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.835 0.854 . . . . 0.0 110.586 -177.554 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -64.68 -41.66 95.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.962 0.801 . . . . 0.0 110.247 177.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.35 -47.61 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 110.74 88.1 0.0 OUTLIER 'General case' 0 C--N 1.345 0.411 0 C-N-CA 130.612 3.565 . . . . 0.0 114.009 162.397 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.41 -20.43 58.8 Favored Glycine 0 CA--C 1.551 2.301 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 156.192 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 163.92 3.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 129.214 3.006 . . . . 0.0 111.356 175.067 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.43 124.86 9.89 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.248 1.419 . . . . 0.0 107.494 177.281 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.65 178.46 5.8 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 CA-C-N 120.525 1.223 . . . . 0.0 112.464 -8.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 109.01 21.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 110.295 179.598 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -41.54 -53.8 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.388 1.475 . . . . 0.0 109.943 176.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -44.1 -55.4 4.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.267 2.227 . . . . 0.0 111.513 -178.168 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -50.22 -37.46 35.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.492 0.717 . . . . 0.0 112.332 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 m -84.34 -59.45 2.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 110.325 -179.496 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -59.91 -42.49 93.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.956 1.302 . . . . 0.0 113.069 -174.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.63 -38.54 90.63 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.453 0.569 . . . . 0.0 110.015 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -25.3 41.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.43 0.692 . . . . 0.0 111.17 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.99 64.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.44 138.46 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.75 29.3 5.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.331 1.053 . . . . 0.0 111.72 -177.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.06 23.97 74.87 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.804 179.354 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 129.61 84.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 118.566 1.183 . . . . 0.0 108.362 176.423 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.22 122.04 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.256 1.971 . . . . 0.0 109.742 -179.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -86.97 178.32 6.98 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.641 0.734 . . . . 0.0 111.805 -174.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.65 163.45 27.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 171.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 m120 48.07 34.39 4.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.681 0.792 . . . . 0.0 112.865 175.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.05 62.23 62.87 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.7 0.682 . . . . 0.0 112.384 -174.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -39.77 -51.55 2.92 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.151 3.234 . . . . 0.0 114.801 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.66 -40.95 41.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.776 0.831 . . . . 0.0 112.079 -179.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.8 -19.94 64.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.269 0.628 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.32 -35.88 8.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 111.803 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.27 -51.71 1.05 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.053 1.741 . . . . 0.0 113.131 -178.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.7 -24.44 53.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.99 157.38 81.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 O-C-N 121.621 -0.674 . . . . 0.0 110.117 -177.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.08 113.97 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.025 2.483 . . . . 0.0 111.583 178.172 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.46 -36.09 75.3 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 110.602 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 106.08 0.48 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.444 1.498 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.3 -36.03 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 121.844 -0.535 . . . . 0.0 109.563 176.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.99 -24.26 57.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.102 0.961 . . . . 0.0 112.528 177.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -89.34 -49.8 6.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.62 -40.99 41.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.32 -37.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 O-C-N 121.44 -0.787 . . . . 0.0 110.157 179.088 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.59 -47.77 80.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.436 1.016 . . . . 0.0 108.366 177.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -53.93 -37.62 64.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.124 0.17 . . . . 0.0 110.754 175.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.5 m -74.06 -48.7 28.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.911 -0.493 . . . . 0.0 110.713 -177.641 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.62 81.31 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.66 -35.04 60.5 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.38 0.672 . . . . 0.0 111.809 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 152.31 23.66 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -176.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -153.53 141.46 20.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -119.93 18.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.07 3.48 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.839 0.855 . . . . 0.0 112.095 178.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.6 ttp -69.74 123.65 89.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.047 0.84 . . . . 0.0 110.144 -178.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.26 145.15 59.12 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.568 1.512 . . . . 0.0 108.622 176.192 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.86 57.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.416 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -97.56 -36.82 10.17 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.109 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 t70 38.76 -144.52 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.228 2.211 . . . . 0.0 111.76 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.4 -20.4 5.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.999 2.238 . . . . 0.0 113.211 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -61.84 -30.3 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.483 1.141 . . . . 0.0 109.614 176.594 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.15 106.91 11.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -63.11 86.84 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.432 1.893 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 16.37 -64.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.516 3.526 . . . . 0.0 115.513 174.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -50.25 -35.79 28.42 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 111.065 178.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.27 -55.31 29.59 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.69 0.757 . . . . 0.0 109.588 178.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.4 mt -52.49 -53.56 44.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.738 1.215 . . . . 0.0 109.551 176.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.2 t -44.6 -58.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.453 1.101 . . . . 0.0 109.603 176.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -57.04 -39.76 75.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 118.891 0.768 . . . . 0.0 112.461 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.28 96.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.4 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.32 -47.14 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 108.74 179.318 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -52.69 -51.81 58.7 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -55.37 -54.36 44.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.072 178.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -52.1 -47.96 64.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.096 0.559 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.76 -35.62 80.4 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.861 -0.525 . . . . 0.0 110.312 177.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.5 m -73.5 39.08 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.391 -0.818 . . . . 0.0 113.2 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.8 p -131.16 -14.32 3.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.979 1.711 . . . . 0.0 109.764 173.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.516 -1.707 . . . . 0.0 110.135 -178.446 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.21 -57.99 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.607 1.163 . . . . 0.0 109.37 178.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -56.95 -48.26 78.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.125 0.57 . . . . 0.0 111.763 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.34 -48.49 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.231 -174.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -5.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -172.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.23 37.46 3.51 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.072 1.306 . . . . 0.0 111.144 -176.061 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.6 151.46 49.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.422 1.489 . . . . 0.0 108.131 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.74 13.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.59 1.156 . . . . 0.0 109.695 -177.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.55 162.02 44.69 Favored 'Cis proline' 0 N--CA 1.455 -0.758 0 CA-C-N 120.266 1.131 . . . . 0.0 109.544 -13.163 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -67.97 129.1 38.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.776 0.83 . . . . 0.0 110.467 -177.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.48 -46.85 83.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 -178.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 p -39.16 -55.19 1.68 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.709 2.004 . . . . 0.0 112.74 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -43.09 -38.03 2.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.666 1.186 . . . . 0.0 112.916 -178.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.34 -57.14 2.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.15 -177.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -70.27 -24.23 63.02 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -172.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.47 -54.82 38.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.036 0.834 . . . . 0.0 109.89 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -16.28 28.02 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.442 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 45.84 7.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 p -58.7 141.33 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.09 29.1 5.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.019 0.928 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.84 75.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.814 179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 137.1 88.34 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 118.787 1.294 . . . . 0.0 108.208 175.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.42 117.34 4.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.552 2.168 . . . . 0.0 109.782 -178.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -76.31 175.87 8.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.943 0.877 . . . . 0.0 109.282 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.47 149.78 21.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 63.25 31.11 15.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.413 0.685 . . . . 0.0 109.506 -173.713 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.58 57.77 27.19 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.04 0.936 . . . . 0.0 112.618 -177.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -34.36 -48.14 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 114.267 -179.464 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -39.65 -46.79 1.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.006 1.722 . . . . 0.0 112.68 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -76.55 -29.54 56.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.146 0.43 . . . . 0.0 111.522 -177.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -85.36 -20.69 29.53 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.403 0.681 . . . . 0.0 111.43 -177.034 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.58 -45.46 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.448 1.899 . . . . 0.0 113.758 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -94.08 -14.96 25.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.795 0.838 . . . . 0.0 112.825 -177.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -79.88 127.24 78.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.945 0.898 . . . . 0.0 109.093 -177.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.44 126.35 19.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.602 2.202 . . . . 0.0 111.558 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -65.68 -27.07 68.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.314 0.646 . . . . 0.0 111.126 179.568 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.0 102.68 0.05 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 111.243 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -42.52 -51.17 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 124.211 1.004 . . . . 0.0 110.195 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -51.7 -44.54 63.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.98 -47.59 82.5 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.16 -38.65 87.23 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.649 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.26 -40.3 88.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -60.39 -48.92 79.67 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.282 0.946 . . . . 0.0 109.547 174.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -54.06 -43.87 70.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.499 0.59 . . . . 0.0 111.158 177.459 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -69.04 -44.71 72.11 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.91 -0.494 . . . . 0.0 110.011 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -55.4 -53.29 58.12 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.369 -0.832 . . . . 0.0 110.601 177.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.05 -26.01 43.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.72 1.208 . . . . 0.0 113.342 -176.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.86 160.66 31.87 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.145 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -158.21 119.98 3.59 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.91 -119.34 17.44 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -178.443 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.6 -21.46 55.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.761 0.424 . . . . 0.0 111.598 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.0 ttp -69.0 121.96 83.51 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 118.795 0.725 . . . . 0.0 110.236 -177.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.7 157.28 39.91 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.57 2.18 . . . . 0.0 110.179 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.49 123.0 16.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.324 177.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -89.72 -10.21 46.53 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.223 0.92 . . . . 0.0 112.71 178.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -50.01 111.8 0.57 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.927 0.491 . . . . 0.0 110.436 178.735 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.81 -36.96 4.0 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.477 1.037 . . . . 0.0 111.72 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.2 mtm-85 -85.41 -47.62 9.8 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.13 0.965 . . . . 0.0 110.052 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.75 126.91 53.83 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.404 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.34 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -25.92 -52.13 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.181 2.192 . . . . 0.0 112.074 170.342 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -60.28 -49.86 75.92 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.433 0.56 . . . . 0.0 111.576 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -55.47 -55.61 29.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 122.139 0.971 . . . . 0.0 109.024 178.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.7 mt -49.7 -58.92 4.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.946 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.67 -55.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.672 1.589 . . . . 0.0 110.587 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -58.54 -44.16 89.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.224 0.61 . . . . 0.0 111.199 -178.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.67 -45.08 88.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.695 -0.628 . . . . 0.0 109.938 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.59 -46.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.614 1.166 . . . . 0.0 111.303 -175.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.28 -42.06 90.38 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.28 1.4 . . . . 0.0 109.402 178.28 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -62.29 -50.04 73.25 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.6 ttm -48.89 -52.95 21.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.846 0.858 . . . . 0.0 109.264 178.587 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.53 -39.12 89.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.106 0.562 . . . . 0.0 111.745 178.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.2 p -62.4 -8.61 6.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.45 1.023 . . . . 0.0 113.536 -177.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 p -79.26 -14.75 58.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.519 1.054 . . . . 0.0 111.007 176.115 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.603 -1.665 . . . . 0.0 111.03 -174.888 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.572 0.701 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.72 -54.98 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.888 1.275 . . . . 0.0 108.873 -178.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -60.3 -47.15 87.25 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.217 0.462 . . . . 0.0 111.495 -177.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mm -70.78 -46.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.558 -172.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -149.95 -11.71 0.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.098 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.11 35.37 4.29 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 120.114 1.324 . . . . 0.0 111.773 -174.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -135.56 152.39 51.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.956 1.303 . . . . 0.0 108.051 177.634 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.744 -178.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 158.92 26.32 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 119.941 1.015 . . . . 0.0 111.853 -10.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 122.0 19.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.338 1.055 . . . . 0.0 109.712 179.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.26 -50.52 61.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 0.0 110.379 -178.145 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -40.28 -55.83 2.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.445 1.898 . . . . 0.0 112.695 178.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.1 m -46.04 -32.48 2.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 113.01 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -99.05 -57.04 2.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.044 0.384 . . . . 0.0 111.026 179.444 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -68.44 -32.27 72.18 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.65 -42.7 86.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 118.828 0.74 . . . . 0.0 109.126 179.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.94 -27.96 35.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.313 -178.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.75 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 139.9 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.141 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.21 28.56 5.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.088 0.955 . . . . 0.0 111.546 -177.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.44 24.11 76.82 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.365 -0.686 . . . . 0.0 112.857 179.597 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.57 131.78 77.36 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.767 1.283 . . . . 0.0 108.498 175.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -60.47 117.56 4.33 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 109.28 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -89.21 178.86 6.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.749 0.785 . . . . 0.0 112.771 -171.213 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.99 159.21 23.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.16 53.87 0.73 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.685 1.594 . . . . 0.0 112.541 177.053 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.57 59.34 24.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.171 0.989 . . . . 0.0 110.461 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.66 -52.45 2.59 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.455 3.437 . . . . 0.0 114.489 -175.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -49.87 -35.08 22.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.246 1.018 . . . . 0.0 112.765 -179.26 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.43 -28.17 60.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.783 0.72 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -91.86 -30.2 16.3 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.568 0.747 . . . . 0.0 111.981 -177.154 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.89 -51.14 0.69 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.647 1.979 . . . . 0.0 113.484 -178.003 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.44 -25.28 54.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.764 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.98 152.65 82.56 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 110.033 -177.167 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.73 110.64 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.538 1.492 . . . . 0.0 108.482 176.038 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.52 -28.96 57.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -53.48 103.85 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.884 1.674 . . . . 0.0 111.444 178.402 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.6 t -51.14 -39.64 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.555 0.742 . . . . 0.0 110.337 178.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.97 -23.46 45.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.383 1.073 . . . . 0.0 112.679 179.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -90.55 -53.04 4.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.374 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -49.84 -39.81 40.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.114 0.966 . . . . 0.0 112.506 179.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -33.81 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 121.664 -0.648 . . . . 0.0 110.266 179.103 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.45 -46.87 78.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.453 1.024 . . . . 0.0 108.735 176.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -53.54 -44.45 69.2 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -65.95 -47.61 74.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.078 0.551 . . . . 0.0 110.684 -179.5 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.24 -49.1 79.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.359 -0.838 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.79 61.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.394 1.078 . . . . 0.0 112.572 -177.588 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.36 161.32 31.45 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -175.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -159.62 114.4 2.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.581 0.69 . . . . 0.0 109.725 -177.216 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.67 -117.76 12.61 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.108 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.201 177.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.8 ttp -65.63 119.2 58.31 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.33 -177.469 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.02 160.78 46.67 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.29 1.994 . . . . 0.0 110.154 178.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.19 117.35 9.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -82.16 -7.77 59.63 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.646 0.657 . . . . 0.0 112.368 178.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -49.88 113.64 0.89 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.821 0.737 . . . . 0.0 110.321 176.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.7 -28.95 9.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.061 0.838 . . . . 0.0 112.121 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -76.07 -43.91 41.46 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.646 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.9 49.83 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.831 0.852 . . . . 0.0 108.73 176.875 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -88.95 132.89 34.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -29.65 -47.4 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.402 2.281 . . . . 0.0 113.391 173.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -69.01 -41.7 77.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 111.312 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 -46.5 83.0 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.737 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -51.99 -61.12 2.46 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.557 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 t -41.12 -56.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.348 1.459 . . . . 0.0 109.594 177.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.8 -44.01 73.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.926 0.49 . . . . 0.0 111.512 179.658 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -48.2 75.67 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.707 -0.62 . . . . 0.0 109.852 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.5 mt -57.52 -50.42 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 123.871 0.868 . . . . 0.0 110.602 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -40.76 96.46 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 120.253 1.388 . . . . 0.0 109.294 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -57.76 -50.62 72.62 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.724 0.693 . . . . 0.0 109.561 176.885 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.66 -52.82 54.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 178.385 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.81 -33.8 68.98 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.745 -0.597 . . . . 0.0 111.839 176.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -73.01 38.0 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.402 1.001 . . . . 0.0 113.423 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.9 p -132.01 -15.77 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.314 1.845 . . . . 0.0 109.479 171.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.724 179.96 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -44.94 -57.39 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.293 1.037 . . . . 0.0 110.508 -178.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.74 -47.21 72.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.919 0.487 . . . . 0.0 111.721 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.55 -46.79 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -172.686 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -145.22 -5.06 0.69 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -170.608 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.43 33.95 6.17 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 120.168 1.349 . . . . 0.0 112.042 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.64 150.52 51.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.119 1.768 . . . . 0.0 107.403 177.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.58 109.62 14.69 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 0.0 110.272 -177.172 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.01 163.07 50.14 Favored 'Cis proline' 0 N--CA 1.455 -0.79 0 CA-C-N 120.292 1.14 . . . . 0.0 110.065 -10.725 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -69.17 129.42 39.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.327 1.051 . . . . 0.0 110.177 -178.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -59.19 -46.51 88.22 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.443 0.639 . . . . 0.0 111.044 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -37.27 -57.19 0.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.207 2.203 . . . . 0.0 112.168 179.24 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.15 -34.52 0.18 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.512 1.925 . . . . 0.0 113.677 -178.417 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.55 -57.89 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.497 0.719 . . . . 0.0 110.625 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -64.27 -24.07 67.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -172.212 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -73.59 -22.0 60.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 119.986 1.266 . . . . 0.0 111.052 177.231 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -107.5 -24.76 11.68 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.91 0.884 . . . . 0.0 111.683 -178.304 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.35 32.62 51.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.78 140.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.57 28.8 6.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -177.192 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.98 77.0 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.319 -0.712 . . . . 0.0 112.892 179.39 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 130.76 82.88 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 118.798 1.299 . . . . 0.0 108.644 176.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.14 121.73 9.49 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.601 2.201 . . . . 0.0 108.648 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -89.28 178.67 6.28 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.954 0.883 . . . . 0.0 113.277 -171.335 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.9 160.92 29.8 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.729 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.78 52.9 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.769 1.628 . . . . 0.0 111.674 177.165 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.23 64.34 19.71 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 110.456 -177.518 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -38.68 -50.55 2.43 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.302 3.335 . . . . 0.0 114.099 -177.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -49.22 -39.98 31.92 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.179 0.992 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -64.16 -28.65 69.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.259 0.624 . . . . 0.0 111.337 -179.15 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.83 -27.01 13.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.712 1.205 . . . . 0.0 112.384 -174.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.84 -43.88 0.98 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.061 1.744 . . . . 0.0 113.744 -178.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.8 -15.89 25.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.586 0.754 . . . . 0.0 112.771 -176.373 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.3 133.93 44.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 109.597 -177.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.19 105.32 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.991 2.461 . . . . 0.0 110.302 176.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.98 -24.87 63.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.876 0.87 . . . . 0.0 113.038 -175.56 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -52.48 102.24 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.441 1.497 . . . . 0.0 111.424 179.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.0 t -47.6 -45.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.293 1.037 . . . . 0.0 110.255 179.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.35 -29.32 58.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.915 1.286 . . . . 0.0 112.168 -179.014 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -86.19 -50.73 6.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.431 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.3 mt -50.46 -40.94 52.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.062 0.545 . . . . 0.0 112.21 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -59.6 -30.8 45.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.984 178.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.7 -50.04 68.54 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.224 1.375 . . . . 0.0 108.471 177.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -53.81 -42.67 68.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.173 0.589 . . . . 0.0 110.128 176.238 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -68.22 -44.36 75.9 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.813 0.34 . . . . 0.0 110.681 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.66 -47.24 86.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.83 -31.19 51.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 112.716 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 159.0 28.58 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -175.075 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -156.77 124.55 5.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.86 -114.89 6.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.3 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.67 -18.86 33.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.738 0.815 . . . . 0.0 112.028 178.243 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.4 ttp -62.25 124.57 82.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 118.948 0.795 . . . . 0.0 110.439 -176.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.49 158.24 51.44 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.082 1.854 . . . . 0.0 109.31 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 114.5 6.57 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.78 -7.41 58.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.306 179.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.74 113.18 0.66 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.842 0.747 . . . . 0.0 110.936 177.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 -27.18 11.55 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.164 0.887 . . . . 0.0 112.331 179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.73 -49.73 13.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.71 134.56 47.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.69 149.0 34.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.472 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -27.72 -50.16 0.06 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.144 1.777 . . . . 0.0 112.402 168.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -69.02 -39.63 79.13 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.638 -0.664 . . . . 0.0 112.21 -178.637 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.38 -53.27 60.15 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.618 1.099 . . . . 0.0 108.208 175.595 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -49.61 -59.4 3.82 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 125.802 1.641 . . . . 0.0 109.155 177.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 t -43.19 -57.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 109.077 176.243 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -58.63 -31.96 68.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.545 -0.74 . . . . 0.0 112.106 -176.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.87 -52.63 14.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.222 0.919 . . . . 0.0 109.262 176.93 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.7 mt -53.03 -39.71 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.468 1.107 . . . . 0.0 110.073 178.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -52.31 -56.61 13.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.092 0.86 . . . . 0.0 109.637 176.226 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -55.83 -53.88 51.37 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.3 ttm -47.22 -61.07 2.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.101 0.96 . . . . 0.0 110.331 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.45 -35.74 78.45 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.042 -0.411 . . . . 0.0 111.137 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -62.53 -5.0 2.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.787 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -88.97 -13.83 38.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.393 1.451 . . . . 0.0 111.265 176.399 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.638 -176.659 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.28 -55.26 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.431 1.014 . . . . 0.0 108.759 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -69.56 -50.46 44.55 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -178.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.38 -50.53 72.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.531 -174.425 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -158.73 51.86 0.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -169.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.38 35.7 0.52 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.408 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.23 154.41 50.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.228 1.811 . . . . 0.0 106.586 175.48 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.58 105.34 10.89 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.091 -176.187 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.21 155.97 77.1 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.208 1.11 . . . . 0.0 110.417 -7.038 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 129.9 42.42 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.615 1.166 . . . . 0.0 110.719 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -52.47 -48.51 65.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.409 1.1 . . . . 0.0 110.143 178.721 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -49.29 -39.57 31.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.334 1.853 . . . . 0.0 112.207 179.205 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -47.0 -40.39 14.44 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.893 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -99.37 -51.29 3.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.954 0.783 . . . . 0.0 110.929 -177.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -69.27 -22.97 63.78 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.7 -42.9 90.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.469 1.031 . . . . 0.0 110.127 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.01 -25.32 17.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.701 0.8 . . . . 0.0 111.569 179.181 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 37.83 13.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.027 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.18 149.09 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -176.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.29 30.11 7.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.136 0.974 . . . . 0.0 111.291 -178.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.75 23.16 78.39 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.63 132.57 91.3 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.908 1.354 . . . . 0.0 108.132 176.382 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.63 118.08 5.03 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.181 1.92 . . . . 0.0 107.778 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -75.72 162.72 27.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.834 0.825 . . . . 0.0 111.52 -174.343 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.95 159.47 34.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 170.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.57 56.8 2.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.599 1.159 . . . . 0.0 111.191 -177.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 63.3 5.45 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 0.0 109.65 -177.679 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -45.35 -44.5 16.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.063 3.175 . . . . 0.0 113.43 -175.116 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -50.0 -34.59 21.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.904 0.881 . . . . 0.0 112.335 178.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.11 -28.61 64.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.025 0.53 . . . . 0.0 111.455 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -99.09 -15.68 18.92 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.417 1.087 . . . . 0.0 111.958 -176.162 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.36 -45.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.236 1.814 . . . . 0.0 112.935 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.33 30.47 7.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.042 0.937 . . . . 0.0 112.638 -176.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -121.1 124.42 27.39 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 108.074 177.604 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.88 108.71 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.417 2.745 . . . . 0.0 110.826 178.121 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.01 -24.78 59.67 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.589 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -49.1 105.54 0.08 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.016 1.727 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -49.45 -45.25 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.484 0.714 . . . . 0.0 109.442 177.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.44 -23.4 49.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.858 1.263 . . . . 0.0 113.145 -179.122 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.58 -55.05 3.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.1 mt -50.82 -39.49 53.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.733 1.213 . . . . 0.0 112.444 -178.589 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.39 -35.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.623 -0.673 . . . . 0.0 109.949 179.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -48.8 75.08 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.173 0.897 . . . . 0.0 108.69 177.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -53.16 -37.35 61.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.696 0.798 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -75.15 -47.53 28.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.109 0.564 . . . . 0.0 109.996 -178.792 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.58 -48.8 80.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.441 1.097 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.02 -33.63 65.85 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.889 0.876 . . . . 0.0 110.921 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.32 86.85 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.255 0.919 . . . . 0.0 111.272 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -77.72 144.99 36.82 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.915 1.286 . . . . 0.0 109.97 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.91 5.99 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.018 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.69 -0.26 51.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.028 0.931 . . . . 0.0 112.424 -179.352 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.5 mtm -71.57 139.51 83.79 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 119.413 1.006 . . . . 0.0 111.179 -178.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.91 153.54 58.3 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 171.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.53 113.91 5.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -78.4 -16.16 57.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.533 -179.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -49.6 113.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.51 1.05 . . . . 0.0 110.511 175.285 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.41 -32.55 7.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.38 0.99 . . . . 0.0 111.493 -179.002 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -76.27 -46.21 29.0 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.397 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.51 138.26 39.49 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.488 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -79.1 147.65 32.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -30.53 -51.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.489 1.915 . . . . 0.0 111.782 169.412 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.32 -29.43 65.01 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.543 -0.723 . . . . 0.0 112.168 -176.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.31 -58.98 4.17 Favored 'General case' 0 N--CA 1.459 0.021 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.18 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -44.18 -55.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.097 1.759 . . . . 0.0 110.18 179.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -38.5 -51.66 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 111.266 178.306 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -59.0 -47.0 86.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.451 0.643 . . . . 0.0 110.791 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.44 94.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.929 -0.482 . . . . 0.0 109.775 -179.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.41 -49.47 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.501 1.12 . . . . 0.0 110.405 -178.649 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.1 -41.12 99.3 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.155 -0.966 . . . . 0.0 109.243 -179.334 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -58.17 -55.7 31.54 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.838 0.745 . . . . 0.0 109.299 176.66 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.8 ttm -43.34 -53.29 5.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.201 1.8 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.52 -38.51 91.27 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.995 -0.44 . . . . 0.0 111.348 178.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.9 m -75.25 45.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.861 0.864 . . . . 0.0 113.024 -178.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.2 p -138.77 -18.96 1.04 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.091 1.756 . . . . 0.0 110.398 173.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.492 -1.718 . . . . 0.0 110.922 -177.478 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.1 -41.2 52.81 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.95 -52.58 64.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -51.11 -52.34 44.69 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.592 0.633 . . . . 0.0 110.511 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.2 mt -53.0 -59.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.534 0.734 . . . . 0.0 109.544 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -52.17 -49.07 64.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 112.435 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.1 -50.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.556 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -138.98 -17.09 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.99 36.1 3.77 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 120.075 1.307 . . . . 0.0 111.34 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -136.77 150.51 48.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.611 1.564 . . . . 0.0 108.013 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.18 109.59 5.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.653 1.181 . . . . 0.0 109.274 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.33 153.68 31.56 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 CA-C-N 120.105 1.073 . . . . 0.0 111.82 -9.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.45 124.85 24.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 109.667 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.03 -48.1 81.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.418 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -39.59 -56.86 1.59 Allowed 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.447 1.899 . . . . 0.0 112.253 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -43.52 -31.61 0.76 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.408 1.483 . . . . 0.0 113.375 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.2 m -104.28 -56.53 2.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.897 0.479 . . . . 0.0 111.277 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -68.62 -28.55 67.01 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.4 -39.24 93.98 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.95 0.795 . . . . 0.0 110.318 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ttm105 -95.32 -28.71 14.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.414 1.086 . . . . 0.0 111.978 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.6 6.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.81 133.18 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.69 31.24 7.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.628 1.171 . . . . 0.0 111.636 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.4 76.25 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.659 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.91 136.5 72.91 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 118.511 1.156 . . . . 0.0 108.402 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.86 120.15 7.71 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.339 2.026 . . . . 0.0 108.596 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.49 167.96 16.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.65 158.75 33.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.547 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.39 49.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.375 1.47 . . . . 0.0 111.9 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.23 62.17 19.47 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.651 1.58 . . . . 0.0 109.036 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -44.1 -41.41 12.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.238 3.292 . . . . 0.0 113.779 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -49.51 -41.11 40.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.514 1.125 . . . . 0.0 111.315 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.3 -24.89 67.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.671 0.788 . . . . 0.0 111.956 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -104.95 -30.87 9.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.316 1.046 . . . . 0.0 112.353 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.59 -49.9 1.56 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.627 1.571 . . . . 0.0 112.795 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -27.68 60.56 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -76.74 151.0 82.25 Favored Pre-proline 0 CA--C 1.534 0.333 0 O-C-N 121.64 -0.663 . . . . 0.0 110.03 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.08 85.83 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 107.982 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.45 -25.55 25.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.56 1.944 . . . . 0.0 113.304 -171.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.3 m -48.17 113.82 0.82 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.495 1.118 . . . . 0.0 110.651 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.81 -46.14 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.373 1.069 . . . . 0.0 110.512 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -58.19 -24.64 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.779 1.232 . . . . 0.0 112.852 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -90.06 -53.0 4.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.3 mt -47.85 -42.01 25.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.298 1.039 . . . . 0.0 111.861 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.44 -34.64 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.755 -0.591 . . . . 0.0 111.289 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -64.52 -50.12 68.62 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 119.375 0.988 . . . . 0.0 108.653 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -51.13 -46.1 61.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.673 0.789 . . . . 0.0 109.844 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -50.56 71.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.825 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.02 -45.42 92.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.294 -0.879 . . . . 0.0 111.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -32.67 67.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.877 0.871 . . . . 0.0 112.227 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.56 160.19 28.93 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -157.61 122.01 4.29 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.974 -0.721 . . . . 0.0 109.263 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.08 9.34 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.02 53.86 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.003 0.521 . . . . 0.0 111.807 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.4 ttp -65.89 115.89 27.25 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.733 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.13 164.84 23.73 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.369 2.046 . . . . 0.0 110.947 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.33 134.68 50.69 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -97.03 -15.06 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -47.79 100.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.671 0.788 . . . . 0.0 112.624 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.05 -37.97 3.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.062 1.315 . . . . 0.0 111.781 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -76.42 -38.92 54.85 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.786 0.793 . . . . 0.0 110.134 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.65 136.61 46.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.79 144.83 30.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -32.31 -44.95 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.63 1.972 . . . . 0.0 111.496 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.64 -49.53 76.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.942 0.792 . . . . 0.0 111.561 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -56.1 -56.92 15.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 122.728 1.251 . . . . 0.0 108.626 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.4 mt -48.62 -58.56 4.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.823 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 t -46.09 -53.54 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.426 1.09 . . . . 0.0 110.024 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -59.02 -39.03 80.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.656 0.382 . . . . 0.0 111.192 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.56 71.9 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.47 -49.95 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.601 1.16 . . . . 0.0 109.825 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.07 -39.14 85.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.135 0.88 . . . . 0.0 109.228 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.1 -47.51 85.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mtp -54.03 -59.31 4.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.01 -35.94 64.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 112.634 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -62.9 -10.65 14.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.419 1.008 . . . . 0.0 113.173 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -89.62 -11.61 42.11 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.783 1.174 . . . . 0.0 111.558 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.216 -1.85 . . . . 0.0 111.875 -175.068 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.24 24.07 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -55.77 -53.72 53.23 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -53.82 41.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.06 0.544 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.96 -57.46 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.699 0.799 . . . . 0.0 110.175 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.71 -49.25 77.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.825 0.85 . . . . 0.0 112.31 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.15 -48.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.084 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.52 -18.19 1.95 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.85 -34.43 38.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.842 1.201 . . . . 0.0 112.364 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 p -73.06 151.32 41.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.419 0.609 . . . . 0.0 110.444 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.68 106.72 6.42 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.872 1.269 . . . . 0.0 108.559 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.16 150.65 36.01 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.351 1.161 . . . . 0.0 111.738 -5.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.06 124.53 22.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.676 1.19 . . . . 0.0 109.142 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -54.43 -46.34 73.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.026 0.83 . . . . 0.0 110.558 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 p -40.4 -52.46 2.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.111 2.165 . . . . 0.0 112.338 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -38.47 -48.2 1.36 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 112.082 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.9 m -93.02 -55.05 3.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.208 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -64.84 -25.95 68.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 120.289 1.404 . . . . 0.0 111.356 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -119.72 -15.05 8.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.963 0.905 . . . . 0.0 112.466 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.74 34.23 44.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.2 t -55.13 132.62 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.34 31.53 7.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.729 1.211 . . . . 0.0 111.911 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.61 22.24 75.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.398 -0.668 . . . . 0.0 113.044 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.15 131.66 80.5 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 118.707 1.253 . . . . 0.0 109.324 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.7 119.57 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.411 2.074 . . . . 0.0 108.211 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.39 179.78 6.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.811 0.815 . . . . 0.0 112.567 -172.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.43 159.37 24.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.14 54.11 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.084 1.754 . . . . 0.0 112.238 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.21 58.56 15.4 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.034 0.933 . . . . 0.0 110.96 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -38.48 -48.27 2.51 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.557 3.505 . . . . 0.0 114.152 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -47.77 -40.1 19.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.363 1.465 . . . . 0.0 111.988 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.71 -27.9 58.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.923 0.329 . . . . 0.0 111.455 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.94 -26.14 19.42 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.756 0.822 . . . . 0.0 112.004 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -34.76 -46.81 0.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.493 2.317 . . . . 0.0 114.456 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.05 2.7 35.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -83.37 158.29 63.78 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 118.978 0.808 . . . . 0.0 109.821 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.01 120.88 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.258 2.639 . . . . 0.0 110.833 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -64.36 -39.16 93.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -82.35 133.33 35.22 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 122.067 -0.395 . . . . 0.0 111.115 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -52.98 -40.7 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -54.34 -29.48 48.14 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.024 1.33 . . . . 0.0 112.598 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.28 -52.49 6.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.89 -40.15 60.2 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -60.2 -33.97 55.43 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 CA-C-N 119.528 1.058 . . . . 0.0 110.743 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -62.47 -49.81 73.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 m -52.27 -46.95 66.06 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.453 0.57 . . . . 0.0 109.817 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 m -61.12 -40.35 93.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.491 0.717 . . . . 0.0 111.487 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . 0.286 0.9 OUTLIER -111.02 36.65 3.07 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.37 -44.49 2.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.474 1.91 . . . . 0.0 107.175 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.33 145.63 9.76 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.89 1.71 . . . . 0.0 109.462 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -156.36 132.95 10.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.8 -117.64 11.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.36 1.01 38.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.186 0.994 . . . . 0.0 112.064 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.7 ttp -69.58 122.83 87.03 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.067 0.849 . . . . 0.0 110.308 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.82 152.55 47.23 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.155 1.903 . . . . 0.0 108.86 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.58 119.14 13.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -76.34 1.97 14.75 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -46.37 112.51 0.5 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 110.924 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.37 -30.01 6.73 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.636 0.636 . . . . 0.0 112.149 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -72.7 -46.28 54.51 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.29 124.56 13.78 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.0 155.4 28.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -29.32 -49.81 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.496 1.918 . . . . 0.0 111.852 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -64.7 -41.05 96.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.258 0.936 . . . . 0.0 112.304 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.12 -58.0 8.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 122.437 1.113 . . . . 0.0 108.443 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.3 mt -46.03 -57.9 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 127.047 2.139 . . . . 0.0 110.48 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -39.84 -55.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 110.813 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -60.58 -37.25 80.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.284 1.034 . . . . 0.0 111.816 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.64 32.27 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.74 -0.6 . . . . 0.0 109.442 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.67 -50.85 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.049 0.94 . . . . 0.0 110.785 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.94 -41.65 92.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.847 1.203 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -59.03 -51.52 69.71 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.27 -53.61 48.35 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.33 -38.24 76.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.118 0.567 . . . . 0.0 111.78 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.7 p -63.5 -5.22 3.49 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -87.06 -12.43 47.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.771 1.168 . . . . 0.0 111.093 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.656 -1.64 . . . . 0.0 110.197 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.65 -0.691 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.83 -40.36 26.29 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.99 -54.86 42.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -49.39 64.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.357 0.663 . . . . 0.0 110.383 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.02 -58.15 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.2 -50.24 65.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.176 0.99 . . . . 0.0 112.17 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.2 mt -69.21 -48.04 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.468 -174.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -145.32 -12.74 0.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.55 38.85 2.99 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 120.244 1.384 . . . . 0.0 111.257 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.16 153.76 51.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.135 1.374 . . . . 0.0 109.073 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.08 108.63 8.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.495 1.118 . . . . 0.0 110.968 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -57.02 159.27 24.89 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.843 0.98 . . . . 0.0 111.83 -12.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.82 122.66 19.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.484 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -54.72 -47.51 73.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.712 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 p -41.48 -52.47 3.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.339 1.856 . . . . 0.0 112.263 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -48.51 -24.78 1.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.065 1.346 . . . . 0.0 113.874 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -109.03 -54.1 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.743 0.817 . . . . 0.0 110.951 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -69.84 -21.67 63.35 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.25 -58.05 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.366 0.985 . . . . 0.0 109.773 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -26.29 32.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.635 0.374 . . . . 0.0 111.563 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.81 6.15 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.32 144.4 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.47 29.8 7.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.076 0.95 . . . . 0.0 111.491 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.27 79.16 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.05 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.71 132.64 88.96 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.754 1.277 . . . . 0.0 108.409 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.17 119.02 5.93 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.793 2.329 . . . . 0.0 109.398 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -82.55 177.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.9 0.857 . . . . 0.0 111.255 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -82.98 157.53 22.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m120 50.4 41.48 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.94 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.28 52.93 8.64 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.443 1.097 . . . . 0.0 110.24 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -46.88 -39.61 24.63 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.75 2.967 . . . . 0.0 112.643 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -49.66 -40.63 40.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.404 1.081 . . . . 0.0 111.48 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.41 -27.36 60.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.234 0.614 . . . . 0.0 111.199 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.06 -27.24 19.82 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.839 -0.538 . . . . 0.0 111.697 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.2 -50.58 0.73 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.6 1.96 . . . . 0.0 113.503 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.74 -23.43 42.29 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.62 135.5 75.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.647 -0.658 . . . . 0.0 109.423 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.72 113.99 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.295 1.997 . . . . 0.0 111.256 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.61 -32.4 58.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.144 0.978 . . . . 0.0 111.834 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -53.99 101.81 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.457 1.503 . . . . 0.0 111.279 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -45.43 -40.82 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.011 1.324 . . . . 0.0 109.933 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.94 -36.52 5.54 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.963 2.105 . . . . 0.0 112.639 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -84.03 -50.14 8.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -52.66 -39.27 61.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.046 0.938 . . . . 0.0 112.019 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 m -60.1 -36.07 65.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.143 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -67.5 -48.76 66.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.677 1.126 . . . . 0.0 108.451 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 m -50.7 -46.42 58.86 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -67.34 -50.89 58.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.649 0.379 . . . . 0.0 111.179 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.0 -44.77 94.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.188 -0.945 . . . . 0.0 111.031 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.32 -35.36 54.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.544 0.738 . . . . 0.0 112.462 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 158.23 24.36 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -164.47 133.53 3.67 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.891 0.846 . . . . 0.0 109.803 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.76 -84.84 0.28 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.96 -6.28 2.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.193 1.797 . . . . 0.0 111.453 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.3 ttp -64.61 124.01 84.83 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.067 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.49 158.68 55.28 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.124 1.883 . . . . 0.0 109.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 147.02 53.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -111.81 -12.75 13.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.098 1.359 . . . . 0.0 111.232 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.75 123.04 6.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.416 1.086 . . . . 0.0 110.136 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.6 -26.07 23.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.387 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -97.74 -54.64 3.05 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.498 1.149 . . . . 0.0 110.361 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.03 125.91 33.12 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.55 51.39 1.06 Allowed 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.719 1.608 . . . . 0.0 111.921 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 52.05 -62.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.928 3.291 . . . . 0.0 113.734 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -50.92 -34.85 30.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.763 1.225 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -53.0 -56.63 14.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.734 1.614 . . . . 0.0 109.143 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.07 -53.32 58.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 125.44 1.496 . . . . 0.0 109.684 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.2 t -43.39 -57.51 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 122.899 0.479 . . . . 0.0 109.875 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -60.72 -43.86 97.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.876 0.471 . . . . 0.0 112.056 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.55 95.6 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.802 -0.561 . . . . 0.0 110.398 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.89 -49.63 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.49 1.516 . . . . 0.0 110.087 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.69 -39.81 89.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -58.22 -53.05 62.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.389 0.54 . . . . 0.0 109.617 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.7 mtp -48.25 -58.58 4.35 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -55.61 -39.86 71.33 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.811 0.844 . . . . 0.0 112.078 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.0 m -67.17 -6.53 18.26 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.506 -0.746 . . . . 0.0 112.006 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -119.14 42.44 2.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.597 1.559 . . . . 0.0 109.635 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.136 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.9 -38.0 36.95 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.25 -57.37 12.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.787 0.435 . . . . 0.0 110.169 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -56.61 -46.41 80.9 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.859 -0.526 . . . . 0.0 110.567 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.7 mt -53.91 -57.53 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 109.978 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -57.07 -50.34 73.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.236 1.014 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.91 -51.18 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.88 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.996 0.816 . . . . 0.0 112.851 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.76 38.94 1.51 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 157.51 45.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.231 1.813 . . . . 0.0 108.44 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.714 0.805 . . . . 0.0 110.629 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.06 160.35 23.48 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 CA-C-N 119.941 1.015 . . . . 0.0 111.878 -12.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.31 127.45 32.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.706 0.802 . . . . 0.0 109.558 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -57.71 -50.77 72.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.457 0.646 . . . . 0.0 111.199 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -39.42 -56.13 1.64 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.642 1.977 . . . . 0.0 112.986 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.67 -38.0 0.83 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.337 1.455 . . . . 0.0 112.564 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -96.83 -59.25 1.84 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 0.0 110.372 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -60.69 -46.11 91.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -22.18 64.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.862 0.301 . . . . 0.0 111.759 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -114.87 11.99 16.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.209 1.004 . . . . 0.0 111.293 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.71 38.39 29.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.124 0.869 . . . . 0.0 113.63 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.8 t -55.14 132.74 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.52 31.44 7.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 111.883 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.71 22.32 75.12 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.742 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.49 136.25 82.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.253 1.027 . . . . 0.0 108.697 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.22 126.94 21.47 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.346 2.031 . . . . 0.0 109.626 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -94.07 174.47 7.14 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.449 0.643 . . . . 0.0 112.014 -174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.82 162.3 19.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.09 53.6 0.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.758 1.623 . . . . 0.0 112.125 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.79 64.5 22.18 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 124.235 1.014 . . . . 0.0 109.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -41.17 -51.55 3.87 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.024 3.15 . . . . 0.0 114.29 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -44.15 -51.92 7.71 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.144 1.378 . . . . 0.0 110.843 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.55 -45.38 56.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.953 0.901 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -85.6 -30.6 23.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.325 0.65 . . . . 0.0 111.379 -173.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.41 93.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.411 1.084 . . . . 0.0 109.408 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.89 -42.15 97.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.014 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -74.85 162.66 72.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.528 0.731 . . . . 0.0 111.266 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -68.03 84.33 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.36 2.04 . . . . 0.0 107.798 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -48.9 -28.82 4.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.462 1.905 . . . . 0.0 113.247 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.79 106.82 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.748 2.019 . . . . 0.0 110.911 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.0 t -47.75 -44.41 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.248 1.019 . . . . 0.0 110.939 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -53.78 -36.0 61.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.755 1.622 . . . . 0.0 111.842 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.69 -50.7 10.22 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.7 -42.31 45.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.128 0.971 . . . . 0.0 112.408 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.62 -36.11 68.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.818 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -65.46 -49.43 69.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 119.763 1.165 . . . . 0.0 108.581 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 m -52.07 -46.11 65.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.078 0.466 . . . . 0.0 109.812 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -65.19 -49.98 67.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.761 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.53 -45.29 94.82 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.315 -0.866 . . . . 0.0 110.81 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.79 74.91 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.715 0.806 . . . . 0.0 111.819 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 164.95 26.04 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -156.36 106.98 2.39 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.85 -0.794 . . . . 0.0 109.389 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.59 -111.55 3.33 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.79 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.088 0.555 . . . . 0.0 111.117 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -65.0 117.96 44.38 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.323 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.47 157.51 52.8 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.531 2.154 . . . . 0.0 109.644 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 145.68 52.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.456 0.302 . . . . 0.0 110.302 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -110.81 -12.31 14.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.192 1.397 . . . . 0.0 111.349 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -46.51 123.58 5.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.978 1.311 . . . . 0.0 110.548 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.69 -25.38 21.5 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.119 0.866 . . . . 0.0 112.34 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -98.1 -57.1 2.3 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.384 1.092 . . . . 0.0 110.325 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.11 119.61 26.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.46 84.92 4.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 15.32 -59.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 131.389 3.876 . . . . 0.0 115.866 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -48.28 -35.39 12.07 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.2 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -54.99 -59.75 4.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.211 1.405 . . . . 0.0 108.787 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 mt -55.51 -53.84 51.34 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 126.282 1.833 . . . . 0.0 109.858 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.3 t -45.38 -57.03 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.32 0.648 . . . . 0.0 109.422 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -60.3 -41.24 93.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.766 -0.584 . . . . 0.0 111.651 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.36 99.01 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 109.787 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.88 -44.18 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.64 1.176 . . . . 0.0 108.565 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.14 -50.72 68.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -55.26 -51.64 65.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.522 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.7 mtt -47.57 -63.79 0.96 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.113 0.959 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -53.3 -36.05 60.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.069 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.4 m -72.07 34.57 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.656 1.116 . . . . 0.0 113.94 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -134.21 -10.86 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.662 1.585 . . . . 0.0 109.85 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.579 -1.677 . . . . 0.0 110.093 -178.771 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.55 -42.97 52.42 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.6 -57.12 14.32 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.031 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -44.71 -50.37 10.02 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.695 1.134 . . . . 0.0 111.633 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.45 -60.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.893 1.677 . . . . 0.0 110.671 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.75 -48.08 73.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.83 0.852 . . . . 0.0 111.589 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.29 -49.98 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.457 1.103 . . . . 0.0 111.021 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.65 33.77 0.27 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.42 37.85 1.75 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 156.04 48.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.287 1.835 . . . . 0.0 107.751 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.42 108.82 6.73 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.859 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.8 155.73 27.72 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.074 1.062 . . . . 0.0 111.581 -9.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.17 128.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.54 0.736 . . . . 0.0 109.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.3 m -58.35 -49.41 77.3 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 0.0 110.117 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -41.18 -55.5 2.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.405 1.882 . . . . 0.0 113.49 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.27 -36.38 3.98 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.941 0.896 . . . . 0.0 112.339 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.41 -57.91 2.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -67.06 -36.12 81.35 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -68.21 -33.84 75.16 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -84.46 -26.8 27.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.112 0.965 . . . . 0.0 111.122 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.18 33.3 57.13 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.62 139.46 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.9 29.43 6.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.126 0.97 . . . . 0.0 111.572 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.22 24.49 76.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.718 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.67 80.41 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.608 1.204 . . . . 0.0 108.275 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.6 122.01 10.61 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.257 1.972 . . . . 0.0 110.051 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -90.56 177.18 6.43 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.606 0.717 . . . . 0.0 111.65 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 156.77 29.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 51.08 35.48 13.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.614 0.766 . . . . 0.0 111.845 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.79 67.27 79.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.06 1.344 . . . . 0.0 110.352 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.18 -50.82 5.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.148 3.232 . . . . 0.0 114.454 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -50.93 -35.21 32.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.946 1.299 . . . . 0.0 112.227 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.37 -27.66 68.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.149 0.431 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -101.53 -35.42 9.16 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.548 1.139 . . . . 0.0 112.097 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.34 -51.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.587 1.555 . . . . 0.0 113.125 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.89 -23.18 45.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -79.53 144.28 60.95 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.38 93.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.72 2.28 . . . . 0.0 108.457 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.56 -21.12 36.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.044 1.337 . . . . 0.0 112.994 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.41 106.93 0.11 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.571 1.948 . . . . 0.0 110.455 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.0 -42.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.937 0.895 . . . . 0.0 110.632 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.82 -31.23 64.52 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.371 1.469 . . . . 0.0 112.36 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.83 -53.49 5.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt -48.62 -45.61 38.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.502 0.721 . . . . 0.0 111.877 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.94 -35.98 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 121.854 -0.529 . . . . 0.0 110.976 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.89 -45.09 75.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 m -53.96 -44.08 70.45 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.3 m -64.55 -50.61 66.62 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.81 0.444 . . . . 0.0 110.49 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.48 -44.97 89.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.411 -0.806 . . . . 0.0 110.924 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.9 68.49 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.799 0.84 . . . . 0.0 112.288 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.09 161.25 26.47 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -159.66 117.31 2.68 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.892 -0.769 . . . . 0.0 109.215 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.18 -117.62 11.63 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.44 54.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.883 0.473 . . . . 0.0 111.447 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -67.98 121.47 79.99 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 118.784 0.72 . . . . 0.0 110.112 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.73 161.29 39.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.629 2.219 . . . . 0.0 110.195 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.02 136.83 57.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.89 -14.05 18.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.121 0.968 . . . . 0.0 113.247 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -49.41 102.83 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.311 0.644 . . . . 0.0 112.142 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.73 -36.24 4.28 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.14 1.352 . . . . 0.0 111.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -79.17 -41.11 29.19 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 117.828 0.814 . . . . 0.0 110.184 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.35 132.76 39.87 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.56 144.94 30.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -28.29 -52.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -62.45 -40.65 97.31 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.674 -0.641 . . . . 0.0 112.033 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.23 -58.91 6.38 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 122.429 1.109 . . . . 0.0 108.199 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -46.09 -56.02 6.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.493 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -41.53 -54.49 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.815 1.246 . . . . 0.0 110.572 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -57.04 -42.53 80.68 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.342 -0.224 . . . . 0.0 111.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.99 81.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.54 -45.47 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.578 0.751 . . . . 0.0 109.344 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -55.1 -51.0 67.77 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.875 0.87 . . . . 0.0 108.824 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -55.87 -52.05 65.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.414 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.6 mtp -49.73 -54.41 19.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.391 0.677 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.19 -36.81 76.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.03 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.6 m -74.41 42.49 0.16 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.468 -0.77 . . . . 0.0 112.766 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -135.93 -7.78 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.77 1.228 . . . . 0.0 110.307 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.22 -1.371 . . . . 0.0 108.999 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.51 -39.55 22.69 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.525 1.059 . . . . 0.0 111.719 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.14 -59.59 5.17 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.3 -50.23 40.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.865 1.266 . . . . 0.0 110.736 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.7 -59.78 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.632 1.573 . . . . 0.0 109.96 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -58.12 -48.56 79.85 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.135 0.574 . . . . 0.0 111.441 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.6 mt -69.84 -46.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.877 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.69 39.07 0.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.45 39.49 1.16 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -139.16 156.9 46.79 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.458 1.903 . . . . 0.0 107.496 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.51 108.17 6.63 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.814 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.32 154.55 31.27 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 CA-C-N 120.104 1.073 . . . . 0.0 111.827 -9.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.08 121.73 16.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.561 1.145 . . . . 0.0 109.179 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -52.71 -49.71 64.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.206 0.527 . . . . 0.0 110.496 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -43.39 -51.26 6.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.029 1.732 . . . . 0.0 112.77 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -47.39 -34.21 6.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.655 0.782 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 m -96.85 -55.74 2.79 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -66.06 -36.91 84.5 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.99 -43.26 88.27 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -72.55 -30.23 64.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.626 0.77 . . . . 0.0 111.076 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.2 56.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.02 143.15 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.63 30.69 6.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.11 0.964 . . . . 0.0 111.383 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.43 27.56 73.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.622 -0.543 . . . . 0.0 112.494 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.32 131.89 90.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.51 1.155 . . . . 0.0 108.299 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.68 112.52 1.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.756 2.304 . . . . 0.0 109.564 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.54 175.33 9.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.638 1.208 . . . . 0.0 109.896 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.63 140.77 29.11 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 68.29 35.43 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.231 1.013 . . . . 0.0 109.795 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.89 58.23 37.42 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.218 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.79 -47.23 2.72 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.537 3.492 . . . . 0.0 114.315 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -47.53 -40.46 18.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.488 1.515 . . . . 0.0 112.026 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.51 -25.64 54.42 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.954 0.343 . . . . 0.0 111.464 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -92.05 -23.48 19.48 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.605 0.762 . . . . 0.0 111.734 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.71 -46.36 0.43 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.873 2.069 . . . . 0.0 114.155 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -101.07 -3.3 29.54 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -83.74 145.78 48.07 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.849 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.78 118.59 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.993 2.462 . . . . 0.0 111.65 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -62.26 -32.71 73.45 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 103.94 0.13 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.299 2.24 . . . . 0.0 111.507 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.09 -40.09 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.774 -0.579 . . . . 0.0 109.5 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.02 -26.0 34.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.576 1.55 . . . . 0.0 112.428 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.67 -53.42 4.53 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.22 -40.89 48.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.43 -31.52 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.668 -0.645 . . . . 0.0 110.38 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -65.85 -51.02 62.36 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.538 1.063 . . . . 0.0 108.296 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -49.97 -44.92 51.01 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.864 0.866 . . . . 0.0 109.98 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 m -64.54 -52.26 58.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.948 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.51 -41.57 98.92 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.025 -1.047 . . . . 0.0 111.867 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.6 -33.96 31.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.971 0.909 . . . . 0.0 112.283 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 151.56 17.45 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -155.18 136.99 14.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.73 -115.68 7.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.07 -0.46 33.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 ttp -65.43 127.0 92.58 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.891 0.769 . . . . 0.0 110.088 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.84 154.74 67.08 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.708 1.605 . . . . 0.0 109.247 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 121.64 15.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.14 -10.18 57.98 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -53.79 84.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.451 1.101 . . . . 0.0 113.751 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.1 -30.91 5.09 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.452 1.977 . . . . 0.0 111.77 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.49 80.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.022 0.911 . . . . 0.0 109.338 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -133.8 147.44 51.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 176.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -82.75 142.17 31.81 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -34.15 -44.69 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.422 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -46.02 91.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.421 1.01 . . . . 0.0 111.068 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -55.84 -56.34 21.76 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 122.128 0.966 . . . . 0.0 108.394 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.3 mt -48.6 -60.41 2.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.256 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 t -43.85 -56.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.692 1.197 . . . . 0.0 110.063 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.6 -40.74 84.12 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.206 -0.309 . . . . 0.0 111.246 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.69 -55.32 27.89 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -49.83 -47.09 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.138 1.375 . . . . 0.0 110.099 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -53.98 -51.2 64.66 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.714 0.688 . . . . 0.0 109.239 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.56 -49.72 75.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.0 mtp -49.11 -54.78 14.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.827 . . . . 0.0 109.525 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.79 -35.16 77.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.017 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.03 41.42 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.351 -0.843 . . . . 0.0 113.188 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.6 p -138.37 -3.75 1.71 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.475 1.51 . . . . 0.0 110.044 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.713 -1.613 . . . . 0.0 110.271 -174.648 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.8 t0 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.1 52.32 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 106.491 -2.643 . . . . 0.0 106.491 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 38.33 60.51 1.28 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.588 1.955 . . . . 0.0 110.952 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -156.11 -61.52 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.707 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.98 -53.97 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.423 0.556 . . . . 0.0 109.871 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -66.46 -39.34 88.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.711 0.404 . . . . 0.0 111.36 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -76.87 -50.82 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -138.5 -14.42 1.27 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.19 -37.72 31.49 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.748 1.158 . . . . 0.0 111.786 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -69.02 150.54 47.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 122.359 -0.495 . . . . 0.0 110.303 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.32 114.57 7.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.468 1.107 . . . . 0.0 108.549 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.23 151.49 18.19 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.504 1.216 . . . . 0.0 111.408 -13.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.11 121.75 16.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.796 1.639 . . . . 0.0 109.883 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 m -54.03 -48.68 70.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.417 0.627 . . . . 0.0 110.273 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -41.17 -56.16 2.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.918 2.087 . . . . 0.0 112.373 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -45.54 -33.98 3.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.501 1.12 . . . . 0.0 113.038 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -98.16 -57.66 2.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.054 0.388 . . . . 0.0 110.322 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.08 -16.8 64.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.91 5.87 50.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.783 0.72 . . . . 0.0 109.974 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -128.71 -27.62 2.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.269 1.028 . . . . 0.0 112.232 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.42 27.07 62.17 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 140.05 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.96 29.22 5.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.091 0.956 . . . . 0.0 111.513 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.36 25.5 75.27 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.956 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.34 79.11 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.768 1.284 . . . . 0.0 108.977 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.83 110.36 1.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 N-CA-C 106.742 -2.061 . . . . 0.0 106.742 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -72.93 156.16 39.14 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.94 171.87 8.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.26 33.97 16.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.15 74.47 6.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.622 -170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -37.92 -50.94 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.359 3.373 . . . . 0.0 114.403 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.34 -43.23 15.81 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.194 1.397 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.05 -22.04 66.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.504 0.722 . . . . 0.0 111.95 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -109.37 -29.42 8.46 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.226 1.01 . . . . 0.0 112.584 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.36 -49.92 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.794 1.637 . . . . 0.0 113.11 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.66 -27.29 58.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.721 0.809 . . . . 0.0 113.166 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -79.32 155.41 76.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.492 0.717 . . . . 0.0 110.342 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.29 124.52 15.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.952 1.768 . . . . 0.0 110.284 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 p -66.16 -26.53 67.47 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.632 -0.668 . . . . 0.0 110.32 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -55.22 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.347 1.859 . . . . 0.0 112.395 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.1 t -47.85 -43.44 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.537 1.135 . . . . 0.0 109.689 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -52.7 -28.94 24.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.806 1.642 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.47 -48.63 6.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.388 1.075 . . . . 0.0 109.069 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -49.4 -41.56 39.86 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.603 0.361 . . . . 0.0 111.088 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.94 -35.29 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.566 -0.708 . . . . 0.0 111.019 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -64.25 -48.25 76.48 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.461 1.028 . . . . 0.0 108.466 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -53.64 -44.13 69.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -62.54 -49.35 75.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.575 0.35 . . . . 0.0 110.482 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.95 -46.74 89.51 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.267 -0.896 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 -33.33 74.96 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.664 0.786 . . . . 0.0 112.062 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.27 159.67 31.21 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.07 120.93 2.66 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.784 -0.833 . . . . 0.0 109.248 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.99 -119.97 20.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.51 -17.42 54.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.7 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -68.67 118.55 61.54 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 119.142 0.883 . . . . 0.0 109.424 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 158.69 53.38 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.266 1.978 . . . . 0.0 110.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.82 47.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -97.79 -11.55 23.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.215 1.006 . . . . 0.0 111.922 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -41.6 113.03 0.37 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.262 1.425 . . . . 0.0 112.153 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.43 -21.73 16.29 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.166 0.889 . . . . 0.0 113.089 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -85.17 -48.11 9.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.084 0.942 . . . . 0.0 109.179 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.57 141.14 48.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -83.9 140.8 31.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -29.83 -45.86 0.06 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 126.281 1.832 . . . . 0.0 111.46 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -60.16 -49.49 77.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.946 1.248 . . . . 0.0 111.526 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -53.71 -59.14 4.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.832 1.301 . . . . 0.0 108.995 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.3 mt -49.11 -58.72 4.48 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 126.098 1.759 . . . . 0.0 110.491 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -47.76 -56.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.526 1.13 . . . . 0.0 109.657 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -55.41 -39.05 69.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.079 0.552 . . . . 0.0 111.508 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.94 68.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.744 0.418 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.86 -46.64 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.692 1.197 . . . . 0.0 109.007 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.9 -53.83 43.47 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.91 -50.62 71.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.305 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 ttp -50.45 -59.82 3.63 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.3 mp -55.05 -37.86 67.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.811 -0.556 . . . . 0.0 111.431 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -62.79 -6.69 3.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.661 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.1 p -89.13 -15.25 34.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.57 1.532 . . . . 0.0 111.227 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.193 -1.384 . . . . 0.0 110.289 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -53.93 -43.46 71.51 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -58.92 -56.02 27.64 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.02 -49.62 50.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.898 0.772 . . . . 0.0 110.946 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.83 -57.95 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -57.42 -44.32 84.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.923 0.889 . . . . 0.0 112.195 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.6 mt -76.44 -49.68 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.199 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -136.63 -17.15 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.2 -33.73 39.3 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 119.965 1.257 . . . . 0.0 112.003 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -73.61 154.13 39.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.36 0.58 . . . . 0.0 110.98 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 110.37 5.86 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.66 1.184 . . . . 0.0 109.436 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.98 151.85 20.56 Favored 'Cis proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.1 1.071 . . . . 0.0 111.784 -11.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.74 123.1 19.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.153 1.381 . . . . 0.0 109.129 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.3 -47.66 75.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.849 0.356 . . . . 0.0 110.483 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 p -39.91 -56.26 1.84 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 126.432 1.893 . . . . 0.0 112.315 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -41.57 -36.32 0.9 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.31 1.444 . . . . 0.0 112.763 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.8 m -101.21 -57.01 2.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.51 0.324 . . . . 0.0 111.459 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -68.36 -33.33 74.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.57 -36.3 73.54 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -82.01 -27.3 33.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.234 1.013 . . . . 0.0 111.587 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.07 32.23 60.81 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.66 141.58 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.8 29.69 6.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.136 0.974 . . . . 0.0 111.424 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 24.54 77.0 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.876 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 134.55 79.56 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.745 1.273 . . . . 0.0 108.203 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.31 124.86 15.58 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.454 2.102 . . . . 0.0 108.75 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.56 172.68 8.34 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 160.3 23.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 35.7 51.67 0.71 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.891 1.676 . . . . 0.0 111.956 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.18 64.12 25.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.886 1.274 . . . . 0.0 110.143 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -39.85 -48.24 3.68 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.247 3.298 . . . . 0.0 114.63 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.08 -34.42 56.46 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.639 0.776 . . . . 0.0 112.213 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -66.96 -25.51 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.871 0.468 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -105.61 -29.61 10.02 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.451 1.1 . . . . 0.0 112.79 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.04 -50.17 0.89 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.687 1.595 . . . . 0.0 113.116 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.88 -19.74 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -80.54 157.32 72.58 Favored Pre-proline 0 CA--C 1.537 0.465 0 O-C-N 121.511 -0.743 . . . . 0.0 110.661 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.23 111.2 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.965 2.443 . . . . 0.0 111.436 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -60.89 -31.76 71.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.91 101.86 0.07 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.301 2.24 . . . . 0.0 111.421 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.62 -40.37 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.676 0.791 . . . . 0.0 110.038 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.11 -33.56 62.94 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.818 1.647 . . . . 0.0 112.029 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.04 -50.35 9.78 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.86 -44.03 39.39 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 m -57.22 -42.39 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 119.468 1.031 . . . . 0.0 110.449 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.69 -43.52 93.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -55.24 -40.8 71.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.2 0.455 . . . . 0.0 110.408 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -68.22 -55.46 12.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.321 0.649 . . . . 0.0 109.438 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 mt -54.9 -41.14 70.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.411 1.485 . . . . 0.0 111.816 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.69 -34.42 58.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.973 0.909 . . . . 0.0 111.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.58 162.99 35.28 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -167.04 130.04 1.79 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.04 -136.27 50.68 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.36 -25.91 68.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.427 -0.887 . . . . 0.0 111.73 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.2 ttp -64.56 117.42 37.66 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 119.265 0.939 . . . . 0.0 110.73 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.63 156.61 57.35 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.533 2.156 . . . . 0.0 109.538 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.79 114.58 3.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -72.4 -12.7 61.23 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.461 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -37.3 109.78 0.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.328 0.967 . . . . 0.0 112.859 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.77 -19.41 54.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.359 0.981 . . . . 0.0 114.533 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -78.63 -57.58 3.69 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.8 1.3 . . . . 0.0 111.321 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.47 141.28 49.3 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.56 1.144 . . . . 0.0 107.972 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.48 150.08 28.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -27.38 -52.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.807 2.043 . . . . 0.0 111.492 168.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.45 -48.26 80.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.698 0.681 . . . . 0.0 111.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -55.11 -57.15 12.91 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 122.138 0.97 . . . . 0.0 108.938 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.26 -58.83 4.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.722 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.86 -57.5 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 124.052 0.941 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -58.76 -40.91 85.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.118 0.417 . . . . 0.0 111.778 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.18 92.27 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.988 -0.445 . . . . 0.0 109.92 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.88 -46.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.765 0.826 . . . . 0.0 109.133 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -54.54 -48.95 71.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -57.02 -53.88 53.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.517 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 ptm -57.12 -49.71 75.06 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.922 0.783 . . . . 0.0 109.395 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.77 -36.13 73.91 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.07 -1.018 . . . . 0.0 111.399 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t -63.53 -5.65 4.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.121 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -92.2 -12.18 33.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.331 1.423 . . . . 0.0 110.701 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.64 -1.172 . . . . 0.0 110.99 -176.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.42 -38.66 7.05 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.571 1.082 . . . . 0.0 112.076 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.84 -64.36 0.96 Allowed 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -44.83 -50.62 10.17 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.263 1.425 . . . . 0.0 111.214 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.03 -60.33 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.269 1.428 . . . . 0.0 110.173 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -56.59 -47.09 80.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.559 0.743 . . . . 0.0 111.439 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.5 -47.01 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.451 0.7 . . . . 0.0 111.793 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -9.69 0.33 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 -28.69 52.06 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.707 1.139 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -76.34 154.49 34.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.445 0.623 . . . . 0.0 110.41 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.23 104.96 4.09 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 108.122 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.46 146.66 32.95 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.499 1.214 . . . . 0.0 111.897 -3.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.92 120.89 14.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.751 1.621 . . . . 0.0 109.56 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 m -54.23 -49.71 68.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.166 0.508 . . . . 0.0 110.116 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -41.0 -55.56 2.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.256 1.822 . . . . 0.0 112.676 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -46.21 -33.72 3.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.241 1.016 . . . . 0.0 113.002 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.4 m -97.3 -56.67 2.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 117.888 0.313 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.9 -45.07 94.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.096 0.862 . . . . 0.0 109.708 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -76.98 -36.23 56.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.29 0.636 . . . . 0.0 111.948 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.89 38.76 5.68 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.84 130.55 17.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.5 31.47 7.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.503 1.121 . . . . 0.0 111.576 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.89 26.38 74.07 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.556 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.69 134.37 71.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.402 1.101 . . . . 0.0 108.573 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -62.6 112.02 1.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.694 2.263 . . . . 0.0 108.85 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -82.64 179.77 7.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.369 1.068 . . . . 0.0 112.35 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.21 159.55 28.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.96 52.19 0.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.984 1.714 . . . . 0.0 112.045 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.67 56.62 15.86 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.942 1.297 . . . . 0.0 111.026 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -41.32 -45.9 5.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.817 3.011 . . . . 0.0 114.967 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.04 -41.11 33.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.687 0.795 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.25 -16.34 61.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 112.336 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.55 -26.19 11.5 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 112.52 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.46 -51.52 0.62 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.437 1.895 . . . . 0.0 113.67 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.87 -17.46 40.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -78.64 151.74 77.36 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 121.462 -0.774 . . . . 0.0 110.639 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 115.28 2.11 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.071 2.514 . . . . 0.0 111.56 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -63.19 -32.23 73.58 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.124 -0.985 . . . . 0.0 110.11 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 104.99 0.17 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.479 2.312 . . . . 0.0 111.753 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -50.06 -43.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.525 0.73 . . . . 0.0 109.638 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -53.64 -30.91 45.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 112.482 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.88 -51.93 6.77 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.0 mt -50.16 -40.1 45.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.812 0.845 . . . . 0.0 112.829 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.63 -39.34 69.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 119.216 0.916 . . . . 0.0 110.375 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -66.19 -46.31 77.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.226 0.921 . . . . 0.0 108.71 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 m -52.64 -45.74 66.8 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.079 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 m -67.84 -48.69 65.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.749 0.42 . . . . 0.0 110.761 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.79 -40.85 96.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.101 -0.999 . . . . 0.0 111.098 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 -32.43 60.78 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.0 111.357 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.81 167.58 37.77 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -160.52 112.54 1.96 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.09 -111.25 2.69 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -35.09 74.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.113 0.565 . . . . 0.0 111.066 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.01 118.3 47.78 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.063 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.16 156.43 55.49 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.551 2.167 . . . . 0.0 109.933 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 115.96 5.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.811 0.444 . . . . 0.0 109.833 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.98 -7.95 57.51 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -55.87 83.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.295 1.038 . . . . 0.0 112.644 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.16 -34.59 2.29 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.76 1.647 . . . . 0.0 111.043 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -84.11 -38.88 20.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.184 0.994 . . . . 0.0 110.984 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.6 129.47 20.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.33 151.62 25.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -29.96 -49.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.69 1.996 . . . . 0.0 112.648 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.55 -35.84 81.21 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.363 0.983 . . . . 0.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.79 -59.01 4.71 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.6 mt -46.33 -57.91 4.19 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.218 2.207 . . . . 0.0 110.652 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -36.32 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.533 1.533 . . . . 0.0 110.299 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -60.16 -42.4 94.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.554 0.342 . . . . 0.0 111.606 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -48.49 69.17 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.764 0.426 . . . . 0.0 110.01 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 mt -56.72 -50.21 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.61 1.164 . . . . 0.0 109.203 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -55.83 -52.01 65.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -54.05 -56.26 19.64 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.572 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptm -60.94 -45.14 95.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.869 0.759 . . . . 0.0 109.629 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.04 -36.84 70.96 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.45 -0.781 . . . . 0.0 110.974 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -63.34 -6.52 4.8 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.7 p -90.34 -8.7 50.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.221 1.373 . . . . 0.0 111.047 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.47 -1.729 . . . . 0.0 110.832 -176.645 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.51 47.0 3.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 68.49 -40.32 0.43 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.843 2.457 . . . . 0.0 113.159 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -45.16 -56.43 4.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.977 2.511 . . . . 0.0 113.671 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -49.25 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.16 -48.51 78.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.903 0.481 . . . . 0.0 111.528 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.1 mt -73.47 -43.67 55.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.999 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.68 -8.24 0.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.75 -32.49 40.84 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.801 1.182 . . . . 0.0 111.321 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -73.47 155.45 39.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.449 0.624 . . . . 0.0 110.722 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.56 110.41 6.26 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.463 1.105 . . . . 0.0 108.966 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.93 153.28 16.95 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.323 1.151 . . . . 0.0 112.04 -11.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -70.24 114.35 8.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.625 1.57 . . . . 0.0 109.037 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.08 -48.4 22.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.662 0.785 . . . . 0.0 110.986 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -41.91 -50.57 4.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.608 1.963 . . . . 0.0 112.808 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -48.71 -32.47 8.48 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.316 0.647 . . . . 0.0 112.604 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.04 -54.99 2.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.903 0.481 . . . . 0.0 110.786 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.62 -32.79 71.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.04 -40.06 87.08 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.18 -28.58 42.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.573 0.749 . . . . 0.0 111.472 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.71 34.81 52.68 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.59 139.1 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.82 29.84 6.37 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.187 0.995 . . . . 0.0 111.593 -177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.62 24.25 76.5 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.764 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 135.31 82.99 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 118.554 1.177 . . . . 0.0 108.23 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.77 123.73 13.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.567 2.178 . . . . 0.0 110.006 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.65 179.03 5.76 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.774 0.797 . . . . 0.0 112.117 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.94 161.84 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.17 54.16 0.74 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.125 1.77 . . . . 0.0 111.662 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 65.03 17.52 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.194 0.998 . . . . 0.0 110.124 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.06 -52.93 2.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.195 3.263 . . . . 0.0 114.381 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -49.48 -35.61 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.7 1.2 . . . . 0.0 112.615 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -65.45 -28.12 69.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.342 0.519 . . . . 0.0 111.245 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -102.32 -36.61 8.4 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.652 1.181 . . . . 0.0 112.43 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.68 -52.02 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.093 1.757 . . . . 0.0 113.082 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.79 -24.92 56.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.55 150.94 79.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 121.525 -0.734 . . . . 0.0 110.202 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.23 87.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.883 2.389 . . . . 0.0 108.207 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -24.59 22.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.366 1.866 . . . . 0.0 113.252 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.33 110.33 0.32 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.358 1.463 . . . . 0.0 110.46 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -47.93 -46.2 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.611 0.764 . . . . 0.0 110.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.91 -29.17 55.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.74 1.216 . . . . 0.0 113.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.67 -51.5 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.1 mt -49.79 -42.46 46.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.234 0.614 . . . . 0.0 112.188 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.25 -33.68 54.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.119 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.34 -49.06 70.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.895 1.225 . . . . 0.0 108.577 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -51.23 -46.47 62.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.57 0.748 . . . . 0.0 110.225 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -63.92 -49.94 70.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.83 -42.56 99.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.852 -1.155 . . . . 0.0 111.157 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.71 -30.53 61.57 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.074 0.95 . . . . 0.0 111.865 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.62 157.11 30.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.08 115.51 3.85 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.131 -0.629 . . . . 0.0 109.506 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.67 -116.58 9.17 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -24.88 58.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.923 0.489 . . . . 0.0 111.472 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.29 119.63 66.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.589 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.66 157.63 51.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.447 2.098 . . . . 0.0 110.276 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.76 120.18 11.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.333 0.653 . . . . 0.0 110.064 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.05 -12.46 58.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -45.48 112.55 0.47 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.73 0.812 . . . . 0.0 111.146 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 -32.39 7.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.457 1.027 . . . . 0.0 112.599 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -88.51 -49.99 6.57 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.404 1.102 . . . . 0.0 110.733 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.83 121.81 34.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -80.49 152.72 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -26.65 -51.57 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.859 2.064 . . . . 0.0 111.564 168.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -63.01 -43.48 98.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.237 0.926 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.27 -56.67 17.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 122.339 1.066 . . . . 0.0 108.369 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.4 mt -47.8 -57.52 5.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -37.81 -55.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.537 1.535 . . . . 0.0 110.135 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.1 mttp -55.65 -42.75 75.48 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.331 0.394 . . . . 0.0 111.628 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.92 -48.5 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 122.729 0.411 . . . . 0.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -37.49 84.07 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.638 1.108 . . . . 0.0 109.11 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -60.43 -47.38 86.34 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.055 0.843 . . . . 0.0 110.147 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.0 mtt -49.54 -65.65 0.53 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.1 mp -49.78 -40.56 41.84 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.067 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -61.24 -8.47 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.2 p -92.92 -11.53 33.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.521 1.51 . . . . 0.0 111.357 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.679 -177.432 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 118.65 -0.691 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -46.07 -41.82 11.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.134 0.873 . . . . 0.0 111.253 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.28 -62.48 1.63 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.6 -49.25 14.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.083 0.953 . . . . 0.0 111.133 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -57.86 -59.94 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.786 0.834 . . . . 0.0 109.683 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -54.18 -47.42 72.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 0.0 111.801 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.44 -47.55 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.421 0.688 . . . . 0.0 111.502 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -148.61 -15.51 0.32 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.05 3.48 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 120.099 1.318 . . . . 0.0 111.288 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -133.69 149.95 51.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.562 1.545 . . . . 0.0 107.627 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.26 6.08 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.421 1.088 . . . . 0.0 109.377 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.35 152.57 31.78 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.204 1.109 . . . . 0.0 111.808 -8.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.67 126.28 29.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.487 1.115 . . . . 0.0 109.888 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -59.52 -50.17 74.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -37.66 -61.04 0.65 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.024 2.13 . . . . 0.0 113.101 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -38.63 3.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.666 1.187 . . . . 0.0 112.3 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.6 m -91.11 -58.34 2.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 117.665 0.211 . . . . 0.0 110.985 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -67.54 -41.96 83.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.24 -34.6 78.02 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.654 -0.654 . . . . 0.0 110.607 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.15 -24.71 18.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.787 0.835 . . . . 0.0 112.678 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.77 35.12 13.8 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.101 0.858 . . . . 0.0 111.472 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -56.75 131.63 20.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.65 31.24 7.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 111.451 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.48 26.06 74.72 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.632 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.5 134.08 77.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.418 1.109 . . . . 0.0 108.568 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.84 120.29 8.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.479 2.119 . . . . 0.0 109.493 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -88.0 174.14 8.47 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.466 0.65 . . . . 0.0 111.923 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.94 165.56 24.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 45.82 41.23 7.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.549 1.14 . . . . 0.0 111.655 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.1 59.44 10.7 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -47.43 -34.41 19.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.421 3.414 . . . . 0.0 113.713 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -51.67 -38.87 56.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 110.7 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 15.7 4.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.453 0.701 . . . . 0.0 112.113 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -134.66 -40.28 0.79 Allowed 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.011 0.823 . . . . 0.0 111.485 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -40.41 -46.71 2.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.998 1.319 . . . . 0.0 112.505 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.58 -26.41 50.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 113.195 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -75.28 159.33 82.5 Favored Pre-proline 0 CA--C 1.534 0.347 0 O-C-N 121.576 -0.703 . . . . 0.0 109.976 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.07 121.43 10.05 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.839 1.693 . . . . 0.0 109.677 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -64.56 -39.16 93.24 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 109.634 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 m -50.72 102.51 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.142 1.777 . . . . 0.0 112.036 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.7 -40.19 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.302 1.041 . . . . 0.0 109.964 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.73 -35.29 65.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.798 0.839 . . . . 0.0 112.253 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -77.74 -48.2 17.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.01 -43.6 70.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 122.879 0.472 . . . . 0.0 111.612 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -60.41 -44.29 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.911 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.15 -46.22 79.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.746 1.157 . . . . 0.0 109.652 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -54.23 -37.77 64.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.042 0.383 . . . . 0.0 111.392 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -68.0 -50.39 55.87 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.614 0.766 . . . . 0.0 109.357 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -42.42 94.34 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 120.158 1.345 . . . . 0.0 111.472 177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.11 -38.49 78.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.044 0.538 . . . . 0.0 111.981 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.98 155.32 29.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -155.48 135.17 12.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.66 -118.44 13.83 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.59 -3.32 46.59 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.694 0.798 . . . . 0.0 112.242 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.0 ttp -68.1 122.02 82.36 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 119.259 0.936 . . . . 0.0 110.595 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.29 153.12 55.49 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.034 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 112.62 6.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -71.32 -3.07 18.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.26 110.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 0.0 111.072 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.82 -11.27 62.54 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.345 0.974 . . . . 0.0 114.596 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -76.1 -47.94 22.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.044 1.422 . . . . 0.0 109.906 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.64 156.23 46.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.56 140.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -32.83 -44.21 0.1 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.577 1.951 . . . . 0.0 112.436 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.78 -47.8 83.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.811 1.187 . . . . 0.0 111.197 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.4 -56.77 16.96 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 122.902 1.334 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.3 mt -48.08 -57.27 6.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.857 179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.19 -53.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.892 1.277 . . . . 0.0 109.919 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -57.87 -38.91 76.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.498 0.319 . . . . 0.0 111.258 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.13 81.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.915 -0.49 . . . . 0.0 109.896 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.4 mt -66.7 -52.61 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.613 0.765 . . . . 0.0 109.991 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.29 -39.7 76.27 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.234 0.924 . . . . 0.0 109.086 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.14 -52.73 64.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.128 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 ptm -54.44 -43.35 71.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.611 0.641 . . . . 0.0 109.346 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.6 mt -65.15 -35.18 80.28 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.476 -0.765 . . . . 0.0 110.763 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 m -74.83 37.93 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.009 -1.057 . . . . 0.0 112.634 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -148.59 24.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.582 1.153 . . . . 0.0 109.918 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.252 1.232 0 CA-C-O 116.148 -1.882 . . . . 0.0 107.132 -177.439 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.56 -38.33 7.17 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.965 1.269 . . . . 0.0 112.586 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.54 -56.19 11.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.28 -51.63 52.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.947 1.299 . . . . 0.0 109.399 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.23 -57.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.842 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -57.64 -52.15 66.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.888 0.475 . . . . 0.0 111.623 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.57 -46.34 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.557 -173.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.57 38.81 0.33 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.298 0.954 . . . . 0.0 113.04 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.75 40.33 1.09 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -137.25 156.94 47.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.436 1.895 . . . . 0.0 107.841 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 106.64 5.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.861 0.864 . . . . 0.0 108.904 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.83 152.85 24.35 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 120.378 1.171 . . . . 0.0 112.142 -7.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.38 123.79 19.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -51.0 62.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.912 0.885 . . . . 0.0 111.439 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 p -40.88 -54.41 2.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.447 1.899 . . . . 0.0 111.872 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.91 -38.74 1.64 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.61 1.164 . . . . 0.0 113.094 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -98.43 -57.15 2.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.964 0.347 . . . . 0.0 111.49 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -73.71 -19.47 60.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -172.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.37 -53.57 18.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.535 1.061 . . . . 0.0 108.989 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -79.98 -31.13 39.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.467 0.307 . . . . 0.0 111.052 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.5 42.85 5.69 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.26 142.81 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.37 28.62 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.066 0.947 . . . . 0.0 111.502 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.95 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.715 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 134.14 87.54 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.738 1.269 . . . . 0.0 108.377 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.78 115.76 3.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.701 2.267 . . . . 0.0 108.258 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -86.16 179.08 7.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.901 0.857 . . . . 0.0 113.215 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.23 159.94 22.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 34.61 52.38 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.545 1.538 . . . . 0.0 112.565 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.9 61.96 31.28 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.317 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.73 -46.76 6.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.045 3.163 . . . . 0.0 114.683 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -49.88 -39.99 41.37 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.822 1.249 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.67 -15.45 61.7 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.873 0.869 . . . . 0.0 112.463 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -110.94 -25.57 9.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.508 1.123 . . . . 0.0 112.294 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.05 -46.26 0.48 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.921 2.088 . . . . 0.0 114.433 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.39 -5.57 32.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -81.48 154.96 71.63 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 121.483 -0.761 . . . . 0.0 110.211 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.52 115.6 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.072 2.515 . . . . 0.0 111.462 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -60.72 -34.03 73.77 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.26 99.96 0.07 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.754 2.022 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.2 t -53.33 -38.44 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.616 -0.677 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.29 -26.2 51.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 112.415 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.13 -50.81 5.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -49.02 -41.01 33.23 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.694 0.798 . . . . 0.0 112.117 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.85 -30.4 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.533 -0.729 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.29 -49.62 68.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -50.99 -46.29 61.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.619 0.767 . . . . 0.0 109.796 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 m -60.68 -51.9 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.05 -45.46 93.46 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.245 -0.909 . . . . 0.0 111.456 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 -32.37 63.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.833 0.853 . . . . 0.0 112.369 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 161.01 27.8 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.45 115.1 2.49 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.962 -0.728 . . . . 0.0 109.163 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.62 -116.95 9.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.25 -24.58 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.371 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.38 121.18 75.57 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.946 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 165.26 29.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.711 2.274 . . . . 0.0 109.781 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.78 134.03 48.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.79 -14.77 20.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.125 0.97 . . . . 0.0 112.326 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.77 101.02 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.269 1.028 . . . . 0.0 112.539 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.48 -37.28 3.77 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.009 1.29 . . . . 0.0 111.481 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -77.02 -36.45 56.25 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-N 117.756 0.778 . . . . 0.0 109.913 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.8 149.11 50.87 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 173.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.29 130.45 37.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -31.69 -44.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.029 2.132 . . . . 0.0 112.818 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.46 -48.95 75.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.684 1.129 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.76 -47.93 81.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.012 0.925 . . . . 0.0 108.797 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -51.86 -55.91 17.2 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.037 176.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -45.2 -57.81 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.211 1.004 . . . . 0.0 109.271 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -56.36 -39.8 73.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 118.483 0.583 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.97 95.01 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.722 -0.611 . . . . 0.0 110.073 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.73 -47.76 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -53.47 -52.46 59.44 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -54.56 -52.15 63.01 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.56 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.19 -50.57 64.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.13 -30.12 71.2 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.945 -0.472 . . . . 0.0 110.997 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.1 m -74.25 40.59 0.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.073 -1.017 . . . . 0.0 112.782 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.5 p -135.43 -10.92 2.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 109.827 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.7 -1.619 . . . . 0.0 110.25 -177.839 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.89 11.93 84.31 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 68.53 -53.94 0.54 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 129.068 2.947 . . . . 0.0 112.256 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p -31.17 -56.75 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.728 2.411 . . . . 0.0 112.868 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.29 -50.51 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.408 1.083 . . . . 0.0 110.483 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -68.29 -46.39 70.46 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.694 0.397 . . . . 0.0 110.398 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.85 -42.11 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.958 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 32.47 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.24 14.85 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.096 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -97.89 168.8 10.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.644 0.778 . . . . 0.0 111.497 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.5 115.53 25.18 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.0 1.32 . . . . 0.0 107.822 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.51 169.66 35.43 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.609 1.253 . . . . 0.0 110.057 -10.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -78.25 149.68 33.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 m -61.87 -44.54 96.6 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -50.56 -47.41 57.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.086 1.355 . . . . 0.0 111.651 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -42.64 -40.35 2.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.782 0.719 . . . . 0.0 112.167 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.8 m -98.29 -57.93 2.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.468 0.175 . . . . 0.0 111.188 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -62.2 -40.38 95.89 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.47 -29.77 64.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.138 0.426 . . . . 0.0 111.107 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -115.61 17.73 16.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.708 0.803 . . . . 0.0 111.681 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 48.09 40.23 20.55 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 123.899 0.761 . . . . 0.0 113.8 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.94 135.49 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.082 -0.658 . . . . 0.0 109.381 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 31.31 7.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.756 1.223 . . . . 0.0 111.806 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.55 23.38 77.09 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.667 -0.518 . . . . 0.0 112.628 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.73 140.77 75.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.222 1.011 . . . . 0.0 108.791 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -58.27 119.44 6.69 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.489 2.126 . . . . 0.0 107.81 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.52 167.58 19.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.832 1.301 . . . . 0.0 111.26 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mp -77.01 162.26 27.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.873 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.23 53.56 1.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.939 1.296 . . . . 0.0 110.601 -176.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.92 64.93 11.75 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.006 1.723 . . . . 0.0 109.427 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -39.12 -55.46 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.588 3.525 . . . . 0.0 114.358 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -44.71 -45.44 9.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.01 1.324 . . . . 0.0 112.281 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -53.76 -39.16 65.12 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.463 0.705 . . . . 0.0 110.762 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -92.88 -29.9 15.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.846 0.859 . . . . 0.0 111.169 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.19 98.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 109.617 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.99 -41.75 97.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 110.326 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -76.36 164.15 61.69 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.683 1.193 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.0 88.66 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 107.539 -1.754 . . . . 0.0 107.539 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -51.98 -22.2 3.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.293 1.437 . . . . 0.0 112.463 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -56.77 108.3 0.48 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.287 1.035 . . . . 0.0 110.453 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.53 -46.33 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.736 1.214 . . . . 0.0 110.047 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.89 -36.83 3.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.201 2.2 . . . . 0.0 112.335 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.21 -52.74 4.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.298 1.039 . . . . 0.0 109.182 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -44.72 -45.93 10.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.773 0.829 . . . . 0.0 112.634 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.2 m -61.35 -34.31 60.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 O-C-N 121.348 -0.845 . . . . 0.0 111.585 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.2 -47.18 71.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 m -53.5 -46.26 69.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.06 0.544 . . . . 0.0 110.051 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -62.17 -52.02 65.48 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.982 0.513 . . . . 0.0 111.345 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -40.48 84.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.56 -0.713 . . . . 0.0 109.698 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.43 76.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.145 0.578 . . . . 0.0 111.617 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.52 154.99 24.26 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -158.38 125.64 4.98 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.45 -137.67 49.15 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.06 -16.88 64.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.624 -0.788 . . . . 0.0 111.997 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.42 117.28 51.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.652 1.115 . . . . 0.0 109.801 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.32 155.06 64.91 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.441 2.094 . . . . 0.0 109.951 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.11 133.58 55.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.65 6.58 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.951 0.9 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -40.69 108.84 0.1 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.243 1.817 . . . . 0.0 112.688 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.28 -20.27 5.02 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.529 0.585 . . . . 0.0 113.021 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -76.37 -44.3 36.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.72 25.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.73 152.61 33.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -23.16 -52.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.219 2.208 . . . . 0.0 111.692 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -60.54 -56.68 18.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.351 0.523 . . . . 0.0 111.811 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.67 -49.89 69.53 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.411 1.084 . . . . 0.0 109.687 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 71.0 mt -52.13 -58.6 6.09 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.291 1.436 . . . . 0.0 110.057 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.16 -58.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.753 0.821 . . . . 0.0 109.509 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.08 -26.1 62.12 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.17 1.388 . . . . 0.0 113.068 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 -59.39 2.72 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 mt -51.17 -44.53 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.643 1.177 . . . . 0.0 111.459 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -53.86 -37.85 64.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.865 0.757 . . . . 0.0 110.708 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.95 -44.21 90.16 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.996 0.816 . . . . 0.0 109.664 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.7 mtp -53.55 -58.39 7.34 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.3 -36.79 66.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.688 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -62.49 -10.36 11.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.388 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -89.01 -9.02 52.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.462 1.483 . . . . 0.0 111.158 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 116.554 -1.689 . . . . 0.0 111.033 -176.288 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -47.6 -42.13 19.65 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 119.328 0.967 . . . . 0.0 111.403 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -49.9 -55.62 13.71 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.119 0.967 . . . . 0.0 108.751 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -57.19 -50.47 72.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.982 1.313 . . . . 0.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -50.65 -60.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.51 -52.56 63.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.241 1.416 . . . . 0.0 112.027 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.1 mt -67.84 -47.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.015 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.04 11.94 0.3 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.49 34.55 5.52 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.629 1.104 . . . . 0.0 111.591 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.21 157.64 45.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.486 1.514 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.58 107.75 9.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.207 1.003 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.16 159.17 68.99 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.172 1.097 . . . . 0.0 110.053 -8.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -68.13 118.55 11.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.06 1.344 . . . . 0.0 110.429 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 m -46.49 -48.56 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.981 0.913 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -45.46 -44.73 12.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.979 1.712 . . . . 0.0 112.547 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -53.2 -26.16 16.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.016 0.526 . . . . 0.0 112.255 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -104.02 -58.26 1.91 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.097 0.408 . . . . 0.0 109.941 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -66.89 -35.52 80.2 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.67 -41.67 75.18 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.102 0.865 . . . . 0.0 109.834 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -80.57 -28.7 37.11 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.097 0.559 . . . . 0.0 111.513 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.27 38.71 7.64 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.04 125.53 11.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.51 32.77 9.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.031 0.932 . . . . 0.0 111.128 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.41 76.95 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.941 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.45 113.33 5.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.57 1.185 . . . . 0.0 108.591 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -36.32 116.79 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 125.014 3.809 . . . . 0.0 114.493 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.39 173.69 10.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 111.701 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.58 159.52 32.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 49.43 29.71 2.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.848 0.859 . . . . 0.0 112.119 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.07 61.53 33.43 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.989 0.916 . . . . 0.0 110.954 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -45.35 -42.35 17.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.72 2.947 . . . . 0.0 112.799 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.36 -39.67 32.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 112.198 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -67.97 -25.07 65.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.125 0.57 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -105.52 -23.37 12.81 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.453 1.101 . . . . 0.0 112.893 -173.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -51.25 0.72 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.548 1.939 . . . . 0.0 113.582 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.71 -22.08 43.79 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -77.14 151.69 81.61 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.875 0.87 . . . . 0.0 110.206 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.3 125.28 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.675 1.583 . . . . 0.0 108.768 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -62.58 -29.63 70.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.797 -0.565 . . . . 0.0 110.35 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -56.01 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.986 1.714 . . . . 0.0 111.945 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.09 -42.39 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.304 1.441 . . . . 0.0 109.411 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.41 -37.43 11.42 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.386 2.274 . . . . 0.0 112.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.42 -50.86 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.1 mt -47.71 -42.16 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.88 0.872 . . . . 0.0 112.401 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.94 -32.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.16 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.58 -50.03 68.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -51.26 -47.33 62.49 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.599 0.76 . . . . 0.0 109.908 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.1 m -61.73 -49.54 75.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.74 -45.52 93.59 Favored 'General case' 0 N--CA 1.458 -0.063 0 O-C-N 121.132 -0.98 . . . . 0.0 111.143 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.51 -31.16 65.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.944 0.897 . . . . 0.0 112.289 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.01 160.71 29.53 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -155.51 108.86 2.77 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.964 -0.727 . . . . 0.0 109.327 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.01 -113.95 5.88 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.69 -30.19 64.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.688 0.395 . . . . 0.0 111.0 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.1 ttp -63.62 120.35 62.12 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.913 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.57 156.66 44.94 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.843 2.362 . . . . 0.0 110.01 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.71 135.1 56.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -100.46 -13.89 18.51 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 113.329 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.97 102.79 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 112.148 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.38 -38.97 3.03 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.126 1.346 . . . . 0.0 111.537 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -76.79 -39.74 50.47 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 117.68 0.74 . . . . 0.0 110.112 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.43 130.54 30.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -79.72 146.72 32.23 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -27.93 -53.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.377 170.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -41.94 96.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.134 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.49 -59.58 5.17 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.4 mt -46.07 -58.66 3.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.495 1.518 . . . . 0.0 111.004 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -39.34 -51.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.812 2.045 . . . . 0.0 111.149 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -58.06 -45.57 86.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.703 0.801 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -47.69 78.15 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.407 -0.808 . . . . 0.0 109.826 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.9 mt -56.98 -52.16 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.876 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.41 -39.98 92.72 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.984 -1.072 . . . . 0.0 109.28 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -57.08 -49.5 75.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.418 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.5 mtt -48.13 -63.62 1.02 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.17 0.986 . . . . 0.0 108.649 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mp -49.83 -41.55 45.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.669 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -62.17 -10.94 11.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 p -90.1 -13.38 35.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.195 1.362 . . . . 0.0 111.207 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.6 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.566 -174.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.16 -39.8 65.05 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.72 -49.97 75.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -50.32 -52.72 34.32 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.865 0.757 . . . . 0.0 110.45 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.14 -57.07 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.795 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -56.18 -50.46 71.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.307 1.043 . . . . 0.0 111.651 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.72 -46.9 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.859 -174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.11 36.38 0.29 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 33.17 2.28 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.845 0.748 . . . . 0.0 111.252 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 155.68 48.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.687 1.995 . . . . 0.0 107.189 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.01 108.23 18.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -62.52 166.07 37.45 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.216 1.113 . . . . 0.0 109.341 -11.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -67.54 136.09 53.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 m -49.7 -43.48 47.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 0.687 . . . . 0.0 109.426 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.8 p -47.21 -41.44 18.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.066 1.347 . . . . 0.0 112.561 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.1 m -46.2 -39.16 9.31 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.3 0.64 . . . . 0.0 111.316 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -102.96 -52.33 3.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -72.0 -27.5 62.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.39 -47.08 62.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -68.17 -41.87 80.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.203 1.001 . . . . 0.0 110.367 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 34.81 13.08 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.57 145.55 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.68 32.24 6.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.22 1.008 . . . . 0.0 111.576 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.58 24.43 73.9 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.34 126.62 75.01 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.818 1.309 . . . . 0.0 108.038 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.85 116.51 3.4 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.628 2.219 . . . . 0.0 108.294 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -74.68 -149.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.516 1.127 . . . . 0.0 111.433 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.63 145.78 51.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.496 1.518 . . . . 0.0 107.474 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' OXT' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 49.14 48.13 21.23 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -168.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.42 51.78 1.41 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.341 2.257 . . . . 0.0 111.499 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -47.89 -34.97 23.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.336 3.358 . . . . 0.0 113.807 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -50.33 -40.13 48.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.917 1.287 . . . . 0.0 110.966 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.22 -5.67 52.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -107.96 -44.99 4.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.58 46.03 26.05 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.913 0.863 . . . . 0.0 110.236 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.86 53.11 2.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 0.0 112.216 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -57.04 157.29 11.55 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.33 101.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.73 2.286 . . . . 0.0 111.073 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -59.05 -23.69 62.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.457 1.103 . . . . 0.0 111.989 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -55.07 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.71 1.604 . . . . 0.0 110.721 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -43.59 -41.47 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.279 1.431 . . . . 0.0 109.709 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -42.5 -38.02 1.81 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.345 2.258 . . . . 0.0 112.609 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.13 -50.53 5.79 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.636 0.774 . . . . 0.0 110.17 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -51.09 -40.48 58.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.426 0.69 . . . . 0.0 111.844 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.02 -34.41 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.695 -0.628 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.09 -44.04 81.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.7 m -54.46 -44.99 73.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -67.01 -45.09 78.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.027 0.531 . . . . 0.0 110.889 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 O-C-N 121.259 -0.9 . . . . 0.0 110.68 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.39 51.79 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.416 1.086 . . . . 0.0 112.697 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 161.47 30.57 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -161.57 117.79 2.13 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.083 -0.657 . . . . 0.0 109.319 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.41 -118.06 13.51 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.34 -25.34 51.0 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.209 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.5 ttp -62.22 118.68 42.21 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.178 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.46 160.52 46.58 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.509 2.139 . . . . 0.0 110.065 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.8 116.73 8.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -82.49 -7.46 59.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.676 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -55.9 88.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.931 0.892 . . . . 0.0 112.091 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 -41.9 1.44 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 110.572 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -75.55 -35.27 60.72 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.393 0.677 . . . . 0.0 110.384 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.72 130.72 20.54 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.57 149.66 32.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -32.04 -47.49 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.124 1.77 . . . . 0.0 111.494 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.68 -49.16 77.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.838 0.745 . . . . 0.0 111.66 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.43 -56.34 22.38 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 122.556 1.169 . . . . 0.0 108.791 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.5 mt -48.68 -60.71 2.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.085 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -43.29 -51.72 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.887 1.675 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -59.21 -33.87 71.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.395 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.14 13.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.781 0.719 . . . . 0.0 109.39 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.4 mt -54.76 -45.77 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.121 0.968 . . . . 0.0 111.279 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.66 -41.39 90.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.036 1.289 . . . . 0.0 110.599 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.63 -54.14 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 ttm -45.75 -55.06 6.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.121 1.368 . . . . 0.0 109.782 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.85 -26.62 58.86 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.239 0.615 . . . . 0.0 112.535 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -79.83 10.49 4.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.83 0.741 . . . . 0.0 112.372 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -177.05 54.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' CD1' ' C ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.91 -44.11 61.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.994 0.806 . . . . 0.0 111.134 176.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -57.63 -59.65 4.86 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.662 0.731 . . . . 0.0 109.448 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 p -54.5 -43.91 72.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 111.438 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.73 -55.46 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.24 -48.44 78.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.167 0.987 . . . . 0.0 111.872 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.24 -51.73 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.538 -175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.85 8.69 0.37 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -173.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.39 4.42 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 119.795 1.18 . . . . 0.0 111.253 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -137.82 156.18 48.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.793 1.637 . . . . 0.0 108.155 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.0 110.79 10.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.761 0.825 . . . . 0.0 110.596 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.09 160.77 15.66 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 CA-C-N 119.915 1.005 . . . . 0.0 111.851 -15.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -70.34 114.9 8.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.355 1.062 . . . . 0.0 108.982 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -44.54 -48.27 10.23 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.19 0.996 . . . . 0.0 111.324 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -43.76 -47.93 8.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.374 1.87 . . . . 0.0 112.184 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -49.46 -34.6 17.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 m -96.7 -58.03 2.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.63 0.252 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -67.4 -36.36 81.14 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.26 -41.37 85.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -30.13 56.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.667 0.787 . . . . 0.0 110.572 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.47 40.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.4 136.95 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.02 28.21 5.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.119 0.968 . . . . 0.0 111.471 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 24.76 76.67 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.955 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.76 132.96 47.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.903 1.351 . . . . 0.0 108.422 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -49.48 104.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.958 3.106 . . . . 0.0 110.917 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -75.24 176.23 7.57 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.514 1.149 . . . . 0.0 109.666 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.4 142.43 27.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.14 33.11 12.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.348 0.659 . . . . 0.0 109.461 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.66 55.87 17.72 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.641 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -37.09 -46.57 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.486 3.457 . . . . 0.0 114.242 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -41.47 -45.36 3.17 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.046 1.338 . . . . 0.0 112.738 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -76.84 -25.05 52.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.679 0.672 . . . . 0.0 112.261 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -91.08 -23.49 20.3 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.411 0.684 . . . . 0.0 111.429 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -47.39 0.53 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.32 2.248 . . . . 0.0 114.355 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -91.33 -14.37 30.87 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.428 0.691 . . . . 0.0 112.852 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -78.59 147.58 71.72 Favored Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 123.839 0.856 . . . . 0.0 109.731 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.15 110.3 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.844 1.696 . . . . 0.0 108.573 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.34 -27.47 47.4 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.135 0.574 . . . . 0.0 112.007 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 109.24 0.36 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.844 1.658 . . . . 0.0 111.482 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.3 t -51.95 -42.07 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.86 -20.96 40.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -93.64 -53.85 3.88 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.8 mt -47.65 -41.72 22.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.62 0.768 . . . . 0.0 112.163 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.71 -37.1 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 121.688 -0.632 . . . . 0.0 110.41 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.7 -48.26 75.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -52.3 -46.04 65.78 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.811 0.845 . . . . 0.0 110.4 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -67.82 -40.97 83.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.058 0.543 . . . . 0.0 111.216 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.09 -56.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.37 61.72 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.567 1.147 . . . . 0.0 112.354 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.75 152.76 25.24 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -151.76 142.75 23.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -90.37 0.08 OUTLIER Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.98 16.0 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.365 1.466 . . . . 0.0 112.058 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.0 mtm -67.89 134.78 92.02 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 119.29 0.95 . . . . 0.0 110.847 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.42 78.42 3.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.99 2.46 . . . . 0.0 108.784 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -10.08 106.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 128.315 2.646 . . . . 0.0 112.403 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -76.21 -6.65 52.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -47.29 114.83 0.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.557 0.743 . . . . 0.0 111.272 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.12 -26.95 21.45 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.206 0.908 . . . . 0.0 112.717 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -90.28 -52.44 4.93 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.514 1.157 . . . . 0.0 110.349 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.57 133.79 54.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.06 147.42 31.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -32.23 -45.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.38 1.872 . . . . 0.0 111.546 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.0 -47.18 84.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.211 0.914 . . . . 0.0 111.667 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.94 -58.65 7.23 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 122.577 1.179 . . . . 0.0 108.738 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.8 mt -47.14 -57.37 5.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.406 1.882 . . . . 0.0 110.078 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -46.24 -57.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 124.844 1.257 . . . . 0.0 109.713 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.78 -43.65 81.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.802 0.274 . . . . 0.0 111.441 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.25 72.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.6 mt -57.75 -47.33 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.251 1.42 . . . . 0.0 109.463 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.26 -51.69 65.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -55.95 -50.8 69.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.361 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 79.0 mtp -51.84 -53.46 40.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.291 0.636 . . . . 0.0 109.987 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.78 -37.44 73.71 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.577 0.751 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.3 m -72.67 41.18 0.09 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.3 p -135.64 -16.35 1.78 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.36 1.864 . . . . 0.0 110.014 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.033 -178.126 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -43.6 -49.85 7.1 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.397 0.999 . . . . 0.0 112.946 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -56.12 -40.58 73.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.543 -0.386 . . . . 0.0 111.303 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -52.81 -42.09 64.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.553 0.615 . . . . 0.0 111.054 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.33 -59.59 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.296 1.438 . . . . 0.0 109.197 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.32 -51.42 70.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 111.349 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 mm -65.73 -46.02 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.816 0.446 . . . . 0.0 111.065 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.13 44.03 0.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.97 36.67 1.21 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.44 157.27 46.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.732 2.013 . . . . 0.0 107.47 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.92 113.49 6.41 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.802 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.73 152.5 19.71 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 CA-C-N 120.321 1.15 . . . . 0.0 111.065 -13.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.31 125.17 24.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.609 1.164 . . . . 0.0 109.775 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -54.74 -51.05 66.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -39.54 -61.06 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.509 1.923 . . . . 0.0 112.214 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.0 m -41.51 -39.62 1.6 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.441 1.497 . . . . 0.0 113.387 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.46 -56.82 2.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.045 0.45 . . . . 0.0 110.923 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -60.67 -41.18 94.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -48.31 -40.93 26.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.668 0.787 . . . . 0.0 112.109 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -116.43 26.08 10.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.991 0.516 . . . . 0.0 111.863 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.21 43.08 18.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.566 0.603 . . . . 0.0 113.54 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.25 136.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.69 30.36 8.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.549 1.14 . . . . 0.0 111.676 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.0 23.49 74.45 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.6 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.01 142.91 84.88 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 118.459 1.129 . . . . 0.0 109.323 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -59.78 121.53 9.98 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 106.848 -2.02 . . . . 0.0 106.848 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.47 176.76 7.23 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.671 1.7 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.5 tp -97.46 140.46 31.87 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.518 -2.128 . . . . 0.0 107.525 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 64.59 35.98 8.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.353 0.661 . . . . 0.0 109.459 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.62 71.26 81.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.467 1.107 . . . . 0.0 111.233 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -41.0 -57.99 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 124.344 3.363 . . . . 0.0 114.456 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -43.53 -47.92 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.154 1.381 . . . . 0.0 112.164 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.26 -39.56 63.96 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 110.972 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -91.03 -29.89 17.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.318 0.647 . . . . 0.0 111.073 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.0 97.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.359 0.663 . . . . 0.0 109.396 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.56 -41.86 96.05 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -77.29 164.68 57.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.586 1.154 . . . . 0.0 111.085 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -67.82 89.8 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 N-CA-C 107.632 -1.719 . . . . 0.0 107.632 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -21.96 7.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.702 1.201 . . . . 0.0 112.322 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.94 109.5 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.434 1.893 . . . . 0.0 110.932 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.13 -44.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.251 1.02 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.41 -29.09 61.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.009 1.724 . . . . 0.0 112.606 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.81 -55.35 3.89 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 mt -45.61 -44.36 13.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.833 1.253 . . . . 0.0 112.994 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.89 -37.33 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 O-C-N 121.722 -0.611 . . . . 0.0 110.607 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -65.58 -47.24 76.44 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.192 0.905 . . . . 0.0 108.905 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -53.04 -46.6 68.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.386 0.674 . . . . 0.0 110.259 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -64.13 -46.45 84.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.002 0.521 . . . . 0.0 110.356 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -57.06 -54.41 47.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.791 -0.568 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.48 64.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.22 1.008 . . . . 0.0 112.988 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.61 160.27 33.12 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -157.68 126.36 5.65 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.861 -0.787 . . . . 0.0 109.05 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.0 -120.68 22.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.92 -14.44 54.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.746 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.2 ttp -71.69 118.23 64.67 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 119.166 0.894 . . . . 0.0 108.716 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.23 160.56 48.56 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.389 2.059 . . . . 0.0 110.611 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.2 133.14 53.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -101.65 -11.55 19.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.615 0.766 . . . . 0.0 111.363 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -46.37 117.53 1.62 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.364 1.065 . . . . 0.0 111.558 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.52 -25.0 11.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.267 0.937 . . . . 0.0 112.34 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -86.35 -47.38 9.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.86 0.83 . . . . 0.0 108.865 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -110.08 142.24 41.82 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -80.36 131.03 35.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -28.35 -49.88 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.205 2.202 . . . . 0.0 112.659 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -61.28 -49.04 78.66 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.82 -0.55 . . . . 0.0 111.225 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.35 86.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 123.93 0.892 . . . . 0.0 109.141 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.9 mt -51.63 -58.99 4.79 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.64 -54.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.158 1.383 . . . . 0.0 110.484 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -56.72 -45.55 81.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.139 0.427 . . . . 0.0 111.333 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.34 98.43 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.798 -0.564 . . . . 0.0 110.179 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.2 -55.85 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 109.268 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -59.26 -38.86 81.12 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.643 1.11 . . . . 0.0 109.773 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.53 -49.81 76.34 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttp -53.52 -54.27 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.7 mt -56.36 -38.97 72.13 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.619 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -61.42 -6.5 2.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.882 1.219 . . . . 0.0 113.951 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.0 p -86.75 -5.28 59.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.725 1.148 . . . . 0.0 110.684 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.224 -1.37 . . . . 0.0 110.688 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.937 -0.554 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.29 -40.64 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.82 -47.33 85.58 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 117.883 0.841 . . . . 0.0 109.557 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -48.39 76.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.238 0.615 . . . . 0.0 109.628 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.39 -55.95 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 109.6 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -56.66 -50.48 71.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.914 0.886 . . . . 0.0 111.607 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.46 -45.29 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.131 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.91 36.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -173.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.04 33.0 2.22 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.98 157.45 46.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.271 2.228 . . . . 0.0 106.408 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.49 113.19 6.62 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.755 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -50.08 153.73 7.78 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 120.522 1.222 . . . . 0.0 110.752 -15.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.2 p -67.01 144.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -56.25 -38.89 71.75 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.076 0.853 . . . . 0.0 108.906 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -56.28 -23.27 35.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 112.8 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.0 m -57.48 -28.32 63.3 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.488 1.04 . . . . 0.0 110.628 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.2 m -122.54 -52.31 1.93 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -70.09 -20.35 63.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.21 -52.12 65.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.818 0.735 . . . . 0.0 109.869 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -91.47 -22.95 20.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 111.339 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 42.15 8.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.35 146.6 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.51 30.17 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.081 0.952 . . . . 0.0 111.417 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.4 79.96 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.027 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.95 135.61 90.31 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.873 1.336 . . . . 0.0 108.272 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -60.31 128.83 27.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.459 2.106 . . . . 0.0 109.915 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -89.02 171.44 9.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.264 1.031 . . . . 0.0 112.937 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.48 156.42 36.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.891 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 52.32 36.56 20.03 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.889 0.876 . . . . 0.0 111.265 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.37 65.52 68.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.842 -175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -39.74 -47.03 3.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 124.324 3.349 . . . . 0.0 114.428 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -51.11 -39.59 56.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.865 1.266 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.49 -21.88 66.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.426 0.69 . . . . 0.0 111.733 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -108.58 -30.73 8.09 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.4 1.08 . . . . 0.0 112.903 -174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.49 -50.79 1.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.728 1.611 . . . . 0.0 113.048 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 -24.51 50.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.92 143.85 67.14 Favored Pre-proline 0 CA--C 1.535 0.381 0 O-C-N 121.529 -0.732 . . . . 0.0 110.276 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.79 96.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.675 2.25 . . . . 0.0 108.895 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -55.78 -26.88 48.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.815 1.246 . . . . 0.0 112.943 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 m -50.0 104.28 0.07 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.827 1.651 . . . . 0.0 111.48 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.14 -44.07 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.167 1.387 . . . . 0.0 111.54 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.18 -31.86 67.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.183 0.593 . . . . 0.0 112.045 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -81.63 -48.01 12.28 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.67 -41.3 61.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 m -59.94 -34.18 55.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.87 -48.48 81.6 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.531 1.514 . . . . 0.0 109.057 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.69 -42.21 67.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.795 0.838 . . . . 0.0 111.205 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -70.39 -44.57 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.384 0.673 . . . . 0.0 110.334 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -64.18 -50.66 67.25 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 124.795 1.238 . . . . 0.0 109.751 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.12 61.59 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.201 1.001 . . . . 0.0 112.214 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 158.53 31.48 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -157.15 118.34 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.013 -0.698 . . . . 0.0 109.482 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 -117.77 12.28 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.39 -23.13 54.06 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.744 0.418 . . . . 0.0 111.461 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.4 ttp -66.41 118.49 54.04 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.466 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.34 154.38 56.13 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.481 2.121 . . . . 0.0 109.954 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.84 123.36 17.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.827 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -92.28 -11.9 33.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.967 0.803 . . . . 0.0 111.756 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -44.26 116.01 0.94 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.062 0.945 . . . . 0.0 112.037 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -26.36 9.73 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.154 0.883 . . . . 0.0 112.4 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -83.91 -44.75 13.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.23 146.39 37.04 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.55 132.58 34.91 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -31.96 -44.32 0.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.141 1.776 . . . . 0.0 112.64 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -57.02 -44.62 83.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.819 1.191 . . . . 0.0 111.645 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -54.03 -57.76 9.84 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.17 0.986 . . . . 0.0 108.531 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.7 mt -50.34 -59.12 4.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.545 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.0 t -43.38 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.445 1.098 . . . . 0.0 109.687 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.36 -40.79 97.58 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 122.11 -0.369 . . . . 0.0 111.815 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.88 97.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.0 mt -65.22 -48.13 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.105 0.962 . . . . 0.0 109.111 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.27 -51.73 51.5 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.59 -53.73 54.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.107 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ptm -55.66 -47.34 76.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.507 0.594 . . . . 0.0 109.68 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.73 -38.52 90.83 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.832 -0.542 . . . . 0.0 110.449 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.2 m -61.71 -5.4 1.92 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.5 p -88.38 -16.31 33.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.207 1.367 . . . . 0.0 111.19 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.657 -1.64 . . . . 0.0 110.601 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.62 -49.24 61.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -48.43 -49.75 33.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.274 1.029 . . . . 0.0 110.536 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -47.38 -40.3 17.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.385 1.074 . . . . 0.0 111.602 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mt -58.23 -49.23 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -68.05 -44.72 75.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.967 0.907 . . . . 0.0 110.743 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.9 mt -69.32 -50.97 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.311 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.2 -9.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -171.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.2 -40.18 42.37 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 119.847 1.203 . . . . 0.0 111.131 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -72.57 158.59 35.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.76 111.88 5.78 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.439 1.096 . . . . 0.0 109.792 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 151.34 12.04 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.249 1.125 . . . . 0.0 110.86 -13.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 p -66.3 134.35 52.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -51.4 -41.41 60.7 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.63 0.729 . . . . 0.0 109.334 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 p -50.93 -37.05 41.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 112.814 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -44.75 -39.28 5.07 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.876 0.762 . . . . 0.0 111.407 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.7 m -107.04 -56.31 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.514 0.725 . . . . 0.0 110.439 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -62.7 -26.83 68.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.46 -1.52 53.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.69 0.677 . . . . 0.0 111.026 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -127.35 -17.69 4.64 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.925 0.89 . . . . 0.0 111.65 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.56 27.17 65.9 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.597 -0.69 . . . . 0.0 111.488 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.87 141.64 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.38 27.76 5.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 111.575 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.47 74.49 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.65 129.2 80.91 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.595 1.198 . . . . 0.0 108.311 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -64.54 123.56 11.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.24 1.96 . . . . 0.0 109.269 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.29 -179.53 5.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.703 0.763 . . . . 0.0 113.053 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.67 159.57 34.16 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 48.06 32.34 2.89 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 112.356 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.16 61.85 59.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.406 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -37.24 -49.11 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.456 3.437 . . . . 0.0 114.01 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.02 -43.78 9.52 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.245 1.418 . . . . 0.0 111.951 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.01 -27.0 67.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.747 0.819 . . . . 0.0 111.924 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -103.62 -18.55 14.69 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.689 1.195 . . . . 0.0 112.429 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -47.05 0.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.407 1.883 . . . . 0.0 114.013 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -9.84 30.16 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -81.27 131.57 58.54 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.62 109.79 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.959 2.439 . . . . 0.0 110.888 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -56.59 -26.26 54.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.764 0.826 . . . . 0.0 112.446 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -49.43 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.31 1.844 . . . . 0.0 111.618 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.0 t -48.47 -38.56 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.67 0.788 . . . . 0.0 110.715 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.01 -44.01 82.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.844 0.458 . . . . 0.0 111.383 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -68.71 -45.96 70.19 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -56.51 -44.51 80.83 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.448 0.299 . . . . 0.0 111.553 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.12 -36.26 77.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -52.66 64.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.951 0.796 . . . . 0.0 109.798 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 m -51.17 -43.26 61.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.908 0.883 . . . . 0.0 111.106 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -69.12 -44.0 73.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.933 0.493 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.26 -52.5 64.47 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.337 -0.852 . . . . 0.0 109.947 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.5 77.91 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.677 0.791 . . . . 0.0 110.905 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.26 87.14 1.43 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.542 1.068 . . . . 0.0 110.867 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -77.79 146.58 35.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.652 1.181 . . . . 0.0 109.82 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.83 -110.85 3.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.24 9.49 28.01 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.684 1.193 . . . . 0.0 111.903 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 42.8 mtm -71.25 137.83 84.25 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 119.172 0.896 . . . . 0.0 111.627 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.52 139.37 69.98 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 N-CA-C 106.961 -1.977 . . . . 0.0 106.961 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 114.99 3.67 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -80.82 -8.74 59.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.846 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -51.7 112.15 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.94 0.791 . . . . 0.0 110.609 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.83 -26.14 10.25 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.945 0.783 . . . . 0.0 111.916 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -74.6 -44.19 51.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.435 1.094 . . . . 0.0 108.696 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.99 157.11 40.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.79 1.236 . . . . 0.0 108.338 175.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.47 129.82 35.35 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -33.6 -43.81 0.13 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.532 1.933 . . . . 0.0 112.046 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.86 -48.82 80.05 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.401 1.0 . . . . 0.0 111.522 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -48.81 78.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.8 mt -50.8 -58.73 5.22 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.127 0.489 . . . . 0.0 109.693 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 t -47.36 -56.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.796 1.239 . . . . 0.0 109.823 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -57.12 -40.38 76.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.873 0.469 . . . . 0.0 111.72 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.62 93.98 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.36 -46.77 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -53.78 -51.42 63.48 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -54.17 -54.11 44.27 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.306 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.3 mtp -49.33 -60.03 3.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.407 0.683 . . . . 0.0 109.394 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.13 -39.15 66.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.54 0.736 . . . . 0.0 111.678 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -62.82 -9.01 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.321 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -88.8 -14.1 37.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.17 1.35 . . . . 0.0 110.932 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.122 -175.631 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.47 -37.36 19.02 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.462 1.03 . . . . 0.0 111.698 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.93 -60.85 2.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -47.21 -46.12 23.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.679 1.192 . . . . 0.0 110.677 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.91 -53.37 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -59.52 -45.43 91.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.905 0.32 . . . . 0.0 111.67 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.76 -52.82 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.375 0.67 . . . . 0.0 112.035 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -133.23 -18.6 2.26 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.4 -32.34 43.03 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.916 1.235 . . . . 0.0 112.845 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 150.45 45.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.583 0.692 . . . . 0.0 110.687 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.73 111.89 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.021 1.329 . . . . 0.0 109.46 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.46 159.14 59.07 Favored 'Cis proline' 0 N--CA 1.453 -0.877 0 CA-C-N 120.343 1.158 . . . . 0.0 109.402 -12.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -65.22 121.04 13.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.394 1.477 . . . . 0.0 110.31 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 m -51.17 -47.02 62.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.011 0.524 . . . . 0.0 110.552 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.8 p -41.44 -52.42 3.6 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 126.582 1.953 . . . . 0.0 112.226 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -47.62 -33.54 6.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.249 1.02 . . . . 0.0 112.552 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.4 m -99.28 -56.0 2.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.049 0.386 . . . . 0.0 110.838 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -70.65 -38.81 73.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.36 -42.98 78.4 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.359 0.981 . . . . 0.0 108.994 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -38.91 79.36 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.212 1.005 . . . . 0.0 111.509 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.54 34.91 8.19 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.813 1.197 . . . . 0.0 110.362 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.98 129.46 17.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 30.96 6.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.481 1.112 . . . . 0.0 111.361 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.99 24.2 77.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.357 -0.69 . . . . 0.0 112.823 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.36 131.58 52.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.548 1.174 . . . . 0.0 108.33 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -60.09 116.95 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.077 2.518 . . . . 0.0 109.226 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -84.54 173.61 10.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.184 0.994 . . . . 0.0 112.631 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.09 161.68 29.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 m120 49.36 32.03 4.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.549 0.74 . . . . 0.0 112.622 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 59.56 38.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.373 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.55 -45.89 3.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.055 3.17 . . . . 0.0 114.468 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.59 -44.48 18.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.663 1.185 . . . . 0.0 111.519 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.09 -18.15 61.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.171 0.989 . . . . 0.0 112.327 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -104.89 -18.22 14.28 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.32 1.048 . . . . 0.0 112.153 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -46.2 0.59 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.391 1.876 . . . . 0.0 114.243 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.41 -14.91 27.9 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.616 0.767 . . . . 0.0 112.991 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -81.31 124.93 80.22 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.09 0.956 . . . . 0.0 109.373 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.31 120.99 8.17 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.571 2.181 . . . . 0.0 111.473 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.73 -31.05 57.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.827 0.851 . . . . 0.0 112.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -48.72 102.17 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.568 1.947 . . . . 0.0 112.855 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.1 -43.06 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.689 0.796 . . . . 0.0 109.404 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.24 -27.35 63.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.444 1.098 . . . . 0.0 112.769 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.85 -54.06 4.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.2 mt -52.92 -40.69 63.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.793 0.837 . . . . 0.0 112.521 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.97 -28.51 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.505 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.74 -47.39 83.77 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.681 1.128 . . . . 0.0 108.867 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 m -54.22 -48.22 71.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 109.892 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -62.02 -45.24 94.46 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.921 -0.487 . . . . 0.0 111.066 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -62.14 -53.44 55.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.197 0.599 . . . . 0.0 110.98 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.89 -21.42 47.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.067 1.347 . . . . 0.0 112.976 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.4 162.63 35.32 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -159.91 114.33 2.29 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -115.33 7.14 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -27.96 60.4 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.49 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 33.3 ttp -62.98 115.45 17.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.688 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.21 130.27 10.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.032 2.488 . . . . 0.0 110.415 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.62 114.69 0.55 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.434 1.494 . . . . 0.0 111.848 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -83.14 -13.63 55.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.483 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -48.99 112.85 0.68 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.89 0.768 . . . . 0.0 111.258 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.08 -32.92 6.56 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.278 0.942 . . . . 0.0 111.651 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -79.15 -44.66 21.51 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.98 135.83 49.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 172.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.54 146.88 32.39 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -32.2 -47.89 0.16 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.234 1.814 . . . . 0.0 111.31 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.1 -46.02 92.31 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.673 0.67 . . . . 0.0 111.371 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.24 -58.15 9.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 122.08 0.943 . . . . 0.0 108.632 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 72.5 mt -45.87 -58.03 3.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.543 1.537 . . . . 0.0 110.416 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.5 t -41.63 -51.67 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 125.158 1.383 . . . . 0.0 111.214 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -57.85 -38.84 76.4 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.572 0.169 . . . . 0.0 111.416 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -48.15 56.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -58.1 -49.08 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.315 0.646 . . . . 0.0 111.114 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.5 -44.19 97.53 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.022 -1.049 . . . . 0.0 109.629 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -56.95 -53.51 57.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.286 0.494 . . . . 0.0 109.68 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttm -48.2 -53.57 16.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.806 1.642 . . . . 0.0 109.907 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.34 -37.87 84.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.233 -0.292 . . . . 0.0 110.489 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 m -73.4 39.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.3 p -129.43 -12.93 4.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.932 1.693 . . . . 0.0 109.559 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.352 -1.308 . . . . 0.0 110.304 -176.282 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.32 -42.66 9.4 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.568 1.08 . . . . 0.0 111.77 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -54.0 -61.99 1.94 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.542 1.137 . . . . 0.0 108.846 175.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.56 -53.21 24.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 110.538 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.3 mt -52.7 -61.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.427 . . . . 0.0 110.0 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.77 -48.82 77.01 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.288 0.635 . . . . 0.0 112.035 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.69 -44.02 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.153 -173.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 6.14 0.19 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -174.249 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.04 40.04 2.65 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.827 1.194 . . . . 0.0 111.323 -177.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.94 49.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.527 1.531 . . . . 0.0 108.585 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.25 109.19 8.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.738 0.815 . . . . 0.0 110.158 -177.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.73 156.69 32.27 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.802 0.965 . . . . 0.0 111.462 -12.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.1 123.17 19.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.915 1.286 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -55.79 -49.3 73.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.497 0.665 . . . . 0.0 111.011 -177.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -41.52 -51.1 3.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.282 1.833 . . . . 0.0 112.543 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -44.44 -35.34 2.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.793 1.237 . . . . 0.0 113.345 -178.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -102.23 -52.73 3.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.747 0.419 . . . . 0.0 110.729 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -67.12 -25.63 66.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.39 -44.32 97.35 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.3 0.954 . . . . 0.0 110.249 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -30.19 16.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 111.152 178.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.94 40.1 5.01 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -176.181 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.7 136.22 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.411 0.685 . . . . 0.0 109.36 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.54 32.25 8.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.776 1.23 . . . . 0.0 112.097 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.76 81.18 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.267 -0.74 . . . . 0.0 113.278 178.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.23 130.38 68.7 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.529 1.165 . . . . 0.0 108.61 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.88 119.17 6.16 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.004 1.802 . . . . 0.0 109.402 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.4 158.52 33.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.526 0.679 . . . . 0.0 110.323 -176.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.92 151.08 25.28 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 64.45 34.82 9.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.985 0.914 . . . . 0.0 109.363 -174.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.8 68.46 43.43 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.765 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -38.65 -52.39 2.07 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.291 3.328 . . . . 0.0 114.275 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -48.52 -39.99 25.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.322 1.449 . . . . 0.0 111.812 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.04 -30.85 71.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.808 0.443 . . . . 0.0 111.339 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -101.25 -27.67 13.07 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.783 0.833 . . . . 0.0 112.359 -175.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.55 0.92 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.05 1.74 . . . . 0.0 112.98 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.54 -21.31 38.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -177.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -81.36 156.5 71.24 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.872 0.869 . . . . 0.0 110.268 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.89 109.85 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.008 2.472 . . . . 0.0 111.646 176.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.96 -31.52 72.64 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.031 -1.043 . . . . 0.0 110.423 177.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 105.17 0.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 111.68 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -48.77 -39.7 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.001 0.92 . . . . 0.0 110.599 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.55 -39.67 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.841 1.256 . . . . 0.0 111.648 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.29 -44.18 47.0 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.1 mt -56.11 -49.73 73.06 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.8 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -59.41 -44.69 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.291 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.64 -44.69 85.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.322 0.964 . . . . 0.0 109.596 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -59.58 -33.2 71.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.084 176.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.7 m -72.38 -45.31 60.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.5 0.72 . . . . 0.0 109.751 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -54.65 -52.31 62.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.86 1.209 . . . . 0.0 110.517 174.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.83 82.26 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.358 0.411 . . . . 0.0 111.762 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.21 124.21 3.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -101.12 139.87 36.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.133 1.373 . . . . 0.0 107.748 178.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.06 3.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.39 8.61 43.52 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.088 0.955 . . . . 0.0 112.723 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 37.1 mtm -68.06 148.25 98.37 Favored Pre-proline 0 C--N 1.338 0.091 0 CA-C-N 119.756 1.162 . . . . 0.0 112.261 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.32 140.92 25.16 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 N-CA-C 106.345 -2.214 . . . . 0.0 106.345 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.85 117.66 6.17 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.0 4.07 10.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.071 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -50.67 104.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 111.713 177.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -8.43 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.186 0.898 . . . . 0.0 113.214 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -78.75 -42.21 28.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.84 144.91 47.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 174.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.47 143.21 32.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -27.72 -50.31 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.4 2.28 . . . . 0.0 112.295 169.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.77 -49.88 71.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.539 0.609 . . . . 0.0 111.095 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.93 -50.65 72.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.35 1.06 . . . . 0.0 109.377 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -51.29 -56.84 10.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.251 1.42 . . . . 0.0 109.986 177.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.3 t -52.44 -53.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.175 0.59 . . . . 0.0 109.98 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -56.33 -36.83 69.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.672 0.789 . . . . 0.0 111.529 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.72 38.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.16 -48.72 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 -176.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.28 -42.17 90.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.208 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -61.14 -48.85 79.71 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.557 0.617 . . . . 0.0 110.152 177.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.0 mtp -48.02 -58.05 4.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.016 0.912 . . . . 0.0 109.149 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -56.28 -40.05 73.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.086 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 m -74.17 42.36 0.15 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.122 -0.987 . . . . 0.0 113.583 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.6 p -132.01 -15.62 2.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.441 1.496 . . . . 0.0 109.949 171.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.927 -177.33 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.78 -40.37 41.33 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 176.486 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.36 -58.8 6.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.3 -47.98 18.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.905 0.775 . . . . 0.0 111.609 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.38 -57.11 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.162 0.985 . . . . 0.0 110.06 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -54.9 -44.68 74.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -74.48 -51.71 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.956 -173.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -16.55 1.83 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.47 -35.06 43.01 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.654 1.115 . . . . 0.0 112.112 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -70.25 147.05 50.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.026 0.53 . . . . 0.0 110.791 -178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.69 109.81 13.3 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.704 1.202 . . . . 0.0 109.349 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.35 161.25 58.86 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.257 1.128 . . . . 0.0 110.371 -8.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -70.73 125.48 26.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.26 1.424 . . . . 0.0 110.934 -177.609 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 m -56.18 -48.74 75.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.268 0.556 . . . . 0.0 110.389 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 p -38.44 -58.51 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.941 2.096 . . . . 0.0 111.888 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -41.1 -38.74 1.1 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.947 1.299 . . . . 0.0 113.113 -179.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.6 m -94.64 -56.07 2.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.828 0.285 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -65.65 -33.48 75.98 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.323 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.01 -39.88 83.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 119.752 1.16 . . . . 0.0 109.471 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -76.79 -29.99 56.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.174 0.99 . . . . 0.0 110.712 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.65 31.47 62.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -174.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -58.42 140.2 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.27 29.31 6.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.084 0.954 . . . . 0.0 111.414 -177.317 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 25.62 74.47 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.391 -0.672 . . . . 0.0 112.651 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 135.36 82.75 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.621 1.21 . . . . 0.0 108.622 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -62.9 122.64 11.0 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.389 2.06 . . . . 0.0 109.178 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -87.77 177.48 7.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.795 0.807 . . . . 0.0 111.955 -174.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.15 161.14 31.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.23 51.05 0.78 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.573 1.549 . . . . 0.0 111.786 177.882 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.41 63.13 27.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.8 1.24 . . . . 0.0 110.275 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -40.19 -46.42 4.14 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.245 3.297 . . . . 0.0 114.523 -176.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.31 -39.93 33.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.92 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.41 -24.45 66.47 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.53 0.732 . . . . 0.0 111.781 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -106.6 -22.3 12.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.69 1.196 . . . . 0.0 112.938 -174.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.33 -49.53 0.71 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.935 1.694 . . . . 0.0 113.484 -178.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.1 -15.27 36.67 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -81.63 153.36 70.59 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 118.944 0.793 . . . . 0.0 110.512 -177.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.24 125.92 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.455 176.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -67.37 -40.18 85.74 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.04 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -49.42 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.006 2.522 . . . . 0.0 112.19 178.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.62 -40.1 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.025 0.93 . . . . 0.0 109.703 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.5 -25.39 36.81 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.324 1.85 . . . . 0.0 112.373 176.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -89.83 -51.23 5.6 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -51.35 -38.99 56.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.728 0.811 . . . . 0.0 112.158 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.76 -33.62 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.542 -0.724 . . . . 0.0 110.286 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -65.1 -49.45 69.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.598 1.09 . . . . 0.0 108.424 177.642 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -53.04 -43.69 66.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.047 0.539 . . . . 0.0 109.831 177.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -67.96 -46.23 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.028 -0.42 . . . . 0.0 110.716 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.7 mt -56.18 -51.09 69.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.673 -0.642 . . . . 0.0 110.083 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.79 -27.81 55.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.598 1.159 . . . . 0.0 113.134 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 163.3 32.92 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -175.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -157.42 119.63 3.82 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.916 -0.755 . . . . 0.0 109.499 -178.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.01 -118.06 12.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.8 -21.21 55.46 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.743 0.417 . . . . 0.0 111.588 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.6 ttp -68.54 118.66 62.19 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 118.942 0.792 . . . . 0.0 110.075 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.57 158.37 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.486 2.124 . . . . 0.0 109.798 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.24 148.01 38.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.92 -9.18 12.47 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.417 1.087 . . . . 0.0 113.14 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -48.13 110.24 0.31 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.084 0.856 . . . . 0.0 111.796 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.38 -31.33 7.55 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.084 0.849 . . . . 0.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -74.33 -46.46 40.72 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.01 129.02 46.05 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.84 145.16 38.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -30.69 -46.19 0.08 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 127.113 2.165 . . . . 0.0 112.153 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.6 -54.51 44.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.475 1.034 . . . . 0.0 110.89 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -51.06 71.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.433 1.093 . . . . 0.0 109.382 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -50.4 -56.96 9.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.522 1.129 . . . . 0.0 110.103 177.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 t -50.42 -57.35 2.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 123.877 0.871 . . . . 0.0 109.395 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -54.2 -43.58 70.86 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.965 0.348 . . . . 0.0 111.525 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.06 95.36 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.07 -51.52 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.395 0.678 . . . . 0.0 109.886 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.45 -40.11 85.78 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 120.107 1.321 . . . . 0.0 108.878 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -57.2 -51.66 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.464 0.574 . . . . 0.0 109.945 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ptm -56.55 -46.61 80.58 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -35.12 79.45 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.658 -0.651 . . . . 0.0 111.204 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.8 m -62.81 -7.59 5.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.047 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.4 p -88.03 -12.19 45.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.867 1.212 . . . . 0.0 111.0 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 116.486 -1.721 . . . . 0.0 111.095 -175.92 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -43.99 -39.93 5.34 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.569 1.557 . . . . 0.0 112.476 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.32 -44.34 95.22 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.851 0.825 . . . . 0.0 110.023 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -53.48 57.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.21 -59.34 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.806 1.243 . . . . 0.0 110.292 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -58.29 -52.1 67.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.06 0.944 . . . . 0.0 111.893 -178.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.16 -44.21 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.292 -173.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 44.03 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 37.16 0.98 Allowed Glycine 0 CA--C 1.524 0.63 0 O-C-N 121.638 -0.664 . . . . 0.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -138.87 157.53 45.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.464 1.906 . . . . 0.0 107.587 177.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.39 107.92 8.64 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.562 0.745 . . . . 0.0 109.755 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.25 158.2 27.59 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 CA-C-N 119.991 1.033 . . . . 0.0 112.314 -9.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.98 117.31 11.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.278 1.031 . . . . 0.0 109.116 178.004 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m -46.43 -48.62 18.82 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.709 0.804 . . . . 0.0 111.194 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 p -44.45 -46.91 9.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.026 1.73 . . . . 0.0 112.586 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -50.91 -30.29 14.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.163 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 m -101.66 -56.37 2.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.895 0.316 . . . . 0.0 110.786 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -71.7 -23.14 61.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -172.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.48 -50.78 62.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.52 1.054 . . . . 0.0 109.024 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.89 35.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.6 44.53 9.3 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -175.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 144.2 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.28 29.91 7.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.965 0.906 . . . . 0.0 111.319 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.87 20.41 79.83 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.109 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 137.61 84.49 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.931 1.365 . . . . 0.0 108.416 176.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.54 128.49 26.1 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.561 2.174 . . . . 0.0 109.842 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.9 174.73 7.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.291 1.043 . . . . 0.0 113.347 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.08 166.71 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 113.497 -1.683 . . . . 0.0 106.853 169.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 48.03 34.77 4.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.558 0.743 . . . . 0.0 111.111 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.34 61.16 16.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.794 -173.541 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -40.09 -49.22 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.846 3.031 . . . . 0.0 113.729 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.83 -40.93 10.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.396 1.478 . . . . 0.0 112.264 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -63.41 -26.04 68.56 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.859 0.464 . . . . 0.0 111.661 -177.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -106.26 -28.68 10.27 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.257 1.423 . . . . 0.0 111.961 -175.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.24 -46.15 0.5 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.754 2.022 . . . . 0.0 112.86 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.63 30.64 6.11 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.215 1.006 . . . . 0.0 112.888 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -134.69 159.36 72.46 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.549 1.14 . . . . 0.0 108.414 176.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.32 109.15 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.154 2.569 . . . . 0.0 112.77 -177.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.46 -32.4 73.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.211 -0.931 . . . . 0.0 110.276 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -55.92 103.94 0.12 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.479 1.912 . . . . 0.0 112.399 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.42 -39.43 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.72 -24.74 51.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.36 1.064 . . . . 0.0 112.569 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.21 -55.08 3.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.6 mt -47.82 -40.7 21.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.79 -35.02 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.933 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.45 -48.41 75.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.398 0.999 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m -54.98 -41.64 71.44 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.825 0.45 . . . . 0.0 109.799 176.397 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -67.64 -45.0 76.6 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.07 -0.394 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.09 -51.82 68.12 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.649 -0.657 . . . . 0.0 109.981 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.68 61.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.748 1.219 . . . . 0.0 113.432 -176.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.24 163.9 24.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -158.8 114.76 2.64 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.977 -0.719 . . . . 0.0 109.323 -177.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.42 -116.22 8.19 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.33 -26.17 60.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.88 0.472 . . . . 0.0 111.554 178.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.5 ttp -67.97 116.54 39.67 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.75 -177.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.57 166.2 24.76 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.23 1.953 . . . . 0.0 110.738 176.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.35 133.55 49.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -101.25 -10.43 20.36 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 113.256 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -49.25 110.09 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.549 0.613 . . . . 0.0 111.013 179.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.01 -37.44 3.77 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.725 1.155 . . . . 0.0 111.666 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -43.99 42.91 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 117.994 0.897 . . . . 0.0 108.836 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.84 132.14 41.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 176.013 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -79.23 150.84 31.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.037 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -32.18 -46.65 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.328 1.851 . . . . 0.0 111.715 171.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.81 -44.92 88.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.434 1.015 . . . . 0.0 111.329 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.9 -56.31 23.83 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 122.459 1.123 . . . . 0.0 108.619 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.9 mt -47.63 -58.97 3.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.164 178.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 t -45.17 -57.39 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 124.515 1.126 . . . . 0.0 109.636 177.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -58.68 -41.71 86.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.349 0.522 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.31 93.84 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.718 -0.614 . . . . 0.0 110.02 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.41 -48.01 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -53.19 -51.47 61.98 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.7 -52.7 61.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.222 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -51.31 -56.52 12.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.69 -37.6 68.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.837 -0.539 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -67.92 -3.34 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 113.461 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.2 p -110.76 15.26 22.02 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 120.19 1.359 . . . . 0.0 111.242 177.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.62 179.613 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -49.38 -38.75 27.65 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.275 0.941 . . . . 0.0 111.811 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.16 -60.97 3.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.33 -51.24 35.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.983 1.313 . . . . 0.0 110.53 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.67 -57.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.041 0.937 . . . . 0.0 109.747 -177.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -58.03 -46.92 84.53 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.8 mt -71.82 -49.07 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.787 -172.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.92 -13.74 0.93 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -170.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.33 -30.73 36.23 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 120.079 1.309 . . . . 0.0 112.66 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -75.21 156.59 35.64 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.715 0.757 . . . . 0.0 111.161 -177.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.34 111.49 7.1 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.913 1.285 . . . . 0.0 108.954 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.26 150.77 55.54 Favored 'Cis proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.435 1.191 . . . . 0.0 109.645 -11.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.93 118.62 7.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.227 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 m -48.26 -47.04 36.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.476 0.655 . . . . 0.0 110.535 -178.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -45.09 -43.81 9.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.983 1.713 . . . . 0.0 112.557 178.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -51.13 -33.06 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.595 0.634 . . . . 0.0 112.025 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.3 m -100.05 -53.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.424 0.289 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.85 -29.3 66.51 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -173.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.73 -42.44 86.27 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.344 0.974 . . . . 0.0 108.855 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -81.76 -27.6 33.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.289 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.84 46.42 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.45 144.69 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 O-C-N 122.09 -0.653 . . . . 0.0 109.289 -176.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.03 29.71 6.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.205 1.002 . . . . 0.0 111.534 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.3 23.04 78.59 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.306 -0.719 . . . . 0.0 112.799 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 131.0 84.37 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.761 1.28 . . . . 0.0 108.028 176.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -61.65 121.72 9.97 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.218 1.945 . . . . 0.0 109.041 -178.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.02 163.2 24.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.435 1.112 . . . . 0.0 111.121 -176.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.79 161.97 29.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 171.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.18 55.0 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 111.19 -178.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.71 64.66 7.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.759 0.824 . . . . 0.0 111.093 -178.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -36.86 -49.79 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.776 3.651 . . . . 0.0 114.523 -178.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.98 -43.01 13.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.128 1.371 . . . . 0.0 111.794 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.7 -24.51 66.26 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.037 0.935 . . . . 0.0 112.008 -177.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -106.01 -19.39 13.74 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.443 1.097 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.43 -49.14 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.524 1.53 . . . . 0.0 113.342 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.11 -14.75 33.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.141 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -82.03 131.63 56.16 Favored Pre-proline 0 CA--C 1.535 0.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.856 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.51 113.71 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.913 2.408 . . . . 0.0 111.198 177.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -58.05 -26.56 62.65 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.461 0.704 . . . . 0.0 112.395 -178.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -50.71 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 111.662 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.8 t -41.36 -53.03 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 124.592 1.157 . . . . 0.0 110.619 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.89 -43.26 69.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -61.52 -47.11 87.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.118 0.872 . . . . 0.0 108.782 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.6 -37.51 81.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.383 178.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.03 -43.57 97.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.81 -46.22 91.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.406 1.003 . . . . 0.0 109.724 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -54.3 -45.54 72.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.345 . . . . 0.0 110.454 176.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -67.37 -45.31 76.65 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.922 -0.486 . . . . 0.0 110.531 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 mt -54.11 -54.93 32.73 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.726 -0.609 . . . . 0.0 109.712 177.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.54 74.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.926 0.891 . . . . 0.0 112.613 -177.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.95 164.29 31.28 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 -174.481 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -157.58 108.79 2.28 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.761 -0.846 . . . . 0.0 109.569 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.54 -115.08 6.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.47 -29.47 64.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.725 0.41 . . . . 0.0 111.052 178.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.4 ttp -65.16 120.05 64.06 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.421 -178.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.78 160.15 44.13 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.442 2.095 . . . . 0.0 110.354 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.68 52.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.6 -10.83 16.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.961 0.904 . . . . 0.0 111.019 177.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.0 123.81 7.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.0 111.037 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -16.36 33.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.186 0.898 . . . . 0.0 112.739 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 mtm105 -97.25 -48.84 5.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.225 1.013 . . . . 0.0 109.223 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 127.14 42.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 65' ' ' GLU . 13.5 m-20 -76.69 83.01 3.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 3.2 -47.91 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 1 C-N-CA 132.522 4.329 . . . . 0.0 117.221 -178.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 63' ' ' ASP . 42.9 mt-10 -50.07 -37.43 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.961 1.255 . . . . 0.0 109.265 173.49 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.02 -57.68 8.02 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.687 1.995 . . . . 0.0 109.818 173.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.66 -56.41 22.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.749 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.1 t -43.85 -57.14 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.199 1.0 . . . . 0.0 109.725 176.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -56.51 -48.9 76.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.242 1.017 . . . . 0.0 111.094 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.46 77.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.682 -0.636 . . . . 0.0 109.362 -178.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.37 -46.78 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.546 1.138 . . . . 0.0 110.846 -176.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.57 -38.17 80.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.937 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -62.14 -51.35 68.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.173 176.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.0 mtp -44.45 -58.9 2.69 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.088 0.947 . . . . 0.0 109.632 177.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.3 -41.05 83.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.275 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -74.58 42.55 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.4 p -136.46 -13.2 1.78 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.437 1.495 . . . . 0.0 110.096 171.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.268 -178.408 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -49.08 -43.73 32.41 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -51.05 -61.65 2.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.351 1.06 . . . . 0.0 108.598 175.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -51.49 -48.99 62.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.76 1.224 . . . . 0.0 110.819 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.46 -55.04 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -59.28 -48.53 81.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.249 0.62 . . . . 0.0 111.843 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.95 -49.39 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.175 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -135.06 -17.68 1.84 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.49 -34.52 35.58 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.978 1.263 . . . . 0.0 112.543 -176.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -70.25 151.18 45.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 117.361 0.58 . . . . 0.0 110.424 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.09 111.22 7.89 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 109.133 -179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 151.97 24.81 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.306 1.145 . . . . 0.0 111.449 -11.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.91 124.98 23.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.805 1.242 . . . . 0.0 109.309 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.15 -45.36 79.65 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.393 0.616 . . . . 0.0 110.57 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 p -42.27 -50.51 4.95 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.567 1.947 . . . . 0.0 112.067 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.16 -37.35 2.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.292 1.037 . . . . 0.0 112.5 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -102.14 -57.37 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.637 0.375 . . . . 0.0 111.046 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -67.95 -20.96 65.11 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.43 -2.65 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.164 0.893 . . . . 0.0 110.882 176.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -135.44 -9.6 2.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 35.5 51.88 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.694 -0.629 . . . . 0.0 111.908 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.1 133.47 20.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.31 31.1 8.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.304 1.041 . . . . 0.0 111.462 -177.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.33 23.18 78.36 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.622 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 139.75 80.24 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.334 1.067 . . . . 0.0 109.251 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.09 126.08 18.63 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.373 2.049 . . . . 0.0 109.308 179.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.66 171.72 9.46 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.182 0.992 . . . . 0.0 112.491 -175.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 161.08 19.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.929 172.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 37.7 52.96 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.136 1.374 . . . . 0.0 112.009 176.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.04 65.41 11.94 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.796 0.838 . . . . 0.0 110.469 -177.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.67 -51.56 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.781 3.654 . . . . 0.0 114.695 -177.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.16 -39.34 28.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.136 0.974 . . . . 0.0 112.196 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.91 -26.8 68.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.564 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -104.24 -29.86 10.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.026 1.33 . . . . 0.0 112.269 -175.153 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.02 -41.51 1.69 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.957 1.703 . . . . 0.0 113.605 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.59 -22.65 26.13 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.541 0.737 . . . . 0.0 112.317 -176.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -80.93 143.51 53.65 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.022 0.929 . . . . 0.0 110.026 -176.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 85.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.063 2.509 . . . . 0.0 108.267 173.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -23.86 26.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.728 2.011 . . . . 0.0 113.543 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -51.18 112.69 0.77 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.649 1.18 . . . . 0.0 110.683 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -46.64 -44.58 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.524 1.13 . . . . 0.0 110.553 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.79 -31.53 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.236 1.415 . . . . 0.0 113.001 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.44 -52.83 4.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 109.046 177.009 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 mt -48.36 -41.32 28.31 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 122.824 0.449 . . . . 0.0 111.994 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.14 -37.71 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 121.747 -0.596 . . . . 0.0 110.903 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -65.85 -48.12 72.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 m -53.56 -42.28 67.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.708 0.29 . . . . 0.0 110.299 176.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -67.04 -48.83 67.12 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.282 0.633 . . . . 0.0 111.235 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.8 -43.02 69.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 109.528 -174.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.7 73.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.538 0.735 . . . . 0.0 111.073 178.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 152.3 27.92 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.623 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -153.5 149.52 27.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.27 -116.98 8.69 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.29 14.21 22.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.453 1.101 . . . . 0.0 111.495 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.96 127.31 93.32 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.495 -0.753 . . . . 0.0 110.416 -178.621 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.76 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.492 2.128 . . . . 0.0 109.19 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -25.55 123.29 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.178 2.191 . . . . 0.0 112.11 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.6 6.57 48.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.839 0.456 . . . . 0.0 112.096 -176.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -42.09 109.45 0.13 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.497 1.519 . . . . 0.0 112.695 178.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 -14.43 8.03 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.73 0.681 . . . . 0.0 113.449 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 mtm105 -82.05 -46.94 13.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.28 1.04 . . . . 0.0 108.507 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.05 126.27 45.95 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 172.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.22 150.26 33.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -27.24 -49.89 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 126.177 1.791 . . . . 0.0 112.102 170.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.67 -50.35 73.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.115 1.325 . . . . 0.0 111.56 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -54.29 -56.12 21.55 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 122.662 1.22 . . . . 0.0 109.031 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.38 -59.48 3.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -45.05 -53.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 125.394 1.478 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -56.33 -33.94 66.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.048 0.539 . . . . 0.0 112.055 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.68 27.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.747 0.703 . . . . 0.0 109.924 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.61 -49.92 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.825 . . . . 0.0 110.233 -176.371 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.65 -44.29 73.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.185 0.902 . . . . 0.0 109.777 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.14 -50.51 72.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 ptm -54.5 -44.19 72.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.53 -34.74 77.71 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.627 -0.671 . . . . 0.0 110.696 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -73.92 56.64 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.005 0.922 . . . . 0.0 111.793 179.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.6 p -150.81 -32.71 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.444 2.298 . . . . 0.0 109.598 177.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.523 1.929 . . . . 0.0 110.413 178.885 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.89 -43.6 61.04 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.03 -56.73 18.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -48.71 -45.77 39.77 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.089 0.859 . . . . 0.0 111.709 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.14 -56.4 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.494 1.118 . . . . 0.0 109.826 -178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.47 -48.07 80.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.756 0.822 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 mm -70.42 -48.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.425 0.69 . . . . 0.0 111.146 -174.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 39.79 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -173.122 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.81 38.91 1.17 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -139.07 155.95 47.55 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.502 1.921 . . . . 0.0 107.587 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 105.29 16.85 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 123.715 0.806 . . . . 0.0 111.198 -176.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.54 164.47 61.49 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 CA-C-N 120.286 1.138 . . . . 0.0 110.113 -8.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -67.31 119.11 11.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.543 1.137 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -46.89 -45.46 20.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.895 0.878 . . . . 0.0 111.228 -176.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -46.02 -42.71 13.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.715 1.606 . . . . 0.0 112.311 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -55.94 -16.27 4.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.3 m -115.27 -57.43 2.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.788 175.566 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -71.14 -22.9 62.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -173.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.54 -48.6 66.51 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.751 1.16 . . . . 0.0 109.615 -178.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -86.54 -25.19 25.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.917 0.887 . . . . 0.0 111.1 178.652 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.38 41.97 8.85 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.51 140.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.41 28.58 5.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.993 0.917 . . . . 0.0 111.476 -177.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.46 79.62 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.009 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 121.25 43.14 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.823 1.311 . . . . 0.0 108.247 176.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -44.15 114.99 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.869 3.046 . . . . 0.0 113.636 -177.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.81 169.63 17.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.758 0.79 . . . . 0.0 111.759 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 159.72 28.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.31 51.08 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.362 1.465 . . . . 0.0 111.733 178.053 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.96 62.04 31.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.919 0.888 . . . . 0.0 111.055 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -38.17 -45.85 2.15 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 124.33 3.353 . . . . 0.0 114.198 -178.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.42 -43.67 11.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.896 1.278 . . . . 0.0 111.957 178.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -69.3 -25.54 64.28 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.658 0.783 . . . . 0.0 112.074 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -104.26 -18.2 14.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.795 1.238 . . . . 0.0 112.754 -174.559 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.04 -48.4 0.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.937 2.095 . . . . 0.0 113.969 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -98.65 -4.13 34.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -87.26 128.81 53.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.486 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.95 123.87 13.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.525 2.15 . . . . 0.0 110.967 177.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -64.25 -23.57 67.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.295 0.638 . . . . 0.0 110.668 178.094 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -49.33 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.856 2.062 . . . . 0.0 112.264 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.44 -41.5 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.316 0.646 . . . . 0.0 109.43 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -50.61 -38.6 46.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.847 1.259 . . . . 0.0 112.262 177.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -79.57 -49.64 11.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.29 -40.66 62.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.913 0.485 . . . . 0.0 111.915 -178.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -61.69 -35.05 65.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.298 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.9 -46.3 78.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 120.204 1.365 . . . . 0.0 108.698 178.292 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 m -52.89 -45.7 67.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.947 0.404 . . . . 0.0 110.162 175.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -69.5 -44.41 71.14 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.924 -0.485 . . . . 0.0 110.97 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.16 -51.14 70.96 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.283 -0.886 . . . . 0.0 110.347 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.74 59.2 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.36 1.064 . . . . 0.0 112.376 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.14 163.64 28.67 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -176.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -157.06 111.12 2.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.97 -0.723 . . . . 0.0 109.324 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.15 -113.52 5.2 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.65 -30.67 63.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.945 0.498 . . . . 0.0 111.168 177.847 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.3 ttp -63.07 119.29 50.89 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.255 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.84 160.46 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.365 2.044 . . . . 0.0 110.28 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.57 119.78 12.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -87.22 -4.45 59.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.785 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.83 89.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 179.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.2 2.54 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.889 1.709 . . . . 0.0 110.589 -178.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -87.23 -37.27 17.39 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.258 1.023 . . . . 0.0 111.106 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 126.14 18.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.33 153.57 24.54 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.203 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -29.17 -47.53 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.577 1.951 . . . . 0.0 112.047 171.724 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -62.81 -50.72 69.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.991 1.268 . . . . 0.0 111.665 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -54.96 -55.31 32.16 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.824 1.297 . . . . 0.0 108.955 178.498 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.4 mt -49.93 -60.46 2.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.151 179.093 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.4 t -42.09 -56.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 109.765 177.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -56.99 -43.07 81.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.512 0.142 . . . . 0.0 111.22 -178.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.89 53.34 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.9 mt -54.66 -46.62 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.964 1.306 . . . . 0.0 110.135 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -53.51 -52.58 59.14 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -55.94 -50.5 70.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.605 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.5 mtp -50.83 -58.16 6.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.377 0.671 . . . . 0.0 109.731 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.07 -36.73 73.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.884 0.874 . . . . 0.0 111.59 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -74.7 50.92 0.45 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.023 0.829 . . . . 0.0 112.659 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.7 p -149.24 -25.75 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.282 2.233 . . . . 0.0 110.035 174.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.62 -1.657 . . . . 0.0 110.421 179.528 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.5 54.46 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.524 1.059 . . . . 0.0 111.744 178.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -45.83 69.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.753 0.776 . . . . 0.0 109.882 178.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -56.72 -44.6 81.75 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 121.444 -0.785 . . . . 0.0 108.936 179.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.08 -53.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -57.47 -42.87 83.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 112.738 -177.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -84.37 -39.93 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.709 -175.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -130.55 -34.73 1.54 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -172.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.73 32.12 4.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.473 1.033 . . . . 0.0 113.343 -172.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -133.7 144.98 49.48 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.12 107.78 19.8 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.929 1.292 . . . . 0.0 110.388 -177.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.57 161.46 66.24 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.327 1.153 . . . . 0.0 109.718 -9.712 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.23 130.79 45.28 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.514 0.726 . . . . 0.0 110.145 -178.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.9 -41.92 71.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.023 0.829 . . . . 0.0 109.683 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 t -59.25 -8.71 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 m -67.08 -30.42 70.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 120.352 1.433 . . . . 0.0 109.898 175.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.0 m -113.95 -63.75 1.41 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 112.407 -172.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -57.93 -23.36 53.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.006 1.322 . . . . 0.0 113.555 -174.224 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.18 -25.13 64.19 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.133 -0.355 . . . . 0.0 111.535 178.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -121.11 -12.28 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.251 1.021 . . . . 0.0 112.218 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.3 35.89 51.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.87 145.47 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.19 28.09 6.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.898 0.879 . . . . 0.0 111.466 -177.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.53 21.37 79.56 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.032 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 132.55 87.25 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.855 1.327 . . . . 0.0 108.669 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.07 122.54 10.57 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.469 2.112 . . . . 0.0 108.769 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.23 172.15 10.72 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -170.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.41 158.48 23.63 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.04 50.83 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 0.0 112.078 177.727 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.15 60.84 24.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.624 1.17 . . . . 0.0 110.885 -178.65 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.93 -48.46 1.5 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.599 3.533 . . . . 0.0 114.322 -178.715 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.39 -44.35 8.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.208 1.403 . . . . 0.0 111.838 178.45 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.69 -26.93 67.26 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.978 0.911 . . . . 0.0 112.014 -177.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -103.19 -15.96 15.86 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.826 1.25 . . . . 0.0 112.452 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.68 -47.07 0.64 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.243 1.817 . . . . 0.0 113.709 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -99.72 -4.29 31.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.836 0.854 . . . . 0.0 113.27 -176.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -88.25 126.92 59.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.812 0.845 . . . . 0.0 109.405 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.33 106.03 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.784 2.323 . . . . 0.0 110.529 177.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.7 -23.05 49.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.767 0.827 . . . . 0.0 112.509 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.81 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.159 2.184 . . . . 0.0 111.031 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -49.69 -41.94 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 110.001 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -53.49 -34.97 60.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.986 1.714 . . . . 0.0 112.194 177.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.84 -52.12 7.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.8 mt -51.76 -37.82 52.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.88 -37.94 69.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.408 1.004 . . . . 0.0 110.149 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.38 -47.05 77.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.667 1.121 . . . . 0.0 108.814 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -52.61 -43.92 65.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.629 0.372 . . . . 0.0 110.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -71.97 -44.6 63.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.887 0.475 . . . . 0.0 111.066 -178.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.2 mt -57.69 -50.24 73.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 121.442 -0.786 . . . . 0.0 109.898 179.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.09 65.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.956 0.902 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 118.61 3.06 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -106.63 135.01 48.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.319 1.048 . . . . 0.0 108.456 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.22 -121.48 26.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.12 -1.56 58.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.473 0.709 . . . . 0.0 112.32 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.0 ttp -65.19 127.59 93.01 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 119.016 0.825 . . . . 0.0 111.082 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 144.44 99.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.0 109.964 173.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.39 121.53 15.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -88.28 -4.93 58.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.432 -178.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -54.55 84.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.433 1.093 . . . . 0.0 113.538 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.56 -36.86 2.46 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.982 2.229 . . . . 0.0 110.419 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -42.24 75.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.642 0.721 . . . . 0.0 109.202 177.128 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.24 129.2 21.9 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -84.06 154.2 23.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -29.85 -49.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.407 1.883 . . . . 0.0 112.011 171.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.01 -45.12 93.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.373 0.988 . . . . 0.0 111.784 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.52 -57.56 12.43 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 122.612 1.196 . . . . 0.0 108.77 177.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.8 mt -47.25 -57.9 4.69 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.906 2.082 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 t -40.38 -54.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 0.0 110.459 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -60.34 -44.52 95.44 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.072 0.232 . . . . 0.0 111.394 -178.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.25 63.97 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.515 -0.74 . . . . 0.0 109.919 -179.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.64 -52.67 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.894 1.278 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -60.6 -42.37 96.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.631 1.105 . . . . 0.0 109.616 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -57.18 -51.96 67.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.644 0.656 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 ttp -54.16 -54.52 38.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -56.3 -37.68 70.21 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.918 -0.489 . . . . 0.0 111.137 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.8 m -63.46 -7.45 6.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.084 -0.96 . . . . 0.0 113.493 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 p -87.6 -11.75 47.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.289 1.404 . . . . 0.0 110.802 175.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.05 -176.067 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.584 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.57 -38.29 1.04 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 124.125 0.891 . . . . 0.0 112.907 174.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -56.92 6.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.417 0.687 . . . . 0.0 110.892 -177.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m -55.94 -43.97 77.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.501 0.721 . . . . 0.0 111.198 -177.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 mt -62.94 -57.82 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.106 1.762 . . . . 0.0 109.323 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -58.47 -51.09 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.287 1.035 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.38 -48.32 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.926 -174.008 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.59 39.89 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.049 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.84 36.95 1.48 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 118.867 0.758 . . . . 0.0 111.737 179.13 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.23 158.74 43.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.02 1.728 . . . . 0.0 108.01 178.025 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.12 107.59 6.81 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.773 -178.159 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 154.39 29.51 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 120.146 1.088 . . . . 0.0 111.732 -9.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.65 126.14 27.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.2 m -53.03 -48.35 67.66 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.848 0.749 . . . . 0.0 110.607 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -42.6 -49.47 5.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.043 1.737 . . . . 0.0 112.454 178.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.03 -36.18 3.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.168 0.987 . . . . 0.0 112.766 -178.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.2 m -99.88 -54.4 2.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.317 0.247 . . . . 0.0 110.996 -178.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -69.65 -24.23 63.59 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.58 -42.42 82.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.864 0.756 . . . . 0.0 109.475 178.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -89.54 -24.9 21.63 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.207 1.003 . . . . 0.0 112.027 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.8 35.14 40.89 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -174.257 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.33 145.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -176.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.35 29.3 6.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 111.392 -177.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.84 24.21 76.95 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.868 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 132.9 87.68 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 118.852 1.326 . . . . 0.0 108.346 176.289 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.42 121.54 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.294 1.996 . . . . 0.0 107.954 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.24 159.89 19.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.159 0.981 . . . . 0.0 112.88 -172.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.52 142.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.272 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 69.28 27.08 5.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.079 1.352 . . . . 0.0 111.315 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 70.3 76.32 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.621 1.168 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.27 -52.05 3.08 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.667 3.578 . . . . 0.0 114.23 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -50.46 -34.07 23.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.514 1.526 . . . . 0.0 112.518 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.65 -27.49 66.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.282 0.492 . . . . 0.0 111.181 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -101.05 -24.92 14.22 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 111.864 -176.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.24 -43.73 0.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.793 1.637 . . . . 0.0 112.688 178.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -111.81 36.14 3.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.283 1.033 . . . . 0.0 112.08 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -128.89 155.74 79.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.36 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.8 126.84 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.562 2.175 . . . . 0.0 111.367 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -70.22 -41.65 73.31 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -51.86 102.45 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.532 1.933 . . . . 0.0 112.893 -179.678 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -49.25 -43.17 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.848 0.859 . . . . 0.0 108.912 174.561 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.44 -34.96 26.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.557 1.943 . . . . 0.0 112.667 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -87.03 -49.68 7.16 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.046 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 mt -49.75 -40.59 41.54 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.777 0.431 . . . . 0.0 111.979 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.13 -32.45 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 O-C-N 121.378 -0.826 . . . . 0.0 110.76 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.72 -47.24 79.02 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.773 1.17 . . . . 0.0 108.457 177.116 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.87 -44.24 70.25 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -66.54 -45.56 79.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.878 0.37 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.65 -49.41 77.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.447 -0.783 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.84 -31.16 61.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.483 1.113 . . . . 0.0 112.798 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.17 164.47 29.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -176.087 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -158.72 114.05 2.58 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.996 -0.708 . . . . 0.0 109.145 -178.003 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.98 -116.12 7.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 -26.42 60.93 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.968 0.507 . . . . 0.0 111.437 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.3 ttp -67.55 121.12 77.74 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 118.631 0.65 . . . . 0.0 109.847 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.86 160.19 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.49 2.127 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 122.59 17.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -89.15 -9.96 49.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.256 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -54.22 91.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.408 1.004 . . . . 0.0 113.056 -177.838 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.66 -42.2 1.72 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.463 1.506 . . . . 0.0 110.361 -178.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -39.4 89.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.247 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.41 164.94 26.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.09 140.74 40.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.933 0.893 . . . . 0.0 108.961 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ttt-85 -29.24 -50.48 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.289 2.235 . . . . 0.0 113.234 173.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.14 -45.5 84.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.329 0.968 . . . . 0.0 111.366 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.25 -54.5 45.07 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.881 0.848 . . . . 0.0 109.017 177.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.6 mt -47.38 -57.84 4.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.371 1.468 . . . . 0.0 109.867 176.859 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -43.82 -55.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.622 1.169 . . . . 0.0 109.74 178.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.61 -43.16 89.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.35 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.85 84.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.394 -0.816 . . . . 0.0 109.573 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.35 -42.52 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.902 1.281 . . . . 0.0 109.79 177.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.12 -52.52 64.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.305 0.957 . . . . 0.0 109.032 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -54.25 -54.02 45.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.4 ttm -47.1 -56.16 7.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 110.079 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.15 -33.27 73.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.557 -0.714 . . . . 0.0 112.431 177.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 m -74.66 43.44 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.179 0.9 . . . . 0.0 112.367 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.1 p -135.81 -17.06 1.7 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.196 1.799 . . . . 0.0 109.819 173.805 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.445 -1.264 . . . . 0.0 109.569 178.547 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.62 -41.42 56.91 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 176.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.51 -52.57 65.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -50.67 -52.98 34.85 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.058 0.39 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.26 -58.98 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.12 1.368 . . . . 0.0 110.643 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -56.62 -52.41 64.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 0.0 112.087 -178.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.22 -44.94 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.246 -174.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.82 44.66 0.19 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.276 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.57 38.14 0.95 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 176.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.33 159.5 42.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.845 2.058 . . . . 0.0 107.378 177.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.94 113.68 6.41 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.265 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.61 152.05 13.24 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 120.307 1.145 . . . . 0.0 111.33 -15.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.61 116.81 7.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.507 1.123 . . . . 0.0 108.6 177.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -46.68 -48.25 20.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.546 0.738 . . . . 0.0 110.788 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -45.92 -46.35 16.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.212 1.805 . . . . 0.0 112.739 178.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -52.04 -29.66 22.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.143 0.429 . . . . 0.0 112.051 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.83 -56.97 2.24 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.777 0.262 . . . . 0.0 110.644 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -66.92 -32.76 74.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -173.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.81 -43.04 76.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 119.103 0.865 . . . . 0.0 109.139 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.12 -26.6 39.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.625 -177.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.55 50.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -176.29 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.97 141.01 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.61 29.17 5.29 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 0.0 111.394 -177.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.61 28.41 71.03 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.754 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.09 134.84 84.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.862 1.331 . . . . 0.0 108.368 175.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -64.91 111.99 1.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.6 2.2 . . . . 0.0 107.984 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -84.87 175.82 8.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.978 0.894 . . . . 0.0 111.425 -174.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.48 154.34 41.61 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 171.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 48.28 32.96 3.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.312 1.845 . . . . 0.0 112.661 178.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.86 59.25 4.11 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 109.666 178.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -47.62 -41.72 30.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.054 3.169 . . . . 0.0 113.053 -174.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -47.75 -37.67 13.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.903 0.881 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.52 -27.71 56.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.198 0.454 . . . . 0.0 111.37 -178.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -92.09 -13.3 31.03 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.57 0.748 . . . . 0.0 111.616 -177.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.72 -45.16 0.36 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.274 1.83 . . . . 0.0 112.899 177.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -113.74 28.6 8.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.121 0.968 . . . . 0.0 112.552 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -115.13 119.61 38.38 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.514 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.69 118.7 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.761 2.307 . . . . 0.0 110.786 177.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 -22.17 66.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.073 0.549 . . . . 0.0 111.343 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.04 103.65 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.087 2.155 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -49.34 -44.23 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.638 0.775 . . . . 0.0 109.706 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.98 -34.0 54.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.172 1.789 . . . . 0.0 112.295 177.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.47 -51.16 8.08 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.1 mt -52.79 -38.81 61.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.702 0.801 . . . . 0.0 112.34 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.61 -38.46 75.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 119.243 0.928 . . . . 0.0 109.984 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.16 -45.52 80.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.708 1.14 . . . . 0.0 108.911 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 m -53.5 -44.97 69.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -70.76 -44.75 66.07 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.103 -0.373 . . . . 0.0 110.8 -178.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -57.53 -52.19 66.43 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 121.393 -0.817 . . . . 0.0 109.999 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.76 65.05 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.943 0.897 . . . . 0.0 111.817 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.29 159.38 34.71 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -175.573 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -162.16 139.4 8.33 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.78 -138.57 48.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 108.284 -1.926 . . . . 0.0 108.284 -175.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.11 -21.03 66.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.689 -0.755 . . . . 0.0 111.835 176.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.7 ttp -65.49 117.04 36.88 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 119.663 1.12 . . . . 0.0 110.888 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.42 153.64 55.58 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.327 2.018 . . . . 0.0 110.021 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 123.46 16.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.333 0.653 . . . . 0.0 109.947 178.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -90.25 -4.44 57.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.844 0.747 . . . . 0.0 111.992 177.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -44.16 114.33 0.66 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.491 1.116 . . . . 0.0 111.893 176.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.71 -21.2 19.9 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.292 0.948 . . . . 0.0 112.898 178.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -87.71 -44.49 11.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.974 0.909 . . . . 0.0 109.298 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 126.93 45.9 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.64 152.37 28.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -30.55 -46.76 0.08 Allowed 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 126.07 1.748 . . . . 0.0 111.686 170.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.08 -50.49 73.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.583 1.083 . . . . 0.0 111.923 178.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -57.04 -54.93 41.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.096 1.358 . . . . 0.0 109.202 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.6 mt -50.33 -57.55 7.64 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 125.989 1.716 . . . . 0.0 109.711 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.64 -56.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.882 1.273 . . . . 0.0 109.668 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -57.94 -39.23 77.56 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.136 0.575 . . . . 0.0 111.634 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.69 -48.12 64.7 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.539 -0.726 . . . . 0.0 109.777 177.9 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.37 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.084 1.353 . . . . 0.0 110.768 -176.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.37 -39.54 87.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.949 1.249 . . . . 0.0 109.763 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.53 -59.54 5.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 85.9 mtp -41.33 -64.75 0.51 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.619 1.168 . . . . 0.0 108.709 177.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 mt -46.64 -31.98 3.21 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.845 2.058 . . . . 0.0 113.371 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 m -64.87 -4.86 4.9 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.512 1.051 . . . . 0.0 112.287 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.3 p -154.33 22.85 0.48 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.685 3.994 . . . . 0.0 106.0 -179.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 C-N-CA 128.257 2.623 . . . . 0.0 113.795 -170.321 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.53 96.4 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -57.22 -57.73 11.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -53.46 -45.53 69.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.542 0.61 . . . . 0.0 111.396 -179.039 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.72 -56.48 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 0.0 109.889 -178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -56.95 -47.19 81.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.992 0.917 . . . . 0.0 111.264 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.92 -64.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.357 -175.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -141.5 43.81 1.74 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.77 0.714 . . . . 0.0 111.374 -173.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.69 36.89 1.22 Allowed Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.225 -0.922 . . . . 0.0 112.304 177.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.97 155.43 48.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.31 1.844 . . . . 0.0 107.703 176.306 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.06 113.28 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.572 -177.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.71 142.91 12.57 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.045 1.052 . . . . 0.0 110.363 -14.352 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -67.83 128.66 37.33 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.503 -178.096 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.2 m -54.38 -48.15 71.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.39 0.676 . . . . 0.0 111.149 -175.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -42.47 -54.65 3.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.184 1.793 . . . . 0.0 112.105 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.7 -35.69 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.236 1.414 . . . . 0.0 112.878 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.0 m -100.78 -57.28 2.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.559 0.343 . . . . 0.0 111.414 -178.024 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -70.5 -35.12 73.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -41.59 88.77 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -74.98 -31.33 61.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.291 1.436 . . . . 0.0 111.344 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.62 33.73 51.27 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -175.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.15 143.08 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 122.096 -0.649 . . . . 0.0 109.744 -176.638 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.47 32.61 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.361 1.064 . . . . 0.0 111.834 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.0 22.3 77.12 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.443 -0.643 . . . . 0.0 113.095 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 136.23 83.27 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.689 1.245 . . . . 0.0 107.745 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.36 123.12 13.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.049 1.833 . . . . 0.0 109.969 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.89 169.45 17.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.267 1.032 . . . . 0.0 110.172 -178.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.87 151.12 19.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.096 179.744 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.81 37.36 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.49 68.34 31.6 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.517 0.727 . . . . 0.0 111.915 -175.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -38.98 -51.42 2.43 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.653 3.569 . . . . 0.0 114.867 -177.403 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.98 -40.25 21.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.346 1.059 . . . . 0.0 111.988 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.21 -22.38 66.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.469 0.707 . . . . 0.0 111.884 -177.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -110.15 -30.21 7.85 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.747 1.219 . . . . 0.0 112.607 -175.625 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.31 -51.03 1.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.68 1.592 . . . . 0.0 113.021 -178.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.22 -26.42 56.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -78.24 142.38 63.33 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.121 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.48 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.179 2.586 . . . . 0.0 108.257 173.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -20.65 55.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.892 1.677 . . . . 0.0 113.639 -170.007 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -50.12 115.83 1.59 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.886 1.274 . . . . 0.0 110.651 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.3 t -48.18 -46.21 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.445 0.698 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.95 -24.31 64.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.853 0.861 . . . . 0.0 113.02 -178.379 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.29 -54.56 4.13 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 mt -47.84 -43.32 28.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -59.91 -37.05 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 121.915 -0.491 . . . . 0.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.3 -44.42 79.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -47.32 72.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.162 0.506 . . . . 0.0 110.19 174.325 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -62.57 -45.99 90.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.9 mt -58.26 -51.83 68.11 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.59 -0.694 . . . . 0.0 109.226 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.06 79.63 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.093 0.557 . . . . 0.0 112.151 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.94 157.19 32.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 108.299 -1.921 . . . . 0.0 108.299 -174.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -156.38 129.48 7.99 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.816 -0.814 . . . . 0.0 109.034 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 -136.85 50.45 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.24 -23.62 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.811 176.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -65.88 115.5 23.49 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 111.147 -177.278 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.45 162.32 27.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.655 2.237 . . . . 0.0 111.255 177.549 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 136.66 43.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.83 -8.02 19.02 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.093 0.957 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -43.42 115.89 0.85 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.321 1.848 . . . . 0.0 111.714 177.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.67 -23.24 9.11 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.912 0.768 . . . . 0.0 112.559 177.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -83.92 -46.83 11.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.924 0.862 . . . . 0.0 108.746 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.29 138.1 37.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.58 25.93 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -173.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 62.19 -41.4 0.16 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.224 2.21 . . . . 0.0 111.979 -173.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -64.81 -36.85 85.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.323 -1.485 . . . . 0.0 110.198 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.92 -58.36 7.21 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 123.229 1.49 . . . . 0.0 108.547 178.728 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.08 -58.64 6.84 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 126.484 1.914 . . . . 0.0 110.022 178.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -41.94 -54.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.481 0.713 . . . . 0.0 110.451 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -61.71 -40.53 95.38 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.77 71.56 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.554 -0.717 . . . . 0.0 110.082 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.21 -48.04 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.838 2.055 . . . . 0.0 110.38 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.74 -44.17 90.44 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.891 1.223 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -61.77 -52.59 63.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 ttm -46.17 -50.26 15.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 110.513 179.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.84 -35.39 80.95 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.124 -0.36 . . . . 0.0 110.823 178.131 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -74.8 59.14 0.86 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.588 0.755 . . . . 0.0 111.218 178.666 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 -40.57 0.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.739 2.016 . . . . 0.0 108.979 176.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.344 2.657 . . . . 0.0 111.213 179.441 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.19 -42.71 41.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 173.78 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -57.43 -53.25 60.31 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.956 0.878 . . . . 0.0 109.609 175.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.87 -49.36 59.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.865 0.466 . . . . 0.0 110.5 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mt -70.68 -35.56 61.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -60.56 -45.02 95.47 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.346 -1.471 . . . . 0.0 109.989 176.448 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 mt -82.4 -28.82 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.548 -0.72 . . . . 0.0 111.545 -177.703 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -125.97 38.09 4.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.724 1.209 . . . . 0.0 110.707 -174.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.76 46.85 2.08 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 129.488 3.423 . . . . 0.0 112.041 -178.213 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.259 3.1 p 69.73 -142.11 0.08 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.414 1.885 . . . . 0.0 111.553 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.31 124.56 29.43 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 124.307 1.043 . . . . 0.0 110.863 -172.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -62.56 177.73 9.52 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 119.541 0.872 . . . . 0.0 110.112 -18.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 136.85 33.27 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 m -54.62 -51.62 64.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.306 0.643 . . . . 0.0 110.222 -176.248 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -40.91 -61.34 0.99 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.518 1.927 . . . . 0.0 112.817 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.72 -35.02 13.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.042 0.937 . . . . 0.0 112.55 -178.267 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.5 m -85.92 -59.9 2.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 118.594 0.634 . . . . 0.0 110.165 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -61.23 -50.81 71.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.643 0.777 . . . . 0.0 113.028 -173.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.86 -39.68 71.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.199 0.454 . . . . 0.0 110.994 -178.463 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -88.23 -2.07 58.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.078 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 35.68 82.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.389 0.995 . . . . 0.0 112.443 -177.764 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.79 130.75 17.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 O-C-N 121.931 -0.746 . . . . 0.0 109.195 -179.242 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.92 31.41 8.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 111.479 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.67 78.95 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.355 -0.692 . . . . 0.0 112.568 179.749 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.43 137.9 68.71 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.578 1.189 . . . . 0.0 108.53 176.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.72 121.06 9.13 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.239 1.959 . . . . 0.0 109.098 -179.032 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.42 166.56 23.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.404 1.097 . . . . 0.0 112.359 -174.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.3 164.38 26.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.131 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.66 53.32 0.46 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.173 1.389 . . . . 0.0 111.735 -178.713 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.67 68.13 19.47 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.702 -176.094 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.89 -48.59 2.78 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.453 3.435 . . . . 0.0 114.44 -177.351 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -50.61 -40.53 52.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.05 -23.85 66.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.339 0.655 . . . . 0.0 111.535 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -105.51 -30.71 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.348 1.059 . . . . 0.0 112.749 -174.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.54 -50.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.784 1.634 . . . . 0.0 112.998 -178.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.9 -22.31 42.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -78.99 158.06 75.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.569 -0.707 . . . . 0.0 110.377 -177.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.52 108.91 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.886 2.391 . . . . 0.0 110.939 176.508 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.87 -37.02 75.6 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 m -59.69 107.97 0.67 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.752 1.621 . . . . 0.0 111.555 178.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -48.41 -41.92 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.494 1.118 . . . . 0.0 110.405 178.182 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.0 -27.16 17.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.231 1.412 . . . . 0.0 112.869 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.26 -49.57 7.17 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 mt -51.14 -39.44 56.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.875 0.87 . . . . 0.0 112.457 179.099 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.15 -33.16 49.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.652 177.571 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.17 -49.59 71.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.48 1.491 . . . . 0.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -51.83 -47.2 64.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.067 0.947 . . . . 0.0 110.114 175.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -66.87 -42.16 86.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.212 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.99 -56.13 24.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.04 -27.92 57.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.233 1.013 . . . . 0.0 112.869 -176.378 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 164.69 29.11 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -175.263 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -157.96 112.15 2.57 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -113.48 5.1 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -178.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.26 -31.33 65.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.969 0.508 . . . . 0.0 111.243 178.043 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.2 ttp -64.7 118.47 48.54 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.55 -176.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.5 157.5 40.63 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.742 2.295 . . . . 0.0 110.058 179.068 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 139.05 58.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.969 0.508 . . . . 0.0 110.685 178.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -114.53 -0.45 13.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.84 0.856 . . . . 0.0 111.63 175.436 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -46.67 117.86 1.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.232 1.013 . . . . 0.0 111.781 175.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.31 -19.62 21.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.1 0.857 . . . . 0.0 112.548 179.73 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -88.95 -45.18 9.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.489 1.115 . . . . 0.0 108.662 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.5 123.09 42.09 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.95 146.05 48.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -25.65 -52.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.449 2.3 . . . . 0.0 112.01 168.058 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.1 -45.64 84.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.86 0.464 . . . . 0.0 111.788 -178.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.17 -48.51 79.77 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.6 mt -52.34 -59.48 4.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 t -42.77 -59.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.288 1.035 . . . . 0.0 109.673 177.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -54.99 -42.69 72.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 118.37 0.532 . . . . 0.0 112.335 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.65 -53.67 47.7 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -55.36 -44.14 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.609 1.163 . . . . 0.0 110.262 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -56.02 -55.59 31.01 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 118.784 0.72 . . . . 0.0 109.097 177.877 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -55.19 -51.28 67.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.297 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 ttm -48.58 -62.14 1.66 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.603 1.161 . . . . 0.0 109.326 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.55 -35.58 68.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.485 0.714 . . . . 0.0 111.661 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 m -62.95 -5.54 3.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.472 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -87.9 -14.67 38.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.484 1.493 . . . . 0.0 111.004 175.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 116.718 -1.61 . . . . 0.0 110.401 -177.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.72 48.81 3.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 175.024 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 41.67 55.64 3.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.336 1.455 . . . . 0.0 110.89 178.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -149.3 -63.94 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.333 -176.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.38 -55.93 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.843 0.747 . . . . 0.0 109.842 179.189 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -63.54 -43.01 98.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -178.649 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.75 -45.17 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 112.091 -172.187 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -151.41 -10.9 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.78 3.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.026 1.285 . . . . 0.0 111.442 -176.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -136.08 147.16 47.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.256 1.822 . . . . 0.0 106.766 177.377 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.5 109.23 10.26 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.813 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.24 159.87 30.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 CA-C-N 120.193 1.105 . . . . 0.0 111.85 -8.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -74.18 122.58 22.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.117 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -54.4 -51.6 64.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.548 0.69 . . . . 0.0 110.102 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -39.68 -61.37 0.84 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.006 2.122 . . . . 0.0 112.419 179.654 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -42.92 -43.49 4.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.002 1.321 . . . . 0.0 113.068 -177.826 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.31 -55.61 3.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.463 0.305 . . . . 0.0 111.305 -177.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -64.75 -33.97 77.22 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.863 0.865 . . . . 0.0 113.172 -173.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.83 -48.02 82.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.544 0.611 . . . . 0.0 109.355 177.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -73.05 -30.58 63.82 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.229 0.612 . . . . 0.0 111.31 179.237 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.35 49.45 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -174.664 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.67 141.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.11 31.5 6.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.287 1.035 . . . . 0.0 111.668 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.61 76.38 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.993 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.25 87.58 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.564 1.182 . . . . 0.0 108.674 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -62.75 114.97 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.74 2.293 . . . . 0.0 108.764 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -80.93 174.23 11.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.729 0.776 . . . . 0.0 112.667 -172.544 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.6 160.64 16.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 170.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.73 51.88 0.96 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.176 1.39 . . . . 0.0 112.419 176.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.33 59.01 19.09 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 123.807 0.843 . . . . 0.0 111.005 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -38.56 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.558 3.505 . . . . 0.0 114.025 -177.753 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -47.66 -40.8 20.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.402 1.481 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.94 -26.09 53.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.637 -177.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -91.6 -26.08 18.88 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.587 0.755 . . . . 0.0 111.736 -177.359 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.14 -46.33 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.159 2.184 . . . . 0.0 114.437 -178.129 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -91.91 -15.14 28.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.441 0.697 . . . . 0.0 112.816 -175.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -81.08 148.78 64.92 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.489 0.716 . . . . 0.0 109.655 -177.496 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.34 129.41 28.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.58 2.186 . . . . 0.0 111.157 176.774 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -67.21 -40.84 86.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.415 0.626 . . . . 0.0 110.348 179.203 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.74 110.32 1.13 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.393 1.477 . . . . 0.0 111.425 -177.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.74 -36.78 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.21 1.004 . . . . 0.0 109.891 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.48 -33.71 63.91 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.356 1.863 . . . . 0.0 111.343 177.49 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -83.4 -50.67 8.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -51.73 -38.12 53.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 118.946 -1.101 . . . . 0.0 110.467 177.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.15 -44.9 83.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.734 1.606 . . . . 0.0 109.409 -179.418 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -58.04 -33.05 68.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 110.468 174.312 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -75.73 -47.47 25.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.179 0.991 . . . . 0.0 110.007 -179.167 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.8 -48.06 73.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 120.598 -1.314 . . . . 0.0 110.099 174.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.32 74.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 112.692 -178.134 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.9 162.63 29.88 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -175.074 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.1 129.63 4.49 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.769 0.784 . . . . 0.0 109.083 -178.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.89 -120.28 21.78 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -177.696 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.2 -13.92 48.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.916 177.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.0 ttp -66.53 117.16 41.52 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 119.254 0.934 . . . . 0.0 110.38 -178.261 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.27 159.72 38.21 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.346 2.031 . . . . 0.0 111.064 177.302 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.83 118.58 10.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.191 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -82.02 -4.22 56.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.467 1.031 . . . . 0.0 113.205 -179.092 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.57 86.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.292 1.037 . . . . 0.0 112.484 -179.656 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 128.02 -33.97 3.08 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.548 1.547 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -78.33 -34.76 48.36 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.667 0.734 . . . . 0.0 110.936 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.39 146.01 36.06 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.99 138.94 31.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.209 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -30.59 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.274 2.23 . . . . 0.0 113.028 173.111 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.17 -57.64 11.96 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.619 0.645 . . . . 0.0 110.441 177.808 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.49 -53.71 47.56 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.98 0.895 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.5 mt -47.73 -55.27 9.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.85 1.66 . . . . 0.0 110.561 176.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.7 t -51.22 -58.67 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.181 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -54.51 -37.36 65.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.117 0.567 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.1 82.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.36 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.54 -47.38 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.507 178.637 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -45.25 -56.43 4.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.605 1.093 . . . . 0.0 109.751 176.56 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -55.66 -52.66 63.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.917 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 ptm -54.85 -43.62 73.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.533 0.606 . . . . 0.0 110.251 -178.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.3 mt -69.71 -29.78 67.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.625 -0.672 . . . . 0.0 111.057 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 m -73.96 43.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.036 0.834 . . . . 0.0 112.678 179.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -135.89 -13.83 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.783 2.033 . . . . 0.0 109.914 174.155 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.035 -179.109 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -57.16 -41.21 92.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 174.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.59 -42.97 56.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.251 1.02 . . . . 0.0 110.967 175.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -54.84 -39.19 68.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.546 -0.721 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.81 -40.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.835 0.854 . . . . 0.0 110.586 -177.554 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -64.68 -41.66 95.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.962 0.801 . . . . 0.0 110.247 177.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.35 -47.61 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 110.74 88.1 0.0 OUTLIER 'General case' 0 C--N 1.345 0.411 0 C-N-CA 130.612 3.565 . . . . 0.0 114.009 162.397 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.41 -20.43 58.8 Favored Glycine 0 CA--C 1.551 2.301 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 156.192 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 163.92 3.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 129.214 3.006 . . . . 0.0 111.356 175.067 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.43 124.86 9.89 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.248 1.419 . . . . 0.0 107.494 177.281 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.65 178.46 5.8 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 CA-C-N 120.525 1.223 . . . . 0.0 112.464 -8.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.18 109.01 21.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 110.295 179.598 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -41.54 -53.8 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.388 1.475 . . . . 0.0 109.943 176.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -44.1 -55.4 4.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.267 2.227 . . . . 0.0 111.513 -178.168 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -50.22 -37.46 35.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.492 0.717 . . . . 0.0 112.332 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 m -84.34 -59.45 2.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 110.325 -179.496 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -59.91 -42.49 93.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.956 1.302 . . . . 0.0 113.069 -174.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.63 -38.54 90.63 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.453 0.569 . . . . 0.0 110.015 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -25.3 41.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.43 0.692 . . . . 0.0 111.17 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.99 64.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.44 138.46 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.75 29.3 5.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.331 1.053 . . . . 0.0 111.72 -177.791 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.06 23.97 74.87 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.804 179.354 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 129.61 84.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 118.566 1.183 . . . . 0.0 108.362 176.423 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.22 122.04 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.256 1.971 . . . . 0.0 109.742 -179.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -86.97 178.32 6.98 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.641 0.734 . . . . 0.0 111.805 -174.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -70.65 163.45 27.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 171.861 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 m120 48.07 34.39 4.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.681 0.792 . . . . 0.0 112.865 175.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.05 62.23 62.87 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.7 0.682 . . . . 0.0 112.384 -174.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -39.77 -51.55 2.92 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.151 3.234 . . . . 0.0 114.801 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.66 -40.95 41.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.776 0.831 . . . . 0.0 112.079 -179.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.8 -19.94 64.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.269 0.628 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -102.32 -35.88 8.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 111.803 -178.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.27 -51.71 1.05 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.053 1.741 . . . . 0.0 113.131 -178.419 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.7 -24.44 53.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.047 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.99 157.38 81.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 O-C-N 121.621 -0.674 . . . . 0.0 110.117 -177.681 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.08 113.97 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.025 2.483 . . . . 0.0 111.583 178.172 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.46 -36.09 75.3 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 110.602 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 106.08 0.48 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.444 1.498 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.3 -36.03 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 121.844 -0.535 . . . . 0.0 109.563 176.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.99 -24.26 57.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.102 0.961 . . . . 0.0 112.528 177.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -89.34 -49.8 6.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.642 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.62 -40.99 41.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.32 -37.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 O-C-N 121.44 -0.787 . . . . 0.0 110.157 179.088 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.59 -47.77 80.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.436 1.016 . . . . 0.0 108.366 177.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -53.93 -37.62 64.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.124 0.17 . . . . 0.0 110.754 175.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.5 m -74.06 -48.7 28.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.911 -0.493 . . . . 0.0 110.713 -177.641 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -44.62 81.31 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.66 -35.04 60.5 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.38 0.672 . . . . 0.0 111.809 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 152.31 23.66 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -176.521 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -153.53 141.46 20.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -119.93 18.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.07 3.48 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.839 0.855 . . . . 0.0 112.095 178.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.6 ttp -69.74 123.65 89.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.047 0.84 . . . . 0.0 110.144 -178.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.26 145.15 59.12 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.568 1.512 . . . . 0.0 108.622 176.192 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.86 57.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.416 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -97.56 -36.82 10.17 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.109 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 t70 38.76 -144.52 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.228 2.211 . . . . 0.0 111.76 -179.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.4 -20.4 5.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.999 2.238 . . . . 0.0 113.211 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -61.84 -30.3 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.483 1.141 . . . . 0.0 109.614 176.594 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.15 106.91 11.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.123 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -63.11 86.84 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.432 1.893 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 16.37 -64.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.516 3.526 . . . . 0.0 115.513 174.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -50.25 -35.79 28.42 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 111.065 178.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.27 -55.31 29.59 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.69 0.757 . . . . 0.0 109.588 178.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.4 mt -52.49 -53.56 44.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.738 1.215 . . . . 0.0 109.551 176.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.2 t -44.6 -58.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.453 1.101 . . . . 0.0 109.603 176.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -57.04 -39.76 75.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 118.891 0.768 . . . . 0.0 112.461 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.28 96.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.4 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.32 -47.14 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 108.74 179.318 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -52.69 -51.81 58.7 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -55.37 -54.36 44.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.072 178.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -52.1 -47.96 64.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.096 0.559 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.76 -35.62 80.4 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.861 -0.525 . . . . 0.0 110.312 177.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.5 m -73.5 39.08 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.391 -0.818 . . . . 0.0 113.2 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.8 p -131.16 -14.32 3.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.979 1.711 . . . . 0.0 109.764 173.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.516 -1.707 . . . . 0.0 110.135 -178.446 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.38 -25.68 3.69 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.134 0.896 . . . . 0.0 110.925 176.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.73 -59.8 4.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.858 1.263 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -50.08 -47.04 53.9 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.086 0.554 . . . . 0.0 110.098 -179.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.21 -57.99 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.607 1.163 . . . . 0.0 109.37 178.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -56.95 -48.26 78.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.125 0.57 . . . . 0.0 111.763 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.34 -48.49 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.231 -174.154 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -5.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -172.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.23 37.46 3.51 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.072 1.306 . . . . 0.0 111.144 -176.061 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.6 151.46 49.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.422 1.489 . . . . 0.0 108.131 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.74 13.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.59 1.156 . . . . 0.0 109.695 -177.834 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.55 162.02 44.69 Favored 'Cis proline' 0 N--CA 1.455 -0.758 0 CA-C-N 120.266 1.131 . . . . 0.0 109.544 -13.163 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -67.97 129.1 38.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.776 0.83 . . . . 0.0 110.467 -177.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.48 -46.85 83.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 -178.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 p -39.16 -55.19 1.68 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.709 2.004 . . . . 0.0 112.74 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -43.09 -38.03 2.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.666 1.186 . . . . 0.0 112.916 -178.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.34 -57.14 2.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.15 -177.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -70.27 -24.23 63.02 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -172.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.47 -54.82 38.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.036 0.834 . . . . 0.0 109.89 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -16.28 28.02 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.442 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 45.84 7.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 p -58.7 141.33 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.09 29.1 5.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.019 0.928 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.84 75.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.814 179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 137.1 88.34 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 118.787 1.294 . . . . 0.0 108.208 175.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.42 117.34 4.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.552 2.168 . . . . 0.0 109.782 -178.484 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -76.31 175.87 8.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.943 0.877 . . . . 0.0 109.282 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.47 149.78 21.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 63.25 31.11 15.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.413 0.685 . . . . 0.0 109.506 -173.713 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.58 57.77 27.19 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.04 0.936 . . . . 0.0 112.618 -177.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -34.36 -48.14 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 114.267 -179.464 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -39.65 -46.79 1.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.006 1.722 . . . . 0.0 112.68 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -76.55 -29.54 56.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.146 0.43 . . . . 0.0 111.522 -177.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -85.36 -20.69 29.53 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.403 0.681 . . . . 0.0 111.43 -177.034 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.58 -45.46 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.448 1.899 . . . . 0.0 113.758 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -94.08 -14.96 25.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.795 0.838 . . . . 0.0 112.825 -177.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -79.88 127.24 78.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.945 0.898 . . . . 0.0 109.093 -177.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.44 126.35 19.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.602 2.202 . . . . 0.0 111.558 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -65.68 -27.07 68.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.314 0.646 . . . . 0.0 111.126 179.568 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.0 102.68 0.05 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 111.243 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.6 t -42.52 -51.17 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 124.211 1.004 . . . . 0.0 110.195 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -51.7 -44.54 63.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.98 -47.59 82.5 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.16 -38.65 87.23 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.649 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.6 t -64.26 -40.3 88.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -60.39 -48.92 79.67 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.282 0.946 . . . . 0.0 109.547 174.868 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -54.06 -43.87 70.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.499 0.59 . . . . 0.0 111.158 177.459 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -69.04 -44.71 72.11 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.91 -0.494 . . . . 0.0 110.011 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -55.4 -53.29 58.12 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.369 -0.832 . . . . 0.0 110.601 177.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.05 -26.01 43.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.72 1.208 . . . . 0.0 113.342 -176.006 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.86 160.66 31.87 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.145 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -158.21 119.98 3.59 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.91 -119.34 17.44 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -178.443 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.6 -21.46 55.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.761 0.424 . . . . 0.0 111.598 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.0 ttp -69.0 121.96 83.51 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 118.795 0.725 . . . . 0.0 110.236 -177.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.7 157.28 39.91 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.57 2.18 . . . . 0.0 110.179 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.49 123.0 16.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.324 177.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -89.72 -10.21 46.53 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.223 0.92 . . . . 0.0 112.71 178.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -50.01 111.8 0.57 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.927 0.491 . . . . 0.0 110.436 178.735 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.81 -36.96 4.0 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.477 1.037 . . . . 0.0 111.72 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.2 mtm-85 -85.41 -47.62 9.8 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.13 0.965 . . . . 0.0 110.052 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.75 126.91 53.83 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.404 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.34 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -25.92 -52.13 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.181 2.192 . . . . 0.0 112.074 170.342 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -60.28 -49.86 75.92 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.433 0.56 . . . . 0.0 111.576 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -55.47 -55.61 29.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 122.139 0.971 . . . . 0.0 109.024 178.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.7 mt -49.7 -58.92 4.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.946 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.67 -55.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.672 1.589 . . . . 0.0 110.587 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -58.54 -44.16 89.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.224 0.61 . . . . 0.0 111.199 -178.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.67 -45.08 88.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.695 -0.628 . . . . 0.0 109.938 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.59 -46.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.614 1.166 . . . . 0.0 111.303 -175.9 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.28 -42.06 90.38 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.28 1.4 . . . . 0.0 109.402 178.28 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -62.29 -50.04 73.25 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.881 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.6 ttm -48.89 -52.95 21.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.846 0.858 . . . . 0.0 109.264 178.587 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.53 -39.12 89.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.106 0.562 . . . . 0.0 111.745 178.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.2 p -62.4 -8.61 6.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.45 1.023 . . . . 0.0 113.536 -177.06 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 p -79.26 -14.75 58.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.519 1.054 . . . . 0.0 111.007 176.115 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.603 -1.665 . . . . 0.0 111.03 -174.888 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -36.4 -49.04 1.25 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.767 1.651 . . . . 0.0 113.46 -177.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -59.38 -63.86 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.455 0.702 . . . . 0.0 109.765 178.124 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -49.45 15.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.503 1.121 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.72 -54.98 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.888 1.275 . . . . 0.0 108.873 -178.331 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -60.3 -47.15 87.25 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.217 0.462 . . . . 0.0 111.495 -177.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mm -70.78 -46.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.558 -172.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -149.95 -11.71 0.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.098 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.11 35.37 4.29 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 120.114 1.324 . . . . 0.0 111.773 -174.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -135.56 152.39 51.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.956 1.303 . . . . 0.0 108.051 177.634 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.744 -178.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 158.92 26.32 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 119.941 1.015 . . . . 0.0 111.853 -10.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 122.0 19.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.338 1.055 . . . . 0.0 109.712 179.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.26 -50.52 61.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 0.0 110.379 -178.145 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -40.28 -55.83 2.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.445 1.898 . . . . 0.0 112.695 178.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.1 m -46.04 -32.48 2.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 113.01 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -99.05 -57.04 2.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.044 0.384 . . . . 0.0 111.026 179.444 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -68.44 -32.27 72.18 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.65 -42.7 86.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 118.828 0.74 . . . . 0.0 109.126 179.271 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.94 -27.96 35.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.313 -178.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.75 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 139.9 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.141 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.21 28.56 5.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.088 0.955 . . . . 0.0 111.546 -177.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.44 24.11 76.82 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.365 -0.686 . . . . 0.0 112.857 179.597 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.57 131.78 77.36 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.767 1.283 . . . . 0.0 108.498 175.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -60.47 117.56 4.33 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 109.28 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -89.21 178.86 6.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.749 0.785 . . . . 0.0 112.771 -171.213 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.99 159.21 23.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.16 53.87 0.73 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.685 1.594 . . . . 0.0 112.541 177.053 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.57 59.34 24.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.171 0.989 . . . . 0.0 110.461 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.66 -52.45 2.59 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.455 3.437 . . . . 0.0 114.489 -175.815 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -49.87 -35.08 22.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.246 1.018 . . . . 0.0 112.765 -179.26 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.43 -28.17 60.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.783 0.72 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -91.86 -30.2 16.3 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.568 0.747 . . . . 0.0 111.981 -177.154 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.89 -51.14 0.69 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.647 1.979 . . . . 0.0 113.484 -178.003 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.44 -25.28 54.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.764 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.98 152.65 82.56 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 110.033 -177.167 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.73 110.64 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.538 1.492 . . . . 0.0 108.482 176.038 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.52 -28.96 57.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -53.48 103.85 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.884 1.674 . . . . 0.0 111.444 178.402 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.6 t -51.14 -39.64 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.555 0.742 . . . . 0.0 110.337 178.409 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.97 -23.46 45.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.383 1.073 . . . . 0.0 112.679 179.768 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -90.55 -53.04 4.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.374 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -49.84 -39.81 40.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.114 0.966 . . . . 0.0 112.506 179.747 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -33.81 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 121.664 -0.648 . . . . 0.0 110.266 179.103 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.45 -46.87 78.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.453 1.024 . . . . 0.0 108.735 176.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -53.54 -44.45 69.2 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -65.95 -47.61 74.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.078 0.551 . . . . 0.0 110.684 -179.5 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.24 -49.1 79.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.359 -0.838 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.79 61.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.394 1.078 . . . . 0.0 112.572 -177.588 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.36 161.32 31.45 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -175.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -159.62 114.4 2.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.581 0.69 . . . . 0.0 109.725 -177.216 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.67 -117.76 12.61 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.108 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.201 177.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.8 ttp -65.63 119.2 58.31 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.33 -177.469 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.02 160.78 46.67 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.29 1.994 . . . . 0.0 110.154 178.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.19 117.35 9.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -82.16 -7.77 59.63 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.646 0.657 . . . . 0.0 112.368 178.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -49.88 113.64 0.89 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.821 0.737 . . . . 0.0 110.321 176.92 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.7 -28.95 9.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.061 0.838 . . . . 0.0 112.121 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -76.07 -43.91 41.46 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.646 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -131.02 152.9 49.83 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.831 0.852 . . . . 0.0 108.73 176.875 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -88.95 132.89 34.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -29.65 -47.4 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.402 2.281 . . . . 0.0 113.391 173.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -69.01 -41.7 77.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 111.312 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 -46.5 83.0 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.737 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -51.99 -61.12 2.46 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.557 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 t -41.12 -56.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.348 1.459 . . . . 0.0 109.594 177.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.8 -44.01 73.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.926 0.49 . . . . 0.0 111.512 179.658 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -48.2 75.67 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.707 -0.62 . . . . 0.0 109.852 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.5 mt -57.52 -50.42 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 123.871 0.868 . . . . 0.0 110.602 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -40.76 96.46 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 120.253 1.388 . . . . 0.0 109.294 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -57.76 -50.62 72.62 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.724 0.693 . . . . 0.0 109.561 176.885 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.66 -52.82 54.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 178.385 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.81 -33.8 68.98 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.745 -0.597 . . . . 0.0 111.839 176.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -73.01 38.0 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.402 1.001 . . . . 0.0 113.423 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.9 p -132.01 -15.77 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.314 1.845 . . . . 0.0 109.479 171.681 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.724 179.96 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 CA--C 1.516 -0.353 0 CA-C-O 117.426 -1.274 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.49 19.24 57.2 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -171.301 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 66.87 -62.07 0.31 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 129.802 3.241 . . . . 0.0 111.76 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 p -26.28 -64.78 0.07 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.479 3.112 . . . . 0.0 112.806 179.392 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -44.94 -57.39 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.293 1.037 . . . . 0.0 110.508 -178.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.74 -47.21 72.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.919 0.487 . . . . 0.0 111.721 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.55 -46.79 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -172.686 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -145.22 -5.06 0.69 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -170.608 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.43 33.95 6.17 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 120.168 1.349 . . . . 0.0 112.042 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.64 150.52 51.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.119 1.768 . . . . 0.0 107.403 177.525 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.58 109.62 14.69 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 0.0 110.272 -177.172 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.01 163.07 50.14 Favored 'Cis proline' 0 N--CA 1.455 -0.79 0 CA-C-N 120.292 1.14 . . . . 0.0 110.065 -10.725 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -69.17 129.42 39.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.327 1.051 . . . . 0.0 110.177 -178.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -59.19 -46.51 88.22 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.443 0.639 . . . . 0.0 111.044 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -37.27 -57.19 0.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.207 2.203 . . . . 0.0 112.168 179.24 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.15 -34.52 0.18 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.512 1.925 . . . . 0.0 113.677 -178.417 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.55 -57.89 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.497 0.719 . . . . 0.0 110.625 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -64.27 -24.07 67.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -172.212 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -73.59 -22.0 60.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 119.986 1.266 . . . . 0.0 111.052 177.231 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -107.5 -24.76 11.68 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.91 0.884 . . . . 0.0 111.683 -178.304 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.35 32.62 51.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.78 140.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.57 28.8 6.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -177.192 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.98 77.0 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.319 -0.712 . . . . 0.0 112.892 179.39 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 130.76 82.88 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 118.798 1.299 . . . . 0.0 108.644 176.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.14 121.73 9.49 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.601 2.201 . . . . 0.0 108.648 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -89.28 178.67 6.28 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.954 0.883 . . . . 0.0 113.277 -171.335 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.9 160.92 29.8 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.729 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.78 52.9 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.769 1.628 . . . . 0.0 111.674 177.165 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.23 64.34 19.71 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 110.456 -177.518 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -38.68 -50.55 2.43 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.302 3.335 . . . . 0.0 114.099 -177.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -49.22 -39.98 31.92 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.179 0.992 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -64.16 -28.65 69.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.259 0.624 . . . . 0.0 111.337 -179.15 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.83 -27.01 13.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.712 1.205 . . . . 0.0 112.384 -174.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.84 -43.88 0.98 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.061 1.744 . . . . 0.0 113.744 -178.884 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.8 -15.89 25.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.586 0.754 . . . . 0.0 112.771 -176.373 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.3 133.93 44.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 109.597 -177.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.19 105.32 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.991 2.461 . . . . 0.0 110.302 176.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.98 -24.87 63.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.876 0.87 . . . . 0.0 113.038 -175.56 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -52.48 102.24 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.441 1.497 . . . . 0.0 111.424 179.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.0 t -47.6 -45.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.293 1.037 . . . . 0.0 110.255 179.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.35 -29.32 58.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.915 1.286 . . . . 0.0 112.168 -179.014 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -86.19 -50.73 6.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.431 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.3 mt -50.46 -40.94 52.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.062 0.545 . . . . 0.0 112.21 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -59.6 -30.8 45.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.984 178.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.7 -50.04 68.54 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.224 1.375 . . . . 0.0 108.471 177.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -53.81 -42.67 68.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.173 0.589 . . . . 0.0 110.128 176.238 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -68.22 -44.36 75.9 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.813 0.34 . . . . 0.0 110.681 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.66 -47.24 86.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.83 -31.19 51.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 112.716 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 159.0 28.58 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -175.075 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -156.77 124.55 5.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.86 -114.89 6.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.3 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.67 -18.86 33.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.738 0.815 . . . . 0.0 112.028 178.243 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.4 ttp -62.25 124.57 82.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 118.948 0.795 . . . . 0.0 110.439 -176.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.49 158.24 51.44 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.082 1.854 . . . . 0.0 109.31 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 114.5 6.57 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.78 -7.41 58.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.306 179.473 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.74 113.18 0.66 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.842 0.747 . . . . 0.0 110.936 177.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 -27.18 11.55 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.164 0.887 . . . . 0.0 112.331 179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.73 -49.73 13.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.71 134.56 47.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.183 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.69 149.0 34.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.472 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -27.72 -50.16 0.06 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.144 1.777 . . . . 0.0 112.402 168.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -69.02 -39.63 79.13 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.638 -0.664 . . . . 0.0 112.21 -178.637 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.38 -53.27 60.15 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.618 1.099 . . . . 0.0 108.208 175.595 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -49.61 -59.4 3.82 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 125.802 1.641 . . . . 0.0 109.155 177.158 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 t -43.19 -57.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 109.077 176.243 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -58.63 -31.96 68.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.545 -0.74 . . . . 0.0 112.106 -176.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.87 -52.63 14.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.222 0.919 . . . . 0.0 109.262 176.93 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.7 mt -53.03 -39.71 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.468 1.107 . . . . 0.0 110.073 178.782 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -52.31 -56.61 13.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.092 0.86 . . . . 0.0 109.637 176.226 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -55.83 -53.88 51.37 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.3 ttm -47.22 -61.07 2.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.101 0.96 . . . . 0.0 110.331 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.45 -35.74 78.45 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.042 -0.411 . . . . 0.0 111.137 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -62.53 -5.0 2.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.787 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -88.97 -13.83 38.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.393 1.451 . . . . 0.0 111.265 176.399 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.638 -176.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 117.045 -1.455 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.4 -75.63 0.28 Allowed Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.453 1.501 . . . . 0.0 110.798 175.062 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.04 -34.29 6.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.979 -2.61 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m 70.59 -62.78 0.43 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.163 2.185 . . . . 0.0 107.395 -176.9 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.28 -55.26 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.431 1.014 . . . . 0.0 108.759 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -69.56 -50.46 44.55 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -178.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.38 -50.53 72.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.531 -174.425 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -158.73 51.86 0.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -169.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.38 35.7 0.52 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.408 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.23 154.41 50.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.228 1.811 . . . . 0.0 106.586 175.48 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.58 105.34 10.89 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.091 -176.187 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.21 155.97 77.1 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.208 1.11 . . . . 0.0 110.417 -7.038 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 129.9 42.42 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.615 1.166 . . . . 0.0 110.719 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -52.47 -48.51 65.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.409 1.1 . . . . 0.0 110.143 178.721 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -49.29 -39.57 31.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.334 1.853 . . . . 0.0 112.207 179.205 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -47.0 -40.39 14.44 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.893 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -99.37 -51.29 3.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.954 0.783 . . . . 0.0 110.929 -177.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -69.27 -22.97 63.78 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.7 -42.9 90.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.469 1.031 . . . . 0.0 110.127 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.01 -25.32 17.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.701 0.8 . . . . 0.0 111.569 179.181 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 37.83 13.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.027 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.18 149.09 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -176.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.29 30.11 7.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.136 0.974 . . . . 0.0 111.291 -178.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.75 23.16 78.39 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.63 132.57 91.3 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.908 1.354 . . . . 0.0 108.132 176.382 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.63 118.08 5.03 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.181 1.92 . . . . 0.0 107.778 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -75.72 162.72 27.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.834 0.825 . . . . 0.0 111.52 -174.343 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.95 159.47 34.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 170.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.57 56.8 2.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.599 1.159 . . . . 0.0 111.191 -177.356 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 63.3 5.45 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 0.0 109.65 -177.679 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -45.35 -44.5 16.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.063 3.175 . . . . 0.0 113.43 -175.116 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -50.0 -34.59 21.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.904 0.881 . . . . 0.0 112.335 178.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.11 -28.61 64.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.025 0.53 . . . . 0.0 111.455 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -99.09 -15.68 18.92 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.417 1.087 . . . . 0.0 111.958 -176.162 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.36 -45.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.236 1.814 . . . . 0.0 112.935 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.33 30.47 7.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.042 0.937 . . . . 0.0 112.638 -176.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -121.1 124.42 27.39 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 108.074 177.604 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.88 108.71 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.417 2.745 . . . . 0.0 110.826 178.121 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.01 -24.78 59.67 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.589 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -49.1 105.54 0.08 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.016 1.727 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -49.45 -45.25 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.484 0.714 . . . . 0.0 109.442 177.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.44 -23.4 49.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.858 1.263 . . . . 0.0 113.145 -179.122 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.58 -55.05 3.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.1 mt -50.82 -39.49 53.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.733 1.213 . . . . 0.0 112.444 -178.589 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.39 -35.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.623 -0.673 . . . . 0.0 109.949 179.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -48.8 75.08 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.173 0.897 . . . . 0.0 108.69 177.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -53.16 -37.35 61.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.696 0.798 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -75.15 -47.53 28.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.109 0.564 . . . . 0.0 109.996 -178.792 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.58 -48.8 80.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.441 1.097 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.02 -33.63 65.85 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.889 0.876 . . . . 0.0 110.921 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.32 86.85 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.255 0.919 . . . . 0.0 111.272 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -77.72 144.99 36.82 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.915 1.286 . . . . 0.0 109.97 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.91 5.99 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.018 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.69 -0.26 51.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.028 0.931 . . . . 0.0 112.424 -179.352 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.5 mtm -71.57 139.51 83.79 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 119.413 1.006 . . . . 0.0 111.179 -178.402 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.91 153.54 58.3 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 171.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.53 113.91 5.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -78.4 -16.16 57.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.533 -179.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -49.6 113.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.51 1.05 . . . . 0.0 110.511 175.285 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.41 -32.55 7.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.38 0.99 . . . . 0.0 111.493 -179.002 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -76.27 -46.21 29.0 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.397 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.51 138.26 39.49 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.488 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -79.1 147.65 32.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -30.53 -51.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.489 1.915 . . . . 0.0 111.782 169.412 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.32 -29.43 65.01 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.543 -0.723 . . . . 0.0 112.168 -176.991 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.31 -58.98 4.17 Favored 'General case' 0 N--CA 1.459 0.021 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.18 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.5 mt -44.18 -55.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.097 1.759 . . . . 0.0 110.18 179.544 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -38.5 -51.66 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 111.266 178.306 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -59.0 -47.0 86.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.451 0.643 . . . . 0.0 110.791 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.44 94.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.929 -0.482 . . . . 0.0 109.775 -179.664 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.41 -49.47 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.501 1.12 . . . . 0.0 110.405 -178.649 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.1 -41.12 99.3 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.155 -0.966 . . . . 0.0 109.243 -179.334 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -58.17 -55.7 31.54 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.838 0.745 . . . . 0.0 109.299 176.66 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.8 ttm -43.34 -53.29 5.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.201 1.8 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.52 -38.51 91.27 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.995 -0.44 . . . . 0.0 111.348 178.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.9 m -75.25 45.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.861 0.864 . . . . 0.0 113.024 -178.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.2 p -138.77 -18.96 1.04 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.091 1.756 . . . . 0.0 110.398 173.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.492 -1.718 . . . . 0.0 110.922 -177.478 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.2 mt -53.0 -59.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.534 0.734 . . . . 0.0 109.544 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -52.17 -49.07 64.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 112.435 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.1 -50.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.556 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -138.98 -17.09 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.99 36.1 3.77 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 120.075 1.307 . . . . 0.0 111.34 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -136.77 150.51 48.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.611 1.564 . . . . 0.0 108.013 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.18 109.59 5.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.653 1.181 . . . . 0.0 109.274 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.33 153.68 31.56 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 CA-C-N 120.105 1.073 . . . . 0.0 111.82 -9.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.45 124.85 24.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 109.667 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.03 -48.1 81.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.418 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -39.59 -56.86 1.59 Allowed 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.447 1.899 . . . . 0.0 112.253 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -43.52 -31.61 0.76 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.408 1.483 . . . . 0.0 113.375 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.2 m -104.28 -56.53 2.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.897 0.479 . . . . 0.0 111.277 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -68.62 -28.55 67.01 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.4 -39.24 93.98 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.95 0.795 . . . . 0.0 110.318 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ttm105 -95.32 -28.71 14.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.414 1.086 . . . . 0.0 111.978 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.6 6.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.81 133.18 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.69 31.24 7.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.628 1.171 . . . . 0.0 111.636 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.4 76.25 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.659 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.91 136.5 72.91 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 118.511 1.156 . . . . 0.0 108.402 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.86 120.15 7.71 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.339 2.026 . . . . 0.0 108.596 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.49 167.96 16.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.65 158.75 33.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.547 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.39 49.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.375 1.47 . . . . 0.0 111.9 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.23 62.17 19.47 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.651 1.58 . . . . 0.0 109.036 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -44.1 -41.41 12.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.238 3.292 . . . . 0.0 113.779 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -49.51 -41.11 40.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.514 1.125 . . . . 0.0 111.315 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.3 -24.89 67.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.671 0.788 . . . . 0.0 111.956 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -104.95 -30.87 9.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.316 1.046 . . . . 0.0 112.353 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.59 -49.9 1.56 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.627 1.571 . . . . 0.0 112.795 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -27.68 60.56 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -76.74 151.0 82.25 Favored Pre-proline 0 CA--C 1.534 0.333 0 O-C-N 121.64 -0.663 . . . . 0.0 110.03 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.08 85.83 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 107.982 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.45 -25.55 25.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.56 1.944 . . . . 0.0 113.304 -171.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.3 m -48.17 113.82 0.82 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.495 1.118 . . . . 0.0 110.651 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.81 -46.14 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.373 1.069 . . . . 0.0 110.512 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -58.19 -24.64 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.779 1.232 . . . . 0.0 112.852 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -90.06 -53.0 4.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.3 mt -47.85 -42.01 25.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.298 1.039 . . . . 0.0 111.861 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.44 -34.64 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.755 -0.591 . . . . 0.0 111.289 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -64.52 -50.12 68.62 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 119.375 0.988 . . . . 0.0 108.653 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -51.13 -46.1 61.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.673 0.789 . . . . 0.0 109.844 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -50.56 71.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.825 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.02 -45.42 92.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.294 -0.879 . . . . 0.0 111.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -32.67 67.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.877 0.871 . . . . 0.0 112.227 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.56 160.19 28.93 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -157.61 122.01 4.29 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.974 -0.721 . . . . 0.0 109.263 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.08 9.34 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.02 53.86 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.003 0.521 . . . . 0.0 111.807 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.4 ttp -65.89 115.89 27.25 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.733 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.13 164.84 23.73 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.369 2.046 . . . . 0.0 110.947 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.33 134.68 50.69 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -97.03 -15.06 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -47.79 100.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.671 0.788 . . . . 0.0 112.624 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.05 -37.97 3.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.062 1.315 . . . . 0.0 111.781 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -76.42 -38.92 54.85 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.786 0.793 . . . . 0.0 110.134 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.65 136.61 46.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.79 144.83 30.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -32.31 -44.95 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.63 1.972 . . . . 0.0 111.496 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.64 -49.53 76.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.942 0.792 . . . . 0.0 111.561 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -56.1 -56.92 15.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 122.728 1.251 . . . . 0.0 108.626 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 62.4 mt -48.62 -58.56 4.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.823 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 t -46.09 -53.54 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.426 1.09 . . . . 0.0 110.024 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -59.02 -39.03 80.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.656 0.382 . . . . 0.0 111.192 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.56 71.9 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.47 -49.95 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.601 1.16 . . . . 0.0 109.825 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.07 -39.14 85.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.135 0.88 . . . . 0.0 109.228 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.1 -47.51 85.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mtp -54.03 -59.31 4.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.01 -35.94 64.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 112.634 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -62.9 -10.65 14.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.419 1.008 . . . . 0.0 113.173 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -89.62 -11.61 42.11 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.783 1.174 . . . . 0.0 111.558 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.216 -1.85 . . . . 0.0 111.875 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.96 -57.46 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.699 0.799 . . . . 0.0 110.175 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.71 -49.25 77.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.825 0.85 . . . . 0.0 112.31 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.15 -48.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.084 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.52 -18.19 1.95 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.85 -34.43 38.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.842 1.201 . . . . 0.0 112.364 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 p -73.06 151.32 41.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.419 0.609 . . . . 0.0 110.444 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.68 106.72 6.42 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.872 1.269 . . . . 0.0 108.559 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.16 150.65 36.01 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.351 1.161 . . . . 0.0 111.738 -5.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.06 124.53 22.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.676 1.19 . . . . 0.0 109.142 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -54.43 -46.34 73.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.026 0.83 . . . . 0.0 110.558 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 p -40.4 -52.46 2.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.111 2.165 . . . . 0.0 112.338 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -38.47 -48.2 1.36 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 112.082 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.9 m -93.02 -55.05 3.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.208 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -64.84 -25.95 68.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 120.289 1.404 . . . . 0.0 111.356 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -119.72 -15.05 8.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.963 0.905 . . . . 0.0 112.466 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.74 34.23 44.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.2 t -55.13 132.62 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.34 31.53 7.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.729 1.211 . . . . 0.0 111.911 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.61 22.24 75.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.398 -0.668 . . . . 0.0 113.044 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.15 131.66 80.5 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 118.707 1.253 . . . . 0.0 109.324 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.7 119.57 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.411 2.074 . . . . 0.0 108.211 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.39 179.78 6.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.811 0.815 . . . . 0.0 112.567 -172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.43 159.37 24.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.14 54.11 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.084 1.754 . . . . 0.0 112.238 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.21 58.56 15.4 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.034 0.933 . . . . 0.0 110.96 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -38.48 -48.27 2.51 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.557 3.505 . . . . 0.0 114.152 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -47.77 -40.1 19.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.363 1.465 . . . . 0.0 111.988 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.71 -27.9 58.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.923 0.329 . . . . 0.0 111.455 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.94 -26.14 19.42 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.756 0.822 . . . . 0.0 112.004 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -34.76 -46.81 0.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.493 2.317 . . . . 0.0 114.456 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.05 2.7 35.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -83.37 158.29 63.78 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 118.978 0.808 . . . . 0.0 109.821 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.01 120.88 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.258 2.639 . . . . 0.0 110.833 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -64.36 -39.16 93.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -82.35 133.33 35.22 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 122.067 -0.395 . . . . 0.0 111.115 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -52.98 -40.7 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -54.34 -29.48 48.14 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.024 1.33 . . . . 0.0 112.598 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.28 -52.49 6.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.89 -40.15 60.2 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -60.2 -33.97 55.43 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 CA-C-N 119.528 1.058 . . . . 0.0 110.743 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -62.47 -49.81 73.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 m -52.27 -46.95 66.06 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.453 0.57 . . . . 0.0 109.817 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 m -61.12 -40.35 93.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.491 0.717 . . . . 0.0 111.487 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . 0.286 0.9 OUTLIER -111.02 36.65 3.07 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.37 -44.49 2.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.474 1.91 . . . . 0.0 107.175 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.33 145.63 9.76 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.89 1.71 . . . . 0.0 109.462 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -156.36 132.95 10.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.8 -117.64 11.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.36 1.01 38.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.186 0.994 . . . . 0.0 112.064 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.7 ttp -69.58 122.83 87.03 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.067 0.849 . . . . 0.0 110.308 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.82 152.55 47.23 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.155 1.903 . . . . 0.0 108.86 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.58 119.14 13.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -76.34 1.97 14.75 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -46.37 112.51 0.5 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 110.924 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.37 -30.01 6.73 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.636 0.636 . . . . 0.0 112.149 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -72.7 -46.28 54.51 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.29 124.56 13.78 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.0 155.4 28.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -29.32 -49.81 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.496 1.918 . . . . 0.0 111.852 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -64.7 -41.05 96.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.258 0.936 . . . . 0.0 112.304 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.12 -58.0 8.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 122.437 1.113 . . . . 0.0 108.443 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.3 mt -46.03 -57.9 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 127.047 2.139 . . . . 0.0 110.48 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -39.84 -55.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 110.813 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -60.58 -37.25 80.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.284 1.034 . . . . 0.0 111.816 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.64 32.27 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.74 -0.6 . . . . 0.0 109.442 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.67 -50.85 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.049 0.94 . . . . 0.0 110.785 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.94 -41.65 92.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.847 1.203 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -59.03 -51.52 69.71 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.27 -53.61 48.35 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.33 -38.24 76.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.118 0.567 . . . . 0.0 111.78 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.7 p -63.5 -5.22 3.49 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -87.06 -12.43 47.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.771 1.168 . . . . 0.0 111.093 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.656 -1.64 . . . . 0.0 110.197 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 121.349 0.595 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.02 -58.15 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.2 -50.24 65.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.176 0.99 . . . . 0.0 112.17 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.2 mt -69.21 -48.04 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.468 -174.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -145.32 -12.74 0.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.55 38.85 2.99 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 120.244 1.384 . . . . 0.0 111.257 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.16 153.76 51.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.135 1.374 . . . . 0.0 109.073 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.08 108.63 8.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.495 1.118 . . . . 0.0 110.968 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -57.02 159.27 24.89 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.843 0.98 . . . . 0.0 111.83 -12.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.82 122.66 19.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.484 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -54.72 -47.51 73.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.712 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 p -41.48 -52.47 3.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.339 1.856 . . . . 0.0 112.263 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -48.51 -24.78 1.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.065 1.346 . . . . 0.0 113.874 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -109.03 -54.1 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.743 0.817 . . . . 0.0 110.951 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -69.84 -21.67 63.35 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.25 -58.05 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.366 0.985 . . . . 0.0 109.773 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -26.29 32.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.635 0.374 . . . . 0.0 111.563 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.81 6.15 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.32 144.4 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.47 29.8 7.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.076 0.95 . . . . 0.0 111.491 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.27 79.16 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.05 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.71 132.64 88.96 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.754 1.277 . . . . 0.0 108.409 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.17 119.02 5.93 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.793 2.329 . . . . 0.0 109.398 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -82.55 177.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.9 0.857 . . . . 0.0 111.255 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -82.98 157.53 22.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m120 50.4 41.48 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.94 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.28 52.93 8.64 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.443 1.097 . . . . 0.0 110.24 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -46.88 -39.61 24.63 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.75 2.967 . . . . 0.0 112.643 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -49.66 -40.63 40.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.404 1.081 . . . . 0.0 111.48 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.41 -27.36 60.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.234 0.614 . . . . 0.0 111.199 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.06 -27.24 19.82 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.839 -0.538 . . . . 0.0 111.697 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.2 -50.58 0.73 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.6 1.96 . . . . 0.0 113.503 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.74 -23.43 42.29 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.62 135.5 75.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.647 -0.658 . . . . 0.0 109.423 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.72 113.99 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.295 1.997 . . . . 0.0 111.256 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.61 -32.4 58.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.144 0.978 . . . . 0.0 111.834 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -53.99 101.81 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.457 1.503 . . . . 0.0 111.279 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -45.43 -40.82 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.011 1.324 . . . . 0.0 109.933 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.94 -36.52 5.54 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.963 2.105 . . . . 0.0 112.639 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -84.03 -50.14 8.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -52.66 -39.27 61.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.046 0.938 . . . . 0.0 112.019 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 m -60.1 -36.07 65.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.143 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -67.5 -48.76 66.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.677 1.126 . . . . 0.0 108.451 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 m -50.7 -46.42 58.86 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -67.34 -50.89 58.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.649 0.379 . . . . 0.0 111.179 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.0 -44.77 94.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.188 -0.945 . . . . 0.0 111.031 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.32 -35.36 54.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.544 0.738 . . . . 0.0 112.462 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 158.23 24.36 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -164.47 133.53 3.67 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.891 0.846 . . . . 0.0 109.803 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.76 -84.84 0.28 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.96 -6.28 2.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.193 1.797 . . . . 0.0 111.453 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.3 ttp -64.61 124.01 84.83 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.067 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.49 158.68 55.28 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.124 1.883 . . . . 0.0 109.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 147.02 53.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -111.81 -12.75 13.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.098 1.359 . . . . 0.0 111.232 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.75 123.04 6.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.416 1.086 . . . . 0.0 110.136 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.6 -26.07 23.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.387 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -97.74 -54.64 3.05 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.498 1.149 . . . . 0.0 110.361 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.03 125.91 33.12 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.55 51.39 1.06 Allowed 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.719 1.608 . . . . 0.0 111.921 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 52.05 -62.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.928 3.291 . . . . 0.0 113.734 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -50.92 -34.85 30.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.763 1.225 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -53.0 -56.63 14.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.734 1.614 . . . . 0.0 109.143 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.07 -53.32 58.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 125.44 1.496 . . . . 0.0 109.684 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.2 t -43.39 -57.51 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 122.899 0.479 . . . . 0.0 109.875 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -60.72 -43.86 97.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.876 0.471 . . . . 0.0 112.056 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.55 95.6 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.802 -0.561 . . . . 0.0 110.398 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.89 -49.63 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.49 1.516 . . . . 0.0 110.087 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.69 -39.81 89.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -58.22 -53.05 62.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.389 0.54 . . . . 0.0 109.617 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.7 mtp -48.25 -58.58 4.35 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -55.61 -39.86 71.33 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.811 0.844 . . . . 0.0 112.078 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.0 m -67.17 -6.53 18.26 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.506 -0.746 . . . . 0.0 112.006 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -119.14 42.44 2.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.597 1.559 . . . . 0.0 109.635 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.136 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 119.578 -0.249 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.7 mt -53.91 -57.53 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 109.978 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -57.07 -50.34 73.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.236 1.014 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.91 -51.18 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.88 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.996 0.816 . . . . 0.0 112.851 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.76 38.94 1.51 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 157.51 45.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.231 1.813 . . . . 0.0 108.44 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.714 0.805 . . . . 0.0 110.629 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.06 160.35 23.48 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 CA-C-N 119.941 1.015 . . . . 0.0 111.878 -12.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.31 127.45 32.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.706 0.802 . . . . 0.0 109.558 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -57.71 -50.77 72.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.457 0.646 . . . . 0.0 111.199 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -39.42 -56.13 1.64 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.642 1.977 . . . . 0.0 112.986 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.67 -38.0 0.83 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.337 1.455 . . . . 0.0 112.564 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -96.83 -59.25 1.84 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 0.0 110.372 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -60.69 -46.11 91.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -22.18 64.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.862 0.301 . . . . 0.0 111.759 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -114.87 11.99 16.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.209 1.004 . . . . 0.0 111.293 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.71 38.39 29.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.124 0.869 . . . . 0.0 113.63 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.8 t -55.14 132.74 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.52 31.44 7.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 111.883 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.71 22.32 75.12 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.742 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.49 136.25 82.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.253 1.027 . . . . 0.0 108.697 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.9 Cg_endo -60.22 126.94 21.47 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.346 2.031 . . . . 0.0 109.626 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -94.07 174.47 7.14 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.449 0.643 . . . . 0.0 112.014 -174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.82 162.3 19.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.09 53.6 0.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.758 1.623 . . . . 0.0 112.125 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.79 64.5 22.18 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 124.235 1.014 . . . . 0.0 109.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -41.17 -51.55 3.87 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.024 3.15 . . . . 0.0 114.29 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -44.15 -51.92 7.71 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.144 1.378 . . . . 0.0 110.843 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.55 -45.38 56.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.953 0.901 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 92.1 m95 -85.6 -30.6 23.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.325 0.65 . . . . 0.0 111.379 -173.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.41 93.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.411 1.084 . . . . 0.0 109.408 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.89 -42.15 97.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.014 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -74.85 162.66 72.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.528 0.731 . . . . 0.0 111.266 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -68.03 84.33 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.36 2.04 . . . . 0.0 107.798 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -48.9 -28.82 4.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.462 1.905 . . . . 0.0 113.247 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.79 106.82 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.748 2.019 . . . . 0.0 110.911 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.0 t -47.75 -44.41 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.248 1.019 . . . . 0.0 110.939 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -53.78 -36.0 61.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.755 1.622 . . . . 0.0 111.842 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.69 -50.7 10.22 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.7 -42.31 45.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.128 0.971 . . . . 0.0 112.408 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.62 -36.11 68.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.818 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -65.46 -49.43 69.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 119.763 1.165 . . . . 0.0 108.581 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 m -52.07 -46.11 65.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.078 0.466 . . . . 0.0 109.812 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -65.19 -49.98 67.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.761 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.53 -45.29 94.82 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.315 -0.866 . . . . 0.0 110.81 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.79 74.91 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.715 0.806 . . . . 0.0 111.819 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 164.95 26.04 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -156.36 106.98 2.39 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.85 -0.794 . . . . 0.0 109.389 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.59 -111.55 3.33 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.79 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.088 0.555 . . . . 0.0 111.117 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -65.0 117.96 44.38 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.323 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.47 157.51 52.8 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.531 2.154 . . . . 0.0 109.644 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 145.68 52.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.456 0.302 . . . . 0.0 110.302 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -110.81 -12.31 14.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.192 1.397 . . . . 0.0 111.349 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -46.51 123.58 5.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.978 1.311 . . . . 0.0 110.548 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.69 -25.38 21.5 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.119 0.866 . . . . 0.0 112.34 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -98.1 -57.1 2.3 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.384 1.092 . . . . 0.0 110.325 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.11 119.61 26.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.46 84.92 4.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 15.32 -59.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 131.389 3.876 . . . . 0.0 115.866 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -48.28 -35.39 12.07 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.2 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -54.99 -59.75 4.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.211 1.405 . . . . 0.0 108.787 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 mt -55.51 -53.84 51.34 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 126.282 1.833 . . . . 0.0 109.858 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.3 t -45.38 -57.03 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.32 0.648 . . . . 0.0 109.422 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -60.3 -41.24 93.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.766 -0.584 . . . . 0.0 111.651 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.36 99.01 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 109.787 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.88 -44.18 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.64 1.176 . . . . 0.0 108.565 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.14 -50.72 68.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -55.26 -51.64 65.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.522 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.7 mtt -47.57 -63.79 0.96 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.113 0.959 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -53.3 -36.05 60.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.069 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.4 m -72.07 34.57 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.656 1.116 . . . . 0.0 113.94 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -134.21 -10.86 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.662 1.585 . . . . 0.0 109.85 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.579 -1.677 . . . . 0.0 110.093 -178.771 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.627 0.251 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.45 -60.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.893 1.677 . . . . 0.0 110.671 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.75 -48.08 73.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.83 0.852 . . . . 0.0 111.589 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.29 -49.98 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.457 1.103 . . . . 0.0 111.021 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.65 33.77 0.27 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.42 37.85 1.75 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 156.04 48.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.287 1.835 . . . . 0.0 107.751 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.42 108.82 6.73 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.859 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.8 155.73 27.72 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.074 1.062 . . . . 0.0 111.581 -9.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.17 128.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.54 0.736 . . . . 0.0 109.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.3 m -58.35 -49.41 77.3 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 0.0 110.117 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -41.18 -55.5 2.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.405 1.882 . . . . 0.0 113.49 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.27 -36.38 3.98 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.941 0.896 . . . . 0.0 112.339 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.41 -57.91 2.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -67.06 -36.12 81.35 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -68.21 -33.84 75.16 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -84.46 -26.8 27.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.112 0.965 . . . . 0.0 111.122 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.18 33.3 57.13 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.62 139.46 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.9 29.43 6.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.126 0.97 . . . . 0.0 111.572 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.22 24.49 76.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.718 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.67 80.41 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.608 1.204 . . . . 0.0 108.275 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.6 122.01 10.61 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.257 1.972 . . . . 0.0 110.051 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -90.56 177.18 6.43 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.606 0.717 . . . . 0.0 111.65 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 156.77 29.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 51.08 35.48 13.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.614 0.766 . . . . 0.0 111.845 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.79 67.27 79.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.06 1.344 . . . . 0.0 110.352 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.18 -50.82 5.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.148 3.232 . . . . 0.0 114.454 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -50.93 -35.21 32.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.946 1.299 . . . . 0.0 112.227 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.37 -27.66 68.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.149 0.431 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -101.53 -35.42 9.16 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.548 1.139 . . . . 0.0 112.097 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.34 -51.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.587 1.555 . . . . 0.0 113.125 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.89 -23.18 45.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -79.53 144.28 60.95 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.38 93.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.72 2.28 . . . . 0.0 108.457 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.56 -21.12 36.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.044 1.337 . . . . 0.0 112.994 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.41 106.93 0.11 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.571 1.948 . . . . 0.0 110.455 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.0 -42.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.937 0.895 . . . . 0.0 110.632 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.82 -31.23 64.52 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.371 1.469 . . . . 0.0 112.36 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.83 -53.49 5.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt -48.62 -45.61 38.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.502 0.721 . . . . 0.0 111.877 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.94 -35.98 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 121.854 -0.529 . . . . 0.0 110.976 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.89 -45.09 75.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 m -53.96 -44.08 70.45 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.3 m -64.55 -50.61 66.62 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.81 0.444 . . . . 0.0 110.49 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.48 -44.97 89.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.411 -0.806 . . . . 0.0 110.924 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.9 68.49 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.799 0.84 . . . . 0.0 112.288 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.09 161.25 26.47 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -159.66 117.31 2.68 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.892 -0.769 . . . . 0.0 109.215 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.18 -117.62 11.63 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.44 54.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.883 0.473 . . . . 0.0 111.447 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -67.98 121.47 79.99 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 118.784 0.72 . . . . 0.0 110.112 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.73 161.29 39.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.629 2.219 . . . . 0.0 110.195 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.02 136.83 57.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.89 -14.05 18.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.121 0.968 . . . . 0.0 113.247 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -49.41 102.83 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.311 0.644 . . . . 0.0 112.142 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.73 -36.24 4.28 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.14 1.352 . . . . 0.0 111.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -79.17 -41.11 29.19 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 117.828 0.814 . . . . 0.0 110.184 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.35 132.76 39.87 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.56 144.94 30.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -28.29 -52.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -62.45 -40.65 97.31 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.674 -0.641 . . . . 0.0 112.033 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.23 -58.91 6.38 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 122.429 1.109 . . . . 0.0 108.199 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 62' ' ' ALA . 77.9 mt -46.09 -56.02 6.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.493 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -41.53 -54.49 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.815 1.246 . . . . 0.0 110.572 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -57.04 -42.53 80.68 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.342 -0.224 . . . . 0.0 111.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.99 81.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.54 -45.47 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.578 0.751 . . . . 0.0 109.344 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -55.1 -51.0 67.77 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.875 0.87 . . . . 0.0 108.824 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -55.87 -52.05 65.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.414 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.6 mtp -49.73 -54.41 19.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.391 0.677 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.19 -36.81 76.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.03 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.6 m -74.41 42.49 0.16 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.468 -0.77 . . . . 0.0 112.766 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -135.93 -7.78 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.77 1.228 . . . . 0.0 110.307 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.22 -1.371 . . . . 0.0 108.999 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.522 0.201 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.7 -59.78 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.632 1.573 . . . . 0.0 109.96 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -58.12 -48.56 79.85 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.135 0.574 . . . . 0.0 111.441 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.6 mt -69.84 -46.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.877 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.69 39.07 0.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.45 39.49 1.16 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -139.16 156.9 46.79 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.458 1.903 . . . . 0.0 107.496 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.51 108.17 6.63 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.814 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.32 154.55 31.27 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 CA-C-N 120.104 1.073 . . . . 0.0 111.827 -9.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.08 121.73 16.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.561 1.145 . . . . 0.0 109.179 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -52.71 -49.71 64.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.206 0.527 . . . . 0.0 110.496 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -43.39 -51.26 6.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.029 1.732 . . . . 0.0 112.77 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -47.39 -34.21 6.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.655 0.782 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 m -96.85 -55.74 2.79 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -66.06 -36.91 84.5 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.99 -43.26 88.27 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -72.55 -30.23 64.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.626 0.77 . . . . 0.0 111.076 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.2 56.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.02 143.15 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.63 30.69 6.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.11 0.964 . . . . 0.0 111.383 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.43 27.56 73.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.622 -0.543 . . . . 0.0 112.494 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.32 131.89 90.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.51 1.155 . . . . 0.0 108.299 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.0 Cg_endo -60.68 112.52 1.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.756 2.304 . . . . 0.0 109.564 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.54 175.33 9.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.638 1.208 . . . . 0.0 109.896 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.63 140.77 29.11 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 68.29 35.43 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.231 1.013 . . . . 0.0 109.795 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.89 58.23 37.42 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.218 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.79 -47.23 2.72 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.537 3.492 . . . . 0.0 114.315 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -47.53 -40.46 18.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.488 1.515 . . . . 0.0 112.026 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.51 -25.64 54.42 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.954 0.343 . . . . 0.0 111.464 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.444 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 93.2 m95 -92.05 -23.48 19.48 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.605 0.762 . . . . 0.0 111.734 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.71 -46.36 0.43 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.873 2.069 . . . . 0.0 114.155 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -101.07 -3.3 29.54 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -83.74 145.78 48.07 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.849 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.78 118.59 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.993 2.462 . . . . 0.0 111.65 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -62.26 -32.71 73.45 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 103.94 0.13 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.299 2.24 . . . . 0.0 111.507 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.09 -40.09 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.774 -0.579 . . . . 0.0 109.5 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.02 -26.0 34.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.576 1.55 . . . . 0.0 112.428 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.67 -53.42 4.53 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.22 -40.89 48.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.43 -31.52 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.668 -0.645 . . . . 0.0 110.38 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -65.85 -51.02 62.36 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.538 1.063 . . . . 0.0 108.296 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -49.97 -44.92 51.01 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.864 0.866 . . . . 0.0 109.98 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 m -64.54 -52.26 58.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.948 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.51 -41.57 98.92 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.025 -1.047 . . . . 0.0 111.867 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.6 -33.96 31.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.971 0.909 . . . . 0.0 112.283 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 151.56 17.45 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 55' ' ' MET . 28.0 tptp -155.18 136.99 14.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.73 -115.68 7.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.07 -0.46 33.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.456 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.2 ttp -65.43 127.0 92.58 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.891 0.769 . . . . 0.0 110.088 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.84 154.74 67.08 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.708 1.605 . . . . 0.0 109.247 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 121.64 15.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.14 -10.18 57.98 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -53.79 84.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.451 1.101 . . . . 0.0 113.751 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.1 -30.91 5.09 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.452 1.977 . . . . 0.0 111.77 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.49 80.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.022 0.911 . . . . 0.0 109.338 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -133.8 147.44 51.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -82.75 142.17 31.81 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -34.15 -44.69 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.422 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -46.02 91.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.421 1.01 . . . . 0.0 111.068 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -55.84 -56.34 21.76 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 122.128 0.966 . . . . 0.0 108.394 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.3 mt -48.6 -60.41 2.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.256 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 t -43.85 -56.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.692 1.197 . . . . 0.0 110.063 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.6 -40.74 84.12 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.206 -0.309 . . . . 0.0 111.246 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.69 -55.32 27.89 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -49.83 -47.09 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.138 1.375 . . . . 0.0 110.099 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -53.98 -51.2 64.66 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.714 0.688 . . . . 0.0 109.239 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.56 -49.72 75.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.0 mtp -49.11 -54.78 14.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.827 . . . . 0.0 109.525 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.79 -35.16 77.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.017 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.03 41.42 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.351 -0.843 . . . . 0.0 113.188 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.6 p -138.37 -3.75 1.71 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.475 1.51 . . . . 0.0 110.044 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.713 -1.613 . . . . 0.0 110.271 -174.648 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.98 -53.97 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.423 0.556 . . . . 0.0 109.871 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -66.46 -39.34 88.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.711 0.404 . . . . 0.0 111.36 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -76.87 -50.82 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -138.5 -14.42 1.27 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.19 -37.72 31.49 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.748 1.158 . . . . 0.0 111.786 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -69.02 150.54 47.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 122.359 -0.495 . . . . 0.0 110.303 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.32 114.57 7.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.468 1.107 . . . . 0.0 108.549 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.23 151.49 18.19 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.504 1.216 . . . . 0.0 111.408 -13.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.11 121.75 16.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.796 1.639 . . . . 0.0 109.883 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 m -54.03 -48.68 70.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.417 0.627 . . . . 0.0 110.273 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -41.17 -56.16 2.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.918 2.087 . . . . 0.0 112.373 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -45.54 -33.98 3.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.501 1.12 . . . . 0.0 113.038 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -98.16 -57.66 2.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.054 0.388 . . . . 0.0 110.322 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.08 -16.8 64.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.91 5.87 50.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.783 0.72 . . . . 0.0 109.974 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -128.71 -27.62 2.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.269 1.028 . . . . 0.0 112.232 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.42 27.07 62.17 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 140.05 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.96 29.22 5.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.091 0.956 . . . . 0.0 111.513 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.36 25.5 75.27 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.956 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.34 79.11 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.768 1.284 . . . . 0.0 108.977 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.83 110.36 1.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 N-CA-C 106.742 -2.061 . . . . 0.0 106.742 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -72.93 156.16 39.14 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.94 171.87 8.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.26 33.97 16.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.15 74.47 6.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.622 -170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -37.92 -50.94 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.359 3.373 . . . . 0.0 114.403 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.34 -43.23 15.81 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.194 1.397 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.05 -22.04 66.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.504 0.722 . . . . 0.0 111.95 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -109.37 -29.42 8.46 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.226 1.01 . . . . 0.0 112.584 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.36 -49.92 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.794 1.637 . . . . 0.0 113.11 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.66 -27.29 58.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.721 0.809 . . . . 0.0 113.166 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -79.32 155.41 76.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.492 0.717 . . . . 0.0 110.342 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.29 124.52 15.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.952 1.768 . . . . 0.0 110.284 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 p -66.16 -26.53 67.47 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.632 -0.668 . . . . 0.0 110.32 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -55.22 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.347 1.859 . . . . 0.0 112.395 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.1 t -47.85 -43.44 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.537 1.135 . . . . 0.0 109.689 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -52.7 -28.94 24.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.806 1.642 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.47 -48.63 6.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.388 1.075 . . . . 0.0 109.069 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -49.4 -41.56 39.86 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.603 0.361 . . . . 0.0 111.088 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.94 -35.29 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.566 -0.708 . . . . 0.0 111.019 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -64.25 -48.25 76.48 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.461 1.028 . . . . 0.0 108.466 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -53.64 -44.13 69.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -62.54 -49.35 75.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.575 0.35 . . . . 0.0 110.482 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.95 -46.74 89.51 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.267 -0.896 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 -33.33 74.96 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.664 0.786 . . . . 0.0 112.062 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.27 159.67 31.21 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.07 120.93 2.66 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.784 -0.833 . . . . 0.0 109.248 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.99 -119.97 20.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.51 -17.42 54.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.7 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -68.67 118.55 61.54 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 119.142 0.883 . . . . 0.0 109.424 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 158.69 53.38 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.266 1.978 . . . . 0.0 110.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.82 47.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -97.79 -11.55 23.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.215 1.006 . . . . 0.0 111.922 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -41.6 113.03 0.37 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.262 1.425 . . . . 0.0 112.153 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.43 -21.73 16.29 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.166 0.889 . . . . 0.0 113.089 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -85.17 -48.11 9.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.084 0.942 . . . . 0.0 109.179 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.57 141.14 48.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 173.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -83.9 140.8 31.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -29.83 -45.86 0.06 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 126.281 1.832 . . . . 0.0 111.46 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -60.16 -49.49 77.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.946 1.248 . . . . 0.0 111.526 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -53.71 -59.14 4.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.832 1.301 . . . . 0.0 108.995 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 62' ' ' ALA . 33.3 mt -49.11 -58.72 4.48 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 126.098 1.759 . . . . 0.0 110.491 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -47.76 -56.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.526 1.13 . . . . 0.0 109.657 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -55.41 -39.05 69.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.079 0.552 . . . . 0.0 111.508 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.94 68.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.744 0.418 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.86 -46.64 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.692 1.197 . . . . 0.0 109.007 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.9 -53.83 43.47 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.91 -50.62 71.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.305 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 ttp -50.45 -59.82 3.63 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.3 mp -55.05 -37.86 67.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.811 -0.556 . . . . 0.0 111.431 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -62.79 -6.69 3.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.661 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.1 p -89.13 -15.25 34.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.57 1.532 . . . . 0.0 111.227 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.193 -1.384 . . . . 0.0 110.289 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.83 -57.95 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -57.42 -44.32 84.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.923 0.889 . . . . 0.0 112.195 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.6 mt -76.44 -49.68 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.199 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -136.63 -17.15 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.2 -33.73 39.3 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 119.965 1.257 . . . . 0.0 112.003 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -73.61 154.13 39.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.36 0.58 . . . . 0.0 110.98 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 110.37 5.86 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.66 1.184 . . . . 0.0 109.436 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.98 151.85 20.56 Favored 'Cis proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.1 1.071 . . . . 0.0 111.784 -11.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.74 123.1 19.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.153 1.381 . . . . 0.0 109.129 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.3 -47.66 75.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.849 0.356 . . . . 0.0 110.483 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 p -39.91 -56.26 1.84 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 126.432 1.893 . . . . 0.0 112.315 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -41.57 -36.32 0.9 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.31 1.444 . . . . 0.0 112.763 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.8 m -101.21 -57.01 2.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.51 0.324 . . . . 0.0 111.459 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -68.36 -33.33 74.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.57 -36.3 73.54 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -82.01 -27.3 33.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.234 1.013 . . . . 0.0 111.587 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.07 32.23 60.81 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.66 141.58 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.8 29.69 6.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.136 0.974 . . . . 0.0 111.424 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 24.54 77.0 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.876 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 134.55 79.56 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.745 1.273 . . . . 0.0 108.203 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.31 124.86 15.58 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.454 2.102 . . . . 0.0 108.75 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.56 172.68 8.34 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 160.3 23.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 35.7 51.67 0.71 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.891 1.676 . . . . 0.0 111.956 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.18 64.12 25.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.886 1.274 . . . . 0.0 110.143 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -39.85 -48.24 3.68 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.247 3.298 . . . . 0.0 114.63 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.08 -34.42 56.46 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.639 0.776 . . . . 0.0 112.213 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -66.96 -25.51 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.871 0.468 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -105.61 -29.61 10.02 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.451 1.1 . . . . 0.0 112.79 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.04 -50.17 0.89 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.687 1.595 . . . . 0.0 113.116 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.88 -19.74 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -80.54 157.32 72.58 Favored Pre-proline 0 CA--C 1.537 0.465 0 O-C-N 121.511 -0.743 . . . . 0.0 110.661 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.23 111.2 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.965 2.443 . . . . 0.0 111.436 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -60.89 -31.76 71.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.91 101.86 0.07 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.301 2.24 . . . . 0.0 111.421 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.62 -40.37 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.676 0.791 . . . . 0.0 110.038 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.11 -33.56 62.94 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.818 1.647 . . . . 0.0 112.029 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.04 -50.35 9.78 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.86 -44.03 39.39 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' A' ' 67' ' ' LEU . 5.0 m -57.22 -42.39 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 119.468 1.031 . . . . 0.0 110.449 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.69 -43.52 93.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -55.24 -40.8 71.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.2 0.455 . . . . 0.0 110.408 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -68.22 -55.46 12.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.321 0.649 . . . . 0.0 109.438 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 mt -54.9 -41.14 70.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.411 1.485 . . . . 0.0 111.816 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.69 -34.42 58.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.973 0.909 . . . . 0.0 111.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.58 162.99 35.28 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -167.04 130.04 1.79 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.04 -136.27 50.68 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.36 -25.91 68.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.427 -0.887 . . . . 0.0 111.73 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.2 ttp -64.56 117.42 37.66 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 119.265 0.939 . . . . 0.0 110.73 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.63 156.61 57.35 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.533 2.156 . . . . 0.0 109.538 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.79 114.58 3.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -72.4 -12.7 61.23 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.461 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -37.3 109.78 0.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.328 0.967 . . . . 0.0 112.859 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.77 -19.41 54.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.359 0.981 . . . . 0.0 114.533 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -78.63 -57.58 3.69 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.8 1.3 . . . . 0.0 111.321 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.47 141.28 49.3 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.56 1.144 . . . . 0.0 107.972 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.48 150.08 28.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -27.38 -52.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.807 2.043 . . . . 0.0 111.492 168.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.45 -48.26 80.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.698 0.681 . . . . 0.0 111.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -55.11 -57.15 12.91 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 122.138 0.97 . . . . 0.0 108.938 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HB3' HG12 ' A' ' 45' ' ' VAL . 97.0 mt -49.26 -58.83 4.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.722 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.86 -57.5 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 124.052 0.941 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -58.76 -40.91 85.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.118 0.417 . . . . 0.0 111.778 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.18 92.27 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.988 -0.445 . . . . 0.0 109.92 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.88 -46.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.765 0.826 . . . . 0.0 109.133 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -54.54 -48.95 71.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -57.02 -53.88 53.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.517 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 ptm -57.12 -49.71 75.06 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.922 0.783 . . . . 0.0 109.395 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.77 -36.13 73.91 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.07 -1.018 . . . . 0.0 111.399 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t -63.53 -5.65 4.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.121 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -92.2 -12.18 33.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.331 1.423 . . . . 0.0 110.701 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.64 -1.172 . . . . 0.0 110.99 -176.988 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.03 -60.33 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.269 1.428 . . . . 0.0 110.173 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -56.59 -47.09 80.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.559 0.743 . . . . 0.0 111.439 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.5 -47.01 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.451 0.7 . . . . 0.0 111.793 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -9.69 0.33 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 -28.69 52.06 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.707 1.139 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -76.34 154.49 34.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.445 0.623 . . . . 0.0 110.41 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.23 104.96 4.09 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 108.122 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.46 146.66 32.95 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.499 1.214 . . . . 0.0 111.897 -3.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.92 120.89 14.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.751 1.621 . . . . 0.0 109.56 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 m -54.23 -49.71 68.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.166 0.508 . . . . 0.0 110.116 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -41.0 -55.56 2.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.256 1.822 . . . . 0.0 112.676 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -46.21 -33.72 3.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.241 1.016 . . . . 0.0 113.002 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.4 m -97.3 -56.67 2.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 117.888 0.313 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.9 -45.07 94.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.096 0.862 . . . . 0.0 109.708 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -76.98 -36.23 56.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.29 0.636 . . . . 0.0 111.948 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.89 38.76 5.68 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.84 130.55 17.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.5 31.47 7.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.503 1.121 . . . . 0.0 111.576 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.89 26.38 74.07 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.556 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.69 134.37 71.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.402 1.101 . . . . 0.0 108.573 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -62.6 112.02 1.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.694 2.263 . . . . 0.0 108.85 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -82.64 179.77 7.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.369 1.068 . . . . 0.0 112.35 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.21 159.55 28.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.96 52.19 0.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.984 1.714 . . . . 0.0 112.045 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.67 56.62 15.86 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.942 1.297 . . . . 0.0 111.026 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -41.32 -45.9 5.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.817 3.011 . . . . 0.0 114.967 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.04 -41.11 33.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.687 0.795 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.25 -16.34 61.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 112.336 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.55 -26.19 11.5 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 112.52 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.46 -51.52 0.62 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.437 1.895 . . . . 0.0 113.67 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.87 -17.46 40.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -78.64 151.74 77.36 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 121.462 -0.774 . . . . 0.0 110.639 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 115.28 2.11 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.071 2.514 . . . . 0.0 111.56 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -63.19 -32.23 73.58 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.124 -0.985 . . . . 0.0 110.11 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 104.99 0.17 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.479 2.312 . . . . 0.0 111.753 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -50.06 -43.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.525 0.73 . . . . 0.0 109.638 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -53.64 -30.91 45.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 112.482 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.88 -51.93 6.77 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.0 mt -50.16 -40.1 45.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.812 0.845 . . . . 0.0 112.829 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.63 -39.34 69.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 119.216 0.916 . . . . 0.0 110.375 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -66.19 -46.31 77.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.226 0.921 . . . . 0.0 108.71 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 m -52.64 -45.74 66.8 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.079 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 m -67.84 -48.69 65.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.749 0.42 . . . . 0.0 110.761 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.79 -40.85 96.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.101 -0.999 . . . . 0.0 111.098 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 -32.43 60.78 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.0 111.357 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.81 167.58 37.77 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -160.52 112.54 1.96 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.09 -111.25 2.69 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -35.09 74.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.113 0.565 . . . . 0.0 111.066 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.01 118.3 47.78 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.063 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.16 156.43 55.49 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.551 2.167 . . . . 0.0 109.933 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 115.96 5.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.811 0.444 . . . . 0.0 109.833 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.98 -7.95 57.51 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -55.87 83.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.295 1.038 . . . . 0.0 112.644 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.16 -34.59 2.29 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.76 1.647 . . . . 0.0 111.043 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -84.11 -38.88 20.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.184 0.994 . . . . 0.0 110.984 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -142.6 129.47 20.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.33 151.62 25.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -29.96 -49.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.69 1.996 . . . . 0.0 112.648 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.55 -35.84 81.21 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.363 0.983 . . . . 0.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.79 -59.01 4.71 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' ALA . 56.6 mt -46.33 -57.91 4.19 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.218 2.207 . . . . 0.0 110.652 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -36.32 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.533 1.533 . . . . 0.0 110.299 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -60.16 -42.4 94.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.554 0.342 . . . . 0.0 111.606 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -48.49 69.17 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.764 0.426 . . . . 0.0 110.01 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 mt -56.72 -50.21 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.61 1.164 . . . . 0.0 109.203 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -55.83 -52.01 65.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -54.05 -56.26 19.64 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.572 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptm -60.94 -45.14 95.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.869 0.759 . . . . 0.0 109.629 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.04 -36.84 70.96 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.45 -0.781 . . . . 0.0 110.974 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -63.34 -6.52 4.8 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.7 p -90.34 -8.7 50.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.221 1.373 . . . . 0.0 111.047 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.47 -1.729 . . . . 0.0 110.832 -176.645 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -49.25 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.16 -48.51 78.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.903 0.481 . . . . 0.0 111.528 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.1 mt -73.47 -43.67 55.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.999 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.68 -8.24 0.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.75 -32.49 40.84 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.801 1.182 . . . . 0.0 111.321 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -73.47 155.45 39.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.449 0.624 . . . . 0.0 110.722 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.56 110.41 6.26 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.463 1.105 . . . . 0.0 108.966 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.93 153.28 16.95 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.323 1.151 . . . . 0.0 112.04 -11.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -70.24 114.35 8.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.625 1.57 . . . . 0.0 109.037 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.08 -48.4 22.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.662 0.785 . . . . 0.0 110.986 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -41.91 -50.57 4.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.608 1.963 . . . . 0.0 112.808 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -48.71 -32.47 8.48 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.316 0.647 . . . . 0.0 112.604 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.04 -54.99 2.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.903 0.481 . . . . 0.0 110.786 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.62 -32.79 71.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.04 -40.06 87.08 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.18 -28.58 42.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.573 0.749 . . . . 0.0 111.472 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.71 34.81 52.68 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.59 139.1 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.82 29.84 6.37 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.187 0.995 . . . . 0.0 111.593 -177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.62 24.25 76.5 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.764 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 135.31 82.99 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 118.554 1.177 . . . . 0.0 108.23 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.8 Cg_endo -59.77 123.73 13.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.567 2.178 . . . . 0.0 110.006 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.65 179.03 5.76 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.774 0.797 . . . . 0.0 112.117 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.94 161.84 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.17 54.16 0.74 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.125 1.77 . . . . 0.0 111.662 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 65.03 17.52 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.194 0.998 . . . . 0.0 110.124 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.06 -52.93 2.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.195 3.263 . . . . 0.0 114.381 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -49.48 -35.61 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.7 1.2 . . . . 0.0 112.615 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -65.45 -28.12 69.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.342 0.519 . . . . 0.0 111.245 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.3 m95 -102.32 -36.61 8.4 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.652 1.181 . . . . 0.0 112.43 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.68 -52.02 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.093 1.757 . . . . 0.0 113.082 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.79 -24.92 56.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.55 150.94 79.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 121.525 -0.734 . . . . 0.0 110.202 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.23 87.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.883 2.389 . . . . 0.0 108.207 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -24.59 22.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.366 1.866 . . . . 0.0 113.252 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.33 110.33 0.32 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.358 1.463 . . . . 0.0 110.46 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -47.93 -46.2 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.611 0.764 . . . . 0.0 110.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.91 -29.17 55.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.74 1.216 . . . . 0.0 113.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.67 -51.5 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.1 mt -49.79 -42.46 46.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.234 0.614 . . . . 0.0 112.188 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.25 -33.68 54.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.119 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.34 -49.06 70.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.895 1.225 . . . . 0.0 108.577 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -51.23 -46.47 62.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.57 0.748 . . . . 0.0 110.225 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -63.92 -49.94 70.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.83 -42.56 99.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.852 -1.155 . . . . 0.0 111.157 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.71 -30.53 61.57 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.074 0.95 . . . . 0.0 111.865 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.62 157.11 30.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.08 115.51 3.85 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.131 -0.629 . . . . 0.0 109.506 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.67 -116.58 9.17 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -24.88 58.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.923 0.489 . . . . 0.0 111.472 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.29 119.63 66.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.589 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.66 157.63 51.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.447 2.098 . . . . 0.0 110.276 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.76 120.18 11.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.333 0.653 . . . . 0.0 110.064 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.05 -12.46 58.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -45.48 112.55 0.47 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.73 0.812 . . . . 0.0 111.146 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 -32.39 7.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.457 1.027 . . . . 0.0 112.599 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -88.51 -49.99 6.57 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.404 1.102 . . . . 0.0 110.733 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.83 121.81 34.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -80.49 152.72 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -26.65 -51.57 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.859 2.064 . . . . 0.0 111.564 168.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -63.01 -43.48 98.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.237 0.926 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.27 -56.67 17.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 122.339 1.066 . . . . 0.0 108.369 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.4 mt -47.8 -57.52 5.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -37.81 -55.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.537 1.535 . . . . 0.0 110.135 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.1 mttp -55.65 -42.75 75.48 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.331 0.394 . . . . 0.0 111.628 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.92 -48.5 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 122.729 0.411 . . . . 0.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -37.49 84.07 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.638 1.108 . . . . 0.0 109.11 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -60.43 -47.38 86.34 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.055 0.843 . . . . 0.0 110.147 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.0 mtt -49.54 -65.65 0.53 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.1 mp -49.78 -40.56 41.84 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.067 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -61.24 -8.47 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.2 p -92.92 -11.53 33.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.521 1.51 . . . . 0.0 111.357 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.679 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -57.86 -59.94 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.786 0.834 . . . . 0.0 109.683 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -54.18 -47.42 72.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 0.0 111.801 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.44 -47.55 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.421 0.688 . . . . 0.0 111.502 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -148.61 -15.51 0.32 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.05 3.48 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 120.099 1.318 . . . . 0.0 111.288 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -133.69 149.95 51.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.562 1.545 . . . . 0.0 107.627 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.26 6.08 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.421 1.088 . . . . 0.0 109.377 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.35 152.57 31.78 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.204 1.109 . . . . 0.0 111.808 -8.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.67 126.28 29.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.487 1.115 . . . . 0.0 109.888 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -59.52 -50.17 74.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -37.66 -61.04 0.65 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.024 2.13 . . . . 0.0 113.101 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -38.63 3.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.666 1.187 . . . . 0.0 112.3 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.6 m -91.11 -58.34 2.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 117.665 0.211 . . . . 0.0 110.985 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -67.54 -41.96 83.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.24 -34.6 78.02 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.654 -0.654 . . . . 0.0 110.607 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.15 -24.71 18.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.787 0.835 . . . . 0.0 112.678 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.77 35.12 13.8 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.101 0.858 . . . . 0.0 111.472 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -56.75 131.63 20.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.65 31.24 7.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 111.451 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.48 26.06 74.72 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.632 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.5 134.08 77.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.418 1.109 . . . . 0.0 108.568 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.84 120.29 8.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.479 2.119 . . . . 0.0 109.493 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -88.0 174.14 8.47 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.466 0.65 . . . . 0.0 111.923 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.94 165.56 24.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 45.82 41.23 7.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.549 1.14 . . . . 0.0 111.655 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.1 59.44 10.7 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -47.43 -34.41 19.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.421 3.414 . . . . 0.0 113.713 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -51.67 -38.87 56.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 110.7 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 15.7 4.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.453 0.701 . . . . 0.0 112.113 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -134.66 -40.28 0.79 Allowed 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.011 0.823 . . . . 0.0 111.485 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -40.41 -46.71 2.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.998 1.319 . . . . 0.0 112.505 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.58 -26.41 50.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 113.195 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -75.28 159.33 82.5 Favored Pre-proline 0 CA--C 1.534 0.347 0 O-C-N 121.576 -0.703 . . . . 0.0 109.976 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.07 121.43 10.05 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.839 1.693 . . . . 0.0 109.677 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -64.56 -39.16 93.24 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 109.634 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 m -50.72 102.51 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.142 1.777 . . . . 0.0 112.036 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.7 -40.19 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.302 1.041 . . . . 0.0 109.964 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.73 -35.29 65.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.798 0.839 . . . . 0.0 112.253 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -77.74 -48.2 17.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.01 -43.6 70.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 122.879 0.472 . . . . 0.0 111.612 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 49' ' ' LEU . 11.0 p -60.41 -44.29 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.911 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.15 -46.22 79.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.746 1.157 . . . . 0.0 109.652 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -54.23 -37.77 64.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.042 0.383 . . . . 0.0 111.392 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -68.0 -50.39 55.87 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.614 0.766 . . . . 0.0 109.357 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.02 -42.42 94.34 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 120.158 1.345 . . . . 0.0 111.472 177.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.11 -38.49 78.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.044 0.538 . . . . 0.0 111.981 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.98 155.32 29.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -155.48 135.17 12.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.66 -118.44 13.83 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.59 -3.32 46.59 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.694 0.798 . . . . 0.0 112.242 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.0 ttp -68.1 122.02 82.36 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 119.259 0.936 . . . . 0.0 110.595 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.29 153.12 55.49 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.034 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 112.62 6.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -71.32 -3.07 18.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.26 110.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 0.0 111.072 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.82 -11.27 62.54 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.345 0.974 . . . . 0.0 114.596 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -76.1 -47.94 22.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.044 1.422 . . . . 0.0 109.906 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -139.64 156.23 46.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.56 140.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 45' ' ' VAL . 26.3 ttt180 -32.83 -44.21 0.1 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.577 1.951 . . . . 0.0 112.436 172.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.78 -47.8 83.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.811 1.187 . . . . 0.0 111.197 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.4 -56.77 16.96 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 122.902 1.334 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 62' ' ' ALA . 79.3 mt -48.08 -57.27 6.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.857 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.19 -53.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.892 1.277 . . . . 0.0 109.919 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -57.87 -38.91 76.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.498 0.319 . . . . 0.0 111.258 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.13 81.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.915 -0.49 . . . . 0.0 109.896 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.4 mt -66.7 -52.61 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.613 0.765 . . . . 0.0 109.991 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.29 -39.7 76.27 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.234 0.924 . . . . 0.0 109.086 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.14 -52.73 64.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.128 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 ptm -54.44 -43.35 71.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.611 0.641 . . . . 0.0 109.346 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.6 mt -65.15 -35.18 80.28 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.476 -0.765 . . . . 0.0 110.763 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 m -74.83 37.93 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.009 -1.057 . . . . 0.0 112.634 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -148.59 24.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.582 1.153 . . . . 0.0 109.918 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.252 1.232 0 CA-C-O 116.148 -1.882 . . . . 0.0 107.132 -177.439 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.23 -57.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.842 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -57.64 -52.15 66.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.888 0.475 . . . . 0.0 111.623 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.57 -46.34 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.557 -173.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.57 38.81 0.33 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.298 0.954 . . . . 0.0 113.04 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.75 40.33 1.09 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -137.25 156.94 47.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.436 1.895 . . . . 0.0 107.841 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 106.64 5.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.861 0.864 . . . . 0.0 108.904 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.83 152.85 24.35 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 120.378 1.171 . . . . 0.0 112.142 -7.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.38 123.79 19.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -51.0 62.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.912 0.885 . . . . 0.0 111.439 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 p -40.88 -54.41 2.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.447 1.899 . . . . 0.0 111.872 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.91 -38.74 1.64 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.61 1.164 . . . . 0.0 113.094 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -98.43 -57.15 2.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.964 0.347 . . . . 0.0 111.49 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -73.71 -19.47 60.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -172.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.37 -53.57 18.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.535 1.061 . . . . 0.0 108.989 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -79.98 -31.13 39.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.467 0.307 . . . . 0.0 111.052 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.5 42.85 5.69 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.26 142.81 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.37 28.62 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.066 0.947 . . . . 0.0 111.502 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.95 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.715 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 134.14 87.54 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.738 1.269 . . . . 0.0 108.377 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.78 115.76 3.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.701 2.267 . . . . 0.0 108.258 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -86.16 179.08 7.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.901 0.857 . . . . 0.0 113.215 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.23 159.94 22.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 34.61 52.38 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.545 1.538 . . . . 0.0 112.565 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.9 61.96 31.28 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.317 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.73 -46.76 6.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.045 3.163 . . . . 0.0 114.683 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -49.88 -39.99 41.37 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.822 1.249 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.67 -15.45 61.7 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.873 0.869 . . . . 0.0 112.463 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -110.94 -25.57 9.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.508 1.123 . . . . 0.0 112.294 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.05 -46.26 0.48 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.921 2.088 . . . . 0.0 114.433 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.39 -5.57 32.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -81.48 154.96 71.63 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 121.483 -0.761 . . . . 0.0 110.211 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.52 115.6 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.072 2.515 . . . . 0.0 111.462 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -60.72 -34.03 73.77 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.26 99.96 0.07 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.754 2.022 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.2 t -53.33 -38.44 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.616 -0.677 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.29 -26.2 51.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 112.415 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.13 -50.81 5.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -49.02 -41.01 33.23 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.694 0.798 . . . . 0.0 112.117 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.85 -30.4 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.533 -0.729 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.29 -49.62 68.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -50.99 -46.29 61.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.619 0.767 . . . . 0.0 109.796 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 m -60.68 -51.9 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.05 -45.46 93.46 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.245 -0.909 . . . . 0.0 111.456 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 -32.37 63.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.833 0.853 . . . . 0.0 112.369 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 161.01 27.8 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.45 115.1 2.49 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.962 -0.728 . . . . 0.0 109.163 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.62 -116.95 9.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.25 -24.58 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.371 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.38 121.18 75.57 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.946 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 165.26 29.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.711 2.274 . . . . 0.0 109.781 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.78 134.03 48.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.79 -14.77 20.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.125 0.97 . . . . 0.0 112.326 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.77 101.02 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.269 1.028 . . . . 0.0 112.539 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.48 -37.28 3.77 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.009 1.29 . . . . 0.0 111.481 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -77.02 -36.45 56.25 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-N 117.756 0.778 . . . . 0.0 109.913 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.8 149.11 50.87 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.29 130.45 37.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -31.69 -44.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.029 2.132 . . . . 0.0 112.818 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.46 -48.95 75.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.684 1.129 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.76 -47.93 81.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.012 0.925 . . . . 0.0 108.797 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 62' ' ' ALA . 37.4 mt -51.86 -55.91 17.2 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.037 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -45.2 -57.81 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.211 1.004 . . . . 0.0 109.271 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -56.36 -39.8 73.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 118.483 0.583 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.97 95.01 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.722 -0.611 . . . . 0.0 110.073 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.73 -47.76 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -53.47 -52.46 59.44 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -54.56 -52.15 63.01 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.56 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.19 -50.57 64.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.13 -30.12 71.2 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.945 -0.472 . . . . 0.0 110.997 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.1 m -74.25 40.59 0.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.073 -1.017 . . . . 0.0 112.782 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.5 p -135.43 -10.92 2.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 109.827 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.7 -1.619 . . . . 0.0 110.25 -177.839 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.29 -50.51 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.408 1.083 . . . . 0.0 110.483 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -68.29 -46.39 70.46 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.694 0.397 . . . . 0.0 110.398 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.85 -42.11 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.958 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 32.47 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.24 14.85 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.096 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -97.89 168.8 10.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.644 0.778 . . . . 0.0 111.497 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.5 115.53 25.18 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.0 1.32 . . . . 0.0 107.822 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.51 169.66 35.43 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.609 1.253 . . . . 0.0 110.057 -10.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -78.25 149.68 33.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 m -61.87 -44.54 96.6 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -50.56 -47.41 57.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.086 1.355 . . . . 0.0 111.651 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -42.64 -40.35 2.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.782 0.719 . . . . 0.0 112.167 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.8 m -98.29 -57.93 2.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.468 0.175 . . . . 0.0 111.188 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -62.2 -40.38 95.89 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.47 -29.77 64.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.138 0.426 . . . . 0.0 111.107 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -115.61 17.73 16.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.708 0.803 . . . . 0.0 111.681 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 48.09 40.23 20.55 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 123.899 0.761 . . . . 0.0 113.8 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.94 135.49 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.082 -0.658 . . . . 0.0 109.381 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 31.31 7.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.756 1.223 . . . . 0.0 111.806 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.55 23.38 77.09 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.667 -0.518 . . . . 0.0 112.628 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.73 140.77 75.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.222 1.011 . . . . 0.0 108.791 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -58.27 119.44 6.69 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.489 2.126 . . . . 0.0 107.81 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.52 167.58 19.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.832 1.301 . . . . 0.0 111.26 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mp -77.01 162.26 27.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.873 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.23 53.56 1.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.939 1.296 . . . . 0.0 110.601 -176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.92 64.93 11.75 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.006 1.723 . . . . 0.0 109.427 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -39.12 -55.46 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.588 3.525 . . . . 0.0 114.358 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -44.71 -45.44 9.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.01 1.324 . . . . 0.0 112.281 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -53.76 -39.16 65.12 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.463 0.705 . . . . 0.0 110.762 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -92.88 -29.9 15.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.846 0.859 . . . . 0.0 111.169 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.19 98.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 109.617 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.99 -41.75 97.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 110.326 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -76.36 164.15 61.69 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.683 1.193 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.0 88.66 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 107.539 -1.754 . . . . 0.0 107.539 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -51.98 -22.2 3.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.293 1.437 . . . . 0.0 112.463 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -56.77 108.3 0.48 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.287 1.035 . . . . 0.0 110.453 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.53 -46.33 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.736 1.214 . . . . 0.0 110.047 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.89 -36.83 3.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.201 2.2 . . . . 0.0 112.335 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.21 -52.74 4.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.298 1.039 . . . . 0.0 109.182 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -44.72 -45.93 10.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.773 0.829 . . . . 0.0 112.634 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 67' ' ' LEU . 19.2 m -61.35 -34.31 60.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 O-C-N 121.348 -0.845 . . . . 0.0 111.585 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.2 -47.18 71.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 m -53.5 -46.26 69.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.06 0.544 . . . . 0.0 110.051 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -62.17 -52.02 65.48 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.982 0.513 . . . . 0.0 111.345 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -40.48 84.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.56 -0.713 . . . . 0.0 109.698 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.43 76.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.145 0.578 . . . . 0.0 111.617 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.52 154.99 24.26 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -158.38 125.64 4.98 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.45 -137.67 49.15 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.06 -16.88 64.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.624 -0.788 . . . . 0.0 111.997 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.42 117.28 51.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.652 1.115 . . . . 0.0 109.801 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.32 155.06 64.91 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.441 2.094 . . . . 0.0 109.951 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.11 133.58 55.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.65 6.58 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.951 0.9 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -40.69 108.84 0.1 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.243 1.817 . . . . 0.0 112.688 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.28 -20.27 5.02 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.529 0.585 . . . . 0.0 113.021 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -76.37 -44.3 36.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.72 25.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.73 152.61 33.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -23.16 -52.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.219 2.208 . . . . 0.0 111.692 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -60.54 -56.68 18.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.351 0.523 . . . . 0.0 111.811 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.67 -49.89 69.53 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.411 1.084 . . . . 0.0 109.687 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' HB3' HG12 ' A' ' 45' ' ' VAL . 71.0 mt -52.13 -58.6 6.09 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.291 1.436 . . . . 0.0 110.057 178.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.16 -58.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.753 0.821 . . . . 0.0 109.509 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.08 -26.1 62.12 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.17 1.388 . . . . 0.0 113.068 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 -59.39 2.72 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 mt -51.17 -44.53 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.643 1.177 . . . . 0.0 111.459 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -53.86 -37.85 64.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.865 0.757 . . . . 0.0 110.708 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.95 -44.21 90.16 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.996 0.816 . . . . 0.0 109.664 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.7 mtp -53.55 -58.39 7.34 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.3 -36.79 66.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.688 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -62.49 -10.36 11.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.388 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -89.01 -9.02 52.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.462 1.483 . . . . 0.0 111.158 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 116.554 -1.689 . . . . 0.0 111.033 -176.288 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -50.65 -60.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.51 -52.56 63.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.241 1.416 . . . . 0.0 112.027 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.1 mt -67.84 -47.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.015 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.04 11.94 0.3 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.49 34.55 5.52 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.629 1.104 . . . . 0.0 111.591 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.21 157.64 45.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.486 1.514 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.58 107.75 9.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.207 1.003 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.16 159.17 68.99 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.172 1.097 . . . . 0.0 110.053 -8.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -68.13 118.55 11.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.06 1.344 . . . . 0.0 110.429 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 m -46.49 -48.56 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.981 0.913 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -45.46 -44.73 12.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.979 1.712 . . . . 0.0 112.547 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -53.2 -26.16 16.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.016 0.526 . . . . 0.0 112.255 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -104.02 -58.26 1.91 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.097 0.408 . . . . 0.0 109.941 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -66.89 -35.52 80.2 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.67 -41.67 75.18 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.102 0.865 . . . . 0.0 109.834 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -80.57 -28.7 37.11 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.097 0.559 . . . . 0.0 111.513 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.27 38.71 7.64 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.04 125.53 11.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.51 32.77 9.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.031 0.932 . . . . 0.0 111.128 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.41 76.95 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.941 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.45 113.33 5.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.57 1.185 . . . . 0.0 108.591 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 66.0 Cg_exo -36.32 116.79 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 125.014 3.809 . . . . 0.0 114.493 -175.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.39 173.69 10.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 111.701 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.58 159.52 32.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 49.43 29.71 2.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.848 0.859 . . . . 0.0 112.119 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.07 61.53 33.43 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.989 0.916 . . . . 0.0 110.954 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -45.35 -42.35 17.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.72 2.947 . . . . 0.0 112.799 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.36 -39.67 32.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 112.198 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -67.97 -25.07 65.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.125 0.57 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 86.3 m95 -105.52 -23.37 12.81 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.453 1.101 . . . . 0.0 112.893 -173.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -51.25 0.72 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.548 1.939 . . . . 0.0 113.582 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.71 -22.08 43.79 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -77.14 151.69 81.61 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.875 0.87 . . . . 0.0 110.206 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.3 125.28 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.675 1.583 . . . . 0.0 108.768 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -62.58 -29.63 70.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.797 -0.565 . . . . 0.0 110.35 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -56.01 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.986 1.714 . . . . 0.0 111.945 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.09 -42.39 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.304 1.441 . . . . 0.0 109.411 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.41 -37.43 11.42 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.386 2.274 . . . . 0.0 112.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.42 -50.86 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.1 mt -47.71 -42.16 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.88 0.872 . . . . 0.0 112.401 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.94 -32.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.16 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.58 -50.03 68.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -51.26 -47.33 62.49 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.599 0.76 . . . . 0.0 109.908 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.1 m -61.73 -49.54 75.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.74 -45.52 93.59 Favored 'General case' 0 N--CA 1.458 -0.063 0 O-C-N 121.132 -0.98 . . . . 0.0 111.143 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.51 -31.16 65.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.944 0.897 . . . . 0.0 112.289 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.01 160.71 29.53 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -155.51 108.86 2.77 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.964 -0.727 . . . . 0.0 109.327 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.01 -113.95 5.88 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.69 -30.19 64.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.688 0.395 . . . . 0.0 111.0 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.1 ttp -63.62 120.35 62.12 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.913 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.57 156.66 44.94 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.843 2.362 . . . . 0.0 110.01 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.71 135.1 56.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -100.46 -13.89 18.51 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 113.329 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.97 102.79 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 112.148 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.38 -38.97 3.03 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.126 1.346 . . . . 0.0 111.537 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -76.79 -39.74 50.47 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 117.68 0.74 . . . . 0.0 110.112 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.5 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.43 130.54 30.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -79.72 146.72 32.23 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -27.93 -53.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.377 170.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -41.94 96.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.134 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.49 -59.58 5.17 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 62' ' ' ALA . 76.4 mt -46.07 -58.66 3.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.495 1.518 . . . . 0.0 111.004 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -39.34 -51.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.812 2.045 . . . . 0.0 111.149 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -58.06 -45.57 86.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.703 0.801 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -47.69 78.15 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.407 -0.808 . . . . 0.0 109.826 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.9 mt -56.98 -52.16 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.876 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.41 -39.98 92.72 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.984 -1.072 . . . . 0.0 109.28 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -57.08 -49.5 75.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.418 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.5 mtt -48.13 -63.62 1.02 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.17 0.986 . . . . 0.0 108.649 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mp -49.83 -41.55 45.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.669 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -62.17 -10.94 11.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 p -90.1 -13.38 35.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.195 1.362 . . . . 0.0 111.207 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.6 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.566 -174.826 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.14 -57.07 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.795 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -56.18 -50.46 71.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.307 1.043 . . . . 0.0 111.651 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.72 -46.9 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.859 -174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.11 36.38 0.29 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 33.17 2.28 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.845 0.748 . . . . 0.0 111.252 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 155.68 48.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.687 1.995 . . . . 0.0 107.189 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.01 108.23 18.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -62.52 166.07 37.45 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.216 1.113 . . . . 0.0 109.341 -11.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -67.54 136.09 53.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 m -49.7 -43.48 47.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 0.687 . . . . 0.0 109.426 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.8 p -47.21 -41.44 18.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.066 1.347 . . . . 0.0 112.561 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.1 m -46.2 -39.16 9.31 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.3 0.64 . . . . 0.0 111.316 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -102.96 -52.33 3.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -72.0 -27.5 62.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.39 -47.08 62.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -68.17 -41.87 80.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.203 1.001 . . . . 0.0 110.367 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 34.81 13.08 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.57 145.55 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.68 32.24 6.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.22 1.008 . . . . 0.0 111.576 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.58 24.43 73.9 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.34 126.62 75.01 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.818 1.309 . . . . 0.0 108.038 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.85 116.51 3.4 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.628 2.219 . . . . 0.0 108.294 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -74.68 -149.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.516 1.127 . . . . 0.0 111.433 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.63 145.78 51.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.496 1.518 . . . . 0.0 107.474 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' OXT' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 49.14 48.13 21.23 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -168.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.42 51.78 1.41 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.341 2.257 . . . . 0.0 111.499 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -47.89 -34.97 23.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.336 3.358 . . . . 0.0 113.807 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -50.33 -40.13 48.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.917 1.287 . . . . 0.0 110.966 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.22 -5.67 52.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 73.2 m95 -107.96 -44.99 4.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.58 46.03 26.05 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.913 0.863 . . . . 0.0 110.236 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.86 53.11 2.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 0.0 112.216 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -57.04 157.29 11.55 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.33 101.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.73 2.286 . . . . 0.0 111.073 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -59.05 -23.69 62.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.457 1.103 . . . . 0.0 111.989 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -55.07 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.71 1.604 . . . . 0.0 110.721 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -43.59 -41.47 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.279 1.431 . . . . 0.0 109.709 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -42.5 -38.02 1.81 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.345 2.258 . . . . 0.0 112.609 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.13 -50.53 5.79 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.636 0.774 . . . . 0.0 110.17 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -51.09 -40.48 58.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.426 0.69 . . . . 0.0 111.844 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.02 -34.41 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.695 -0.628 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.09 -44.04 81.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.7 m -54.46 -44.99 73.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -67.01 -45.09 78.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.027 0.531 . . . . 0.0 110.889 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 O-C-N 121.259 -0.9 . . . . 0.0 110.68 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.39 51.79 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.416 1.086 . . . . 0.0 112.697 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 161.47 30.57 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -161.57 117.79 2.13 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.083 -0.657 . . . . 0.0 109.319 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.41 -118.06 13.51 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.34 -25.34 51.0 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.209 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.5 ttp -62.22 118.68 42.21 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.178 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.46 160.52 46.58 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.509 2.139 . . . . 0.0 110.065 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.8 116.73 8.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -82.49 -7.46 59.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.676 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -55.9 88.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.931 0.892 . . . . 0.0 112.091 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 -41.9 1.44 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 110.572 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -75.55 -35.27 60.72 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.393 0.677 . . . . 0.0 110.384 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -143.72 130.72 20.54 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.57 149.66 32.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -32.04 -47.49 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.124 1.77 . . . . 0.0 111.494 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.68 -49.16 77.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.838 0.745 . . . . 0.0 111.66 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.43 -56.34 22.38 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 122.556 1.169 . . . . 0.0 108.791 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 80.5 mt -48.68 -60.71 2.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -43.29 -51.72 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.887 1.675 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -59.21 -33.87 71.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.395 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.14 13.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.781 0.719 . . . . 0.0 109.39 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.4 mt -54.76 -45.77 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.121 0.968 . . . . 0.0 111.279 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.66 -41.39 90.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.036 1.289 . . . . 0.0 110.599 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.63 -54.14 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 ttm -45.75 -55.06 6.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.121 1.368 . . . . 0.0 109.782 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.85 -26.62 58.86 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.239 0.615 . . . . 0.0 112.535 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -79.83 10.49 4.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.83 0.741 . . . . 0.0 112.372 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -177.05 54.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.736 ' OXT' HD12 ' A' ' 78' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.73 -55.46 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.24 -48.44 78.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.167 0.987 . . . . 0.0 111.872 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.24 -51.73 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.538 -175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.85 8.69 0.37 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -173.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.39 4.42 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 119.795 1.18 . . . . 0.0 111.253 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -137.82 156.18 48.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.793 1.637 . . . . 0.0 108.155 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.0 110.79 10.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.761 0.825 . . . . 0.0 110.596 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.09 160.77 15.66 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 CA-C-N 119.915 1.005 . . . . 0.0 111.851 -15.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -70.34 114.9 8.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.355 1.062 . . . . 0.0 108.982 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -44.54 -48.27 10.23 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.19 0.996 . . . . 0.0 111.324 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -43.76 -47.93 8.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.374 1.87 . . . . 0.0 112.184 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -49.46 -34.6 17.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 m -96.7 -58.03 2.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.63 0.252 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -67.4 -36.36 81.14 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.26 -41.37 85.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -30.13 56.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.667 0.787 . . . . 0.0 110.572 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.47 40.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.4 136.95 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.02 28.21 5.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.119 0.968 . . . . 0.0 111.471 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 24.76 76.67 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.955 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.76 132.96 47.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.903 1.351 . . . . 0.0 108.422 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -49.48 104.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.958 3.106 . . . . 0.0 110.917 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -75.24 176.23 7.57 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.514 1.149 . . . . 0.0 109.666 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.4 142.43 27.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.14 33.11 12.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.348 0.659 . . . . 0.0 109.461 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.66 55.87 17.72 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.641 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -37.09 -46.57 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.486 3.457 . . . . 0.0 114.242 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -41.47 -45.36 3.17 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.046 1.338 . . . . 0.0 112.738 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -76.84 -25.05 52.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.679 0.672 . . . . 0.0 112.261 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -91.08 -23.49 20.3 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.411 0.684 . . . . 0.0 111.429 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -47.39 0.53 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.32 2.248 . . . . 0.0 114.355 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -91.33 -14.37 30.87 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.428 0.691 . . . . 0.0 112.852 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -78.59 147.58 71.72 Favored Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 123.839 0.856 . . . . 0.0 109.731 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.15 110.3 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.844 1.696 . . . . 0.0 108.573 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.34 -27.47 47.4 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.135 0.574 . . . . 0.0 112.007 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 109.24 0.36 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.844 1.658 . . . . 0.0 111.482 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.3 t -51.95 -42.07 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.86 -20.96 40.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -93.64 -53.85 3.88 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.8 mt -47.65 -41.72 22.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.62 0.768 . . . . 0.0 112.163 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.71 -37.1 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 121.688 -0.632 . . . . 0.0 110.41 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.7 -48.26 75.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -52.3 -46.04 65.78 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.811 0.845 . . . . 0.0 110.4 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -67.82 -40.97 83.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.058 0.543 . . . . 0.0 111.216 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.09 -56.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.37 61.72 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.567 1.147 . . . . 0.0 112.354 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.75 152.76 25.24 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -151.76 142.75 23.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -90.37 0.08 OUTLIER Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.98 16.0 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.365 1.466 . . . . 0.0 112.058 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.0 mtm -67.89 134.78 92.02 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 119.29 0.95 . . . . 0.0 110.847 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.42 78.42 3.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.99 2.46 . . . . 0.0 108.784 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -10.08 106.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 128.315 2.646 . . . . 0.0 112.403 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -76.21 -6.65 52.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -47.29 114.83 0.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.557 0.743 . . . . 0.0 111.272 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.12 -26.95 21.45 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.206 0.908 . . . . 0.0 112.717 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -90.28 -52.44 4.93 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.514 1.157 . . . . 0.0 110.349 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -112.57 133.79 54.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.06 147.42 31.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -32.23 -45.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.38 1.872 . . . . 0.0 111.546 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.0 -47.18 84.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.211 0.914 . . . . 0.0 111.667 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.94 -58.65 7.23 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 122.577 1.179 . . . . 0.0 108.738 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.8 mt -47.14 -57.37 5.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.406 1.882 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -46.24 -57.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 124.844 1.257 . . . . 0.0 109.713 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.78 -43.65 81.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.802 0.274 . . . . 0.0 111.441 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.25 72.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.6 mt -57.75 -47.33 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.251 1.42 . . . . 0.0 109.463 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.26 -51.69 65.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -55.95 -50.8 69.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.361 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 79.0 mtp -51.84 -53.46 40.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.291 0.636 . . . . 0.0 109.987 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.78 -37.44 73.71 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.577 0.751 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.3 m -72.67 41.18 0.09 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.3 p -135.64 -16.35 1.78 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.36 1.864 . . . . 0.0 110.014 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.033 -178.126 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 119.969 -0.062 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.33 -59.59 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.296 1.438 . . . . 0.0 109.197 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.32 -51.42 70.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 111.349 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 mm -65.73 -46.02 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.816 0.446 . . . . 0.0 111.065 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.13 44.03 0.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.97 36.67 1.21 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.44 157.27 46.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.732 2.013 . . . . 0.0 107.47 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.92 113.49 6.41 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.802 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.73 152.5 19.71 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 CA-C-N 120.321 1.15 . . . . 0.0 111.065 -13.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.31 125.17 24.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.609 1.164 . . . . 0.0 109.775 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -54.74 -51.05 66.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -39.54 -61.06 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.509 1.923 . . . . 0.0 112.214 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.0 m -41.51 -39.62 1.6 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.441 1.497 . . . . 0.0 113.387 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.46 -56.82 2.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.045 0.45 . . . . 0.0 110.923 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -60.67 -41.18 94.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -48.31 -40.93 26.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.668 0.787 . . . . 0.0 112.109 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -116.43 26.08 10.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.991 0.516 . . . . 0.0 111.863 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.21 43.08 18.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.566 0.603 . . . . 0.0 113.54 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.25 136.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.69 30.36 8.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.549 1.14 . . . . 0.0 111.676 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.0 23.49 74.45 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.6 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.01 142.91 84.88 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 118.459 1.129 . . . . 0.0 109.323 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -59.78 121.53 9.98 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 106.848 -2.02 . . . . 0.0 106.848 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.47 176.76 7.23 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.671 1.7 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.5 tp -97.46 140.46 31.87 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.518 -2.128 . . . . 0.0 107.525 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 64.59 35.98 8.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.353 0.661 . . . . 0.0 109.459 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.62 71.26 81.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.467 1.107 . . . . 0.0 111.233 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -41.0 -57.99 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 124.344 3.363 . . . . 0.0 114.456 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -43.53 -47.92 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.154 1.381 . . . . 0.0 112.164 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.26 -39.56 63.96 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 110.972 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -91.03 -29.89 17.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.318 0.647 . . . . 0.0 111.073 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.0 97.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.359 0.663 . . . . 0.0 109.396 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.56 -41.86 96.05 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -77.29 164.68 57.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.586 1.154 . . . . 0.0 111.085 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -67.82 89.8 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 N-CA-C 107.632 -1.719 . . . . 0.0 107.632 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -21.96 7.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.702 1.201 . . . . 0.0 112.322 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.94 109.5 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.434 1.893 . . . . 0.0 110.932 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.13 -44.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.251 1.02 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.41 -29.09 61.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.009 1.724 . . . . 0.0 112.606 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.81 -55.35 3.89 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 mt -45.61 -44.36 13.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.833 1.253 . . . . 0.0 112.994 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.89 -37.33 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 O-C-N 121.722 -0.611 . . . . 0.0 110.607 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -65.58 -47.24 76.44 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.192 0.905 . . . . 0.0 108.905 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -53.04 -46.6 68.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.386 0.674 . . . . 0.0 110.259 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -64.13 -46.45 84.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.002 0.521 . . . . 0.0 110.356 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -57.06 -54.41 47.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.791 -0.568 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.48 64.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.22 1.008 . . . . 0.0 112.988 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.61 160.27 33.12 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -157.68 126.36 5.65 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.861 -0.787 . . . . 0.0 109.05 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.0 -120.68 22.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.92 -14.44 54.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.746 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.2 ttp -71.69 118.23 64.67 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 119.166 0.894 . . . . 0.0 108.716 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.23 160.56 48.56 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.389 2.059 . . . . 0.0 110.611 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.2 133.14 53.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -101.65 -11.55 19.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.615 0.766 . . . . 0.0 111.363 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -46.37 117.53 1.62 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.364 1.065 . . . . 0.0 111.558 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.52 -25.0 11.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.267 0.937 . . . . 0.0 112.34 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -86.35 -47.38 9.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.86 0.83 . . . . 0.0 108.865 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -110.08 142.24 41.82 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -80.36 131.03 35.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -28.35 -49.88 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.205 2.202 . . . . 0.0 112.659 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -61.28 -49.04 78.66 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.82 -0.55 . . . . 0.0 111.225 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.35 86.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 123.93 0.892 . . . . 0.0 109.141 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 62' ' ' ALA . 40.9 mt -51.63 -58.99 4.79 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.64 -54.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.158 1.383 . . . . 0.0 110.484 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -56.72 -45.55 81.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.139 0.427 . . . . 0.0 111.333 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.34 98.43 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.798 -0.564 . . . . 0.0 110.179 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.2 -55.85 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 109.268 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -59.26 -38.86 81.12 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.643 1.11 . . . . 0.0 109.773 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.53 -49.81 76.34 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttp -53.52 -54.27 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.7 mt -56.36 -38.97 72.13 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.619 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -61.42 -6.5 2.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.882 1.219 . . . . 0.0 113.951 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.0 p -86.75 -5.28 59.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.725 1.148 . . . . 0.0 110.684 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.224 -1.37 . . . . 0.0 110.688 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.39 -55.95 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 109.6 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -56.66 -50.48 71.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.914 0.886 . . . . 0.0 111.607 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.46 -45.29 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.131 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.91 36.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.04 33.0 2.22 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.98 157.45 46.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.271 2.228 . . . . 0.0 106.408 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.49 113.19 6.62 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.755 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -50.08 153.73 7.78 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 120.522 1.222 . . . . 0.0 110.752 -15.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.2 p -67.01 144.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -56.25 -38.89 71.75 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.076 0.853 . . . . 0.0 108.906 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -56.28 -23.27 35.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 112.8 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.0 m -57.48 -28.32 63.3 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.488 1.04 . . . . 0.0 110.628 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.2 m -122.54 -52.31 1.93 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -70.09 -20.35 63.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.21 -52.12 65.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.818 0.735 . . . . 0.0 109.869 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -91.47 -22.95 20.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 111.339 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 42.15 8.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.35 146.6 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.51 30.17 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.081 0.952 . . . . 0.0 111.417 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.4 79.96 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.027 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.95 135.61 90.31 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.873 1.336 . . . . 0.0 108.272 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 39.3 Cg_endo -60.31 128.83 27.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.459 2.106 . . . . 0.0 109.915 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -89.02 171.44 9.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.264 1.031 . . . . 0.0 112.937 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.48 156.42 36.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.891 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 52.32 36.56 20.03 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.889 0.876 . . . . 0.0 111.265 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.37 65.52 68.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.842 -175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -39.74 -47.03 3.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 124.324 3.349 . . . . 0.0 114.428 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -51.11 -39.59 56.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.865 1.266 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.49 -21.88 66.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.426 0.69 . . . . 0.0 111.733 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.402 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.1 m95 -108.58 -30.73 8.09 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.4 1.08 . . . . 0.0 112.903 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.49 -50.79 1.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.728 1.611 . . . . 0.0 113.048 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 -24.51 50.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.92 143.85 67.14 Favored Pre-proline 0 CA--C 1.535 0.381 0 O-C-N 121.529 -0.732 . . . . 0.0 110.276 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.79 96.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.675 2.25 . . . . 0.0 108.895 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -55.78 -26.88 48.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.815 1.246 . . . . 0.0 112.943 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 m -50.0 104.28 0.07 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.827 1.651 . . . . 0.0 111.48 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.14 -44.07 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.167 1.387 . . . . 0.0 111.54 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.18 -31.86 67.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.183 0.593 . . . . 0.0 112.045 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -81.63 -48.01 12.28 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.67 -41.3 61.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 m -59.94 -34.18 55.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.87 -48.48 81.6 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.531 1.514 . . . . 0.0 109.057 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.69 -42.21 67.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.795 0.838 . . . . 0.0 111.205 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -70.39 -44.57 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.384 0.673 . . . . 0.0 110.334 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -64.18 -50.66 67.25 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 124.795 1.238 . . . . 0.0 109.751 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.12 61.59 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.201 1.001 . . . . 0.0 112.214 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 158.53 31.48 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -157.15 118.34 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.013 -0.698 . . . . 0.0 109.482 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 -117.77 12.28 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.39 -23.13 54.06 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.744 0.418 . . . . 0.0 111.461 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.4 ttp -66.41 118.49 54.04 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.466 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.34 154.38 56.13 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.481 2.121 . . . . 0.0 109.954 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.84 123.36 17.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.827 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -92.28 -11.9 33.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.967 0.803 . . . . 0.0 111.756 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -44.26 116.01 0.94 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.062 0.945 . . . . 0.0 112.037 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -26.36 9.73 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.154 0.883 . . . . 0.0 112.4 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -83.91 -44.75 13.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -111.23 146.39 37.04 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.55 132.58 34.91 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -31.96 -44.32 0.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.141 1.776 . . . . 0.0 112.64 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -57.02 -44.62 83.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.819 1.191 . . . . 0.0 111.645 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -54.03 -57.76 9.84 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.17 0.986 . . . . 0.0 108.531 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.7 mt -50.34 -59.12 4.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.545 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.0 t -43.38 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.445 1.098 . . . . 0.0 109.687 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.36 -40.79 97.58 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 122.11 -0.369 . . . . 0.0 111.815 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.88 97.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.0 mt -65.22 -48.13 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.105 0.962 . . . . 0.0 109.111 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.27 -51.73 51.5 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.59 -53.73 54.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.107 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ptm -55.66 -47.34 76.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.507 0.594 . . . . 0.0 109.68 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.73 -38.52 90.83 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.832 -0.542 . . . . 0.0 110.449 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.2 m -61.71 -5.4 1.92 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.5 p -88.38 -16.31 33.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.207 1.367 . . . . 0.0 111.19 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.657 -1.64 . . . . 0.0 110.601 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mt -58.23 -49.23 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -68.05 -44.72 75.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.967 0.907 . . . . 0.0 110.743 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.9 mt -69.32 -50.97 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.311 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.2 -9.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -171.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.2 -40.18 42.37 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 119.847 1.203 . . . . 0.0 111.131 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -72.57 158.59 35.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.76 111.88 5.78 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.439 1.096 . . . . 0.0 109.792 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 151.34 12.04 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.249 1.125 . . . . 0.0 110.86 -13.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 p -66.3 134.35 52.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -51.4 -41.41 60.7 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.63 0.729 . . . . 0.0 109.334 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 p -50.93 -37.05 41.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 112.814 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -44.75 -39.28 5.07 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.876 0.762 . . . . 0.0 111.407 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.7 m -107.04 -56.31 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.514 0.725 . . . . 0.0 110.439 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -62.7 -26.83 68.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.46 -1.52 53.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.69 0.677 . . . . 0.0 111.026 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -127.35 -17.69 4.64 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.925 0.89 . . . . 0.0 111.65 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.56 27.17 65.9 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.597 -0.69 . . . . 0.0 111.488 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.87 141.64 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.38 27.76 5.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 111.575 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.47 74.49 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.65 129.2 80.91 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.595 1.198 . . . . 0.0 108.311 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -64.54 123.56 11.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.24 1.96 . . . . 0.0 109.269 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.29 -179.53 5.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.703 0.763 . . . . 0.0 113.053 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.67 159.57 34.16 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 48.06 32.34 2.89 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 112.356 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.16 61.85 59.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.406 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -37.24 -49.11 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.456 3.437 . . . . 0.0 114.01 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.02 -43.78 9.52 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.245 1.418 . . . . 0.0 111.951 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.01 -27.0 67.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.747 0.819 . . . . 0.0 111.924 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -103.62 -18.55 14.69 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.689 1.195 . . . . 0.0 112.429 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -47.05 0.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.407 1.883 . . . . 0.0 114.013 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -9.84 30.16 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -81.27 131.57 58.54 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.62 109.79 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.959 2.439 . . . . 0.0 110.888 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -56.59 -26.26 54.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.764 0.826 . . . . 0.0 112.446 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -49.43 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.31 1.844 . . . . 0.0 111.618 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.0 t -48.47 -38.56 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.67 0.788 . . . . 0.0 110.715 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.01 -44.01 82.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.844 0.458 . . . . 0.0 111.383 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -68.71 -45.96 70.19 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -56.51 -44.51 80.83 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.448 0.299 . . . . 0.0 111.553 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.12 -36.26 77.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -52.66 64.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.951 0.796 . . . . 0.0 109.798 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 m -51.17 -43.26 61.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.908 0.883 . . . . 0.0 111.106 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -69.12 -44.0 73.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.933 0.493 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.26 -52.5 64.47 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.337 -0.852 . . . . 0.0 109.947 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.5 77.91 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.677 0.791 . . . . 0.0 110.905 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.26 87.14 1.43 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.542 1.068 . . . . 0.0 110.867 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -77.79 146.58 35.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.652 1.181 . . . . 0.0 109.82 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.83 -110.85 3.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.24 9.49 28.01 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.684 1.193 . . . . 0.0 111.903 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 42.8 mtm -71.25 137.83 84.25 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 119.172 0.896 . . . . 0.0 111.627 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.52 139.37 69.98 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 N-CA-C 106.961 -1.977 . . . . 0.0 106.961 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 114.99 3.67 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -80.82 -8.74 59.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.846 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -51.7 112.15 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.94 0.791 . . . . 0.0 110.609 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.83 -26.14 10.25 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.945 0.783 . . . . 0.0 111.916 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -74.6 -44.19 51.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.435 1.094 . . . . 0.0 108.696 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.512 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -126.99 157.11 40.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.79 1.236 . . . . 0.0 108.338 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.47 129.82 35.35 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -33.6 -43.81 0.13 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.532 1.933 . . . . 0.0 112.046 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.86 -48.82 80.05 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.401 1.0 . . . . 0.0 111.522 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -48.81 78.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.8 mt -50.8 -58.73 5.22 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.127 0.489 . . . . 0.0 109.693 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 t -47.36 -56.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.796 1.239 . . . . 0.0 109.823 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -57.12 -40.38 76.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.873 0.469 . . . . 0.0 111.72 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.62 93.98 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.36 -46.77 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -53.78 -51.42 63.48 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -54.17 -54.11 44.27 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.306 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.3 mtp -49.33 -60.03 3.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.407 0.683 . . . . 0.0 109.394 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.13 -39.15 66.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.54 0.736 . . . . 0.0 111.678 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -62.82 -9.01 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.321 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -88.8 -14.1 37.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.17 1.35 . . . . 0.0 110.932 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.122 -175.631 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.526 0.679 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.91 -53.37 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -59.52 -45.43 91.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.905 0.32 . . . . 0.0 111.67 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.76 -52.82 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.375 0.67 . . . . 0.0 112.035 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -133.23 -18.6 2.26 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.4 -32.34 43.03 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.916 1.235 . . . . 0.0 112.845 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 150.45 45.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.583 0.692 . . . . 0.0 110.687 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.73 111.89 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.021 1.329 . . . . 0.0 109.46 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.46 159.14 59.07 Favored 'Cis proline' 0 N--CA 1.453 -0.877 0 CA-C-N 120.343 1.158 . . . . 0.0 109.402 -12.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -65.22 121.04 13.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.394 1.477 . . . . 0.0 110.31 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 m -51.17 -47.02 62.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.011 0.524 . . . . 0.0 110.552 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.8 p -41.44 -52.42 3.6 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 126.582 1.953 . . . . 0.0 112.226 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -47.62 -33.54 6.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.249 1.02 . . . . 0.0 112.552 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.4 m -99.28 -56.0 2.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.049 0.386 . . . . 0.0 110.838 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -70.65 -38.81 73.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.36 -42.98 78.4 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.359 0.981 . . . . 0.0 108.994 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -38.91 79.36 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.212 1.005 . . . . 0.0 111.509 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.54 34.91 8.19 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.813 1.197 . . . . 0.0 110.362 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.98 129.46 17.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 30.96 6.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.481 1.112 . . . . 0.0 111.361 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.99 24.2 77.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.357 -0.69 . . . . 0.0 112.823 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.36 131.58 52.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.548 1.174 . . . . 0.0 108.33 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -60.09 116.95 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.077 2.518 . . . . 0.0 109.226 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -84.54 173.61 10.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.184 0.994 . . . . 0.0 112.631 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.09 161.68 29.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 m120 49.36 32.03 4.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.549 0.74 . . . . 0.0 112.622 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 59.56 38.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.373 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.55 -45.89 3.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.055 3.17 . . . . 0.0 114.468 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.59 -44.48 18.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.663 1.185 . . . . 0.0 111.519 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.09 -18.15 61.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.171 0.989 . . . . 0.0 112.327 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -104.89 -18.22 14.28 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.32 1.048 . . . . 0.0 112.153 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -46.2 0.59 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.391 1.876 . . . . 0.0 114.243 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.41 -14.91 27.9 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.616 0.767 . . . . 0.0 112.991 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -81.31 124.93 80.22 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.09 0.956 . . . . 0.0 109.373 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.31 120.99 8.17 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.571 2.181 . . . . 0.0 111.473 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.73 -31.05 57.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.827 0.851 . . . . 0.0 112.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -48.72 102.17 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.568 1.947 . . . . 0.0 112.855 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.1 -43.06 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.689 0.796 . . . . 0.0 109.404 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.24 -27.35 63.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.444 1.098 . . . . 0.0 112.769 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.85 -54.06 4.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.2 mt -52.92 -40.69 63.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.793 0.837 . . . . 0.0 112.521 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.97 -28.51 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.505 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.74 -47.39 83.77 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.681 1.128 . . . . 0.0 108.867 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 m -54.22 -48.22 71.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 109.892 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -62.02 -45.24 94.46 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.921 -0.487 . . . . 0.0 111.066 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -62.14 -53.44 55.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.197 0.599 . . . . 0.0 110.98 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.89 -21.42 47.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.067 1.347 . . . . 0.0 112.976 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.4 162.63 35.32 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -159.91 114.33 2.29 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -115.33 7.14 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -27.96 60.4 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.49 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 33.3 ttp -62.98 115.45 17.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.688 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.21 130.27 10.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.032 2.488 . . . . 0.0 110.415 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.62 114.69 0.55 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.434 1.494 . . . . 0.0 111.848 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -83.14 -13.63 55.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.483 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -48.99 112.85 0.68 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.89 0.768 . . . . 0.0 111.258 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.08 -32.92 6.56 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.278 0.942 . . . . 0.0 111.651 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -79.15 -44.66 21.51 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.98 135.83 49.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 172.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.54 146.88 32.39 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -32.2 -47.89 0.16 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.234 1.814 . . . . 0.0 111.31 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.1 -46.02 92.31 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.673 0.67 . . . . 0.0 111.371 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.24 -58.15 9.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 122.08 0.943 . . . . 0.0 108.632 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 62' ' ' ALA . 72.5 mt -45.87 -58.03 3.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.543 1.537 . . . . 0.0 110.416 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.5 t -41.63 -51.67 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 125.158 1.383 . . . . 0.0 111.214 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -57.85 -38.84 76.4 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.572 0.169 . . . . 0.0 111.416 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -48.15 56.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -58.1 -49.08 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.315 0.646 . . . . 0.0 111.114 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.5 -44.19 97.53 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.022 -1.049 . . . . 0.0 109.629 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -56.95 -53.51 57.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.286 0.494 . . . . 0.0 109.68 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttm -48.2 -53.57 16.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.806 1.642 . . . . 0.0 109.907 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.34 -37.87 84.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.233 -0.292 . . . . 0.0 110.489 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 m -73.4 39.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.3 p -129.43 -12.93 4.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.932 1.693 . . . . 0.0 109.559 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.352 -1.308 . . . . 0.0 110.304 -176.282 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.3 mt -52.7 -61.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.427 . . . . 0.0 110.0 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.77 -48.82 77.01 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.288 0.635 . . . . 0.0 112.035 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.69 -44.02 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.153 -173.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 6.14 0.19 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -174.249 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.04 40.04 2.65 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.827 1.194 . . . . 0.0 111.323 -177.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.94 49.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.527 1.531 . . . . 0.0 108.585 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.25 109.19 8.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.738 0.815 . . . . 0.0 110.158 -177.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.73 156.69 32.27 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.802 0.965 . . . . 0.0 111.462 -12.769 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.1 123.17 19.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.915 1.286 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -55.79 -49.3 73.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.497 0.665 . . . . 0.0 111.011 -177.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -41.52 -51.1 3.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.282 1.833 . . . . 0.0 112.543 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -44.44 -35.34 2.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.793 1.237 . . . . 0.0 113.345 -178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -102.23 -52.73 3.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.747 0.419 . . . . 0.0 110.729 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -67.12 -25.63 66.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.39 -44.32 97.35 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.3 0.954 . . . . 0.0 110.249 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -30.19 16.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 111.152 178.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.94 40.1 5.01 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -176.181 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.7 136.22 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.411 0.685 . . . . 0.0 109.36 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.54 32.25 8.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.776 1.23 . . . . 0.0 112.097 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.76 81.18 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.267 -0.74 . . . . 0.0 113.278 178.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.23 130.38 68.7 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.529 1.165 . . . . 0.0 108.61 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.88 119.17 6.16 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.004 1.802 . . . . 0.0 109.402 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.4 158.52 33.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.526 0.679 . . . . 0.0 110.323 -176.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.92 151.08 25.28 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 64.45 34.82 9.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.985 0.914 . . . . 0.0 109.363 -174.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.8 68.46 43.43 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.765 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -38.65 -52.39 2.07 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.291 3.328 . . . . 0.0 114.275 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -48.52 -39.99 25.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.322 1.449 . . . . 0.0 111.812 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.04 -30.85 71.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.808 0.443 . . . . 0.0 111.339 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -101.25 -27.67 13.07 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.783 0.833 . . . . 0.0 112.359 -175.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.55 0.92 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.05 1.74 . . . . 0.0 112.98 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.54 -21.31 38.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -177.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -81.36 156.5 71.24 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.872 0.869 . . . . 0.0 110.268 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.89 109.85 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.008 2.472 . . . . 0.0 111.646 176.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.96 -31.52 72.64 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.031 -1.043 . . . . 0.0 110.423 177.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 105.17 0.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 111.68 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -48.77 -39.7 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.001 0.92 . . . . 0.0 110.599 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.55 -39.67 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.841 1.256 . . . . 0.0 111.648 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.29 -44.18 47.0 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.1 mt -56.11 -49.73 73.06 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.8 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 11.8 p -59.41 -44.69 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.64 -44.69 85.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.322 0.964 . . . . 0.0 109.596 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -59.58 -33.2 71.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.084 176.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.7 m -72.38 -45.31 60.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.5 0.72 . . . . 0.0 109.751 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 45' ' ' VAL . 2.2 mm? -54.65 -52.31 62.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.86 1.209 . . . . 0.0 110.517 174.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.83 82.26 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.358 0.411 . . . . 0.0 111.762 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.21 124.21 3.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -101.12 139.87 36.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.133 1.373 . . . . 0.0 107.748 178.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.06 3.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.39 8.61 43.52 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.088 0.955 . . . . 0.0 112.723 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 37.1 mtm -68.06 148.25 98.37 Favored Pre-proline 0 C--N 1.338 0.091 0 CA-C-N 119.756 1.162 . . . . 0.0 112.261 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.32 140.92 25.16 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 N-CA-C 106.345 -2.214 . . . . 0.0 106.345 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.85 117.66 6.17 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.0 4.07 10.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.071 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -50.67 104.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 111.713 177.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -8.43 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.186 0.898 . . . . 0.0 113.214 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -78.75 -42.21 28.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.84 144.91 47.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 174.05 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.47 143.21 32.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -27.72 -50.31 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.4 2.28 . . . . 0.0 112.295 169.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.77 -49.88 71.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.539 0.609 . . . . 0.0 111.095 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.93 -50.65 72.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.35 1.06 . . . . 0.0 109.377 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 62' ' ' ALA . 44.2 mt -51.29 -56.84 10.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.251 1.42 . . . . 0.0 109.986 177.021 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.3 t -52.44 -53.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.175 0.59 . . . . 0.0 109.98 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -56.33 -36.83 69.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.672 0.789 . . . . 0.0 111.529 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.72 38.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.16 -48.72 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 -176.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.28 -42.17 90.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.208 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -61.14 -48.85 79.71 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.557 0.617 . . . . 0.0 110.152 177.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.0 mtp -48.02 -58.05 4.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.016 0.912 . . . . 0.0 109.149 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -56.28 -40.05 73.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.086 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 m -74.17 42.36 0.15 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.122 -0.987 . . . . 0.0 113.583 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.6 p -132.01 -15.62 2.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.441 1.496 . . . . 0.0 109.949 171.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.927 -177.33 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.38 -57.11 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.162 0.985 . . . . 0.0 110.06 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -54.9 -44.68 74.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -74.48 -51.71 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.956 -173.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -16.55 1.83 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.47 -35.06 43.01 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.654 1.115 . . . . 0.0 112.112 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -70.25 147.05 50.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.026 0.53 . . . . 0.0 110.791 -178.049 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.69 109.81 13.3 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.704 1.202 . . . . 0.0 109.349 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.35 161.25 58.86 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.257 1.128 . . . . 0.0 110.371 -8.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -70.73 125.48 26.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.26 1.424 . . . . 0.0 110.934 -177.609 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 m -56.18 -48.74 75.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.268 0.556 . . . . 0.0 110.389 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 p -38.44 -58.51 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.941 2.096 . . . . 0.0 111.888 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -41.1 -38.74 1.1 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.947 1.299 . . . . 0.0 113.113 -179.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.6 m -94.64 -56.07 2.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.828 0.285 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -65.65 -33.48 75.98 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.323 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.01 -39.88 83.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 119.752 1.16 . . . . 0.0 109.471 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -76.79 -29.99 56.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.174 0.99 . . . . 0.0 110.712 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.65 31.47 62.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -174.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -58.42 140.2 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.27 29.31 6.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.084 0.954 . . . . 0.0 111.414 -177.317 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 25.62 74.47 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.391 -0.672 . . . . 0.0 112.651 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 135.36 82.75 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.621 1.21 . . . . 0.0 108.622 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 57.7 Cg_endo -62.9 122.64 11.0 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.389 2.06 . . . . 0.0 109.178 -179.048 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -87.77 177.48 7.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.795 0.807 . . . . 0.0 111.955 -174.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.15 161.14 31.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.23 51.05 0.78 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.573 1.549 . . . . 0.0 111.786 177.882 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.41 63.13 27.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.8 1.24 . . . . 0.0 110.275 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -40.19 -46.42 4.14 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.245 3.297 . . . . 0.0 114.523 -176.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.31 -39.93 33.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.92 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.41 -24.45 66.47 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.53 0.732 . . . . 0.0 111.781 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 86.4 m95 -106.6 -22.3 12.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.69 1.196 . . . . 0.0 112.938 -174.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.33 -49.53 0.71 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.935 1.694 . . . . 0.0 113.484 -178.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.1 -15.27 36.67 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -81.63 153.36 70.59 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 118.944 0.793 . . . . 0.0 110.512 -177.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.24 125.92 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.455 176.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -67.37 -40.18 85.74 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.04 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -49.42 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.006 2.522 . . . . 0.0 112.19 178.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.62 -40.1 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.025 0.93 . . . . 0.0 109.703 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.5 -25.39 36.81 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.324 1.85 . . . . 0.0 112.373 176.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -89.83 -51.23 5.6 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -51.35 -38.99 56.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.728 0.811 . . . . 0.0 112.158 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.76 -33.62 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.542 -0.724 . . . . 0.0 110.286 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -65.1 -49.45 69.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.598 1.09 . . . . 0.0 108.424 177.642 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -53.04 -43.69 66.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.047 0.539 . . . . 0.0 109.831 177.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -67.96 -46.23 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.028 -0.42 . . . . 0.0 110.716 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.7 mt -56.18 -51.09 69.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.673 -0.642 . . . . 0.0 110.083 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.79 -27.81 55.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.598 1.159 . . . . 0.0 113.134 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 163.3 32.92 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -175.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -157.42 119.63 3.82 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.916 -0.755 . . . . 0.0 109.499 -178.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.01 -118.06 12.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.8 -21.21 55.46 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.743 0.417 . . . . 0.0 111.588 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.6 ttp -68.54 118.66 62.19 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 118.942 0.792 . . . . 0.0 110.075 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.57 158.37 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.486 2.124 . . . . 0.0 109.798 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.24 148.01 38.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.92 -9.18 12.47 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.417 1.087 . . . . 0.0 113.14 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -48.13 110.24 0.31 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.084 0.856 . . . . 0.0 111.796 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.38 -31.33 7.55 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.084 0.849 . . . . 0.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -74.33 -46.46 40.72 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.01 129.02 46.05 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.84 145.16 38.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -30.69 -46.19 0.08 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 127.113 2.165 . . . . 0.0 112.153 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.6 -54.51 44.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.475 1.034 . . . . 0.0 110.89 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -51.06 71.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.433 1.093 . . . . 0.0 109.382 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 62' ' ' ALA . 29.9 mt -50.4 -56.96 9.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.522 1.129 . . . . 0.0 110.103 177.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 t -50.42 -57.35 2.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 123.877 0.871 . . . . 0.0 109.395 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -54.2 -43.58 70.86 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.965 0.348 . . . . 0.0 111.525 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.06 95.36 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.07 -51.52 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.395 0.678 . . . . 0.0 109.886 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.45 -40.11 85.78 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 120.107 1.321 . . . . 0.0 108.878 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -57.2 -51.66 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.464 0.574 . . . . 0.0 109.945 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ptm -56.55 -46.61 80.58 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -35.12 79.45 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.658 -0.651 . . . . 0.0 111.204 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.8 m -62.81 -7.59 5.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.4 p -88.03 -12.19 45.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.867 1.212 . . . . 0.0 111.0 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 116.486 -1.721 . . . . 0.0 111.095 -175.92 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.21 -59.34 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.806 1.243 . . . . 0.0 110.292 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -58.29 -52.1 67.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.06 0.944 . . . . 0.0 111.893 -178.452 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.16 -44.21 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.292 -173.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -159.09 44.03 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 37.16 0.98 Allowed Glycine 0 CA--C 1.524 0.63 0 O-C-N 121.638 -0.664 . . . . 0.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -138.87 157.53 45.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.464 1.906 . . . . 0.0 107.587 177.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.39 107.92 8.64 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.562 0.745 . . . . 0.0 109.755 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.25 158.2 27.59 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 CA-C-N 119.991 1.033 . . . . 0.0 112.314 -9.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.98 117.31 11.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.278 1.031 . . . . 0.0 109.116 178.004 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m -46.43 -48.62 18.82 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.709 0.804 . . . . 0.0 111.194 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 p -44.45 -46.91 9.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.026 1.73 . . . . 0.0 112.586 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -50.91 -30.29 14.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.163 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 m -101.66 -56.37 2.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.895 0.316 . . . . 0.0 110.786 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -71.7 -23.14 61.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -172.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.48 -50.78 62.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.52 1.054 . . . . 0.0 109.024 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.89 35.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.6 44.53 9.3 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -175.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 144.2 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.28 29.91 7.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.965 0.906 . . . . 0.0 111.319 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.87 20.41 79.83 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.109 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 137.61 84.49 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.931 1.365 . . . . 0.0 108.416 176.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.54 128.49 26.1 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.561 2.174 . . . . 0.0 109.842 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.9 174.73 7.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.291 1.043 . . . . 0.0 113.347 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.08 166.71 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 113.497 -1.683 . . . . 0.0 106.853 169.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 48.03 34.77 4.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.558 0.743 . . . . 0.0 111.111 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.34 61.16 16.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.794 -173.541 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -40.09 -49.22 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.846 3.031 . . . . 0.0 113.729 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.83 -40.93 10.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.396 1.478 . . . . 0.0 112.264 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -63.41 -26.04 68.56 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.859 0.464 . . . . 0.0 111.661 -177.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -106.26 -28.68 10.27 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.257 1.423 . . . . 0.0 111.961 -175.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.24 -46.15 0.5 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.754 2.022 . . . . 0.0 112.86 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.63 30.64 6.11 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.215 1.006 . . . . 0.0 112.888 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -134.69 159.36 72.46 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.549 1.14 . . . . 0.0 108.414 176.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.32 109.15 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.154 2.569 . . . . 0.0 112.77 -177.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.46 -32.4 73.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.211 -0.931 . . . . 0.0 110.276 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -55.92 103.94 0.12 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.479 1.912 . . . . 0.0 112.399 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.42 -39.43 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.72 -24.74 51.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.36 1.064 . . . . 0.0 112.569 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.21 -55.08 3.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.114 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.6 mt -47.82 -40.7 21.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.79 -35.02 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.933 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.45 -48.41 75.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.398 0.999 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m -54.98 -41.64 71.44 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.825 0.45 . . . . 0.0 109.799 176.397 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -67.64 -45.0 76.6 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.07 -0.394 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.09 -51.82 68.12 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.649 -0.657 . . . . 0.0 109.981 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.68 61.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.748 1.219 . . . . 0.0 113.432 -176.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.24 163.9 24.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -158.8 114.76 2.64 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.977 -0.719 . . . . 0.0 109.323 -177.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.42 -116.22 8.19 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.33 -26.17 60.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.88 0.472 . . . . 0.0 111.554 178.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.5 ttp -67.97 116.54 39.67 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.75 -177.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.57 166.2 24.76 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.23 1.953 . . . . 0.0 110.738 176.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.35 133.55 49.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -101.25 -10.43 20.36 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 113.256 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -49.25 110.09 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.549 0.613 . . . . 0.0 111.013 179.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.01 -37.44 3.77 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.725 1.155 . . . . 0.0 111.666 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -43.99 42.91 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 117.994 0.897 . . . . 0.0 108.836 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.84 132.14 41.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 176.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -79.23 150.84 31.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.037 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -32.18 -46.65 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.328 1.851 . . . . 0.0 111.715 171.062 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.81 -44.92 88.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.434 1.015 . . . . 0.0 111.329 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.9 -56.31 23.83 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 122.459 1.123 . . . . 0.0 108.619 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.9 mt -47.63 -58.97 3.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.164 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 t -45.17 -57.39 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 124.515 1.126 . . . . 0.0 109.636 177.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -58.68 -41.71 86.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.349 0.522 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.31 93.84 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.718 -0.614 . . . . 0.0 110.02 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.41 -48.01 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -53.19 -51.47 61.98 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.7 -52.7 61.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.222 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -51.31 -56.52 12.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.69 -37.6 68.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.837 -0.539 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -67.92 -3.34 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 113.461 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.2 p -110.76 15.26 22.02 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 120.19 1.359 . . . . 0.0 111.242 177.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.62 179.613 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.656 0.741 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.67 -57.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.041 0.937 . . . . 0.0 109.747 -177.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -58.03 -46.92 84.53 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.8 mt -71.82 -49.07 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.787 -172.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.92 -13.74 0.93 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -170.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.33 -30.73 36.23 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 120.079 1.309 . . . . 0.0 112.66 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -75.21 156.59 35.64 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.715 0.757 . . . . 0.0 111.161 -177.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.34 111.49 7.1 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.913 1.285 . . . . 0.0 108.954 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.26 150.77 55.54 Favored 'Cis proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.435 1.191 . . . . 0.0 109.645 -11.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.93 118.62 7.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.227 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 m -48.26 -47.04 36.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.476 0.655 . . . . 0.0 110.535 -178.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -45.09 -43.81 9.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.983 1.713 . . . . 0.0 112.557 178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -51.13 -33.06 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.595 0.634 . . . . 0.0 112.025 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.3 m -100.05 -53.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.424 0.289 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.85 -29.3 66.51 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -173.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.73 -42.44 86.27 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.344 0.974 . . . . 0.0 108.855 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -81.76 -27.6 33.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.289 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.84 46.42 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.45 144.69 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 O-C-N 122.09 -0.653 . . . . 0.0 109.289 -176.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.03 29.71 6.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.205 1.002 . . . . 0.0 111.534 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.3 23.04 78.59 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.306 -0.719 . . . . 0.0 112.799 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 131.0 84.37 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.761 1.28 . . . . 0.0 108.028 176.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -61.65 121.72 9.97 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.218 1.945 . . . . 0.0 109.041 -178.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.02 163.2 24.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.435 1.112 . . . . 0.0 111.121 -176.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.79 161.97 29.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 171.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.18 55.0 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 111.19 -178.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.71 64.66 7.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.759 0.824 . . . . 0.0 111.093 -178.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -36.86 -49.79 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.776 3.651 . . . . 0.0 114.523 -178.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.98 -43.01 13.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.128 1.371 . . . . 0.0 111.794 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.7 -24.51 66.26 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.037 0.935 . . . . 0.0 112.008 -177.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -106.01 -19.39 13.74 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.443 1.097 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.43 -49.14 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.524 1.53 . . . . 0.0 113.342 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.11 -14.75 33.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.141 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -82.03 131.63 56.16 Favored Pre-proline 0 CA--C 1.535 0.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.856 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.51 113.71 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.913 2.408 . . . . 0.0 111.198 177.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -58.05 -26.56 62.65 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.461 0.704 . . . . 0.0 112.395 -178.695 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -50.71 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 111.662 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.8 t -41.36 -53.03 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 124.592 1.157 . . . . 0.0 110.619 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.89 -43.26 69.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -61.52 -47.11 87.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.118 0.872 . . . . 0.0 108.782 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.6 -37.51 81.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.383 178.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 71' ' ' ILE . 77.2 t -62.03 -43.57 97.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.201 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.81 -46.22 91.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.406 1.003 . . . . 0.0 109.724 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -54.3 -45.54 72.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.345 . . . . 0.0 110.454 176.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -67.37 -45.31 76.65 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.922 -0.486 . . . . 0.0 110.531 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 mt -54.11 -54.93 32.73 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.726 -0.609 . . . . 0.0 109.712 177.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.54 74.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.926 0.891 . . . . 0.0 112.613 -177.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.95 164.29 31.28 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 -174.481 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -157.58 108.79 2.28 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.761 -0.846 . . . . 0.0 109.569 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.54 -115.08 6.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.47 -29.47 64.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.725 0.41 . . . . 0.0 111.052 178.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.4 ttp -65.16 120.05 64.06 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.421 -178.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.78 160.15 44.13 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.442 2.095 . . . . 0.0 110.354 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.68 52.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.6 -10.83 16.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.961 0.904 . . . . 0.0 111.019 177.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.0 123.81 7.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.0 111.037 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -16.36 33.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.186 0.898 . . . . 0.0 112.739 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 mtm105 -97.25 -48.84 5.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.225 1.013 . . . . 0.0 109.223 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 127.14 42.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 65' ' ' GLU . 13.5 m-20 -76.69 83.01 3.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 3.2 -47.91 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 1 C-N-CA 132.522 4.329 . . . . 0.0 117.221 -178.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 63' ' ' ASP . 42.9 mt-10 -50.07 -37.43 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.961 1.255 . . . . 0.0 109.265 173.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.02 -57.68 8.02 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.687 1.995 . . . . 0.0 109.818 173.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.66 -56.41 22.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.749 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG22 HG21 ' A' ' 45' ' ' VAL . 53.1 t -43.85 -57.14 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.199 1.0 . . . . 0.0 109.725 176.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -56.51 -48.9 76.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.242 1.017 . . . . 0.0 111.094 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.46 77.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.682 -0.636 . . . . 0.0 109.362 -178.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 45' ' ' VAL . 73.2 mt -62.37 -46.78 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.546 1.138 . . . . 0.0 110.846 -176.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.57 -38.17 80.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.937 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -62.14 -51.35 68.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.173 176.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.0 mtp -44.45 -58.9 2.69 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.088 0.947 . . . . 0.0 109.632 177.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.3 -41.05 83.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.275 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -74.58 42.55 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.4 p -136.46 -13.2 1.78 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.437 1.495 . . . . 0.0 110.096 171.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.268 -178.408 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.84 0.353 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.46 -55.04 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -59.28 -48.53 81.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.249 0.62 . . . . 0.0 111.843 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.95 -49.39 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.175 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -135.06 -17.68 1.84 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.49 -34.52 35.58 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.978 1.263 . . . . 0.0 112.543 -176.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -70.25 151.18 45.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 117.361 0.58 . . . . 0.0 110.424 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.09 111.22 7.89 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 109.133 -179.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 151.97 24.81 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.306 1.145 . . . . 0.0 111.449 -11.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.91 124.98 23.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.805 1.242 . . . . 0.0 109.309 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.15 -45.36 79.65 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.393 0.616 . . . . 0.0 110.57 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 p -42.27 -50.51 4.95 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.567 1.947 . . . . 0.0 112.067 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.16 -37.35 2.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.292 1.037 . . . . 0.0 112.5 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -102.14 -57.37 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.637 0.375 . . . . 0.0 111.046 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -67.95 -20.96 65.11 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.43 -2.65 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.164 0.893 . . . . 0.0 110.882 176.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -135.44 -9.6 2.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 35.5 51.88 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.694 -0.629 . . . . 0.0 111.908 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.1 133.47 20.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.31 31.1 8.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.304 1.041 . . . . 0.0 111.462 -177.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.33 23.18 78.36 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.622 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 139.75 80.24 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.334 1.067 . . . . 0.0 109.251 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.8 Cg_endo -61.09 126.08 18.63 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.373 2.049 . . . . 0.0 109.308 179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.66 171.72 9.46 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.182 0.992 . . . . 0.0 112.491 -175.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 161.08 19.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.929 172.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 37.7 52.96 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.136 1.374 . . . . 0.0 112.009 176.08 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.04 65.41 11.94 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.796 0.838 . . . . 0.0 110.469 -177.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.67 -51.56 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.781 3.654 . . . . 0.0 114.695 -177.007 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.16 -39.34 28.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.136 0.974 . . . . 0.0 112.196 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.91 -26.8 68.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.564 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 80.5 m95 -104.24 -29.86 10.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.026 1.33 . . . . 0.0 112.269 -175.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.02 -41.51 1.69 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.957 1.703 . . . . 0.0 113.605 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.59 -22.65 26.13 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.541 0.737 . . . . 0.0 112.317 -176.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -80.93 143.51 53.65 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.022 0.929 . . . . 0.0 110.026 -176.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 85.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.063 2.509 . . . . 0.0 108.267 173.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -23.86 26.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.728 2.011 . . . . 0.0 113.543 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -51.18 112.69 0.77 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.649 1.18 . . . . 0.0 110.683 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -46.64 -44.58 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.524 1.13 . . . . 0.0 110.553 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.79 -31.53 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.236 1.415 . . . . 0.0 113.001 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.44 -52.83 4.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 109.046 177.009 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 mt -48.36 -41.32 28.31 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 122.824 0.449 . . . . 0.0 111.994 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.14 -37.71 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 121.747 -0.596 . . . . 0.0 110.903 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -65.85 -48.12 72.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 m -53.56 -42.28 67.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.708 0.29 . . . . 0.0 110.299 176.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -67.04 -48.83 67.12 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.282 0.633 . . . . 0.0 111.235 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.8 -43.02 69.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 109.528 -174.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.7 73.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.538 0.735 . . . . 0.0 111.073 178.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 152.3 27.92 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.623 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -153.5 149.52 27.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.27 -116.98 8.69 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.29 14.21 22.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.453 1.101 . . . . 0.0 111.495 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.96 127.31 93.32 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.495 -0.753 . . . . 0.0 110.416 -178.621 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.76 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.492 2.128 . . . . 0.0 109.19 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -25.55 123.29 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.178 2.191 . . . . 0.0 112.11 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.6 6.57 48.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.839 0.456 . . . . 0.0 112.096 -176.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -42.09 109.45 0.13 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.497 1.519 . . . . 0.0 112.695 178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 -14.43 8.03 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.73 0.681 . . . . 0.0 113.449 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 mtm105 -82.05 -46.94 13.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.28 1.04 . . . . 0.0 108.507 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.05 126.27 45.95 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 172.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.22 150.26 33.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -27.24 -49.89 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 126.177 1.791 . . . . 0.0 112.102 170.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.67 -50.35 73.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.115 1.325 . . . . 0.0 111.56 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -54.29 -56.12 21.55 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 122.662 1.22 . . . . 0.0 109.031 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.38 -59.48 3.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -45.05 -53.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 125.394 1.478 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -56.33 -33.94 66.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.048 0.539 . . . . 0.0 112.055 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.68 27.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.747 0.703 . . . . 0.0 109.924 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.61 -49.92 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.825 . . . . 0.0 110.233 -176.371 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.65 -44.29 73.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.185 0.902 . . . . 0.0 109.777 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.14 -50.51 72.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 ptm -54.5 -44.19 72.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.53 -34.74 77.71 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.627 -0.671 . . . . 0.0 110.696 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -73.92 56.64 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.005 0.922 . . . . 0.0 111.793 179.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.6 p -150.81 -32.71 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.444 2.298 . . . . 0.0 109.598 177.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.523 1.929 . . . . 0.0 110.413 178.885 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.14 -56.4 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.494 1.118 . . . . 0.0 109.826 -178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.47 -48.07 80.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.756 0.822 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 mm -70.42 -48.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.425 0.69 . . . . 0.0 111.146 -174.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 39.79 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -173.122 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.81 38.91 1.17 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -139.07 155.95 47.55 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.502 1.921 . . . . 0.0 107.587 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 105.29 16.85 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 123.715 0.806 . . . . 0.0 111.198 -176.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.54 164.47 61.49 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 CA-C-N 120.286 1.138 . . . . 0.0 110.113 -8.616 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -67.31 119.11 11.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.543 1.137 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -46.89 -45.46 20.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.895 0.878 . . . . 0.0 111.228 -176.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -46.02 -42.71 13.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.715 1.606 . . . . 0.0 112.311 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -55.94 -16.27 4.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.3 m -115.27 -57.43 2.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.788 175.566 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -71.14 -22.9 62.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -173.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.54 -48.6 66.51 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.751 1.16 . . . . 0.0 109.615 -178.596 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -86.54 -25.19 25.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.917 0.887 . . . . 0.0 111.1 178.652 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.38 41.97 8.85 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.51 140.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.41 28.58 5.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.993 0.917 . . . . 0.0 111.476 -177.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.46 79.62 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.009 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 121.25 43.14 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.823 1.311 . . . . 0.0 108.247 176.172 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 74.1 Cg_exo -44.15 114.99 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.869 3.046 . . . . 0.0 113.636 -177.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.81 169.63 17.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.758 0.79 . . . . 0.0 111.759 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 159.72 28.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.31 51.08 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.362 1.465 . . . . 0.0 111.733 178.053 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.96 62.04 31.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.919 0.888 . . . . 0.0 111.055 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -38.17 -45.85 2.15 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 124.33 3.353 . . . . 0.0 114.198 -178.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.42 -43.67 11.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.896 1.278 . . . . 0.0 111.957 178.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -69.3 -25.54 64.28 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.658 0.783 . . . . 0.0 112.074 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 88.5 m95 -104.26 -18.2 14.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.795 1.238 . . . . 0.0 112.754 -174.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.04 -48.4 0.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.937 2.095 . . . . 0.0 113.969 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -98.65 -4.13 34.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -87.26 128.81 53.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.486 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.95 123.87 13.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.525 2.15 . . . . 0.0 110.967 177.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -64.25 -23.57 67.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.295 0.638 . . . . 0.0 110.668 178.094 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -49.33 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.856 2.062 . . . . 0.0 112.264 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.44 -41.5 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.316 0.646 . . . . 0.0 109.43 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -50.61 -38.6 46.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.847 1.259 . . . . 0.0 112.262 177.135 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -79.57 -49.64 11.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.29 -40.66 62.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.913 0.485 . . . . 0.0 111.915 -178.108 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -61.69 -35.05 65.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.298 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.9 -46.3 78.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 120.204 1.365 . . . . 0.0 108.698 178.292 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 m -52.89 -45.7 67.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.947 0.404 . . . . 0.0 110.162 175.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -69.5 -44.41 71.14 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.924 -0.485 . . . . 0.0 110.97 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.16 -51.14 70.96 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.283 -0.886 . . . . 0.0 110.347 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.74 59.2 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.36 1.064 . . . . 0.0 112.376 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.14 163.64 28.67 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -176.35 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -157.06 111.12 2.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.97 -0.723 . . . . 0.0 109.324 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.15 -113.52 5.2 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.65 -30.67 63.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.945 0.498 . . . . 0.0 111.168 177.847 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.3 ttp -63.07 119.29 50.89 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.255 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.84 160.46 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.365 2.044 . . . . 0.0 110.28 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.57 119.78 12.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -87.22 -4.45 59.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.785 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.83 89.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 179.051 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.2 2.54 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.889 1.709 . . . . 0.0 110.589 -178.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -87.23 -37.27 17.39 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.258 1.023 . . . . 0.0 111.106 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 126.14 18.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.014 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.33 153.57 24.54 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.203 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -29.17 -47.53 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.577 1.951 . . . . 0.0 112.047 171.724 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -62.81 -50.72 69.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.991 1.268 . . . . 0.0 111.665 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -54.96 -55.31 32.16 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.824 1.297 . . . . 0.0 108.955 178.498 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.4 mt -49.93 -60.46 2.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.151 179.093 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.4 t -42.09 -56.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 109.765 177.865 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -56.99 -43.07 81.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.512 0.142 . . . . 0.0 111.22 -178.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.89 53.34 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.9 mt -54.66 -46.62 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.964 1.306 . . . . 0.0 110.135 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -53.51 -52.58 59.14 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -55.94 -50.5 70.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.605 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.5 mtp -50.83 -58.16 6.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.377 0.671 . . . . 0.0 109.731 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.07 -36.73 73.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.884 0.874 . . . . 0.0 111.59 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -74.7 50.92 0.45 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.023 0.829 . . . . 0.0 112.659 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.7 p -149.24 -25.75 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.282 2.233 . . . . 0.0 110.035 174.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.62 -1.657 . . . . 0.0 110.421 179.528 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.08 -53.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -57.47 -42.87 83.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 112.738 -177.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -84.37 -39.93 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.709 -175.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -130.55 -34.73 1.54 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -172.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.73 32.12 4.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.473 1.033 . . . . 0.0 113.343 -172.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -133.7 144.98 49.48 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.12 107.78 19.8 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.929 1.292 . . . . 0.0 110.388 -177.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.57 161.46 66.24 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.327 1.153 . . . . 0.0 109.718 -9.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.23 130.79 45.28 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.514 0.726 . . . . 0.0 110.145 -178.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.9 -41.92 71.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.023 0.829 . . . . 0.0 109.683 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 t -59.25 -8.71 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 m -67.08 -30.42 70.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 120.352 1.433 . . . . 0.0 109.898 175.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.0 m -113.95 -63.75 1.41 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 112.407 -172.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -57.93 -23.36 53.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.006 1.322 . . . . 0.0 113.555 -174.224 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.18 -25.13 64.19 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.133 -0.355 . . . . 0.0 111.535 178.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -121.11 -12.28 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.251 1.021 . . . . 0.0 112.218 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.3 35.89 51.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.87 145.47 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.19 28.09 6.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.898 0.879 . . . . 0.0 111.466 -177.08 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.53 21.37 79.56 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.032 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 132.55 87.25 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.855 1.327 . . . . 0.0 108.669 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.07 122.54 10.57 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.469 2.112 . . . . 0.0 108.769 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.23 172.15 10.72 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -170.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.41 158.48 23.63 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.04 50.83 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 0.0 112.078 177.727 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.15 60.84 24.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.624 1.17 . . . . 0.0 110.885 -178.65 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.93 -48.46 1.5 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.599 3.533 . . . . 0.0 114.322 -178.715 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.39 -44.35 8.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.208 1.403 . . . . 0.0 111.838 178.45 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.69 -26.93 67.26 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.978 0.911 . . . . 0.0 112.014 -177.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -103.19 -15.96 15.86 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.826 1.25 . . . . 0.0 112.452 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.68 -47.07 0.64 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.243 1.817 . . . . 0.0 113.709 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -99.72 -4.29 31.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.836 0.854 . . . . 0.0 113.27 -176.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -88.25 126.92 59.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.812 0.845 . . . . 0.0 109.405 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.33 106.03 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.784 2.323 . . . . 0.0 110.529 177.127 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.7 -23.05 49.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.767 0.827 . . . . 0.0 112.509 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.81 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.159 2.184 . . . . 0.0 111.031 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -49.69 -41.94 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 110.001 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -53.49 -34.97 60.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.986 1.714 . . . . 0.0 112.194 177.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.84 -52.12 7.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.8 mt -51.76 -37.82 52.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.88 -37.94 69.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.408 1.004 . . . . 0.0 110.149 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.38 -47.05 77.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.667 1.121 . . . . 0.0 108.814 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -52.61 -43.92 65.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.629 0.372 . . . . 0.0 110.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -71.97 -44.6 63.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.887 0.475 . . . . 0.0 111.066 -178.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.2 mt -57.69 -50.24 73.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 121.442 -0.786 . . . . 0.0 109.898 179.461 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.09 65.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.956 0.902 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 118.61 3.06 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -106.63 135.01 48.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.319 1.048 . . . . 0.0 108.456 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.22 -121.48 26.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.12 -1.56 58.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.473 0.709 . . . . 0.0 112.32 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.0 ttp -65.19 127.59 93.01 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 119.016 0.825 . . . . 0.0 111.082 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 144.44 99.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.0 109.964 173.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.39 121.53 15.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -88.28 -4.93 58.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.432 -178.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -54.55 84.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.433 1.093 . . . . 0.0 113.538 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.56 -36.86 2.46 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.982 2.229 . . . . 0.0 110.419 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -42.24 75.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.642 0.721 . . . . 0.0 109.202 177.128 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.24 129.2 21.9 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -84.06 154.2 23.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -29.85 -49.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.407 1.883 . . . . 0.0 112.011 171.35 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.01 -45.12 93.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.373 0.988 . . . . 0.0 111.784 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.52 -57.56 12.43 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 122.612 1.196 . . . . 0.0 108.77 177.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.8 mt -47.25 -57.9 4.69 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.906 2.082 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 t -40.38 -54.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 0.0 110.459 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -60.34 -44.52 95.44 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.072 0.232 . . . . 0.0 111.394 -178.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.25 63.97 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.515 -0.74 . . . . 0.0 109.919 -179.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.64 -52.67 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.894 1.278 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -60.6 -42.37 96.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.631 1.105 . . . . 0.0 109.616 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -57.18 -51.96 67.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.644 0.656 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 ttp -54.16 -54.52 38.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -56.3 -37.68 70.21 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.918 -0.489 . . . . 0.0 111.137 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.8 m -63.46 -7.45 6.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.084 -0.96 . . . . 0.0 113.493 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 p -87.6 -11.75 47.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.289 1.404 . . . . 0.0 110.802 175.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.05 -176.067 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.557 0.217 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 mt -62.94 -57.82 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.106 1.762 . . . . 0.0 109.323 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -58.47 -51.09 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.287 1.035 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.38 -48.32 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.926 -174.008 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.59 39.89 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.049 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.84 36.95 1.48 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 118.867 0.758 . . . . 0.0 111.737 179.13 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.23 158.74 43.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.02 1.728 . . . . 0.0 108.01 178.025 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.12 107.59 6.81 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.773 -178.159 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 154.39 29.51 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 120.146 1.088 . . . . 0.0 111.732 -9.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.65 126.14 27.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.2 m -53.03 -48.35 67.66 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.848 0.749 . . . . 0.0 110.607 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -42.6 -49.47 5.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.043 1.737 . . . . 0.0 112.454 178.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.03 -36.18 3.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.168 0.987 . . . . 0.0 112.766 -178.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.2 m -99.88 -54.4 2.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.317 0.247 . . . . 0.0 110.996 -178.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -69.65 -24.23 63.59 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.58 -42.42 82.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.864 0.756 . . . . 0.0 109.475 178.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -89.54 -24.9 21.63 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.207 1.003 . . . . 0.0 112.027 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.8 35.14 40.89 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -174.257 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.33 145.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -176.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.35 29.3 6.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 111.392 -177.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.84 24.21 76.95 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.868 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 132.9 87.68 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 118.852 1.326 . . . . 0.0 108.346 176.289 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.42 121.54 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.294 1.996 . . . . 0.0 107.954 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.24 159.89 19.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.159 0.981 . . . . 0.0 112.88 -172.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.52 142.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.272 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 69.28 27.08 5.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.079 1.352 . . . . 0.0 111.315 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 70.3 76.32 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.621 1.168 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.27 -52.05 3.08 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.667 3.578 . . . . 0.0 114.23 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -50.46 -34.07 23.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.514 1.526 . . . . 0.0 112.518 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.65 -27.49 66.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.282 0.492 . . . . 0.0 111.181 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -101.05 -24.92 14.22 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 111.864 -176.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.24 -43.73 0.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.793 1.637 . . . . 0.0 112.688 178.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -111.81 36.14 3.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.283 1.033 . . . . 0.0 112.08 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -128.89 155.74 79.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.36 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.8 126.84 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.562 2.175 . . . . 0.0 111.367 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -70.22 -41.65 73.31 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.113 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -51.86 102.45 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.532 1.933 . . . . 0.0 112.893 -179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -49.25 -43.17 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.848 0.859 . . . . 0.0 108.912 174.561 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.44 -34.96 26.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.557 1.943 . . . . 0.0 112.667 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -87.03 -49.68 7.16 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.046 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 mt -49.75 -40.59 41.54 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.777 0.431 . . . . 0.0 111.979 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.13 -32.45 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 O-C-N 121.378 -0.826 . . . . 0.0 110.76 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.72 -47.24 79.02 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.773 1.17 . . . . 0.0 108.457 177.116 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.87 -44.24 70.25 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -66.54 -45.56 79.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.878 0.37 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.65 -49.41 77.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.447 -0.783 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.84 -31.16 61.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.483 1.113 . . . . 0.0 112.798 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.17 164.47 29.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -176.087 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -158.72 114.05 2.58 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.996 -0.708 . . . . 0.0 109.145 -178.003 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.98 -116.12 7.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 -26.42 60.93 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.968 0.507 . . . . 0.0 111.437 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.3 ttp -67.55 121.12 77.74 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 118.631 0.65 . . . . 0.0 109.847 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.86 160.19 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.49 2.127 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 122.59 17.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.82 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -89.15 -9.96 49.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.256 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -54.22 91.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.408 1.004 . . . . 0.0 113.056 -177.838 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.66 -42.2 1.72 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.463 1.506 . . . . 0.0 110.361 -178.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -39.4 89.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.247 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -136.41 164.94 26.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.09 140.74 40.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.933 0.893 . . . . 0.0 108.961 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ttt-85 -29.24 -50.48 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.289 2.235 . . . . 0.0 113.234 173.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.14 -45.5 84.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.329 0.968 . . . . 0.0 111.366 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.25 -54.5 45.07 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.881 0.848 . . . . 0.0 109.017 177.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 35.6 mt -47.38 -57.84 4.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.371 1.468 . . . . 0.0 109.867 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -43.82 -55.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.622 1.169 . . . . 0.0 109.74 178.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.61 -43.16 89.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.35 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.85 84.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.394 -0.816 . . . . 0.0 109.573 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.35 -42.52 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.902 1.281 . . . . 0.0 109.79 177.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.12 -52.52 64.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.305 0.957 . . . . 0.0 109.032 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -54.25 -54.02 45.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.4 ttm -47.1 -56.16 7.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 110.079 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.15 -33.27 73.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.557 -0.714 . . . . 0.0 112.431 177.158 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 m -74.66 43.44 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.179 0.9 . . . . 0.0 112.367 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.1 p -135.81 -17.06 1.7 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.196 1.799 . . . . 0.0 109.819 173.805 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.445 -1.264 . . . . 0.0 109.569 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.26 -58.98 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.12 1.368 . . . . 0.0 110.643 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -56.62 -52.41 64.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 0.0 112.087 -178.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.22 -44.94 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.246 -174.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.82 44.66 0.19 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.276 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.57 38.14 0.95 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 176.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.33 159.5 42.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.845 2.058 . . . . 0.0 107.378 177.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.94 113.68 6.41 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.265 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.61 152.05 13.24 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 120.307 1.145 . . . . 0.0 111.33 -15.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.61 116.81 7.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.507 1.123 . . . . 0.0 108.6 177.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -46.68 -48.25 20.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.546 0.738 . . . . 0.0 110.788 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -45.92 -46.35 16.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.212 1.805 . . . . 0.0 112.739 178.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -52.04 -29.66 22.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.143 0.429 . . . . 0.0 112.051 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.83 -56.97 2.24 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.777 0.262 . . . . 0.0 110.644 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -66.92 -32.76 74.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -173.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.81 -43.04 76.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 119.103 0.865 . . . . 0.0 109.139 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.12 -26.6 39.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.625 -177.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.55 50.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -176.29 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.97 141.01 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.074 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.61 29.17 5.29 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 0.0 111.394 -177.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.61 28.41 71.03 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.754 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.09 134.84 84.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.862 1.331 . . . . 0.0 108.368 175.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 73.9 Cg_endo -64.91 111.99 1.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.6 2.2 . . . . 0.0 107.984 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -84.87 175.82 8.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.978 0.894 . . . . 0.0 111.425 -174.778 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.48 154.34 41.61 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 171.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 48.28 32.96 3.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.312 1.845 . . . . 0.0 112.661 178.25 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.86 59.25 4.11 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 109.666 178.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -47.62 -41.72 30.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.054 3.169 . . . . 0.0 113.053 -174.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -47.75 -37.67 13.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.903 0.881 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.52 -27.71 56.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.198 0.454 . . . . 0.0 111.37 -178.416 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 81.5 m95 -92.09 -13.3 31.03 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.57 0.748 . . . . 0.0 111.616 -177.784 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.72 -45.16 0.36 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.274 1.83 . . . . 0.0 112.899 177.694 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -113.74 28.6 8.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.121 0.968 . . . . 0.0 112.552 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -115.13 119.61 38.38 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.514 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.69 118.7 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.761 2.307 . . . . 0.0 110.786 177.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 -22.17 66.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.073 0.549 . . . . 0.0 111.343 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.04 103.65 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.087 2.155 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -49.34 -44.23 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.638 0.775 . . . . 0.0 109.706 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.98 -34.0 54.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.172 1.789 . . . . 0.0 112.295 177.903 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.47 -51.16 8.08 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.1 mt -52.79 -38.81 61.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.702 0.801 . . . . 0.0 112.34 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.61 -38.46 75.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 119.243 0.928 . . . . 0.0 109.984 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.16 -45.52 80.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.708 1.14 . . . . 0.0 108.911 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 m -53.5 -44.97 69.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -70.76 -44.75 66.07 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.103 -0.373 . . . . 0.0 110.8 -178.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -57.53 -52.19 66.43 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 121.393 -0.817 . . . . 0.0 109.999 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.76 65.05 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.943 0.897 . . . . 0.0 111.817 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.29 159.38 34.71 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -175.573 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -162.16 139.4 8.33 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.78 -138.57 48.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 108.284 -1.926 . . . . 0.0 108.284 -175.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.11 -21.03 66.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.689 -0.755 . . . . 0.0 111.835 176.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.7 ttp -65.49 117.04 36.88 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 119.663 1.12 . . . . 0.0 110.888 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.42 153.64 55.58 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.327 2.018 . . . . 0.0 110.021 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 123.46 16.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.333 0.653 . . . . 0.0 109.947 178.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -90.25 -4.44 57.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.844 0.747 . . . . 0.0 111.992 177.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -44.16 114.33 0.66 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.491 1.116 . . . . 0.0 111.893 176.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.71 -21.2 19.9 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.292 0.948 . . . . 0.0 112.898 178.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -87.71 -44.49 11.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.974 0.909 . . . . 0.0 109.298 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 126.93 45.9 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.64 152.37 28.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -30.55 -46.76 0.08 Allowed 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 126.07 1.748 . . . . 0.0 111.686 170.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.08 -50.49 73.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.583 1.083 . . . . 0.0 111.923 178.357 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -57.04 -54.93 41.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.096 1.358 . . . . 0.0 109.202 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.6 mt -50.33 -57.55 7.64 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 125.989 1.716 . . . . 0.0 109.711 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.64 -56.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.882 1.273 . . . . 0.0 109.668 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -57.94 -39.23 77.56 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.136 0.575 . . . . 0.0 111.634 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.69 -48.12 64.7 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.539 -0.726 . . . . 0.0 109.777 177.9 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.37 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.084 1.353 . . . . 0.0 110.768 -176.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.37 -39.54 87.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.949 1.249 . . . . 0.0 109.763 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.53 -59.54 5.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 85.9 mtp -41.33 -64.75 0.51 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.619 1.168 . . . . 0.0 108.709 177.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 mt -46.64 -31.98 3.21 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.845 2.058 . . . . 0.0 113.371 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 m -64.87 -4.86 4.9 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.512 1.051 . . . . 0.0 112.287 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.3 p -154.33 22.85 0.48 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.685 3.994 . . . . 0.0 106.0 -179.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 34' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 C-N-CA 128.257 2.623 . . . . 0.0 113.795 -170.321 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 119.717 -0.182 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.72 -56.48 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 0.0 109.889 -178.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -56.95 -47.19 81.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.992 0.917 . . . . 0.0 111.264 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.92 -64.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.357 -175.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -141.5 43.81 1.74 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.77 0.714 . . . . 0.0 111.374 -173.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.69 36.89 1.22 Allowed Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.225 -0.922 . . . . 0.0 112.304 177.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.97 155.43 48.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.31 1.844 . . . . 0.0 107.703 176.306 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.06 113.28 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.572 -177.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.71 142.91 12.57 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.045 1.052 . . . . 0.0 110.363 -14.352 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -67.83 128.66 37.33 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.503 -178.096 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.2 m -54.38 -48.15 71.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.39 0.676 . . . . 0.0 111.149 -175.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -42.47 -54.65 3.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.184 1.793 . . . . 0.0 112.105 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.7 -35.69 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.236 1.414 . . . . 0.0 112.878 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.0 m -100.78 -57.28 2.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.559 0.343 . . . . 0.0 111.414 -178.024 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -70.5 -35.12 73.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -41.59 88.77 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -74.98 -31.33 61.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.291 1.436 . . . . 0.0 111.344 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.62 33.73 51.27 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -175.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.15 143.08 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 122.096 -0.649 . . . . 0.0 109.744 -176.638 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.47 32.61 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.361 1.064 . . . . 0.0 111.834 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.0 22.3 77.12 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.443 -0.643 . . . . 0.0 113.095 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 136.23 83.27 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.689 1.245 . . . . 0.0 107.745 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.36 123.12 13.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.049 1.833 . . . . 0.0 109.969 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.89 169.45 17.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.267 1.032 . . . . 0.0 110.172 -178.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.87 151.12 19.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.096 179.744 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.81 37.36 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.49 68.34 31.6 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.517 0.727 . . . . 0.0 111.915 -175.068 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -38.98 -51.42 2.43 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.653 3.569 . . . . 0.0 114.867 -177.403 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.98 -40.25 21.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.346 1.059 . . . . 0.0 111.988 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.21 -22.38 66.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.469 0.707 . . . . 0.0 111.884 -177.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -110.15 -30.21 7.85 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.747 1.219 . . . . 0.0 112.607 -175.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.31 -51.03 1.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.68 1.592 . . . . 0.0 113.021 -178.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.22 -26.42 56.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -78.24 142.38 63.33 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.121 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.48 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.179 2.586 . . . . 0.0 108.257 173.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -20.65 55.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.892 1.677 . . . . 0.0 113.639 -170.007 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -50.12 115.83 1.59 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.886 1.274 . . . . 0.0 110.651 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.3 t -48.18 -46.21 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.445 0.698 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.95 -24.31 64.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.853 0.861 . . . . 0.0 113.02 -178.379 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.29 -54.56 4.13 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 mt -47.84 -43.32 28.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -59.91 -37.05 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 121.915 -0.491 . . . . 0.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.3 -44.42 79.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -47.32 72.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.162 0.506 . . . . 0.0 110.19 174.325 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -62.57 -45.99 90.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.9 mt -58.26 -51.83 68.11 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.59 -0.694 . . . . 0.0 109.226 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.06 79.63 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.093 0.557 . . . . 0.0 112.151 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.94 157.19 32.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 108.299 -1.921 . . . . 0.0 108.299 -174.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -156.38 129.48 7.99 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.816 -0.814 . . . . 0.0 109.034 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 -136.85 50.45 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.24 -23.62 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.811 176.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -65.88 115.5 23.49 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 111.147 -177.278 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.45 162.32 27.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.655 2.237 . . . . 0.0 111.255 177.549 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 136.66 43.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.83 -8.02 19.02 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.093 0.957 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -43.42 115.89 0.85 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.321 1.848 . . . . 0.0 111.714 177.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.67 -23.24 9.11 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.912 0.768 . . . . 0.0 112.559 177.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -83.92 -46.83 11.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.924 0.862 . . . . 0.0 108.746 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.29 138.1 37.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.58 25.93 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -173.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 62.19 -41.4 0.16 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.224 2.21 . . . . 0.0 111.979 -173.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -64.81 -36.85 85.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.323 -1.485 . . . . 0.0 110.198 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.92 -58.36 7.21 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 123.229 1.49 . . . . 0.0 108.547 178.728 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.08 -58.64 6.84 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 126.484 1.914 . . . . 0.0 110.022 178.346 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -41.94 -54.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.481 0.713 . . . . 0.0 110.451 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -61.71 -40.53 95.38 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.77 71.56 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.554 -0.717 . . . . 0.0 110.082 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.21 -48.04 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.838 2.055 . . . . 0.0 110.38 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.74 -44.17 90.44 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.891 1.223 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -61.77 -52.59 63.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 ttm -46.17 -50.26 15.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 110.513 179.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.84 -35.39 80.95 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.124 -0.36 . . . . 0.0 110.823 178.131 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -74.8 59.14 0.86 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.588 0.755 . . . . 0.0 111.218 178.666 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 -40.57 0.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.739 2.016 . . . . 0.0 108.979 176.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.344 2.657 . . . . 0.0 111.213 179.441 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mt -70.68 -35.56 61.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.233 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -60.56 -45.02 95.47 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.346 -1.471 . . . . 0.0 109.989 176.448 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 mt -82.4 -28.82 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.548 -0.72 . . . . 0.0 111.545 -177.703 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -125.97 38.09 4.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.724 1.209 . . . . 0.0 110.707 -174.253 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.76 46.85 2.08 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 129.488 3.423 . . . . 0.0 112.041 -178.213 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.259 3.1 p 69.73 -142.11 0.08 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.414 1.885 . . . . 0.0 111.553 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.31 124.56 29.43 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 124.307 1.043 . . . . 0.0 110.863 -172.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -62.56 177.73 9.52 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 119.541 0.872 . . . . 0.0 110.112 -18.111 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 136.85 33.27 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.877 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 m -54.62 -51.62 64.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.306 0.643 . . . . 0.0 110.222 -176.248 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -40.91 -61.34 0.99 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.518 1.927 . . . . 0.0 112.817 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.72 -35.02 13.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.042 0.937 . . . . 0.0 112.55 -178.267 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.5 m -85.92 -59.9 2.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 118.594 0.634 . . . . 0.0 110.165 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -61.23 -50.81 71.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.643 0.777 . . . . 0.0 113.028 -173.6 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.86 -39.68 71.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.199 0.454 . . . . 0.0 110.994 -178.463 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -88.23 -2.07 58.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.078 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 35.68 82.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.389 0.995 . . . . 0.0 112.443 -177.764 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.79 130.75 17.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 O-C-N 121.931 -0.746 . . . . 0.0 109.195 -179.242 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.92 31.41 8.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 111.479 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.67 78.95 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.355 -0.692 . . . . 0.0 112.568 179.749 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.43 137.9 68.71 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.578 1.189 . . . . 0.0 108.53 176.134 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.72 121.06 9.13 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.239 1.959 . . . . 0.0 109.098 -179.032 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.42 166.56 23.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.404 1.097 . . . . 0.0 112.359 -174.223 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.3 164.38 26.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.131 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.66 53.32 0.46 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.173 1.389 . . . . 0.0 111.735 -178.713 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.67 68.13 19.47 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.702 -176.094 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.89 -48.59 2.78 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.453 3.435 . . . . 0.0 114.44 -177.351 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -50.61 -40.53 52.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.05 -23.85 66.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.339 0.655 . . . . 0.0 111.535 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -105.51 -30.71 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.348 1.059 . . . . 0.0 112.749 -174.959 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.54 -50.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.784 1.634 . . . . 0.0 112.998 -178.907 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.9 -22.31 42.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.954 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -78.99 158.06 75.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.569 -0.707 . . . . 0.0 110.377 -177.302 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.52 108.91 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.886 2.391 . . . . 0.0 110.939 176.508 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.87 -37.02 75.6 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 m -59.69 107.97 0.67 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.752 1.621 . . . . 0.0 111.555 178.854 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -48.41 -41.92 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.494 1.118 . . . . 0.0 110.405 178.182 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.0 -27.16 17.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.231 1.412 . . . . 0.0 112.869 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.26 -49.57 7.17 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.233 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 mt -51.14 -39.44 56.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.875 0.87 . . . . 0.0 112.457 179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.15 -33.16 49.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.652 177.571 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.17 -49.59 71.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.48 1.491 . . . . 0.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -51.83 -47.2 64.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.067 0.947 . . . . 0.0 110.114 175.395 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -66.87 -42.16 86.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.212 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.99 -56.13 24.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.04 -27.92 57.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.233 1.013 . . . . 0.0 112.869 -176.378 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 164.69 29.11 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -175.263 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -157.96 112.15 2.57 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -113.48 5.1 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -178.898 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.26 -31.33 65.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.969 0.508 . . . . 0.0 111.243 178.043 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.2 ttp -64.7 118.47 48.54 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.55 -176.427 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.5 157.5 40.63 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.742 2.295 . . . . 0.0 110.058 179.068 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 139.05 58.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.969 0.508 . . . . 0.0 110.685 178.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -114.53 -0.45 13.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.84 0.856 . . . . 0.0 111.63 175.436 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -46.67 117.86 1.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.232 1.013 . . . . 0.0 111.781 175.834 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.31 -19.62 21.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.1 0.857 . . . . 0.0 112.548 179.73 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -88.95 -45.18 9.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.489 1.115 . . . . 0.0 108.662 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -120.5 123.09 42.09 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.799 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.95 146.05 48.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.327 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -25.65 -52.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.449 2.3 . . . . 0.0 112.01 168.058 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.1 -45.64 84.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.86 0.464 . . . . 0.0 111.788 -178.511 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.17 -48.51 79.77 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 62' ' ' ALA . 92.6 mt -52.34 -59.48 4.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.168 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 t -42.77 -59.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.288 1.035 . . . . 0.0 109.673 177.036 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -54.99 -42.69 72.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 118.37 0.532 . . . . 0.0 112.335 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.65 -53.67 47.7 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -55.36 -44.14 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.609 1.163 . . . . 0.0 110.262 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -56.02 -55.59 31.01 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 118.784 0.72 . . . . 0.0 109.097 177.877 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -55.19 -51.28 67.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.297 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 ttm -48.58 -62.14 1.66 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.603 1.161 . . . . 0.0 109.326 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.55 -35.58 68.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.485 0.714 . . . . 0.0 111.661 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 m -62.95 -5.54 3.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.472 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -87.9 -14.67 38.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.484 1.493 . . . . 0.0 111.004 175.588 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 116.718 -1.61 . . . . 0.0 110.401 -177.883 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.38 -55.93 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.843 0.747 . . . . 0.0 109.842 179.189 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -63.54 -43.01 98.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -178.649 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.75 -45.17 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 112.091 -172.187 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -151.41 -10.9 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.437 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.78 3.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.026 1.285 . . . . 0.0 111.442 -176.126 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -136.08 147.16 47.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.256 1.822 . . . . 0.0 106.766 177.377 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.5 109.23 10.26 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.813 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.24 159.87 30.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 CA-C-N 120.193 1.105 . . . . 0.0 111.85 -8.945 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -74.18 122.58 22.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.117 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -54.4 -51.6 64.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.548 0.69 . . . . 0.0 110.102 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -39.68 -61.37 0.84 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.006 2.122 . . . . 0.0 112.419 179.654 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -42.92 -43.49 4.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.002 1.321 . . . . 0.0 113.068 -177.826 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.31 -55.61 3.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.463 0.305 . . . . 0.0 111.305 -177.911 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -64.75 -33.97 77.22 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.863 0.865 . . . . 0.0 113.172 -173.728 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.83 -48.02 82.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.544 0.611 . . . . 0.0 109.355 177.656 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -73.05 -30.58 63.82 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.229 0.612 . . . . 0.0 111.31 179.237 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.35 49.45 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -174.664 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.67 141.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.673 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.11 31.5 6.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.287 1.035 . . . . 0.0 111.668 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.61 76.38 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.993 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.25 87.58 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.564 1.182 . . . . 0.0 108.674 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -62.75 114.97 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.74 2.293 . . . . 0.0 108.764 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -80.93 174.23 11.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.729 0.776 . . . . 0.0 112.667 -172.544 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.6 160.64 16.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 170.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.73 51.88 0.96 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.176 1.39 . . . . 0.0 112.419 176.696 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.33 59.01 19.09 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 123.807 0.843 . . . . 0.0 111.005 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -38.56 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.558 3.505 . . . . 0.0 114.025 -177.753 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -47.66 -40.8 20.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.402 1.481 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.94 -26.09 53.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.637 -177.572 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -91.6 -26.08 18.88 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.587 0.755 . . . . 0.0 111.736 -177.359 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.14 -46.33 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.159 2.184 . . . . 0.0 114.437 -178.129 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -91.91 -15.14 28.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.441 0.697 . . . . 0.0 112.816 -175.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -81.08 148.78 64.92 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.489 0.716 . . . . 0.0 109.655 -177.496 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.34 129.41 28.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.58 2.186 . . . . 0.0 111.157 176.774 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -67.21 -40.84 86.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.415 0.626 . . . . 0.0 110.348 179.203 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.74 110.32 1.13 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.393 1.477 . . . . 0.0 111.425 -177.869 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.74 -36.78 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.21 1.004 . . . . 0.0 109.891 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.48 -33.71 63.91 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.356 1.863 . . . . 0.0 111.343 177.49 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -83.4 -50.67 8.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -51.73 -38.12 53.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 68' ' ' VAL . 4.1 m -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 118.946 -1.101 . . . . 0.0 110.467 177.989 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.15 -44.9 83.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.734 1.606 . . . . 0.0 109.409 -179.418 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -58.04 -33.05 68.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 110.468 174.312 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -75.73 -47.47 25.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.179 0.991 . . . . 0.0 110.007 -179.167 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.8 -48.06 73.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 120.598 -1.314 . . . . 0.0 110.099 174.595 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.32 74.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 112.692 -178.134 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.9 162.63 29.88 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -175.074 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.1 129.63 4.49 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.769 0.784 . . . . 0.0 109.083 -178.173 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.89 -120.28 21.78 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -177.696 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.2 -13.92 48.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.916 177.782 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.0 ttp -66.53 117.16 41.52 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 119.254 0.934 . . . . 0.0 110.38 -178.261 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.27 159.72 38.21 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.346 2.031 . . . . 0.0 111.064 177.302 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.83 118.58 10.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.191 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -82.02 -4.22 56.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.467 1.031 . . . . 0.0 113.205 -179.092 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.57 86.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.292 1.037 . . . . 0.0 112.484 -179.656 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 128.02 -33.97 3.08 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.548 1.547 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -78.33 -34.76 48.36 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.667 0.734 . . . . 0.0 110.936 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -141.39 146.01 36.06 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.762 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.99 138.94 31.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.209 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -30.59 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.274 2.23 . . . . 0.0 113.028 173.111 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.17 -57.64 11.96 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.619 0.645 . . . . 0.0 110.441 177.808 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.49 -53.71 47.56 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.98 0.895 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 62' ' ' ALA . 28.5 mt -47.73 -55.27 9.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.85 1.66 . . . . 0.0 110.561 176.484 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 HG11 ' A' ' 45' ' ' VAL . 1.7 t -51.22 -58.67 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.181 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -54.51 -37.36 65.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.117 0.567 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.1 82.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.36 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 45' ' ' VAL . 54.3 mt -62.54 -47.38 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.507 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -45.25 -56.43 4.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.605 1.093 . . . . 0.0 109.751 176.56 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -55.66 -52.66 63.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.917 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 ptm -54.85 -43.62 73.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.533 0.606 . . . . 0.0 110.251 -178.587 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.3 mt -69.71 -29.78 67.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.625 -0.672 . . . . 0.0 111.057 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 m -73.96 43.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.036 0.834 . . . . 0.0 112.678 179.835 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -135.89 -13.83 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.783 2.033 . . . . 0.0 109.914 174.155 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.035 -179.109 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.827 0.346 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.81 -40.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.835 0.854 . . . . 0.0 110.586 -177.554 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 28' ' ' LEU . 38.5 t80 -64.68 -41.66 95.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.962 0.801 . . . . 0.0 110.247 177.609 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.35 -47.61 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.914 ' HB2' HG22 ' A' ' 13' ' ' THR . 30.5 m-80 110.74 88.1 0.0 OUTLIER 'General case' 0 C--N 1.345 0.411 0 C-N-CA 130.612 3.565 . . . . 0.0 114.009 162.397 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.41 -20.43 58.8 Favored Glycine 0 CA--C 1.551 2.301 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 156.192 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 163.92 3.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 129.214 3.006 . . . . 0.0 111.356 175.067 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.43 124.86 9.89 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.248 1.419 . . . . 0.0 107.494 177.281 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.65 178.46 5.8 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 CA-C-N 120.525 1.223 . . . . 0.0 112.464 -8.896 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -100.18 109.01 21.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 110.295 179.598 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -41.54 -53.8 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.388 1.475 . . . . 0.0 109.943 176.687 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -44.1 -55.4 4.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.267 2.227 . . . . 0.0 111.513 -178.168 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -50.22 -37.46 35.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.492 0.717 . . . . 0.0 112.332 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 m -84.34 -59.45 2.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 110.325 -179.496 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -59.91 -42.49 93.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.956 1.302 . . . . 0.0 113.069 -174.67 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.63 -38.54 90.63 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.453 0.569 . . . . 0.0 110.015 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -25.3 41.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.43 0.692 . . . . 0.0 111.17 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.99 64.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.743 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.44 138.46 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.75 29.3 5.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.331 1.053 . . . . 0.0 111.72 -177.791 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.06 23.97 74.87 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.804 179.354 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 129.61 84.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 118.566 1.183 . . . . 0.0 108.362 176.423 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.9 Cg_endo -61.22 122.04 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.256 1.971 . . . . 0.0 109.742 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -86.97 178.32 6.98 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.641 0.734 . . . . 0.0 111.805 -174.434 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' OH ' ' A' ' 6' ' ' TYR . 2.3 mm? -70.65 163.45 27.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 171.861 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 m120 48.07 34.39 4.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.681 0.792 . . . . 0.0 112.865 175.58 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.05 62.23 62.87 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.7 0.682 . . . . 0.0 112.384 -174.971 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -39.77 -51.55 2.92 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.151 3.234 . . . . 0.0 114.801 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.66 -40.95 41.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.776 0.831 . . . . 0.0 112.079 -179.083 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.8 -19.94 64.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.269 0.628 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 96.5 m95 -102.32 -35.88 8.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 111.803 -178.58 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.27 -51.71 1.05 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.053 1.741 . . . . 0.0 113.131 -178.419 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.7 -24.44 53.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.047 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.99 157.38 81.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 O-C-N 121.621 -0.674 . . . . 0.0 110.117 -177.681 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.08 113.97 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.025 2.483 . . . . 0.0 111.583 178.172 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.46 -36.09 75.3 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 110.602 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 106.08 0.48 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.444 1.498 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.3 -36.03 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 121.844 -0.535 . . . . 0.0 109.563 176.914 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.99 -24.26 57.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.102 0.961 . . . . 0.0 112.528 177.655 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -89.34 -49.8 6.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.642 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.62 -40.99 41.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.32 -37.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 O-C-N 121.44 -0.787 . . . . 0.0 110.157 179.088 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.59 -47.77 80.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.436 1.016 . . . . 0.0 108.366 177.973 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -53.93 -37.62 64.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.124 0.17 . . . . 0.0 110.754 175.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.5 m -74.06 -48.7 28.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.911 -0.493 . . . . 0.0 110.713 -177.641 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -66.68 -44.62 81.31 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.587 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.66 -35.04 60.5 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.38 0.672 . . . . 0.0 111.809 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 152.31 23.66 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -176.521 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' H ' ' HB3' ' A' ' 55' ' ' MET . 85.4 tttt -153.53 141.46 20.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -119.93 18.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.08 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.07 3.48 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.839 0.855 . . . . 0.0 112.095 178.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.6 ttp -69.74 123.65 89.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.047 0.84 . . . . 0.0 110.144 -178.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.26 145.15 59.12 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.568 1.512 . . . . 0.0 108.622 176.192 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.86 57.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.416 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -97.56 -36.82 10.17 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.109 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 t70 38.76 -144.52 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.228 2.211 . . . . 0.0 111.76 -179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.4 -20.4 5.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.999 2.238 . . . . 0.0 113.211 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -61.84 -30.3 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.483 1.141 . . . . 0.0 109.614 176.594 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.15 106.91 11.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.123 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -63.11 86.84 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.432 1.893 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 16.37 -64.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.516 3.526 . . . . 0.0 115.513 174.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -50.25 -35.79 28.42 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 111.065 178.69 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.27 -55.31 29.59 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.69 0.757 . . . . 0.0 109.588 178.177 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.4 mt -52.49 -53.56 44.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.738 1.215 . . . . 0.0 109.551 176.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.2 t -44.6 -58.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.453 1.101 . . . . 0.0 109.603 176.935 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -57.04 -39.76 75.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 118.891 0.768 . . . . 0.0 112.461 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.28 96.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.4 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.32 -47.14 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 108.74 179.318 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -52.69 -51.81 58.7 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.517 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -55.37 -54.36 44.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.072 178.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -52.1 -47.96 64.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.096 0.559 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.76 -35.62 80.4 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.861 -0.525 . . . . 0.0 110.312 177.735 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.5 m -73.5 39.08 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.391 -0.818 . . . . 0.0 113.2 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.8 p -131.16 -14.32 3.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.979 1.711 . . . . 0.0 109.764 173.055 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.516 -1.707 . . . . 0.0 110.135 -178.446 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.21 -57.99 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.607 1.163 . . . . 0.0 109.37 178.95 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -56.95 -48.26 78.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.125 0.57 . . . . 0.0 111.763 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.34 -48.49 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.231 -174.154 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -5.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -172.916 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.23 37.46 3.51 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.072 1.306 . . . . 0.0 111.144 -176.061 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.6 151.46 49.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.422 1.489 . . . . 0.0 108.131 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.74 13.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.59 1.156 . . . . 0.0 109.695 -177.834 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.55 162.02 44.69 Favored 'Cis proline' 0 N--CA 1.455 -0.758 0 CA-C-N 120.266 1.131 . . . . 0.0 109.544 -13.163 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -67.97 129.1 38.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.776 0.83 . . . . 0.0 110.467 -177.867 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.48 -46.85 83.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 -178.584 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 p -39.16 -55.19 1.68 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.709 2.004 . . . . 0.0 112.74 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -43.09 -38.03 2.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.666 1.186 . . . . 0.0 112.916 -178.496 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.34 -57.14 2.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.15 -177.617 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -70.27 -24.23 63.02 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -172.871 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.47 -54.82 38.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.036 0.834 . . . . 0.0 109.89 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -16.28 28.02 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.442 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 45.84 7.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 p -58.7 141.33 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.697 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.09 29.1 5.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.019 0.928 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.84 75.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.814 179.869 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 137.1 88.34 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 118.787 1.294 . . . . 0.0 108.208 175.778 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.42 117.34 4.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.552 2.168 . . . . 0.0 109.782 -178.484 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -76.31 175.87 8.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.943 0.877 . . . . 0.0 109.282 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.47 149.78 21.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 63.25 31.11 15.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.413 0.685 . . . . 0.0 109.506 -173.713 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.58 57.77 27.19 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.04 0.936 . . . . 0.0 112.618 -177.663 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -34.36 -48.14 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 114.267 -179.464 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -39.65 -46.79 1.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.006 1.722 . . . . 0.0 112.68 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -76.55 -29.54 56.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.146 0.43 . . . . 0.0 111.522 -177.024 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -85.36 -20.69 29.53 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.403 0.681 . . . . 0.0 111.43 -177.034 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.58 -45.46 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.448 1.899 . . . . 0.0 113.758 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -94.08 -14.96 25.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.795 0.838 . . . . 0.0 112.825 -177.032 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -79.88 127.24 78.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.945 0.898 . . . . 0.0 109.093 -177.778 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.44 126.35 19.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.602 2.202 . . . . 0.0 111.558 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -65.68 -27.07 68.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.314 0.646 . . . . 0.0 111.126 179.568 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.0 102.68 0.05 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 111.243 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 45' ' ' VAL . 44.6 t -42.52 -51.17 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 124.211 1.004 . . . . 0.0 110.195 179.492 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -51.7 -44.54 63.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.98 -47.59 82.5 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.16 -38.65 87.23 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.649 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG22 HD12 ' A' ' 71' ' ' ILE . 86.6 t -64.26 -40.3 88.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.326 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -60.39 -48.92 79.67 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.282 0.946 . . . . 0.0 109.547 174.868 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -54.06 -43.87 70.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.499 0.59 . . . . 0.0 111.158 177.459 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -69.04 -44.71 72.11 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.91 -0.494 . . . . 0.0 110.011 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -55.4 -53.29 58.12 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.369 -0.832 . . . . 0.0 110.601 177.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.05 -26.01 43.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.72 1.208 . . . . 0.0 113.342 -176.006 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.86 160.66 31.87 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.145 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -158.21 119.98 3.59 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.633 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.91 -119.34 17.44 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -178.443 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.6 -21.46 55.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.761 0.424 . . . . 0.0 111.598 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.0 ttp -69.0 121.96 83.51 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 118.795 0.725 . . . . 0.0 110.236 -177.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.7 157.28 39.91 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.57 2.18 . . . . 0.0 110.179 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.49 123.0 16.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.324 177.397 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -89.72 -10.21 46.53 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.223 0.92 . . . . 0.0 112.71 178.414 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -50.01 111.8 0.57 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.927 0.491 . . . . 0.0 110.436 178.735 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.81 -36.96 4.0 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.477 1.037 . . . . 0.0 111.72 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.2 mtm-85 -85.41 -47.62 9.8 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.13 0.965 . . . . 0.0 110.052 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.75 126.91 53.83 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.404 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.34 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -25.92 -52.13 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.181 2.192 . . . . 0.0 112.074 170.342 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -60.28 -49.86 75.92 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.433 0.56 . . . . 0.0 111.576 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -55.47 -55.61 29.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 122.139 0.971 . . . . 0.0 109.024 178.531 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.7 mt -49.7 -58.92 4.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.946 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.67 -55.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.672 1.589 . . . . 0.0 110.587 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -58.54 -44.16 89.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.224 0.61 . . . . 0.0 111.199 -178.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.67 -45.08 88.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.695 -0.628 . . . . 0.0 109.938 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.435 HD12 HG22 ' A' ' 45' ' ' VAL . 60.1 mt -67.59 -46.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.614 1.166 . . . . 0.0 111.303 -175.9 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.28 -42.06 90.38 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.28 1.4 . . . . 0.0 109.402 178.28 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -62.29 -50.04 73.25 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.881 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.6 ttm -48.89 -52.95 21.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.846 0.858 . . . . 0.0 109.264 178.587 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.53 -39.12 89.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.106 0.562 . . . . 0.0 111.745 178.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.2 p -62.4 -8.61 6.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.45 1.023 . . . . 0.0 113.536 -177.06 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 p -79.26 -14.75 58.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.519 1.054 . . . . 0.0 111.007 176.115 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.603 -1.665 . . . . 0.0 111.03 -174.888 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.572 0.701 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.72 -54.98 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.888 1.275 . . . . 0.0 108.873 -178.331 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -60.3 -47.15 87.25 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.217 0.462 . . . . 0.0 111.495 -177.682 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mm -70.78 -46.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.558 -172.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -149.95 -11.71 0.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.098 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.11 35.37 4.29 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 120.114 1.324 . . . . 0.0 111.773 -174.518 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -135.56 152.39 51.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.956 1.303 . . . . 0.0 108.051 177.634 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.744 -178.681 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 158.92 26.32 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 119.941 1.015 . . . . 0.0 111.853 -10.6 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 122.0 19.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.338 1.055 . . . . 0.0 109.712 179.353 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.26 -50.52 61.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 0.0 110.379 -178.145 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -40.28 -55.83 2.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.445 1.898 . . . . 0.0 112.695 178.88 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.1 m -46.04 -32.48 2.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 113.01 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -99.05 -57.04 2.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.044 0.384 . . . . 0.0 111.026 179.444 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -68.44 -32.27 72.18 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.222 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.65 -42.7 86.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 118.828 0.74 . . . . 0.0 109.126 179.271 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.94 -27.96 35.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.313 -178.315 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.75 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.566 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 139.9 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.141 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.21 28.56 5.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.088 0.955 . . . . 0.0 111.546 -177.57 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.44 24.11 76.82 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.365 -0.686 . . . . 0.0 112.857 179.597 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.57 131.78 77.36 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.767 1.283 . . . . 0.0 108.498 175.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -60.47 117.56 4.33 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 109.28 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -89.21 178.86 6.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.749 0.785 . . . . 0.0 112.771 -171.213 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.99 159.21 23.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.432 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.16 53.87 0.73 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.685 1.594 . . . . 0.0 112.541 177.053 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.57 59.34 24.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.171 0.989 . . . . 0.0 110.461 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.66 -52.45 2.59 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.455 3.437 . . . . 0.0 114.489 -175.815 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -49.87 -35.08 22.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.246 1.018 . . . . 0.0 112.765 -179.26 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.43 -28.17 60.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.783 0.72 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -91.86 -30.2 16.3 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.568 0.747 . . . . 0.0 111.981 -177.154 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.89 -51.14 0.69 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.647 1.979 . . . . 0.0 113.484 -178.003 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.44 -25.28 54.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.764 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.98 152.65 82.56 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 110.033 -177.167 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.73 110.64 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.538 1.492 . . . . 0.0 108.482 176.038 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.52 -28.96 57.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -53.48 103.85 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.884 1.674 . . . . 0.0 111.444 178.402 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.6 t -51.14 -39.64 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.555 0.742 . . . . 0.0 110.337 178.409 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.97 -23.46 45.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.383 1.073 . . . . 0.0 112.679 179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -90.55 -53.04 4.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.374 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -49.84 -39.81 40.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.114 0.966 . . . . 0.0 112.506 179.747 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -33.81 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 121.664 -0.648 . . . . 0.0 110.266 179.103 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.45 -46.87 78.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.453 1.024 . . . . 0.0 108.735 176.954 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -53.54 -44.45 69.2 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.252 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -65.95 -47.61 74.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.078 0.551 . . . . 0.0 110.684 -179.5 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.24 -49.1 79.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.359 -0.838 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.79 61.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.394 1.078 . . . . 0.0 112.572 -177.588 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.36 161.32 31.45 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -175.898 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -159.62 114.4 2.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.581 0.69 . . . . 0.0 109.725 -177.216 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.67 -117.76 12.61 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.108 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.201 177.828 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.8 ttp -65.63 119.2 58.31 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.33 -177.469 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.02 160.78 46.67 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.29 1.994 . . . . 0.0 110.154 178.797 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.19 117.35 9.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.876 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -82.16 -7.77 59.63 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.646 0.657 . . . . 0.0 112.368 178.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -49.88 113.64 0.89 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.821 0.737 . . . . 0.0 110.321 176.92 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.7 -28.95 9.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.061 0.838 . . . . 0.0 112.121 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -76.07 -43.91 41.46 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.646 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -131.02 152.9 49.83 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.831 0.852 . . . . 0.0 108.73 176.875 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -88.95 132.89 34.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.994 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -29.65 -47.4 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.402 2.281 . . . . 0.0 113.391 173.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -69.01 -41.7 77.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 111.312 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 -46.5 83.0 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.737 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 62' ' ' ALA . 55.3 mt -51.99 -61.12 2.46 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.557 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 t -41.12 -56.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.348 1.459 . . . . 0.0 109.594 177.54 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.8 -44.01 73.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.926 0.49 . . . . 0.0 111.512 179.658 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -48.2 75.67 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.707 -0.62 . . . . 0.0 109.852 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.5 mt -57.52 -50.42 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 123.871 0.868 . . . . 0.0 110.602 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -40.76 96.46 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 120.253 1.388 . . . . 0.0 109.294 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -57.76 -50.62 72.62 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.724 0.693 . . . . 0.0 109.561 176.885 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.66 -52.82 54.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 178.385 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.81 -33.8 68.98 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.745 -0.597 . . . . 0.0 111.839 176.975 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -73.01 38.0 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.402 1.001 . . . . 0.0 113.423 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.9 p -132.01 -15.77 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.314 1.845 . . . . 0.0 109.479 171.681 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.724 179.96 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -44.94 -57.39 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.293 1.037 . . . . 0.0 110.508 -178.025 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.74 -47.21 72.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.919 0.487 . . . . 0.0 111.721 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.55 -46.79 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -172.686 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -145.22 -5.06 0.69 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -170.608 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.43 33.95 6.17 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 120.168 1.349 . . . . 0.0 112.042 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.64 150.52 51.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.119 1.768 . . . . 0.0 107.403 177.525 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.58 109.62 14.69 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 0.0 110.272 -177.172 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.01 163.07 50.14 Favored 'Cis proline' 0 N--CA 1.455 -0.79 0 CA-C-N 120.292 1.14 . . . . 0.0 110.065 -10.725 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -69.17 129.42 39.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.327 1.051 . . . . 0.0 110.177 -178.341 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -59.19 -46.51 88.22 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.443 0.639 . . . . 0.0 111.044 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -37.27 -57.19 0.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.207 2.203 . . . . 0.0 112.168 179.24 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.15 -34.52 0.18 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.512 1.925 . . . . 0.0 113.677 -178.417 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.55 -57.89 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.497 0.719 . . . . 0.0 110.625 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -64.27 -24.07 67.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -172.212 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -73.59 -22.0 60.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 119.986 1.266 . . . . 0.0 111.052 177.231 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -107.5 -24.76 11.68 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.91 0.884 . . . . 0.0 111.683 -178.304 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.35 32.62 51.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.78 140.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.313 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.57 28.8 6.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -177.192 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.98 77.0 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.319 -0.712 . . . . 0.0 112.892 179.39 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 130.76 82.88 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 118.798 1.299 . . . . 0.0 108.644 176.851 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.14 121.73 9.49 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.601 2.201 . . . . 0.0 108.648 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -89.28 178.67 6.28 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.954 0.883 . . . . 0.0 113.277 -171.335 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.9 160.92 29.8 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.729 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.78 52.9 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.769 1.628 . . . . 0.0 111.674 177.165 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.23 64.34 19.71 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 110.456 -177.518 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -38.68 -50.55 2.43 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.302 3.335 . . . . 0.0 114.099 -177.947 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -49.22 -39.98 31.92 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.179 0.992 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -64.16 -28.65 69.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.259 0.624 . . . . 0.0 111.337 -179.15 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.83 -27.01 13.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.712 1.205 . . . . 0.0 112.384 -174.873 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.84 -43.88 0.98 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.061 1.744 . . . . 0.0 113.744 -178.884 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.8 -15.89 25.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.586 0.754 . . . . 0.0 112.771 -176.373 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.3 133.93 44.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 109.597 -177.574 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.19 105.32 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.991 2.461 . . . . 0.0 110.302 176.938 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.98 -24.87 63.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.876 0.87 . . . . 0.0 113.038 -175.56 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -52.48 102.24 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.441 1.497 . . . . 0.0 111.424 179.781 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.0 t -47.6 -45.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.293 1.037 . . . . 0.0 110.255 179.29 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.35 -29.32 58.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.915 1.286 . . . . 0.0 112.168 -179.014 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -86.19 -50.73 6.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.431 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.3 mt -50.46 -40.94 52.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.062 0.545 . . . . 0.0 112.21 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -59.6 -30.8 45.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.984 178.881 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.7 -50.04 68.54 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.224 1.375 . . . . 0.0 108.471 177.966 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -53.81 -42.67 68.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.173 0.589 . . . . 0.0 110.128 176.238 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -68.22 -44.36 75.9 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.813 0.34 . . . . 0.0 110.681 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.66 -47.24 86.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.83 -31.19 51.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 112.716 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 159.0 28.58 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -175.075 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.495 ' H ' ' HB3' ' A' ' 55' ' ' MET . 53.9 tttp -156.77 124.55 5.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.86 -114.89 6.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.3 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.67 -18.86 33.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.738 0.815 . . . . 0.0 112.028 178.243 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.4 ttp -62.25 124.57 82.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 118.948 0.795 . . . . 0.0 110.439 -176.994 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.49 158.24 51.44 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.082 1.854 . . . . 0.0 109.31 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 114.5 6.57 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.99 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.78 -7.41 58.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.306 179.473 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.74 113.18 0.66 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.842 0.747 . . . . 0.0 110.936 177.148 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 -27.18 11.55 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.164 0.887 . . . . 0.0 112.331 179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.73 -49.73 13.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.838 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -130.71 134.56 47.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.183 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.69 149.0 34.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.472 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -27.72 -50.16 0.06 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.144 1.777 . . . . 0.0 112.402 168.641 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -69.02 -39.63 79.13 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.638 -0.664 . . . . 0.0 112.21 -178.637 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.38 -53.27 60.15 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.618 1.099 . . . . 0.0 108.208 175.595 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 62' ' ' ALA . 54.7 mt -49.61 -59.4 3.82 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 125.802 1.641 . . . . 0.0 109.155 177.158 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 t -43.19 -57.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 109.077 176.243 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -58.63 -31.96 68.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.545 -0.74 . . . . 0.0 112.106 -176.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.87 -52.63 14.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.222 0.919 . . . . 0.0 109.262 176.93 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.7 mt -53.03 -39.71 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.468 1.107 . . . . 0.0 110.073 178.782 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -52.31 -56.61 13.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.092 0.86 . . . . 0.0 109.637 176.226 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -55.83 -53.88 51.37 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.3 ttm -47.22 -61.07 2.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.101 0.96 . . . . 0.0 110.331 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.45 -35.74 78.45 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.042 -0.411 . . . . 0.0 111.137 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -62.53 -5.0 2.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.787 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -88.97 -13.83 38.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.393 1.451 . . . . 0.0 111.265 176.399 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.638 -176.659 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.28 -55.26 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.431 1.014 . . . . 0.0 108.759 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -69.56 -50.46 44.55 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -178.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.38 -50.53 72.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.531 -174.425 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -158.73 51.86 0.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -169.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.38 35.7 0.52 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.408 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.23 154.41 50.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.228 1.811 . . . . 0.0 106.586 175.48 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.58 105.34 10.89 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.091 -176.187 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.21 155.97 77.1 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.208 1.11 . . . . 0.0 110.417 -7.038 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 129.9 42.42 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.615 1.166 . . . . 0.0 110.719 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -52.47 -48.51 65.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.409 1.1 . . . . 0.0 110.143 178.721 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -49.29 -39.57 31.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.334 1.853 . . . . 0.0 112.207 179.205 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -47.0 -40.39 14.44 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.893 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -99.37 -51.29 3.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.954 0.783 . . . . 0.0 110.929 -177.152 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -69.27 -22.97 63.78 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.67 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.7 -42.9 90.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.469 1.031 . . . . 0.0 110.127 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.01 -25.32 17.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.701 0.8 . . . . 0.0 111.569 179.181 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 37.83 13.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.027 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.18 149.09 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -176.591 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.29 30.11 7.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.136 0.974 . . . . 0.0 111.291 -178.108 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.75 23.16 78.39 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.63 132.57 91.3 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.908 1.354 . . . . 0.0 108.132 176.382 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.63 118.08 5.03 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.181 1.92 . . . . 0.0 107.778 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -75.72 162.72 27.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.834 0.825 . . . . 0.0 111.52 -174.343 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.95 159.47 34.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 170.566 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.57 56.8 2.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.599 1.159 . . . . 0.0 111.191 -177.356 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 63.3 5.45 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 0.0 109.65 -177.679 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -45.35 -44.5 16.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.063 3.175 . . . . 0.0 113.43 -175.116 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -50.0 -34.59 21.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.904 0.881 . . . . 0.0 112.335 178.441 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.11 -28.61 64.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.025 0.53 . . . . 0.0 111.455 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -99.09 -15.68 18.92 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.417 1.087 . . . . 0.0 111.958 -176.162 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.36 -45.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.236 1.814 . . . . 0.0 112.935 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.33 30.47 7.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.042 0.937 . . . . 0.0 112.638 -176.872 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -121.1 124.42 27.39 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 108.074 177.604 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.88 108.71 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.417 2.745 . . . . 0.0 110.826 178.121 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.01 -24.78 59.67 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.589 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -49.1 105.54 0.08 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.016 1.727 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -49.45 -45.25 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.484 0.714 . . . . 0.0 109.442 177.658 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.44 -23.4 49.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.858 1.263 . . . . 0.0 113.145 -179.122 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.58 -55.05 3.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.566 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.1 mt -50.82 -39.49 53.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.733 1.213 . . . . 0.0 112.444 -178.589 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.39 -35.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.623 -0.673 . . . . 0.0 109.949 179.485 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -48.8 75.08 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.173 0.897 . . . . 0.0 108.69 177.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -53.16 -37.35 61.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.696 0.798 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -75.15 -47.53 28.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.109 0.564 . . . . 0.0 109.996 -178.792 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.58 -48.8 80.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.441 1.097 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.02 -33.63 65.85 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.889 0.876 . . . . 0.0 110.921 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.32 86.85 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.255 0.919 . . . . 0.0 111.272 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -77.72 144.99 36.82 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.915 1.286 . . . . 0.0 109.97 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.91 5.99 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.018 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.69 -0.26 51.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.028 0.931 . . . . 0.0 112.424 -179.352 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.5 mtm -71.57 139.51 83.79 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 119.413 1.006 . . . . 0.0 111.179 -178.402 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.91 153.54 58.3 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 171.901 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.53 113.91 5.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -78.4 -16.16 57.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.533 -179.801 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -49.6 113.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.51 1.05 . . . . 0.0 110.511 175.285 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.41 -32.55 7.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.38 0.99 . . . . 0.0 111.493 -179.002 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -76.27 -46.21 29.0 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.397 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.51 138.26 39.49 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.488 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -79.1 147.65 32.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 68' ' ' VAL . 67.1 ttt-85 -30.53 -51.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.489 1.915 . . . . 0.0 111.782 169.412 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.32 -29.43 65.01 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.543 -0.723 . . . . 0.0 112.168 -176.991 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.31 -58.98 4.17 Favored 'General case' 0 N--CA 1.459 0.021 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.18 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 62' ' ' ALA . 74.5 mt -44.18 -55.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.097 1.759 . . . . 0.0 110.18 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ARG . 3.3 t -38.5 -51.66 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 111.266 178.306 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -59.0 -47.0 86.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.451 0.643 . . . . 0.0 110.791 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.44 94.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.929 -0.482 . . . . 0.0 109.775 -179.664 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.41 -49.47 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.501 1.12 . . . . 0.0 110.405 -178.649 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.1 -41.12 99.3 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.155 -0.966 . . . . 0.0 109.243 -179.334 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -58.17 -55.7 31.54 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.838 0.745 . . . . 0.0 109.299 176.66 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.8 ttm -43.34 -53.29 5.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.201 1.8 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.52 -38.51 91.27 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.995 -0.44 . . . . 0.0 111.348 178.762 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.9 m -75.25 45.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.861 0.864 . . . . 0.0 113.024 -178.395 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.2 p -138.77 -18.96 1.04 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.091 1.756 . . . . 0.0 110.398 173.854 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.492 -1.718 . . . . 0.0 110.922 -177.478 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.1 -41.2 52.81 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.95 -52.58 64.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -51.11 -52.34 44.69 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.592 0.633 . . . . 0.0 110.511 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.2 mt -53.0 -59.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.534 0.734 . . . . 0.0 109.544 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -52.17 -49.07 64.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 112.435 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.1 -50.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.556 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -138.98 -17.09 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.99 36.1 3.77 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 120.075 1.307 . . . . 0.0 111.34 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -136.77 150.51 48.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.611 1.564 . . . . 0.0 108.013 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.18 109.59 5.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.653 1.181 . . . . 0.0 109.274 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.33 153.68 31.56 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 CA-C-N 120.105 1.073 . . . . 0.0 111.82 -9.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.45 124.85 24.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 109.667 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.03 -48.1 81.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.418 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -39.59 -56.86 1.59 Allowed 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.447 1.899 . . . . 0.0 112.253 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -43.52 -31.61 0.76 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.408 1.483 . . . . 0.0 113.375 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.2 m -104.28 -56.53 2.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.897 0.479 . . . . 0.0 111.277 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -68.62 -28.55 67.01 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.4 -39.24 93.98 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.95 0.795 . . . . 0.0 110.318 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ttm105 -95.32 -28.71 14.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.414 1.086 . . . . 0.0 111.978 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.6 6.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.81 133.18 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.69 31.24 7.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.628 1.171 . . . . 0.0 111.636 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.4 76.25 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.659 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.91 136.5 72.91 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 118.511 1.156 . . . . 0.0 108.402 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.86 120.15 7.71 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.339 2.026 . . . . 0.0 108.596 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.49 167.96 16.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.65 158.75 33.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.547 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.39 49.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.375 1.47 . . . . 0.0 111.9 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.23 62.17 19.47 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.651 1.58 . . . . 0.0 109.036 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -44.1 -41.41 12.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.238 3.292 . . . . 0.0 113.779 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -49.51 -41.11 40.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.514 1.125 . . . . 0.0 111.315 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.3 -24.89 67.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.671 0.788 . . . . 0.0 111.956 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -104.95 -30.87 9.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.316 1.046 . . . . 0.0 112.353 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.59 -49.9 1.56 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.627 1.571 . . . . 0.0 112.795 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -27.68 60.56 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -76.74 151.0 82.25 Favored Pre-proline 0 CA--C 1.534 0.333 0 O-C-N 121.64 -0.663 . . . . 0.0 110.03 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.08 85.83 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 107.982 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.45 -25.55 25.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.56 1.944 . . . . 0.0 113.304 -171.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.3 m -48.17 113.82 0.82 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.495 1.118 . . . . 0.0 110.651 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.81 -46.14 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.373 1.069 . . . . 0.0 110.512 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -58.19 -24.64 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.779 1.232 . . . . 0.0 112.852 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -90.06 -53.0 4.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.3 mt -47.85 -42.01 25.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.298 1.039 . . . . 0.0 111.861 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.44 -34.64 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.755 -0.591 . . . . 0.0 111.289 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -64.52 -50.12 68.62 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 119.375 0.988 . . . . 0.0 108.653 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -51.13 -46.1 61.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.673 0.789 . . . . 0.0 109.844 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -50.56 71.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.825 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.02 -45.42 92.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.294 -0.879 . . . . 0.0 111.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -32.67 67.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.877 0.871 . . . . 0.0 112.227 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.56 160.19 28.93 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -157.61 122.01 4.29 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.974 -0.721 . . . . 0.0 109.263 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.08 9.34 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.02 53.86 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.003 0.521 . . . . 0.0 111.807 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.4 ttp -65.89 115.89 27.25 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.733 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.13 164.84 23.73 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.369 2.046 . . . . 0.0 110.947 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.33 134.68 50.69 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -97.03 -15.06 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -47.79 100.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.671 0.788 . . . . 0.0 112.624 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.05 -37.97 3.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.062 1.315 . . . . 0.0 111.781 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -76.42 -38.92 54.85 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.786 0.793 . . . . 0.0 110.134 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.65 136.61 46.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 173.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.79 144.83 30.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -32.31 -44.95 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.63 1.972 . . . . 0.0 111.496 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.64 -49.53 76.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.942 0.792 . . . . 0.0 111.561 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -56.1 -56.92 15.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 122.728 1.251 . . . . 0.0 108.626 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 62.4 mt -48.62 -58.56 4.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.823 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 t -46.09 -53.54 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.426 1.09 . . . . 0.0 110.024 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -59.02 -39.03 80.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.656 0.382 . . . . 0.0 111.192 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.56 71.9 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.47 -49.95 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.601 1.16 . . . . 0.0 109.825 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.07 -39.14 85.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.135 0.88 . . . . 0.0 109.228 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.1 -47.51 85.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mtp -54.03 -59.31 4.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.01 -35.94 64.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 112.634 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -62.9 -10.65 14.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.419 1.008 . . . . 0.0 113.173 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -89.62 -11.61 42.11 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.783 1.174 . . . . 0.0 111.558 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.216 -1.85 . . . . 0.0 111.875 -175.068 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.24 24.07 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -55.77 -53.72 53.23 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -53.82 41.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.06 0.544 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.96 -57.46 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.699 0.799 . . . . 0.0 110.175 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.71 -49.25 77.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.825 0.85 . . . . 0.0 112.31 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.15 -48.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.084 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.52 -18.19 1.95 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.85 -34.43 38.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.842 1.201 . . . . 0.0 112.364 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 p -73.06 151.32 41.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.419 0.609 . . . . 0.0 110.444 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.68 106.72 6.42 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.872 1.269 . . . . 0.0 108.559 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.16 150.65 36.01 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.351 1.161 . . . . 0.0 111.738 -5.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.06 124.53 22.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.676 1.19 . . . . 0.0 109.142 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -54.43 -46.34 73.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.026 0.83 . . . . 0.0 110.558 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 p -40.4 -52.46 2.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.111 2.165 . . . . 0.0 112.338 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -38.47 -48.2 1.36 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 112.082 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.9 m -93.02 -55.05 3.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.208 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -64.84 -25.95 68.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 120.289 1.404 . . . . 0.0 111.356 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -119.72 -15.05 8.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.963 0.905 . . . . 0.0 112.466 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.74 34.23 44.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.2 t -55.13 132.62 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.34 31.53 7.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.729 1.211 . . . . 0.0 111.911 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.61 22.24 75.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.398 -0.668 . . . . 0.0 113.044 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.15 131.66 80.5 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 118.707 1.253 . . . . 0.0 109.324 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.7 119.57 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.411 2.074 . . . . 0.0 108.211 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.39 179.78 6.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.811 0.815 . . . . 0.0 112.567 -172.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.43 159.37 24.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.14 54.11 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.084 1.754 . . . . 0.0 112.238 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.21 58.56 15.4 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.034 0.933 . . . . 0.0 110.96 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -38.48 -48.27 2.51 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.557 3.505 . . . . 0.0 114.152 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -47.77 -40.1 19.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.363 1.465 . . . . 0.0 111.988 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.71 -27.9 58.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.923 0.329 . . . . 0.0 111.455 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.94 -26.14 19.42 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.756 0.822 . . . . 0.0 112.004 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -34.76 -46.81 0.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.493 2.317 . . . . 0.0 114.456 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.05 2.7 35.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -83.37 158.29 63.78 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 118.978 0.808 . . . . 0.0 109.821 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.01 120.88 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.258 2.639 . . . . 0.0 110.833 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -64.36 -39.16 93.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -82.35 133.33 35.22 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 122.067 -0.395 . . . . 0.0 111.115 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -52.98 -40.7 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -54.34 -29.48 48.14 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.024 1.33 . . . . 0.0 112.598 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.28 -52.49 6.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.89 -40.15 60.2 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -60.2 -33.97 55.43 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 CA-C-N 119.528 1.058 . . . . 0.0 110.743 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -62.47 -49.81 73.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 m -52.27 -46.95 66.06 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.453 0.57 . . . . 0.0 109.817 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 m -61.12 -40.35 93.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.491 0.717 . . . . 0.0 111.487 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . 0.286 0.9 OUTLIER -111.02 36.65 3.07 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.37 -44.49 2.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.474 1.91 . . . . 0.0 107.175 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.33 145.63 9.76 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.89 1.71 . . . . 0.0 109.462 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -156.36 132.95 10.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.8 -117.64 11.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.36 1.01 38.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.186 0.994 . . . . 0.0 112.064 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.7 ttp -69.58 122.83 87.03 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.067 0.849 . . . . 0.0 110.308 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.82 152.55 47.23 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.155 1.903 . . . . 0.0 108.86 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.58 119.14 13.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -76.34 1.97 14.75 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -46.37 112.51 0.5 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 110.924 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.37 -30.01 6.73 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.636 0.636 . . . . 0.0 112.149 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -72.7 -46.28 54.51 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.29 124.56 13.78 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.0 155.4 28.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -29.32 -49.81 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.496 1.918 . . . . 0.0 111.852 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -64.7 -41.05 96.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.258 0.936 . . . . 0.0 112.304 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.12 -58.0 8.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 122.437 1.113 . . . . 0.0 108.443 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.3 mt -46.03 -57.9 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 127.047 2.139 . . . . 0.0 110.48 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -39.84 -55.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 110.813 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -60.58 -37.25 80.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.284 1.034 . . . . 0.0 111.816 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.64 32.27 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.74 -0.6 . . . . 0.0 109.442 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.67 -50.85 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.049 0.94 . . . . 0.0 110.785 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.94 -41.65 92.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.847 1.203 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -59.03 -51.52 69.71 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.27 -53.61 48.35 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.33 -38.24 76.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.118 0.567 . . . . 0.0 111.78 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.7 p -63.5 -5.22 3.49 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -87.06 -12.43 47.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.771 1.168 . . . . 0.0 111.093 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.656 -1.64 . . . . 0.0 110.197 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.65 -0.691 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.83 -40.36 26.29 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.99 -54.86 42.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -49.39 64.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.357 0.663 . . . . 0.0 110.383 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.02 -58.15 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.2 -50.24 65.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.176 0.99 . . . . 0.0 112.17 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.2 mt -69.21 -48.04 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.468 -174.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -145.32 -12.74 0.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.55 38.85 2.99 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 120.244 1.384 . . . . 0.0 111.257 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.16 153.76 51.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.135 1.374 . . . . 0.0 109.073 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.08 108.63 8.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.495 1.118 . . . . 0.0 110.968 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -57.02 159.27 24.89 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.843 0.98 . . . . 0.0 111.83 -12.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.82 122.66 19.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.484 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -54.72 -47.51 73.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.712 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 p -41.48 -52.47 3.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.339 1.856 . . . . 0.0 112.263 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -48.51 -24.78 1.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.065 1.346 . . . . 0.0 113.874 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -109.03 -54.1 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.743 0.817 . . . . 0.0 110.951 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -69.84 -21.67 63.35 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.25 -58.05 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.366 0.985 . . . . 0.0 109.773 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -26.29 32.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.635 0.374 . . . . 0.0 111.563 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.81 6.15 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.32 144.4 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.47 29.8 7.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.076 0.95 . . . . 0.0 111.491 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.27 79.16 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.05 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.71 132.64 88.96 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.754 1.277 . . . . 0.0 108.409 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.17 119.02 5.93 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.793 2.329 . . . . 0.0 109.398 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -82.55 177.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.9 0.857 . . . . 0.0 111.255 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -82.98 157.53 22.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m120 50.4 41.48 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.94 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.28 52.93 8.64 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.443 1.097 . . . . 0.0 110.24 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -46.88 -39.61 24.63 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.75 2.967 . . . . 0.0 112.643 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -49.66 -40.63 40.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.404 1.081 . . . . 0.0 111.48 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.41 -27.36 60.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.234 0.614 . . . . 0.0 111.199 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.06 -27.24 19.82 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.839 -0.538 . . . . 0.0 111.697 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.2 -50.58 0.73 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.6 1.96 . . . . 0.0 113.503 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.74 -23.43 42.29 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.62 135.5 75.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.647 -0.658 . . . . 0.0 109.423 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.72 113.99 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.295 1.997 . . . . 0.0 111.256 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.61 -32.4 58.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.144 0.978 . . . . 0.0 111.834 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -53.99 101.81 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.457 1.503 . . . . 0.0 111.279 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -45.43 -40.82 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.011 1.324 . . . . 0.0 109.933 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.94 -36.52 5.54 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.963 2.105 . . . . 0.0 112.639 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -84.03 -50.14 8.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -52.66 -39.27 61.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.046 0.938 . . . . 0.0 112.019 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 m -60.1 -36.07 65.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.143 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -67.5 -48.76 66.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.677 1.126 . . . . 0.0 108.451 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 m -50.7 -46.42 58.86 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -67.34 -50.89 58.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.649 0.379 . . . . 0.0 111.179 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.0 -44.77 94.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.188 -0.945 . . . . 0.0 111.031 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.32 -35.36 54.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.544 0.738 . . . . 0.0 112.462 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 158.23 24.36 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -164.47 133.53 3.67 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.891 0.846 . . . . 0.0 109.803 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.76 -84.84 0.28 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.96 -6.28 2.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.193 1.797 . . . . 0.0 111.453 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.3 ttp -64.61 124.01 84.83 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.067 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.593 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 71.8 Cg_endo -70.49 158.68 55.28 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.124 1.883 . . . . 0.0 109.251 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 147.02 53.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -111.81 -12.75 13.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.098 1.359 . . . . 0.0 111.232 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.75 123.04 6.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.416 1.086 . . . . 0.0 110.136 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.6 -26.07 23.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.387 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -97.74 -54.64 3.05 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.498 1.149 . . . . 0.0 110.361 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.03 125.91 33.12 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.55 51.39 1.06 Allowed 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.719 1.608 . . . . 0.0 111.921 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 52.05 -62.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.928 3.291 . . . . 0.0 113.734 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -50.92 -34.85 30.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.763 1.225 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -53.0 -56.63 14.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.734 1.614 . . . . 0.0 109.143 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.07 -53.32 58.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 125.44 1.496 . . . . 0.0 109.684 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.2 t -43.39 -57.51 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 122.899 0.479 . . . . 0.0 109.875 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -60.72 -43.86 97.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.876 0.471 . . . . 0.0 112.056 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.55 95.6 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.802 -0.561 . . . . 0.0 110.398 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.89 -49.63 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.49 1.516 . . . . 0.0 110.087 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.69 -39.81 89.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -58.22 -53.05 62.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.389 0.54 . . . . 0.0 109.617 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.7 mtp -48.25 -58.58 4.35 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -55.61 -39.86 71.33 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.811 0.844 . . . . 0.0 112.078 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.0 m -67.17 -6.53 18.26 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.506 -0.746 . . . . 0.0 112.006 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -119.14 42.44 2.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.597 1.559 . . . . 0.0 109.635 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.136 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.593 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.9 -38.0 36.95 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.25 -57.37 12.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.787 0.435 . . . . 0.0 110.169 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -56.61 -46.41 80.9 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.859 -0.526 . . . . 0.0 110.567 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.7 mt -53.91 -57.53 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 109.978 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -57.07 -50.34 73.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.236 1.014 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.91 -51.18 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.88 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.996 0.816 . . . . 0.0 112.851 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.76 38.94 1.51 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 157.51 45.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.231 1.813 . . . . 0.0 108.44 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.714 0.805 . . . . 0.0 110.629 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.06 160.35 23.48 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 CA-C-N 119.941 1.015 . . . . 0.0 111.878 -12.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.31 127.45 32.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.706 0.802 . . . . 0.0 109.558 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -57.71 -50.77 72.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.457 0.646 . . . . 0.0 111.199 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -39.42 -56.13 1.64 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.642 1.977 . . . . 0.0 112.986 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.67 -38.0 0.83 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.337 1.455 . . . . 0.0 112.564 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -96.83 -59.25 1.84 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 0.0 110.372 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -60.69 -46.11 91.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -22.18 64.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.862 0.301 . . . . 0.0 111.759 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -114.87 11.99 16.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.209 1.004 . . . . 0.0 111.293 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.71 38.39 29.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.124 0.869 . . . . 0.0 113.63 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.8 t -55.14 132.74 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.52 31.44 7.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 111.883 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.71 22.32 75.12 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.742 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.49 136.25 82.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.253 1.027 . . . . 0.0 108.697 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.9 Cg_endo -60.22 126.94 21.47 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.346 2.031 . . . . 0.0 109.626 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -94.07 174.47 7.14 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.449 0.643 . . . . 0.0 112.014 -174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.82 162.3 19.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.09 53.6 0.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.758 1.623 . . . . 0.0 112.125 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.79 64.5 22.18 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 124.235 1.014 . . . . 0.0 109.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -41.17 -51.55 3.87 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.024 3.15 . . . . 0.0 114.29 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -44.15 -51.92 7.71 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.144 1.378 . . . . 0.0 110.843 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.55 -45.38 56.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.953 0.901 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 92.1 m95 -85.6 -30.6 23.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.325 0.65 . . . . 0.0 111.379 -173.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.41 93.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.411 1.084 . . . . 0.0 109.408 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.89 -42.15 97.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.014 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -74.85 162.66 72.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.528 0.731 . . . . 0.0 111.266 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -68.03 84.33 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.36 2.04 . . . . 0.0 107.798 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -48.9 -28.82 4.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.462 1.905 . . . . 0.0 113.247 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.79 106.82 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.748 2.019 . . . . 0.0 110.911 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.0 t -47.75 -44.41 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.248 1.019 . . . . 0.0 110.939 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -53.78 -36.0 61.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.755 1.622 . . . . 0.0 111.842 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.69 -50.7 10.22 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.7 -42.31 45.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.128 0.971 . . . . 0.0 112.408 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.62 -36.11 68.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.818 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -65.46 -49.43 69.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 119.763 1.165 . . . . 0.0 108.581 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 m -52.07 -46.11 65.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.078 0.466 . . . . 0.0 109.812 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -65.19 -49.98 67.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.761 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.53 -45.29 94.82 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.315 -0.866 . . . . 0.0 110.81 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.79 74.91 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.715 0.806 . . . . 0.0 111.819 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 164.95 26.04 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -156.36 106.98 2.39 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.85 -0.794 . . . . 0.0 109.389 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.59 -111.55 3.33 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.79 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.088 0.555 . . . . 0.0 111.117 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -65.0 117.96 44.38 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.323 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 85.6 Cg_endo -72.47 157.51 52.8 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.531 2.154 . . . . 0.0 109.644 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 145.68 52.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.456 0.302 . . . . 0.0 110.302 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -110.81 -12.31 14.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.192 1.397 . . . . 0.0 111.349 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -46.51 123.58 5.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.978 1.311 . . . . 0.0 110.548 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.69 -25.38 21.5 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.119 0.866 . . . . 0.0 112.34 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -98.1 -57.1 2.3 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.384 1.092 . . . . 0.0 110.325 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.11 119.61 26.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.46 84.92 4.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 15.32 -59.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 131.389 3.876 . . . . 0.0 115.866 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -48.28 -35.39 12.07 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.2 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -54.99 -59.75 4.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.211 1.405 . . . . 0.0 108.787 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 mt -55.51 -53.84 51.34 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 126.282 1.833 . . . . 0.0 109.858 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.3 t -45.38 -57.03 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.32 0.648 . . . . 0.0 109.422 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -60.3 -41.24 93.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.766 -0.584 . . . . 0.0 111.651 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.36 99.01 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 109.787 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.88 -44.18 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.64 1.176 . . . . 0.0 108.565 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.14 -50.72 68.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -55.26 -51.64 65.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.522 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.7 mtt -47.57 -63.79 0.96 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.113 0.959 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -53.3 -36.05 60.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.069 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.4 m -72.07 34.57 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.656 1.116 . . . . 0.0 113.94 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -134.21 -10.86 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.662 1.585 . . . . 0.0 109.85 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.579 -1.677 . . . . 0.0 110.093 -178.771 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.451 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.55 -42.97 52.42 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.6 -57.12 14.32 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.031 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -44.71 -50.37 10.02 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.695 1.134 . . . . 0.0 111.633 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.45 -60.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.893 1.677 . . . . 0.0 110.671 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.75 -48.08 73.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.83 0.852 . . . . 0.0 111.589 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.29 -49.98 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.457 1.103 . . . . 0.0 111.021 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.65 33.77 0.27 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.42 37.85 1.75 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 156.04 48.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.287 1.835 . . . . 0.0 107.751 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.42 108.82 6.73 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.859 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.8 155.73 27.72 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.074 1.062 . . . . 0.0 111.581 -9.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.17 128.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.54 0.736 . . . . 0.0 109.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.3 m -58.35 -49.41 77.3 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 0.0 110.117 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -41.18 -55.5 2.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.405 1.882 . . . . 0.0 113.49 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.27 -36.38 3.98 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.941 0.896 . . . . 0.0 112.339 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.41 -57.91 2.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -67.06 -36.12 81.35 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -68.21 -33.84 75.16 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -84.46 -26.8 27.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.112 0.965 . . . . 0.0 111.122 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.18 33.3 57.13 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.62 139.46 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.9 29.43 6.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.126 0.97 . . . . 0.0 111.572 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.22 24.49 76.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.718 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.67 80.41 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.608 1.204 . . . . 0.0 108.275 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.6 122.01 10.61 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.257 1.972 . . . . 0.0 110.051 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -90.56 177.18 6.43 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.606 0.717 . . . . 0.0 111.65 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 156.77 29.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 51.08 35.48 13.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.614 0.766 . . . . 0.0 111.845 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.79 67.27 79.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.06 1.344 . . . . 0.0 110.352 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.18 -50.82 5.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.148 3.232 . . . . 0.0 114.454 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -50.93 -35.21 32.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.946 1.299 . . . . 0.0 112.227 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.37 -27.66 68.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.149 0.431 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -101.53 -35.42 9.16 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.548 1.139 . . . . 0.0 112.097 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.34 -51.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.587 1.555 . . . . 0.0 113.125 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.89 -23.18 45.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -79.53 144.28 60.95 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.38 93.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.72 2.28 . . . . 0.0 108.457 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.56 -21.12 36.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.044 1.337 . . . . 0.0 112.994 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.41 106.93 0.11 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.571 1.948 . . . . 0.0 110.455 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.0 -42.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.937 0.895 . . . . 0.0 110.632 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.82 -31.23 64.52 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.371 1.469 . . . . 0.0 112.36 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.83 -53.49 5.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt -48.62 -45.61 38.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.502 0.721 . . . . 0.0 111.877 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.94 -35.98 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 121.854 -0.529 . . . . 0.0 110.976 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.89 -45.09 75.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 m -53.96 -44.08 70.45 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.3 m -64.55 -50.61 66.62 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.81 0.444 . . . . 0.0 110.49 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.48 -44.97 89.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.411 -0.806 . . . . 0.0 110.924 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.9 68.49 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.799 0.84 . . . . 0.0 112.288 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.09 161.25 26.47 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -159.66 117.31 2.68 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.892 -0.769 . . . . 0.0 109.215 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.18 -117.62 11.63 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.44 54.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.883 0.473 . . . . 0.0 111.447 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -67.98 121.47 79.99 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 118.784 0.72 . . . . 0.0 110.112 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 92.0 Cg_endo -74.73 161.29 39.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.629 2.219 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.02 136.83 57.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.89 -14.05 18.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.121 0.968 . . . . 0.0 113.247 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -49.41 102.83 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.311 0.644 . . . . 0.0 112.142 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.73 -36.24 4.28 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.14 1.352 . . . . 0.0 111.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -79.17 -41.11 29.19 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 117.828 0.814 . . . . 0.0 110.184 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.35 132.76 39.87 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.56 144.94 30.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -28.29 -52.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -62.45 -40.65 97.31 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.674 -0.641 . . . . 0.0 112.033 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.23 -58.91 6.38 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 122.429 1.109 . . . . 0.0 108.199 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 62' ' ' ALA . 77.9 mt -46.09 -56.02 6.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.493 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -41.53 -54.49 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.815 1.246 . . . . 0.0 110.572 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -57.04 -42.53 80.68 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.342 -0.224 . . . . 0.0 111.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.99 81.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.54 -45.47 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.578 0.751 . . . . 0.0 109.344 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -55.1 -51.0 67.77 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.875 0.87 . . . . 0.0 108.824 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -55.87 -52.05 65.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.414 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.6 mtp -49.73 -54.41 19.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.391 0.677 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.19 -36.81 76.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.03 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.6 m -74.41 42.49 0.16 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.468 -0.77 . . . . 0.0 112.766 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -135.93 -7.78 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.77 1.228 . . . . 0.0 110.307 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.22 -1.371 . . . . 0.0 108.999 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.407 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.51 -39.55 22.69 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.525 1.059 . . . . 0.0 111.719 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.14 -59.59 5.17 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.3 -50.23 40.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.865 1.266 . . . . 0.0 110.736 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.7 -59.78 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.632 1.573 . . . . 0.0 109.96 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -58.12 -48.56 79.85 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.135 0.574 . . . . 0.0 111.441 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.6 mt -69.84 -46.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.877 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.69 39.07 0.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.45 39.49 1.16 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -139.16 156.9 46.79 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.458 1.903 . . . . 0.0 107.496 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.51 108.17 6.63 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.814 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.32 154.55 31.27 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 CA-C-N 120.104 1.073 . . . . 0.0 111.827 -9.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.08 121.73 16.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.561 1.145 . . . . 0.0 109.179 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -52.71 -49.71 64.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.206 0.527 . . . . 0.0 110.496 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -43.39 -51.26 6.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.029 1.732 . . . . 0.0 112.77 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -47.39 -34.21 6.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.655 0.782 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 m -96.85 -55.74 2.79 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -66.06 -36.91 84.5 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.99 -43.26 88.27 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -72.55 -30.23 64.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.626 0.77 . . . . 0.0 111.076 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.2 56.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.02 143.15 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.63 30.69 6.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.11 0.964 . . . . 0.0 111.383 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.43 27.56 73.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.622 -0.543 . . . . 0.0 112.494 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.32 131.89 90.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.51 1.155 . . . . 0.0 108.299 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.0 Cg_endo -60.68 112.52 1.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.756 2.304 . . . . 0.0 109.564 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.54 175.33 9.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.638 1.208 . . . . 0.0 109.896 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.63 140.77 29.11 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 68.29 35.43 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.231 1.013 . . . . 0.0 109.795 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.89 58.23 37.42 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.218 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.79 -47.23 2.72 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.537 3.492 . . . . 0.0 114.315 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -47.53 -40.46 18.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.488 1.515 . . . . 0.0 112.026 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.51 -25.64 54.42 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.954 0.343 . . . . 0.0 111.464 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.444 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 93.2 m95 -92.05 -23.48 19.48 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.605 0.762 . . . . 0.0 111.734 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.71 -46.36 0.43 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.873 2.069 . . . . 0.0 114.155 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -101.07 -3.3 29.54 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -83.74 145.78 48.07 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.849 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.78 118.59 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.993 2.462 . . . . 0.0 111.65 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -62.26 -32.71 73.45 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 103.94 0.13 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.299 2.24 . . . . 0.0 111.507 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.09 -40.09 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.774 -0.579 . . . . 0.0 109.5 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.02 -26.0 34.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.576 1.55 . . . . 0.0 112.428 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.67 -53.42 4.53 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.22 -40.89 48.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.43 -31.52 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.668 -0.645 . . . . 0.0 110.38 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -65.85 -51.02 62.36 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.538 1.063 . . . . 0.0 108.296 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -49.97 -44.92 51.01 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.864 0.866 . . . . 0.0 109.98 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 m -64.54 -52.26 58.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.948 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.51 -41.57 98.92 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.025 -1.047 . . . . 0.0 111.867 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.6 -33.96 31.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.971 0.909 . . . . 0.0 112.283 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 151.56 17.45 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 55' ' ' MET . 28.0 tptp -155.18 136.99 14.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.73 -115.68 7.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.07 -0.46 33.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.456 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.2 ttp -65.43 127.0 92.58 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.891 0.769 . . . . 0.0 110.088 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 73.2 Cg_endo -69.84 154.74 67.08 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.708 1.605 . . . . 0.0 109.247 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 121.64 15.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.14 -10.18 57.98 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -53.79 84.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.451 1.101 . . . . 0.0 113.751 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.1 -30.91 5.09 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.452 1.977 . . . . 0.0 111.77 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.49 80.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.022 0.911 . . . . 0.0 109.338 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -133.8 147.44 51.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -82.75 142.17 31.81 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -34.15 -44.69 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.422 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -46.02 91.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.421 1.01 . . . . 0.0 111.068 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -55.84 -56.34 21.76 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 122.128 0.966 . . . . 0.0 108.394 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.3 mt -48.6 -60.41 2.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.256 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 t -43.85 -56.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.692 1.197 . . . . 0.0 110.063 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.6 -40.74 84.12 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.206 -0.309 . . . . 0.0 111.246 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.69 -55.32 27.89 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -49.83 -47.09 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.138 1.375 . . . . 0.0 110.099 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -53.98 -51.2 64.66 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.714 0.688 . . . . 0.0 109.239 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.56 -49.72 75.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.0 mtp -49.11 -54.78 14.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.827 . . . . 0.0 109.525 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.79 -35.16 77.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.017 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.03 41.42 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.351 -0.843 . . . . 0.0 113.188 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.6 p -138.37 -3.75 1.71 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.475 1.51 . . . . 0.0 110.044 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.713 -1.613 . . . . 0.0 110.271 -174.648 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.535 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.8 t0 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.1 52.32 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 106.491 -2.643 . . . . 0.0 106.491 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 38.33 60.51 1.28 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.588 1.955 . . . . 0.0 110.952 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -156.11 -61.52 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.707 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.98 -53.97 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.423 0.556 . . . . 0.0 109.871 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -66.46 -39.34 88.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.711 0.404 . . . . 0.0 111.36 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -76.87 -50.82 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -138.5 -14.42 1.27 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.19 -37.72 31.49 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.748 1.158 . . . . 0.0 111.786 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -69.02 150.54 47.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 122.359 -0.495 . . . . 0.0 110.303 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.32 114.57 7.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.468 1.107 . . . . 0.0 108.549 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.23 151.49 18.19 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.504 1.216 . . . . 0.0 111.408 -13.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.11 121.75 16.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.796 1.639 . . . . 0.0 109.883 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 m -54.03 -48.68 70.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.417 0.627 . . . . 0.0 110.273 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -41.17 -56.16 2.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.918 2.087 . . . . 0.0 112.373 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -45.54 -33.98 3.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.501 1.12 . . . . 0.0 113.038 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -98.16 -57.66 2.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.054 0.388 . . . . 0.0 110.322 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.08 -16.8 64.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.91 5.87 50.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.783 0.72 . . . . 0.0 109.974 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -128.71 -27.62 2.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.269 1.028 . . . . 0.0 112.232 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.42 27.07 62.17 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 140.05 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.96 29.22 5.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.091 0.956 . . . . 0.0 111.513 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.36 25.5 75.27 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.956 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.34 79.11 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.768 1.284 . . . . 0.0 108.977 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.83 110.36 1.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 N-CA-C 106.742 -2.061 . . . . 0.0 106.742 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -72.93 156.16 39.14 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.94 171.87 8.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.26 33.97 16.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.15 74.47 6.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.622 -170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -37.92 -50.94 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.359 3.373 . . . . 0.0 114.403 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.34 -43.23 15.81 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.194 1.397 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.05 -22.04 66.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.504 0.722 . . . . 0.0 111.95 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -109.37 -29.42 8.46 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.226 1.01 . . . . 0.0 112.584 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.36 -49.92 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.794 1.637 . . . . 0.0 113.11 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.66 -27.29 58.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.721 0.809 . . . . 0.0 113.166 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -79.32 155.41 76.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.492 0.717 . . . . 0.0 110.342 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.29 124.52 15.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.952 1.768 . . . . 0.0 110.284 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 p -66.16 -26.53 67.47 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.632 -0.668 . . . . 0.0 110.32 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -55.22 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.347 1.859 . . . . 0.0 112.395 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.1 t -47.85 -43.44 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.537 1.135 . . . . 0.0 109.689 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -52.7 -28.94 24.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.806 1.642 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.47 -48.63 6.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.388 1.075 . . . . 0.0 109.069 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -49.4 -41.56 39.86 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.603 0.361 . . . . 0.0 111.088 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.94 -35.29 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.566 -0.708 . . . . 0.0 111.019 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -64.25 -48.25 76.48 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.461 1.028 . . . . 0.0 108.466 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -53.64 -44.13 69.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -62.54 -49.35 75.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.575 0.35 . . . . 0.0 110.482 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.95 -46.74 89.51 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.267 -0.896 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 -33.33 74.96 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.664 0.786 . . . . 0.0 112.062 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.27 159.67 31.21 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.07 120.93 2.66 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.784 -0.833 . . . . 0.0 109.248 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.99 -119.97 20.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.51 -17.42 54.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.7 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -68.67 118.55 61.54 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 119.142 0.883 . . . . 0.0 109.424 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 158.69 53.38 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.266 1.978 . . . . 0.0 110.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.82 47.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -97.79 -11.55 23.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.215 1.006 . . . . 0.0 111.922 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -41.6 113.03 0.37 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.262 1.425 . . . . 0.0 112.153 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.43 -21.73 16.29 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.166 0.889 . . . . 0.0 113.089 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -85.17 -48.11 9.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.084 0.942 . . . . 0.0 109.179 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.57 141.14 48.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 173.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -83.9 140.8 31.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -29.83 -45.86 0.06 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 126.281 1.832 . . . . 0.0 111.46 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -60.16 -49.49 77.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.946 1.248 . . . . 0.0 111.526 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -53.71 -59.14 4.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.832 1.301 . . . . 0.0 108.995 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 62' ' ' ALA . 33.3 mt -49.11 -58.72 4.48 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 126.098 1.759 . . . . 0.0 110.491 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -47.76 -56.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.526 1.13 . . . . 0.0 109.657 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -55.41 -39.05 69.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.079 0.552 . . . . 0.0 111.508 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.94 68.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.744 0.418 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.86 -46.64 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.692 1.197 . . . . 0.0 109.007 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.9 -53.83 43.47 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.91 -50.62 71.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.305 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 ttp -50.45 -59.82 3.63 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.3 mp -55.05 -37.86 67.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.811 -0.556 . . . . 0.0 111.431 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -62.79 -6.69 3.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.661 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.1 p -89.13 -15.25 34.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.57 1.532 . . . . 0.0 111.227 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.193 -1.384 . . . . 0.0 110.289 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -53.93 -43.46 71.51 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -58.92 -56.02 27.64 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.02 -49.62 50.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.898 0.772 . . . . 0.0 110.946 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.83 -57.95 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -57.42 -44.32 84.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.923 0.889 . . . . 0.0 112.195 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.6 mt -76.44 -49.68 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.199 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -136.63 -17.15 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.2 -33.73 39.3 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 119.965 1.257 . . . . 0.0 112.003 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -73.61 154.13 39.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.36 0.58 . . . . 0.0 110.98 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 110.37 5.86 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.66 1.184 . . . . 0.0 109.436 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.98 151.85 20.56 Favored 'Cis proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.1 1.071 . . . . 0.0 111.784 -11.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.74 123.1 19.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.153 1.381 . . . . 0.0 109.129 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.3 -47.66 75.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.849 0.356 . . . . 0.0 110.483 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 p -39.91 -56.26 1.84 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 126.432 1.893 . . . . 0.0 112.315 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -41.57 -36.32 0.9 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.31 1.444 . . . . 0.0 112.763 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.8 m -101.21 -57.01 2.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.51 0.324 . . . . 0.0 111.459 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -68.36 -33.33 74.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.57 -36.3 73.54 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -82.01 -27.3 33.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.234 1.013 . . . . 0.0 111.587 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.07 32.23 60.81 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.66 141.58 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.8 29.69 6.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.136 0.974 . . . . 0.0 111.424 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 24.54 77.0 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.876 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 134.55 79.56 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.745 1.273 . . . . 0.0 108.203 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.31 124.86 15.58 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.454 2.102 . . . . 0.0 108.75 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.56 172.68 8.34 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 160.3 23.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 35.7 51.67 0.71 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.891 1.676 . . . . 0.0 111.956 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.18 64.12 25.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.886 1.274 . . . . 0.0 110.143 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -39.85 -48.24 3.68 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.247 3.298 . . . . 0.0 114.63 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.08 -34.42 56.46 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.639 0.776 . . . . 0.0 112.213 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -66.96 -25.51 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.871 0.468 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -105.61 -29.61 10.02 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.451 1.1 . . . . 0.0 112.79 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.04 -50.17 0.89 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.687 1.595 . . . . 0.0 113.116 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.88 -19.74 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -80.54 157.32 72.58 Favored Pre-proline 0 CA--C 1.537 0.465 0 O-C-N 121.511 -0.743 . . . . 0.0 110.661 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.23 111.2 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.965 2.443 . . . . 0.0 111.436 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -60.89 -31.76 71.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.91 101.86 0.07 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.301 2.24 . . . . 0.0 111.421 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.62 -40.37 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.676 0.791 . . . . 0.0 110.038 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.11 -33.56 62.94 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.818 1.647 . . . . 0.0 112.029 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.04 -50.35 9.78 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.86 -44.03 39.39 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' A' ' 67' ' ' LEU . 5.0 m -57.22 -42.39 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 119.468 1.031 . . . . 0.0 110.449 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.69 -43.52 93.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -55.24 -40.8 71.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.2 0.455 . . . . 0.0 110.408 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -68.22 -55.46 12.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.321 0.649 . . . . 0.0 109.438 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 mt -54.9 -41.14 70.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.411 1.485 . . . . 0.0 111.816 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.69 -34.42 58.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.973 0.909 . . . . 0.0 111.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.58 162.99 35.28 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -167.04 130.04 1.79 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.04 -136.27 50.68 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.36 -25.91 68.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.427 -0.887 . . . . 0.0 111.73 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.2 ttp -64.56 117.42 37.66 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 119.265 0.939 . . . . 0.0 110.73 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.63 156.61 57.35 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.533 2.156 . . . . 0.0 109.538 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.79 114.58 3.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -72.4 -12.7 61.23 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.461 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -37.3 109.78 0.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.328 0.967 . . . . 0.0 112.859 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.77 -19.41 54.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.359 0.981 . . . . 0.0 114.533 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -78.63 -57.58 3.69 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.8 1.3 . . . . 0.0 111.321 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.47 141.28 49.3 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.56 1.144 . . . . 0.0 107.972 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.48 150.08 28.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -27.38 -52.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.807 2.043 . . . . 0.0 111.492 168.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.45 -48.26 80.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.698 0.681 . . . . 0.0 111.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -55.11 -57.15 12.91 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 122.138 0.97 . . . . 0.0 108.938 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HB3' HG12 ' A' ' 45' ' ' VAL . 97.0 mt -49.26 -58.83 4.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.722 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.86 -57.5 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 124.052 0.941 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -58.76 -40.91 85.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.118 0.417 . . . . 0.0 111.778 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.18 92.27 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.988 -0.445 . . . . 0.0 109.92 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.88 -46.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.765 0.826 . . . . 0.0 109.133 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -54.54 -48.95 71.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -57.02 -53.88 53.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.517 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 ptm -57.12 -49.71 75.06 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.922 0.783 . . . . 0.0 109.395 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.77 -36.13 73.91 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.07 -1.018 . . . . 0.0 111.399 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t -63.53 -5.65 4.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.121 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -92.2 -12.18 33.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.331 1.423 . . . . 0.0 110.701 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.64 -1.172 . . . . 0.0 110.99 -176.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.42 -38.66 7.05 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.571 1.082 . . . . 0.0 112.076 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.84 -64.36 0.96 Allowed 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -44.83 -50.62 10.17 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.263 1.425 . . . . 0.0 111.214 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.03 -60.33 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.269 1.428 . . . . 0.0 110.173 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -56.59 -47.09 80.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.559 0.743 . . . . 0.0 111.439 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.5 -47.01 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.451 0.7 . . . . 0.0 111.793 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -9.69 0.33 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 -28.69 52.06 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.707 1.139 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -76.34 154.49 34.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.445 0.623 . . . . 0.0 110.41 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.23 104.96 4.09 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 108.122 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.46 146.66 32.95 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.499 1.214 . . . . 0.0 111.897 -3.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.92 120.89 14.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.751 1.621 . . . . 0.0 109.56 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 m -54.23 -49.71 68.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.166 0.508 . . . . 0.0 110.116 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -41.0 -55.56 2.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.256 1.822 . . . . 0.0 112.676 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -46.21 -33.72 3.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.241 1.016 . . . . 0.0 113.002 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.4 m -97.3 -56.67 2.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 117.888 0.313 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.9 -45.07 94.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.096 0.862 . . . . 0.0 109.708 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -76.98 -36.23 56.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.29 0.636 . . . . 0.0 111.948 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.89 38.76 5.68 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.84 130.55 17.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.5 31.47 7.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.503 1.121 . . . . 0.0 111.576 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.89 26.38 74.07 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.556 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.69 134.37 71.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.402 1.101 . . . . 0.0 108.573 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -62.6 112.02 1.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.694 2.263 . . . . 0.0 108.85 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -82.64 179.77 7.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.369 1.068 . . . . 0.0 112.35 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.21 159.55 28.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.96 52.19 0.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.984 1.714 . . . . 0.0 112.045 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.67 56.62 15.86 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.942 1.297 . . . . 0.0 111.026 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -41.32 -45.9 5.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.817 3.011 . . . . 0.0 114.967 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.04 -41.11 33.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.687 0.795 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.25 -16.34 61.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 112.336 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.55 -26.19 11.5 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 112.52 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.46 -51.52 0.62 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.437 1.895 . . . . 0.0 113.67 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.87 -17.46 40.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -78.64 151.74 77.36 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 121.462 -0.774 . . . . 0.0 110.639 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 115.28 2.11 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.071 2.514 . . . . 0.0 111.56 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -63.19 -32.23 73.58 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.124 -0.985 . . . . 0.0 110.11 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 104.99 0.17 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.479 2.312 . . . . 0.0 111.753 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -50.06 -43.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.525 0.73 . . . . 0.0 109.638 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -53.64 -30.91 45.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 112.482 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.88 -51.93 6.77 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.0 mt -50.16 -40.1 45.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.812 0.845 . . . . 0.0 112.829 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.63 -39.34 69.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 119.216 0.916 . . . . 0.0 110.375 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -66.19 -46.31 77.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.226 0.921 . . . . 0.0 108.71 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 m -52.64 -45.74 66.8 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.079 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 m -67.84 -48.69 65.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.749 0.42 . . . . 0.0 110.761 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.79 -40.85 96.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.101 -0.999 . . . . 0.0 111.098 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 -32.43 60.78 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.0 111.357 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.81 167.58 37.77 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -160.52 112.54 1.96 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.09 -111.25 2.69 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -35.09 74.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.113 0.565 . . . . 0.0 111.066 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.01 118.3 47.78 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.063 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.16 156.43 55.49 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.551 2.167 . . . . 0.0 109.933 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 115.96 5.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.811 0.444 . . . . 0.0 109.833 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.98 -7.95 57.51 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -55.87 83.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.295 1.038 . . . . 0.0 112.644 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.16 -34.59 2.29 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.76 1.647 . . . . 0.0 111.043 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -84.11 -38.88 20.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.184 0.994 . . . . 0.0 110.984 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -142.6 129.47 20.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.33 151.62 25.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -29.96 -49.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.69 1.996 . . . . 0.0 112.648 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.55 -35.84 81.21 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.363 0.983 . . . . 0.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.79 -59.01 4.71 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' ALA . 56.6 mt -46.33 -57.91 4.19 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.218 2.207 . . . . 0.0 110.652 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -36.32 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.533 1.533 . . . . 0.0 110.299 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -60.16 -42.4 94.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.554 0.342 . . . . 0.0 111.606 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -48.49 69.17 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.764 0.426 . . . . 0.0 110.01 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 mt -56.72 -50.21 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.61 1.164 . . . . 0.0 109.203 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -55.83 -52.01 65.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -54.05 -56.26 19.64 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.572 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptm -60.94 -45.14 95.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.869 0.759 . . . . 0.0 109.629 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.04 -36.84 70.96 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.45 -0.781 . . . . 0.0 110.974 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -63.34 -6.52 4.8 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.7 p -90.34 -8.7 50.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.221 1.373 . . . . 0.0 111.047 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.47 -1.729 . . . . 0.0 110.832 -176.645 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.51 47.0 3.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 68.49 -40.32 0.43 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.843 2.457 . . . . 0.0 113.159 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -45.16 -56.43 4.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.977 2.511 . . . . 0.0 113.671 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -49.25 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.16 -48.51 78.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.903 0.481 . . . . 0.0 111.528 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.1 mt -73.47 -43.67 55.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.999 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.68 -8.24 0.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.75 -32.49 40.84 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.801 1.182 . . . . 0.0 111.321 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -73.47 155.45 39.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.449 0.624 . . . . 0.0 110.722 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.56 110.41 6.26 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.463 1.105 . . . . 0.0 108.966 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.93 153.28 16.95 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.323 1.151 . . . . 0.0 112.04 -11.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -70.24 114.35 8.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.625 1.57 . . . . 0.0 109.037 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.08 -48.4 22.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.662 0.785 . . . . 0.0 110.986 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -41.91 -50.57 4.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.608 1.963 . . . . 0.0 112.808 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -48.71 -32.47 8.48 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.316 0.647 . . . . 0.0 112.604 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.04 -54.99 2.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.903 0.481 . . . . 0.0 110.786 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.62 -32.79 71.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.04 -40.06 87.08 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.18 -28.58 42.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.573 0.749 . . . . 0.0 111.472 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.71 34.81 52.68 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.59 139.1 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.82 29.84 6.37 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.187 0.995 . . . . 0.0 111.593 -177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.62 24.25 76.5 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.764 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 135.31 82.99 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 118.554 1.177 . . . . 0.0 108.23 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.8 Cg_endo -59.77 123.73 13.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.567 2.178 . . . . 0.0 110.006 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.65 179.03 5.76 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.774 0.797 . . . . 0.0 112.117 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.94 161.84 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.17 54.16 0.74 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.125 1.77 . . . . 0.0 111.662 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 65.03 17.52 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.194 0.998 . . . . 0.0 110.124 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.06 -52.93 2.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.195 3.263 . . . . 0.0 114.381 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -49.48 -35.61 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.7 1.2 . . . . 0.0 112.615 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -65.45 -28.12 69.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.342 0.519 . . . . 0.0 111.245 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.3 m95 -102.32 -36.61 8.4 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.652 1.181 . . . . 0.0 112.43 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.68 -52.02 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.093 1.757 . . . . 0.0 113.082 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.79 -24.92 56.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.55 150.94 79.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 121.525 -0.734 . . . . 0.0 110.202 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.23 87.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.883 2.389 . . . . 0.0 108.207 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -24.59 22.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.366 1.866 . . . . 0.0 113.252 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.33 110.33 0.32 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.358 1.463 . . . . 0.0 110.46 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -47.93 -46.2 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.611 0.764 . . . . 0.0 110.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.91 -29.17 55.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.74 1.216 . . . . 0.0 113.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.67 -51.5 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.1 mt -49.79 -42.46 46.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.234 0.614 . . . . 0.0 112.188 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.25 -33.68 54.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.119 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.34 -49.06 70.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.895 1.225 . . . . 0.0 108.577 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -51.23 -46.47 62.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.57 0.748 . . . . 0.0 110.225 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -63.92 -49.94 70.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.83 -42.56 99.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.852 -1.155 . . . . 0.0 111.157 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.71 -30.53 61.57 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.074 0.95 . . . . 0.0 111.865 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.62 157.11 30.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.08 115.51 3.85 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.131 -0.629 . . . . 0.0 109.506 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.67 -116.58 9.17 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -24.88 58.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.923 0.489 . . . . 0.0 111.472 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.29 119.63 66.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.589 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.66 157.63 51.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.447 2.098 . . . . 0.0 110.276 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.76 120.18 11.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.333 0.653 . . . . 0.0 110.064 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.05 -12.46 58.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -45.48 112.55 0.47 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.73 0.812 . . . . 0.0 111.146 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 -32.39 7.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.457 1.027 . . . . 0.0 112.599 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -88.51 -49.99 6.57 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.404 1.102 . . . . 0.0 110.733 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.83 121.81 34.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -80.49 152.72 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -26.65 -51.57 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.859 2.064 . . . . 0.0 111.564 168.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -63.01 -43.48 98.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.237 0.926 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.27 -56.67 17.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 122.339 1.066 . . . . 0.0 108.369 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.4 mt -47.8 -57.52 5.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -37.81 -55.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.537 1.535 . . . . 0.0 110.135 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.1 mttp -55.65 -42.75 75.48 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.331 0.394 . . . . 0.0 111.628 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.92 -48.5 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 122.729 0.411 . . . . 0.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -37.49 84.07 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.638 1.108 . . . . 0.0 109.11 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -60.43 -47.38 86.34 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.055 0.843 . . . . 0.0 110.147 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.0 mtt -49.54 -65.65 0.53 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.1 mp -49.78 -40.56 41.84 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.067 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -61.24 -8.47 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.2 p -92.92 -11.53 33.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.521 1.51 . . . . 0.0 111.357 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.679 -177.432 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 118.65 -0.691 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -46.07 -41.82 11.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.134 0.873 . . . . 0.0 111.253 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.28 -62.48 1.63 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.6 -49.25 14.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.083 0.953 . . . . 0.0 111.133 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -57.86 -59.94 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.786 0.834 . . . . 0.0 109.683 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -54.18 -47.42 72.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 0.0 111.801 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.44 -47.55 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.421 0.688 . . . . 0.0 111.502 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -148.61 -15.51 0.32 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.05 3.48 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 120.099 1.318 . . . . 0.0 111.288 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -133.69 149.95 51.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.562 1.545 . . . . 0.0 107.627 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.26 6.08 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.421 1.088 . . . . 0.0 109.377 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.35 152.57 31.78 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.204 1.109 . . . . 0.0 111.808 -8.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.67 126.28 29.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.487 1.115 . . . . 0.0 109.888 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -59.52 -50.17 74.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -37.66 -61.04 0.65 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.024 2.13 . . . . 0.0 113.101 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -38.63 3.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.666 1.187 . . . . 0.0 112.3 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.6 m -91.11 -58.34 2.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 117.665 0.211 . . . . 0.0 110.985 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -67.54 -41.96 83.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.24 -34.6 78.02 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.654 -0.654 . . . . 0.0 110.607 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.15 -24.71 18.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.787 0.835 . . . . 0.0 112.678 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.77 35.12 13.8 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.101 0.858 . . . . 0.0 111.472 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -56.75 131.63 20.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.65 31.24 7.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 111.451 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.48 26.06 74.72 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.632 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.5 134.08 77.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.418 1.109 . . . . 0.0 108.568 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.84 120.29 8.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.479 2.119 . . . . 0.0 109.493 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -88.0 174.14 8.47 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.466 0.65 . . . . 0.0 111.923 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.94 165.56 24.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 45.82 41.23 7.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.549 1.14 . . . . 0.0 111.655 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.1 59.44 10.7 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -47.43 -34.41 19.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.421 3.414 . . . . 0.0 113.713 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -51.67 -38.87 56.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 110.7 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 15.7 4.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.453 0.701 . . . . 0.0 112.113 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -134.66 -40.28 0.79 Allowed 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.011 0.823 . . . . 0.0 111.485 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -40.41 -46.71 2.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.998 1.319 . . . . 0.0 112.505 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.58 -26.41 50.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 113.195 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -75.28 159.33 82.5 Favored Pre-proline 0 CA--C 1.534 0.347 0 O-C-N 121.576 -0.703 . . . . 0.0 109.976 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.07 121.43 10.05 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.839 1.693 . . . . 0.0 109.677 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -64.56 -39.16 93.24 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 109.634 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 m -50.72 102.51 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.142 1.777 . . . . 0.0 112.036 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.7 -40.19 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.302 1.041 . . . . 0.0 109.964 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.73 -35.29 65.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.798 0.839 . . . . 0.0 112.253 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -77.74 -48.2 17.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.01 -43.6 70.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 122.879 0.472 . . . . 0.0 111.612 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 49' ' ' LEU . 11.0 p -60.41 -44.29 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.911 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.15 -46.22 79.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.746 1.157 . . . . 0.0 109.652 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -54.23 -37.77 64.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.042 0.383 . . . . 0.0 111.392 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -68.0 -50.39 55.87 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.614 0.766 . . . . 0.0 109.357 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.02 -42.42 94.34 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 120.158 1.345 . . . . 0.0 111.472 177.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.11 -38.49 78.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.044 0.538 . . . . 0.0 111.981 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.98 155.32 29.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -155.48 135.17 12.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.66 -118.44 13.83 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.59 -3.32 46.59 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.694 0.798 . . . . 0.0 112.242 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.0 ttp -68.1 122.02 82.36 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 119.259 0.936 . . . . 0.0 110.595 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.468 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 50.6 Cg_exo -59.29 153.12 55.49 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.034 176.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 112.62 6.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -71.32 -3.07 18.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.26 110.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 0.0 111.072 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.82 -11.27 62.54 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.345 0.974 . . . . 0.0 114.596 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -76.1 -47.94 22.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.044 1.422 . . . . 0.0 109.906 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -139.64 156.23 46.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.56 140.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 45' ' ' VAL . 26.3 ttt180 -32.83 -44.21 0.1 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.577 1.951 . . . . 0.0 112.436 172.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.78 -47.8 83.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.811 1.187 . . . . 0.0 111.197 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.4 -56.77 16.96 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 122.902 1.334 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 62' ' ' ALA . 79.3 mt -48.08 -57.27 6.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.857 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.19 -53.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.892 1.277 . . . . 0.0 109.919 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -57.87 -38.91 76.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.498 0.319 . . . . 0.0 111.258 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.13 81.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.915 -0.49 . . . . 0.0 109.896 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.4 mt -66.7 -52.61 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.613 0.765 . . . . 0.0 109.991 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.29 -39.7 76.27 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.234 0.924 . . . . 0.0 109.086 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.14 -52.73 64.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.128 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 ptm -54.44 -43.35 71.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.611 0.641 . . . . 0.0 109.346 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.6 mt -65.15 -35.18 80.28 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.476 -0.765 . . . . 0.0 110.763 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 m -74.83 37.93 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.009 -1.057 . . . . 0.0 112.634 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -148.59 24.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.582 1.153 . . . . 0.0 109.918 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.252 1.232 0 CA-C-O 116.148 -1.882 . . . . 0.0 107.132 -177.439 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.468 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.56 -38.33 7.17 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.965 1.269 . . . . 0.0 112.586 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.54 -56.19 11.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.28 -51.63 52.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.947 1.299 . . . . 0.0 109.399 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.23 -57.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.842 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -57.64 -52.15 66.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.888 0.475 . . . . 0.0 111.623 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.57 -46.34 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.557 -173.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.57 38.81 0.33 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.298 0.954 . . . . 0.0 113.04 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.75 40.33 1.09 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.796 HG21 HBB1 ' A' ' 0' ' ' HEM . 1.1 p -137.25 156.94 47.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.436 1.895 . . . . 0.0 107.841 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 106.64 5.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.861 0.864 . . . . 0.0 108.904 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.83 152.85 24.35 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 120.378 1.171 . . . . 0.0 112.142 -7.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.38 123.79 19.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HA ' ' HAB' ' A' ' 0' ' ' HEM . 0.5 OUTLIER -52.93 -51.0 62.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.912 0.885 . . . . 0.0 111.439 -176.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 p -40.88 -54.41 2.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.447 1.899 . . . . 0.0 111.872 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.91 -38.74 1.64 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.61 1.164 . . . . 0.0 113.094 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -98.43 -57.15 2.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.964 0.347 . . . . 0.0 111.49 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -73.71 -19.47 60.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -172.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.37 -53.57 18.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.535 1.061 . . . . 0.0 108.989 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -79.98 -31.13 39.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.467 0.307 . . . . 0.0 111.052 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.5 42.85 5.69 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.26 142.81 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.37 28.62 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.066 0.947 . . . . 0.0 111.502 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.95 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.715 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 134.14 87.54 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.738 1.269 . . . . 0.0 108.377 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.78 115.76 3.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.701 2.267 . . . . 0.0 108.258 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -86.16 179.08 7.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.901 0.857 . . . . 0.0 113.215 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.23 159.94 22.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 34.61 52.38 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.545 1.538 . . . . 0.0 112.565 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.9 61.96 31.28 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.317 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.73 -46.76 6.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.045 3.163 . . . . 0.0 114.683 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -49.88 -39.99 41.37 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.822 1.249 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.67 -15.45 61.7 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.873 0.869 . . . . 0.0 112.463 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -110.94 -25.57 9.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.508 1.123 . . . . 0.0 112.294 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.05 -46.26 0.48 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.921 2.088 . . . . 0.0 114.433 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.39 -5.57 32.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -81.48 154.96 71.63 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 121.483 -0.761 . . . . 0.0 110.211 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.52 115.6 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.072 2.515 . . . . 0.0 111.462 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -60.72 -34.03 73.77 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.26 99.96 0.07 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.754 2.022 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.2 t -53.33 -38.44 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.616 -0.677 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.29 -26.2 51.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 112.415 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.13 -50.81 5.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -49.02 -41.01 33.23 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.694 0.798 . . . . 0.0 112.117 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.85 -30.4 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.533 -0.729 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.29 -49.62 68.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -50.99 -46.29 61.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.619 0.767 . . . . 0.0 109.796 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 m -60.68 -51.9 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.05 -45.46 93.46 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.245 -0.909 . . . . 0.0 111.456 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 -32.37 63.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.833 0.853 . . . . 0.0 112.369 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 161.01 27.8 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.45 115.1 2.49 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.962 -0.728 . . . . 0.0 109.163 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.62 -116.95 9.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.25 -24.58 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.371 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.38 121.18 75.57 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.946 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.523 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 90.8 Cg_endo -76.38 165.26 29.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.711 2.274 . . . . 0.0 109.781 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.78 134.03 48.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.79 -14.77 20.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.125 0.97 . . . . 0.0 112.326 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.77 101.02 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.269 1.028 . . . . 0.0 112.539 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.48 -37.28 3.77 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.009 1.29 . . . . 0.0 111.481 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -77.02 -36.45 56.25 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-N 117.756 0.778 . . . . 0.0 109.913 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.8 149.11 50.87 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.29 130.45 37.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -31.69 -44.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.029 2.132 . . . . 0.0 112.818 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.46 -48.95 75.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.684 1.129 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.76 -47.93 81.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.012 0.925 . . . . 0.0 108.797 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 62' ' ' ALA . 37.4 mt -51.86 -55.91 17.2 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.037 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -45.2 -57.81 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.211 1.004 . . . . 0.0 109.271 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -56.36 -39.8 73.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 118.483 0.583 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.97 95.01 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.722 -0.611 . . . . 0.0 110.073 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.73 -47.76 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -53.47 -52.46 59.44 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -54.56 -52.15 63.01 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.56 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.19 -50.57 64.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.13 -30.12 71.2 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.945 -0.472 . . . . 0.0 110.997 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.1 m -74.25 40.59 0.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.073 -1.017 . . . . 0.0 112.782 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.5 p -135.43 -10.92 2.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 109.827 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.7 -1.619 . . . . 0.0 110.25 -177.839 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.796 HBB1 HG21 ' A' ' 10' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.89 11.93 84.31 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 68.53 -53.94 0.54 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 129.068 2.947 . . . . 0.0 112.256 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p -31.17 -56.75 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.728 2.411 . . . . 0.0 112.868 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.29 -50.51 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.408 1.083 . . . . 0.0 110.483 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -68.29 -46.39 70.46 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.694 0.397 . . . . 0.0 110.398 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.85 -42.11 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.958 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 32.47 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.24 14.85 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.096 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.48 HG21 HBB1 ' A' ' 0' ' ' HEM . 81.3 p -97.89 168.8 10.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.644 0.778 . . . . 0.0 111.497 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.5 115.53 25.18 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.0 1.32 . . . . 0.0 107.822 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.51 169.66 35.43 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.609 1.253 . . . . 0.0 110.057 -10.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -78.25 149.68 33.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 m -61.87 -44.54 96.6 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -50.56 -47.41 57.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.086 1.355 . . . . 0.0 111.651 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -42.64 -40.35 2.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.782 0.719 . . . . 0.0 112.167 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.8 m -98.29 -57.93 2.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.468 0.175 . . . . 0.0 111.188 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -62.2 -40.38 95.89 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.47 -29.77 64.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.138 0.426 . . . . 0.0 111.107 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -115.61 17.73 16.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.708 0.803 . . . . 0.0 111.681 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 48.09 40.23 20.55 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 123.899 0.761 . . . . 0.0 113.8 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.94 135.49 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.082 -0.658 . . . . 0.0 109.381 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 31.31 7.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.756 1.223 . . . . 0.0 111.806 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.55 23.38 77.09 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.667 -0.518 . . . . 0.0 112.628 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.73 140.77 75.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.222 1.011 . . . . 0.0 108.791 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -58.27 119.44 6.69 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.489 2.126 . . . . 0.0 107.81 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.52 167.58 19.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.832 1.301 . . . . 0.0 111.26 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mp -77.01 162.26 27.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.873 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.23 53.56 1.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.939 1.296 . . . . 0.0 110.601 -176.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.92 64.93 11.75 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.006 1.723 . . . . 0.0 109.427 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -39.12 -55.46 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.588 3.525 . . . . 0.0 114.358 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -44.71 -45.44 9.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.01 1.324 . . . . 0.0 112.281 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -53.76 -39.16 65.12 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.463 0.705 . . . . 0.0 110.762 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -92.88 -29.9 15.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.846 0.859 . . . . 0.0 111.169 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.19 98.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 109.617 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.99 -41.75 97.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 110.326 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -76.36 164.15 61.69 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.683 1.193 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.0 88.66 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 107.539 -1.754 . . . . 0.0 107.539 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -51.98 -22.2 3.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.293 1.437 . . . . 0.0 112.463 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -56.77 108.3 0.48 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.287 1.035 . . . . 0.0 110.453 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.53 -46.33 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.736 1.214 . . . . 0.0 110.047 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.89 -36.83 3.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.201 2.2 . . . . 0.0 112.335 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.21 -52.74 4.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.298 1.039 . . . . 0.0 109.182 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -44.72 -45.93 10.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.773 0.829 . . . . 0.0 112.634 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 67' ' ' LEU . 19.2 m -61.35 -34.31 60.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 O-C-N 121.348 -0.845 . . . . 0.0 111.585 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.2 -47.18 71.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 m -53.5 -46.26 69.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.06 0.544 . . . . 0.0 110.051 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -62.17 -52.02 65.48 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.982 0.513 . . . . 0.0 111.345 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -40.48 84.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.56 -0.713 . . . . 0.0 109.698 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.43 76.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.145 0.578 . . . . 0.0 111.617 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.52 154.99 24.26 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -158.38 125.64 4.98 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.45 -137.67 49.15 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.06 -16.88 64.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.624 -0.788 . . . . 0.0 111.997 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.42 117.28 51.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.652 1.115 . . . . 0.0 109.801 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.32 155.06 64.91 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.441 2.094 . . . . 0.0 109.951 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.11 133.58 55.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.65 6.58 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.951 0.9 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -40.69 108.84 0.1 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.243 1.817 . . . . 0.0 112.688 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.28 -20.27 5.02 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.529 0.585 . . . . 0.0 113.021 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -76.37 -44.3 36.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.72 25.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.73 152.61 33.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -23.16 -52.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.219 2.208 . . . . 0.0 111.692 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -60.54 -56.68 18.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.351 0.523 . . . . 0.0 111.811 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.67 -49.89 69.53 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.411 1.084 . . . . 0.0 109.687 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' HB3' HG12 ' A' ' 45' ' ' VAL . 71.0 mt -52.13 -58.6 6.09 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.291 1.436 . . . . 0.0 110.057 178.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.16 -58.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.753 0.821 . . . . 0.0 109.509 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.08 -26.1 62.12 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.17 1.388 . . . . 0.0 113.068 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 -59.39 2.72 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 mt -51.17 -44.53 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.643 1.177 . . . . 0.0 111.459 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -53.86 -37.85 64.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.865 0.757 . . . . 0.0 110.708 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.95 -44.21 90.16 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.996 0.816 . . . . 0.0 109.664 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.7 mtp -53.55 -58.39 7.34 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.3 -36.79 66.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.688 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -62.49 -10.36 11.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.388 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -89.01 -9.02 52.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.462 1.483 . . . . 0.0 111.158 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 116.554 -1.689 . . . . 0.0 111.033 -176.288 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.48 HBB1 HG21 ' A' ' 10' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -47.6 -42.13 19.65 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 119.328 0.967 . . . . 0.0 111.403 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 2.0 mp0 -49.9 -55.62 13.71 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.119 0.967 . . . . 0.0 108.751 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -57.19 -50.47 72.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.982 1.313 . . . . 0.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -50.65 -60.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.51 -52.56 63.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.241 1.416 . . . . 0.0 112.027 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.1 mt -67.84 -47.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.015 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.04 11.94 0.3 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.49 34.55 5.52 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.629 1.104 . . . . 0.0 111.591 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.21 157.64 45.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.486 1.514 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.58 107.75 9.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.207 1.003 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.16 159.17 68.99 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.172 1.097 . . . . 0.0 110.053 -8.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -68.13 118.55 11.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.06 1.344 . . . . 0.0 110.429 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 m -46.49 -48.56 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.981 0.913 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -45.46 -44.73 12.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.979 1.712 . . . . 0.0 112.547 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -53.2 -26.16 16.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.016 0.526 . . . . 0.0 112.255 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -104.02 -58.26 1.91 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.097 0.408 . . . . 0.0 109.941 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -66.89 -35.52 80.2 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.67 -41.67 75.18 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.102 0.865 . . . . 0.0 109.834 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -80.57 -28.7 37.11 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.097 0.559 . . . . 0.0 111.513 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.27 38.71 7.64 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.04 125.53 11.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.51 32.77 9.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.031 0.932 . . . . 0.0 111.128 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.41 76.95 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.941 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.45 113.33 5.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.57 1.185 . . . . 0.0 108.591 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 66.0 Cg_exo -36.32 116.79 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 125.014 3.809 . . . . 0.0 114.493 -175.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.39 173.69 10.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 111.701 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.58 159.52 32.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 49.43 29.71 2.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.848 0.859 . . . . 0.0 112.119 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.07 61.53 33.43 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.989 0.916 . . . . 0.0 110.954 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -45.35 -42.35 17.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.72 2.947 . . . . 0.0 112.799 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.36 -39.67 32.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 112.198 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -67.97 -25.07 65.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.125 0.57 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 86.3 m95 -105.52 -23.37 12.81 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.453 1.101 . . . . 0.0 112.893 -173.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -51.25 0.72 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.548 1.939 . . . . 0.0 113.582 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.71 -22.08 43.79 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -77.14 151.69 81.61 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.875 0.87 . . . . 0.0 110.206 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.3 125.28 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.675 1.583 . . . . 0.0 108.768 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -62.58 -29.63 70.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.797 -0.565 . . . . 0.0 110.35 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -56.01 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.986 1.714 . . . . 0.0 111.945 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.09 -42.39 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.304 1.441 . . . . 0.0 109.411 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.41 -37.43 11.42 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.386 2.274 . . . . 0.0 112.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.42 -50.86 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.1 mt -47.71 -42.16 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.88 0.872 . . . . 0.0 112.401 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.94 -32.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.16 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.58 -50.03 68.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -51.26 -47.33 62.49 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.599 0.76 . . . . 0.0 109.908 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.1 m -61.73 -49.54 75.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.74 -45.52 93.59 Favored 'General case' 0 N--CA 1.458 -0.063 0 O-C-N 121.132 -0.98 . . . . 0.0 111.143 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.51 -31.16 65.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.944 0.897 . . . . 0.0 112.289 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.01 160.71 29.53 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -155.51 108.86 2.77 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.964 -0.727 . . . . 0.0 109.327 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.01 -113.95 5.88 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.69 -30.19 64.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.688 0.395 . . . . 0.0 111.0 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.1 ttp -63.62 120.35 62.12 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.913 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 93.6 Cg_endo -74.57 156.66 44.94 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.843 2.362 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.71 135.1 56.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -100.46 -13.89 18.51 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 113.329 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.97 102.79 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 112.148 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.38 -38.97 3.03 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.126 1.346 . . . . 0.0 111.537 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -76.79 -39.74 50.47 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 117.68 0.74 . . . . 0.0 110.112 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.43 130.54 30.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -79.72 146.72 32.23 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -27.93 -53.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.377 170.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -41.94 96.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.134 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.49 -59.58 5.17 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 62' ' ' ALA . 76.4 mt -46.07 -58.66 3.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.495 1.518 . . . . 0.0 111.004 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -39.34 -51.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.812 2.045 . . . . 0.0 111.149 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -58.06 -45.57 86.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.703 0.801 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -47.69 78.15 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.407 -0.808 . . . . 0.0 109.826 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.9 mt -56.98 -52.16 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.876 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.41 -39.98 92.72 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.984 -1.072 . . . . 0.0 109.28 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -57.08 -49.5 75.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.418 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.5 mtt -48.13 -63.62 1.02 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.17 0.986 . . . . 0.0 108.649 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mp -49.83 -41.55 45.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.669 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -62.17 -10.94 11.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 p -90.1 -13.38 35.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.195 1.362 . . . . 0.0 111.207 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.6 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.566 -174.826 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.564 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.16 -39.8 65.05 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.72 -49.97 75.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -50.32 -52.72 34.32 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.865 0.757 . . . . 0.0 110.45 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.14 -57.07 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.795 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -56.18 -50.46 71.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.307 1.043 . . . . 0.0 111.651 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.72 -46.9 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.859 -174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.11 36.38 0.29 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 33.17 2.28 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.845 0.748 . . . . 0.0 111.252 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 155.68 48.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.687 1.995 . . . . 0.0 107.189 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.01 108.23 18.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -62.52 166.07 37.45 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.216 1.113 . . . . 0.0 109.341 -11.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -67.54 136.09 53.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 m -49.7 -43.48 47.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 0.687 . . . . 0.0 109.426 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.8 p -47.21 -41.44 18.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.066 1.347 . . . . 0.0 112.561 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.1 m -46.2 -39.16 9.31 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.3 0.64 . . . . 0.0 111.316 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -102.96 -52.33 3.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -72.0 -27.5 62.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.39 -47.08 62.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -68.17 -41.87 80.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.203 1.001 . . . . 0.0 110.367 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 34.81 13.08 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.57 145.55 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.68 32.24 6.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.22 1.008 . . . . 0.0 111.576 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.58 24.43 73.9 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.34 126.62 75.01 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.818 1.309 . . . . 0.0 108.038 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.85 116.51 3.4 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.628 2.219 . . . . 0.0 108.294 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -74.68 -149.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.516 1.127 . . . . 0.0 111.433 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.63 145.78 51.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.496 1.518 . . . . 0.0 107.474 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' OXT' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 49.14 48.13 21.23 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -168.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.42 51.78 1.41 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.341 2.257 . . . . 0.0 111.499 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -47.89 -34.97 23.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.336 3.358 . . . . 0.0 113.807 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -50.33 -40.13 48.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.917 1.287 . . . . 0.0 110.966 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.22 -5.67 52.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 73.2 m95 -107.96 -44.99 4.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.58 46.03 26.05 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.913 0.863 . . . . 0.0 110.236 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.86 53.11 2.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 0.0 112.216 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -57.04 157.29 11.55 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.33 101.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.73 2.286 . . . . 0.0 111.073 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -59.05 -23.69 62.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.457 1.103 . . . . 0.0 111.989 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -55.07 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.71 1.604 . . . . 0.0 110.721 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -43.59 -41.47 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.279 1.431 . . . . 0.0 109.709 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -42.5 -38.02 1.81 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.345 2.258 . . . . 0.0 112.609 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.13 -50.53 5.79 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.636 0.774 . . . . 0.0 110.17 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -51.09 -40.48 58.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.426 0.69 . . . . 0.0 111.844 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.02 -34.41 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.695 -0.628 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.09 -44.04 81.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.7 m -54.46 -44.99 73.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -67.01 -45.09 78.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.027 0.531 . . . . 0.0 110.889 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 O-C-N 121.259 -0.9 . . . . 0.0 110.68 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.39 51.79 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.416 1.086 . . . . 0.0 112.697 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 161.47 30.57 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -161.57 117.79 2.13 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.083 -0.657 . . . . 0.0 109.319 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.41 -118.06 13.51 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.34 -25.34 51.0 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.209 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.5 ttp -62.22 118.68 42.21 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.178 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 93.3 Cg_endo -72.46 160.52 46.58 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.509 2.139 . . . . 0.0 110.065 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.8 116.73 8.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -82.49 -7.46 59.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.676 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -55.9 88.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.931 0.892 . . . . 0.0 112.091 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 -41.9 1.44 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 110.572 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -75.55 -35.27 60.72 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.393 0.677 . . . . 0.0 110.384 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -143.72 130.72 20.54 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.57 149.66 32.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -32.04 -47.49 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.124 1.77 . . . . 0.0 111.494 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.68 -49.16 77.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.838 0.745 . . . . 0.0 111.66 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.43 -56.34 22.38 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 122.556 1.169 . . . . 0.0 108.791 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 80.5 mt -48.68 -60.71 2.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -43.29 -51.72 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.887 1.675 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -59.21 -33.87 71.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.395 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.14 13.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.781 0.719 . . . . 0.0 109.39 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.4 mt -54.76 -45.77 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.121 0.968 . . . . 0.0 111.279 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.66 -41.39 90.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.036 1.289 . . . . 0.0 110.599 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.63 -54.14 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 ttm -45.75 -55.06 6.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.121 1.368 . . . . 0.0 109.782 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.85 -26.62 58.86 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.239 0.615 . . . . 0.0 112.535 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -79.83 10.49 4.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.83 0.741 . . . . 0.0 112.372 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -177.05 54.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.736 ' OXT' HD12 ' A' ' 78' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.592 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.91 -44.11 61.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.994 0.806 . . . . 0.0 111.134 176.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -57.63 -59.65 4.86 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.662 0.731 . . . . 0.0 109.448 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 p -54.5 -43.91 72.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 111.438 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.73 -55.46 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.24 -48.44 78.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.167 0.987 . . . . 0.0 111.872 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.24 -51.73 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.538 -175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.85 8.69 0.37 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -173.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.39 4.42 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 119.795 1.18 . . . . 0.0 111.253 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -137.82 156.18 48.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.793 1.637 . . . . 0.0 108.155 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.0 110.79 10.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.761 0.825 . . . . 0.0 110.596 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.09 160.77 15.66 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 CA-C-N 119.915 1.005 . . . . 0.0 111.851 -15.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -70.34 114.9 8.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.355 1.062 . . . . 0.0 108.982 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -44.54 -48.27 10.23 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.19 0.996 . . . . 0.0 111.324 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -43.76 -47.93 8.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.374 1.87 . . . . 0.0 112.184 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -49.46 -34.6 17.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 m -96.7 -58.03 2.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.63 0.252 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -67.4 -36.36 81.14 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.26 -41.37 85.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -30.13 56.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.667 0.787 . . . . 0.0 110.572 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.47 40.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.4 136.95 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.02 28.21 5.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.119 0.968 . . . . 0.0 111.471 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 24.76 76.67 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.955 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.76 132.96 47.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.903 1.351 . . . . 0.0 108.422 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -49.48 104.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.958 3.106 . . . . 0.0 110.917 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -75.24 176.23 7.57 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.514 1.149 . . . . 0.0 109.666 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.4 142.43 27.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.14 33.11 12.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.348 0.659 . . . . 0.0 109.461 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.66 55.87 17.72 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.641 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -37.09 -46.57 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.486 3.457 . . . . 0.0 114.242 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -41.47 -45.36 3.17 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.046 1.338 . . . . 0.0 112.738 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -76.84 -25.05 52.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.679 0.672 . . . . 0.0 112.261 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -91.08 -23.49 20.3 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.411 0.684 . . . . 0.0 111.429 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -47.39 0.53 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.32 2.248 . . . . 0.0 114.355 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -91.33 -14.37 30.87 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.428 0.691 . . . . 0.0 112.852 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -78.59 147.58 71.72 Favored Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 123.839 0.856 . . . . 0.0 109.731 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.15 110.3 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.844 1.696 . . . . 0.0 108.573 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.34 -27.47 47.4 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.135 0.574 . . . . 0.0 112.007 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 109.24 0.36 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.844 1.658 . . . . 0.0 111.482 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.3 t -51.95 -42.07 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.86 -20.96 40.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -93.64 -53.85 3.88 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.8 mt -47.65 -41.72 22.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.62 0.768 . . . . 0.0 112.163 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.71 -37.1 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 121.688 -0.632 . . . . 0.0 110.41 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.7 -48.26 75.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -52.3 -46.04 65.78 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.811 0.845 . . . . 0.0 110.4 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -67.82 -40.97 83.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.058 0.543 . . . . 0.0 111.216 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.09 -56.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.37 61.72 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.567 1.147 . . . . 0.0 112.354 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.75 152.76 25.24 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -151.76 142.75 23.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -90.37 0.08 OUTLIER Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.98 16.0 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.365 1.466 . . . . 0.0 112.058 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.0 mtm -67.89 134.78 92.02 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 119.29 0.95 . . . . 0.0 110.847 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.57 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 92.9 Cg_endo -75.42 78.42 3.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.99 2.46 . . . . 0.0 108.784 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -10.08 106.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 128.315 2.646 . . . . 0.0 112.403 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -76.21 -6.65 52.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -47.29 114.83 0.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.557 0.743 . . . . 0.0 111.272 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.12 -26.95 21.45 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.206 0.908 . . . . 0.0 112.717 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -90.28 -52.44 4.93 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.514 1.157 . . . . 0.0 110.349 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -112.57 133.79 54.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.06 147.42 31.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -32.23 -45.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.38 1.872 . . . . 0.0 111.546 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.0 -47.18 84.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.211 0.914 . . . . 0.0 111.667 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.94 -58.65 7.23 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 122.577 1.179 . . . . 0.0 108.738 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.8 mt -47.14 -57.37 5.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.406 1.882 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -46.24 -57.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 124.844 1.257 . . . . 0.0 109.713 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.78 -43.65 81.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.802 0.274 . . . . 0.0 111.441 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.25 72.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.6 mt -57.75 -47.33 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.251 1.42 . . . . 0.0 109.463 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.26 -51.69 65.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -55.95 -50.8 69.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.361 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 79.0 mtp -51.84 -53.46 40.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.291 0.636 . . . . 0.0 109.987 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.78 -37.44 73.71 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.577 0.751 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.3 m -72.67 41.18 0.09 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.3 p -135.64 -16.35 1.78 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.36 1.864 . . . . 0.0 110.014 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.033 -178.126 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.57 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -43.6 -49.85 7.1 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.397 0.999 . . . . 0.0 112.946 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -56.12 -40.58 73.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.543 -0.386 . . . . 0.0 111.303 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -52.81 -42.09 64.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.553 0.615 . . . . 0.0 111.054 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.33 -59.59 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.296 1.438 . . . . 0.0 109.197 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.32 -51.42 70.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 111.349 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 mm -65.73 -46.02 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.816 0.446 . . . . 0.0 111.065 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.13 44.03 0.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.97 36.67 1.21 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.44 157.27 46.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.732 2.013 . . . . 0.0 107.47 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.92 113.49 6.41 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.802 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.73 152.5 19.71 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 CA-C-N 120.321 1.15 . . . . 0.0 111.065 -13.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.31 125.17 24.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.609 1.164 . . . . 0.0 109.775 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -54.74 -51.05 66.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -39.54 -61.06 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.509 1.923 . . . . 0.0 112.214 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.0 m -41.51 -39.62 1.6 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.441 1.497 . . . . 0.0 113.387 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.46 -56.82 2.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.045 0.45 . . . . 0.0 110.923 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -60.67 -41.18 94.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -48.31 -40.93 26.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.668 0.787 . . . . 0.0 112.109 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -116.43 26.08 10.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.991 0.516 . . . . 0.0 111.863 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.21 43.08 18.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.566 0.603 . . . . 0.0 113.54 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.25 136.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.69 30.36 8.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.549 1.14 . . . . 0.0 111.676 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.0 23.49 74.45 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.6 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.01 142.91 84.88 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 118.459 1.129 . . . . 0.0 109.323 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -59.78 121.53 9.98 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 106.848 -2.02 . . . . 0.0 106.848 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.47 176.76 7.23 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.671 1.7 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.5 tp -97.46 140.46 31.87 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.518 -2.128 . . . . 0.0 107.525 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 64.59 35.98 8.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.353 0.661 . . . . 0.0 109.459 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.62 71.26 81.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.467 1.107 . . . . 0.0 111.233 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -41.0 -57.99 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 124.344 3.363 . . . . 0.0 114.456 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -43.53 -47.92 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.154 1.381 . . . . 0.0 112.164 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.26 -39.56 63.96 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 110.972 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -91.03 -29.89 17.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.318 0.647 . . . . 0.0 111.073 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.0 97.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.359 0.663 . . . . 0.0 109.396 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.56 -41.86 96.05 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -77.29 164.68 57.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.586 1.154 . . . . 0.0 111.085 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -67.82 89.8 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 N-CA-C 107.632 -1.719 . . . . 0.0 107.632 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -21.96 7.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.702 1.201 . . . . 0.0 112.322 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.94 109.5 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.434 1.893 . . . . 0.0 110.932 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.13 -44.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.251 1.02 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.41 -29.09 61.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.009 1.724 . . . . 0.0 112.606 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.81 -55.35 3.89 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 mt -45.61 -44.36 13.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.833 1.253 . . . . 0.0 112.994 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.89 -37.33 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 O-C-N 121.722 -0.611 . . . . 0.0 110.607 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -65.58 -47.24 76.44 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.192 0.905 . . . . 0.0 108.905 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -53.04 -46.6 68.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.386 0.674 . . . . 0.0 110.259 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -64.13 -46.45 84.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.002 0.521 . . . . 0.0 110.356 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -57.06 -54.41 47.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.791 -0.568 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.48 64.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.22 1.008 . . . . 0.0 112.988 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.61 160.27 33.12 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -157.68 126.36 5.65 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.861 -0.787 . . . . 0.0 109.05 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.0 -120.68 22.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.92 -14.44 54.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.746 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.2 ttp -71.69 118.23 64.67 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 119.166 0.894 . . . . 0.0 108.716 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.23 160.56 48.56 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.389 2.059 . . . . 0.0 110.611 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.2 133.14 53.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -101.65 -11.55 19.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.615 0.766 . . . . 0.0 111.363 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -46.37 117.53 1.62 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.364 1.065 . . . . 0.0 111.558 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.52 -25.0 11.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.267 0.937 . . . . 0.0 112.34 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -86.35 -47.38 9.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.86 0.83 . . . . 0.0 108.865 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -110.08 142.24 41.82 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -80.36 131.03 35.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -28.35 -49.88 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.205 2.202 . . . . 0.0 112.659 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -61.28 -49.04 78.66 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.82 -0.55 . . . . 0.0 111.225 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.35 86.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 123.93 0.892 . . . . 0.0 109.141 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 62' ' ' ALA . 40.9 mt -51.63 -58.99 4.79 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.64 -54.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.158 1.383 . . . . 0.0 110.484 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -56.72 -45.55 81.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.139 0.427 . . . . 0.0 111.333 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.34 98.43 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.798 -0.564 . . . . 0.0 110.179 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.2 -55.85 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 109.268 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -59.26 -38.86 81.12 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.643 1.11 . . . . 0.0 109.773 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.53 -49.81 76.34 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttp -53.52 -54.27 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.7 mt -56.36 -38.97 72.13 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.619 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -61.42 -6.5 2.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.882 1.219 . . . . 0.0 113.951 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.0 p -86.75 -5.28 59.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.725 1.148 . . . . 0.0 110.684 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.224 -1.37 . . . . 0.0 110.688 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.937 -0.554 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.29 -40.64 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.82 -47.33 85.58 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 117.883 0.841 . . . . 0.0 109.557 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -48.39 76.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.238 0.615 . . . . 0.0 109.628 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.39 -55.95 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 109.6 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -56.66 -50.48 71.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.914 0.886 . . . . 0.0 111.607 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.46 -45.29 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.131 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.91 36.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.04 33.0 2.22 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.98 157.45 46.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.271 2.228 . . . . 0.0 106.408 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.49 113.19 6.62 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.755 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -50.08 153.73 7.78 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 120.522 1.222 . . . . 0.0 110.752 -15.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.2 p -67.01 144.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -56.25 -38.89 71.75 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.076 0.853 . . . . 0.0 108.906 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -56.28 -23.27 35.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 112.8 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.0 m -57.48 -28.32 63.3 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.488 1.04 . . . . 0.0 110.628 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.2 m -122.54 -52.31 1.93 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -70.09 -20.35 63.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.21 -52.12 65.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.818 0.735 . . . . 0.0 109.869 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -91.47 -22.95 20.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 111.339 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 42.15 8.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.35 146.6 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.51 30.17 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.081 0.952 . . . . 0.0 111.417 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.4 79.96 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.027 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.95 135.61 90.31 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.873 1.336 . . . . 0.0 108.272 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 39.3 Cg_endo -60.31 128.83 27.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.459 2.106 . . . . 0.0 109.915 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -89.02 171.44 9.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.264 1.031 . . . . 0.0 112.937 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.48 156.42 36.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.891 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 52.32 36.56 20.03 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.889 0.876 . . . . 0.0 111.265 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.37 65.52 68.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.842 -175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -39.74 -47.03 3.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 124.324 3.349 . . . . 0.0 114.428 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -51.11 -39.59 56.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.865 1.266 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.49 -21.88 66.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.426 0.69 . . . . 0.0 111.733 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.402 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.1 m95 -108.58 -30.73 8.09 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.4 1.08 . . . . 0.0 112.903 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.49 -50.79 1.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.728 1.611 . . . . 0.0 113.048 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 -24.51 50.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.92 143.85 67.14 Favored Pre-proline 0 CA--C 1.535 0.381 0 O-C-N 121.529 -0.732 . . . . 0.0 110.276 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.79 96.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.675 2.25 . . . . 0.0 108.895 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -55.78 -26.88 48.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.815 1.246 . . . . 0.0 112.943 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 m -50.0 104.28 0.07 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.827 1.651 . . . . 0.0 111.48 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.14 -44.07 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.167 1.387 . . . . 0.0 111.54 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.18 -31.86 67.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.183 0.593 . . . . 0.0 112.045 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -81.63 -48.01 12.28 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.67 -41.3 61.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 m -59.94 -34.18 55.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.87 -48.48 81.6 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.531 1.514 . . . . 0.0 109.057 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.69 -42.21 67.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.795 0.838 . . . . 0.0 111.205 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -70.39 -44.57 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.384 0.673 . . . . 0.0 110.334 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -64.18 -50.66 67.25 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 124.795 1.238 . . . . 0.0 109.751 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.12 61.59 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.201 1.001 . . . . 0.0 112.214 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 158.53 31.48 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -157.15 118.34 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.013 -0.698 . . . . 0.0 109.482 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 -117.77 12.28 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.39 -23.13 54.06 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.744 0.418 . . . . 0.0 111.461 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.4 ttp -66.41 118.49 54.04 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.466 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.34 154.38 56.13 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.481 2.121 . . . . 0.0 109.954 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.84 123.36 17.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.827 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -92.28 -11.9 33.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.967 0.803 . . . . 0.0 111.756 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -44.26 116.01 0.94 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.062 0.945 . . . . 0.0 112.037 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -26.36 9.73 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.154 0.883 . . . . 0.0 112.4 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -83.91 -44.75 13.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -111.23 146.39 37.04 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.55 132.58 34.91 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -31.96 -44.32 0.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.141 1.776 . . . . 0.0 112.64 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -57.02 -44.62 83.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.819 1.191 . . . . 0.0 111.645 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -54.03 -57.76 9.84 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.17 0.986 . . . . 0.0 108.531 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.7 mt -50.34 -59.12 4.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.545 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.0 t -43.38 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.445 1.098 . . . . 0.0 109.687 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.36 -40.79 97.58 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 122.11 -0.369 . . . . 0.0 111.815 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.88 97.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.0 mt -65.22 -48.13 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.105 0.962 . . . . 0.0 109.111 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.27 -51.73 51.5 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.59 -53.73 54.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.107 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ptm -55.66 -47.34 76.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.507 0.594 . . . . 0.0 109.68 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.73 -38.52 90.83 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.832 -0.542 . . . . 0.0 110.449 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.2 m -61.71 -5.4 1.92 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.5 p -88.38 -16.31 33.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.207 1.367 . . . . 0.0 111.19 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.657 -1.64 . . . . 0.0 110.601 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.62 -49.24 61.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -48.43 -49.75 33.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.274 1.029 . . . . 0.0 110.536 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -47.38 -40.3 17.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.385 1.074 . . . . 0.0 111.602 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mt -58.23 -49.23 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -68.05 -44.72 75.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.967 0.907 . . . . 0.0 110.743 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.9 mt -69.32 -50.97 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.311 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.2 -9.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -171.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.2 -40.18 42.37 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 119.847 1.203 . . . . 0.0 111.131 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -72.57 158.59 35.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.76 111.88 5.78 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.439 1.096 . . . . 0.0 109.792 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 151.34 12.04 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.249 1.125 . . . . 0.0 110.86 -13.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 p -66.3 134.35 52.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -51.4 -41.41 60.7 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.63 0.729 . . . . 0.0 109.334 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 p -50.93 -37.05 41.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 112.814 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -44.75 -39.28 5.07 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.876 0.762 . . . . 0.0 111.407 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.7 m -107.04 -56.31 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.514 0.725 . . . . 0.0 110.439 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -62.7 -26.83 68.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.46 -1.52 53.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.69 0.677 . . . . 0.0 111.026 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -127.35 -17.69 4.64 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.925 0.89 . . . . 0.0 111.65 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.56 27.17 65.9 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.597 -0.69 . . . . 0.0 111.488 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.87 141.64 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.38 27.76 5.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 111.575 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.47 74.49 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.65 129.2 80.91 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.595 1.198 . . . . 0.0 108.311 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -64.54 123.56 11.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.24 1.96 . . . . 0.0 109.269 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.29 -179.53 5.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.703 0.763 . . . . 0.0 113.053 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.67 159.57 34.16 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 48.06 32.34 2.89 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 112.356 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.16 61.85 59.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.406 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -37.24 -49.11 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.456 3.437 . . . . 0.0 114.01 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.02 -43.78 9.52 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.245 1.418 . . . . 0.0 111.951 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.01 -27.0 67.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.747 0.819 . . . . 0.0 111.924 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -103.62 -18.55 14.69 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.689 1.195 . . . . 0.0 112.429 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -47.05 0.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.407 1.883 . . . . 0.0 114.013 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -9.84 30.16 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -81.27 131.57 58.54 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.62 109.79 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.959 2.439 . . . . 0.0 110.888 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -56.59 -26.26 54.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.764 0.826 . . . . 0.0 112.446 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -49.43 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.31 1.844 . . . . 0.0 111.618 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.0 t -48.47 -38.56 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.67 0.788 . . . . 0.0 110.715 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.01 -44.01 82.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.844 0.458 . . . . 0.0 111.383 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -68.71 -45.96 70.19 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -56.51 -44.51 80.83 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.448 0.299 . . . . 0.0 111.553 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.12 -36.26 77.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -52.66 64.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.951 0.796 . . . . 0.0 109.798 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 m -51.17 -43.26 61.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.908 0.883 . . . . 0.0 111.106 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -69.12 -44.0 73.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.933 0.493 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.26 -52.5 64.47 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.337 -0.852 . . . . 0.0 109.947 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.5 77.91 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.677 0.791 . . . . 0.0 110.905 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.26 87.14 1.43 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.542 1.068 . . . . 0.0 110.867 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -77.79 146.58 35.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.652 1.181 . . . . 0.0 109.82 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.83 -110.85 3.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.24 9.49 28.01 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.684 1.193 . . . . 0.0 111.903 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 42.8 mtm -71.25 137.83 84.25 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 119.172 0.896 . . . . 0.0 111.627 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 22.8 Cg_exo -63.52 139.37 69.98 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 N-CA-C 106.961 -1.977 . . . . 0.0 106.961 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 114.99 3.67 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -80.82 -8.74 59.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.846 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -51.7 112.15 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.94 0.791 . . . . 0.0 110.609 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.83 -26.14 10.25 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.945 0.783 . . . . 0.0 111.916 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -74.6 -44.19 51.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.435 1.094 . . . . 0.0 108.696 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -126.99 157.11 40.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.79 1.236 . . . . 0.0 108.338 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.47 129.82 35.35 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -33.6 -43.81 0.13 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.532 1.933 . . . . 0.0 112.046 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.86 -48.82 80.05 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.401 1.0 . . . . 0.0 111.522 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -48.81 78.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.8 mt -50.8 -58.73 5.22 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.127 0.489 . . . . 0.0 109.693 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 t -47.36 -56.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.796 1.239 . . . . 0.0 109.823 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -57.12 -40.38 76.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.873 0.469 . . . . 0.0 111.72 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.62 93.98 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.36 -46.77 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -53.78 -51.42 63.48 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -54.17 -54.11 44.27 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.306 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.3 mtp -49.33 -60.03 3.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.407 0.683 . . . . 0.0 109.394 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.13 -39.15 66.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.54 0.736 . . . . 0.0 111.678 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -62.82 -9.01 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.321 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -88.8 -14.1 37.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.17 1.35 . . . . 0.0 110.932 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.122 -175.631 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.433 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.47 -37.36 19.02 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.462 1.03 . . . . 0.0 111.698 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.93 -60.85 2.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -47.21 -46.12 23.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.679 1.192 . . . . 0.0 110.677 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.91 -53.37 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -59.52 -45.43 91.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.905 0.32 . . . . 0.0 111.67 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.76 -52.82 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.375 0.67 . . . . 0.0 112.035 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -133.23 -18.6 2.26 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.4 -32.34 43.03 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.916 1.235 . . . . 0.0 112.845 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 150.45 45.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.583 0.692 . . . . 0.0 110.687 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.73 111.89 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.021 1.329 . . . . 0.0 109.46 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.46 159.14 59.07 Favored 'Cis proline' 0 N--CA 1.453 -0.877 0 CA-C-N 120.343 1.158 . . . . 0.0 109.402 -12.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -65.22 121.04 13.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.394 1.477 . . . . 0.0 110.31 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 m -51.17 -47.02 62.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.011 0.524 . . . . 0.0 110.552 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.8 p -41.44 -52.42 3.6 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 126.582 1.953 . . . . 0.0 112.226 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -47.62 -33.54 6.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.249 1.02 . . . . 0.0 112.552 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.4 m -99.28 -56.0 2.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.049 0.386 . . . . 0.0 110.838 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -70.65 -38.81 73.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.36 -42.98 78.4 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.359 0.981 . . . . 0.0 108.994 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -38.91 79.36 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.212 1.005 . . . . 0.0 111.509 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.54 34.91 8.19 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.813 1.197 . . . . 0.0 110.362 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.98 129.46 17.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 30.96 6.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.481 1.112 . . . . 0.0 111.361 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.99 24.2 77.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.357 -0.69 . . . . 0.0 112.823 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.36 131.58 52.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.548 1.174 . . . . 0.0 108.33 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -60.09 116.95 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.077 2.518 . . . . 0.0 109.226 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -84.54 173.61 10.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.184 0.994 . . . . 0.0 112.631 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.09 161.68 29.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 m120 49.36 32.03 4.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.549 0.74 . . . . 0.0 112.622 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 59.56 38.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.373 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.55 -45.89 3.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.055 3.17 . . . . 0.0 114.468 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.59 -44.48 18.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.663 1.185 . . . . 0.0 111.519 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.09 -18.15 61.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.171 0.989 . . . . 0.0 112.327 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -104.89 -18.22 14.28 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.32 1.048 . . . . 0.0 112.153 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -46.2 0.59 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.391 1.876 . . . . 0.0 114.243 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.41 -14.91 27.9 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.616 0.767 . . . . 0.0 112.991 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -81.31 124.93 80.22 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.09 0.956 . . . . 0.0 109.373 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.31 120.99 8.17 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.571 2.181 . . . . 0.0 111.473 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.73 -31.05 57.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.827 0.851 . . . . 0.0 112.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -48.72 102.17 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.568 1.947 . . . . 0.0 112.855 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.1 -43.06 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.689 0.796 . . . . 0.0 109.404 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.24 -27.35 63.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.444 1.098 . . . . 0.0 112.769 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.85 -54.06 4.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.2 mt -52.92 -40.69 63.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.793 0.837 . . . . 0.0 112.521 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.97 -28.51 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.505 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.74 -47.39 83.77 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.681 1.128 . . . . 0.0 108.867 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 m -54.22 -48.22 71.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 109.892 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -62.02 -45.24 94.46 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.921 -0.487 . . . . 0.0 111.066 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -62.14 -53.44 55.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.197 0.599 . . . . 0.0 110.98 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.89 -21.42 47.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.067 1.347 . . . . 0.0 112.976 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.4 162.63 35.32 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -159.91 114.33 2.29 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -115.33 7.14 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -27.96 60.4 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.49 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 33.3 ttp -62.98 115.45 17.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.688 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 94.2 Cg_endo -77.21 130.27 10.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.032 2.488 . . . . 0.0 110.415 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.62 114.69 0.55 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.434 1.494 . . . . 0.0 111.848 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -83.14 -13.63 55.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.483 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -48.99 112.85 0.68 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.89 0.768 . . . . 0.0 111.258 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.08 -32.92 6.56 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.278 0.942 . . . . 0.0 111.651 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -79.15 -44.66 21.51 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.98 135.83 49.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 172.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.54 146.88 32.39 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -32.2 -47.89 0.16 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.234 1.814 . . . . 0.0 111.31 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.1 -46.02 92.31 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.673 0.67 . . . . 0.0 111.371 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.24 -58.15 9.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 122.08 0.943 . . . . 0.0 108.632 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 62' ' ' ALA . 72.5 mt -45.87 -58.03 3.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.543 1.537 . . . . 0.0 110.416 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.5 t -41.63 -51.67 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 125.158 1.383 . . . . 0.0 111.214 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -57.85 -38.84 76.4 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.572 0.169 . . . . 0.0 111.416 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -48.15 56.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -58.1 -49.08 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.315 0.646 . . . . 0.0 111.114 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.5 -44.19 97.53 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.022 -1.049 . . . . 0.0 109.629 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -56.95 -53.51 57.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.286 0.494 . . . . 0.0 109.68 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttm -48.2 -53.57 16.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.806 1.642 . . . . 0.0 109.907 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.34 -37.87 84.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.233 -0.292 . . . . 0.0 110.489 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 m -73.4 39.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.3 p -129.43 -12.93 4.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.932 1.693 . . . . 0.0 109.559 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.352 -1.308 . . . . 0.0 110.304 -176.282 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.408 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.32 -42.66 9.4 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.568 1.08 . . . . 0.0 111.77 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -54.0 -61.99 1.94 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.542 1.137 . . . . 0.0 108.846 175.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.56 -53.21 24.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 110.538 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.3 mt -52.7 -61.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.427 . . . . 0.0 110.0 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.77 -48.82 77.01 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.288 0.635 . . . . 0.0 112.035 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.69 -44.02 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.153 -173.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 6.14 0.19 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -174.249 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.04 40.04 2.65 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.827 1.194 . . . . 0.0 111.323 -177.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.94 49.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.527 1.531 . . . . 0.0 108.585 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.25 109.19 8.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.738 0.815 . . . . 0.0 110.158 -177.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.73 156.69 32.27 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.802 0.965 . . . . 0.0 111.462 -12.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.1 123.17 19.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.915 1.286 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -55.79 -49.3 73.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.497 0.665 . . . . 0.0 111.011 -177.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -41.52 -51.1 3.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.282 1.833 . . . . 0.0 112.543 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -44.44 -35.34 2.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.793 1.237 . . . . 0.0 113.345 -178.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -102.23 -52.73 3.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.747 0.419 . . . . 0.0 110.729 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -67.12 -25.63 66.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.39 -44.32 97.35 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.3 0.954 . . . . 0.0 110.249 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -30.19 16.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 111.152 178.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.94 40.1 5.01 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -176.181 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.7 136.22 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.411 0.685 . . . . 0.0 109.36 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.54 32.25 8.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.776 1.23 . . . . 0.0 112.097 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.76 81.18 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.267 -0.74 . . . . 0.0 113.278 178.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.23 130.38 68.7 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.529 1.165 . . . . 0.0 108.61 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.88 119.17 6.16 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.004 1.802 . . . . 0.0 109.402 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.4 158.52 33.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.526 0.679 . . . . 0.0 110.323 -176.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.92 151.08 25.28 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 64.45 34.82 9.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.985 0.914 . . . . 0.0 109.363 -174.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.8 68.46 43.43 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.765 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -38.65 -52.39 2.07 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.291 3.328 . . . . 0.0 114.275 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -48.52 -39.99 25.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.322 1.449 . . . . 0.0 111.812 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.04 -30.85 71.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.808 0.443 . . . . 0.0 111.339 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -101.25 -27.67 13.07 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.783 0.833 . . . . 0.0 112.359 -175.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.55 0.92 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.05 1.74 . . . . 0.0 112.98 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.54 -21.31 38.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -177.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.456 HH22 ' CGD' ' A' ' 0' ' ' HEM . 91.8 mtt-85 -81.36 156.5 71.24 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.872 0.869 . . . . 0.0 110.268 -177.369 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.89 109.85 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.008 2.472 . . . . 0.0 111.646 176.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.96 -31.52 72.64 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.031 -1.043 . . . . 0.0 110.423 177.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 105.17 0.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 111.68 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -48.77 -39.7 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.001 0.92 . . . . 0.0 110.599 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.55 -39.67 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.841 1.256 . . . . 0.0 111.648 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.29 -44.18 47.0 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.1 mt -56.11 -49.73 73.06 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.8 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 11.8 p -59.41 -44.69 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.64 -44.69 85.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.322 0.964 . . . . 0.0 109.596 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -59.58 -33.2 71.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.084 176.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.7 m -72.38 -45.31 60.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.5 0.72 . . . . 0.0 109.751 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 45' ' ' VAL . 2.2 mm? -54.65 -52.31 62.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.86 1.209 . . . . 0.0 110.517 174.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.83 82.26 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.358 0.411 . . . . 0.0 111.762 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.21 124.21 3.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -101.12 139.87 36.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.133 1.373 . . . . 0.0 107.748 178.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.06 3.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.39 8.61 43.52 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.088 0.955 . . . . 0.0 112.723 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 37.1 mtm -68.06 148.25 98.37 Favored Pre-proline 0 C--N 1.338 0.091 0 CA-C-N 119.756 1.162 . . . . 0.0 112.261 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.32 140.92 25.16 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 N-CA-C 106.345 -2.214 . . . . 0.0 106.345 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.85 117.66 6.17 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.0 4.07 10.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.071 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -50.67 104.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 111.713 177.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -8.43 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.186 0.898 . . . . 0.0 113.214 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -78.75 -42.21 28.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.84 144.91 47.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 174.05 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.47 143.21 32.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -27.72 -50.31 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.4 2.28 . . . . 0.0 112.295 169.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.77 -49.88 71.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.539 0.609 . . . . 0.0 111.095 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.93 -50.65 72.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.35 1.06 . . . . 0.0 109.377 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 62' ' ' ALA . 44.2 mt -51.29 -56.84 10.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.251 1.42 . . . . 0.0 109.986 177.021 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.3 t -52.44 -53.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.175 0.59 . . . . 0.0 109.98 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -56.33 -36.83 69.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.672 0.789 . . . . 0.0 111.529 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.72 38.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.16 -48.72 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 -176.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.28 -42.17 90.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.208 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -61.14 -48.85 79.71 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.557 0.617 . . . . 0.0 110.152 177.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.0 mtp -48.02 -58.05 4.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.016 0.912 . . . . 0.0 109.149 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -56.28 -40.05 73.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.086 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 m -74.17 42.36 0.15 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.122 -0.987 . . . . 0.0 113.583 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.6 p -132.01 -15.62 2.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.441 1.496 . . . . 0.0 109.949 171.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.927 -177.33 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.456 ' CGD' HH22 ' A' ' 37' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.78 -40.37 41.33 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 176.486 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.36 -58.8 6.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.3 -47.98 18.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.905 0.775 . . . . 0.0 111.609 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.38 -57.11 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.162 0.985 . . . . 0.0 110.06 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -54.9 -44.68 74.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -74.48 -51.71 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.956 -173.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -16.55 1.83 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.47 -35.06 43.01 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.654 1.115 . . . . 0.0 112.112 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -70.25 147.05 50.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.026 0.53 . . . . 0.0 110.791 -178.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.69 109.81 13.3 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.704 1.202 . . . . 0.0 109.349 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.35 161.25 58.86 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.257 1.128 . . . . 0.0 110.371 -8.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -70.73 125.48 26.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.26 1.424 . . . . 0.0 110.934 -177.609 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 m -56.18 -48.74 75.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.268 0.556 . . . . 0.0 110.389 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 p -38.44 -58.51 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.941 2.096 . . . . 0.0 111.888 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -41.1 -38.74 1.1 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.947 1.299 . . . . 0.0 113.113 -179.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.6 m -94.64 -56.07 2.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.828 0.285 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -65.65 -33.48 75.98 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.323 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.01 -39.88 83.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 119.752 1.16 . . . . 0.0 109.471 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -76.79 -29.99 56.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.174 0.99 . . . . 0.0 110.712 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.65 31.47 62.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -174.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -58.42 140.2 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.27 29.31 6.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.084 0.954 . . . . 0.0 111.414 -177.317 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 25.62 74.47 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.391 -0.672 . . . . 0.0 112.651 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 135.36 82.75 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.621 1.21 . . . . 0.0 108.622 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 57.7 Cg_endo -62.9 122.64 11.0 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.389 2.06 . . . . 0.0 109.178 -179.048 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -87.77 177.48 7.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.795 0.807 . . . . 0.0 111.955 -174.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.15 161.14 31.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.23 51.05 0.78 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.573 1.549 . . . . 0.0 111.786 177.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.41 63.13 27.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.8 1.24 . . . . 0.0 110.275 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -40.19 -46.42 4.14 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.245 3.297 . . . . 0.0 114.523 -176.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.31 -39.93 33.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.92 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.41 -24.45 66.47 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.53 0.732 . . . . 0.0 111.781 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 86.4 m95 -106.6 -22.3 12.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.69 1.196 . . . . 0.0 112.938 -174.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.33 -49.53 0.71 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.935 1.694 . . . . 0.0 113.484 -178.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.1 -15.27 36.67 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -81.63 153.36 70.59 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 118.944 0.793 . . . . 0.0 110.512 -177.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.24 125.92 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.455 176.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -67.37 -40.18 85.74 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.04 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -49.42 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.006 2.522 . . . . 0.0 112.19 178.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.62 -40.1 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.025 0.93 . . . . 0.0 109.703 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.5 -25.39 36.81 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.324 1.85 . . . . 0.0 112.373 176.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -89.83 -51.23 5.6 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -51.35 -38.99 56.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.728 0.811 . . . . 0.0 112.158 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.76 -33.62 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.542 -0.724 . . . . 0.0 110.286 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -65.1 -49.45 69.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.598 1.09 . . . . 0.0 108.424 177.642 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -53.04 -43.69 66.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.047 0.539 . . . . 0.0 109.831 177.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -67.96 -46.23 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.028 -0.42 . . . . 0.0 110.716 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.7 mt -56.18 -51.09 69.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.673 -0.642 . . . . 0.0 110.083 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.79 -27.81 55.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.598 1.159 . . . . 0.0 113.134 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 163.3 32.92 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -175.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -157.42 119.63 3.82 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.916 -0.755 . . . . 0.0 109.499 -178.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.01 -118.06 12.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.8 -21.21 55.46 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.743 0.417 . . . . 0.0 111.588 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.6 ttp -68.54 118.66 62.19 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 118.942 0.792 . . . . 0.0 110.075 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.57 158.37 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.486 2.124 . . . . 0.0 109.798 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.24 148.01 38.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.92 -9.18 12.47 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.417 1.087 . . . . 0.0 113.14 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -48.13 110.24 0.31 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.084 0.856 . . . . 0.0 111.796 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.38 -31.33 7.55 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.084 0.849 . . . . 0.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -74.33 -46.46 40.72 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.01 129.02 46.05 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.84 145.16 38.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -30.69 -46.19 0.08 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 127.113 2.165 . . . . 0.0 112.153 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.6 -54.51 44.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.475 1.034 . . . . 0.0 110.89 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -51.06 71.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.433 1.093 . . . . 0.0 109.382 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 62' ' ' ALA . 29.9 mt -50.4 -56.96 9.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.522 1.129 . . . . 0.0 110.103 177.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 t -50.42 -57.35 2.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 123.877 0.871 . . . . 0.0 109.395 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -54.2 -43.58 70.86 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.965 0.348 . . . . 0.0 111.525 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.06 95.36 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.07 -51.52 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.395 0.678 . . . . 0.0 109.886 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.45 -40.11 85.78 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 120.107 1.321 . . . . 0.0 108.878 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -57.2 -51.66 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.464 0.574 . . . . 0.0 109.945 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ptm -56.55 -46.61 80.58 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -35.12 79.45 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.658 -0.651 . . . . 0.0 111.204 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.8 m -62.81 -7.59 5.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.047 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.4 p -88.03 -12.19 45.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.867 1.212 . . . . 0.0 111.0 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 116.486 -1.721 . . . . 0.0 111.095 -175.92 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -43.99 -39.93 5.34 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.569 1.557 . . . . 0.0 112.476 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.32 -44.34 95.22 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.851 0.825 . . . . 0.0 110.023 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -53.48 57.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.21 -59.34 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.806 1.243 . . . . 0.0 110.292 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -58.29 -52.1 67.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.06 0.944 . . . . 0.0 111.893 -178.452 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.16 -44.21 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.292 -173.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -159.09 44.03 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 37.16 0.98 Allowed Glycine 0 CA--C 1.524 0.63 0 O-C-N 121.638 -0.664 . . . . 0.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -138.87 157.53 45.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.464 1.906 . . . . 0.0 107.587 177.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.39 107.92 8.64 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.562 0.745 . . . . 0.0 109.755 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.25 158.2 27.59 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 CA-C-N 119.991 1.033 . . . . 0.0 112.314 -9.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.98 117.31 11.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.278 1.031 . . . . 0.0 109.116 178.004 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m -46.43 -48.62 18.82 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.709 0.804 . . . . 0.0 111.194 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 p -44.45 -46.91 9.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.026 1.73 . . . . 0.0 112.586 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -50.91 -30.29 14.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.163 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 m -101.66 -56.37 2.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.895 0.316 . . . . 0.0 110.786 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -71.7 -23.14 61.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -172.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.48 -50.78 62.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.52 1.054 . . . . 0.0 109.024 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.89 35.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.6 44.53 9.3 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -175.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 144.2 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.28 29.91 7.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.965 0.906 . . . . 0.0 111.319 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.87 20.41 79.83 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.109 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 137.61 84.49 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.931 1.365 . . . . 0.0 108.416 176.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.54 128.49 26.1 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.561 2.174 . . . . 0.0 109.842 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.9 174.73 7.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.291 1.043 . . . . 0.0 113.347 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.08 166.71 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 113.497 -1.683 . . . . 0.0 106.853 169.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 48.03 34.77 4.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.558 0.743 . . . . 0.0 111.111 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.34 61.16 16.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.794 -173.541 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -40.09 -49.22 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.846 3.031 . . . . 0.0 113.729 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.83 -40.93 10.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.396 1.478 . . . . 0.0 112.264 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -63.41 -26.04 68.56 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.859 0.464 . . . . 0.0 111.661 -177.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -106.26 -28.68 10.27 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.257 1.423 . . . . 0.0 111.961 -175.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.24 -46.15 0.5 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.754 2.022 . . . . 0.0 112.86 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.63 30.64 6.11 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.215 1.006 . . . . 0.0 112.888 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -134.69 159.36 72.46 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.549 1.14 . . . . 0.0 108.414 176.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.32 109.15 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.154 2.569 . . . . 0.0 112.77 -177.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.46 -32.4 73.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.211 -0.931 . . . . 0.0 110.276 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -55.92 103.94 0.12 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.479 1.912 . . . . 0.0 112.399 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.42 -39.43 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.72 -24.74 51.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.36 1.064 . . . . 0.0 112.569 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.21 -55.08 3.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.6 mt -47.82 -40.7 21.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.79 -35.02 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.933 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.45 -48.41 75.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.398 0.999 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m -54.98 -41.64 71.44 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.825 0.45 . . . . 0.0 109.799 176.397 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -67.64 -45.0 76.6 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.07 -0.394 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.09 -51.82 68.12 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.649 -0.657 . . . . 0.0 109.981 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.68 61.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.748 1.219 . . . . 0.0 113.432 -176.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.24 163.9 24.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -158.8 114.76 2.64 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.977 -0.719 . . . . 0.0 109.323 -177.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.42 -116.22 8.19 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.33 -26.17 60.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.88 0.472 . . . . 0.0 111.554 178.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.5 ttp -67.97 116.54 39.67 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.75 -177.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.57 166.2 24.76 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.23 1.953 . . . . 0.0 110.738 176.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.35 133.55 49.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -101.25 -10.43 20.36 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 113.256 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -49.25 110.09 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.549 0.613 . . . . 0.0 111.013 179.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.01 -37.44 3.77 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.725 1.155 . . . . 0.0 111.666 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -43.99 42.91 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 117.994 0.897 . . . . 0.0 108.836 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.84 132.14 41.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 176.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -79.23 150.84 31.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.037 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -32.18 -46.65 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.328 1.851 . . . . 0.0 111.715 171.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.81 -44.92 88.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.434 1.015 . . . . 0.0 111.329 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.9 -56.31 23.83 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 122.459 1.123 . . . . 0.0 108.619 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.9 mt -47.63 -58.97 3.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.164 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 t -45.17 -57.39 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 124.515 1.126 . . . . 0.0 109.636 177.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -58.68 -41.71 86.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.349 0.522 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.31 93.84 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.718 -0.614 . . . . 0.0 110.02 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.41 -48.01 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -53.19 -51.47 61.98 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.7 -52.7 61.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.222 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -51.31 -56.52 12.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.69 -37.6 68.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.837 -0.539 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -67.92 -3.34 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 113.461 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.2 p -110.76 15.26 22.02 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 120.19 1.359 . . . . 0.0 111.242 177.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.62 179.613 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -49.38 -38.75 27.65 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.275 0.941 . . . . 0.0 111.811 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.16 -60.97 3.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.33 -51.24 35.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.983 1.313 . . . . 0.0 110.53 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.67 -57.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.041 0.937 . . . . 0.0 109.747 -177.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -58.03 -46.92 84.53 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.8 mt -71.82 -49.07 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.787 -172.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.92 -13.74 0.93 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -170.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.33 -30.73 36.23 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 120.079 1.309 . . . . 0.0 112.66 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -75.21 156.59 35.64 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.715 0.757 . . . . 0.0 111.161 -177.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.34 111.49 7.1 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.913 1.285 . . . . 0.0 108.954 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.26 150.77 55.54 Favored 'Cis proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.435 1.191 . . . . 0.0 109.645 -11.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.93 118.62 7.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.227 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 m -48.26 -47.04 36.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.476 0.655 . . . . 0.0 110.535 -178.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -45.09 -43.81 9.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.983 1.713 . . . . 0.0 112.557 178.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -51.13 -33.06 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.595 0.634 . . . . 0.0 112.025 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.3 m -100.05 -53.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.424 0.289 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.85 -29.3 66.51 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -173.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.73 -42.44 86.27 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.344 0.974 . . . . 0.0 108.855 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -81.76 -27.6 33.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.289 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.84 46.42 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.45 144.69 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 O-C-N 122.09 -0.653 . . . . 0.0 109.289 -176.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.03 29.71 6.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.205 1.002 . . . . 0.0 111.534 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.3 23.04 78.59 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.306 -0.719 . . . . 0.0 112.799 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 131.0 84.37 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.761 1.28 . . . . 0.0 108.028 176.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -61.65 121.72 9.97 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.218 1.945 . . . . 0.0 109.041 -178.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.02 163.2 24.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.435 1.112 . . . . 0.0 111.121 -176.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.79 161.97 29.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 171.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.18 55.0 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 111.19 -178.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.71 64.66 7.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.759 0.824 . . . . 0.0 111.093 -178.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -36.86 -49.79 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.776 3.651 . . . . 0.0 114.523 -178.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.98 -43.01 13.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.128 1.371 . . . . 0.0 111.794 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.7 -24.51 66.26 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.037 0.935 . . . . 0.0 112.008 -177.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -106.01 -19.39 13.74 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.443 1.097 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.43 -49.14 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.524 1.53 . . . . 0.0 113.342 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.11 -14.75 33.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.141 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -82.03 131.63 56.16 Favored Pre-proline 0 CA--C 1.535 0.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.856 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.51 113.71 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.913 2.408 . . . . 0.0 111.198 177.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -58.05 -26.56 62.65 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.461 0.704 . . . . 0.0 112.395 -178.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -50.71 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 111.662 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.8 t -41.36 -53.03 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 124.592 1.157 . . . . 0.0 110.619 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.89 -43.26 69.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -61.52 -47.11 87.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.118 0.872 . . . . 0.0 108.782 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.6 -37.51 81.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.383 178.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 71' ' ' ILE . 77.2 t -62.03 -43.57 97.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.201 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.81 -46.22 91.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.406 1.003 . . . . 0.0 109.724 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -54.3 -45.54 72.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.345 . . . . 0.0 110.454 176.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -67.37 -45.31 76.65 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.922 -0.486 . . . . 0.0 110.531 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 mt -54.11 -54.93 32.73 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.726 -0.609 . . . . 0.0 109.712 177.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.54 74.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.926 0.891 . . . . 0.0 112.613 -177.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.95 164.29 31.28 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 -174.481 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -157.58 108.79 2.28 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.761 -0.846 . . . . 0.0 109.569 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.54 -115.08 6.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.47 -29.47 64.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.725 0.41 . . . . 0.0 111.052 178.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.4 ttp -65.16 120.05 64.06 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.421 -178.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.78 160.15 44.13 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.442 2.095 . . . . 0.0 110.354 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.68 52.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.6 -10.83 16.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.961 0.904 . . . . 0.0 111.019 177.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.0 123.81 7.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.0 111.037 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -16.36 33.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.186 0.898 . . . . 0.0 112.739 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 mtm105 -97.25 -48.84 5.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.225 1.013 . . . . 0.0 109.223 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 127.14 42.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 65' ' ' GLU . 13.5 m-20 -76.69 83.01 3.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 3.2 -47.91 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 1 C-N-CA 132.522 4.329 . . . . 0.0 117.221 -178.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 63' ' ' ASP . 42.9 mt-10 -50.07 -37.43 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.961 1.255 . . . . 0.0 109.265 173.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.02 -57.68 8.02 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.687 1.995 . . . . 0.0 109.818 173.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.66 -56.41 22.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.749 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG22 HG21 ' A' ' 45' ' ' VAL . 53.1 t -43.85 -57.14 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.199 1.0 . . . . 0.0 109.725 176.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -56.51 -48.9 76.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.242 1.017 . . . . 0.0 111.094 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.46 77.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.682 -0.636 . . . . 0.0 109.362 -178.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 45' ' ' VAL . 73.2 mt -62.37 -46.78 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.546 1.138 . . . . 0.0 110.846 -176.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.57 -38.17 80.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.937 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -62.14 -51.35 68.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.173 176.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.0 mtp -44.45 -58.9 2.69 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.088 0.947 . . . . 0.0 109.632 177.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.3 -41.05 83.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.275 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -74.58 42.55 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.4 p -136.46 -13.2 1.78 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.437 1.495 . . . . 0.0 110.096 171.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.268 -178.408 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -49.08 -43.73 32.41 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 mp0 -51.05 -61.65 2.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.351 1.06 . . . . 0.0 108.598 175.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -51.49 -48.99 62.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.76 1.224 . . . . 0.0 110.819 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.46 -55.04 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -59.28 -48.53 81.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.249 0.62 . . . . 0.0 111.843 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.95 -49.39 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.175 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -135.06 -17.68 1.84 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.49 -34.52 35.58 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.978 1.263 . . . . 0.0 112.543 -176.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -70.25 151.18 45.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 117.361 0.58 . . . . 0.0 110.424 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.09 111.22 7.89 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 109.133 -179.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 151.97 24.81 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.306 1.145 . . . . 0.0 111.449 -11.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.91 124.98 23.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.805 1.242 . . . . 0.0 109.309 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.15 -45.36 79.65 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.393 0.616 . . . . 0.0 110.57 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 p -42.27 -50.51 4.95 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.567 1.947 . . . . 0.0 112.067 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.16 -37.35 2.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.292 1.037 . . . . 0.0 112.5 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -102.14 -57.37 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.637 0.375 . . . . 0.0 111.046 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -67.95 -20.96 65.11 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.43 -2.65 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.164 0.893 . . . . 0.0 110.882 176.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -135.44 -9.6 2.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 35.5 51.88 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.694 -0.629 . . . . 0.0 111.908 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.1 133.47 20.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.31 31.1 8.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.304 1.041 . . . . 0.0 111.462 -177.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.33 23.18 78.36 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.622 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 139.75 80.24 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.334 1.067 . . . . 0.0 109.251 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.8 Cg_endo -61.09 126.08 18.63 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.373 2.049 . . . . 0.0 109.308 179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.66 171.72 9.46 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.182 0.992 . . . . 0.0 112.491 -175.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 161.08 19.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.929 172.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 37.7 52.96 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.136 1.374 . . . . 0.0 112.009 176.08 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.04 65.41 11.94 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.796 0.838 . . . . 0.0 110.469 -177.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.67 -51.56 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.781 3.654 . . . . 0.0 114.695 -177.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.16 -39.34 28.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.136 0.974 . . . . 0.0 112.196 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.91 -26.8 68.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.564 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 80.5 m95 -104.24 -29.86 10.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.026 1.33 . . . . 0.0 112.269 -175.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.02 -41.51 1.69 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.957 1.703 . . . . 0.0 113.605 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.59 -22.65 26.13 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.541 0.737 . . . . 0.0 112.317 -176.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -80.93 143.51 53.65 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.022 0.929 . . . . 0.0 110.026 -176.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 85.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.063 2.509 . . . . 0.0 108.267 173.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -23.86 26.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.728 2.011 . . . . 0.0 113.543 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -51.18 112.69 0.77 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.649 1.18 . . . . 0.0 110.683 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -46.64 -44.58 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.524 1.13 . . . . 0.0 110.553 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.79 -31.53 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.236 1.415 . . . . 0.0 113.001 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.44 -52.83 4.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 109.046 177.009 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 mt -48.36 -41.32 28.31 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 122.824 0.449 . . . . 0.0 111.994 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.14 -37.71 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 121.747 -0.596 . . . . 0.0 110.903 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -65.85 -48.12 72.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 m -53.56 -42.28 67.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.708 0.29 . . . . 0.0 110.299 176.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -67.04 -48.83 67.12 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.282 0.633 . . . . 0.0 111.235 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.8 -43.02 69.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 109.528 -174.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.7 73.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.538 0.735 . . . . 0.0 111.073 178.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 152.3 27.92 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.623 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -153.5 149.52 27.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.27 -116.98 8.69 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.29 14.21 22.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.453 1.101 . . . . 0.0 111.495 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.96 127.31 93.32 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.495 -0.753 . . . . 0.0 110.416 -178.621 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.685 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 72.7 Cg_endo -73.76 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.492 2.128 . . . . 0.0 109.19 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -25.55 123.29 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.178 2.191 . . . . 0.0 112.11 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.6 6.57 48.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.839 0.456 . . . . 0.0 112.096 -176.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -42.09 109.45 0.13 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.497 1.519 . . . . 0.0 112.695 178.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 -14.43 8.03 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.73 0.681 . . . . 0.0 113.449 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 mtm105 -82.05 -46.94 13.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.28 1.04 . . . . 0.0 108.507 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.05 126.27 45.95 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 172.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.22 150.26 33.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -27.24 -49.89 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 126.177 1.791 . . . . 0.0 112.102 170.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.67 -50.35 73.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.115 1.325 . . . . 0.0 111.56 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -54.29 -56.12 21.55 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 122.662 1.22 . . . . 0.0 109.031 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.38 -59.48 3.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -45.05 -53.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 125.394 1.478 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -56.33 -33.94 66.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.048 0.539 . . . . 0.0 112.055 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.68 27.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.747 0.703 . . . . 0.0 109.924 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.61 -49.92 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.825 . . . . 0.0 110.233 -176.371 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.65 -44.29 73.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.185 0.902 . . . . 0.0 109.777 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.14 -50.51 72.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 ptm -54.5 -44.19 72.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.53 -34.74 77.71 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.627 -0.671 . . . . 0.0 110.696 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -73.92 56.64 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.005 0.922 . . . . 0.0 111.793 179.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.6 p -150.81 -32.71 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.444 2.298 . . . . 0.0 109.598 177.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.523 1.929 . . . . 0.0 110.413 178.885 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.685 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.89 -43.6 61.04 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.03 -56.73 18.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -48.71 -45.77 39.77 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.089 0.859 . . . . 0.0 111.709 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.14 -56.4 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.494 1.118 . . . . 0.0 109.826 -178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.47 -48.07 80.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.756 0.822 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 mm -70.42 -48.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.425 0.69 . . . . 0.0 111.146 -174.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 39.79 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -173.122 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.81 38.91 1.17 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -139.07 155.95 47.55 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.502 1.921 . . . . 0.0 107.587 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 105.29 16.85 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 123.715 0.806 . . . . 0.0 111.198 -176.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.54 164.47 61.49 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 CA-C-N 120.286 1.138 . . . . 0.0 110.113 -8.616 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -67.31 119.11 11.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.543 1.137 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -46.89 -45.46 20.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.895 0.878 . . . . 0.0 111.228 -176.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -46.02 -42.71 13.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.715 1.606 . . . . 0.0 112.311 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -55.94 -16.27 4.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.3 m -115.27 -57.43 2.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.788 175.566 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -71.14 -22.9 62.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -173.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.54 -48.6 66.51 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.751 1.16 . . . . 0.0 109.615 -178.596 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -86.54 -25.19 25.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.917 0.887 . . . . 0.0 111.1 178.652 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.38 41.97 8.85 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.51 140.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.41 28.58 5.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.993 0.917 . . . . 0.0 111.476 -177.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.46 79.62 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.009 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 121.25 43.14 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.823 1.311 . . . . 0.0 108.247 176.172 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 74.1 Cg_exo -44.15 114.99 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.869 3.046 . . . . 0.0 113.636 -177.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.81 169.63 17.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.758 0.79 . . . . 0.0 111.759 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 159.72 28.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.31 51.08 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.362 1.465 . . . . 0.0 111.733 178.053 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.96 62.04 31.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.919 0.888 . . . . 0.0 111.055 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -38.17 -45.85 2.15 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 124.33 3.353 . . . . 0.0 114.198 -178.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.42 -43.67 11.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.896 1.278 . . . . 0.0 111.957 178.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -69.3 -25.54 64.28 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.658 0.783 . . . . 0.0 112.074 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 88.5 m95 -104.26 -18.2 14.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.795 1.238 . . . . 0.0 112.754 -174.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.04 -48.4 0.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.937 2.095 . . . . 0.0 113.969 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -98.65 -4.13 34.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -87.26 128.81 53.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.486 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.95 123.87 13.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.525 2.15 . . . . 0.0 110.967 177.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -64.25 -23.57 67.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.295 0.638 . . . . 0.0 110.668 178.094 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -49.33 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.856 2.062 . . . . 0.0 112.264 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.44 -41.5 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.316 0.646 . . . . 0.0 109.43 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -50.61 -38.6 46.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.847 1.259 . . . . 0.0 112.262 177.135 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -79.57 -49.64 11.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.29 -40.66 62.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.913 0.485 . . . . 0.0 111.915 -178.108 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -61.69 -35.05 65.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.298 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.9 -46.3 78.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 120.204 1.365 . . . . 0.0 108.698 178.292 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 m -52.89 -45.7 67.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.947 0.404 . . . . 0.0 110.162 175.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -69.5 -44.41 71.14 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.924 -0.485 . . . . 0.0 110.97 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.16 -51.14 70.96 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.283 -0.886 . . . . 0.0 110.347 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.74 59.2 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.36 1.064 . . . . 0.0 112.376 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.14 163.64 28.67 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -176.35 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -157.06 111.12 2.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.97 -0.723 . . . . 0.0 109.324 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.15 -113.52 5.2 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.65 -30.67 63.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.945 0.498 . . . . 0.0 111.168 177.847 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.3 ttp -63.07 119.29 50.89 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.255 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.84 160.46 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.365 2.044 . . . . 0.0 110.28 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.57 119.78 12.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -87.22 -4.45 59.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.785 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.83 89.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 179.051 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.2 2.54 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.889 1.709 . . . . 0.0 110.589 -178.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -87.23 -37.27 17.39 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.258 1.023 . . . . 0.0 111.106 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 126.14 18.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.014 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.33 153.57 24.54 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.203 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -29.17 -47.53 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.577 1.951 . . . . 0.0 112.047 171.724 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -62.81 -50.72 69.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.991 1.268 . . . . 0.0 111.665 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -54.96 -55.31 32.16 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.824 1.297 . . . . 0.0 108.955 178.498 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.4 mt -49.93 -60.46 2.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.151 179.093 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.4 t -42.09 -56.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 109.765 177.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -56.99 -43.07 81.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.512 0.142 . . . . 0.0 111.22 -178.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.89 53.34 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.9 mt -54.66 -46.62 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.964 1.306 . . . . 0.0 110.135 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -53.51 -52.58 59.14 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -55.94 -50.5 70.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.605 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.5 mtp -50.83 -58.16 6.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.377 0.671 . . . . 0.0 109.731 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.07 -36.73 73.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.884 0.874 . . . . 0.0 111.59 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -74.7 50.92 0.45 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.023 0.829 . . . . 0.0 112.659 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.7 p -149.24 -25.75 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.282 2.233 . . . . 0.0 110.035 174.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.62 -1.657 . . . . 0.0 110.421 179.528 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.5 54.46 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.524 1.059 . . . . 0.0 111.744 178.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -45.83 69.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.753 0.776 . . . . 0.0 109.882 178.312 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -56.72 -44.6 81.75 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 121.444 -0.785 . . . . 0.0 108.936 179.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.08 -53.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -57.47 -42.87 83.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 112.738 -177.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -84.37 -39.93 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.709 -175.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -130.55 -34.73 1.54 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -172.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.73 32.12 4.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.473 1.033 . . . . 0.0 113.343 -172.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -133.7 144.98 49.48 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.12 107.78 19.8 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.929 1.292 . . . . 0.0 110.388 -177.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.57 161.46 66.24 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.327 1.153 . . . . 0.0 109.718 -9.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.23 130.79 45.28 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.514 0.726 . . . . 0.0 110.145 -178.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.9 -41.92 71.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.023 0.829 . . . . 0.0 109.683 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 t -59.25 -8.71 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 m -67.08 -30.42 70.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 120.352 1.433 . . . . 0.0 109.898 175.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.0 m -113.95 -63.75 1.41 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 112.407 -172.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -57.93 -23.36 53.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.006 1.322 . . . . 0.0 113.555 -174.224 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.18 -25.13 64.19 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.133 -0.355 . . . . 0.0 111.535 178.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -121.11 -12.28 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.251 1.021 . . . . 0.0 112.218 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.3 35.89 51.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.87 145.47 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.19 28.09 6.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.898 0.879 . . . . 0.0 111.466 -177.08 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.53 21.37 79.56 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.032 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 132.55 87.25 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.855 1.327 . . . . 0.0 108.669 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.07 122.54 10.57 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.469 2.112 . . . . 0.0 108.769 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.23 172.15 10.72 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -170.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.41 158.48 23.63 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.04 50.83 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 0.0 112.078 177.727 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.15 60.84 24.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.624 1.17 . . . . 0.0 110.885 -178.65 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.93 -48.46 1.5 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.599 3.533 . . . . 0.0 114.322 -178.715 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.39 -44.35 8.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.208 1.403 . . . . 0.0 111.838 178.45 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.69 -26.93 67.26 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.978 0.911 . . . . 0.0 112.014 -177.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -103.19 -15.96 15.86 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.826 1.25 . . . . 0.0 112.452 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.68 -47.07 0.64 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.243 1.817 . . . . 0.0 113.709 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -99.72 -4.29 31.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.836 0.854 . . . . 0.0 113.27 -176.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -88.25 126.92 59.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.812 0.845 . . . . 0.0 109.405 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.33 106.03 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.784 2.323 . . . . 0.0 110.529 177.127 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.7 -23.05 49.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.767 0.827 . . . . 0.0 112.509 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.81 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.159 2.184 . . . . 0.0 111.031 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -49.69 -41.94 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 110.001 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -53.49 -34.97 60.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.986 1.714 . . . . 0.0 112.194 177.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.84 -52.12 7.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.8 mt -51.76 -37.82 52.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.88 -37.94 69.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.408 1.004 . . . . 0.0 110.149 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.38 -47.05 77.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.667 1.121 . . . . 0.0 108.814 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -52.61 -43.92 65.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.629 0.372 . . . . 0.0 110.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -71.97 -44.6 63.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.887 0.475 . . . . 0.0 111.066 -178.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.2 mt -57.69 -50.24 73.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 121.442 -0.786 . . . . 0.0 109.898 179.461 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.09 65.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.956 0.902 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 118.61 3.06 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -106.63 135.01 48.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.319 1.048 . . . . 0.0 108.456 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.22 -121.48 26.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.12 -1.56 58.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.473 0.709 . . . . 0.0 112.32 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.0 ttp -65.19 127.59 93.01 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 119.016 0.825 . . . . 0.0 111.082 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 50.2 Cg_exo -59.41 144.44 99.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.0 109.964 173.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.39 121.53 15.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -88.28 -4.93 58.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.432 -178.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -54.55 84.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.433 1.093 . . . . 0.0 113.538 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.56 -36.86 2.46 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.982 2.229 . . . . 0.0 110.419 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -42.24 75.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.642 0.721 . . . . 0.0 109.202 177.128 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.24 129.2 21.9 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -84.06 154.2 23.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -29.85 -49.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.407 1.883 . . . . 0.0 112.011 171.35 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.01 -45.12 93.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.373 0.988 . . . . 0.0 111.784 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.52 -57.56 12.43 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 122.612 1.196 . . . . 0.0 108.77 177.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.8 mt -47.25 -57.9 4.69 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.906 2.082 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 t -40.38 -54.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 0.0 110.459 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -60.34 -44.52 95.44 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.072 0.232 . . . . 0.0 111.394 -178.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.25 63.97 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.515 -0.74 . . . . 0.0 109.919 -179.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.64 -52.67 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.894 1.278 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -60.6 -42.37 96.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.631 1.105 . . . . 0.0 109.616 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -57.18 -51.96 67.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.644 0.656 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 ttp -54.16 -54.52 38.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -56.3 -37.68 70.21 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.918 -0.489 . . . . 0.0 111.137 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.8 m -63.46 -7.45 6.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.084 -0.96 . . . . 0.0 113.493 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 p -87.6 -11.75 47.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.289 1.404 . . . . 0.0 110.802 175.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.05 -176.067 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.657 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.584 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.57 -38.29 1.04 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 124.125 0.891 . . . . 0.0 112.907 174.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -56.92 6.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.417 0.687 . . . . 0.0 110.892 -177.268 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m -55.94 -43.97 77.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.501 0.721 . . . . 0.0 111.198 -177.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 mt -62.94 -57.82 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.106 1.762 . . . . 0.0 109.323 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -58.47 -51.09 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.287 1.035 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.38 -48.32 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.926 -174.008 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.59 39.89 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.049 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.84 36.95 1.48 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 118.867 0.758 . . . . 0.0 111.737 179.13 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.23 158.74 43.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.02 1.728 . . . . 0.0 108.01 178.025 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.12 107.59 6.81 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.773 -178.159 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 154.39 29.51 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 120.146 1.088 . . . . 0.0 111.732 -9.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.65 126.14 27.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.2 m -53.03 -48.35 67.66 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.848 0.749 . . . . 0.0 110.607 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -42.6 -49.47 5.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.043 1.737 . . . . 0.0 112.454 178.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.03 -36.18 3.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.168 0.987 . . . . 0.0 112.766 -178.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.2 m -99.88 -54.4 2.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.317 0.247 . . . . 0.0 110.996 -178.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -69.65 -24.23 63.59 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.58 -42.42 82.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.864 0.756 . . . . 0.0 109.475 178.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -89.54 -24.9 21.63 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.207 1.003 . . . . 0.0 112.027 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.8 35.14 40.89 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -174.257 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.33 145.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -176.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.35 29.3 6.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 111.392 -177.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.84 24.21 76.95 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.868 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 132.9 87.68 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 118.852 1.326 . . . . 0.0 108.346 176.289 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.42 121.54 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.294 1.996 . . . . 0.0 107.954 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.24 159.89 19.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.159 0.981 . . . . 0.0 112.88 -172.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.52 142.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.272 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 69.28 27.08 5.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.079 1.352 . . . . 0.0 111.315 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 70.3 76.32 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.621 1.168 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.27 -52.05 3.08 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.667 3.578 . . . . 0.0 114.23 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -50.46 -34.07 23.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.514 1.526 . . . . 0.0 112.518 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.65 -27.49 66.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.282 0.492 . . . . 0.0 111.181 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -101.05 -24.92 14.22 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 111.864 -176.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.24 -43.73 0.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.793 1.637 . . . . 0.0 112.688 178.426 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -111.81 36.14 3.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.283 1.033 . . . . 0.0 112.08 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -128.89 155.74 79.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.36 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.8 126.84 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.562 2.175 . . . . 0.0 111.367 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -70.22 -41.65 73.31 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -51.86 102.45 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.532 1.933 . . . . 0.0 112.893 -179.678 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -49.25 -43.17 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.848 0.859 . . . . 0.0 108.912 174.561 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.44 -34.96 26.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.557 1.943 . . . . 0.0 112.667 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -87.03 -49.68 7.16 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.046 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 mt -49.75 -40.59 41.54 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.777 0.431 . . . . 0.0 111.979 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.13 -32.45 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 O-C-N 121.378 -0.826 . . . . 0.0 110.76 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.72 -47.24 79.02 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.773 1.17 . . . . 0.0 108.457 177.116 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.87 -44.24 70.25 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -66.54 -45.56 79.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.878 0.37 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.65 -49.41 77.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.447 -0.783 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.84 -31.16 61.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.483 1.113 . . . . 0.0 112.798 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.17 164.47 29.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -176.087 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -158.72 114.05 2.58 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.996 -0.708 . . . . 0.0 109.145 -178.003 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.98 -116.12 7.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 -26.42 60.93 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.968 0.507 . . . . 0.0 111.437 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.3 ttp -67.55 121.12 77.74 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 118.631 0.65 . . . . 0.0 109.847 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.86 160.19 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.49 2.127 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 122.59 17.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -89.15 -9.96 49.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.256 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -54.22 91.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.408 1.004 . . . . 0.0 113.056 -177.838 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.66 -42.2 1.72 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.463 1.506 . . . . 0.0 110.361 -178.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -39.4 89.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.247 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -136.41 164.94 26.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.09 140.74 40.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.933 0.893 . . . . 0.0 108.961 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ttt-85 -29.24 -50.48 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.289 2.235 . . . . 0.0 113.234 173.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.14 -45.5 84.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.329 0.968 . . . . 0.0 111.366 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.25 -54.5 45.07 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.881 0.848 . . . . 0.0 109.017 177.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 35.6 mt -47.38 -57.84 4.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.371 1.468 . . . . 0.0 109.867 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -43.82 -55.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.622 1.169 . . . . 0.0 109.74 178.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.61 -43.16 89.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.35 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.85 84.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.394 -0.816 . . . . 0.0 109.573 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.35 -42.52 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.902 1.281 . . . . 0.0 109.79 177.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.12 -52.52 64.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.305 0.957 . . . . 0.0 109.032 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -54.25 -54.02 45.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.4 ttm -47.1 -56.16 7.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 110.079 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.15 -33.27 73.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.557 -0.714 . . . . 0.0 112.431 177.158 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 m -74.66 43.44 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.179 0.9 . . . . 0.0 112.367 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.1 p -135.81 -17.06 1.7 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.196 1.799 . . . . 0.0 109.819 173.805 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.445 -1.264 . . . . 0.0 109.569 178.547 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.62 -41.42 56.91 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 176.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.51 -52.57 65.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -50.67 -52.98 34.85 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.058 0.39 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.26 -58.98 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.12 1.368 . . . . 0.0 110.643 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -56.62 -52.41 64.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 0.0 112.087 -178.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.22 -44.94 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.246 -174.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.82 44.66 0.19 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.276 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.57 38.14 0.95 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 176.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.33 159.5 42.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.845 2.058 . . . . 0.0 107.378 177.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.94 113.68 6.41 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.265 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.61 152.05 13.24 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 120.307 1.145 . . . . 0.0 111.33 -15.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.61 116.81 7.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.507 1.123 . . . . 0.0 108.6 177.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -46.68 -48.25 20.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.546 0.738 . . . . 0.0 110.788 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -45.92 -46.35 16.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.212 1.805 . . . . 0.0 112.739 178.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -52.04 -29.66 22.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.143 0.429 . . . . 0.0 112.051 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.83 -56.97 2.24 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.777 0.262 . . . . 0.0 110.644 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -66.92 -32.76 74.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -173.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.81 -43.04 76.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 119.103 0.865 . . . . 0.0 109.139 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.12 -26.6 39.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.625 -177.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.55 50.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -176.29 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.97 141.01 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.074 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.61 29.17 5.29 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 0.0 111.394 -177.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.61 28.41 71.03 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.754 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.09 134.84 84.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.862 1.331 . . . . 0.0 108.368 175.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 73.9 Cg_endo -64.91 111.99 1.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.6 2.2 . . . . 0.0 107.984 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -84.87 175.82 8.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.978 0.894 . . . . 0.0 111.425 -174.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.48 154.34 41.61 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 171.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 48.28 32.96 3.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.312 1.845 . . . . 0.0 112.661 178.25 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.86 59.25 4.11 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 109.666 178.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -47.62 -41.72 30.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.054 3.169 . . . . 0.0 113.053 -174.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -47.75 -37.67 13.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.903 0.881 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.52 -27.71 56.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.198 0.454 . . . . 0.0 111.37 -178.416 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 81.5 m95 -92.09 -13.3 31.03 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.57 0.748 . . . . 0.0 111.616 -177.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.72 -45.16 0.36 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.274 1.83 . . . . 0.0 112.899 177.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -113.74 28.6 8.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.121 0.968 . . . . 0.0 112.552 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -115.13 119.61 38.38 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.514 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.69 118.7 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.761 2.307 . . . . 0.0 110.786 177.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 -22.17 66.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.073 0.549 . . . . 0.0 111.343 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.04 103.65 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.087 2.155 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -49.34 -44.23 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.638 0.775 . . . . 0.0 109.706 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.98 -34.0 54.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.172 1.789 . . . . 0.0 112.295 177.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.47 -51.16 8.08 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.1 mt -52.79 -38.81 61.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.702 0.801 . . . . 0.0 112.34 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.61 -38.46 75.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 119.243 0.928 . . . . 0.0 109.984 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.16 -45.52 80.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.708 1.14 . . . . 0.0 108.911 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 m -53.5 -44.97 69.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -70.76 -44.75 66.07 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.103 -0.373 . . . . 0.0 110.8 -178.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -57.53 -52.19 66.43 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 121.393 -0.817 . . . . 0.0 109.999 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.76 65.05 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.943 0.897 . . . . 0.0 111.817 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.29 159.38 34.71 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -175.573 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -162.16 139.4 8.33 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.78 -138.57 48.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 108.284 -1.926 . . . . 0.0 108.284 -175.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.11 -21.03 66.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.689 -0.755 . . . . 0.0 111.835 176.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HB2' ' C1D' ' A' ' 0' ' ' HEM . 31.7 ttp -65.49 117.04 36.88 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 119.663 1.12 . . . . 0.0 110.888 -176.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.42 153.64 55.58 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.327 2.018 . . . . 0.0 110.021 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 123.46 16.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.333 0.653 . . . . 0.0 109.947 178.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -90.25 -4.44 57.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.844 0.747 . . . . 0.0 111.992 177.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -44.16 114.33 0.66 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.491 1.116 . . . . 0.0 111.893 176.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.71 -21.2 19.9 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.292 0.948 . . . . 0.0 112.898 178.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -87.71 -44.49 11.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.974 0.909 . . . . 0.0 109.298 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 126.93 45.9 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.64 152.37 28.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -30.55 -46.76 0.08 Allowed 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 126.07 1.748 . . . . 0.0 111.686 170.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.08 -50.49 73.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.583 1.083 . . . . 0.0 111.923 178.357 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -57.04 -54.93 41.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.096 1.358 . . . . 0.0 109.202 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.6 mt -50.33 -57.55 7.64 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 125.989 1.716 . . . . 0.0 109.711 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.64 -56.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.882 1.273 . . . . 0.0 109.668 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -57.94 -39.23 77.56 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.136 0.575 . . . . 0.0 111.634 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.69 -48.12 64.7 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.539 -0.726 . . . . 0.0 109.777 177.9 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.37 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.084 1.353 . . . . 0.0 110.768 -176.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.37 -39.54 87.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.949 1.249 . . . . 0.0 109.763 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.53 -59.54 5.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 85.9 mtp -41.33 -64.75 0.51 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.619 1.168 . . . . 0.0 108.709 177.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 mt -46.64 -31.98 3.21 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.845 2.058 . . . . 0.0 113.371 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 m -64.87 -4.86 4.9 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.512 1.051 . . . . 0.0 112.287 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.3 p -154.33 22.85 0.48 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.685 3.994 . . . . 0.0 106.0 -179.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 34' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 C-N-CA 128.257 2.623 . . . . 0.0 113.795 -170.321 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.405 ' C1D' ' HB2' ' A' ' 55' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.53 96.4 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -57.22 -57.73 11.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -53.46 -45.53 69.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.542 0.61 . . . . 0.0 111.396 -179.039 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.72 -56.48 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 0.0 109.889 -178.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -56.95 -47.19 81.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.992 0.917 . . . . 0.0 111.264 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.92 -64.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.357 -175.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -141.5 43.81 1.74 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.77 0.714 . . . . 0.0 111.374 -173.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.69 36.89 1.22 Allowed Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.225 -0.922 . . . . 0.0 112.304 177.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.97 155.43 48.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.31 1.844 . . . . 0.0 107.703 176.306 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.06 113.28 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.572 -177.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.71 142.91 12.57 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.045 1.052 . . . . 0.0 110.363 -14.352 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -67.83 128.66 37.33 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.503 -178.096 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.2 m -54.38 -48.15 71.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.39 0.676 . . . . 0.0 111.149 -175.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -42.47 -54.65 3.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.184 1.793 . . . . 0.0 112.105 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.7 -35.69 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.236 1.414 . . . . 0.0 112.878 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.0 m -100.78 -57.28 2.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.559 0.343 . . . . 0.0 111.414 -178.024 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -70.5 -35.12 73.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -41.59 88.77 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -74.98 -31.33 61.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.291 1.436 . . . . 0.0 111.344 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.62 33.73 51.27 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -175.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.15 143.08 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 122.096 -0.649 . . . . 0.0 109.744 -176.638 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.47 32.61 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.361 1.064 . . . . 0.0 111.834 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.0 22.3 77.12 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.443 -0.643 . . . . 0.0 113.095 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 136.23 83.27 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.689 1.245 . . . . 0.0 107.745 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.36 123.12 13.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.049 1.833 . . . . 0.0 109.969 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.89 169.45 17.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.267 1.032 . . . . 0.0 110.172 -178.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.87 151.12 19.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.096 179.744 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.81 37.36 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.49 68.34 31.6 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.517 0.727 . . . . 0.0 111.915 -175.068 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -38.98 -51.42 2.43 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.653 3.569 . . . . 0.0 114.867 -177.403 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.98 -40.25 21.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.346 1.059 . . . . 0.0 111.988 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.21 -22.38 66.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.469 0.707 . . . . 0.0 111.884 -177.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -110.15 -30.21 7.85 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.747 1.219 . . . . 0.0 112.607 -175.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.31 -51.03 1.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.68 1.592 . . . . 0.0 113.021 -178.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.22 -26.42 56.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -78.24 142.38 63.33 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.121 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.48 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.179 2.586 . . . . 0.0 108.257 173.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -20.65 55.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.892 1.677 . . . . 0.0 113.639 -170.007 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -50.12 115.83 1.59 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.886 1.274 . . . . 0.0 110.651 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.3 t -48.18 -46.21 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.445 0.698 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.95 -24.31 64.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.853 0.861 . . . . 0.0 113.02 -178.379 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.29 -54.56 4.13 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 mt -47.84 -43.32 28.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -59.91 -37.05 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 121.915 -0.491 . . . . 0.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.3 -44.42 79.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -47.32 72.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.162 0.506 . . . . 0.0 110.19 174.325 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -62.57 -45.99 90.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.9 mt -58.26 -51.83 68.11 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.59 -0.694 . . . . 0.0 109.226 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.06 79.63 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.093 0.557 . . . . 0.0 112.151 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.94 157.19 32.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 108.299 -1.921 . . . . 0.0 108.299 -174.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -156.38 129.48 7.99 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.816 -0.814 . . . . 0.0 109.034 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 -136.85 50.45 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.24 -23.62 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.811 176.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -65.88 115.5 23.49 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 111.147 -177.278 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 38.9 Cg_exo -63.45 162.32 27.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.655 2.237 . . . . 0.0 111.255 177.549 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 136.66 43.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.83 -8.02 19.02 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.093 0.957 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -43.42 115.89 0.85 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.321 1.848 . . . . 0.0 111.714 177.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.67 -23.24 9.11 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.912 0.768 . . . . 0.0 112.559 177.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -83.92 -46.83 11.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.924 0.862 . . . . 0.0 108.746 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.29 138.1 37.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.58 25.93 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -173.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 62.19 -41.4 0.16 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.224 2.21 . . . . 0.0 111.979 -173.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -64.81 -36.85 85.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.323 -1.485 . . . . 0.0 110.198 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.92 -58.36 7.21 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 123.229 1.49 . . . . 0.0 108.547 178.728 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.08 -58.64 6.84 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 126.484 1.914 . . . . 0.0 110.022 178.346 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -41.94 -54.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.481 0.713 . . . . 0.0 110.451 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -61.71 -40.53 95.38 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.77 71.56 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.554 -0.717 . . . . 0.0 110.082 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.21 -48.04 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.838 2.055 . . . . 0.0 110.38 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.74 -44.17 90.44 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.891 1.223 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -61.77 -52.59 63.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 ttm -46.17 -50.26 15.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 110.513 179.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.84 -35.39 80.95 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.124 -0.36 . . . . 0.0 110.823 178.131 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -74.8 59.14 0.86 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.588 0.755 . . . . 0.0 111.218 178.666 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 -40.57 0.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.739 2.016 . . . . 0.0 108.979 176.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.344 2.657 . . . . 0.0 111.213 179.441 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.422 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.19 -42.71 41.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 173.78 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -57.43 -53.25 60.31 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.956 0.878 . . . . 0.0 109.609 175.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.87 -49.36 59.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.865 0.466 . . . . 0.0 110.5 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mt -70.68 -35.56 61.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.233 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -60.56 -45.02 95.47 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.346 -1.471 . . . . 0.0 109.989 176.448 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 mt -82.4 -28.82 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.548 -0.72 . . . . 0.0 111.545 -177.703 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -125.97 38.09 4.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.724 1.209 . . . . 0.0 110.707 -174.253 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.76 46.85 2.08 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 129.488 3.423 . . . . 0.0 112.041 -178.213 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.259 3.1 p 69.73 -142.11 0.08 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.414 1.885 . . . . 0.0 111.553 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.31 124.56 29.43 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 124.307 1.043 . . . . 0.0 110.863 -172.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -62.56 177.73 9.52 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 119.541 0.872 . . . . 0.0 110.112 -18.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 136.85 33.27 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 m -54.62 -51.62 64.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.306 0.643 . . . . 0.0 110.222 -176.248 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -40.91 -61.34 0.99 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.518 1.927 . . . . 0.0 112.817 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.72 -35.02 13.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.042 0.937 . . . . 0.0 112.55 -178.267 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.5 m -85.92 -59.9 2.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 118.594 0.634 . . . . 0.0 110.165 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -61.23 -50.81 71.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.643 0.777 . . . . 0.0 113.028 -173.6 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.86 -39.68 71.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.199 0.454 . . . . 0.0 110.994 -178.463 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -88.23 -2.07 58.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.078 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 35.68 82.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.389 0.995 . . . . 0.0 112.443 -177.764 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.79 130.75 17.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 O-C-N 121.931 -0.746 . . . . 0.0 109.195 -179.242 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.92 31.41 8.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 111.479 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.67 78.95 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.355 -0.692 . . . . 0.0 112.568 179.749 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.43 137.9 68.71 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.578 1.189 . . . . 0.0 108.53 176.134 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.72 121.06 9.13 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.239 1.959 . . . . 0.0 109.098 -179.032 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.42 166.56 23.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.404 1.097 . . . . 0.0 112.359 -174.223 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.3 164.38 26.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.131 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.66 53.32 0.46 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.173 1.389 . . . . 0.0 111.735 -178.713 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.67 68.13 19.47 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.702 -176.094 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.89 -48.59 2.78 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.453 3.435 . . . . 0.0 114.44 -177.351 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -50.61 -40.53 52.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.05 -23.85 66.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.339 0.655 . . . . 0.0 111.535 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -105.51 -30.71 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.348 1.059 . . . . 0.0 112.749 -174.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.54 -50.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.784 1.634 . . . . 0.0 112.998 -178.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.9 -22.31 42.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -78.99 158.06 75.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.569 -0.707 . . . . 0.0 110.377 -177.302 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.52 108.91 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.886 2.391 . . . . 0.0 110.939 176.508 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.87 -37.02 75.6 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 m -59.69 107.97 0.67 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.752 1.621 . . . . 0.0 111.555 178.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -48.41 -41.92 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.494 1.118 . . . . 0.0 110.405 178.182 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.0 -27.16 17.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.231 1.412 . . . . 0.0 112.869 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.26 -49.57 7.17 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.233 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 mt -51.14 -39.44 56.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.875 0.87 . . . . 0.0 112.457 179.099 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.15 -33.16 49.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.652 177.571 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.17 -49.59 71.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.48 1.491 . . . . 0.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -51.83 -47.2 64.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.067 0.947 . . . . 0.0 110.114 175.395 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -66.87 -42.16 86.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.212 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.99 -56.13 24.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.04 -27.92 57.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.233 1.013 . . . . 0.0 112.869 -176.378 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 164.69 29.11 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -175.263 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -157.96 112.15 2.57 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -113.48 5.1 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -178.898 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.26 -31.33 65.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.969 0.508 . . . . 0.0 111.243 178.043 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.2 ttp -64.7 118.47 48.54 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.55 -176.427 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.5 157.5 40.63 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.742 2.295 . . . . 0.0 110.058 179.068 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 139.05 58.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.969 0.508 . . . . 0.0 110.685 178.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -114.53 -0.45 13.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.84 0.856 . . . . 0.0 111.63 175.436 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -46.67 117.86 1.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.232 1.013 . . . . 0.0 111.781 175.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.31 -19.62 21.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.1 0.857 . . . . 0.0 112.548 179.73 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -88.95 -45.18 9.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.489 1.115 . . . . 0.0 108.662 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -120.5 123.09 42.09 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.95 146.05 48.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.327 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -25.65 -52.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.449 2.3 . . . . 0.0 112.01 168.058 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.1 -45.64 84.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.86 0.464 . . . . 0.0 111.788 -178.511 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.17 -48.51 79.77 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 62' ' ' ALA . 92.6 mt -52.34 -59.48 4.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.168 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 t -42.77 -59.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.288 1.035 . . . . 0.0 109.673 177.036 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -54.99 -42.69 72.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 118.37 0.532 . . . . 0.0 112.335 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.65 -53.67 47.7 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -55.36 -44.14 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.609 1.163 . . . . 0.0 110.262 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -56.02 -55.59 31.01 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 118.784 0.72 . . . . 0.0 109.097 177.877 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -55.19 -51.28 67.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.297 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 ttm -48.58 -62.14 1.66 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.603 1.161 . . . . 0.0 109.326 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.55 -35.58 68.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.485 0.714 . . . . 0.0 111.661 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 m -62.95 -5.54 3.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.472 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -87.9 -14.67 38.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.484 1.493 . . . . 0.0 111.004 175.588 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 116.718 -1.61 . . . . 0.0 110.401 -177.883 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.72 48.81 3.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 175.024 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 41.67 55.64 3.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.336 1.455 . . . . 0.0 110.89 178.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -149.3 -63.94 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.333 -176.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.38 -55.93 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.843 0.747 . . . . 0.0 109.842 179.189 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -63.54 -43.01 98.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -178.649 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.75 -45.17 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 112.091 -172.187 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -151.41 -10.9 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.78 3.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.026 1.285 . . . . 0.0 111.442 -176.126 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -136.08 147.16 47.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.256 1.822 . . . . 0.0 106.766 177.377 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.5 109.23 10.26 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.813 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.24 159.87 30.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 CA-C-N 120.193 1.105 . . . . 0.0 111.85 -8.945 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -74.18 122.58 22.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.117 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -54.4 -51.6 64.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.548 0.69 . . . . 0.0 110.102 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -39.68 -61.37 0.84 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.006 2.122 . . . . 0.0 112.419 179.654 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -42.92 -43.49 4.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.002 1.321 . . . . 0.0 113.068 -177.826 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.31 -55.61 3.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.463 0.305 . . . . 0.0 111.305 -177.911 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -64.75 -33.97 77.22 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.863 0.865 . . . . 0.0 113.172 -173.728 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.83 -48.02 82.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.544 0.611 . . . . 0.0 109.355 177.656 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -73.05 -30.58 63.82 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.229 0.612 . . . . 0.0 111.31 179.237 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.35 49.45 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -174.664 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.67 141.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.673 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.11 31.5 6.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.287 1.035 . . . . 0.0 111.668 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.61 76.38 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.993 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.25 87.58 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.564 1.182 . . . . 0.0 108.674 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -62.75 114.97 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.74 2.293 . . . . 0.0 108.764 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -80.93 174.23 11.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.729 0.776 . . . . 0.0 112.667 -172.544 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.6 160.64 16.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 170.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.73 51.88 0.96 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.176 1.39 . . . . 0.0 112.419 176.696 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.33 59.01 19.09 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 123.807 0.843 . . . . 0.0 111.005 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -38.56 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.558 3.505 . . . . 0.0 114.025 -177.753 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -47.66 -40.8 20.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.402 1.481 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.94 -26.09 53.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.637 -177.572 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -91.6 -26.08 18.88 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.587 0.755 . . . . 0.0 111.736 -177.359 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.14 -46.33 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.159 2.184 . . . . 0.0 114.437 -178.129 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -91.91 -15.14 28.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.441 0.697 . . . . 0.0 112.816 -175.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -81.08 148.78 64.92 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.489 0.716 . . . . 0.0 109.655 -177.496 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.34 129.41 28.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.58 2.186 . . . . 0.0 111.157 176.774 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -67.21 -40.84 86.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.415 0.626 . . . . 0.0 110.348 179.203 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.74 110.32 1.13 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.393 1.477 . . . . 0.0 111.425 -177.869 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.74 -36.78 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.21 1.004 . . . . 0.0 109.891 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.48 -33.71 63.91 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.356 1.863 . . . . 0.0 111.343 177.49 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -83.4 -50.67 8.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -51.73 -38.12 53.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 68' ' ' VAL . 4.1 m -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 118.946 -1.101 . . . . 0.0 110.467 177.989 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.15 -44.9 83.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.734 1.606 . . . . 0.0 109.409 -179.418 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -58.04 -33.05 68.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 110.468 174.312 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -75.73 -47.47 25.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.179 0.991 . . . . 0.0 110.007 -179.167 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.8 -48.06 73.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 120.598 -1.314 . . . . 0.0 110.099 174.595 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.32 74.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 112.692 -178.134 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.9 162.63 29.88 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -175.074 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.1 129.63 4.49 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.769 0.784 . . . . 0.0 109.083 -178.173 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.89 -120.28 21.78 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -177.696 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.2 -13.92 48.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.916 177.782 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.4 ' HB2' ' C1D' ' A' ' 0' ' ' HEM . 39.0 ttp -66.53 117.16 41.52 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 119.254 0.934 . . . . 0.0 110.38 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.27 159.72 38.21 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.346 2.031 . . . . 0.0 111.064 177.302 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.83 118.58 10.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.191 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -82.02 -4.22 56.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.467 1.031 . . . . 0.0 113.205 -179.092 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.57 86.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.292 1.037 . . . . 0.0 112.484 -179.656 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 128.02 -33.97 3.08 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.548 1.547 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -78.33 -34.76 48.36 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.667 0.734 . . . . 0.0 110.936 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -141.39 146.01 36.06 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.762 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.99 138.94 31.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.209 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -30.59 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.274 2.23 . . . . 0.0 113.028 173.111 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.17 -57.64 11.96 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.619 0.645 . . . . 0.0 110.441 177.808 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.49 -53.71 47.56 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.98 0.895 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 62' ' ' ALA . 28.5 mt -47.73 -55.27 9.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.85 1.66 . . . . 0.0 110.561 176.484 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 HG11 ' A' ' 45' ' ' VAL . 1.7 t -51.22 -58.67 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.181 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -54.51 -37.36 65.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.117 0.567 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.1 82.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.36 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 45' ' ' VAL . 54.3 mt -62.54 -47.38 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.507 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -45.25 -56.43 4.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.605 1.093 . . . . 0.0 109.751 176.56 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -55.66 -52.66 63.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.917 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 ptm -54.85 -43.62 73.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.533 0.606 . . . . 0.0 110.251 -178.587 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.3 mt -69.71 -29.78 67.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.625 -0.672 . . . . 0.0 111.057 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 m -73.96 43.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.036 0.834 . . . . 0.0 112.678 179.835 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -135.89 -13.83 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.783 2.033 . . . . 0.0 109.914 174.155 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.035 -179.109 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.4 ' C1D' ' HB2' ' A' ' 55' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -57.16 -41.21 92.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 174.913 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.59 -42.97 56.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.251 1.02 . . . . 0.0 110.967 175.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -54.84 -39.19 68.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.546 -0.721 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.81 -40.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.835 0.854 . . . . 0.0 110.586 -177.554 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 28' ' ' LEU . 38.5 t80 -64.68 -41.66 95.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.962 0.801 . . . . 0.0 110.247 177.609 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.35 -47.61 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.914 ' HB2' HG22 ' A' ' 13' ' ' THR . 30.5 m-80 110.74 88.1 0.0 OUTLIER 'General case' 0 C--N 1.345 0.411 0 C-N-CA 130.612 3.565 . . . . 0.0 114.009 162.397 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.41 -20.43 58.8 Favored Glycine 0 CA--C 1.551 2.301 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 156.192 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 163.92 3.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 129.214 3.006 . . . . 0.0 111.356 175.067 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.43 124.86 9.89 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.248 1.419 . . . . 0.0 107.494 177.281 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.65 178.46 5.8 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 CA-C-N 120.525 1.223 . . . . 0.0 112.464 -8.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -100.18 109.01 21.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 110.295 179.598 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -41.54 -53.8 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.388 1.475 . . . . 0.0 109.943 176.687 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -44.1 -55.4 4.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.267 2.227 . . . . 0.0 111.513 -178.168 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -50.22 -37.46 35.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.492 0.717 . . . . 0.0 112.332 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 m -84.34 -59.45 2.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 110.325 -179.496 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -59.91 -42.49 93.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.956 1.302 . . . . 0.0 113.069 -174.67 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.63 -38.54 90.63 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.453 0.569 . . . . 0.0 110.015 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -25.3 41.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.43 0.692 . . . . 0.0 111.17 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.99 64.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.743 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.44 138.46 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.75 29.3 5.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.331 1.053 . . . . 0.0 111.72 -177.791 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.06 23.97 74.87 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.804 179.354 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 129.61 84.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 118.566 1.183 . . . . 0.0 108.362 176.423 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.9 Cg_endo -61.22 122.04 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.256 1.971 . . . . 0.0 109.742 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -86.97 178.32 6.98 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.641 0.734 . . . . 0.0 111.805 -174.434 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' OH ' ' A' ' 6' ' ' TYR . 2.3 mm? -70.65 163.45 27.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 171.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 m120 48.07 34.39 4.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.681 0.792 . . . . 0.0 112.865 175.58 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.05 62.23 62.87 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.7 0.682 . . . . 0.0 112.384 -174.971 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -39.77 -51.55 2.92 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.151 3.234 . . . . 0.0 114.801 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.66 -40.95 41.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.776 0.831 . . . . 0.0 112.079 -179.083 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.8 -19.94 64.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.269 0.628 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 96.5 m95 -102.32 -35.88 8.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 111.803 -178.58 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.27 -51.71 1.05 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.053 1.741 . . . . 0.0 113.131 -178.419 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.7 -24.44 53.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.047 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.99 157.38 81.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 O-C-N 121.621 -0.674 . . . . 0.0 110.117 -177.681 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.08 113.97 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.025 2.483 . . . . 0.0 111.583 178.172 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.46 -36.09 75.3 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 110.602 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 106.08 0.48 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.444 1.498 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.3 -36.03 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 121.844 -0.535 . . . . 0.0 109.563 176.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.99 -24.26 57.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.102 0.961 . . . . 0.0 112.528 177.655 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -89.34 -49.8 6.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.642 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.62 -40.99 41.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.32 -37.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 O-C-N 121.44 -0.787 . . . . 0.0 110.157 179.088 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.59 -47.77 80.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.436 1.016 . . . . 0.0 108.366 177.973 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -53.93 -37.62 64.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.124 0.17 . . . . 0.0 110.754 175.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.5 m -74.06 -48.7 28.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.911 -0.493 . . . . 0.0 110.713 -177.641 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -66.68 -44.62 81.31 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.587 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.66 -35.04 60.5 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.38 0.672 . . . . 0.0 111.809 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 152.31 23.66 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -176.521 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' H ' ' HB3' ' A' ' 55' ' ' MET . 85.4 tttt -153.53 141.46 20.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -119.93 18.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.08 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.07 3.48 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.839 0.855 . . . . 0.0 112.095 178.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.6 ttp -69.74 123.65 89.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.047 0.84 . . . . 0.0 110.144 -178.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.553 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 74.1 Cg_endo -69.26 145.15 59.12 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.568 1.512 . . . . 0.0 108.622 176.192 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.86 57.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.416 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -97.56 -36.82 10.17 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.109 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 t70 38.76 -144.52 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.228 2.211 . . . . 0.0 111.76 -179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.4 -20.4 5.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.999 2.238 . . . . 0.0 113.211 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -61.84 -30.3 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.483 1.141 . . . . 0.0 109.614 176.594 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.15 106.91 11.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.123 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -63.11 86.84 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.432 1.893 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 16.37 -64.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.516 3.526 . . . . 0.0 115.513 174.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -50.25 -35.79 28.42 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 111.065 178.69 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.27 -55.31 29.59 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.69 0.757 . . . . 0.0 109.588 178.177 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.4 mt -52.49 -53.56 44.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.738 1.215 . . . . 0.0 109.551 176.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.2 t -44.6 -58.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.453 1.101 . . . . 0.0 109.603 176.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -57.04 -39.76 75.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 118.891 0.768 . . . . 0.0 112.461 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.28 96.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.4 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.32 -47.14 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 108.74 179.318 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -52.69 -51.81 58.7 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.517 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -55.37 -54.36 44.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.072 178.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -52.1 -47.96 64.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.096 0.559 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.76 -35.62 80.4 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.861 -0.525 . . . . 0.0 110.312 177.735 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.5 m -73.5 39.08 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.391 -0.818 . . . . 0.0 113.2 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.8 p -131.16 -14.32 3.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.979 1.711 . . . . 0.0 109.764 173.055 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.516 -1.707 . . . . 0.0 110.135 -178.446 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.553 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.38 -25.68 3.69 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.134 0.896 . . . . 0.0 110.925 176.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.73 -59.8 4.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.858 1.263 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -50.08 -47.04 53.9 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.086 0.554 . . . . 0.0 110.098 -179.236 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.21 -57.99 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.607 1.163 . . . . 0.0 109.37 178.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -56.95 -48.26 78.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.125 0.57 . . . . 0.0 111.763 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.34 -48.49 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.231 -174.154 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -5.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -172.916 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.23 37.46 3.51 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.072 1.306 . . . . 0.0 111.144 -176.061 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.6 151.46 49.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.422 1.489 . . . . 0.0 108.131 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.74 13.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.59 1.156 . . . . 0.0 109.695 -177.834 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.55 162.02 44.69 Favored 'Cis proline' 0 N--CA 1.455 -0.758 0 CA-C-N 120.266 1.131 . . . . 0.0 109.544 -13.163 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -67.97 129.1 38.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.776 0.83 . . . . 0.0 110.467 -177.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.48 -46.85 83.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 -178.584 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 p -39.16 -55.19 1.68 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.709 2.004 . . . . 0.0 112.74 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -43.09 -38.03 2.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.666 1.186 . . . . 0.0 112.916 -178.496 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.34 -57.14 2.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.15 -177.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -70.27 -24.23 63.02 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -172.871 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.47 -54.82 38.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.036 0.834 . . . . 0.0 109.89 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -16.28 28.02 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.442 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 45.84 7.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 p -58.7 141.33 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.697 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.09 29.1 5.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.019 0.928 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.84 75.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.814 179.869 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 137.1 88.34 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 118.787 1.294 . . . . 0.0 108.208 175.778 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.42 117.34 4.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.552 2.168 . . . . 0.0 109.782 -178.484 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -76.31 175.87 8.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.943 0.877 . . . . 0.0 109.282 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.47 149.78 21.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 63.25 31.11 15.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.413 0.685 . . . . 0.0 109.506 -173.713 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.58 57.77 27.19 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.04 0.936 . . . . 0.0 112.618 -177.663 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -34.36 -48.14 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 114.267 -179.464 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -39.65 -46.79 1.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.006 1.722 . . . . 0.0 112.68 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -76.55 -29.54 56.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.146 0.43 . . . . 0.0 111.522 -177.024 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -85.36 -20.69 29.53 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.403 0.681 . . . . 0.0 111.43 -177.034 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.58 -45.46 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.448 1.899 . . . . 0.0 113.758 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -94.08 -14.96 25.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.795 0.838 . . . . 0.0 112.825 -177.032 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -79.88 127.24 78.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.945 0.898 . . . . 0.0 109.093 -177.778 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.44 126.35 19.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.602 2.202 . . . . 0.0 111.558 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -65.68 -27.07 68.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.314 0.646 . . . . 0.0 111.126 179.568 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.0 102.68 0.05 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 111.243 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 45' ' ' VAL . 44.6 t -42.52 -51.17 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 124.211 1.004 . . . . 0.0 110.195 179.492 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -51.7 -44.54 63.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.98 -47.59 82.5 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.16 -38.65 87.23 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.649 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG22 HD12 ' A' ' 71' ' ' ILE . 86.6 t -64.26 -40.3 88.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.326 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -60.39 -48.92 79.67 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.282 0.946 . . . . 0.0 109.547 174.868 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -54.06 -43.87 70.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.499 0.59 . . . . 0.0 111.158 177.459 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -69.04 -44.71 72.11 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.91 -0.494 . . . . 0.0 110.011 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -55.4 -53.29 58.12 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.369 -0.832 . . . . 0.0 110.601 177.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.05 -26.01 43.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.72 1.208 . . . . 0.0 113.342 -176.006 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.86 160.66 31.87 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.145 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -158.21 119.98 3.59 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.633 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.91 -119.34 17.44 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -178.443 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.6 -21.46 55.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.761 0.424 . . . . 0.0 111.598 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.0 ttp -69.0 121.96 83.51 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 118.795 0.725 . . . . 0.0 110.236 -177.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.7 157.28 39.91 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.57 2.18 . . . . 0.0 110.179 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.49 123.0 16.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.324 177.397 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -89.72 -10.21 46.53 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.223 0.92 . . . . 0.0 112.71 178.414 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -50.01 111.8 0.57 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.927 0.491 . . . . 0.0 110.436 178.735 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.81 -36.96 4.0 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.477 1.037 . . . . 0.0 111.72 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.2 mtm-85 -85.41 -47.62 9.8 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.13 0.965 . . . . 0.0 110.052 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.75 126.91 53.83 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.404 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.34 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -25.92 -52.13 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.181 2.192 . . . . 0.0 112.074 170.342 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -60.28 -49.86 75.92 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.433 0.56 . . . . 0.0 111.576 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -55.47 -55.61 29.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 122.139 0.971 . . . . 0.0 109.024 178.531 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.7 mt -49.7 -58.92 4.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.946 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.67 -55.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.672 1.589 . . . . 0.0 110.587 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -58.54 -44.16 89.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.224 0.61 . . . . 0.0 111.199 -178.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.67 -45.08 88.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.695 -0.628 . . . . 0.0 109.938 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.435 HD12 HG22 ' A' ' 45' ' ' VAL . 60.1 mt -67.59 -46.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.614 1.166 . . . . 0.0 111.303 -175.9 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.28 -42.06 90.38 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.28 1.4 . . . . 0.0 109.402 178.28 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -62.29 -50.04 73.25 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.881 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.6 ttm -48.89 -52.95 21.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.846 0.858 . . . . 0.0 109.264 178.587 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.53 -39.12 89.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.106 0.562 . . . . 0.0 111.745 178.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.2 p -62.4 -8.61 6.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.45 1.023 . . . . 0.0 113.536 -177.06 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 p -79.26 -14.75 58.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.519 1.054 . . . . 0.0 111.007 176.115 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.603 -1.665 . . . . 0.0 111.03 -174.888 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -36.4 -49.04 1.25 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.767 1.651 . . . . 0.0 113.46 -177.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -59.38 -63.86 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.455 0.702 . . . . 0.0 109.765 178.124 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -49.45 15.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.503 1.121 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.72 -54.98 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.888 1.275 . . . . 0.0 108.873 -178.331 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -60.3 -47.15 87.25 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.217 0.462 . . . . 0.0 111.495 -177.682 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mm -70.78 -46.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.558 -172.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -149.95 -11.71 0.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.098 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.11 35.37 4.29 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 120.114 1.324 . . . . 0.0 111.773 -174.518 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -135.56 152.39 51.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.956 1.303 . . . . 0.0 108.051 177.634 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.744 -178.681 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 158.92 26.32 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 119.941 1.015 . . . . 0.0 111.853 -10.6 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 122.0 19.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.338 1.055 . . . . 0.0 109.712 179.353 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.26 -50.52 61.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 0.0 110.379 -178.145 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -40.28 -55.83 2.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.445 1.898 . . . . 0.0 112.695 178.88 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.1 m -46.04 -32.48 2.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 113.01 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -99.05 -57.04 2.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.044 0.384 . . . . 0.0 111.026 179.444 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -68.44 -32.27 72.18 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.222 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.65 -42.7 86.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 118.828 0.74 . . . . 0.0 109.126 179.271 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.94 -27.96 35.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.313 -178.315 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.75 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.566 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 139.9 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.141 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.21 28.56 5.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.088 0.955 . . . . 0.0 111.546 -177.57 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.44 24.11 76.82 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.365 -0.686 . . . . 0.0 112.857 179.597 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.57 131.78 77.36 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.767 1.283 . . . . 0.0 108.498 175.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -60.47 117.56 4.33 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 109.28 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -89.21 178.86 6.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.749 0.785 . . . . 0.0 112.771 -171.213 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.99 159.21 23.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.16 53.87 0.73 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.685 1.594 . . . . 0.0 112.541 177.053 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.57 59.34 24.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.171 0.989 . . . . 0.0 110.461 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.66 -52.45 2.59 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.455 3.437 . . . . 0.0 114.489 -175.815 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -49.87 -35.08 22.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.246 1.018 . . . . 0.0 112.765 -179.26 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.43 -28.17 60.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.783 0.72 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -91.86 -30.2 16.3 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.568 0.747 . . . . 0.0 111.981 -177.154 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.89 -51.14 0.69 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.647 1.979 . . . . 0.0 113.484 -178.003 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.44 -25.28 54.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.764 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.98 152.65 82.56 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 110.033 -177.167 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.73 110.64 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.538 1.492 . . . . 0.0 108.482 176.038 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.52 -28.96 57.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -53.48 103.85 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.884 1.674 . . . . 0.0 111.444 178.402 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.6 t -51.14 -39.64 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.555 0.742 . . . . 0.0 110.337 178.409 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.97 -23.46 45.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.383 1.073 . . . . 0.0 112.679 179.768 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -90.55 -53.04 4.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.374 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -49.84 -39.81 40.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.114 0.966 . . . . 0.0 112.506 179.747 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -33.81 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 121.664 -0.648 . . . . 0.0 110.266 179.103 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.45 -46.87 78.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.453 1.024 . . . . 0.0 108.735 176.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -53.54 -44.45 69.2 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.252 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -65.95 -47.61 74.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.078 0.551 . . . . 0.0 110.684 -179.5 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.24 -49.1 79.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.359 -0.838 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.79 61.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.394 1.078 . . . . 0.0 112.572 -177.588 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.36 161.32 31.45 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -175.898 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -159.62 114.4 2.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.581 0.69 . . . . 0.0 109.725 -177.216 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.67 -117.76 12.61 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.108 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.201 177.828 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.8 ttp -65.63 119.2 58.31 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.33 -177.469 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.02 160.78 46.67 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.29 1.994 . . . . 0.0 110.154 178.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.19 117.35 9.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -82.16 -7.77 59.63 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.646 0.657 . . . . 0.0 112.368 178.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -49.88 113.64 0.89 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.821 0.737 . . . . 0.0 110.321 176.92 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.7 -28.95 9.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.061 0.838 . . . . 0.0 112.121 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -76.07 -43.91 41.46 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.646 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -131.02 152.9 49.83 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.831 0.852 . . . . 0.0 108.73 176.875 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -88.95 132.89 34.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.994 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -29.65 -47.4 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.402 2.281 . . . . 0.0 113.391 173.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -69.01 -41.7 77.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 111.312 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 -46.5 83.0 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.737 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 62' ' ' ALA . 55.3 mt -51.99 -61.12 2.46 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.557 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 t -41.12 -56.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.348 1.459 . . . . 0.0 109.594 177.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.8 -44.01 73.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.926 0.49 . . . . 0.0 111.512 179.658 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -48.2 75.67 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.707 -0.62 . . . . 0.0 109.852 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.5 mt -57.52 -50.42 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 123.871 0.868 . . . . 0.0 110.602 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -40.76 96.46 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 120.253 1.388 . . . . 0.0 109.294 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -57.76 -50.62 72.62 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.724 0.693 . . . . 0.0 109.561 176.885 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.66 -52.82 54.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 178.385 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.81 -33.8 68.98 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.745 -0.597 . . . . 0.0 111.839 176.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -73.01 38.0 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.402 1.001 . . . . 0.0 113.423 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.9 p -132.01 -15.77 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.314 1.845 . . . . 0.0 109.479 171.681 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.724 179.96 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 CA--C 1.516 -0.353 0 CA-C-O 117.426 -1.274 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.49 19.24 57.2 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -171.301 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 66.87 -62.07 0.31 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 129.802 3.241 . . . . 0.0 111.76 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 p -26.28 -64.78 0.07 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.479 3.112 . . . . 0.0 112.806 179.392 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -44.94 -57.39 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.293 1.037 . . . . 0.0 110.508 -178.025 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.74 -47.21 72.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.919 0.487 . . . . 0.0 111.721 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.55 -46.79 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -172.686 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -145.22 -5.06 0.69 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -170.608 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.43 33.95 6.17 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 120.168 1.349 . . . . 0.0 112.042 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.64 150.52 51.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.119 1.768 . . . . 0.0 107.403 177.525 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.58 109.62 14.69 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 0.0 110.272 -177.172 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.01 163.07 50.14 Favored 'Cis proline' 0 N--CA 1.455 -0.79 0 CA-C-N 120.292 1.14 . . . . 0.0 110.065 -10.725 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -69.17 129.42 39.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.327 1.051 . . . . 0.0 110.177 -178.341 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -59.19 -46.51 88.22 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.443 0.639 . . . . 0.0 111.044 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -37.27 -57.19 0.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.207 2.203 . . . . 0.0 112.168 179.24 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.15 -34.52 0.18 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.512 1.925 . . . . 0.0 113.677 -178.417 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.55 -57.89 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.497 0.719 . . . . 0.0 110.625 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -64.27 -24.07 67.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -172.212 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -73.59 -22.0 60.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 119.986 1.266 . . . . 0.0 111.052 177.231 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -107.5 -24.76 11.68 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.91 0.884 . . . . 0.0 111.683 -178.304 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.35 32.62 51.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.78 140.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.313 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.57 28.8 6.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -177.192 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.98 77.0 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.319 -0.712 . . . . 0.0 112.892 179.39 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 130.76 82.88 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 118.798 1.299 . . . . 0.0 108.644 176.851 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.14 121.73 9.49 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.601 2.201 . . . . 0.0 108.648 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -89.28 178.67 6.28 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.954 0.883 . . . . 0.0 113.277 -171.335 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.9 160.92 29.8 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.729 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.78 52.9 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.769 1.628 . . . . 0.0 111.674 177.165 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.23 64.34 19.71 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 110.456 -177.518 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -38.68 -50.55 2.43 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.302 3.335 . . . . 0.0 114.099 -177.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -49.22 -39.98 31.92 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.179 0.992 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -64.16 -28.65 69.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.259 0.624 . . . . 0.0 111.337 -179.15 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.83 -27.01 13.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.712 1.205 . . . . 0.0 112.384 -174.873 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.84 -43.88 0.98 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.061 1.744 . . . . 0.0 113.744 -178.884 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.8 -15.89 25.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.586 0.754 . . . . 0.0 112.771 -176.373 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.3 133.93 44.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 109.597 -177.574 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.19 105.32 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.991 2.461 . . . . 0.0 110.302 176.938 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.98 -24.87 63.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.876 0.87 . . . . 0.0 113.038 -175.56 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -52.48 102.24 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.441 1.497 . . . . 0.0 111.424 179.781 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.0 t -47.6 -45.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.293 1.037 . . . . 0.0 110.255 179.29 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.35 -29.32 58.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.915 1.286 . . . . 0.0 112.168 -179.014 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -86.19 -50.73 6.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.431 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.3 mt -50.46 -40.94 52.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.062 0.545 . . . . 0.0 112.21 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -59.6 -30.8 45.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.984 178.881 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.7 -50.04 68.54 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.224 1.375 . . . . 0.0 108.471 177.966 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -53.81 -42.67 68.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.173 0.589 . . . . 0.0 110.128 176.238 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -68.22 -44.36 75.9 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.813 0.34 . . . . 0.0 110.681 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.66 -47.24 86.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.83 -31.19 51.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 112.716 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 159.0 28.58 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -175.075 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.495 ' H ' ' HB3' ' A' ' 55' ' ' MET . 53.9 tttp -156.77 124.55 5.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.86 -114.89 6.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.3 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.67 -18.86 33.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.738 0.815 . . . . 0.0 112.028 178.243 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.4 ttp -62.25 124.57 82.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 118.948 0.795 . . . . 0.0 110.439 -176.994 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 98.1 Cg_endo -72.49 158.24 51.44 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.082 1.854 . . . . 0.0 109.31 178.017 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 114.5 6.57 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.99 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.78 -7.41 58.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.306 179.473 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.74 113.18 0.66 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.842 0.747 . . . . 0.0 110.936 177.148 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 -27.18 11.55 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.164 0.887 . . . . 0.0 112.331 179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.73 -49.73 13.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -130.71 134.56 47.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.183 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.69 149.0 34.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.472 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -27.72 -50.16 0.06 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.144 1.777 . . . . 0.0 112.402 168.641 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -69.02 -39.63 79.13 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.638 -0.664 . . . . 0.0 112.21 -178.637 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.38 -53.27 60.15 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.618 1.099 . . . . 0.0 108.208 175.595 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 62' ' ' ALA . 54.7 mt -49.61 -59.4 3.82 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 125.802 1.641 . . . . 0.0 109.155 177.158 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 t -43.19 -57.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 109.077 176.243 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -58.63 -31.96 68.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.545 -0.74 . . . . 0.0 112.106 -176.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.87 -52.63 14.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.222 0.919 . . . . 0.0 109.262 176.93 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.7 mt -53.03 -39.71 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.468 1.107 . . . . 0.0 110.073 178.782 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -52.31 -56.61 13.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.092 0.86 . . . . 0.0 109.637 176.226 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -55.83 -53.88 51.37 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.3 ttm -47.22 -61.07 2.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.101 0.96 . . . . 0.0 110.331 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.45 -35.74 78.45 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.042 -0.411 . . . . 0.0 111.137 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -62.53 -5.0 2.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.787 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -88.97 -13.83 38.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.393 1.451 . . . . 0.0 111.265 176.399 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.638 -176.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 0' ' ' HEM . . . . . 0.433 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 117.045 -1.455 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.4 -75.63 0.28 Allowed Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.453 1.501 . . . . 0.0 110.798 175.062 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.04 -34.29 6.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.979 -2.61 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m 70.59 -62.78 0.43 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.163 2.185 . . . . 0.0 107.395 -176.9 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.28 -55.26 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.431 1.014 . . . . 0.0 108.759 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -69.56 -50.46 44.55 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -178.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.38 -50.53 72.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.531 -174.425 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -158.73 51.86 0.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -169.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.38 35.7 0.52 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.408 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.23 154.41 50.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.228 1.811 . . . . 0.0 106.586 175.48 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.58 105.34 10.89 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.091 -176.187 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.21 155.97 77.1 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.208 1.11 . . . . 0.0 110.417 -7.038 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 129.9 42.42 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.615 1.166 . . . . 0.0 110.719 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -52.47 -48.51 65.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.409 1.1 . . . . 0.0 110.143 178.721 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -49.29 -39.57 31.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.334 1.853 . . . . 0.0 112.207 179.205 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -47.0 -40.39 14.44 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.893 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -99.37 -51.29 3.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.954 0.783 . . . . 0.0 110.929 -177.152 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -69.27 -22.97 63.78 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.67 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.7 -42.9 90.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.469 1.031 . . . . 0.0 110.127 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.01 -25.32 17.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.701 0.8 . . . . 0.0 111.569 179.181 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 37.83 13.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.027 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.18 149.09 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -176.591 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.29 30.11 7.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.136 0.974 . . . . 0.0 111.291 -178.108 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.75 23.16 78.39 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.63 132.57 91.3 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.908 1.354 . . . . 0.0 108.132 176.382 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.63 118.08 5.03 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.181 1.92 . . . . 0.0 107.778 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -75.72 162.72 27.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.834 0.825 . . . . 0.0 111.52 -174.343 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.95 159.47 34.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 170.566 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.57 56.8 2.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.599 1.159 . . . . 0.0 111.191 -177.356 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 63.3 5.45 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 0.0 109.65 -177.679 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -45.35 -44.5 16.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.063 3.175 . . . . 0.0 113.43 -175.116 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -50.0 -34.59 21.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.904 0.881 . . . . 0.0 112.335 178.441 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.11 -28.61 64.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.025 0.53 . . . . 0.0 111.455 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -99.09 -15.68 18.92 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.417 1.087 . . . . 0.0 111.958 -176.162 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.36 -45.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.236 1.814 . . . . 0.0 112.935 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.33 30.47 7.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.042 0.937 . . . . 0.0 112.638 -176.872 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -121.1 124.42 27.39 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 108.074 177.604 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.88 108.71 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.417 2.745 . . . . 0.0 110.826 178.121 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.01 -24.78 59.67 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.589 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -49.1 105.54 0.08 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.016 1.727 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -49.45 -45.25 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.484 0.714 . . . . 0.0 109.442 177.658 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.44 -23.4 49.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.858 1.263 . . . . 0.0 113.145 -179.122 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.58 -55.05 3.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.566 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.1 mt -50.82 -39.49 53.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.733 1.213 . . . . 0.0 112.444 -178.589 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.39 -35.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.623 -0.673 . . . . 0.0 109.949 179.485 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -48.8 75.08 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.173 0.897 . . . . 0.0 108.69 177.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -53.16 -37.35 61.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.696 0.798 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -75.15 -47.53 28.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.109 0.564 . . . . 0.0 109.996 -178.792 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.58 -48.8 80.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.441 1.097 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.02 -33.63 65.85 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.889 0.876 . . . . 0.0 110.921 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.32 86.85 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.255 0.919 . . . . 0.0 111.272 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -77.72 144.99 36.82 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.915 1.286 . . . . 0.0 109.97 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.91 5.99 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.018 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.69 -0.26 51.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.028 0.931 . . . . 0.0 112.424 -179.352 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.5 mtm -71.57 139.51 83.79 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 119.413 1.006 . . . . 0.0 111.179 -178.402 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.91 153.54 58.3 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 171.901 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.53 113.91 5.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -78.4 -16.16 57.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.533 -179.801 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -49.6 113.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.51 1.05 . . . . 0.0 110.511 175.285 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.41 -32.55 7.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.38 0.99 . . . . 0.0 111.493 -179.002 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -76.27 -46.21 29.0 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.397 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.51 138.26 39.49 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.488 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -79.1 147.65 32.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 68' ' ' VAL . 67.1 ttt-85 -30.53 -51.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.489 1.915 . . . . 0.0 111.782 169.412 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.32 -29.43 65.01 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.543 -0.723 . . . . 0.0 112.168 -176.991 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.31 -58.98 4.17 Favored 'General case' 0 N--CA 1.459 0.021 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.18 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 62' ' ' ALA . 74.5 mt -44.18 -55.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.097 1.759 . . . . 0.0 110.18 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ARG . 3.3 t -38.5 -51.66 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 111.266 178.306 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -59.0 -47.0 86.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.451 0.643 . . . . 0.0 110.791 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.44 94.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.929 -0.482 . . . . 0.0 109.775 -179.664 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.41 -49.47 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.501 1.12 . . . . 0.0 110.405 -178.649 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.1 -41.12 99.3 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.155 -0.966 . . . . 0.0 109.243 -179.334 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -58.17 -55.7 31.54 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.838 0.745 . . . . 0.0 109.299 176.66 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.8 ttm -43.34 -53.29 5.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.201 1.8 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.52 -38.51 91.27 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.995 -0.44 . . . . 0.0 111.348 178.762 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.9 m -75.25 45.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.861 0.864 . . . . 0.0 113.024 -178.395 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.2 p -138.77 -18.96 1.04 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.091 1.756 . . . . 0.0 110.398 173.854 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.492 -1.718 . . . . 0.0 110.922 -177.478 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.533 0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.2 mt -53.0 -59.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.534 0.734 . . . . 0.0 109.544 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -52.17 -49.07 64.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 112.435 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.1 -50.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.556 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -138.98 -17.09 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.99 36.1 3.77 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 120.075 1.307 . . . . 0.0 111.34 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -136.77 150.51 48.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.611 1.564 . . . . 0.0 108.013 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.18 109.59 5.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.653 1.181 . . . . 0.0 109.274 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.33 153.68 31.56 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 CA-C-N 120.105 1.073 . . . . 0.0 111.82 -9.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.45 124.85 24.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 109.667 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.03 -48.1 81.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.418 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -39.59 -56.86 1.59 Allowed 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.447 1.899 . . . . 0.0 112.253 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -43.52 -31.61 0.76 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.408 1.483 . . . . 0.0 113.375 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.2 m -104.28 -56.53 2.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.897 0.479 . . . . 0.0 111.277 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -68.62 -28.55 67.01 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.4 -39.24 93.98 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.95 0.795 . . . . 0.0 110.318 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ttm105 -95.32 -28.71 14.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.414 1.086 . . . . 0.0 111.978 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.6 6.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.81 133.18 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.69 31.24 7.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.628 1.171 . . . . 0.0 111.636 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.4 76.25 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.659 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.91 136.5 72.91 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 118.511 1.156 . . . . 0.0 108.402 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.86 120.15 7.71 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.339 2.026 . . . . 0.0 108.596 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.49 167.96 16.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.65 158.75 33.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.547 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.39 49.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.375 1.47 . . . . 0.0 111.9 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.23 62.17 19.47 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.651 1.58 . . . . 0.0 109.036 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -44.1 -41.41 12.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.238 3.292 . . . . 0.0 113.779 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -49.51 -41.11 40.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.514 1.125 . . . . 0.0 111.315 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.3 -24.89 67.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.671 0.788 . . . . 0.0 111.956 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -104.95 -30.87 9.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.316 1.046 . . . . 0.0 112.353 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.59 -49.9 1.56 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.627 1.571 . . . . 0.0 112.795 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -27.68 60.56 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -76.74 151.0 82.25 Favored Pre-proline 0 CA--C 1.534 0.333 0 O-C-N 121.64 -0.663 . . . . 0.0 110.03 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.08 85.83 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 107.982 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.45 -25.55 25.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.56 1.944 . . . . 0.0 113.304 -171.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.3 m -48.17 113.82 0.82 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.495 1.118 . . . . 0.0 110.651 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.81 -46.14 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.373 1.069 . . . . 0.0 110.512 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -58.19 -24.64 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.779 1.232 . . . . 0.0 112.852 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -90.06 -53.0 4.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.3 mt -47.85 -42.01 25.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.298 1.039 . . . . 0.0 111.861 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.44 -34.64 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.755 -0.591 . . . . 0.0 111.289 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -64.52 -50.12 68.62 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 119.375 0.988 . . . . 0.0 108.653 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -51.13 -46.1 61.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.673 0.789 . . . . 0.0 109.844 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -50.56 71.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.825 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.02 -45.42 92.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.294 -0.879 . . . . 0.0 111.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -32.67 67.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.877 0.871 . . . . 0.0 112.227 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.56 160.19 28.93 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -157.61 122.01 4.29 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.974 -0.721 . . . . 0.0 109.263 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.08 9.34 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.02 53.86 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.003 0.521 . . . . 0.0 111.807 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.4 ttp -65.89 115.89 27.25 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.733 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.13 164.84 23.73 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.369 2.046 . . . . 0.0 110.947 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.33 134.68 50.69 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -97.03 -15.06 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -47.79 100.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.671 0.788 . . . . 0.0 112.624 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.05 -37.97 3.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.062 1.315 . . . . 0.0 111.781 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -76.42 -38.92 54.85 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.786 0.793 . . . . 0.0 110.134 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.65 136.61 46.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.79 144.83 30.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -32.31 -44.95 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.63 1.972 . . . . 0.0 111.496 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.64 -49.53 76.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.942 0.792 . . . . 0.0 111.561 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -56.1 -56.92 15.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 122.728 1.251 . . . . 0.0 108.626 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 62.4 mt -48.62 -58.56 4.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.823 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 t -46.09 -53.54 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.426 1.09 . . . . 0.0 110.024 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -59.02 -39.03 80.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.656 0.382 . . . . 0.0 111.192 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.56 71.9 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.47 -49.95 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.601 1.16 . . . . 0.0 109.825 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.07 -39.14 85.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.135 0.88 . . . . 0.0 109.228 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.1 -47.51 85.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mtp -54.03 -59.31 4.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.01 -35.94 64.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 112.634 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -62.9 -10.65 14.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.419 1.008 . . . . 0.0 113.173 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -89.62 -11.61 42.11 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.783 1.174 . . . . 0.0 111.558 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.216 -1.85 . . . . 0.0 111.875 -175.068 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.249 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.96 -57.46 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.699 0.799 . . . . 0.0 110.175 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.71 -49.25 77.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.825 0.85 . . . . 0.0 112.31 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.15 -48.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.084 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.52 -18.19 1.95 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.85 -34.43 38.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.842 1.201 . . . . 0.0 112.364 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 p -73.06 151.32 41.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.419 0.609 . . . . 0.0 110.444 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.68 106.72 6.42 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.872 1.269 . . . . 0.0 108.559 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.16 150.65 36.01 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.351 1.161 . . . . 0.0 111.738 -5.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.06 124.53 22.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.676 1.19 . . . . 0.0 109.142 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -54.43 -46.34 73.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.026 0.83 . . . . 0.0 110.558 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 p -40.4 -52.46 2.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.111 2.165 . . . . 0.0 112.338 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -38.47 -48.2 1.36 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 112.082 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.9 m -93.02 -55.05 3.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.208 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -64.84 -25.95 68.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 120.289 1.404 . . . . 0.0 111.356 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -119.72 -15.05 8.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.963 0.905 . . . . 0.0 112.466 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.74 34.23 44.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.2 t -55.13 132.62 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.34 31.53 7.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.729 1.211 . . . . 0.0 111.911 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.61 22.24 75.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.398 -0.668 . . . . 0.0 113.044 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.15 131.66 80.5 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 118.707 1.253 . . . . 0.0 109.324 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.7 119.57 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.411 2.074 . . . . 0.0 108.211 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.39 179.78 6.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.811 0.815 . . . . 0.0 112.567 -172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.43 159.37 24.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.14 54.11 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.084 1.754 . . . . 0.0 112.238 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.21 58.56 15.4 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.034 0.933 . . . . 0.0 110.96 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -38.48 -48.27 2.51 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.557 3.505 . . . . 0.0 114.152 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -47.77 -40.1 19.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.363 1.465 . . . . 0.0 111.988 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.71 -27.9 58.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.923 0.329 . . . . 0.0 111.455 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.94 -26.14 19.42 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.756 0.822 . . . . 0.0 112.004 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -34.76 -46.81 0.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.493 2.317 . . . . 0.0 114.456 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.05 2.7 35.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -83.37 158.29 63.78 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 118.978 0.808 . . . . 0.0 109.821 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.01 120.88 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.258 2.639 . . . . 0.0 110.833 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -64.36 -39.16 93.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -82.35 133.33 35.22 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 122.067 -0.395 . . . . 0.0 111.115 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -52.98 -40.7 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -54.34 -29.48 48.14 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.024 1.33 . . . . 0.0 112.598 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.28 -52.49 6.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.89 -40.15 60.2 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -60.2 -33.97 55.43 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 CA-C-N 119.528 1.058 . . . . 0.0 110.743 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -62.47 -49.81 73.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 m -52.27 -46.95 66.06 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.453 0.57 . . . . 0.0 109.817 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 m -61.12 -40.35 93.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.491 0.717 . . . . 0.0 111.487 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . 0.286 0.9 OUTLIER -111.02 36.65 3.07 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.37 -44.49 2.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.474 1.91 . . . . 0.0 107.175 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.33 145.63 9.76 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.89 1.71 . . . . 0.0 109.462 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -156.36 132.95 10.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.8 -117.64 11.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.36 1.01 38.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.186 0.994 . . . . 0.0 112.064 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.7 ttp -69.58 122.83 87.03 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.067 0.849 . . . . 0.0 110.308 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.82 152.55 47.23 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.155 1.903 . . . . 0.0 108.86 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.58 119.14 13.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -76.34 1.97 14.75 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -46.37 112.51 0.5 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 110.924 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.37 -30.01 6.73 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.636 0.636 . . . . 0.0 112.149 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -72.7 -46.28 54.51 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.29 124.56 13.78 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.0 155.4 28.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -29.32 -49.81 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.496 1.918 . . . . 0.0 111.852 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -64.7 -41.05 96.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.258 0.936 . . . . 0.0 112.304 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.12 -58.0 8.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 122.437 1.113 . . . . 0.0 108.443 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.3 mt -46.03 -57.9 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 127.047 2.139 . . . . 0.0 110.48 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -39.84 -55.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 110.813 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -60.58 -37.25 80.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.284 1.034 . . . . 0.0 111.816 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.64 32.27 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.74 -0.6 . . . . 0.0 109.442 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.67 -50.85 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.049 0.94 . . . . 0.0 110.785 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.94 -41.65 92.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.847 1.203 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -59.03 -51.52 69.71 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.27 -53.61 48.35 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.33 -38.24 76.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.118 0.567 . . . . 0.0 111.78 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.7 p -63.5 -5.22 3.49 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -87.06 -12.43 47.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.771 1.168 . . . . 0.0 111.093 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.656 -1.64 . . . . 0.0 110.197 -177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.532 0.254 0 CA-C-O 121.349 0.595 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.02 -58.15 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.2 -50.24 65.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.176 0.99 . . . . 0.0 112.17 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.2 mt -69.21 -48.04 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.468 -174.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -145.32 -12.74 0.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.55 38.85 2.99 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 120.244 1.384 . . . . 0.0 111.257 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.16 153.76 51.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.135 1.374 . . . . 0.0 109.073 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.08 108.63 8.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.495 1.118 . . . . 0.0 110.968 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -57.02 159.27 24.89 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.843 0.98 . . . . 0.0 111.83 -12.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.82 122.66 19.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.484 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -54.72 -47.51 73.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.712 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 p -41.48 -52.47 3.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.339 1.856 . . . . 0.0 112.263 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -48.51 -24.78 1.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.065 1.346 . . . . 0.0 113.874 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -109.03 -54.1 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.743 0.817 . . . . 0.0 110.951 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -69.84 -21.67 63.35 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.25 -58.05 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.366 0.985 . . . . 0.0 109.773 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -26.29 32.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.635 0.374 . . . . 0.0 111.563 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.81 6.15 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.32 144.4 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.47 29.8 7.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.076 0.95 . . . . 0.0 111.491 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.27 79.16 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.05 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.71 132.64 88.96 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.754 1.277 . . . . 0.0 108.409 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.17 119.02 5.93 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.793 2.329 . . . . 0.0 109.398 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -82.55 177.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.9 0.857 . . . . 0.0 111.255 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -82.98 157.53 22.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m120 50.4 41.48 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.94 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.28 52.93 8.64 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.443 1.097 . . . . 0.0 110.24 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -46.88 -39.61 24.63 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.75 2.967 . . . . 0.0 112.643 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -49.66 -40.63 40.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.404 1.081 . . . . 0.0 111.48 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.41 -27.36 60.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.234 0.614 . . . . 0.0 111.199 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.06 -27.24 19.82 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.839 -0.538 . . . . 0.0 111.697 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.2 -50.58 0.73 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.6 1.96 . . . . 0.0 113.503 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.74 -23.43 42.29 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.62 135.5 75.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.647 -0.658 . . . . 0.0 109.423 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.72 113.99 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.295 1.997 . . . . 0.0 111.256 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.61 -32.4 58.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.144 0.978 . . . . 0.0 111.834 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -53.99 101.81 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.457 1.503 . . . . 0.0 111.279 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -45.43 -40.82 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.011 1.324 . . . . 0.0 109.933 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.94 -36.52 5.54 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.963 2.105 . . . . 0.0 112.639 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -84.03 -50.14 8.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -52.66 -39.27 61.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.046 0.938 . . . . 0.0 112.019 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 m -60.1 -36.07 65.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.143 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -67.5 -48.76 66.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.677 1.126 . . . . 0.0 108.451 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 m -50.7 -46.42 58.86 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -67.34 -50.89 58.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.649 0.379 . . . . 0.0 111.179 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.0 -44.77 94.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.188 -0.945 . . . . 0.0 111.031 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.32 -35.36 54.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.544 0.738 . . . . 0.0 112.462 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 158.23 24.36 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -164.47 133.53 3.67 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.891 0.846 . . . . 0.0 109.803 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.76 -84.84 0.28 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.96 -6.28 2.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.193 1.797 . . . . 0.0 111.453 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.3 ttp -64.61 124.01 84.83 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.067 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.49 158.68 55.28 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.124 1.883 . . . . 0.0 109.251 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 147.02 53.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -111.81 -12.75 13.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.098 1.359 . . . . 0.0 111.232 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.75 123.04 6.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.416 1.086 . . . . 0.0 110.136 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.6 -26.07 23.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.387 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -97.74 -54.64 3.05 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.498 1.149 . . . . 0.0 110.361 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.03 125.91 33.12 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.55 51.39 1.06 Allowed 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.719 1.608 . . . . 0.0 111.921 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 52.05 -62.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.928 3.291 . . . . 0.0 113.734 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -50.92 -34.85 30.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.763 1.225 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -53.0 -56.63 14.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.734 1.614 . . . . 0.0 109.143 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.07 -53.32 58.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 125.44 1.496 . . . . 0.0 109.684 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.2 t -43.39 -57.51 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 122.899 0.479 . . . . 0.0 109.875 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -60.72 -43.86 97.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.876 0.471 . . . . 0.0 112.056 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.55 95.6 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.802 -0.561 . . . . 0.0 110.398 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.89 -49.63 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.49 1.516 . . . . 0.0 110.087 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.69 -39.81 89.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -58.22 -53.05 62.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.389 0.54 . . . . 0.0 109.617 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.7 mtp -48.25 -58.58 4.35 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -55.61 -39.86 71.33 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.811 0.844 . . . . 0.0 112.078 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.0 m -67.17 -6.53 18.26 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.506 -0.746 . . . . 0.0 112.006 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -119.14 42.44 2.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.597 1.559 . . . . 0.0 109.635 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.136 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.533 0.316 0 CA-C-O 119.578 -0.249 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.7 mt -53.91 -57.53 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 109.978 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -57.07 -50.34 73.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.236 1.014 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.91 -51.18 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.88 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.996 0.816 . . . . 0.0 112.851 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.76 38.94 1.51 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 157.51 45.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.231 1.813 . . . . 0.0 108.44 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.714 0.805 . . . . 0.0 110.629 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.06 160.35 23.48 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 CA-C-N 119.941 1.015 . . . . 0.0 111.878 -12.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.31 127.45 32.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.706 0.802 . . . . 0.0 109.558 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -57.71 -50.77 72.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.457 0.646 . . . . 0.0 111.199 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -39.42 -56.13 1.64 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.642 1.977 . . . . 0.0 112.986 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.67 -38.0 0.83 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.337 1.455 . . . . 0.0 112.564 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -96.83 -59.25 1.84 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 0.0 110.372 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -60.69 -46.11 91.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -22.18 64.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.862 0.301 . . . . 0.0 111.759 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -114.87 11.99 16.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.209 1.004 . . . . 0.0 111.293 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.71 38.39 29.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.124 0.869 . . . . 0.0 113.63 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.8 t -55.14 132.74 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.52 31.44 7.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 111.883 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.71 22.32 75.12 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.742 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.49 136.25 82.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.253 1.027 . . . . 0.0 108.697 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.9 Cg_endo -60.22 126.94 21.47 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.346 2.031 . . . . 0.0 109.626 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -94.07 174.47 7.14 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.449 0.643 . . . . 0.0 112.014 -174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.82 162.3 19.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.09 53.6 0.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.758 1.623 . . . . 0.0 112.125 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.79 64.5 22.18 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 124.235 1.014 . . . . 0.0 109.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -41.17 -51.55 3.87 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.024 3.15 . . . . 0.0 114.29 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -44.15 -51.92 7.71 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.144 1.378 . . . . 0.0 110.843 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.55 -45.38 56.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.953 0.901 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 92.1 m95 -85.6 -30.6 23.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.325 0.65 . . . . 0.0 111.379 -173.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.41 93.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.411 1.084 . . . . 0.0 109.408 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.89 -42.15 97.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.014 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -74.85 162.66 72.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.528 0.731 . . . . 0.0 111.266 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -68.03 84.33 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.36 2.04 . . . . 0.0 107.798 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -48.9 -28.82 4.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.462 1.905 . . . . 0.0 113.247 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.79 106.82 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.748 2.019 . . . . 0.0 110.911 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.0 t -47.75 -44.41 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.248 1.019 . . . . 0.0 110.939 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -53.78 -36.0 61.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.755 1.622 . . . . 0.0 111.842 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.69 -50.7 10.22 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.7 -42.31 45.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.128 0.971 . . . . 0.0 112.408 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.62 -36.11 68.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.818 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -65.46 -49.43 69.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 119.763 1.165 . . . . 0.0 108.581 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 m -52.07 -46.11 65.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.078 0.466 . . . . 0.0 109.812 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -65.19 -49.98 67.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.761 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.53 -45.29 94.82 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.315 -0.866 . . . . 0.0 110.81 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.79 74.91 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.715 0.806 . . . . 0.0 111.819 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 164.95 26.04 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -156.36 106.98 2.39 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.85 -0.794 . . . . 0.0 109.389 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.59 -111.55 3.33 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.79 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.088 0.555 . . . . 0.0 111.117 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -65.0 117.96 44.38 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.323 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.47 157.51 52.8 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.531 2.154 . . . . 0.0 109.644 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 145.68 52.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.456 0.302 . . . . 0.0 110.302 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -110.81 -12.31 14.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.192 1.397 . . . . 0.0 111.349 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -46.51 123.58 5.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.978 1.311 . . . . 0.0 110.548 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.69 -25.38 21.5 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.119 0.866 . . . . 0.0 112.34 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -98.1 -57.1 2.3 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.384 1.092 . . . . 0.0 110.325 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.11 119.61 26.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.46 84.92 4.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 15.32 -59.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 131.389 3.876 . . . . 0.0 115.866 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -48.28 -35.39 12.07 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.2 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -54.99 -59.75 4.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.211 1.405 . . . . 0.0 108.787 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 mt -55.51 -53.84 51.34 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 126.282 1.833 . . . . 0.0 109.858 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.3 t -45.38 -57.03 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.32 0.648 . . . . 0.0 109.422 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -60.3 -41.24 93.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.766 -0.584 . . . . 0.0 111.651 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.36 99.01 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 109.787 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.88 -44.18 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.64 1.176 . . . . 0.0 108.565 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.14 -50.72 68.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -55.26 -51.64 65.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.522 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.7 mtt -47.57 -63.79 0.96 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.113 0.959 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -53.3 -36.05 60.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.069 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.4 m -72.07 34.57 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.656 1.116 . . . . 0.0 113.94 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -134.21 -10.86 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.662 1.585 . . . . 0.0 109.85 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.579 -1.677 . . . . 0.0 110.093 -178.771 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.627 0.251 . . . . 0.0 111.633 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.45 -60.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.893 1.677 . . . . 0.0 110.671 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.75 -48.08 73.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.83 0.852 . . . . 0.0 111.589 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.29 -49.98 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.457 1.103 . . . . 0.0 111.021 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.65 33.77 0.27 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.42 37.85 1.75 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 156.04 48.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.287 1.835 . . . . 0.0 107.751 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.42 108.82 6.73 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.859 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.8 155.73 27.72 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.074 1.062 . . . . 0.0 111.581 -9.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.17 128.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.54 0.736 . . . . 0.0 109.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.3 m -58.35 -49.41 77.3 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 0.0 110.117 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -41.18 -55.5 2.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.405 1.882 . . . . 0.0 113.49 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.27 -36.38 3.98 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.941 0.896 . . . . 0.0 112.339 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.41 -57.91 2.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -67.06 -36.12 81.35 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -68.21 -33.84 75.16 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -84.46 -26.8 27.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.112 0.965 . . . . 0.0 111.122 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.18 33.3 57.13 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.62 139.46 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.9 29.43 6.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.126 0.97 . . . . 0.0 111.572 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.22 24.49 76.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.718 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.67 80.41 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.608 1.204 . . . . 0.0 108.275 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.6 122.01 10.61 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.257 1.972 . . . . 0.0 110.051 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -90.56 177.18 6.43 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.606 0.717 . . . . 0.0 111.65 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 156.77 29.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 51.08 35.48 13.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.614 0.766 . . . . 0.0 111.845 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.79 67.27 79.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.06 1.344 . . . . 0.0 110.352 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.18 -50.82 5.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.148 3.232 . . . . 0.0 114.454 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -50.93 -35.21 32.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.946 1.299 . . . . 0.0 112.227 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.37 -27.66 68.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.149 0.431 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -101.53 -35.42 9.16 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.548 1.139 . . . . 0.0 112.097 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.34 -51.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.587 1.555 . . . . 0.0 113.125 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.89 -23.18 45.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -79.53 144.28 60.95 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.38 93.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.72 2.28 . . . . 0.0 108.457 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.56 -21.12 36.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.044 1.337 . . . . 0.0 112.994 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.41 106.93 0.11 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.571 1.948 . . . . 0.0 110.455 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.0 -42.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.937 0.895 . . . . 0.0 110.632 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.82 -31.23 64.52 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.371 1.469 . . . . 0.0 112.36 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.83 -53.49 5.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt -48.62 -45.61 38.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.502 0.721 . . . . 0.0 111.877 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.94 -35.98 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 121.854 -0.529 . . . . 0.0 110.976 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.89 -45.09 75.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 m -53.96 -44.08 70.45 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.3 m -64.55 -50.61 66.62 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.81 0.444 . . . . 0.0 110.49 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.48 -44.97 89.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.411 -0.806 . . . . 0.0 110.924 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.9 68.49 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.799 0.84 . . . . 0.0 112.288 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.09 161.25 26.47 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -159.66 117.31 2.68 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.892 -0.769 . . . . 0.0 109.215 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.18 -117.62 11.63 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.44 54.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.883 0.473 . . . . 0.0 111.447 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -67.98 121.47 79.99 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 118.784 0.72 . . . . 0.0 110.112 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.73 161.29 39.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.629 2.219 . . . . 0.0 110.195 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.02 136.83 57.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.89 -14.05 18.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.121 0.968 . . . . 0.0 113.247 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -49.41 102.83 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.311 0.644 . . . . 0.0 112.142 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.73 -36.24 4.28 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.14 1.352 . . . . 0.0 111.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -79.17 -41.11 29.19 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 117.828 0.814 . . . . 0.0 110.184 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.35 132.76 39.87 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.56 144.94 30.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -28.29 -52.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -62.45 -40.65 97.31 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.674 -0.641 . . . . 0.0 112.033 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.23 -58.91 6.38 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 122.429 1.109 . . . . 0.0 108.199 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 62' ' ' ALA . 77.9 mt -46.09 -56.02 6.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.493 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -41.53 -54.49 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.815 1.246 . . . . 0.0 110.572 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -57.04 -42.53 80.68 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.342 -0.224 . . . . 0.0 111.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.99 81.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.54 -45.47 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.578 0.751 . . . . 0.0 109.344 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -55.1 -51.0 67.77 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.875 0.87 . . . . 0.0 108.824 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -55.87 -52.05 65.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.414 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.6 mtp -49.73 -54.41 19.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.391 0.677 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.19 -36.81 76.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.03 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.6 m -74.41 42.49 0.16 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.468 -0.77 . . . . 0.0 112.766 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -135.93 -7.78 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.77 1.228 . . . . 0.0 110.307 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.22 -1.371 . . . . 0.0 108.999 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.522 0.201 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.7 -59.78 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.632 1.573 . . . . 0.0 109.96 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -58.12 -48.56 79.85 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.135 0.574 . . . . 0.0 111.441 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.6 mt -69.84 -46.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.877 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.69 39.07 0.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.45 39.49 1.16 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -139.16 156.9 46.79 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.458 1.903 . . . . 0.0 107.496 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.51 108.17 6.63 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.814 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.32 154.55 31.27 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 CA-C-N 120.104 1.073 . . . . 0.0 111.827 -9.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.08 121.73 16.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.561 1.145 . . . . 0.0 109.179 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -52.71 -49.71 64.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.206 0.527 . . . . 0.0 110.496 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -43.39 -51.26 6.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.029 1.732 . . . . 0.0 112.77 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -47.39 -34.21 6.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.655 0.782 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 m -96.85 -55.74 2.79 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -66.06 -36.91 84.5 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.99 -43.26 88.27 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -72.55 -30.23 64.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.626 0.77 . . . . 0.0 111.076 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.2 56.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.02 143.15 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.63 30.69 6.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.11 0.964 . . . . 0.0 111.383 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.43 27.56 73.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.622 -0.543 . . . . 0.0 112.494 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.32 131.89 90.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.51 1.155 . . . . 0.0 108.299 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.0 Cg_endo -60.68 112.52 1.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.756 2.304 . . . . 0.0 109.564 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.54 175.33 9.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.638 1.208 . . . . 0.0 109.896 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.63 140.77 29.11 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 68.29 35.43 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.231 1.013 . . . . 0.0 109.795 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.89 58.23 37.42 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.218 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.79 -47.23 2.72 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.537 3.492 . . . . 0.0 114.315 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -47.53 -40.46 18.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.488 1.515 . . . . 0.0 112.026 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.51 -25.64 54.42 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.954 0.343 . . . . 0.0 111.464 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.444 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 93.2 m95 -92.05 -23.48 19.48 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.605 0.762 . . . . 0.0 111.734 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.71 -46.36 0.43 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.873 2.069 . . . . 0.0 114.155 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -101.07 -3.3 29.54 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -83.74 145.78 48.07 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.849 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.78 118.59 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.993 2.462 . . . . 0.0 111.65 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -62.26 -32.71 73.45 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 103.94 0.13 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.299 2.24 . . . . 0.0 111.507 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.09 -40.09 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.774 -0.579 . . . . 0.0 109.5 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.02 -26.0 34.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.576 1.55 . . . . 0.0 112.428 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.67 -53.42 4.53 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.22 -40.89 48.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.43 -31.52 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.668 -0.645 . . . . 0.0 110.38 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -65.85 -51.02 62.36 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.538 1.063 . . . . 0.0 108.296 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -49.97 -44.92 51.01 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.864 0.866 . . . . 0.0 109.98 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 m -64.54 -52.26 58.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.948 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.51 -41.57 98.92 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.025 -1.047 . . . . 0.0 111.867 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.6 -33.96 31.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.971 0.909 . . . . 0.0 112.283 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 151.56 17.45 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 55' ' ' MET . 28.0 tptp -155.18 136.99 14.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.73 -115.68 7.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.07 -0.46 33.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.456 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.2 ttp -65.43 127.0 92.58 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.891 0.769 . . . . 0.0 110.088 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.84 154.74 67.08 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.708 1.605 . . . . 0.0 109.247 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 121.64 15.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.14 -10.18 57.98 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -53.79 84.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.451 1.101 . . . . 0.0 113.751 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.1 -30.91 5.09 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.452 1.977 . . . . 0.0 111.77 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.49 80.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.022 0.911 . . . . 0.0 109.338 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -133.8 147.44 51.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -82.75 142.17 31.81 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -34.15 -44.69 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.422 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -46.02 91.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.421 1.01 . . . . 0.0 111.068 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -55.84 -56.34 21.76 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 122.128 0.966 . . . . 0.0 108.394 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.3 mt -48.6 -60.41 2.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.256 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 t -43.85 -56.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.692 1.197 . . . . 0.0 110.063 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.6 -40.74 84.12 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.206 -0.309 . . . . 0.0 111.246 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.69 -55.32 27.89 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -49.83 -47.09 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.138 1.375 . . . . 0.0 110.099 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -53.98 -51.2 64.66 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.714 0.688 . . . . 0.0 109.239 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.56 -49.72 75.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.0 mtp -49.11 -54.78 14.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.827 . . . . 0.0 109.525 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.79 -35.16 77.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.017 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.03 41.42 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.351 -0.843 . . . . 0.0 113.188 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.6 p -138.37 -3.75 1.71 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.475 1.51 . . . . 0.0 110.044 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.713 -1.613 . . . . 0.0 110.271 -174.648 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.98 -53.97 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.423 0.556 . . . . 0.0 109.871 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -66.46 -39.34 88.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.711 0.404 . . . . 0.0 111.36 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -76.87 -50.82 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -138.5 -14.42 1.27 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.19 -37.72 31.49 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.748 1.158 . . . . 0.0 111.786 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -69.02 150.54 47.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 122.359 -0.495 . . . . 0.0 110.303 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.32 114.57 7.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.468 1.107 . . . . 0.0 108.549 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.23 151.49 18.19 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.504 1.216 . . . . 0.0 111.408 -13.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.11 121.75 16.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.796 1.639 . . . . 0.0 109.883 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 m -54.03 -48.68 70.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.417 0.627 . . . . 0.0 110.273 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -41.17 -56.16 2.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.918 2.087 . . . . 0.0 112.373 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -45.54 -33.98 3.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.501 1.12 . . . . 0.0 113.038 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -98.16 -57.66 2.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.054 0.388 . . . . 0.0 110.322 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.08 -16.8 64.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.91 5.87 50.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.783 0.72 . . . . 0.0 109.974 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -128.71 -27.62 2.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.269 1.028 . . . . 0.0 112.232 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.42 27.07 62.17 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 140.05 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.96 29.22 5.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.091 0.956 . . . . 0.0 111.513 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.36 25.5 75.27 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.956 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.34 79.11 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.768 1.284 . . . . 0.0 108.977 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.83 110.36 1.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 N-CA-C 106.742 -2.061 . . . . 0.0 106.742 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -72.93 156.16 39.14 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.94 171.87 8.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.26 33.97 16.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.15 74.47 6.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.622 -170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -37.92 -50.94 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.359 3.373 . . . . 0.0 114.403 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.34 -43.23 15.81 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.194 1.397 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.05 -22.04 66.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.504 0.722 . . . . 0.0 111.95 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -109.37 -29.42 8.46 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.226 1.01 . . . . 0.0 112.584 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.36 -49.92 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.794 1.637 . . . . 0.0 113.11 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.66 -27.29 58.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.721 0.809 . . . . 0.0 113.166 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -79.32 155.41 76.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.492 0.717 . . . . 0.0 110.342 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.29 124.52 15.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.952 1.768 . . . . 0.0 110.284 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 p -66.16 -26.53 67.47 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.632 -0.668 . . . . 0.0 110.32 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -55.22 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.347 1.859 . . . . 0.0 112.395 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.1 t -47.85 -43.44 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.537 1.135 . . . . 0.0 109.689 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -52.7 -28.94 24.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.806 1.642 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.47 -48.63 6.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.388 1.075 . . . . 0.0 109.069 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -49.4 -41.56 39.86 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.603 0.361 . . . . 0.0 111.088 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.94 -35.29 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.566 -0.708 . . . . 0.0 111.019 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -64.25 -48.25 76.48 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.461 1.028 . . . . 0.0 108.466 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -53.64 -44.13 69.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -62.54 -49.35 75.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.575 0.35 . . . . 0.0 110.482 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.95 -46.74 89.51 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.267 -0.896 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 -33.33 74.96 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.664 0.786 . . . . 0.0 112.062 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.27 159.67 31.21 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.07 120.93 2.66 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.784 -0.833 . . . . 0.0 109.248 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.99 -119.97 20.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.51 -17.42 54.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.7 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -68.67 118.55 61.54 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 119.142 0.883 . . . . 0.0 109.424 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 158.69 53.38 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.266 1.978 . . . . 0.0 110.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.82 47.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -97.79 -11.55 23.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.215 1.006 . . . . 0.0 111.922 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -41.6 113.03 0.37 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.262 1.425 . . . . 0.0 112.153 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.43 -21.73 16.29 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.166 0.889 . . . . 0.0 113.089 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -85.17 -48.11 9.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.084 0.942 . . . . 0.0 109.179 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.57 141.14 48.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 173.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -83.9 140.8 31.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -29.83 -45.86 0.06 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 126.281 1.832 . . . . 0.0 111.46 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -60.16 -49.49 77.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.946 1.248 . . . . 0.0 111.526 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -53.71 -59.14 4.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.832 1.301 . . . . 0.0 108.995 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 62' ' ' ALA . 33.3 mt -49.11 -58.72 4.48 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 126.098 1.759 . . . . 0.0 110.491 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -47.76 -56.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.526 1.13 . . . . 0.0 109.657 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -55.41 -39.05 69.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.079 0.552 . . . . 0.0 111.508 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.94 68.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.744 0.418 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.86 -46.64 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.692 1.197 . . . . 0.0 109.007 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.9 -53.83 43.47 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.91 -50.62 71.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.305 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 ttp -50.45 -59.82 3.63 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.3 mp -55.05 -37.86 67.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.811 -0.556 . . . . 0.0 111.431 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -62.79 -6.69 3.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.661 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.1 p -89.13 -15.25 34.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.57 1.532 . . . . 0.0 111.227 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.193 -1.384 . . . . 0.0 110.289 -176.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 120.829 0.347 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.83 -57.95 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -57.42 -44.32 84.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.923 0.889 . . . . 0.0 112.195 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.6 mt -76.44 -49.68 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.199 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -136.63 -17.15 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.2 -33.73 39.3 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 119.965 1.257 . . . . 0.0 112.003 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -73.61 154.13 39.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.36 0.58 . . . . 0.0 110.98 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 110.37 5.86 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.66 1.184 . . . . 0.0 109.436 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.98 151.85 20.56 Favored 'Cis proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.1 1.071 . . . . 0.0 111.784 -11.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.74 123.1 19.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.153 1.381 . . . . 0.0 109.129 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.3 -47.66 75.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.849 0.356 . . . . 0.0 110.483 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 p -39.91 -56.26 1.84 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 126.432 1.893 . . . . 0.0 112.315 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -41.57 -36.32 0.9 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.31 1.444 . . . . 0.0 112.763 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.8 m -101.21 -57.01 2.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.51 0.324 . . . . 0.0 111.459 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -68.36 -33.33 74.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.57 -36.3 73.54 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -82.01 -27.3 33.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.234 1.013 . . . . 0.0 111.587 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.07 32.23 60.81 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.66 141.58 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.8 29.69 6.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.136 0.974 . . . . 0.0 111.424 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 24.54 77.0 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.876 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 134.55 79.56 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.745 1.273 . . . . 0.0 108.203 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.31 124.86 15.58 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.454 2.102 . . . . 0.0 108.75 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.56 172.68 8.34 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 160.3 23.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 35.7 51.67 0.71 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.891 1.676 . . . . 0.0 111.956 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.18 64.12 25.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.886 1.274 . . . . 0.0 110.143 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -39.85 -48.24 3.68 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.247 3.298 . . . . 0.0 114.63 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.08 -34.42 56.46 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.639 0.776 . . . . 0.0 112.213 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -66.96 -25.51 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.871 0.468 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -105.61 -29.61 10.02 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.451 1.1 . . . . 0.0 112.79 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.04 -50.17 0.89 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.687 1.595 . . . . 0.0 113.116 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.88 -19.74 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -80.54 157.32 72.58 Favored Pre-proline 0 CA--C 1.537 0.465 0 O-C-N 121.511 -0.743 . . . . 0.0 110.661 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.23 111.2 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.965 2.443 . . . . 0.0 111.436 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -60.89 -31.76 71.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.91 101.86 0.07 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.301 2.24 . . . . 0.0 111.421 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.62 -40.37 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.676 0.791 . . . . 0.0 110.038 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.11 -33.56 62.94 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.818 1.647 . . . . 0.0 112.029 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.04 -50.35 9.78 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.86 -44.03 39.39 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' A' ' 67' ' ' LEU . 5.0 m -57.22 -42.39 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 119.468 1.031 . . . . 0.0 110.449 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.69 -43.52 93.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -55.24 -40.8 71.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.2 0.455 . . . . 0.0 110.408 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -68.22 -55.46 12.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.321 0.649 . . . . 0.0 109.438 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 mt -54.9 -41.14 70.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.411 1.485 . . . . 0.0 111.816 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.69 -34.42 58.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.973 0.909 . . . . 0.0 111.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.58 162.99 35.28 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -167.04 130.04 1.79 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.04 -136.27 50.68 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.36 -25.91 68.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.427 -0.887 . . . . 0.0 111.73 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.2 ttp -64.56 117.42 37.66 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 119.265 0.939 . . . . 0.0 110.73 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.63 156.61 57.35 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.533 2.156 . . . . 0.0 109.538 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.79 114.58 3.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -72.4 -12.7 61.23 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.461 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -37.3 109.78 0.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.328 0.967 . . . . 0.0 112.859 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.77 -19.41 54.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.359 0.981 . . . . 0.0 114.533 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -78.63 -57.58 3.69 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.8 1.3 . . . . 0.0 111.321 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.47 141.28 49.3 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.56 1.144 . . . . 0.0 107.972 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.48 150.08 28.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -27.38 -52.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.807 2.043 . . . . 0.0 111.492 168.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.45 -48.26 80.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.698 0.681 . . . . 0.0 111.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -55.11 -57.15 12.91 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 122.138 0.97 . . . . 0.0 108.938 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HB3' HG12 ' A' ' 45' ' ' VAL . 97.0 mt -49.26 -58.83 4.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.722 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.86 -57.5 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 124.052 0.941 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -58.76 -40.91 85.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.118 0.417 . . . . 0.0 111.778 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.18 92.27 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.988 -0.445 . . . . 0.0 109.92 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.88 -46.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.765 0.826 . . . . 0.0 109.133 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -54.54 -48.95 71.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -57.02 -53.88 53.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.517 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 ptm -57.12 -49.71 75.06 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.922 0.783 . . . . 0.0 109.395 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.77 -36.13 73.91 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.07 -1.018 . . . . 0.0 111.399 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t -63.53 -5.65 4.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.121 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -92.2 -12.18 33.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.331 1.423 . . . . 0.0 110.701 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.64 -1.172 . . . . 0.0 110.99 -176.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.534 0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.03 -60.33 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.269 1.428 . . . . 0.0 110.173 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -56.59 -47.09 80.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.559 0.743 . . . . 0.0 111.439 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.5 -47.01 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.451 0.7 . . . . 0.0 111.793 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -9.69 0.33 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 -28.69 52.06 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.707 1.139 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -76.34 154.49 34.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.445 0.623 . . . . 0.0 110.41 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.23 104.96 4.09 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 108.122 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.46 146.66 32.95 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.499 1.214 . . . . 0.0 111.897 -3.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.92 120.89 14.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.751 1.621 . . . . 0.0 109.56 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 m -54.23 -49.71 68.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.166 0.508 . . . . 0.0 110.116 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -41.0 -55.56 2.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.256 1.822 . . . . 0.0 112.676 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -46.21 -33.72 3.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.241 1.016 . . . . 0.0 113.002 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.4 m -97.3 -56.67 2.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 117.888 0.313 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.9 -45.07 94.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.096 0.862 . . . . 0.0 109.708 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -76.98 -36.23 56.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.29 0.636 . . . . 0.0 111.948 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.89 38.76 5.68 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.84 130.55 17.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.5 31.47 7.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.503 1.121 . . . . 0.0 111.576 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.89 26.38 74.07 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.556 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.69 134.37 71.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.402 1.101 . . . . 0.0 108.573 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -62.6 112.02 1.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.694 2.263 . . . . 0.0 108.85 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -82.64 179.77 7.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.369 1.068 . . . . 0.0 112.35 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.21 159.55 28.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.96 52.19 0.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.984 1.714 . . . . 0.0 112.045 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.67 56.62 15.86 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.942 1.297 . . . . 0.0 111.026 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -41.32 -45.9 5.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.817 3.011 . . . . 0.0 114.967 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.04 -41.11 33.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.687 0.795 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.25 -16.34 61.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 112.336 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.55 -26.19 11.5 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 112.52 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.46 -51.52 0.62 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.437 1.895 . . . . 0.0 113.67 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.87 -17.46 40.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -78.64 151.74 77.36 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 121.462 -0.774 . . . . 0.0 110.639 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 115.28 2.11 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.071 2.514 . . . . 0.0 111.56 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -63.19 -32.23 73.58 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.124 -0.985 . . . . 0.0 110.11 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 104.99 0.17 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.479 2.312 . . . . 0.0 111.753 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -50.06 -43.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.525 0.73 . . . . 0.0 109.638 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -53.64 -30.91 45.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 112.482 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.88 -51.93 6.77 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.0 mt -50.16 -40.1 45.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.812 0.845 . . . . 0.0 112.829 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.63 -39.34 69.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 119.216 0.916 . . . . 0.0 110.375 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -66.19 -46.31 77.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.226 0.921 . . . . 0.0 108.71 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 m -52.64 -45.74 66.8 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.079 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 m -67.84 -48.69 65.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.749 0.42 . . . . 0.0 110.761 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.79 -40.85 96.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.101 -0.999 . . . . 0.0 111.098 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 -32.43 60.78 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.0 111.357 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.81 167.58 37.77 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -160.52 112.54 1.96 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.09 -111.25 2.69 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -35.09 74.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.113 0.565 . . . . 0.0 111.066 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.01 118.3 47.78 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.063 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.16 156.43 55.49 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.551 2.167 . . . . 0.0 109.933 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 115.96 5.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.811 0.444 . . . . 0.0 109.833 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.98 -7.95 57.51 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -55.87 83.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.295 1.038 . . . . 0.0 112.644 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.16 -34.59 2.29 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.76 1.647 . . . . 0.0 111.043 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -84.11 -38.88 20.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.184 0.994 . . . . 0.0 110.984 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -142.6 129.47 20.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.33 151.62 25.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -29.96 -49.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.69 1.996 . . . . 0.0 112.648 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.55 -35.84 81.21 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.363 0.983 . . . . 0.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.79 -59.01 4.71 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' ALA . 56.6 mt -46.33 -57.91 4.19 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.218 2.207 . . . . 0.0 110.652 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -36.32 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.533 1.533 . . . . 0.0 110.299 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -60.16 -42.4 94.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.554 0.342 . . . . 0.0 111.606 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -48.49 69.17 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.764 0.426 . . . . 0.0 110.01 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 mt -56.72 -50.21 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.61 1.164 . . . . 0.0 109.203 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -55.83 -52.01 65.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -54.05 -56.26 19.64 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.572 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptm -60.94 -45.14 95.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.869 0.759 . . . . 0.0 109.629 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.04 -36.84 70.96 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.45 -0.781 . . . . 0.0 110.974 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -63.34 -6.52 4.8 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.7 p -90.34 -8.7 50.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.221 1.373 . . . . 0.0 111.047 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.47 -1.729 . . . . 0.0 110.832 -176.645 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.447 -0.593 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -49.25 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.16 -48.51 78.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.903 0.481 . . . . 0.0 111.528 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.1 mt -73.47 -43.67 55.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.999 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.68 -8.24 0.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.75 -32.49 40.84 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.801 1.182 . . . . 0.0 111.321 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -73.47 155.45 39.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.449 0.624 . . . . 0.0 110.722 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.56 110.41 6.26 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.463 1.105 . . . . 0.0 108.966 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.93 153.28 16.95 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.323 1.151 . . . . 0.0 112.04 -11.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -70.24 114.35 8.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.625 1.57 . . . . 0.0 109.037 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.08 -48.4 22.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.662 0.785 . . . . 0.0 110.986 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -41.91 -50.57 4.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.608 1.963 . . . . 0.0 112.808 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -48.71 -32.47 8.48 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.316 0.647 . . . . 0.0 112.604 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.04 -54.99 2.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.903 0.481 . . . . 0.0 110.786 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.62 -32.79 71.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.04 -40.06 87.08 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.18 -28.58 42.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.573 0.749 . . . . 0.0 111.472 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.71 34.81 52.68 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.59 139.1 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.82 29.84 6.37 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.187 0.995 . . . . 0.0 111.593 -177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.62 24.25 76.5 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.764 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 135.31 82.99 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 118.554 1.177 . . . . 0.0 108.23 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.8 Cg_endo -59.77 123.73 13.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.567 2.178 . . . . 0.0 110.006 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.65 179.03 5.76 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.774 0.797 . . . . 0.0 112.117 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.94 161.84 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.17 54.16 0.74 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.125 1.77 . . . . 0.0 111.662 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 65.03 17.52 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.194 0.998 . . . . 0.0 110.124 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.06 -52.93 2.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.195 3.263 . . . . 0.0 114.381 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -49.48 -35.61 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.7 1.2 . . . . 0.0 112.615 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -65.45 -28.12 69.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.342 0.519 . . . . 0.0 111.245 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.3 m95 -102.32 -36.61 8.4 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.652 1.181 . . . . 0.0 112.43 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.68 -52.02 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.093 1.757 . . . . 0.0 113.082 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.79 -24.92 56.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.55 150.94 79.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 121.525 -0.734 . . . . 0.0 110.202 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.23 87.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.883 2.389 . . . . 0.0 108.207 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -24.59 22.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.366 1.866 . . . . 0.0 113.252 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.33 110.33 0.32 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.358 1.463 . . . . 0.0 110.46 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -47.93 -46.2 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.611 0.764 . . . . 0.0 110.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.91 -29.17 55.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.74 1.216 . . . . 0.0 113.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.67 -51.5 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.1 mt -49.79 -42.46 46.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.234 0.614 . . . . 0.0 112.188 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.25 -33.68 54.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.119 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.34 -49.06 70.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.895 1.225 . . . . 0.0 108.577 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -51.23 -46.47 62.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.57 0.748 . . . . 0.0 110.225 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -63.92 -49.94 70.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.83 -42.56 99.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.852 -1.155 . . . . 0.0 111.157 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.71 -30.53 61.57 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.074 0.95 . . . . 0.0 111.865 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.62 157.11 30.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.08 115.51 3.85 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.131 -0.629 . . . . 0.0 109.506 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.67 -116.58 9.17 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -24.88 58.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.923 0.489 . . . . 0.0 111.472 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.29 119.63 66.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.589 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.66 157.63 51.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.447 2.098 . . . . 0.0 110.276 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.76 120.18 11.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.333 0.653 . . . . 0.0 110.064 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.05 -12.46 58.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -45.48 112.55 0.47 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.73 0.812 . . . . 0.0 111.146 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 -32.39 7.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.457 1.027 . . . . 0.0 112.599 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -88.51 -49.99 6.57 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.404 1.102 . . . . 0.0 110.733 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.83 121.81 34.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -80.49 152.72 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -26.65 -51.57 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.859 2.064 . . . . 0.0 111.564 168.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -63.01 -43.48 98.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.237 0.926 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.27 -56.67 17.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 122.339 1.066 . . . . 0.0 108.369 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.4 mt -47.8 -57.52 5.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -37.81 -55.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.537 1.535 . . . . 0.0 110.135 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.1 mttp -55.65 -42.75 75.48 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.331 0.394 . . . . 0.0 111.628 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.92 -48.5 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 122.729 0.411 . . . . 0.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -37.49 84.07 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.638 1.108 . . . . 0.0 109.11 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -60.43 -47.38 86.34 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.055 0.843 . . . . 0.0 110.147 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.0 mtt -49.54 -65.65 0.53 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.1 mp -49.78 -40.56 41.84 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.067 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -61.24 -8.47 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.2 p -92.92 -11.53 33.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.521 1.51 . . . . 0.0 111.357 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.679 -177.432 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.971 0.415 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -57.86 -59.94 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.786 0.834 . . . . 0.0 109.683 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -54.18 -47.42 72.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 0.0 111.801 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.44 -47.55 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.421 0.688 . . . . 0.0 111.502 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -148.61 -15.51 0.32 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.05 3.48 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 120.099 1.318 . . . . 0.0 111.288 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -133.69 149.95 51.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.562 1.545 . . . . 0.0 107.627 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.26 6.08 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.421 1.088 . . . . 0.0 109.377 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.35 152.57 31.78 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.204 1.109 . . . . 0.0 111.808 -8.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.67 126.28 29.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.487 1.115 . . . . 0.0 109.888 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -59.52 -50.17 74.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -37.66 -61.04 0.65 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.024 2.13 . . . . 0.0 113.101 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -38.63 3.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.666 1.187 . . . . 0.0 112.3 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.6 m -91.11 -58.34 2.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 117.665 0.211 . . . . 0.0 110.985 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -67.54 -41.96 83.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.24 -34.6 78.02 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.654 -0.654 . . . . 0.0 110.607 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.15 -24.71 18.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.787 0.835 . . . . 0.0 112.678 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.77 35.12 13.8 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.101 0.858 . . . . 0.0 111.472 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -56.75 131.63 20.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.65 31.24 7.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 111.451 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.48 26.06 74.72 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.632 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.5 134.08 77.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.418 1.109 . . . . 0.0 108.568 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.84 120.29 8.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.479 2.119 . . . . 0.0 109.493 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -88.0 174.14 8.47 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.466 0.65 . . . . 0.0 111.923 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.94 165.56 24.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 45.82 41.23 7.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.549 1.14 . . . . 0.0 111.655 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.1 59.44 10.7 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -47.43 -34.41 19.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.421 3.414 . . . . 0.0 113.713 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -51.67 -38.87 56.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 110.7 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 15.7 4.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.453 0.701 . . . . 0.0 112.113 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -134.66 -40.28 0.79 Allowed 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.011 0.823 . . . . 0.0 111.485 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -40.41 -46.71 2.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.998 1.319 . . . . 0.0 112.505 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.58 -26.41 50.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 113.195 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -75.28 159.33 82.5 Favored Pre-proline 0 CA--C 1.534 0.347 0 O-C-N 121.576 -0.703 . . . . 0.0 109.976 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.07 121.43 10.05 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.839 1.693 . . . . 0.0 109.677 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -64.56 -39.16 93.24 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 109.634 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 m -50.72 102.51 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.142 1.777 . . . . 0.0 112.036 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.7 -40.19 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.302 1.041 . . . . 0.0 109.964 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.73 -35.29 65.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.798 0.839 . . . . 0.0 112.253 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -77.74 -48.2 17.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.01 -43.6 70.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 122.879 0.472 . . . . 0.0 111.612 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 49' ' ' LEU . 11.0 p -60.41 -44.29 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.911 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.15 -46.22 79.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.746 1.157 . . . . 0.0 109.652 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -54.23 -37.77 64.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.042 0.383 . . . . 0.0 111.392 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -68.0 -50.39 55.87 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.614 0.766 . . . . 0.0 109.357 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.02 -42.42 94.34 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 120.158 1.345 . . . . 0.0 111.472 177.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.11 -38.49 78.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.044 0.538 . . . . 0.0 111.981 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.98 155.32 29.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -155.48 135.17 12.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.66 -118.44 13.83 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.59 -3.32 46.59 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.694 0.798 . . . . 0.0 112.242 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.0 ttp -68.1 122.02 82.36 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 119.259 0.936 . . . . 0.0 110.595 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -59.29 153.12 55.49 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.034 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 112.62 6.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -71.32 -3.07 18.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.26 110.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 0.0 111.072 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.82 -11.27 62.54 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.345 0.974 . . . . 0.0 114.596 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -76.1 -47.94 22.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.044 1.422 . . . . 0.0 109.906 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -139.64 156.23 46.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.56 140.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 45' ' ' VAL . 26.3 ttt180 -32.83 -44.21 0.1 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.577 1.951 . . . . 0.0 112.436 172.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.78 -47.8 83.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.811 1.187 . . . . 0.0 111.197 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.4 -56.77 16.96 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 122.902 1.334 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 62' ' ' ALA . 79.3 mt -48.08 -57.27 6.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.857 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.19 -53.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.892 1.277 . . . . 0.0 109.919 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -57.87 -38.91 76.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.498 0.319 . . . . 0.0 111.258 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.13 81.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.915 -0.49 . . . . 0.0 109.896 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.4 mt -66.7 -52.61 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.613 0.765 . . . . 0.0 109.991 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.29 -39.7 76.27 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.234 0.924 . . . . 0.0 109.086 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.14 -52.73 64.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.128 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 ptm -54.44 -43.35 71.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.611 0.641 . . . . 0.0 109.346 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.6 mt -65.15 -35.18 80.28 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.476 -0.765 . . . . 0.0 110.763 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 m -74.83 37.93 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.009 -1.057 . . . . 0.0 112.634 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -148.59 24.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.582 1.153 . . . . 0.0 109.918 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.252 1.232 0 CA-C-O 116.148 -1.882 . . . . 0.0 107.132 -177.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.23 -57.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.842 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -57.64 -52.15 66.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.888 0.475 . . . . 0.0 111.623 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.57 -46.34 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.557 -173.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.57 38.81 0.33 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.298 0.954 . . . . 0.0 113.04 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.75 40.33 1.09 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -137.25 156.94 47.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.436 1.895 . . . . 0.0 107.841 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 106.64 5.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.861 0.864 . . . . 0.0 108.904 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.83 152.85 24.35 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 120.378 1.171 . . . . 0.0 112.142 -7.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.38 123.79 19.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.93 -51.0 62.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.912 0.885 . . . . 0.0 111.439 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 p -40.88 -54.41 2.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.447 1.899 . . . . 0.0 111.872 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.91 -38.74 1.64 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.61 1.164 . . . . 0.0 113.094 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -98.43 -57.15 2.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.964 0.347 . . . . 0.0 111.49 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -73.71 -19.47 60.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -172.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.37 -53.57 18.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.535 1.061 . . . . 0.0 108.989 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -79.98 -31.13 39.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.467 0.307 . . . . 0.0 111.052 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.5 42.85 5.69 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.26 142.81 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.37 28.62 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.066 0.947 . . . . 0.0 111.502 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.95 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.715 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 134.14 87.54 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.738 1.269 . . . . 0.0 108.377 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.78 115.76 3.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.701 2.267 . . . . 0.0 108.258 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -86.16 179.08 7.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.901 0.857 . . . . 0.0 113.215 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.23 159.94 22.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 34.61 52.38 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.545 1.538 . . . . 0.0 112.565 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.9 61.96 31.28 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.317 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.73 -46.76 6.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.045 3.163 . . . . 0.0 114.683 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -49.88 -39.99 41.37 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.822 1.249 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.67 -15.45 61.7 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.873 0.869 . . . . 0.0 112.463 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -110.94 -25.57 9.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.508 1.123 . . . . 0.0 112.294 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.05 -46.26 0.48 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.921 2.088 . . . . 0.0 114.433 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.39 -5.57 32.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -81.48 154.96 71.63 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 121.483 -0.761 . . . . 0.0 110.211 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.52 115.6 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.072 2.515 . . . . 0.0 111.462 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -60.72 -34.03 73.77 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.26 99.96 0.07 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.754 2.022 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.2 t -53.33 -38.44 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.616 -0.677 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.29 -26.2 51.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 112.415 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.13 -50.81 5.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -49.02 -41.01 33.23 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.694 0.798 . . . . 0.0 112.117 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.85 -30.4 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.533 -0.729 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.29 -49.62 68.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -50.99 -46.29 61.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.619 0.767 . . . . 0.0 109.796 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 m -60.68 -51.9 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.05 -45.46 93.46 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.245 -0.909 . . . . 0.0 111.456 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 -32.37 63.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.833 0.853 . . . . 0.0 112.369 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 161.01 27.8 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.45 115.1 2.49 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.962 -0.728 . . . . 0.0 109.163 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.62 -116.95 9.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.25 -24.58 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.371 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.38 121.18 75.57 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.946 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 165.26 29.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.711 2.274 . . . . 0.0 109.781 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.78 134.03 48.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.79 -14.77 20.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.125 0.97 . . . . 0.0 112.326 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.77 101.02 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.269 1.028 . . . . 0.0 112.539 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.48 -37.28 3.77 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.009 1.29 . . . . 0.0 111.481 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -77.02 -36.45 56.25 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-N 117.756 0.778 . . . . 0.0 109.913 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.8 149.11 50.87 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.29 130.45 37.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -31.69 -44.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.029 2.132 . . . . 0.0 112.818 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.46 -48.95 75.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.684 1.129 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.76 -47.93 81.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.012 0.925 . . . . 0.0 108.797 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 62' ' ' ALA . 37.4 mt -51.86 -55.91 17.2 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.037 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -45.2 -57.81 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.211 1.004 . . . . 0.0 109.271 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -56.36 -39.8 73.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 118.483 0.583 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.97 95.01 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.722 -0.611 . . . . 0.0 110.073 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.73 -47.76 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -53.47 -52.46 59.44 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -54.56 -52.15 63.01 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.56 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.19 -50.57 64.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.13 -30.12 71.2 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.945 -0.472 . . . . 0.0 110.997 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.1 m -74.25 40.59 0.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.073 -1.017 . . . . 0.0 112.782 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.5 p -135.43 -10.92 2.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 109.827 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.7 -1.619 . . . . 0.0 110.25 -177.839 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.29 -50.51 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.408 1.083 . . . . 0.0 110.483 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -68.29 -46.39 70.46 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.694 0.397 . . . . 0.0 110.398 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.85 -42.11 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.958 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 32.47 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.24 14.85 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.096 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 p -97.89 168.8 10.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.644 0.778 . . . . 0.0 111.497 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.5 115.53 25.18 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.0 1.32 . . . . 0.0 107.822 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.51 169.66 35.43 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.609 1.253 . . . . 0.0 110.057 -10.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -78.25 149.68 33.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 m -61.87 -44.54 96.6 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -50.56 -47.41 57.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.086 1.355 . . . . 0.0 111.651 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -42.64 -40.35 2.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.782 0.719 . . . . 0.0 112.167 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.8 m -98.29 -57.93 2.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.468 0.175 . . . . 0.0 111.188 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -62.2 -40.38 95.89 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.47 -29.77 64.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.138 0.426 . . . . 0.0 111.107 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -115.61 17.73 16.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.708 0.803 . . . . 0.0 111.681 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 48.09 40.23 20.55 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 123.899 0.761 . . . . 0.0 113.8 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.94 135.49 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.082 -0.658 . . . . 0.0 109.381 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 31.31 7.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.756 1.223 . . . . 0.0 111.806 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.55 23.38 77.09 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.667 -0.518 . . . . 0.0 112.628 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.73 140.77 75.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.222 1.011 . . . . 0.0 108.791 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -58.27 119.44 6.69 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.489 2.126 . . . . 0.0 107.81 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.52 167.58 19.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.832 1.301 . . . . 0.0 111.26 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mp -77.01 162.26 27.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.873 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.23 53.56 1.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.939 1.296 . . . . 0.0 110.601 -176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.92 64.93 11.75 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.006 1.723 . . . . 0.0 109.427 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -39.12 -55.46 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.588 3.525 . . . . 0.0 114.358 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -44.71 -45.44 9.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.01 1.324 . . . . 0.0 112.281 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -53.76 -39.16 65.12 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.463 0.705 . . . . 0.0 110.762 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -92.88 -29.9 15.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.846 0.859 . . . . 0.0 111.169 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.19 98.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 109.617 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.99 -41.75 97.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 110.326 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -76.36 164.15 61.69 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.683 1.193 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.0 88.66 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 107.539 -1.754 . . . . 0.0 107.539 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -51.98 -22.2 3.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.293 1.437 . . . . 0.0 112.463 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -56.77 108.3 0.48 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.287 1.035 . . . . 0.0 110.453 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.53 -46.33 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.736 1.214 . . . . 0.0 110.047 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.89 -36.83 3.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.201 2.2 . . . . 0.0 112.335 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.21 -52.74 4.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.298 1.039 . . . . 0.0 109.182 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -44.72 -45.93 10.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.773 0.829 . . . . 0.0 112.634 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 67' ' ' LEU . 19.2 m -61.35 -34.31 60.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 O-C-N 121.348 -0.845 . . . . 0.0 111.585 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.2 -47.18 71.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 m -53.5 -46.26 69.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.06 0.544 . . . . 0.0 110.051 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -62.17 -52.02 65.48 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.982 0.513 . . . . 0.0 111.345 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -40.48 84.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.56 -0.713 . . . . 0.0 109.698 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.43 76.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.145 0.578 . . . . 0.0 111.617 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.52 154.99 24.26 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -158.38 125.64 4.98 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.45 -137.67 49.15 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.06 -16.88 64.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.624 -0.788 . . . . 0.0 111.997 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.42 117.28 51.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.652 1.115 . . . . 0.0 109.801 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.32 155.06 64.91 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.441 2.094 . . . . 0.0 109.951 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.11 133.58 55.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.65 6.58 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.951 0.9 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -40.69 108.84 0.1 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.243 1.817 . . . . 0.0 112.688 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.28 -20.27 5.02 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.529 0.585 . . . . 0.0 113.021 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -76.37 -44.3 36.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.72 25.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.73 152.61 33.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -23.16 -52.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.219 2.208 . . . . 0.0 111.692 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -60.54 -56.68 18.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.351 0.523 . . . . 0.0 111.811 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.67 -49.89 69.53 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.411 1.084 . . . . 0.0 109.687 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' HB3' HG12 ' A' ' 45' ' ' VAL . 71.0 mt -52.13 -58.6 6.09 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.291 1.436 . . . . 0.0 110.057 178.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.16 -58.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.753 0.821 . . . . 0.0 109.509 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.08 -26.1 62.12 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.17 1.388 . . . . 0.0 113.068 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 -59.39 2.72 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 mt -51.17 -44.53 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.643 1.177 . . . . 0.0 111.459 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -53.86 -37.85 64.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.865 0.757 . . . . 0.0 110.708 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.95 -44.21 90.16 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.996 0.816 . . . . 0.0 109.664 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.7 mtp -53.55 -58.39 7.34 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.3 -36.79 66.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.688 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -62.49 -10.36 11.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.388 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -89.01 -9.02 52.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.462 1.483 . . . . 0.0 111.158 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 116.554 -1.689 . . . . 0.0 111.033 -176.288 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -50.65 -60.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.51 -52.56 63.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.241 1.416 . . . . 0.0 112.027 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.1 mt -67.84 -47.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.015 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.04 11.94 0.3 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.49 34.55 5.52 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.629 1.104 . . . . 0.0 111.591 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.21 157.64 45.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.486 1.514 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.58 107.75 9.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.207 1.003 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.16 159.17 68.99 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.172 1.097 . . . . 0.0 110.053 -8.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -68.13 118.55 11.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.06 1.344 . . . . 0.0 110.429 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 m -46.49 -48.56 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.981 0.913 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -45.46 -44.73 12.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.979 1.712 . . . . 0.0 112.547 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -53.2 -26.16 16.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.016 0.526 . . . . 0.0 112.255 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -104.02 -58.26 1.91 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.097 0.408 . . . . 0.0 109.941 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -66.89 -35.52 80.2 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.67 -41.67 75.18 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.102 0.865 . . . . 0.0 109.834 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -80.57 -28.7 37.11 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.097 0.559 . . . . 0.0 111.513 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.27 38.71 7.64 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.04 125.53 11.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.51 32.77 9.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.031 0.932 . . . . 0.0 111.128 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.41 76.95 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.941 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.45 113.33 5.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.57 1.185 . . . . 0.0 108.591 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 66.0 Cg_exo -36.32 116.79 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 125.014 3.809 . . . . 0.0 114.493 -175.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.39 173.69 10.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 111.701 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.58 159.52 32.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 49.43 29.71 2.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.848 0.859 . . . . 0.0 112.119 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.07 61.53 33.43 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.989 0.916 . . . . 0.0 110.954 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -45.35 -42.35 17.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.72 2.947 . . . . 0.0 112.799 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.36 -39.67 32.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 112.198 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -67.97 -25.07 65.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.125 0.57 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 86.3 m95 -105.52 -23.37 12.81 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.453 1.101 . . . . 0.0 112.893 -173.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -51.25 0.72 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.548 1.939 . . . . 0.0 113.582 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.71 -22.08 43.79 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -77.14 151.69 81.61 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.875 0.87 . . . . 0.0 110.206 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.3 125.28 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.675 1.583 . . . . 0.0 108.768 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -62.58 -29.63 70.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.797 -0.565 . . . . 0.0 110.35 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -56.01 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.986 1.714 . . . . 0.0 111.945 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.09 -42.39 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.304 1.441 . . . . 0.0 109.411 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.41 -37.43 11.42 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.386 2.274 . . . . 0.0 112.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.42 -50.86 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.1 mt -47.71 -42.16 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.88 0.872 . . . . 0.0 112.401 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.94 -32.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.16 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.58 -50.03 68.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -51.26 -47.33 62.49 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.599 0.76 . . . . 0.0 109.908 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.1 m -61.73 -49.54 75.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.74 -45.52 93.59 Favored 'General case' 0 N--CA 1.458 -0.063 0 O-C-N 121.132 -0.98 . . . . 0.0 111.143 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.51 -31.16 65.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.944 0.897 . . . . 0.0 112.289 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.01 160.71 29.53 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -155.51 108.86 2.77 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.964 -0.727 . . . . 0.0 109.327 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.01 -113.95 5.88 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.69 -30.19 64.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.688 0.395 . . . . 0.0 111.0 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.1 ttp -63.62 120.35 62.12 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.913 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -74.57 156.66 44.94 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.843 2.362 . . . . 0.0 110.01 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.71 135.1 56.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -100.46 -13.89 18.51 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 113.329 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.97 102.79 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 112.148 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.38 -38.97 3.03 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.126 1.346 . . . . 0.0 111.537 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -76.79 -39.74 50.47 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 117.68 0.74 . . . . 0.0 110.112 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.5 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.43 130.54 30.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -79.72 146.72 32.23 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -27.93 -53.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.377 170.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -41.94 96.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.134 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.49 -59.58 5.17 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 62' ' ' ALA . 76.4 mt -46.07 -58.66 3.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.495 1.518 . . . . 0.0 111.004 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -39.34 -51.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.812 2.045 . . . . 0.0 111.149 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -58.06 -45.57 86.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.703 0.801 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -47.69 78.15 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.407 -0.808 . . . . 0.0 109.826 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.9 mt -56.98 -52.16 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.876 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.41 -39.98 92.72 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.984 -1.072 . . . . 0.0 109.28 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -57.08 -49.5 75.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.418 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.5 mtt -48.13 -63.62 1.02 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.17 0.986 . . . . 0.0 108.649 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mp -49.83 -41.55 45.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.669 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -62.17 -10.94 11.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 p -90.1 -13.38 35.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.195 1.362 . . . . 0.0 111.207 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.6 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.566 -174.826 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.14 -57.07 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.795 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -56.18 -50.46 71.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.307 1.043 . . . . 0.0 111.651 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.72 -46.9 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.859 -174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.11 36.38 0.29 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 33.17 2.28 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.845 0.748 . . . . 0.0 111.252 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 155.68 48.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.687 1.995 . . . . 0.0 107.189 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.01 108.23 18.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -62.52 166.07 37.45 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.216 1.113 . . . . 0.0 109.341 -11.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -67.54 136.09 53.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 m -49.7 -43.48 47.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 0.687 . . . . 0.0 109.426 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.8 p -47.21 -41.44 18.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.066 1.347 . . . . 0.0 112.561 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.1 m -46.2 -39.16 9.31 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.3 0.64 . . . . 0.0 111.316 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -102.96 -52.33 3.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -72.0 -27.5 62.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.39 -47.08 62.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -68.17 -41.87 80.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.203 1.001 . . . . 0.0 110.367 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 34.81 13.08 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.57 145.55 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.68 32.24 6.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.22 1.008 . . . . 0.0 111.576 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.58 24.43 73.9 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.34 126.62 75.01 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.818 1.309 . . . . 0.0 108.038 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.85 116.51 3.4 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.628 2.219 . . . . 0.0 108.294 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -74.68 -149.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.516 1.127 . . . . 0.0 111.433 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.63 145.78 51.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.496 1.518 . . . . 0.0 107.474 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' OXT' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 49.14 48.13 21.23 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -168.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.42 51.78 1.41 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.341 2.257 . . . . 0.0 111.499 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -47.89 -34.97 23.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.336 3.358 . . . . 0.0 113.807 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -50.33 -40.13 48.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.917 1.287 . . . . 0.0 110.966 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.22 -5.67 52.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 73.2 m95 -107.96 -44.99 4.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.58 46.03 26.05 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.913 0.863 . . . . 0.0 110.236 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.86 53.11 2.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 0.0 112.216 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -57.04 157.29 11.55 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.33 101.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.73 2.286 . . . . 0.0 111.073 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -59.05 -23.69 62.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.457 1.103 . . . . 0.0 111.989 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -55.07 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.71 1.604 . . . . 0.0 110.721 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -43.59 -41.47 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.279 1.431 . . . . 0.0 109.709 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -42.5 -38.02 1.81 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.345 2.258 . . . . 0.0 112.609 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.13 -50.53 5.79 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.636 0.774 . . . . 0.0 110.17 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -51.09 -40.48 58.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.426 0.69 . . . . 0.0 111.844 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.02 -34.41 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.695 -0.628 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.09 -44.04 81.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.7 m -54.46 -44.99 73.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -67.01 -45.09 78.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.027 0.531 . . . . 0.0 110.889 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 O-C-N 121.259 -0.9 . . . . 0.0 110.68 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.39 51.79 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.416 1.086 . . . . 0.0 112.697 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 161.47 30.57 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -161.57 117.79 2.13 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.083 -0.657 . . . . 0.0 109.319 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.41 -118.06 13.51 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.34 -25.34 51.0 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.209 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.5 ttp -62.22 118.68 42.21 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.178 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.46 160.52 46.58 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.509 2.139 . . . . 0.0 110.065 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.8 116.73 8.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -82.49 -7.46 59.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.676 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -55.9 88.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.931 0.892 . . . . 0.0 112.091 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 -41.9 1.44 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 110.572 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -75.55 -35.27 60.72 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.393 0.677 . . . . 0.0 110.384 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -143.72 130.72 20.54 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.57 149.66 32.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -32.04 -47.49 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.124 1.77 . . . . 0.0 111.494 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.68 -49.16 77.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.838 0.745 . . . . 0.0 111.66 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.43 -56.34 22.38 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 122.556 1.169 . . . . 0.0 108.791 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 80.5 mt -48.68 -60.71 2.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -43.29 -51.72 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.887 1.675 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -59.21 -33.87 71.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.395 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.14 13.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.781 0.719 . . . . 0.0 109.39 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.4 mt -54.76 -45.77 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.121 0.968 . . . . 0.0 111.279 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.66 -41.39 90.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.036 1.289 . . . . 0.0 110.599 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.63 -54.14 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 ttm -45.75 -55.06 6.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.121 1.368 . . . . 0.0 109.782 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.85 -26.62 58.86 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.239 0.615 . . . . 0.0 112.535 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -79.83 10.49 4.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.83 0.741 . . . . 0.0 112.372 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -177.05 54.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.736 ' OXT' HD12 ' A' ' 78' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.73 -55.46 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.24 -48.44 78.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.167 0.987 . . . . 0.0 111.872 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.24 -51.73 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.538 -175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.85 8.69 0.37 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -173.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.39 4.42 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 119.795 1.18 . . . . 0.0 111.253 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -137.82 156.18 48.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.793 1.637 . . . . 0.0 108.155 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.0 110.79 10.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.761 0.825 . . . . 0.0 110.596 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.09 160.77 15.66 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 CA-C-N 119.915 1.005 . . . . 0.0 111.851 -15.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -70.34 114.9 8.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.355 1.062 . . . . 0.0 108.982 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -44.54 -48.27 10.23 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.19 0.996 . . . . 0.0 111.324 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -43.76 -47.93 8.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.374 1.87 . . . . 0.0 112.184 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -49.46 -34.6 17.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 m -96.7 -58.03 2.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.63 0.252 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -67.4 -36.36 81.14 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.26 -41.37 85.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -30.13 56.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.667 0.787 . . . . 0.0 110.572 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.47 40.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.4 136.95 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.02 28.21 5.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.119 0.968 . . . . 0.0 111.471 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 24.76 76.67 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.955 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.76 132.96 47.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.903 1.351 . . . . 0.0 108.422 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -49.48 104.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.958 3.106 . . . . 0.0 110.917 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -75.24 176.23 7.57 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.514 1.149 . . . . 0.0 109.666 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.4 142.43 27.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.14 33.11 12.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.348 0.659 . . . . 0.0 109.461 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.66 55.87 17.72 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.641 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -37.09 -46.57 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.486 3.457 . . . . 0.0 114.242 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -41.47 -45.36 3.17 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.046 1.338 . . . . 0.0 112.738 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -76.84 -25.05 52.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.679 0.672 . . . . 0.0 112.261 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -91.08 -23.49 20.3 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.411 0.684 . . . . 0.0 111.429 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -47.39 0.53 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.32 2.248 . . . . 0.0 114.355 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -91.33 -14.37 30.87 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.428 0.691 . . . . 0.0 112.852 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -78.59 147.58 71.72 Favored Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 123.839 0.856 . . . . 0.0 109.731 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.15 110.3 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.844 1.696 . . . . 0.0 108.573 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.34 -27.47 47.4 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.135 0.574 . . . . 0.0 112.007 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 109.24 0.36 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.844 1.658 . . . . 0.0 111.482 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.3 t -51.95 -42.07 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.86 -20.96 40.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -93.64 -53.85 3.88 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.8 mt -47.65 -41.72 22.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.62 0.768 . . . . 0.0 112.163 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.71 -37.1 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 121.688 -0.632 . . . . 0.0 110.41 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.7 -48.26 75.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -52.3 -46.04 65.78 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.811 0.845 . . . . 0.0 110.4 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -67.82 -40.97 83.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.058 0.543 . . . . 0.0 111.216 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.09 -56.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.37 61.72 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.567 1.147 . . . . 0.0 112.354 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.75 152.76 25.24 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -151.76 142.75 23.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -90.37 0.08 OUTLIER Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.98 16.0 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.365 1.466 . . . . 0.0 112.058 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.0 mtm -67.89 134.78 92.02 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 119.29 0.95 . . . . 0.0 110.847 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -75.42 78.42 3.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.99 2.46 . . . . 0.0 108.784 177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -10.08 106.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 128.315 2.646 . . . . 0.0 112.403 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -76.21 -6.65 52.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -47.29 114.83 0.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.557 0.743 . . . . 0.0 111.272 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.12 -26.95 21.45 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.206 0.908 . . . . 0.0 112.717 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -90.28 -52.44 4.93 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.514 1.157 . . . . 0.0 110.349 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -112.57 133.79 54.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.06 147.42 31.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -32.23 -45.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.38 1.872 . . . . 0.0 111.546 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.0 -47.18 84.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.211 0.914 . . . . 0.0 111.667 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.94 -58.65 7.23 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 122.577 1.179 . . . . 0.0 108.738 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.8 mt -47.14 -57.37 5.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.406 1.882 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -46.24 -57.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 124.844 1.257 . . . . 0.0 109.713 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.78 -43.65 81.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.802 0.274 . . . . 0.0 111.441 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.25 72.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.6 mt -57.75 -47.33 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.251 1.42 . . . . 0.0 109.463 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.26 -51.69 65.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -55.95 -50.8 69.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.361 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 79.0 mtp -51.84 -53.46 40.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.291 0.636 . . . . 0.0 109.987 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.78 -37.44 73.71 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.577 0.751 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.3 m -72.67 41.18 0.09 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.3 p -135.64 -16.35 1.78 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.36 1.864 . . . . 0.0 110.014 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.033 -178.126 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 119.969 -0.062 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.33 -59.59 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.296 1.438 . . . . 0.0 109.197 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.32 -51.42 70.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 111.349 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 mm -65.73 -46.02 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.816 0.446 . . . . 0.0 111.065 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.13 44.03 0.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.97 36.67 1.21 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.44 157.27 46.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.732 2.013 . . . . 0.0 107.47 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.92 113.49 6.41 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.802 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.73 152.5 19.71 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 CA-C-N 120.321 1.15 . . . . 0.0 111.065 -13.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.31 125.17 24.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.609 1.164 . . . . 0.0 109.775 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -54.74 -51.05 66.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -39.54 -61.06 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.509 1.923 . . . . 0.0 112.214 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.0 m -41.51 -39.62 1.6 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.441 1.497 . . . . 0.0 113.387 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.46 -56.82 2.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.045 0.45 . . . . 0.0 110.923 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -60.67 -41.18 94.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -48.31 -40.93 26.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.668 0.787 . . . . 0.0 112.109 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -116.43 26.08 10.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.991 0.516 . . . . 0.0 111.863 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.21 43.08 18.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.566 0.603 . . . . 0.0 113.54 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.25 136.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.69 30.36 8.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.549 1.14 . . . . 0.0 111.676 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.0 23.49 74.45 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.6 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.01 142.91 84.88 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 118.459 1.129 . . . . 0.0 109.323 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -59.78 121.53 9.98 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 106.848 -2.02 . . . . 0.0 106.848 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.47 176.76 7.23 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.671 1.7 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.5 tp -97.46 140.46 31.87 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.518 -2.128 . . . . 0.0 107.525 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 64.59 35.98 8.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.353 0.661 . . . . 0.0 109.459 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.62 71.26 81.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.467 1.107 . . . . 0.0 111.233 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -41.0 -57.99 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 124.344 3.363 . . . . 0.0 114.456 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -43.53 -47.92 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.154 1.381 . . . . 0.0 112.164 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.26 -39.56 63.96 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 110.972 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -91.03 -29.89 17.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.318 0.647 . . . . 0.0 111.073 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.0 97.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.359 0.663 . . . . 0.0 109.396 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.56 -41.86 96.05 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -77.29 164.68 57.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.586 1.154 . . . . 0.0 111.085 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -67.82 89.8 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 N-CA-C 107.632 -1.719 . . . . 0.0 107.632 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -21.96 7.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.702 1.201 . . . . 0.0 112.322 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.94 109.5 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.434 1.893 . . . . 0.0 110.932 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.13 -44.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.251 1.02 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.41 -29.09 61.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.009 1.724 . . . . 0.0 112.606 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.81 -55.35 3.89 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 mt -45.61 -44.36 13.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.833 1.253 . . . . 0.0 112.994 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.89 -37.33 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 O-C-N 121.722 -0.611 . . . . 0.0 110.607 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -65.58 -47.24 76.44 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.192 0.905 . . . . 0.0 108.905 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -53.04 -46.6 68.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.386 0.674 . . . . 0.0 110.259 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -64.13 -46.45 84.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.002 0.521 . . . . 0.0 110.356 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -57.06 -54.41 47.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.791 -0.568 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.48 64.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.22 1.008 . . . . 0.0 112.988 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.61 160.27 33.12 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -157.68 126.36 5.65 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.861 -0.787 . . . . 0.0 109.05 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.0 -120.68 22.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.92 -14.44 54.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.746 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.2 ttp -71.69 118.23 64.67 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 119.166 0.894 . . . . 0.0 108.716 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.23 160.56 48.56 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.389 2.059 . . . . 0.0 110.611 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.2 133.14 53.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -101.65 -11.55 19.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.615 0.766 . . . . 0.0 111.363 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -46.37 117.53 1.62 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.364 1.065 . . . . 0.0 111.558 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.52 -25.0 11.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.267 0.937 . . . . 0.0 112.34 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -86.35 -47.38 9.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.86 0.83 . . . . 0.0 108.865 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -110.08 142.24 41.82 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -80.36 131.03 35.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -28.35 -49.88 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.205 2.202 . . . . 0.0 112.659 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -61.28 -49.04 78.66 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.82 -0.55 . . . . 0.0 111.225 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.35 86.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 123.93 0.892 . . . . 0.0 109.141 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 62' ' ' ALA . 40.9 mt -51.63 -58.99 4.79 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.64 -54.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.158 1.383 . . . . 0.0 110.484 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -56.72 -45.55 81.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.139 0.427 . . . . 0.0 111.333 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.34 98.43 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.798 -0.564 . . . . 0.0 110.179 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.2 -55.85 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 109.268 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -59.26 -38.86 81.12 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.643 1.11 . . . . 0.0 109.773 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.53 -49.81 76.34 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttp -53.52 -54.27 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.7 mt -56.36 -38.97 72.13 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.619 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -61.42 -6.5 2.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.882 1.219 . . . . 0.0 113.951 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.0 p -86.75 -5.28 59.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.725 1.148 . . . . 0.0 110.684 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.224 -1.37 . . . . 0.0 110.688 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.39 -55.95 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 109.6 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -56.66 -50.48 71.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.914 0.886 . . . . 0.0 111.607 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.46 -45.29 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.131 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.91 36.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.04 33.0 2.22 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.98 157.45 46.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.271 2.228 . . . . 0.0 106.408 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.49 113.19 6.62 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.755 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -50.08 153.73 7.78 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 120.522 1.222 . . . . 0.0 110.752 -15.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.2 p -67.01 144.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -56.25 -38.89 71.75 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.076 0.853 . . . . 0.0 108.906 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -56.28 -23.27 35.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 112.8 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.0 m -57.48 -28.32 63.3 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.488 1.04 . . . . 0.0 110.628 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.2 m -122.54 -52.31 1.93 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -70.09 -20.35 63.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.21 -52.12 65.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.818 0.735 . . . . 0.0 109.869 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -91.47 -22.95 20.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 111.339 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 42.15 8.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.35 146.6 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.51 30.17 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.081 0.952 . . . . 0.0 111.417 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.4 79.96 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.027 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.95 135.61 90.31 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.873 1.336 . . . . 0.0 108.272 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 39.3 Cg_endo -60.31 128.83 27.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.459 2.106 . . . . 0.0 109.915 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -89.02 171.44 9.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.264 1.031 . . . . 0.0 112.937 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.48 156.42 36.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.891 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 52.32 36.56 20.03 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.889 0.876 . . . . 0.0 111.265 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.37 65.52 68.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.842 -175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -39.74 -47.03 3.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 124.324 3.349 . . . . 0.0 114.428 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -51.11 -39.59 56.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.865 1.266 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.49 -21.88 66.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.426 0.69 . . . . 0.0 111.733 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.402 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.1 m95 -108.58 -30.73 8.09 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.4 1.08 . . . . 0.0 112.903 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.49 -50.79 1.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.728 1.611 . . . . 0.0 113.048 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 -24.51 50.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.92 143.85 67.14 Favored Pre-proline 0 CA--C 1.535 0.381 0 O-C-N 121.529 -0.732 . . . . 0.0 110.276 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.79 96.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.675 2.25 . . . . 0.0 108.895 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -55.78 -26.88 48.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.815 1.246 . . . . 0.0 112.943 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 m -50.0 104.28 0.07 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.827 1.651 . . . . 0.0 111.48 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.14 -44.07 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.167 1.387 . . . . 0.0 111.54 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.18 -31.86 67.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.183 0.593 . . . . 0.0 112.045 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -81.63 -48.01 12.28 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.67 -41.3 61.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 m -59.94 -34.18 55.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.87 -48.48 81.6 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.531 1.514 . . . . 0.0 109.057 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.69 -42.21 67.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.795 0.838 . . . . 0.0 111.205 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -70.39 -44.57 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.384 0.673 . . . . 0.0 110.334 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -64.18 -50.66 67.25 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 124.795 1.238 . . . . 0.0 109.751 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.12 61.59 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.201 1.001 . . . . 0.0 112.214 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 158.53 31.48 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -157.15 118.34 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.013 -0.698 . . . . 0.0 109.482 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 -117.77 12.28 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.39 -23.13 54.06 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.744 0.418 . . . . 0.0 111.461 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.4 ttp -66.41 118.49 54.04 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.466 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.34 154.38 56.13 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.481 2.121 . . . . 0.0 109.954 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.84 123.36 17.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.827 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -92.28 -11.9 33.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.967 0.803 . . . . 0.0 111.756 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -44.26 116.01 0.94 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.062 0.945 . . . . 0.0 112.037 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -26.36 9.73 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.154 0.883 . . . . 0.0 112.4 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -83.91 -44.75 13.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -111.23 146.39 37.04 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.55 132.58 34.91 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -31.96 -44.32 0.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.141 1.776 . . . . 0.0 112.64 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -57.02 -44.62 83.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.819 1.191 . . . . 0.0 111.645 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -54.03 -57.76 9.84 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.17 0.986 . . . . 0.0 108.531 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.7 mt -50.34 -59.12 4.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.545 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.0 t -43.38 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.445 1.098 . . . . 0.0 109.687 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.36 -40.79 97.58 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 122.11 -0.369 . . . . 0.0 111.815 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.88 97.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.0 mt -65.22 -48.13 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.105 0.962 . . . . 0.0 109.111 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.27 -51.73 51.5 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.59 -53.73 54.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.107 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ptm -55.66 -47.34 76.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.507 0.594 . . . . 0.0 109.68 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.73 -38.52 90.83 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.832 -0.542 . . . . 0.0 110.449 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.2 m -61.71 -5.4 1.92 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.5 p -88.38 -16.31 33.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.207 1.367 . . . . 0.0 111.19 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.657 -1.64 . . . . 0.0 110.601 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mt -58.23 -49.23 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -68.05 -44.72 75.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.967 0.907 . . . . 0.0 110.743 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.9 mt -69.32 -50.97 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.311 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.2 -9.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -171.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.2 -40.18 42.37 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 119.847 1.203 . . . . 0.0 111.131 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -72.57 158.59 35.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.76 111.88 5.78 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.439 1.096 . . . . 0.0 109.792 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 151.34 12.04 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.249 1.125 . . . . 0.0 110.86 -13.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 p -66.3 134.35 52.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -51.4 -41.41 60.7 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.63 0.729 . . . . 0.0 109.334 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 p -50.93 -37.05 41.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 112.814 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -44.75 -39.28 5.07 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.876 0.762 . . . . 0.0 111.407 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.7 m -107.04 -56.31 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.514 0.725 . . . . 0.0 110.439 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -62.7 -26.83 68.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.46 -1.52 53.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.69 0.677 . . . . 0.0 111.026 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -127.35 -17.69 4.64 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.925 0.89 . . . . 0.0 111.65 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.56 27.17 65.9 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.597 -0.69 . . . . 0.0 111.488 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.87 141.64 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.38 27.76 5.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 111.575 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.47 74.49 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.65 129.2 80.91 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.595 1.198 . . . . 0.0 108.311 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -64.54 123.56 11.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.24 1.96 . . . . 0.0 109.269 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.29 -179.53 5.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.703 0.763 . . . . 0.0 113.053 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.67 159.57 34.16 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 48.06 32.34 2.89 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 112.356 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.16 61.85 59.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.406 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -37.24 -49.11 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.456 3.437 . . . . 0.0 114.01 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.02 -43.78 9.52 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.245 1.418 . . . . 0.0 111.951 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.01 -27.0 67.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.747 0.819 . . . . 0.0 111.924 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -103.62 -18.55 14.69 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.689 1.195 . . . . 0.0 112.429 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -47.05 0.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.407 1.883 . . . . 0.0 114.013 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -9.84 30.16 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -81.27 131.57 58.54 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.62 109.79 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.959 2.439 . . . . 0.0 110.888 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -56.59 -26.26 54.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.764 0.826 . . . . 0.0 112.446 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -49.43 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.31 1.844 . . . . 0.0 111.618 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.0 t -48.47 -38.56 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.67 0.788 . . . . 0.0 110.715 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.01 -44.01 82.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.844 0.458 . . . . 0.0 111.383 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -68.71 -45.96 70.19 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -56.51 -44.51 80.83 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.448 0.299 . . . . 0.0 111.553 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.12 -36.26 77.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -52.66 64.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.951 0.796 . . . . 0.0 109.798 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 m -51.17 -43.26 61.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.908 0.883 . . . . 0.0 111.106 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -69.12 -44.0 73.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.933 0.493 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.26 -52.5 64.47 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.337 -0.852 . . . . 0.0 109.947 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.5 77.91 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.677 0.791 . . . . 0.0 110.905 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.26 87.14 1.43 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.542 1.068 . . . . 0.0 110.867 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -77.79 146.58 35.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.652 1.181 . . . . 0.0 109.82 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.83 -110.85 3.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.24 9.49 28.01 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.684 1.193 . . . . 0.0 111.903 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 42.8 mtm -71.25 137.83 84.25 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 119.172 0.896 . . . . 0.0 111.627 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -63.52 139.37 69.98 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 N-CA-C 106.961 -1.977 . . . . 0.0 106.961 170.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 114.99 3.67 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -80.82 -8.74 59.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.846 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -51.7 112.15 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.94 0.791 . . . . 0.0 110.609 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.83 -26.14 10.25 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.945 0.783 . . . . 0.0 111.916 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -74.6 -44.19 51.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.435 1.094 . . . . 0.0 108.696 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.512 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -126.99 157.11 40.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.79 1.236 . . . . 0.0 108.338 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.47 129.82 35.35 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -33.6 -43.81 0.13 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.532 1.933 . . . . 0.0 112.046 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.86 -48.82 80.05 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.401 1.0 . . . . 0.0 111.522 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -48.81 78.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.8 mt -50.8 -58.73 5.22 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.127 0.489 . . . . 0.0 109.693 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 t -47.36 -56.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.796 1.239 . . . . 0.0 109.823 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -57.12 -40.38 76.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.873 0.469 . . . . 0.0 111.72 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.62 93.98 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.36 -46.77 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -53.78 -51.42 63.48 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -54.17 -54.11 44.27 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.306 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.3 mtp -49.33 -60.03 3.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.407 0.683 . . . . 0.0 109.394 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.13 -39.15 66.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.54 0.736 . . . . 0.0 111.678 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -62.82 -9.01 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.321 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -88.8 -14.1 37.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.17 1.35 . . . . 0.0 110.932 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.122 -175.631 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 121.526 0.679 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.91 -53.37 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -59.52 -45.43 91.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.905 0.32 . . . . 0.0 111.67 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.76 -52.82 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.375 0.67 . . . . 0.0 112.035 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -133.23 -18.6 2.26 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.4 -32.34 43.03 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.916 1.235 . . . . 0.0 112.845 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 150.45 45.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.583 0.692 . . . . 0.0 110.687 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.73 111.89 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.021 1.329 . . . . 0.0 109.46 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.46 159.14 59.07 Favored 'Cis proline' 0 N--CA 1.453 -0.877 0 CA-C-N 120.343 1.158 . . . . 0.0 109.402 -12.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -65.22 121.04 13.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.394 1.477 . . . . 0.0 110.31 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 m -51.17 -47.02 62.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.011 0.524 . . . . 0.0 110.552 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.8 p -41.44 -52.42 3.6 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 126.582 1.953 . . . . 0.0 112.226 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -47.62 -33.54 6.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.249 1.02 . . . . 0.0 112.552 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.4 m -99.28 -56.0 2.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.049 0.386 . . . . 0.0 110.838 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -70.65 -38.81 73.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.36 -42.98 78.4 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.359 0.981 . . . . 0.0 108.994 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -38.91 79.36 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.212 1.005 . . . . 0.0 111.509 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.54 34.91 8.19 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.813 1.197 . . . . 0.0 110.362 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.98 129.46 17.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 30.96 6.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.481 1.112 . . . . 0.0 111.361 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.99 24.2 77.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.357 -0.69 . . . . 0.0 112.823 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.36 131.58 52.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.548 1.174 . . . . 0.0 108.33 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -60.09 116.95 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.077 2.518 . . . . 0.0 109.226 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -84.54 173.61 10.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.184 0.994 . . . . 0.0 112.631 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.09 161.68 29.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 m120 49.36 32.03 4.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.549 0.74 . . . . 0.0 112.622 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 59.56 38.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.373 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.55 -45.89 3.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.055 3.17 . . . . 0.0 114.468 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.59 -44.48 18.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.663 1.185 . . . . 0.0 111.519 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.09 -18.15 61.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.171 0.989 . . . . 0.0 112.327 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -104.89 -18.22 14.28 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.32 1.048 . . . . 0.0 112.153 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -46.2 0.59 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.391 1.876 . . . . 0.0 114.243 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.41 -14.91 27.9 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.616 0.767 . . . . 0.0 112.991 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -81.31 124.93 80.22 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.09 0.956 . . . . 0.0 109.373 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.31 120.99 8.17 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.571 2.181 . . . . 0.0 111.473 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.73 -31.05 57.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.827 0.851 . . . . 0.0 112.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -48.72 102.17 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.568 1.947 . . . . 0.0 112.855 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.1 -43.06 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.689 0.796 . . . . 0.0 109.404 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.24 -27.35 63.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.444 1.098 . . . . 0.0 112.769 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.85 -54.06 4.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.2 mt -52.92 -40.69 63.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.793 0.837 . . . . 0.0 112.521 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.97 -28.51 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.505 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.74 -47.39 83.77 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.681 1.128 . . . . 0.0 108.867 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 m -54.22 -48.22 71.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 109.892 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -62.02 -45.24 94.46 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.921 -0.487 . . . . 0.0 111.066 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -62.14 -53.44 55.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.197 0.599 . . . . 0.0 110.98 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.89 -21.42 47.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.067 1.347 . . . . 0.0 112.976 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.4 162.63 35.32 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -159.91 114.33 2.29 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -115.33 7.14 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -27.96 60.4 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.49 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 33.3 ttp -62.98 115.45 17.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.688 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.21 130.27 10.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.032 2.488 . . . . 0.0 110.415 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.62 114.69 0.55 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.434 1.494 . . . . 0.0 111.848 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -83.14 -13.63 55.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.483 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -48.99 112.85 0.68 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.89 0.768 . . . . 0.0 111.258 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.08 -32.92 6.56 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.278 0.942 . . . . 0.0 111.651 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -79.15 -44.66 21.51 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.98 135.83 49.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 172.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.54 146.88 32.39 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -32.2 -47.89 0.16 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.234 1.814 . . . . 0.0 111.31 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.1 -46.02 92.31 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.673 0.67 . . . . 0.0 111.371 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.24 -58.15 9.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 122.08 0.943 . . . . 0.0 108.632 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 62' ' ' ALA . 72.5 mt -45.87 -58.03 3.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.543 1.537 . . . . 0.0 110.416 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.5 t -41.63 -51.67 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 125.158 1.383 . . . . 0.0 111.214 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -57.85 -38.84 76.4 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.572 0.169 . . . . 0.0 111.416 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -48.15 56.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -58.1 -49.08 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.315 0.646 . . . . 0.0 111.114 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.5 -44.19 97.53 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.022 -1.049 . . . . 0.0 109.629 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -56.95 -53.51 57.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.286 0.494 . . . . 0.0 109.68 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttm -48.2 -53.57 16.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.806 1.642 . . . . 0.0 109.907 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.34 -37.87 84.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.233 -0.292 . . . . 0.0 110.489 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 m -73.4 39.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.3 p -129.43 -12.93 4.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.932 1.693 . . . . 0.0 109.559 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.352 -1.308 . . . . 0.0 110.304 -176.282 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.655 0.264 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.3 mt -52.7 -61.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.427 . . . . 0.0 110.0 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.77 -48.82 77.01 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.288 0.635 . . . . 0.0 112.035 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.69 -44.02 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.153 -173.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 6.14 0.19 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -174.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.04 40.04 2.65 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.827 1.194 . . . . 0.0 111.323 -177.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.94 49.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.527 1.531 . . . . 0.0 108.585 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.25 109.19 8.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.738 0.815 . . . . 0.0 110.158 -177.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.73 156.69 32.27 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.802 0.965 . . . . 0.0 111.462 -12.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.1 123.17 19.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.915 1.286 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -55.79 -49.3 73.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.497 0.665 . . . . 0.0 111.011 -177.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -41.52 -51.1 3.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.282 1.833 . . . . 0.0 112.543 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -44.44 -35.34 2.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.793 1.237 . . . . 0.0 113.345 -178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -102.23 -52.73 3.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.747 0.419 . . . . 0.0 110.729 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -67.12 -25.63 66.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.39 -44.32 97.35 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.3 0.954 . . . . 0.0 110.249 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -30.19 16.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 111.152 178.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.94 40.1 5.01 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -176.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.7 136.22 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.411 0.685 . . . . 0.0 109.36 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.54 32.25 8.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.776 1.23 . . . . 0.0 112.097 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.76 81.18 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.267 -0.74 . . . . 0.0 113.278 178.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.23 130.38 68.7 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.529 1.165 . . . . 0.0 108.61 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.88 119.17 6.16 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.004 1.802 . . . . 0.0 109.402 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.4 158.52 33.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.526 0.679 . . . . 0.0 110.323 -176.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.92 151.08 25.28 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 64.45 34.82 9.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.985 0.914 . . . . 0.0 109.363 -174.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.8 68.46 43.43 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.765 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -38.65 -52.39 2.07 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.291 3.328 . . . . 0.0 114.275 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -48.52 -39.99 25.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.322 1.449 . . . . 0.0 111.812 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.04 -30.85 71.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.808 0.443 . . . . 0.0 111.339 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -101.25 -27.67 13.07 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.783 0.833 . . . . 0.0 112.359 -175.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.55 0.92 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.05 1.74 . . . . 0.0 112.98 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.54 -21.31 38.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -177.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -81.36 156.5 71.24 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.872 0.869 . . . . 0.0 110.268 -177.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.89 109.85 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.008 2.472 . . . . 0.0 111.646 176.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.96 -31.52 72.64 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.031 -1.043 . . . . 0.0 110.423 177.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 105.17 0.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 111.68 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -48.77 -39.7 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.001 0.92 . . . . 0.0 110.599 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.55 -39.67 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.841 1.256 . . . . 0.0 111.648 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.29 -44.18 47.0 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.1 mt -56.11 -49.73 73.06 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.8 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 11.8 p -59.41 -44.69 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.64 -44.69 85.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.322 0.964 . . . . 0.0 109.596 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -59.58 -33.2 71.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.084 176.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.7 m -72.38 -45.31 60.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.5 0.72 . . . . 0.0 109.751 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 45' ' ' VAL . 2.2 mm? -54.65 -52.31 62.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.86 1.209 . . . . 0.0 110.517 174.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.83 82.26 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.358 0.411 . . . . 0.0 111.762 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.21 124.21 3.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -101.12 139.87 36.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.133 1.373 . . . . 0.0 107.748 178.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.06 3.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.39 8.61 43.52 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.088 0.955 . . . . 0.0 112.723 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 37.1 mtm -68.06 148.25 98.37 Favored Pre-proline 0 C--N 1.338 0.091 0 CA-C-N 119.756 1.162 . . . . 0.0 112.261 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.32 140.92 25.16 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 N-CA-C 106.345 -2.214 . . . . 0.0 106.345 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.85 117.66 6.17 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.0 4.07 10.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -50.67 104.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 111.713 177.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -8.43 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.186 0.898 . . . . 0.0 113.214 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -78.75 -42.21 28.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.84 144.91 47.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 174.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.47 143.21 32.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -27.72 -50.31 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.4 2.28 . . . . 0.0 112.295 169.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.77 -49.88 71.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.539 0.609 . . . . 0.0 111.095 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.93 -50.65 72.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.35 1.06 . . . . 0.0 109.377 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 62' ' ' ALA . 44.2 mt -51.29 -56.84 10.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.251 1.42 . . . . 0.0 109.986 177.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.3 t -52.44 -53.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.175 0.59 . . . . 0.0 109.98 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -56.33 -36.83 69.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.672 0.789 . . . . 0.0 111.529 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.72 38.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.16 -48.72 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 -176.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.28 -42.17 90.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.208 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -61.14 -48.85 79.71 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.557 0.617 . . . . 0.0 110.152 177.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.0 mtp -48.02 -58.05 4.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.016 0.912 . . . . 0.0 109.149 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -56.28 -40.05 73.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.086 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 m -74.17 42.36 0.15 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.122 -0.987 . . . . 0.0 113.583 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.6 p -132.01 -15.62 2.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.441 1.496 . . . . 0.0 109.949 171.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.927 -177.33 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 120.897 0.379 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.38 -57.11 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.162 0.985 . . . . 0.0 110.06 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -54.9 -44.68 74.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -74.48 -51.71 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.956 -173.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -16.55 1.83 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.47 -35.06 43.01 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.654 1.115 . . . . 0.0 112.112 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -70.25 147.05 50.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.026 0.53 . . . . 0.0 110.791 -178.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.69 109.81 13.3 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.704 1.202 . . . . 0.0 109.349 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.35 161.25 58.86 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.257 1.128 . . . . 0.0 110.371 -8.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -70.73 125.48 26.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.26 1.424 . . . . 0.0 110.934 -177.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 m -56.18 -48.74 75.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.268 0.556 . . . . 0.0 110.389 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 p -38.44 -58.51 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.941 2.096 . . . . 0.0 111.888 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -41.1 -38.74 1.1 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.947 1.299 . . . . 0.0 113.113 -179.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.6 m -94.64 -56.07 2.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.828 0.285 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -65.65 -33.48 75.98 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.01 -39.88 83.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 119.752 1.16 . . . . 0.0 109.471 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -76.79 -29.99 56.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.174 0.99 . . . . 0.0 110.712 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.65 31.47 62.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -174.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -58.42 140.2 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.27 29.31 6.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.084 0.954 . . . . 0.0 111.414 -177.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 25.62 74.47 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.391 -0.672 . . . . 0.0 112.651 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 135.36 82.75 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.621 1.21 . . . . 0.0 108.622 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 57.7 Cg_endo -62.9 122.64 11.0 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.389 2.06 . . . . 0.0 109.178 -179.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -87.77 177.48 7.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.795 0.807 . . . . 0.0 111.955 -174.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.15 161.14 31.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.23 51.05 0.78 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.573 1.549 . . . . 0.0 111.786 177.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.41 63.13 27.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.8 1.24 . . . . 0.0 110.275 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -40.19 -46.42 4.14 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.245 3.297 . . . . 0.0 114.523 -176.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.31 -39.93 33.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.92 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.41 -24.45 66.47 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.53 0.732 . . . . 0.0 111.781 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 86.4 m95 -106.6 -22.3 12.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.69 1.196 . . . . 0.0 112.938 -174.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.33 -49.53 0.71 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.935 1.694 . . . . 0.0 113.484 -178.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.1 -15.27 36.67 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -81.63 153.36 70.59 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 118.944 0.793 . . . . 0.0 110.512 -177.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.24 125.92 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.455 176.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -67.37 -40.18 85.74 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -49.42 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.006 2.522 . . . . 0.0 112.19 178.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.62 -40.1 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.025 0.93 . . . . 0.0 109.703 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.5 -25.39 36.81 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.324 1.85 . . . . 0.0 112.373 176.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -89.83 -51.23 5.6 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -51.35 -38.99 56.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.728 0.811 . . . . 0.0 112.158 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.76 -33.62 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.542 -0.724 . . . . 0.0 110.286 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -65.1 -49.45 69.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.598 1.09 . . . . 0.0 108.424 177.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -53.04 -43.69 66.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.047 0.539 . . . . 0.0 109.831 177.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -67.96 -46.23 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.028 -0.42 . . . . 0.0 110.716 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.7 mt -56.18 -51.09 69.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.673 -0.642 . . . . 0.0 110.083 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.79 -27.81 55.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.598 1.159 . . . . 0.0 113.134 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 163.3 32.92 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -175.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -157.42 119.63 3.82 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.916 -0.755 . . . . 0.0 109.499 -178.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.01 -118.06 12.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.8 -21.21 55.46 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.743 0.417 . . . . 0.0 111.588 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.6 ttp -68.54 118.66 62.19 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 118.942 0.792 . . . . 0.0 110.075 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.57 158.37 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.486 2.124 . . . . 0.0 109.798 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.24 148.01 38.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.92 -9.18 12.47 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.417 1.087 . . . . 0.0 113.14 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -48.13 110.24 0.31 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.084 0.856 . . . . 0.0 111.796 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.38 -31.33 7.55 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.084 0.849 . . . . 0.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -74.33 -46.46 40.72 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.01 129.02 46.05 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.84 145.16 38.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -30.69 -46.19 0.08 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 127.113 2.165 . . . . 0.0 112.153 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.6 -54.51 44.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.475 1.034 . . . . 0.0 110.89 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -51.06 71.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.433 1.093 . . . . 0.0 109.382 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 62' ' ' ALA . 29.9 mt -50.4 -56.96 9.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.522 1.129 . . . . 0.0 110.103 177.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 t -50.42 -57.35 2.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 123.877 0.871 . . . . 0.0 109.395 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -54.2 -43.58 70.86 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.965 0.348 . . . . 0.0 111.525 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.06 95.36 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.07 -51.52 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.395 0.678 . . . . 0.0 109.886 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.45 -40.11 85.78 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 120.107 1.321 . . . . 0.0 108.878 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -57.2 -51.66 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.464 0.574 . . . . 0.0 109.945 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ptm -56.55 -46.61 80.58 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -35.12 79.45 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.658 -0.651 . . . . 0.0 111.204 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.8 m -62.81 -7.59 5.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.4 p -88.03 -12.19 45.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.867 1.212 . . . . 0.0 111.0 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 116.486 -1.721 . . . . 0.0 111.095 -175.92 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.21 -59.34 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.806 1.243 . . . . 0.0 110.292 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -58.29 -52.1 67.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.06 0.944 . . . . 0.0 111.893 -178.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.16 -44.21 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.292 -173.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 44.03 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 37.16 0.98 Allowed Glycine 0 CA--C 1.524 0.63 0 O-C-N 121.638 -0.664 . . . . 0.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -138.87 157.53 45.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.464 1.906 . . . . 0.0 107.587 177.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.39 107.92 8.64 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.562 0.745 . . . . 0.0 109.755 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.25 158.2 27.59 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 CA-C-N 119.991 1.033 . . . . 0.0 112.314 -9.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.98 117.31 11.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.278 1.031 . . . . 0.0 109.116 178.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m -46.43 -48.62 18.82 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.709 0.804 . . . . 0.0 111.194 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 p -44.45 -46.91 9.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.026 1.73 . . . . 0.0 112.586 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -50.91 -30.29 14.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 m -101.66 -56.37 2.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.895 0.316 . . . . 0.0 110.786 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -71.7 -23.14 61.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -172.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.48 -50.78 62.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.52 1.054 . . . . 0.0 109.024 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.89 35.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.6 44.53 9.3 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -175.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 144.2 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.28 29.91 7.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.965 0.906 . . . . 0.0 111.319 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.87 20.41 79.83 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.109 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 137.61 84.49 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.931 1.365 . . . . 0.0 108.416 176.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.54 128.49 26.1 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.561 2.174 . . . . 0.0 109.842 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.9 174.73 7.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.291 1.043 . . . . 0.0 113.347 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.08 166.71 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 113.497 -1.683 . . . . 0.0 106.853 169.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 48.03 34.77 4.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.558 0.743 . . . . 0.0 111.111 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.34 61.16 16.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.794 -173.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -40.09 -49.22 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.846 3.031 . . . . 0.0 113.729 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.83 -40.93 10.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.396 1.478 . . . . 0.0 112.264 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -63.41 -26.04 68.56 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.859 0.464 . . . . 0.0 111.661 -177.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -106.26 -28.68 10.27 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.257 1.423 . . . . 0.0 111.961 -175.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.24 -46.15 0.5 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.754 2.022 . . . . 0.0 112.86 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.63 30.64 6.11 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.215 1.006 . . . . 0.0 112.888 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -134.69 159.36 72.46 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.549 1.14 . . . . 0.0 108.414 176.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.32 109.15 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.154 2.569 . . . . 0.0 112.77 -177.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.46 -32.4 73.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.211 -0.931 . . . . 0.0 110.276 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -55.92 103.94 0.12 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.479 1.912 . . . . 0.0 112.399 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.42 -39.43 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.72 -24.74 51.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.36 1.064 . . . . 0.0 112.569 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.21 -55.08 3.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.6 mt -47.82 -40.7 21.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.79 -35.02 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.933 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.45 -48.41 75.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.398 0.999 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m -54.98 -41.64 71.44 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.825 0.45 . . . . 0.0 109.799 176.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -67.64 -45.0 76.6 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.07 -0.394 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.09 -51.82 68.12 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.649 -0.657 . . . . 0.0 109.981 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.68 61.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.748 1.219 . . . . 0.0 113.432 -176.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.24 163.9 24.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -158.8 114.76 2.64 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.977 -0.719 . . . . 0.0 109.323 -177.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.42 -116.22 8.19 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.33 -26.17 60.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.88 0.472 . . . . 0.0 111.554 178.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.5 ttp -67.97 116.54 39.67 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.75 -177.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.57 166.2 24.76 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.23 1.953 . . . . 0.0 110.738 176.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.35 133.55 49.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -101.25 -10.43 20.36 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 113.256 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -49.25 110.09 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.549 0.613 . . . . 0.0 111.013 179.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.01 -37.44 3.77 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.725 1.155 . . . . 0.0 111.666 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -43.99 42.91 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 117.994 0.897 . . . . 0.0 108.836 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.84 132.14 41.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 176.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -79.23 150.84 31.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -32.18 -46.65 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.328 1.851 . . . . 0.0 111.715 171.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.81 -44.92 88.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.434 1.015 . . . . 0.0 111.329 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.9 -56.31 23.83 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 122.459 1.123 . . . . 0.0 108.619 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.9 mt -47.63 -58.97 3.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.164 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 t -45.17 -57.39 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 124.515 1.126 . . . . 0.0 109.636 177.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -58.68 -41.71 86.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.349 0.522 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.31 93.84 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.718 -0.614 . . . . 0.0 110.02 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.41 -48.01 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -53.19 -51.47 61.98 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.7 -52.7 61.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.222 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -51.31 -56.52 12.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.69 -37.6 68.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.837 -0.539 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -67.92 -3.34 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 113.461 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.2 p -110.76 15.26 22.02 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 120.19 1.359 . . . . 0.0 111.242 177.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.62 179.613 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 CA-C-O 121.656 0.741 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.67 -57.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.041 0.937 . . . . 0.0 109.747 -177.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -58.03 -46.92 84.53 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.8 mt -71.82 -49.07 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.787 -172.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.92 -13.74 0.93 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -170.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.33 -30.73 36.23 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 120.079 1.309 . . . . 0.0 112.66 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -75.21 156.59 35.64 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.715 0.757 . . . . 0.0 111.161 -177.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.34 111.49 7.1 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.913 1.285 . . . . 0.0 108.954 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.26 150.77 55.54 Favored 'Cis proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.435 1.191 . . . . 0.0 109.645 -11.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.93 118.62 7.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.227 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 m -48.26 -47.04 36.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.476 0.655 . . . . 0.0 110.535 -178.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -45.09 -43.81 9.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.983 1.713 . . . . 0.0 112.557 178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -51.13 -33.06 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.595 0.634 . . . . 0.0 112.025 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.3 m -100.05 -53.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.424 0.289 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.85 -29.3 66.51 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -173.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.73 -42.44 86.27 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.344 0.974 . . . . 0.0 108.855 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -81.76 -27.6 33.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.289 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.84 46.42 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.45 144.69 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 O-C-N 122.09 -0.653 . . . . 0.0 109.289 -176.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.03 29.71 6.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.205 1.002 . . . . 0.0 111.534 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.3 23.04 78.59 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.306 -0.719 . . . . 0.0 112.799 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 131.0 84.37 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.761 1.28 . . . . 0.0 108.028 176.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -61.65 121.72 9.97 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.218 1.945 . . . . 0.0 109.041 -178.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.02 163.2 24.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.435 1.112 . . . . 0.0 111.121 -176.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.79 161.97 29.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 171.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.18 55.0 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 111.19 -178.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.71 64.66 7.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.759 0.824 . . . . 0.0 111.093 -178.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -36.86 -49.79 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.776 3.651 . . . . 0.0 114.523 -178.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.98 -43.01 13.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.128 1.371 . . . . 0.0 111.794 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.7 -24.51 66.26 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.037 0.935 . . . . 0.0 112.008 -177.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -106.01 -19.39 13.74 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.443 1.097 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.43 -49.14 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.524 1.53 . . . . 0.0 113.342 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.11 -14.75 33.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -82.03 131.63 56.16 Favored Pre-proline 0 CA--C 1.535 0.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.856 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.51 113.71 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.913 2.408 . . . . 0.0 111.198 177.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -58.05 -26.56 62.65 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.461 0.704 . . . . 0.0 112.395 -178.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -50.71 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 111.662 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.8 t -41.36 -53.03 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 124.592 1.157 . . . . 0.0 110.619 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.89 -43.26 69.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -61.52 -47.11 87.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.118 0.872 . . . . 0.0 108.782 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.6 -37.51 81.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.383 178.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 71' ' ' ILE . 77.2 t -62.03 -43.57 97.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.81 -46.22 91.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.406 1.003 . . . . 0.0 109.724 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -54.3 -45.54 72.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.345 . . . . 0.0 110.454 176.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -67.37 -45.31 76.65 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.922 -0.486 . . . . 0.0 110.531 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 mt -54.11 -54.93 32.73 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.726 -0.609 . . . . 0.0 109.712 177.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.54 74.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.926 0.891 . . . . 0.0 112.613 -177.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.95 164.29 31.28 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 -174.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -157.58 108.79 2.28 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.761 -0.846 . . . . 0.0 109.569 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.54 -115.08 6.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.47 -29.47 64.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.725 0.41 . . . . 0.0 111.052 178.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.4 ttp -65.16 120.05 64.06 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.421 -178.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.78 160.15 44.13 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.442 2.095 . . . . 0.0 110.354 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.68 52.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.6 -10.83 16.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.961 0.904 . . . . 0.0 111.019 177.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.0 123.81 7.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.0 111.037 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -16.36 33.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.186 0.898 . . . . 0.0 112.739 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 mtm105 -97.25 -48.84 5.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.225 1.013 . . . . 0.0 109.223 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 127.14 42.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 65' ' ' GLU . 13.5 m-20 -76.69 83.01 3.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 3.2 -47.91 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 1 C-N-CA 132.522 4.329 . . . . 0.0 117.221 -178.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 63' ' ' ASP . 42.9 mt-10 -50.07 -37.43 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.961 1.255 . . . . 0.0 109.265 173.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.02 -57.68 8.02 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.687 1.995 . . . . 0.0 109.818 173.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.66 -56.41 22.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.749 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.403 HG22 HG21 ' A' ' 45' ' ' VAL . 53.1 t -43.85 -57.14 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.199 1.0 . . . . 0.0 109.725 176.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -56.51 -48.9 76.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.242 1.017 . . . . 0.0 111.094 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.46 77.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.682 -0.636 . . . . 0.0 109.362 -178.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 45' ' ' VAL . 73.2 mt -62.37 -46.78 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.546 1.138 . . . . 0.0 110.846 -176.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.57 -38.17 80.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.937 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -62.14 -51.35 68.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.173 176.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.0 mtp -44.45 -58.9 2.69 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.088 0.947 . . . . 0.0 109.632 177.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.3 -41.05 83.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.275 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -74.58 42.55 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.4 p -136.46 -13.2 1.78 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.437 1.495 . . . . 0.0 110.096 171.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.268 -178.408 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.84 0.353 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.46 -55.04 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -59.28 -48.53 81.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.249 0.62 . . . . 0.0 111.843 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.95 -49.39 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.175 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -135.06 -17.68 1.84 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.49 -34.52 35.58 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.978 1.263 . . . . 0.0 112.543 -176.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -70.25 151.18 45.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 117.361 0.58 . . . . 0.0 110.424 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.09 111.22 7.89 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 109.133 -179.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 151.97 24.81 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.306 1.145 . . . . 0.0 111.449 -11.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.91 124.98 23.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.805 1.242 . . . . 0.0 109.309 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.15 -45.36 79.65 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.393 0.616 . . . . 0.0 110.57 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 p -42.27 -50.51 4.95 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.567 1.947 . . . . 0.0 112.067 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.16 -37.35 2.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.292 1.037 . . . . 0.0 112.5 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -102.14 -57.37 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.637 0.375 . . . . 0.0 111.046 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -67.95 -20.96 65.11 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.43 -2.65 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.164 0.893 . . . . 0.0 110.882 176.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -135.44 -9.6 2.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 35.5 51.88 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.694 -0.629 . . . . 0.0 111.908 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.1 133.47 20.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.31 31.1 8.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.304 1.041 . . . . 0.0 111.462 -177.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.33 23.18 78.36 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.622 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 139.75 80.24 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.334 1.067 . . . . 0.0 109.251 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.8 Cg_endo -61.09 126.08 18.63 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.373 2.049 . . . . 0.0 109.308 179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.66 171.72 9.46 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.182 0.992 . . . . 0.0 112.491 -175.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 161.08 19.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.929 172.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 37.7 52.96 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.136 1.374 . . . . 0.0 112.009 176.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.04 65.41 11.94 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.796 0.838 . . . . 0.0 110.469 -177.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.67 -51.56 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.781 3.654 . . . . 0.0 114.695 -177.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.16 -39.34 28.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.136 0.974 . . . . 0.0 112.196 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.91 -26.8 68.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.564 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 80.5 m95 -104.24 -29.86 10.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.026 1.33 . . . . 0.0 112.269 -175.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.02 -41.51 1.69 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.957 1.703 . . . . 0.0 113.605 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.59 -22.65 26.13 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.541 0.737 . . . . 0.0 112.317 -176.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -80.93 143.51 53.65 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.022 0.929 . . . . 0.0 110.026 -176.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 85.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.063 2.509 . . . . 0.0 108.267 173.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -23.86 26.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.728 2.011 . . . . 0.0 113.543 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -51.18 112.69 0.77 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.649 1.18 . . . . 0.0 110.683 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -46.64 -44.58 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.524 1.13 . . . . 0.0 110.553 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.79 -31.53 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.236 1.415 . . . . 0.0 113.001 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.44 -52.83 4.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 109.046 177.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 mt -48.36 -41.32 28.31 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 122.824 0.449 . . . . 0.0 111.994 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.14 -37.71 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 121.747 -0.596 . . . . 0.0 110.903 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -65.85 -48.12 72.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 m -53.56 -42.28 67.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.708 0.29 . . . . 0.0 110.299 176.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -67.04 -48.83 67.12 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.282 0.633 . . . . 0.0 111.235 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.8 -43.02 69.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 109.528 -174.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.7 73.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.538 0.735 . . . . 0.0 111.073 178.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 152.3 27.92 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -153.5 149.52 27.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.27 -116.98 8.69 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.29 14.21 22.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.453 1.101 . . . . 0.0 111.495 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.96 127.31 93.32 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.495 -0.753 . . . . 0.0 110.416 -178.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.76 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.492 2.128 . . . . 0.0 109.19 179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -25.55 123.29 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.178 2.191 . . . . 0.0 112.11 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.6 6.57 48.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.839 0.456 . . . . 0.0 112.096 -176.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -42.09 109.45 0.13 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.497 1.519 . . . . 0.0 112.695 178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 -14.43 8.03 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.73 0.681 . . . . 0.0 113.449 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 mtm105 -82.05 -46.94 13.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.28 1.04 . . . . 0.0 108.507 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.05 126.27 45.95 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 172.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.22 150.26 33.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -27.24 -49.89 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 126.177 1.791 . . . . 0.0 112.102 170.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.67 -50.35 73.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.115 1.325 . . . . 0.0 111.56 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -54.29 -56.12 21.55 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 122.662 1.22 . . . . 0.0 109.031 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.38 -59.48 3.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -45.05 -53.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 125.394 1.478 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -56.33 -33.94 66.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.048 0.539 . . . . 0.0 112.055 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.68 27.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.747 0.703 . . . . 0.0 109.924 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.61 -49.92 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.825 . . . . 0.0 110.233 -176.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.65 -44.29 73.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.185 0.902 . . . . 0.0 109.777 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.14 -50.51 72.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 ptm -54.5 -44.19 72.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.53 -34.74 77.71 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.627 -0.671 . . . . 0.0 110.696 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -73.92 56.64 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.005 0.922 . . . . 0.0 111.793 179.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.6 p -150.81 -32.71 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.444 2.298 . . . . 0.0 109.598 177.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.523 1.929 . . . . 0.0 110.413 178.885 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.14 -56.4 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.494 1.118 . . . . 0.0 109.826 -178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.47 -48.07 80.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.756 0.822 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 mm -70.42 -48.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.425 0.69 . . . . 0.0 111.146 -174.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 39.79 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -173.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.81 38.91 1.17 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -139.07 155.95 47.55 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.502 1.921 . . . . 0.0 107.587 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 105.29 16.85 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 123.715 0.806 . . . . 0.0 111.198 -176.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.54 164.47 61.49 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 CA-C-N 120.286 1.138 . . . . 0.0 110.113 -8.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -67.31 119.11 11.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.543 1.137 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -46.89 -45.46 20.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.895 0.878 . . . . 0.0 111.228 -176.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -46.02 -42.71 13.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.715 1.606 . . . . 0.0 112.311 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -55.94 -16.27 4.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.3 m -115.27 -57.43 2.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.788 175.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -71.14 -22.9 62.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -173.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.54 -48.6 66.51 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.751 1.16 . . . . 0.0 109.615 -178.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -86.54 -25.19 25.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.917 0.887 . . . . 0.0 111.1 178.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.38 41.97 8.85 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.51 140.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.41 28.58 5.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.993 0.917 . . . . 0.0 111.476 -177.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.46 79.62 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.009 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 121.25 43.14 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.823 1.311 . . . . 0.0 108.247 176.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 74.1 Cg_exo -44.15 114.99 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.869 3.046 . . . . 0.0 113.636 -177.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.81 169.63 17.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.758 0.79 . . . . 0.0 111.759 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 159.72 28.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.31 51.08 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.362 1.465 . . . . 0.0 111.733 178.053 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.96 62.04 31.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.919 0.888 . . . . 0.0 111.055 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -38.17 -45.85 2.15 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 124.33 3.353 . . . . 0.0 114.198 -178.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.42 -43.67 11.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.896 1.278 . . . . 0.0 111.957 178.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -69.3 -25.54 64.28 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.658 0.783 . . . . 0.0 112.074 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 88.5 m95 -104.26 -18.2 14.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.795 1.238 . . . . 0.0 112.754 -174.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.04 -48.4 0.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.937 2.095 . . . . 0.0 113.969 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -98.65 -4.13 34.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -87.26 128.81 53.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.486 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.95 123.87 13.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.525 2.15 . . . . 0.0 110.967 177.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -64.25 -23.57 67.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.295 0.638 . . . . 0.0 110.668 178.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -49.33 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.856 2.062 . . . . 0.0 112.264 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.44 -41.5 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.316 0.646 . . . . 0.0 109.43 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -50.61 -38.6 46.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.847 1.259 . . . . 0.0 112.262 177.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -79.57 -49.64 11.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.29 -40.66 62.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.913 0.485 . . . . 0.0 111.915 -178.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -61.69 -35.05 65.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.298 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.9 -46.3 78.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 120.204 1.365 . . . . 0.0 108.698 178.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 m -52.89 -45.7 67.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.947 0.404 . . . . 0.0 110.162 175.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -69.5 -44.41 71.14 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.924 -0.485 . . . . 0.0 110.97 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.16 -51.14 70.96 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.283 -0.886 . . . . 0.0 110.347 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.74 59.2 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.36 1.064 . . . . 0.0 112.376 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.14 163.64 28.67 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -176.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -157.06 111.12 2.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.97 -0.723 . . . . 0.0 109.324 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.15 -113.52 5.2 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.65 -30.67 63.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.945 0.498 . . . . 0.0 111.168 177.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.3 ttp -63.07 119.29 50.89 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.255 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.84 160.46 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.365 2.044 . . . . 0.0 110.28 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.57 119.78 12.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -87.22 -4.45 59.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.785 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.83 89.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 179.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.2 2.54 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.889 1.709 . . . . 0.0 110.589 -178.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -87.23 -37.27 17.39 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.258 1.023 . . . . 0.0 111.106 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 126.14 18.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.33 153.57 24.54 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -29.17 -47.53 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.577 1.951 . . . . 0.0 112.047 171.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -62.81 -50.72 69.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.991 1.268 . . . . 0.0 111.665 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -54.96 -55.31 32.16 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.824 1.297 . . . . 0.0 108.955 178.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.4 mt -49.93 -60.46 2.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.151 179.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.4 t -42.09 -56.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 109.765 177.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -56.99 -43.07 81.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.512 0.142 . . . . 0.0 111.22 -178.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.89 53.34 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.9 mt -54.66 -46.62 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.964 1.306 . . . . 0.0 110.135 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -53.51 -52.58 59.14 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -55.94 -50.5 70.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.605 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.5 mtp -50.83 -58.16 6.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.377 0.671 . . . . 0.0 109.731 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.07 -36.73 73.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.884 0.874 . . . . 0.0 111.59 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -74.7 50.92 0.45 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.023 0.829 . . . . 0.0 112.659 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.7 p -149.24 -25.75 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.282 2.233 . . . . 0.0 110.035 174.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.62 -1.657 . . . . 0.0 110.421 179.528 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.456 -0.134 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.08 -53.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -57.47 -42.87 83.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 112.738 -177.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -84.37 -39.93 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.709 -175.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -130.55 -34.73 1.54 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -172.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.73 32.12 4.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.473 1.033 . . . . 0.0 113.343 -172.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -133.7 144.98 49.48 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.12 107.78 19.8 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.929 1.292 . . . . 0.0 110.388 -177.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.57 161.46 66.24 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.327 1.153 . . . . 0.0 109.718 -9.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.23 130.79 45.28 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.514 0.726 . . . . 0.0 110.145 -178.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.9 -41.92 71.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.023 0.829 . . . . 0.0 109.683 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 t -59.25 -8.71 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 m -67.08 -30.42 70.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 120.352 1.433 . . . . 0.0 109.898 175.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.0 m -113.95 -63.75 1.41 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 112.407 -172.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -57.93 -23.36 53.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.006 1.322 . . . . 0.0 113.555 -174.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.18 -25.13 64.19 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.133 -0.355 . . . . 0.0 111.535 178.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -121.11 -12.28 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.251 1.021 . . . . 0.0 112.218 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.3 35.89 51.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.87 145.47 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.19 28.09 6.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.898 0.879 . . . . 0.0 111.466 -177.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.53 21.37 79.56 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.032 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 132.55 87.25 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.855 1.327 . . . . 0.0 108.669 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.07 122.54 10.57 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.469 2.112 . . . . 0.0 108.769 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.23 172.15 10.72 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -170.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.41 158.48 23.63 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.04 50.83 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 0.0 112.078 177.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.15 60.84 24.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.624 1.17 . . . . 0.0 110.885 -178.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.93 -48.46 1.5 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.599 3.533 . . . . 0.0 114.322 -178.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.39 -44.35 8.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.208 1.403 . . . . 0.0 111.838 178.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.69 -26.93 67.26 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.978 0.911 . . . . 0.0 112.014 -177.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -103.19 -15.96 15.86 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.826 1.25 . . . . 0.0 112.452 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.68 -47.07 0.64 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.243 1.817 . . . . 0.0 113.709 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -99.72 -4.29 31.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.836 0.854 . . . . 0.0 113.27 -176.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -88.25 126.92 59.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.812 0.845 . . . . 0.0 109.405 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.33 106.03 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.784 2.323 . . . . 0.0 110.529 177.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.7 -23.05 49.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.767 0.827 . . . . 0.0 112.509 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.81 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.159 2.184 . . . . 0.0 111.031 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -49.69 -41.94 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 110.001 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -53.49 -34.97 60.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.986 1.714 . . . . 0.0 112.194 177.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.84 -52.12 7.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.8 mt -51.76 -37.82 52.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.88 -37.94 69.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.408 1.004 . . . . 0.0 110.149 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.38 -47.05 77.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.667 1.121 . . . . 0.0 108.814 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -52.61 -43.92 65.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.629 0.372 . . . . 0.0 110.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -71.97 -44.6 63.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.887 0.475 . . . . 0.0 111.066 -178.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.2 mt -57.69 -50.24 73.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 121.442 -0.786 . . . . 0.0 109.898 179.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.09 65.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.956 0.902 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 118.61 3.06 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -106.63 135.01 48.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.319 1.048 . . . . 0.0 108.456 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.22 -121.48 26.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.12 -1.56 58.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.473 0.709 . . . . 0.0 112.32 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.0 ttp -65.19 127.59 93.01 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 119.016 0.825 . . . . 0.0 111.082 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -59.41 144.44 99.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.0 109.964 173.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.39 121.53 15.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -88.28 -4.93 58.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.432 -178.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -54.55 84.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.433 1.093 . . . . 0.0 113.538 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.56 -36.86 2.46 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.982 2.229 . . . . 0.0 110.419 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -42.24 75.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.642 0.721 . . . . 0.0 109.202 177.128 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.24 129.2 21.9 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -84.06 154.2 23.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -29.85 -49.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.407 1.883 . . . . 0.0 112.011 171.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.01 -45.12 93.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.373 0.988 . . . . 0.0 111.784 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.52 -57.56 12.43 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 122.612 1.196 . . . . 0.0 108.77 177.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.8 mt -47.25 -57.9 4.69 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.906 2.082 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 t -40.38 -54.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 0.0 110.459 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -60.34 -44.52 95.44 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.072 0.232 . . . . 0.0 111.394 -178.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.25 63.97 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.515 -0.74 . . . . 0.0 109.919 -179.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.64 -52.67 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.894 1.278 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -60.6 -42.37 96.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.631 1.105 . . . . 0.0 109.616 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -57.18 -51.96 67.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.644 0.656 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 ttp -54.16 -54.52 38.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -56.3 -37.68 70.21 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.918 -0.489 . . . . 0.0 111.137 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.8 m -63.46 -7.45 6.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.084 -0.96 . . . . 0.0 113.493 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 p -87.6 -11.75 47.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.289 1.404 . . . . 0.0 110.802 175.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.05 -176.067 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.557 0.217 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 mt -62.94 -57.82 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.106 1.762 . . . . 0.0 109.323 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -58.47 -51.09 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.287 1.035 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.38 -48.32 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.926 -174.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.59 39.89 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.049 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.84 36.95 1.48 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 118.867 0.758 . . . . 0.0 111.737 179.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.23 158.74 43.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.02 1.728 . . . . 0.0 108.01 178.025 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.12 107.59 6.81 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.773 -178.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 154.39 29.51 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 120.146 1.088 . . . . 0.0 111.732 -9.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.65 126.14 27.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.2 m -53.03 -48.35 67.66 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.848 0.749 . . . . 0.0 110.607 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -42.6 -49.47 5.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.043 1.737 . . . . 0.0 112.454 178.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.03 -36.18 3.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.168 0.987 . . . . 0.0 112.766 -178.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.2 m -99.88 -54.4 2.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.317 0.247 . . . . 0.0 110.996 -178.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -69.65 -24.23 63.59 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.58 -42.42 82.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.864 0.756 . . . . 0.0 109.475 178.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -89.54 -24.9 21.63 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.207 1.003 . . . . 0.0 112.027 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.8 35.14 40.89 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -174.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.33 145.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -176.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.35 29.3 6.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 111.392 -177.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.84 24.21 76.95 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.868 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 132.9 87.68 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 118.852 1.326 . . . . 0.0 108.346 176.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.42 121.54 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.294 1.996 . . . . 0.0 107.954 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.24 159.89 19.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.159 0.981 . . . . 0.0 112.88 -172.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.52 142.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 69.28 27.08 5.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.079 1.352 . . . . 0.0 111.315 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 70.3 76.32 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.621 1.168 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.27 -52.05 3.08 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.667 3.578 . . . . 0.0 114.23 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -50.46 -34.07 23.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.514 1.526 . . . . 0.0 112.518 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.65 -27.49 66.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.282 0.492 . . . . 0.0 111.181 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -101.05 -24.92 14.22 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 111.864 -176.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.24 -43.73 0.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.793 1.637 . . . . 0.0 112.688 178.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -111.81 36.14 3.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.283 1.033 . . . . 0.0 112.08 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -128.89 155.74 79.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.36 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.8 126.84 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.562 2.175 . . . . 0.0 111.367 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -70.22 -41.65 73.31 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -51.86 102.45 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.532 1.933 . . . . 0.0 112.893 -179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -49.25 -43.17 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.848 0.859 . . . . 0.0 108.912 174.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.44 -34.96 26.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.557 1.943 . . . . 0.0 112.667 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -87.03 -49.68 7.16 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 mt -49.75 -40.59 41.54 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.777 0.431 . . . . 0.0 111.979 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.13 -32.45 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 O-C-N 121.378 -0.826 . . . . 0.0 110.76 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.72 -47.24 79.02 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.773 1.17 . . . . 0.0 108.457 177.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.87 -44.24 70.25 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -66.54 -45.56 79.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.878 0.37 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.65 -49.41 77.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.447 -0.783 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.84 -31.16 61.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.483 1.113 . . . . 0.0 112.798 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.17 164.47 29.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -176.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -158.72 114.05 2.58 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.996 -0.708 . . . . 0.0 109.145 -178.003 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.98 -116.12 7.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 -26.42 60.93 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.968 0.507 . . . . 0.0 111.437 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.3 ttp -67.55 121.12 77.74 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 118.631 0.65 . . . . 0.0 109.847 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.86 160.19 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.49 2.127 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 122.59 17.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -89.15 -9.96 49.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.256 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -54.22 91.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.408 1.004 . . . . 0.0 113.056 -177.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.66 -42.2 1.72 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.463 1.506 . . . . 0.0 110.361 -178.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -39.4 89.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -136.41 164.94 26.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.09 140.74 40.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.933 0.893 . . . . 0.0 108.961 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ttt-85 -29.24 -50.48 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.289 2.235 . . . . 0.0 113.234 173.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.14 -45.5 84.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.329 0.968 . . . . 0.0 111.366 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.25 -54.5 45.07 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.881 0.848 . . . . 0.0 109.017 177.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 35.6 mt -47.38 -57.84 4.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.371 1.468 . . . . 0.0 109.867 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -43.82 -55.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.622 1.169 . . . . 0.0 109.74 178.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.61 -43.16 89.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.35 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.85 84.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.394 -0.816 . . . . 0.0 109.573 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.35 -42.52 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.902 1.281 . . . . 0.0 109.79 177.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.12 -52.52 64.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.305 0.957 . . . . 0.0 109.032 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -54.25 -54.02 45.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.4 ttm -47.1 -56.16 7.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 110.079 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.15 -33.27 73.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.557 -0.714 . . . . 0.0 112.431 177.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 m -74.66 43.44 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.179 0.9 . . . . 0.0 112.367 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.1 p -135.81 -17.06 1.7 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.196 1.799 . . . . 0.0 109.819 173.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.445 -1.264 . . . . 0.0 109.569 178.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.26 -58.98 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.12 1.368 . . . . 0.0 110.643 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -56.62 -52.41 64.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 0.0 112.087 -178.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.22 -44.94 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.246 -174.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.82 44.66 0.19 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.57 38.14 0.95 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 176.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.33 159.5 42.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.845 2.058 . . . . 0.0 107.378 177.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.94 113.68 6.41 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.265 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.61 152.05 13.24 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 120.307 1.145 . . . . 0.0 111.33 -15.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.61 116.81 7.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.507 1.123 . . . . 0.0 108.6 177.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -46.68 -48.25 20.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.546 0.738 . . . . 0.0 110.788 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -45.92 -46.35 16.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.212 1.805 . . . . 0.0 112.739 178.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -52.04 -29.66 22.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.143 0.429 . . . . 0.0 112.051 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.83 -56.97 2.24 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.777 0.262 . . . . 0.0 110.644 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -66.92 -32.76 74.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -173.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.81 -43.04 76.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 119.103 0.865 . . . . 0.0 109.139 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.12 -26.6 39.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.625 -177.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.55 50.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -176.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.97 141.01 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.61 29.17 5.29 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 0.0 111.394 -177.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.61 28.41 71.03 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.754 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.09 134.84 84.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.862 1.331 . . . . 0.0 108.368 175.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 73.9 Cg_endo -64.91 111.99 1.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.6 2.2 . . . . 0.0 107.984 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -84.87 175.82 8.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.978 0.894 . . . . 0.0 111.425 -174.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.48 154.34 41.61 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 171.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 48.28 32.96 3.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.312 1.845 . . . . 0.0 112.661 178.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.86 59.25 4.11 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 109.666 178.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -47.62 -41.72 30.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.054 3.169 . . . . 0.0 113.053 -174.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -47.75 -37.67 13.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.903 0.881 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.52 -27.71 56.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.198 0.454 . . . . 0.0 111.37 -178.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 81.5 m95 -92.09 -13.3 31.03 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.57 0.748 . . . . 0.0 111.616 -177.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.72 -45.16 0.36 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.274 1.83 . . . . 0.0 112.899 177.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -113.74 28.6 8.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.121 0.968 . . . . 0.0 112.552 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -115.13 119.61 38.38 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.514 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.69 118.7 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.761 2.307 . . . . 0.0 110.786 177.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 -22.17 66.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.073 0.549 . . . . 0.0 111.343 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.04 103.65 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.087 2.155 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -49.34 -44.23 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.638 0.775 . . . . 0.0 109.706 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.98 -34.0 54.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.172 1.789 . . . . 0.0 112.295 177.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.47 -51.16 8.08 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.1 mt -52.79 -38.81 61.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.702 0.801 . . . . 0.0 112.34 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.61 -38.46 75.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 119.243 0.928 . . . . 0.0 109.984 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.16 -45.52 80.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.708 1.14 . . . . 0.0 108.911 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 m -53.5 -44.97 69.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -70.76 -44.75 66.07 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.103 -0.373 . . . . 0.0 110.8 -178.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -57.53 -52.19 66.43 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 121.393 -0.817 . . . . 0.0 109.999 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.76 65.05 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.943 0.897 . . . . 0.0 111.817 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.29 159.38 34.71 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -175.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -162.16 139.4 8.33 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.78 -138.57 48.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 108.284 -1.926 . . . . 0.0 108.284 -175.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.11 -21.03 66.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.689 -0.755 . . . . 0.0 111.835 176.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.7 ttp -65.49 117.04 36.88 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 119.663 1.12 . . . . 0.0 110.888 -176.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.42 153.64 55.58 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.327 2.018 . . . . 0.0 110.021 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 123.46 16.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.333 0.653 . . . . 0.0 109.947 178.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -90.25 -4.44 57.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.844 0.747 . . . . 0.0 111.992 177.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -44.16 114.33 0.66 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.491 1.116 . . . . 0.0 111.893 176.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.71 -21.2 19.9 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.292 0.948 . . . . 0.0 112.898 178.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -87.71 -44.49 11.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.974 0.909 . . . . 0.0 109.298 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 126.93 45.9 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.64 152.37 28.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -30.55 -46.76 0.08 Allowed 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 126.07 1.748 . . . . 0.0 111.686 170.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.08 -50.49 73.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.583 1.083 . . . . 0.0 111.923 178.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -57.04 -54.93 41.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.096 1.358 . . . . 0.0 109.202 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.6 mt -50.33 -57.55 7.64 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 125.989 1.716 . . . . 0.0 109.711 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.64 -56.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.882 1.273 . . . . 0.0 109.668 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -57.94 -39.23 77.56 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.136 0.575 . . . . 0.0 111.634 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.69 -48.12 64.7 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.539 -0.726 . . . . 0.0 109.777 177.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.37 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.084 1.353 . . . . 0.0 110.768 -176.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.37 -39.54 87.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.949 1.249 . . . . 0.0 109.763 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.53 -59.54 5.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 85.9 mtp -41.33 -64.75 0.51 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.619 1.168 . . . . 0.0 108.709 177.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 mt -46.64 -31.98 3.21 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.845 2.058 . . . . 0.0 113.371 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 m -64.87 -4.86 4.9 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.512 1.051 . . . . 0.0 112.287 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.3 p -154.33 22.85 0.48 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.685 3.994 . . . . 0.0 106.0 -179.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 34' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 C-N-CA 128.257 2.623 . . . . 0.0 113.795 -170.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 119.717 -0.182 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.72 -56.48 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 0.0 109.889 -178.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -56.95 -47.19 81.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.992 0.917 . . . . 0.0 111.264 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.92 -64.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.357 -175.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -141.5 43.81 1.74 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.77 0.714 . . . . 0.0 111.374 -173.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.69 36.89 1.22 Allowed Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.225 -0.922 . . . . 0.0 112.304 177.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.97 155.43 48.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.31 1.844 . . . . 0.0 107.703 176.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.06 113.28 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.572 -177.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.71 142.91 12.57 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.045 1.052 . . . . 0.0 110.363 -14.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -67.83 128.66 37.33 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.503 -178.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.2 m -54.38 -48.15 71.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.39 0.676 . . . . 0.0 111.149 -175.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -42.47 -54.65 3.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.184 1.793 . . . . 0.0 112.105 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.7 -35.69 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.236 1.414 . . . . 0.0 112.878 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.0 m -100.78 -57.28 2.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.559 0.343 . . . . 0.0 111.414 -178.024 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -70.5 -35.12 73.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -41.59 88.77 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -74.98 -31.33 61.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.291 1.436 . . . . 0.0 111.344 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.62 33.73 51.27 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -175.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.15 143.08 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 122.096 -0.649 . . . . 0.0 109.744 -176.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.47 32.61 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.361 1.064 . . . . 0.0 111.834 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.0 22.3 77.12 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.443 -0.643 . . . . 0.0 113.095 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 136.23 83.27 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.689 1.245 . . . . 0.0 107.745 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.36 123.12 13.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.049 1.833 . . . . 0.0 109.969 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.89 169.45 17.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.267 1.032 . . . . 0.0 110.172 -178.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.87 151.12 19.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.096 179.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.81 37.36 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.49 68.34 31.6 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.517 0.727 . . . . 0.0 111.915 -175.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -38.98 -51.42 2.43 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.653 3.569 . . . . 0.0 114.867 -177.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.98 -40.25 21.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.346 1.059 . . . . 0.0 111.988 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.21 -22.38 66.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.469 0.707 . . . . 0.0 111.884 -177.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -110.15 -30.21 7.85 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.747 1.219 . . . . 0.0 112.607 -175.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.31 -51.03 1.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.68 1.592 . . . . 0.0 113.021 -178.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.22 -26.42 56.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -78.24 142.38 63.33 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.121 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.48 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.179 2.586 . . . . 0.0 108.257 173.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -20.65 55.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.892 1.677 . . . . 0.0 113.639 -170.007 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -50.12 115.83 1.59 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.886 1.274 . . . . 0.0 110.651 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.3 t -48.18 -46.21 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.445 0.698 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.95 -24.31 64.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.853 0.861 . . . . 0.0 113.02 -178.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.29 -54.56 4.13 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 mt -47.84 -43.32 28.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -59.91 -37.05 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 121.915 -0.491 . . . . 0.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.3 -44.42 79.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -47.32 72.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.162 0.506 . . . . 0.0 110.19 174.325 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -62.57 -45.99 90.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.9 mt -58.26 -51.83 68.11 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.59 -0.694 . . . . 0.0 109.226 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.06 79.63 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.093 0.557 . . . . 0.0 112.151 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.94 157.19 32.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 108.299 -1.921 . . . . 0.0 108.299 -174.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -156.38 129.48 7.99 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.816 -0.814 . . . . 0.0 109.034 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 -136.85 50.45 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.24 -23.62 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.811 176.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -65.88 115.5 23.49 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 111.147 -177.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -63.45 162.32 27.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.655 2.237 . . . . 0.0 111.255 177.549 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 136.66 43.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.83 -8.02 19.02 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.093 0.957 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -43.42 115.89 0.85 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.321 1.848 . . . . 0.0 111.714 177.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.67 -23.24 9.11 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.912 0.768 . . . . 0.0 112.559 177.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -83.92 -46.83 11.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.924 0.862 . . . . 0.0 108.746 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.29 138.1 37.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.58 25.93 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -173.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 62.19 -41.4 0.16 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.224 2.21 . . . . 0.0 111.979 -173.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -64.81 -36.85 85.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.323 -1.485 . . . . 0.0 110.198 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.92 -58.36 7.21 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 123.229 1.49 . . . . 0.0 108.547 178.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.08 -58.64 6.84 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 126.484 1.914 . . . . 0.0 110.022 178.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -41.94 -54.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.481 0.713 . . . . 0.0 110.451 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -61.71 -40.53 95.38 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.77 71.56 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.554 -0.717 . . . . 0.0 110.082 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.21 -48.04 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.838 2.055 . . . . 0.0 110.38 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.74 -44.17 90.44 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.891 1.223 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -61.77 -52.59 63.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 ttm -46.17 -50.26 15.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 110.513 179.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.84 -35.39 80.95 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.124 -0.36 . . . . 0.0 110.823 178.131 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -74.8 59.14 0.86 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.588 0.755 . . . . 0.0 111.218 178.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 -40.57 0.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.739 2.016 . . . . 0.0 108.979 176.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.344 2.657 . . . . 0.0 111.213 179.441 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.5 -0.185 . . . . 0.0 110.5 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mt -70.68 -35.56 61.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -60.56 -45.02 95.47 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.346 -1.471 . . . . 0.0 109.989 176.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 mt -82.4 -28.82 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.548 -0.72 . . . . 0.0 111.545 -177.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -125.97 38.09 4.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.724 1.209 . . . . 0.0 110.707 -174.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.76 46.85 2.08 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 129.488 3.423 . . . . 0.0 112.041 -178.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.259 3.1 p 69.73 -142.11 0.08 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.414 1.885 . . . . 0.0 111.553 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.31 124.56 29.43 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 124.307 1.043 . . . . 0.0 110.863 -172.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -62.56 177.73 9.52 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 119.541 0.872 . . . . 0.0 110.112 -18.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 136.85 33.27 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 m -54.62 -51.62 64.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.306 0.643 . . . . 0.0 110.222 -176.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -40.91 -61.34 0.99 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.518 1.927 . . . . 0.0 112.817 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.72 -35.02 13.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.042 0.937 . . . . 0.0 112.55 -178.267 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.5 m -85.92 -59.9 2.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 118.594 0.634 . . . . 0.0 110.165 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -61.23 -50.81 71.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.643 0.777 . . . . 0.0 113.028 -173.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.86 -39.68 71.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.199 0.454 . . . . 0.0 110.994 -178.463 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -88.23 -2.07 58.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.078 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 35.68 82.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.389 0.995 . . . . 0.0 112.443 -177.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.79 130.75 17.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 O-C-N 121.931 -0.746 . . . . 0.0 109.195 -179.242 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.92 31.41 8.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 111.479 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.67 78.95 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.355 -0.692 . . . . 0.0 112.568 179.749 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.43 137.9 68.71 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.578 1.189 . . . . 0.0 108.53 176.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.72 121.06 9.13 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.239 1.959 . . . . 0.0 109.098 -179.032 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.42 166.56 23.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.404 1.097 . . . . 0.0 112.359 -174.223 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.3 164.38 26.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.66 53.32 0.46 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.173 1.389 . . . . 0.0 111.735 -178.713 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.67 68.13 19.47 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.702 -176.094 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.89 -48.59 2.78 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.453 3.435 . . . . 0.0 114.44 -177.351 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -50.61 -40.53 52.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.05 -23.85 66.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.339 0.655 . . . . 0.0 111.535 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -105.51 -30.71 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.348 1.059 . . . . 0.0 112.749 -174.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.54 -50.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.784 1.634 . . . . 0.0 112.998 -178.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.9 -22.31 42.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -78.99 158.06 75.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.569 -0.707 . . . . 0.0 110.377 -177.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.52 108.91 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.886 2.391 . . . . 0.0 110.939 176.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.87 -37.02 75.6 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 m -59.69 107.97 0.67 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.752 1.621 . . . . 0.0 111.555 178.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -48.41 -41.92 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.494 1.118 . . . . 0.0 110.405 178.182 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.0 -27.16 17.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.231 1.412 . . . . 0.0 112.869 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.26 -49.57 7.17 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 mt -51.14 -39.44 56.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.875 0.87 . . . . 0.0 112.457 179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.15 -33.16 49.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.652 177.571 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.17 -49.59 71.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.48 1.491 . . . . 0.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -51.83 -47.2 64.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.067 0.947 . . . . 0.0 110.114 175.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -66.87 -42.16 86.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.212 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.99 -56.13 24.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.04 -27.92 57.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.233 1.013 . . . . 0.0 112.869 -176.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 164.69 29.11 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -175.263 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -157.96 112.15 2.57 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -113.48 5.1 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -178.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.26 -31.33 65.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.969 0.508 . . . . 0.0 111.243 178.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.2 ttp -64.7 118.47 48.54 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.55 -176.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.5 157.5 40.63 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.742 2.295 . . . . 0.0 110.058 179.068 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 139.05 58.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.969 0.508 . . . . 0.0 110.685 178.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -114.53 -0.45 13.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.84 0.856 . . . . 0.0 111.63 175.436 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -46.67 117.86 1.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.232 1.013 . . . . 0.0 111.781 175.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.31 -19.62 21.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.1 0.857 . . . . 0.0 112.548 179.73 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -88.95 -45.18 9.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.489 1.115 . . . . 0.0 108.662 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -120.5 123.09 42.09 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.95 146.05 48.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -25.65 -52.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.449 2.3 . . . . 0.0 112.01 168.058 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.1 -45.64 84.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.86 0.464 . . . . 0.0 111.788 -178.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.17 -48.51 79.77 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 62' ' ' ALA . 92.6 mt -52.34 -59.48 4.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.168 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 t -42.77 -59.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.288 1.035 . . . . 0.0 109.673 177.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -54.99 -42.69 72.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 118.37 0.532 . . . . 0.0 112.335 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.65 -53.67 47.7 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -55.36 -44.14 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.609 1.163 . . . . 0.0 110.262 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -56.02 -55.59 31.01 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 118.784 0.72 . . . . 0.0 109.097 177.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -55.19 -51.28 67.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.297 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 ttm -48.58 -62.14 1.66 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.603 1.161 . . . . 0.0 109.326 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.55 -35.58 68.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.485 0.714 . . . . 0.0 111.661 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 m -62.95 -5.54 3.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.472 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -87.9 -14.67 38.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.484 1.493 . . . . 0.0 111.004 175.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 116.718 -1.61 . . . . 0.0 110.401 -177.883 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.38 -55.93 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.843 0.747 . . . . 0.0 109.842 179.189 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -63.54 -43.01 98.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -178.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.75 -45.17 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 112.091 -172.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -151.41 -10.9 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.78 3.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.026 1.285 . . . . 0.0 111.442 -176.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -136.08 147.16 47.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.256 1.822 . . . . 0.0 106.766 177.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.5 109.23 10.26 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.813 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.24 159.87 30.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 CA-C-N 120.193 1.105 . . . . 0.0 111.85 -8.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -74.18 122.58 22.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.117 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -54.4 -51.6 64.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.548 0.69 . . . . 0.0 110.102 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -39.68 -61.37 0.84 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.006 2.122 . . . . 0.0 112.419 179.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -42.92 -43.49 4.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.002 1.321 . . . . 0.0 113.068 -177.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.31 -55.61 3.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.463 0.305 . . . . 0.0 111.305 -177.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -64.75 -33.97 77.22 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.863 0.865 . . . . 0.0 113.172 -173.728 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.83 -48.02 82.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.544 0.611 . . . . 0.0 109.355 177.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -73.05 -30.58 63.82 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.229 0.612 . . . . 0.0 111.31 179.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.35 49.45 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -174.664 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.67 141.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.11 31.5 6.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.287 1.035 . . . . 0.0 111.668 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.61 76.38 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.993 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.25 87.58 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.564 1.182 . . . . 0.0 108.674 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -62.75 114.97 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.74 2.293 . . . . 0.0 108.764 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -80.93 174.23 11.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.729 0.776 . . . . 0.0 112.667 -172.544 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.6 160.64 16.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 170.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.73 51.88 0.96 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.176 1.39 . . . . 0.0 112.419 176.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.33 59.01 19.09 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 123.807 0.843 . . . . 0.0 111.005 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -38.56 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.558 3.505 . . . . 0.0 114.025 -177.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -47.66 -40.8 20.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.402 1.481 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.94 -26.09 53.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.637 -177.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -91.6 -26.08 18.88 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.587 0.755 . . . . 0.0 111.736 -177.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.14 -46.33 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.159 2.184 . . . . 0.0 114.437 -178.129 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -91.91 -15.14 28.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.441 0.697 . . . . 0.0 112.816 -175.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -81.08 148.78 64.92 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.489 0.716 . . . . 0.0 109.655 -177.496 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.34 129.41 28.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.58 2.186 . . . . 0.0 111.157 176.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -67.21 -40.84 86.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.415 0.626 . . . . 0.0 110.348 179.203 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.74 110.32 1.13 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.393 1.477 . . . . 0.0 111.425 -177.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.74 -36.78 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.21 1.004 . . . . 0.0 109.891 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.48 -33.71 63.91 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.356 1.863 . . . . 0.0 111.343 177.49 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -83.4 -50.67 8.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -51.73 -38.12 53.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 68' ' ' VAL . 4.1 m -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 118.946 -1.101 . . . . 0.0 110.467 177.989 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.15 -44.9 83.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.734 1.606 . . . . 0.0 109.409 -179.418 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -58.04 -33.05 68.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 110.468 174.312 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -75.73 -47.47 25.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.179 0.991 . . . . 0.0 110.007 -179.167 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.8 -48.06 73.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 120.598 -1.314 . . . . 0.0 110.099 174.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.32 74.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 112.692 -178.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.9 162.63 29.88 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -175.074 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.1 129.63 4.49 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.769 0.784 . . . . 0.0 109.083 -178.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.89 -120.28 21.78 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -177.696 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.2 -13.92 48.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.916 177.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.0 ttp -66.53 117.16 41.52 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 119.254 0.934 . . . . 0.0 110.38 -178.261 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.27 159.72 38.21 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.346 2.031 . . . . 0.0 111.064 177.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.83 118.58 10.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -82.02 -4.22 56.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.467 1.031 . . . . 0.0 113.205 -179.092 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.57 86.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.292 1.037 . . . . 0.0 112.484 -179.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 128.02 -33.97 3.08 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.548 1.547 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -78.33 -34.76 48.36 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.667 0.734 . . . . 0.0 110.936 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -141.39 146.01 36.06 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.762 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.99 138.94 31.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -30.59 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.274 2.23 . . . . 0.0 113.028 173.111 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.17 -57.64 11.96 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.619 0.645 . . . . 0.0 110.441 177.808 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.49 -53.71 47.56 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.98 0.895 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 62' ' ' ALA . 28.5 mt -47.73 -55.27 9.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.85 1.66 . . . . 0.0 110.561 176.484 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 HG11 ' A' ' 45' ' ' VAL . 1.7 t -51.22 -58.67 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.181 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -54.51 -37.36 65.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.117 0.567 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.1 82.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.36 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 45' ' ' VAL . 54.3 mt -62.54 -47.38 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.507 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -45.25 -56.43 4.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.605 1.093 . . . . 0.0 109.751 176.56 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -55.66 -52.66 63.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.917 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 ptm -54.85 -43.62 73.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.533 0.606 . . . . 0.0 110.251 -178.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.3 mt -69.71 -29.78 67.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.625 -0.672 . . . . 0.0 111.057 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 m -73.96 43.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.036 0.834 . . . . 0.0 112.678 179.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -135.89 -13.83 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.783 2.033 . . . . 0.0 109.914 174.155 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.035 -179.109 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.827 0.346 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.81 -40.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.835 0.854 . . . . 0.0 110.586 -177.554 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 28' ' ' LEU . 38.5 t80 -64.68 -41.66 95.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.962 0.801 . . . . 0.0 110.247 177.609 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.35 -47.61 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.914 ' HB2' HG22 ' A' ' 13' ' ' THR . 30.5 m-80 110.74 88.1 0.0 OUTLIER 'General case' 0 C--N 1.345 0.411 0 C-N-CA 130.612 3.565 . . . . 0.0 114.009 162.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.41 -20.43 58.8 Favored Glycine 0 CA--C 1.551 2.301 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 156.192 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 163.92 3.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 129.214 3.006 . . . . 0.0 111.356 175.067 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.43 124.86 9.89 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.248 1.419 . . . . 0.0 107.494 177.281 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.65 178.46 5.8 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 CA-C-N 120.525 1.223 . . . . 0.0 112.464 -8.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -100.18 109.01 21.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 110.295 179.598 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -41.54 -53.8 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.388 1.475 . . . . 0.0 109.943 176.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -44.1 -55.4 4.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.267 2.227 . . . . 0.0 111.513 -178.168 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -50.22 -37.46 35.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.492 0.717 . . . . 0.0 112.332 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 m -84.34 -59.45 2.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 110.325 -179.496 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -59.91 -42.49 93.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.956 1.302 . . . . 0.0 113.069 -174.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.63 -38.54 90.63 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.453 0.569 . . . . 0.0 110.015 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -25.3 41.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.43 0.692 . . . . 0.0 111.17 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.99 64.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.44 138.46 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.75 29.3 5.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.331 1.053 . . . . 0.0 111.72 -177.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.06 23.97 74.87 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.804 179.354 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 129.61 84.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 118.566 1.183 . . . . 0.0 108.362 176.423 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.9 Cg_endo -61.22 122.04 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.256 1.971 . . . . 0.0 109.742 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -86.97 178.32 6.98 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.641 0.734 . . . . 0.0 111.805 -174.434 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' OH ' ' A' ' 6' ' ' TYR . 2.3 mm? -70.65 163.45 27.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 171.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 m120 48.07 34.39 4.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.681 0.792 . . . . 0.0 112.865 175.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.05 62.23 62.87 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.7 0.682 . . . . 0.0 112.384 -174.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -39.77 -51.55 2.92 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.151 3.234 . . . . 0.0 114.801 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.66 -40.95 41.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.776 0.831 . . . . 0.0 112.079 -179.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.8 -19.94 64.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.269 0.628 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.474 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 96.5 m95 -102.32 -35.88 8.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 111.803 -178.58 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.27 -51.71 1.05 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.053 1.741 . . . . 0.0 113.131 -178.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.7 -24.44 53.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.99 157.38 81.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 O-C-N 121.621 -0.674 . . . . 0.0 110.117 -177.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.08 113.97 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.025 2.483 . . . . 0.0 111.583 178.172 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.46 -36.09 75.3 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 110.602 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 106.08 0.48 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.444 1.498 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.3 -36.03 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 121.844 -0.535 . . . . 0.0 109.563 176.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.99 -24.26 57.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.102 0.961 . . . . 0.0 112.528 177.655 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -89.34 -49.8 6.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.62 -40.99 41.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.32 -37.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 O-C-N 121.44 -0.787 . . . . 0.0 110.157 179.088 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.59 -47.77 80.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.436 1.016 . . . . 0.0 108.366 177.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -53.93 -37.62 64.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.124 0.17 . . . . 0.0 110.754 175.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.5 m -74.06 -48.7 28.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.911 -0.493 . . . . 0.0 110.713 -177.641 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -66.68 -44.62 81.31 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.587 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.66 -35.04 60.5 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.38 0.672 . . . . 0.0 111.809 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 152.31 23.66 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -176.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' H ' ' HB3' ' A' ' 55' ' ' MET . 85.4 tttt -153.53 141.46 20.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -119.93 18.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.07 3.48 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.839 0.855 . . . . 0.0 112.095 178.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.6 ttp -69.74 123.65 89.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.047 0.84 . . . . 0.0 110.144 -178.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.26 145.15 59.12 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.568 1.512 . . . . 0.0 108.622 176.192 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.86 57.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.416 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -97.56 -36.82 10.17 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.109 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 t70 38.76 -144.52 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.228 2.211 . . . . 0.0 111.76 -179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.4 -20.4 5.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.999 2.238 . . . . 0.0 113.211 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -61.84 -30.3 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.483 1.141 . . . . 0.0 109.614 176.594 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.15 106.91 11.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -63.11 86.84 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.432 1.893 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 16.37 -64.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.516 3.526 . . . . 0.0 115.513 174.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -50.25 -35.79 28.42 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 111.065 178.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.27 -55.31 29.59 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.69 0.757 . . . . 0.0 109.588 178.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.4 mt -52.49 -53.56 44.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.738 1.215 . . . . 0.0 109.551 176.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.2 t -44.6 -58.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.453 1.101 . . . . 0.0 109.603 176.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -57.04 -39.76 75.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 118.891 0.768 . . . . 0.0 112.461 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.28 96.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.4 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.32 -47.14 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 108.74 179.318 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -52.69 -51.81 58.7 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -55.37 -54.36 44.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.072 178.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -52.1 -47.96 64.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.096 0.559 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.76 -35.62 80.4 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.861 -0.525 . . . . 0.0 110.312 177.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.5 m -73.5 39.08 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.391 -0.818 . . . . 0.0 113.2 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.8 p -131.16 -14.32 3.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.979 1.711 . . . . 0.0 109.764 173.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.516 -1.707 . . . . 0.0 110.135 -178.446 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.233 0.216 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.21 -57.99 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.607 1.163 . . . . 0.0 109.37 178.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -56.95 -48.26 78.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.125 0.57 . . . . 0.0 111.763 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.34 -48.49 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.231 -174.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -5.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -172.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.23 37.46 3.51 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.072 1.306 . . . . 0.0 111.144 -176.061 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.6 151.46 49.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.422 1.489 . . . . 0.0 108.131 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.74 13.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.59 1.156 . . . . 0.0 109.695 -177.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.55 162.02 44.69 Favored 'Cis proline' 0 N--CA 1.455 -0.758 0 CA-C-N 120.266 1.131 . . . . 0.0 109.544 -13.163 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -67.97 129.1 38.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.776 0.83 . . . . 0.0 110.467 -177.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.48 -46.85 83.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 -178.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 p -39.16 -55.19 1.68 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.709 2.004 . . . . 0.0 112.74 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -43.09 -38.03 2.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.666 1.186 . . . . 0.0 112.916 -178.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.34 -57.14 2.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.15 -177.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -70.27 -24.23 63.02 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -172.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.47 -54.82 38.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.036 0.834 . . . . 0.0 109.89 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -16.28 28.02 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.442 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 45.84 7.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 p -58.7 141.33 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.09 29.1 5.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.019 0.928 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.84 75.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.814 179.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 137.1 88.34 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 118.787 1.294 . . . . 0.0 108.208 175.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.42 117.34 4.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.552 2.168 . . . . 0.0 109.782 -178.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -76.31 175.87 8.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.943 0.877 . . . . 0.0 109.282 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.47 149.78 21.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 63.25 31.11 15.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.413 0.685 . . . . 0.0 109.506 -173.713 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.58 57.77 27.19 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.04 0.936 . . . . 0.0 112.618 -177.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -34.36 -48.14 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 114.267 -179.464 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -39.65 -46.79 1.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.006 1.722 . . . . 0.0 112.68 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -76.55 -29.54 56.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.146 0.43 . . . . 0.0 111.522 -177.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -85.36 -20.69 29.53 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.403 0.681 . . . . 0.0 111.43 -177.034 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.58 -45.46 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.448 1.899 . . . . 0.0 113.758 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -94.08 -14.96 25.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.795 0.838 . . . . 0.0 112.825 -177.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -79.88 127.24 78.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.945 0.898 . . . . 0.0 109.093 -177.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.44 126.35 19.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.602 2.202 . . . . 0.0 111.558 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -65.68 -27.07 68.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.314 0.646 . . . . 0.0 111.126 179.568 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.0 102.68 0.05 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 111.243 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 45' ' ' VAL . 44.6 t -42.52 -51.17 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 124.211 1.004 . . . . 0.0 110.195 179.492 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -51.7 -44.54 63.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.98 -47.59 82.5 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.16 -38.65 87.23 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.649 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG22 HD12 ' A' ' 71' ' ' ILE . 86.6 t -64.26 -40.3 88.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.326 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -60.39 -48.92 79.67 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.282 0.946 . . . . 0.0 109.547 174.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -54.06 -43.87 70.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.499 0.59 . . . . 0.0 111.158 177.459 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -69.04 -44.71 72.11 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.91 -0.494 . . . . 0.0 110.011 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -55.4 -53.29 58.12 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.369 -0.832 . . . . 0.0 110.601 177.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.05 -26.01 43.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.72 1.208 . . . . 0.0 113.342 -176.006 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.86 160.66 31.87 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.145 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -158.21 119.98 3.59 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.633 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.91 -119.34 17.44 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -178.443 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.6 -21.46 55.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.761 0.424 . . . . 0.0 111.598 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.0 ttp -69.0 121.96 83.51 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 118.795 0.725 . . . . 0.0 110.236 -177.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.7 157.28 39.91 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.57 2.18 . . . . 0.0 110.179 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.49 123.0 16.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.324 177.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -89.72 -10.21 46.53 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.223 0.92 . . . . 0.0 112.71 178.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -50.01 111.8 0.57 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.927 0.491 . . . . 0.0 110.436 178.735 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.81 -36.96 4.0 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.477 1.037 . . . . 0.0 111.72 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.2 mtm-85 -85.41 -47.62 9.8 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.13 0.965 . . . . 0.0 110.052 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.75 126.91 53.83 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.404 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.34 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -25.92 -52.13 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.181 2.192 . . . . 0.0 112.074 170.342 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -60.28 -49.86 75.92 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.433 0.56 . . . . 0.0 111.576 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -55.47 -55.61 29.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 122.139 0.971 . . . . 0.0 109.024 178.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.7 mt -49.7 -58.92 4.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.946 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.67 -55.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.672 1.589 . . . . 0.0 110.587 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -58.54 -44.16 89.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.224 0.61 . . . . 0.0 111.199 -178.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.67 -45.08 88.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.695 -0.628 . . . . 0.0 109.938 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.435 HD12 HG22 ' A' ' 45' ' ' VAL . 60.1 mt -67.59 -46.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.614 1.166 . . . . 0.0 111.303 -175.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.28 -42.06 90.38 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.28 1.4 . . . . 0.0 109.402 178.28 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -62.29 -50.04 73.25 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.6 ttm -48.89 -52.95 21.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.846 0.858 . . . . 0.0 109.264 178.587 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.53 -39.12 89.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.106 0.562 . . . . 0.0 111.745 178.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.2 p -62.4 -8.61 6.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.45 1.023 . . . . 0.0 113.536 -177.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 p -79.26 -14.75 58.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.519 1.054 . . . . 0.0 111.007 176.115 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.603 -1.665 . . . . 0.0 111.03 -174.888 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.572 0.701 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.72 -54.98 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.888 1.275 . . . . 0.0 108.873 -178.331 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -60.3 -47.15 87.25 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.217 0.462 . . . . 0.0 111.495 -177.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mm -70.78 -46.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.558 -172.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -149.95 -11.71 0.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.098 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.11 35.37 4.29 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 120.114 1.324 . . . . 0.0 111.773 -174.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -135.56 152.39 51.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.956 1.303 . . . . 0.0 108.051 177.634 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.744 -178.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 158.92 26.32 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 119.941 1.015 . . . . 0.0 111.853 -10.6 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 122.0 19.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.338 1.055 . . . . 0.0 109.712 179.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.26 -50.52 61.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 0.0 110.379 -178.145 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -40.28 -55.83 2.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.445 1.898 . . . . 0.0 112.695 178.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.1 m -46.04 -32.48 2.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 113.01 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -99.05 -57.04 2.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.044 0.384 . . . . 0.0 111.026 179.444 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -68.44 -32.27 72.18 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.65 -42.7 86.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 118.828 0.74 . . . . 0.0 109.126 179.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.94 -27.96 35.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.313 -178.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.75 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 139.9 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.141 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.21 28.56 5.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.088 0.955 . . . . 0.0 111.546 -177.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.44 24.11 76.82 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.365 -0.686 . . . . 0.0 112.857 179.597 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.57 131.78 77.36 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.767 1.283 . . . . 0.0 108.498 175.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -60.47 117.56 4.33 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 109.28 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -89.21 178.86 6.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.749 0.785 . . . . 0.0 112.771 -171.213 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.99 159.21 23.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.16 53.87 0.73 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.685 1.594 . . . . 0.0 112.541 177.053 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.57 59.34 24.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.171 0.989 . . . . 0.0 110.461 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.66 -52.45 2.59 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.455 3.437 . . . . 0.0 114.489 -175.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -49.87 -35.08 22.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.246 1.018 . . . . 0.0 112.765 -179.26 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.43 -28.17 60.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.783 0.72 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -91.86 -30.2 16.3 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.568 0.747 . . . . 0.0 111.981 -177.154 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.89 -51.14 0.69 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.647 1.979 . . . . 0.0 113.484 -178.003 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.44 -25.28 54.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.764 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.98 152.65 82.56 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 110.033 -177.167 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.73 110.64 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.538 1.492 . . . . 0.0 108.482 176.038 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.52 -28.96 57.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -53.48 103.85 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.884 1.674 . . . . 0.0 111.444 178.402 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.6 t -51.14 -39.64 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.555 0.742 . . . . 0.0 110.337 178.409 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.97 -23.46 45.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.383 1.073 . . . . 0.0 112.679 179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -90.55 -53.04 4.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.374 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -49.84 -39.81 40.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.114 0.966 . . . . 0.0 112.506 179.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -33.81 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 121.664 -0.648 . . . . 0.0 110.266 179.103 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.45 -46.87 78.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.453 1.024 . . . . 0.0 108.735 176.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -53.54 -44.45 69.2 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -65.95 -47.61 74.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.078 0.551 . . . . 0.0 110.684 -179.5 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.24 -49.1 79.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.359 -0.838 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.79 61.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.394 1.078 . . . . 0.0 112.572 -177.588 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.36 161.32 31.45 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -175.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -159.62 114.4 2.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.581 0.69 . . . . 0.0 109.725 -177.216 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.67 -117.76 12.61 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.108 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.201 177.828 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.8 ttp -65.63 119.2 58.31 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.33 -177.469 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.02 160.78 46.67 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.29 1.994 . . . . 0.0 110.154 178.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.19 117.35 9.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -82.16 -7.77 59.63 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.646 0.657 . . . . 0.0 112.368 178.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -49.88 113.64 0.89 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.821 0.737 . . . . 0.0 110.321 176.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.7 -28.95 9.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.061 0.838 . . . . 0.0 112.121 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -76.07 -43.91 41.46 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.646 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -131.02 152.9 49.83 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.831 0.852 . . . . 0.0 108.73 176.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -88.95 132.89 34.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -29.65 -47.4 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.402 2.281 . . . . 0.0 113.391 173.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -69.01 -41.7 77.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 111.312 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 -46.5 83.0 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.737 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 62' ' ' ALA . 55.3 mt -51.99 -61.12 2.46 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 t -41.12 -56.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.348 1.459 . . . . 0.0 109.594 177.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.8 -44.01 73.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.926 0.49 . . . . 0.0 111.512 179.658 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -48.2 75.67 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.707 -0.62 . . . . 0.0 109.852 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.5 mt -57.52 -50.42 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 123.871 0.868 . . . . 0.0 110.602 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -40.76 96.46 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 120.253 1.388 . . . . 0.0 109.294 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -57.76 -50.62 72.62 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.724 0.693 . . . . 0.0 109.561 176.885 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.66 -52.82 54.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 178.385 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.81 -33.8 68.98 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.745 -0.597 . . . . 0.0 111.839 176.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -73.01 38.0 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.402 1.001 . . . . 0.0 113.423 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.9 p -132.01 -15.77 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.314 1.845 . . . . 0.0 109.479 171.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.724 179.96 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -44.94 -57.39 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.293 1.037 . . . . 0.0 110.508 -178.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.74 -47.21 72.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.919 0.487 . . . . 0.0 111.721 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.55 -46.79 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -172.686 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -145.22 -5.06 0.69 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -170.608 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.43 33.95 6.17 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 120.168 1.349 . . . . 0.0 112.042 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.64 150.52 51.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.119 1.768 . . . . 0.0 107.403 177.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.58 109.62 14.69 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 0.0 110.272 -177.172 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.01 163.07 50.14 Favored 'Cis proline' 0 N--CA 1.455 -0.79 0 CA-C-N 120.292 1.14 . . . . 0.0 110.065 -10.725 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -69.17 129.42 39.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.327 1.051 . . . . 0.0 110.177 -178.341 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -59.19 -46.51 88.22 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.443 0.639 . . . . 0.0 111.044 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -37.27 -57.19 0.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.207 2.203 . . . . 0.0 112.168 179.24 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.15 -34.52 0.18 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.512 1.925 . . . . 0.0 113.677 -178.417 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.55 -57.89 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.497 0.719 . . . . 0.0 110.625 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -64.27 -24.07 67.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -172.212 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -73.59 -22.0 60.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 119.986 1.266 . . . . 0.0 111.052 177.231 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -107.5 -24.76 11.68 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.91 0.884 . . . . 0.0 111.683 -178.304 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.35 32.62 51.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.78 140.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.57 28.8 6.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -177.192 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.98 77.0 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.319 -0.712 . . . . 0.0 112.892 179.39 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 130.76 82.88 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 118.798 1.299 . . . . 0.0 108.644 176.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.14 121.73 9.49 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.601 2.201 . . . . 0.0 108.648 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -89.28 178.67 6.28 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.954 0.883 . . . . 0.0 113.277 -171.335 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.9 160.92 29.8 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.729 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.78 52.9 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.769 1.628 . . . . 0.0 111.674 177.165 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.23 64.34 19.71 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 110.456 -177.518 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -38.68 -50.55 2.43 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.302 3.335 . . . . 0.0 114.099 -177.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -49.22 -39.98 31.92 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.179 0.992 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -64.16 -28.65 69.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.259 0.624 . . . . 0.0 111.337 -179.15 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.83 -27.01 13.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.712 1.205 . . . . 0.0 112.384 -174.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.84 -43.88 0.98 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.061 1.744 . . . . 0.0 113.744 -178.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.8 -15.89 25.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.586 0.754 . . . . 0.0 112.771 -176.373 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.3 133.93 44.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 109.597 -177.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.19 105.32 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.991 2.461 . . . . 0.0 110.302 176.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.98 -24.87 63.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.876 0.87 . . . . 0.0 113.038 -175.56 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -52.48 102.24 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.441 1.497 . . . . 0.0 111.424 179.781 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.0 t -47.6 -45.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.293 1.037 . . . . 0.0 110.255 179.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.35 -29.32 58.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.915 1.286 . . . . 0.0 112.168 -179.014 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -86.19 -50.73 6.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.431 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.3 mt -50.46 -40.94 52.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.062 0.545 . . . . 0.0 112.21 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -59.6 -30.8 45.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.984 178.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.7 -50.04 68.54 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.224 1.375 . . . . 0.0 108.471 177.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -53.81 -42.67 68.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.173 0.589 . . . . 0.0 110.128 176.238 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -68.22 -44.36 75.9 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.813 0.34 . . . . 0.0 110.681 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.66 -47.24 86.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.83 -31.19 51.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 112.716 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 159.0 28.58 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -175.075 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.495 ' H ' ' HB3' ' A' ' 55' ' ' MET . 53.9 tttp -156.77 124.55 5.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.86 -114.89 6.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.3 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.67 -18.86 33.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.738 0.815 . . . . 0.0 112.028 178.243 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.4 ttp -62.25 124.57 82.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 118.948 0.795 . . . . 0.0 110.439 -176.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.49 158.24 51.44 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.082 1.854 . . . . 0.0 109.31 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 114.5 6.57 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.78 -7.41 58.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.306 179.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.74 113.18 0.66 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.842 0.747 . . . . 0.0 110.936 177.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 -27.18 11.55 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.164 0.887 . . . . 0.0 112.331 179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.73 -49.73 13.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -130.71 134.56 47.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.183 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.69 149.0 34.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.472 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -27.72 -50.16 0.06 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.144 1.777 . . . . 0.0 112.402 168.641 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -69.02 -39.63 79.13 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.638 -0.664 . . . . 0.0 112.21 -178.637 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.38 -53.27 60.15 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.618 1.099 . . . . 0.0 108.208 175.595 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 62' ' ' ALA . 54.7 mt -49.61 -59.4 3.82 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 125.802 1.641 . . . . 0.0 109.155 177.158 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 t -43.19 -57.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 109.077 176.243 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -58.63 -31.96 68.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.545 -0.74 . . . . 0.0 112.106 -176.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.87 -52.63 14.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.222 0.919 . . . . 0.0 109.262 176.93 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.7 mt -53.03 -39.71 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.468 1.107 . . . . 0.0 110.073 178.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -52.31 -56.61 13.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.092 0.86 . . . . 0.0 109.637 176.226 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -55.83 -53.88 51.37 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.3 ttm -47.22 -61.07 2.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.101 0.96 . . . . 0.0 110.331 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.45 -35.74 78.45 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.042 -0.411 . . . . 0.0 111.137 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -62.53 -5.0 2.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.787 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -88.97 -13.83 38.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.393 1.451 . . . . 0.0 111.265 176.399 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.638 -176.659 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.28 -55.26 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.431 1.014 . . . . 0.0 108.759 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -69.56 -50.46 44.55 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -178.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.38 -50.53 72.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.531 -174.425 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -158.73 51.86 0.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -169.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.38 35.7 0.52 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.408 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.23 154.41 50.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.228 1.811 . . . . 0.0 106.586 175.48 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.58 105.34 10.89 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.091 -176.187 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.21 155.97 77.1 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.208 1.11 . . . . 0.0 110.417 -7.038 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 129.9 42.42 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.615 1.166 . . . . 0.0 110.719 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -52.47 -48.51 65.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.409 1.1 . . . . 0.0 110.143 178.721 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -49.29 -39.57 31.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.334 1.853 . . . . 0.0 112.207 179.205 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -47.0 -40.39 14.44 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.893 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -99.37 -51.29 3.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.954 0.783 . . . . 0.0 110.929 -177.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -69.27 -22.97 63.78 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.7 -42.9 90.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.469 1.031 . . . . 0.0 110.127 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.01 -25.32 17.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.701 0.8 . . . . 0.0 111.569 179.181 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 37.83 13.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.027 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.18 149.09 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -176.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.29 30.11 7.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.136 0.974 . . . . 0.0 111.291 -178.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.75 23.16 78.39 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.63 132.57 91.3 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.908 1.354 . . . . 0.0 108.132 176.382 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.63 118.08 5.03 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.181 1.92 . . . . 0.0 107.778 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -75.72 162.72 27.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.834 0.825 . . . . 0.0 111.52 -174.343 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.95 159.47 34.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 170.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.57 56.8 2.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.599 1.159 . . . . 0.0 111.191 -177.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 63.3 5.45 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 0.0 109.65 -177.679 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -45.35 -44.5 16.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.063 3.175 . . . . 0.0 113.43 -175.116 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -50.0 -34.59 21.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.904 0.881 . . . . 0.0 112.335 178.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.11 -28.61 64.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.025 0.53 . . . . 0.0 111.455 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -99.09 -15.68 18.92 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.417 1.087 . . . . 0.0 111.958 -176.162 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.36 -45.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.236 1.814 . . . . 0.0 112.935 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.33 30.47 7.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.042 0.937 . . . . 0.0 112.638 -176.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -121.1 124.42 27.39 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 108.074 177.604 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.88 108.71 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.417 2.745 . . . . 0.0 110.826 178.121 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.01 -24.78 59.67 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.589 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -49.1 105.54 0.08 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.016 1.727 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -49.45 -45.25 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.484 0.714 . . . . 0.0 109.442 177.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.44 -23.4 49.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.858 1.263 . . . . 0.0 113.145 -179.122 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.58 -55.05 3.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.1 mt -50.82 -39.49 53.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.733 1.213 . . . . 0.0 112.444 -178.589 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.39 -35.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.623 -0.673 . . . . 0.0 109.949 179.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -48.8 75.08 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.173 0.897 . . . . 0.0 108.69 177.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -53.16 -37.35 61.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.696 0.798 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -75.15 -47.53 28.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.109 0.564 . . . . 0.0 109.996 -178.792 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.58 -48.8 80.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.441 1.097 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.02 -33.63 65.85 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.889 0.876 . . . . 0.0 110.921 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.32 86.85 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.255 0.919 . . . . 0.0 111.272 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -77.72 144.99 36.82 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.915 1.286 . . . . 0.0 109.97 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.91 5.99 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.018 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.69 -0.26 51.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.028 0.931 . . . . 0.0 112.424 -179.352 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.5 mtm -71.57 139.51 83.79 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 119.413 1.006 . . . . 0.0 111.179 -178.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.91 153.54 58.3 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 171.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.53 113.91 5.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -78.4 -16.16 57.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.533 -179.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -49.6 113.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.51 1.05 . . . . 0.0 110.511 175.285 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.41 -32.55 7.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.38 0.99 . . . . 0.0 111.493 -179.002 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -76.27 -46.21 29.0 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.397 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.51 138.26 39.49 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.488 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -79.1 147.65 32.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 68' ' ' VAL . 67.1 ttt-85 -30.53 -51.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.489 1.915 . . . . 0.0 111.782 169.412 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.32 -29.43 65.01 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.543 -0.723 . . . . 0.0 112.168 -176.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.31 -58.98 4.17 Favored 'General case' 0 N--CA 1.459 0.021 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.18 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 62' ' ' ALA . 74.5 mt -44.18 -55.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.097 1.759 . . . . 0.0 110.18 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ARG . 3.3 t -38.5 -51.66 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 111.266 178.306 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -59.0 -47.0 86.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.451 0.643 . . . . 0.0 110.791 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.44 94.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.929 -0.482 . . . . 0.0 109.775 -179.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.41 -49.47 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.501 1.12 . . . . 0.0 110.405 -178.649 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.1 -41.12 99.3 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.155 -0.966 . . . . 0.0 109.243 -179.334 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -58.17 -55.7 31.54 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.838 0.745 . . . . 0.0 109.299 176.66 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.8 ttm -43.34 -53.29 5.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.201 1.8 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.52 -38.51 91.27 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.995 -0.44 . . . . 0.0 111.348 178.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.9 m -75.25 45.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.861 0.864 . . . . 0.0 113.024 -178.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.2 p -138.77 -18.96 1.04 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.091 1.756 . . . . 0.0 110.398 173.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.492 -1.718 . . . . 0.0 110.922 -177.478 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.1 -41.2 52.81 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.95 -52.58 64.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -51.11 -52.34 44.69 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.592 0.633 . . . . 0.0 110.511 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.2 mt -53.0 -59.66 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.534 0.734 . . . . 0.0 109.544 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -52.17 -49.07 64.55 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.834 0.854 . . . . 0.0 112.435 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 52.9 mt -72.1 -50.65 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.804 -0.617 . . . . 0.0 111.556 -174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -138.98 -17.09 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -171.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -91.99 36.1 3.77 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 120.075 1.307 . . . . 0.0 111.34 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.0 p -136.77 150.51 48.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.611 1.564 . . . . 0.0 108.013 178.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.18 109.59 5.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 124.653 1.181 . . . . 0.0 109.274 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.33 153.68 31.56 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 CA-C-N 120.105 1.073 . . . . 0.0 111.82 -9.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.45 124.85 24.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.737 1.215 . . . . 0.0 109.667 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 m -58.03 -48.1 81.1 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.041 0.448 . . . . 0.0 110.418 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.1 p -39.59 -56.86 1.59 Allowed 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 126.447 1.899 . . . . 0.0 112.253 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -43.52 -31.61 0.76 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.408 1.483 . . . . 0.0 113.375 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.2 m -104.28 -56.53 2.17 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.897 0.479 . . . . 0.0 111.277 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -68.62 -28.55 67.01 Favored 'General case' 0 C--N 1.334 -0.084 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.4 -39.24 93.98 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.95 0.795 . . . . 0.0 110.318 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ttm105 -95.32 -28.71 14.84 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.414 1.086 . . . . 0.0 111.978 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.04 40.6 6.12 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.81 133.18 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.69 31.24 7.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.628 1.171 . . . . 0.0 111.636 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.04 23.4 76.25 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.395 -0.669 . . . . 0.0 112.659 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.91 136.5 72.91 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 118.511 1.156 . . . . 0.0 108.402 175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.86 120.15 7.71 Favored 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.339 2.026 . . . . 0.0 108.596 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.49 167.96 16.93 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 122.254 1.026 . . . . 0.0 112.481 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.65 158.75 33.45 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.032 -0.985 . . . . 0.0 108.547 174.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.39 49.43 0.68 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.375 1.47 . . . . 0.0 111.9 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.23 62.17 19.47 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 125.651 1.58 . . . . 0.0 109.036 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -44.1 -41.41 12.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 124.238 3.292 . . . . 0.0 113.779 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mp0 -49.51 -41.11 40.06 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.514 1.125 . . . . 0.0 111.315 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.3 -24.89 67.81 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.671 0.788 . . . . 0.0 111.956 -178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -104.95 -30.87 9.53 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.316 1.046 . . . . 0.0 112.353 -174.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.59 -49.9 1.56 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.627 1.571 . . . . 0.0 112.795 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -74.62 -27.68 60.56 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -76.74 151.0 82.25 Favored Pre-proline 0 CA--C 1.534 0.333 0 O-C-N 121.64 -0.663 . . . . 0.0 110.03 -177.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.08 85.83 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.88 2.387 . . . . 0.0 107.982 173.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.45 -25.55 25.75 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 126.56 1.944 . . . . 0.0 113.304 -171.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.3 m -48.17 113.82 0.82 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.495 1.118 . . . . 0.0 110.651 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.81 -46.14 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.373 1.069 . . . . 0.0 110.512 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -58.19 -24.64 59.78 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.779 1.232 . . . . 0.0 112.852 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -90.06 -53.0 4.67 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.3 mt -47.85 -42.01 25.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.298 1.039 . . . . 0.0 111.861 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.44 -34.64 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.755 -0.591 . . . . 0.0 111.289 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -64.52 -50.12 68.62 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 119.375 0.988 . . . . 0.0 108.653 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.2 m -51.13 -46.1 61.84 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 123.673 0.789 . . . . 0.0 109.844 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.5 m -62.32 -50.56 71.16 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.825 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.02 -45.42 92.84 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.294 -0.879 . . . . 0.0 111.003 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.95 -32.67 67.53 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.877 0.871 . . . . 0.0 112.227 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.56 160.19 28.93 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -157.61 122.01 4.29 Favored 'General case' 0 CA--C 1.528 0.131 0 O-C-N 121.974 -0.721 . . . . 0.0 109.263 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.08 9.34 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.48 -25.02 53.86 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.003 0.521 . . . . 0.0 111.807 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.4 ttp -65.89 115.89 27.25 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.733 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -65.13 164.84 23.73 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.369 2.046 . . . . 0.0 110.947 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.33 134.68 50.69 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -97.03 -15.06 21.23 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -47.79 100.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.671 0.788 . . . . 0.0 112.624 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.05 -37.97 3.45 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.062 1.315 . . . . 0.0 111.781 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.0 mtm-85 -76.42 -38.92 54.85 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.786 0.793 . . . . 0.0 110.134 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.65 136.61 46.58 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 173.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -81.79 144.83 30.79 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.3 ttt-85 -32.31 -44.95 0.1 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.63 1.972 . . . . 0.0 111.496 171.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -61.64 -49.53 76.17 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.942 0.792 . . . . 0.0 111.561 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -56.1 -56.92 15.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 122.728 1.251 . . . . 0.0 108.626 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 62.4 mt -48.62 -58.56 4.54 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.823 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.3 t -46.09 -53.54 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 124.426 1.09 . . . . 0.0 110.024 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -59.02 -39.03 80.67 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.656 0.382 . . . . 0.0 111.192 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.78 -43.56 71.9 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.604 -0.685 . . . . 0.0 110.151 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.2 mt -63.47 -49.95 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.601 1.16 . . . . 0.0 109.825 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.07 -39.14 85.0 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.135 0.88 . . . . 0.0 109.228 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.1 -47.51 85.58 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.8 mtp -54.03 -59.31 4.82 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mp -55.01 -35.94 64.91 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.836 0.854 . . . . 0.0 112.634 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.9 p -62.9 -10.65 14.22 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.419 1.008 . . . . 0.0 113.173 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -89.62 -11.61 42.11 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.783 1.174 . . . . 0.0 111.558 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 116.216 -1.85 . . . . 0.0 111.875 -175.068 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 21.4 t70 . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.36 -41.24 24.07 Favored Glycine 0 CA--C 1.53 0.988 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -55.77 -53.72 53.23 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -53.82 41.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.06 0.544 . . . . 0.0 110.057 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.2 mt -53.96 -57.46 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 123.699 0.799 . . . . 0.0 110.175 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -57.71 -49.25 77.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.825 0.85 . . . . 0.0 112.31 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.15 -48.19 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-O 118.578 -0.725 . . . . 0.0 112.084 -172.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -134.52 -18.19 1.95 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -171.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.85 -34.43 38.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.842 1.201 . . . . 0.0 112.364 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 p -73.06 151.32 41.74 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 117.419 0.609 . . . . 0.0 110.444 -178.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.68 106.72 6.42 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.872 1.269 . . . . 0.0 108.559 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.16 150.65 36.01 Favored 'Cis proline' 0 N--CA 1.457 -0.626 0 CA-C-N 120.351 1.161 . . . . 0.0 111.738 -5.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.06 124.53 22.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 124.676 1.19 . . . . 0.0 109.142 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -54.43 -46.34 73.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 119.026 0.83 . . . . 0.0 110.558 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 p -40.4 -52.46 2.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.111 2.165 . . . . 0.0 112.338 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -38.47 -48.2 1.36 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.86 1.264 . . . . 0.0 112.082 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.9 m -93.02 -55.05 3.48 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.208 -177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -64.84 -25.95 68.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -74.57 -17.27 60.75 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 120.289 1.404 . . . . 0.0 111.356 176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.9 mtt85 -119.72 -15.05 8.97 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.963 0.905 . . . . 0.0 112.466 -174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.74 34.23 44.2 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 72.2 t -55.13 132.62 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.34 31.53 7.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.729 1.211 . . . . 0.0 111.911 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.61 22.24 75.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 119.398 -0.668 . . . . 0.0 113.044 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.15 131.66 80.5 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 118.707 1.253 . . . . 0.0 109.324 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -63.7 119.57 6.66 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.411 2.074 . . . . 0.0 108.211 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -87.39 179.78 6.52 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.811 0.815 . . . . 0.0 112.567 -172.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -65.43 159.37 24.42 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 173.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.14 54.11 0.73 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.084 1.754 . . . . 0.0 112.238 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.21 58.56 15.4 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 124.034 0.933 . . . . 0.0 110.96 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -38.48 -48.27 2.51 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.557 3.505 . . . . 0.0 114.152 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -47.77 -40.1 19.78 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.363 1.465 . . . . 0.0 111.988 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -75.71 -27.9 58.38 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.923 0.329 . . . . 0.0 111.455 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -90.94 -26.14 19.42 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.756 0.822 . . . . 0.0 112.004 -177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -34.76 -46.81 0.31 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.493 2.317 . . . . 0.0 114.456 -177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -103.05 2.7 35.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -83.37 158.29 63.78 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 118.978 0.808 . . . . 0.0 109.821 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.01 120.88 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.258 2.639 . . . . 0.0 110.833 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -64.36 -39.16 93.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -82.35 133.33 35.22 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 122.067 -0.395 . . . . 0.0 111.115 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.6 t -52.98 -40.7 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -54.34 -29.48 48.14 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.024 1.33 . . . . 0.0 112.598 177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.28 -52.49 6.88 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.89 -40.15 60.2 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 m -60.2 -33.97 55.43 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 CA-C-N 119.528 1.058 . . . . 0.0 110.743 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -62.47 -49.81 73.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.1 m -52.27 -46.95 66.06 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.453 0.57 . . . . 0.0 109.817 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.9 m -61.12 -40.35 93.45 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.491 0.717 . . . . 0.0 111.487 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . 0.286 0.9 OUTLIER -111.02 36.65 3.07 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 175.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.37 -44.49 2.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.474 1.91 . . . . 0.0 107.175 167.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.33 145.63 9.76 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.89 1.71 . . . . 0.0 109.462 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -156.36 132.95 10.18 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.8 -117.64 11.5 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.36 1.01 38.08 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.186 0.994 . . . . 0.0 112.064 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.7 ttp -69.58 122.83 87.03 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 119.067 0.849 . . . . 0.0 110.308 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.82 152.55 47.23 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.155 1.903 . . . . 0.0 108.86 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.58 119.14 13.37 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -76.34 1.97 14.75 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -46.37 112.51 0.5 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 110.924 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.37 -30.01 6.73 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 123.636 0.636 . . . . 0.0 112.149 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -72.7 -46.28 54.51 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.29 124.56 13.78 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -79.0 155.4 28.88 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -29.32 -49.81 0.09 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.496 1.918 . . . . 0.0 111.852 170.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -64.7 -41.05 96.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.258 0.936 . . . . 0.0 112.304 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -63.12 -58.0 8.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 122.437 1.113 . . . . 0.0 108.443 176.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 52.3 mt -46.03 -57.9 4.04 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 127.047 2.139 . . . . 0.0 110.48 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -39.84 -55.37 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 0.0 110.813 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -60.58 -37.25 80.7 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.284 1.034 . . . . 0.0 111.816 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.96 -50.64 32.27 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.74 -0.6 . . . . 0.0 109.442 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.67 -50.85 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.049 0.94 . . . . 0.0 110.785 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.94 -41.65 92.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.847 1.203 . . . . 0.0 110.065 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -59.03 -51.52 69.71 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.27 -53.61 48.35 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -58.33 -38.24 76.74 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.118 0.567 . . . . 0.0 111.78 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 63.7 p -63.5 -5.22 3.49 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -87.06 -12.43 47.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.771 1.168 . . . . 0.0 111.093 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 116.656 -1.64 . . . . 0.0 110.197 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.65 -0.691 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.83 -40.36 26.29 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.99 -54.86 42.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.32 -49.39 64.34 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.357 0.663 . . . . 0.0 110.383 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.02 -58.15 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -53.2 -50.24 65.07 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.176 0.99 . . . . 0.0 112.17 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 65.2 mt -69.21 -48.04 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 118.73 -0.652 . . . . 0.0 111.468 -174.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -145.32 -12.74 0.53 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -172.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.55 38.85 2.99 Favored Glycine 0 CA--C 1.523 0.58 0 CA-C-N 120.244 1.384 . . . . 0.0 111.257 -175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.16 153.76 51.17 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.135 1.374 . . . . 0.0 109.073 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.08 108.63 8.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.495 1.118 . . . . 0.0 110.968 -177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -57.02 159.27 24.89 Favored 'Cis proline' 0 N--CA 1.459 -0.556 0 CA-C-N 119.843 0.98 . . . . 0.0 111.83 -12.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.82 122.66 19.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.484 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -54.72 -47.51 73.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.49 0.662 . . . . 0.0 110.712 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 7.4 p -41.48 -52.47 3.64 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 126.339 1.856 . . . . 0.0 112.263 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -48.51 -24.78 1.4 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.065 1.346 . . . . 0.0 113.874 -178.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.8 m -109.03 -54.1 2.57 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.743 0.817 . . . . 0.0 110.951 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -69.84 -21.67 63.35 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.25 -58.05 9.88 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.366 0.985 . . . . 0.0 109.773 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -26.29 32.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.635 0.374 . . . . 0.0 111.563 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.21 43.81 6.15 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.32 144.4 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.47 29.8 7.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.076 0.95 . . . . 0.0 111.491 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.78 22.27 79.16 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.05 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.71 132.64 88.96 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 118.754 1.277 . . . . 0.0 108.409 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -62.17 119.02 5.93 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.793 2.329 . . . . 0.0 109.398 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -82.55 177.79 8.54 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.9 0.857 . . . . 0.0 111.255 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mt -82.98 157.53 22.92 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.7 m120 50.4 41.48 24.89 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.375 1.07 . . . . 0.0 109.94 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.28 52.93 8.64 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 124.443 1.097 . . . . 0.0 110.24 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -46.88 -39.61 24.63 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.75 2.967 . . . . 0.0 112.643 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -49.66 -40.63 40.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.404 1.081 . . . . 0.0 111.48 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -74.41 -27.36 60.59 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.234 0.614 . . . . 0.0 111.199 -178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -90.06 -27.24 19.82 Favored 'General case' 0 C--O 1.225 -0.189 0 O-C-N 121.839 -0.538 . . . . 0.0 111.697 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.2 -50.58 0.73 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.6 1.96 . . . . 0.0 113.503 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -79.74 -23.43 42.29 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -74.62 135.5 75.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.647 -0.658 . . . . 0.0 109.423 -177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.72 113.99 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.295 1.997 . . . . 0.0 111.256 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.61 -32.4 58.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.144 0.978 . . . . 0.0 111.834 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -53.99 101.81 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.457 1.503 . . . . 0.0 111.279 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -45.43 -40.82 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.011 1.324 . . . . 0.0 109.933 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -45.94 -36.52 5.54 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.963 2.105 . . . . 0.0 112.639 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -84.03 -50.14 8.26 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.0 mt -52.66 -39.27 61.68 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 124.046 0.938 . . . . 0.0 112.019 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.3 m -60.1 -36.07 65.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.143 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -67.5 -48.76 66.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.677 1.126 . . . . 0.0 108.451 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.3 m -50.7 -46.42 58.86 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -67.34 -50.89 58.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.649 0.379 . . . . 0.0 111.179 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -60.0 -44.77 94.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.188 -0.945 . . . . 0.0 111.031 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.32 -35.36 54.91 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.544 0.738 . . . . 0.0 112.462 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.94 158.23 24.36 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 -174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -164.47 133.53 3.67 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 117.891 0.846 . . . . 0.0 109.803 -176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.76 -84.84 0.28 Allowed Glycine 0 C--N 1.336 0.567 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.96 -6.28 2.39 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 126.193 1.797 . . . . 0.0 111.453 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.3 ttp -64.61 124.01 84.83 Favored Pre-proline 0 N--CA 1.452 -0.367 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.067 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.593 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 71.8 Cg_endo -70.49 158.68 55.28 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.124 1.883 . . . . 0.0 109.251 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.7 147.02 53.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -111.81 -12.75 13.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.098 1.359 . . . . 0.0 111.232 174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -48.75 123.04 6.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.416 1.086 . . . . 0.0 110.136 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.6 -26.07 23.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 119.09 -0.839 . . . . 0.0 112.387 178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -97.74 -54.64 3.05 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.498 1.149 . . . . 0.0 110.361 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.03 125.91 33.12 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -78.55 51.39 1.06 Allowed 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 125.719 1.608 . . . . 0.0 111.921 -177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 52.05 -62.17 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 129.928 3.291 . . . . 0.0 113.734 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -50.92 -34.85 30.24 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.763 1.225 . . . . 0.0 110.546 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -53.0 -56.63 14.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.734 1.614 . . . . 0.0 109.143 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 mt -61.07 -53.32 58.54 Favored 'General case' 0 N--CA 1.421 -1.921 0 C-N-CA 125.44 1.496 . . . . 0.0 109.684 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.2 t -43.39 -57.51 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 122.899 0.479 . . . . 0.0 109.875 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -60.72 -43.86 97.34 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.876 0.471 . . . . 0.0 112.056 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.03 -44.55 95.6 Favored 'General case' 0 C--O 1.225 -0.214 0 O-C-N 121.802 -0.561 . . . . 0.0 110.398 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -67.89 -49.63 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 125.49 1.516 . . . . 0.0 110.087 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -60.69 -39.81 89.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.805 -1.158 . . . . 0.0 108.651 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -58.22 -53.05 62.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.389 0.54 . . . . 0.0 109.617 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.7 mtp -48.25 -58.58 4.35 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -55.61 -39.86 71.33 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.811 0.844 . . . . 0.0 112.078 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.0 m -67.17 -6.53 18.26 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.506 -0.746 . . . . 0.0 112.006 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 m -119.14 42.44 2.83 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.597 1.559 . . . . 0.0 109.635 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.249 1.045 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.136 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.593 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.9 -38.0 36.95 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -56.25 -57.37 12.52 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.787 0.435 . . . . 0.0 110.169 178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 p -56.61 -46.41 80.9 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.859 -0.526 . . . . 0.0 110.567 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.7 mt -53.91 -57.53 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 109.978 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -57.07 -50.34 73.06 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.236 1.014 . . . . 0.0 111.695 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.91 -51.18 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.88 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.31 40.36 0.31 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.996 0.816 . . . . 0.0 112.851 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.76 38.94 1.51 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 157.51 45.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.231 1.813 . . . . 0.0 108.44 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 123.714 0.805 . . . . 0.0 110.629 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -57.06 160.35 23.48 Favored 'Cis proline' 0 N--CA 1.459 -0.553 0 CA-C-N 119.941 1.015 . . . . 0.0 111.878 -12.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -68.31 127.45 32.99 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.706 0.802 . . . . 0.0 109.558 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -57.71 -50.77 72.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.457 0.646 . . . . 0.0 111.199 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -39.42 -56.13 1.64 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 126.642 1.977 . . . . 0.0 112.986 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -40.67 -38.0 0.83 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.337 1.455 . . . . 0.0 112.564 -178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.8 m -96.83 -59.25 1.84 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 0.0 110.372 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -60.69 -46.11 91.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -22.18 64.7 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.862 0.301 . . . . 0.0 111.759 -175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -114.87 11.99 16.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.209 1.004 . . . . 0.0 111.293 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 49.71 38.39 29.37 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.124 0.869 . . . . 0.0 113.63 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.8 t -55.14 132.74 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.52 31.44 7.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.682 1.193 . . . . 0.0 111.883 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.71 22.32 75.12 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.742 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.49 136.25 82.02 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 118.253 1.027 . . . . 0.0 108.697 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.9 Cg_endo -60.22 126.94 21.47 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.346 2.031 . . . . 0.0 109.626 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -94.07 174.47 7.14 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.449 0.643 . . . . 0.0 112.014 -174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -65.82 162.3 19.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 171.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.09 53.6 0.93 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.758 1.623 . . . . 0.0 112.125 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.79 64.5 22.18 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 124.235 1.014 . . . . 0.0 109.914 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -41.17 -51.55 3.87 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.024 3.15 . . . . 0.0 114.29 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -44.15 -51.92 7.71 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.144 1.378 . . . . 0.0 110.843 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -50.55 -45.38 56.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.953 0.901 . . . . 0.0 110.851 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.432 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 92.1 m95 -85.6 -30.6 23.17 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.325 0.65 . . . . 0.0 111.379 -173.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.17 -42.41 93.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.411 1.084 . . . . 0.0 109.408 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.89 -42.15 97.55 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.915 0.388 . . . . 0.0 110.014 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -74.85 162.66 72.61 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 123.528 0.731 . . . . 0.0 111.266 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -68.03 84.33 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.36 2.04 . . . . 0.0 107.798 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -48.9 -28.82 4.08 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.462 1.905 . . . . 0.0 113.247 -174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.79 106.82 0.09 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.748 2.019 . . . . 0.0 110.911 177.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.0 t -47.75 -44.41 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.248 1.019 . . . . 0.0 110.939 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -53.78 -36.0 61.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.755 1.622 . . . . 0.0 111.842 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.69 -50.7 10.22 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.7 -42.31 45.52 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 124.128 0.971 . . . . 0.0 112.408 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.62 -36.11 68.19 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.818 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -65.46 -49.43 69.14 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 119.763 1.165 . . . . 0.0 108.581 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.9 m -52.07 -46.11 65.02 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.078 0.466 . . . . 0.0 109.812 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -65.19 -49.98 67.69 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.761 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -61.53 -45.29 94.82 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 121.315 -0.866 . . . . 0.0 110.81 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.89 -35.79 74.91 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.715 0.806 . . . . 0.0 111.819 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.81 164.95 26.04 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -156.36 106.98 2.39 Favored 'General case' 0 CA--C 1.528 0.112 0 O-C-N 121.85 -0.794 . . . . 0.0 109.389 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.59 -111.55 3.33 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.79 68.83 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.088 0.555 . . . . 0.0 111.117 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -65.0 117.96 44.38 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.323 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 85.6 Cg_endo -72.47 157.51 52.8 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.531 2.154 . . . . 0.0 109.644 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.18 145.68 52.8 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.456 0.302 . . . . 0.0 110.302 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -110.81 -12.31 14.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.192 1.397 . . . . 0.0 111.349 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -46.51 123.58 5.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.978 1.311 . . . . 0.0 110.548 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 93.69 -25.38 21.5 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.119 0.866 . . . . 0.0 112.34 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 59.0 mtm-85 -98.1 -57.1 2.3 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.384 1.092 . . . . 0.0 110.325 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.11 119.61 26.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.46 84.92 4.58 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.0 ttm-85 15.32 -59.35 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 131.389 3.876 . . . . 0.0 115.866 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -48.28 -35.39 12.07 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.2 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -54.99 -59.75 4.32 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.211 1.405 . . . . 0.0 108.787 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.3 mt -55.51 -53.84 51.34 Favored 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 126.282 1.833 . . . . 0.0 109.858 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.3 t -45.38 -57.03 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.32 0.648 . . . . 0.0 109.422 176.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -60.3 -41.24 93.01 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.766 -0.584 . . . . 0.0 111.651 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.93 -42.36 99.01 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.787 -0.571 . . . . 0.0 109.787 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.3 mt -65.88 -44.18 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 124.64 1.176 . . . . 0.0 108.565 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.14 -50.72 68.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -55.26 -51.64 65.98 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 118.938 -0.553 . . . . 0.0 110.522 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.7 mtt -47.57 -63.79 0.96 Allowed 'General case' 0 C--N 1.341 0.233 0 CA-C-O 122.113 0.959 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -53.3 -36.05 60.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.069 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.4 m -72.07 34.57 0.06 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.656 1.116 . . . . 0.0 113.94 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.7 p -134.21 -10.86 2.55 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.662 1.585 . . . . 0.0 109.85 171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--O 1.251 1.145 0 CA-C-O 116.579 -1.677 . . . . 0.0 110.093 -178.771 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.451 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.55 -42.97 52.42 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 175.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.6 -57.12 14.32 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.031 176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m -44.71 -50.37 10.02 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.695 1.134 . . . . 0.0 111.633 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.45 -60.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 125.893 1.677 . . . . 0.0 110.671 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -54.75 -48.08 73.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.83 0.852 . . . . 0.0 111.589 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.29 -49.98 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.457 1.103 . . . . 0.0 111.021 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.65 33.77 0.27 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -173.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -138.42 37.85 1.75 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.16 156.04 48.13 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.287 1.835 . . . . 0.0 107.751 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.42 108.82 6.73 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 118.621 -0.704 . . . . 0.0 109.859 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.8 155.73 27.72 Favored 'Cis proline' 0 N--CA 1.457 -0.645 0 CA-C-N 120.074 1.062 . . . . 0.0 111.581 -9.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.17 128.88 38.02 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 123.54 0.736 . . . . 0.0 109.344 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.3 m -58.35 -49.41 77.3 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 0.0 110.117 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.0 p -41.18 -55.5 2.63 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 126.405 1.882 . . . . 0.0 113.49 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.27 -36.38 3.98 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.941 0.896 . . . . 0.0 112.339 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 54.1 m -94.41 -57.91 2.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.679 0.276 . . . . 0.0 110.933 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -67.06 -36.12 81.35 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -68.21 -33.84 75.16 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -84.46 -26.8 27.94 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.112 0.965 . . . . 0.0 111.122 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.18 33.3 57.13 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.62 139.46 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.9 29.43 6.05 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.126 0.97 . . . . 0.0 111.572 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.22 24.49 76.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-O 119.399 -0.667 . . . . 0.0 112.718 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.67 80.41 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 118.608 1.204 . . . . 0.0 108.275 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.6 122.01 10.61 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.257 1.972 . . . . 0.0 110.051 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -90.56 177.18 6.43 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.606 0.717 . . . . 0.0 111.65 -174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.99 156.77 29.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 51.08 35.48 13.08 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.614 0.766 . . . . 0.0 111.845 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.79 67.27 79.09 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.06 1.344 . . . . 0.0 110.352 -177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -42.18 -50.82 5.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.148 3.232 . . . . 0.0 114.454 -174.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -50.93 -35.21 32.09 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.946 1.299 . . . . 0.0 112.227 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -65.37 -27.66 68.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.149 0.431 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -101.53 -35.42 9.16 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.548 1.139 . . . . 0.0 112.097 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.34 -51.01 1.07 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.587 1.555 . . . . 0.0 113.125 -178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.89 -23.18 45.0 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -79.53 144.28 60.95 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -59.38 93.67 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.72 2.28 . . . . 0.0 108.457 173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -57.56 -21.12 36.64 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.044 1.337 . . . . 0.0 112.994 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.41 106.93 0.11 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.571 1.948 . . . . 0.0 110.455 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.0 -42.14 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 123.937 0.895 . . . . 0.0 110.632 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -56.82 -31.23 64.52 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.371 1.469 . . . . 0.0 112.36 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.83 -53.49 5.3 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 mt -48.62 -45.61 38.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.502 0.721 . . . . 0.0 111.877 -178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.8 p -62.94 -35.98 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 121.854 -0.529 . . . . 0.0 110.976 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.89 -45.09 75.44 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 m -53.96 -44.08 70.45 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.3 m -64.55 -50.61 66.62 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.81 0.444 . . . . 0.0 110.49 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 mt -58.48 -44.97 89.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.411 -0.806 . . . . 0.0 110.924 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.9 68.49 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.799 0.84 . . . . 0.0 112.288 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.09 161.25 26.47 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -175.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -159.66 117.31 2.68 Favored 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.892 -0.769 . . . . 0.0 109.215 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.18 -117.62 11.63 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.44 54.33 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.883 0.473 . . . . 0.0 111.447 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -67.98 121.47 79.99 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 118.784 0.72 . . . . 0.0 110.112 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 92.0 Cg_endo -74.73 161.29 39.67 Favored 'Trans proline' 0 N--CA 1.45 -1.088 0 C-N-CA 122.629 2.219 . . . . 0.0 110.195 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.02 136.83 57.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -100.89 -14.05 18.09 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.121 0.968 . . . . 0.0 113.247 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -49.41 102.83 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.311 0.644 . . . . 0.0 112.142 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.73 -36.24 4.28 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 125.14 1.352 . . . . 0.0 111.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -79.17 -41.11 29.19 Favored 'General case' 0 CA--C 1.527 0.078 0 CA-C-N 117.828 0.814 . . . . 0.0 110.184 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.501 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.35 132.76 39.87 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 173.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.56 144.94 30.92 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -28.29 -52.47 0.09 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 170.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -62.45 -40.65 97.31 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.674 -0.641 . . . . 0.0 112.033 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -61.23 -58.91 6.38 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-O 122.429 1.109 . . . . 0.0 108.199 177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD21 ' HB3' ' A' ' 62' ' ' ALA . 77.9 mt -46.09 -56.02 6.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.493 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 t -41.53 -54.49 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 124.815 1.246 . . . . 0.0 110.572 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.6 mttp -57.04 -42.53 80.68 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 122.342 -0.224 . . . . 0.0 111.099 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.46 -44.99 81.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.54 -45.47 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 C-N-CA 123.578 0.751 . . . . 0.0 109.344 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -55.1 -51.0 67.77 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 123.875 0.87 . . . . 0.0 108.824 176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -55.87 -52.05 65.43 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.414 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 48.6 mtp -49.73 -54.41 19.06 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.391 0.677 . . . . 0.0 109.641 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.19 -36.81 76.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.03 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 37.6 m -74.41 42.49 0.16 Allowed 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.468 -0.77 . . . . 0.0 112.766 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.5 p -135.93 -7.78 2.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.77 1.228 . . . . 0.0 110.307 173.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.199 0 CA-C-O 117.22 -1.371 . . . . 0.0 108.999 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.407 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 118.612 -0.708 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.51 -39.55 22.69 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.525 1.059 . . . . 0.0 111.719 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -60.14 -59.59 5.17 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -49.3 -50.23 40.25 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.865 1.266 . . . . 0.0 110.736 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.7 -59.78 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.632 1.573 . . . . 0.0 109.96 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -58.12 -48.56 79.85 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.135 0.574 . . . . 0.0 111.441 -179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.6 mt -69.84 -46.27 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 118.913 -0.565 . . . . 0.0 110.877 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.69 39.07 0.19 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.45 39.49 1.16 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -139.16 156.9 46.79 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.458 1.903 . . . . 0.0 107.496 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.51 108.17 6.63 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.814 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.32 154.55 31.27 Favored 'Cis proline' 0 N--CA 1.457 -0.642 0 CA-C-N 120.104 1.073 . . . . 0.0 111.827 -9.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -67.08 121.73 16.24 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.561 1.145 . . . . 0.0 109.179 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -52.71 -49.71 64.82 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.206 0.527 . . . . 0.0 110.496 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.7 p -43.39 -51.26 6.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 126.029 1.732 . . . . 0.0 112.77 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.3 m -47.39 -34.21 6.81 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.655 0.782 . . . . 0.0 112.548 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 23.7 m -96.85 -55.74 2.79 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 120.676 0.274 . . . . 0.0 110.871 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -66.06 -36.91 84.5 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.99 -43.26 88.27 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -72.55 -30.23 64.25 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.626 0.77 . . . . 0.0 111.076 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.2 56.4 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 -175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.02 143.15 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.63 30.69 6.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.11 0.964 . . . . 0.0 111.383 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.43 27.56 73.71 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 119.622 -0.543 . . . . 0.0 112.494 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.32 131.89 90.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.51 1.155 . . . . 0.0 108.299 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.444 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.0 Cg_endo -60.68 112.52 1.37 Allowed 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.756 2.304 . . . . 0.0 109.564 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -76.54 175.33 9.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.638 1.208 . . . . 0.0 109.896 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.2 mp -88.63 140.77 29.11 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 68.29 35.43 3.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.231 1.013 . . . . 0.0 109.795 -174.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.89 58.23 37.42 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 118.333 -0.841 . . . . 0.0 112.218 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -38.79 -47.23 2.72 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.537 3.492 . . . . 0.0 114.315 -177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.7 mp0 -47.53 -40.46 18.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.488 1.515 . . . . 0.0 112.026 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.51 -25.64 54.42 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.954 0.343 . . . . 0.0 111.464 -177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.444 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 93.2 m95 -92.05 -23.48 19.48 Favored 'General case' 0 C--O 1.226 -0.154 0 C-N-CA 123.605 0.762 . . . . 0.0 111.734 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.71 -46.36 0.43 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.873 2.069 . . . . 0.0 114.155 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -101.07 -3.3 29.54 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 -83.74 145.78 48.07 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.423 -0.798 . . . . 0.0 109.849 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -50.78 118.59 4.3 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.993 2.462 . . . . 0.0 111.65 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 m -62.26 -32.71 73.45 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 103.94 0.13 Allowed 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 127.299 2.24 . . . . 0.0 111.507 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.09 -40.09 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 O-C-N 121.774 -0.579 . . . . 0.0 109.5 177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -55.02 -26.0 34.09 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.576 1.55 . . . . 0.0 112.428 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -89.67 -53.42 4.53 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.22 -40.89 48.78 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 121.542 0.687 . . . . 0.0 112.352 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -61.43 -31.52 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.668 -0.645 . . . . 0.0 110.38 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -65.85 -51.02 62.36 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.538 1.063 . . . . 0.0 108.296 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -49.97 -44.92 51.01 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.864 0.866 . . . . 0.0 109.98 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.8 m -64.54 -52.26 58.62 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.18 0.592 . . . . 0.0 110.948 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.51 -41.57 98.92 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 121.025 -1.047 . . . . 0.0 111.867 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.6 -33.96 31.25 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.971 0.909 . . . . 0.0 112.283 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.35 151.56 17.45 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.336 -1.905 . . . . 0.0 108.336 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' H ' ' HB3' ' A' ' 55' ' ' MET . 28.0 tptp -155.18 136.99 14.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.73 -115.68 7.55 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 -175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.07 -0.46 33.45 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.18 0.992 . . . . 0.0 111.964 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.456 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.2 ttp -65.43 127.0 92.58 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.891 0.769 . . . . 0.0 110.088 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.535 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 73.2 Cg_endo -69.84 154.74 67.08 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 121.708 1.605 . . . . 0.0 109.247 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 121.64 15.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.14 -10.18 57.98 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -53.79 84.86 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.451 1.101 . . . . 0.0 113.751 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 122.1 -30.91 5.09 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 126.452 1.977 . . . . 0.0 111.77 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.49 80.13 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.022 0.911 . . . . 0.0 109.338 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -133.8 147.44 51.24 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 176.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -82.75 142.17 31.81 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.9 ttt85 -34.15 -44.69 0.19 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.163 1.785 . . . . 0.0 112.422 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.57 -46.02 91.68 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.421 1.01 . . . . 0.0 111.068 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -55.84 -56.34 21.76 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 122.128 0.966 . . . . 0.0 108.394 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.52 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.3 mt -48.6 -60.41 2.73 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.256 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.6 t -43.85 -56.04 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.692 1.197 . . . . 0.0 110.063 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -58.6 -40.74 84.12 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.206 -0.309 . . . . 0.0 111.246 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.69 -55.32 27.89 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -49.83 -47.09 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.138 1.375 . . . . 0.0 110.099 177.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -53.98 -51.2 64.66 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.714 0.688 . . . . 0.0 109.239 176.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -57.56 -49.72 75.46 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.694 -0.67 . . . . 0.0 110.859 178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 71.0 mtp -49.11 -54.78 14.61 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.769 0.827 . . . . 0.0 109.525 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.5 mt -61.79 -35.16 77.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.469 0.707 . . . . 0.0 111.017 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 42.4 m -74.03 41.42 0.13 Allowed 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.351 -0.843 . . . . 0.0 113.188 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.6 p -138.37 -3.75 1.71 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.475 1.51 . . . . 0.0 110.044 173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.713 -1.613 . . . . 0.0 110.271 -174.648 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.535 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.8 t0 . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.1 52.32 0.66 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 106.491 -2.643 . . . . 0.0 106.491 172.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 38.33 60.51 1.28 Allowed 'General case' 0 C--N 1.341 0.226 0 C-N-CA 126.588 1.955 . . . . 0.0 110.952 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 p -156.11 -61.52 0.1 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.707 -176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.98 -53.97 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 118.423 0.556 . . . . 0.0 109.871 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -66.46 -39.34 88.77 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.711 0.404 . . . . 0.0 111.36 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -76.87 -50.82 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -172.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -138.5 -14.42 1.27 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.19 -37.72 31.49 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 119.748 1.158 . . . . 0.0 111.786 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -69.02 150.54 47.55 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 122.359 -0.495 . . . . 0.0 110.303 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.32 114.57 7.54 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 124.468 1.107 . . . . 0.0 108.549 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.23 151.49 18.19 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.504 1.216 . . . . 0.0 111.408 -13.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.11 121.75 16.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.796 1.639 . . . . 0.0 109.883 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 m -54.03 -48.68 70.25 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.417 0.627 . . . . 0.0 110.273 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -41.17 -56.16 2.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 126.918 2.087 . . . . 0.0 112.373 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.6 m -45.54 -33.98 3.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.501 1.12 . . . . 0.0 113.038 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.9 m -98.16 -57.66 2.16 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.054 0.388 . . . . 0.0 110.322 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -68.08 -16.8 64.17 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -95.91 5.87 50.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.783 0.72 . . . . 0.0 109.974 175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mmt-85 -128.71 -27.62 2.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.269 1.028 . . . . 0.0 112.232 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.42 27.07 62.17 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 140.05 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.96 29.22 5.91 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.091 0.956 . . . . 0.0 111.513 -177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.36 25.5 75.27 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.956 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.94 138.34 79.11 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.768 1.284 . . . . 0.0 108.977 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -62.83 110.36 1.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 N-CA-C 106.742 -2.061 . . . . 0.0 106.742 176.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -72.93 156.16 39.14 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -91.94 171.87 8.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.26 33.97 16.28 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -168.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.15 74.47 6.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-O 118.764 -0.636 . . . . 0.0 112.622 -170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -37.92 -50.94 1.97 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 124.359 3.373 . . . . 0.0 114.403 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -46.34 -43.23 15.81 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.194 1.397 . . . . 0.0 112.312 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.05 -22.04 66.92 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.504 0.722 . . . . 0.0 111.95 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -109.37 -29.42 8.46 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.226 1.01 . . . . 0.0 112.584 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.36 -49.92 1.01 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.794 1.637 . . . . 0.0 113.11 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.66 -27.29 58.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.721 0.809 . . . . 0.0 113.166 -177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -79.32 155.41 76.75 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 123.492 0.717 . . . . 0.0 110.342 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -59.29 124.52 15.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.952 1.768 . . . . 0.0 110.284 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.7 p -66.16 -26.53 67.47 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.632 -0.668 . . . . 0.0 110.32 176.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -55.22 94.96 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.347 1.859 . . . . 0.0 112.395 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 81.1 t -47.85 -43.44 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.537 1.135 . . . . 0.0 109.689 176.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -52.7 -28.94 24.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.806 1.642 . . . . 0.0 112.994 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -92.47 -48.63 6.54 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.388 1.075 . . . . 0.0 109.069 176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 71.2 mt -49.4 -41.56 39.86 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.603 0.361 . . . . 0.0 111.088 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.94 -35.29 63.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 O-C-N 121.566 -0.708 . . . . 0.0 111.019 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -64.25 -48.25 76.48 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.461 1.028 . . . . 0.0 108.466 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -53.64 -44.13 69.33 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.0 m -62.54 -49.35 75.65 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.575 0.35 . . . . 0.0 110.482 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.7 mt -60.95 -46.74 89.51 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.267 -0.896 . . . . 0.0 110.623 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.4 -33.33 74.96 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.664 0.786 . . . . 0.0 112.062 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.27 159.67 31.21 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 107.635 -2.186 . . . . 0.0 107.635 -174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -161.07 120.93 2.66 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 121.784 -0.833 . . . . 0.0 109.248 -176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.99 -119.97 20.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.51 -17.42 54.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 119.199 -0.429 . . . . 0.0 111.7 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -68.67 118.55 61.54 Favored Pre-proline 0 C--O 1.234 0.264 0 CA-C-N 119.142 0.883 . . . . 0.0 109.424 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.48 158.69 53.38 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 122.266 1.978 . . . . 0.0 110.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.66 131.82 47.99 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -97.79 -11.55 23.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.215 1.006 . . . . 0.0 111.922 176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -41.6 113.03 0.37 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.262 1.425 . . . . 0.0 112.153 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.43 -21.73 16.29 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.166 0.889 . . . . 0.0 113.089 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -85.17 -48.11 9.47 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.084 0.942 . . . . 0.0 109.179 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.473 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.57 141.14 48.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 173.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -83.9 140.8 31.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -29.83 -45.86 0.06 Allowed 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 126.281 1.832 . . . . 0.0 111.46 169.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -60.16 -49.49 77.41 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.946 1.248 . . . . 0.0 111.526 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -53.71 -59.14 4.99 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 122.832 1.301 . . . . 0.0 108.995 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 62' ' ' ALA . 33.3 mt -49.11 -58.72 4.48 Favored 'General case' 0 N--CA 1.425 -1.692 0 C-N-CA 126.098 1.759 . . . . 0.0 110.491 178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.7 t -47.76 -56.83 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 124.526 1.13 . . . . 0.0 109.657 178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -55.41 -39.05 69.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.079 0.552 . . . . 0.0 111.508 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.94 68.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.744 0.418 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 85.2 mt -61.86 -46.64 96.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.692 1.197 . . . . 0.0 109.007 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -52.9 -53.83 43.47 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -56.91 -50.62 71.99 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.305 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.1 ttp -50.45 -59.82 3.63 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.3 mp -55.05 -37.86 67.26 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.811 -0.556 . . . . 0.0 111.431 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.8 m -62.79 -6.69 3.92 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 117.959 -1.02 . . . . 0.0 113.661 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 49.1 p -89.13 -15.25 34.3 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.57 1.532 . . . . 0.0 111.227 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.193 -1.384 . . . . 0.0 110.289 -176.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -53.93 -43.46 71.51 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.359 -1.096 . . . . 0.0 110.359 175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -58.92 -56.02 27.64 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -50.02 -49.62 50.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.898 0.772 . . . . 0.0 110.946 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.83 -57.95 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -57.42 -44.32 84.55 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.923 0.889 . . . . 0.0 112.195 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.6 mt -76.44 -49.68 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 118.868 -0.587 . . . . 0.0 112.199 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -136.63 -17.15 1.49 Allowed 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.2 -33.73 39.3 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-N 119.965 1.257 . . . . 0.0 112.003 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -73.61 154.13 39.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 117.36 0.58 . . . . 0.0 110.98 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.35 110.37 5.86 Favored Pre-proline 0 CA--C 1.537 0.443 0 C-N-CA 124.66 1.184 . . . . 0.0 109.436 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -54.98 151.85 20.56 Favored 'Cis proline' 0 N--CA 1.456 -0.708 0 CA-C-N 120.1 1.071 . . . . 0.0 111.784 -11.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.74 123.1 19.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.153 1.381 . . . . 0.0 109.129 178.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.5 m -55.3 -47.66 75.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.849 0.356 . . . . 0.0 110.483 -177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.1 p -39.91 -56.26 1.84 Allowed 'General case' 0 CA--C 1.522 -0.134 0 C-N-CA 126.432 1.893 . . . . 0.0 112.315 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.0 m -41.57 -36.32 0.9 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.31 1.444 . . . . 0.0 112.763 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.8 m -101.21 -57.01 2.17 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.51 0.324 . . . . 0.0 111.459 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 -68.36 -33.33 74.07 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.57 -36.3 73.54 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -82.01 -27.3 33.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.234 1.013 . . . . 0.0 111.587 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.07 32.23 60.81 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 p -60.66 141.58 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.8 29.69 6.15 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.136 0.974 . . . . 0.0 111.424 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.05 24.54 77.0 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 119.371 -0.683 . . . . 0.0 112.876 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.9 134.55 79.56 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 118.745 1.273 . . . . 0.0 108.203 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -61.31 124.86 15.58 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.454 2.102 . . . . 0.0 108.75 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -91.56 172.68 8.34 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.86 160.3 23.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 35.7 51.67 0.71 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.891 1.676 . . . . 0.0 111.956 177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.18 64.12 25.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.886 1.274 . . . . 0.0 110.143 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -39.85 -48.24 3.68 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 124.247 3.298 . . . . 0.0 114.63 -177.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -53.08 -34.42 56.46 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.639 0.776 . . . . 0.0 112.213 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -66.96 -25.51 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.871 0.468 . . . . 0.0 111.199 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -105.61 -29.61 10.02 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 124.451 1.1 . . . . 0.0 112.79 -174.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.04 -50.17 0.89 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.687 1.595 . . . . 0.0 113.116 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.88 -19.74 36.84 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -80.54 157.32 72.58 Favored Pre-proline 0 CA--C 1.537 0.465 0 O-C-N 121.511 -0.743 . . . . 0.0 110.661 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.23 111.2 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.965 2.443 . . . . 0.0 111.436 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -60.89 -31.76 71.24 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 121.163 -0.961 . . . . 0.0 110.345 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.91 101.86 0.07 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.301 2.24 . . . . 0.0 111.421 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.7 t -50.62 -40.37 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.676 0.791 . . . . 0.0 110.038 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -55.11 -33.56 62.94 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.818 1.647 . . . . 0.0 112.029 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -81.04 -50.35 9.78 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -48.86 -44.03 39.39 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.463 HG12 ' HB3' ' A' ' 67' ' ' LEU . 5.0 m -57.22 -42.39 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 119.468 1.031 . . . . 0.0 110.449 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.69 -43.52 93.26 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -55.24 -40.8 71.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.2 0.455 . . . . 0.0 110.408 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.3 m -68.22 -55.46 12.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.321 0.649 . . . . 0.0 109.438 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.0 mt -54.9 -41.14 70.55 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.411 1.485 . . . . 0.0 111.816 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.69 -34.42 58.19 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.973 0.909 . . . . 0.0 111.338 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.58 162.99 35.28 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -167.04 130.04 1.79 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.04 -136.27 50.68 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.36 -25.91 68.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.427 -0.887 . . . . 0.0 111.73 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.2 ttp -64.56 117.42 37.66 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 119.265 0.939 . . . . 0.0 110.73 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.63 156.61 57.35 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.533 2.156 . . . . 0.0 109.538 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.79 114.58 3.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -72.4 -12.7 61.23 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-O 117.962 -1.018 . . . . 0.0 113.461 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -37.3 109.78 0.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.328 0.967 . . . . 0.0 112.859 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.77 -19.41 54.0 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.359 0.981 . . . . 0.0 114.533 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtt-85 -78.63 -57.58 3.69 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.8 1.3 . . . . 0.0 111.321 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.47 141.28 49.3 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 124.56 1.144 . . . . 0.0 107.972 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.48 150.08 28.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -27.38 -52.25 0.07 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.807 2.043 . . . . 0.0 111.492 168.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.45 -48.26 80.42 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.698 0.681 . . . . 0.0 111.657 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -55.11 -57.15 12.91 Favored 'General case' 0 CA--C 1.523 -0.075 0 CA-C-O 122.138 0.97 . . . . 0.0 108.938 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.463 ' HB3' HG12 ' A' ' 45' ' ' VAL . 97.0 mt -49.26 -58.83 4.37 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.956 -1.475 . . . . 0.0 109.722 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 t -46.86 -57.5 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.201 0 C-N-CA 124.052 0.941 . . . . 0.0 109.495 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -58.76 -40.91 85.28 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.118 0.417 . . . . 0.0 111.778 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.35 -44.18 92.27 Favored 'General case' 0 N--CA 1.457 -0.094 0 O-C-N 121.988 -0.445 . . . . 0.0 109.92 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 88.5 mt -66.88 -46.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.765 0.826 . . . . 0.0 109.133 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 mt-10 -54.54 -48.95 71.39 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -57.02 -53.88 53.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 118.985 -0.531 . . . . 0.0 110.517 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.1 ptm -57.12 -49.71 75.06 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.922 0.783 . . . . 0.0 109.395 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.8 mp -58.77 -36.13 73.91 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.07 -1.018 . . . . 0.0 111.399 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t -63.53 -5.65 4.1 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.583 -1.198 . . . . 0.0 113.121 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 p -92.2 -12.18 33.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 120.331 1.423 . . . . 0.0 110.701 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.4 mt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.64 -1.172 . . . . 0.0 110.99 -176.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.42 -38.66 7.05 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 124.571 1.082 . . . . 0.0 112.076 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.84 -64.36 0.96 Allowed 'General case' 0 C--O 1.222 -0.366 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -44.83 -50.62 10.17 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.263 1.425 . . . . 0.0 111.214 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.4 mt -57.03 -60.33 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 125.269 1.428 . . . . 0.0 110.173 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -56.59 -47.09 80.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.559 0.743 . . . . 0.0 111.439 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.5 -47.01 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 123.451 0.7 . . . . 0.0 111.793 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.17 -9.69 0.33 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.37 -28.69 52.06 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.707 1.139 . . . . 0.0 112.038 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -76.34 154.49 34.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.445 0.623 . . . . 0.0 110.41 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.23 104.96 4.09 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.585 1.154 . . . . 0.0 108.122 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -58.46 146.66 32.95 Favored 'Cis proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.499 1.214 . . . . 0.0 111.897 -3.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.92 120.89 14.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.751 1.621 . . . . 0.0 109.56 178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.0 m -54.23 -49.71 68.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.166 0.508 . . . . 0.0 110.116 -178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.7 p -41.0 -55.56 2.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 126.256 1.822 . . . . 0.0 112.676 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -46.21 -33.72 3.84 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.241 1.016 . . . . 0.0 113.002 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.4 m -97.3 -56.67 2.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 117.888 0.313 . . . . 0.0 110.813 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -67.96 -37.62 81.79 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -172.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.9 -45.07 94.25 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.096 0.862 . . . . 0.0 109.708 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -76.98 -36.23 56.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.29 0.636 . . . . 0.0 111.948 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 91.89 38.76 5.68 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -175.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.84 130.55 17.08 Favored 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.5 31.47 7.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.503 1.121 . . . . 0.0 111.576 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.89 26.38 74.07 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.601 -0.555 . . . . 0.0 112.556 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.69 134.37 71.97 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 118.402 1.101 . . . . 0.0 108.573 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -62.6 112.02 1.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.694 2.263 . . . . 0.0 108.85 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mp0 -82.64 179.77 7.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.369 1.068 . . . . 0.0 112.35 -172.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.21 159.55 28.83 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.96 52.19 0.45 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.984 1.714 . . . . 0.0 112.045 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.67 56.62 15.86 Favored Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 124.942 1.297 . . . . 0.0 111.026 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -41.32 -45.9 5.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.817 3.011 . . . . 0.0 114.967 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -49.04 -41.11 33.79 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.687 0.795 . . . . 0.0 111.85 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.25 -16.34 61.4 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.65 0.78 . . . . 0.0 112.336 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -106.55 -26.19 11.5 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 124.408 1.083 . . . . 0.0 112.52 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.46 -51.52 0.62 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.437 1.895 . . . . 0.0 113.67 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -83.87 -17.46 40.79 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -78.64 151.74 77.36 Favored Pre-proline 0 CA--C 1.535 0.395 0 O-C-N 121.462 -0.774 . . . . 0.0 110.639 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.52 115.28 2.11 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.071 2.514 . . . . 0.0 111.56 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -63.19 -32.23 73.58 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.124 -0.985 . . . . 0.0 110.11 176.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.54 104.99 0.17 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 127.479 2.312 . . . . 0.0 111.753 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -50.06 -43.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 123.525 0.73 . . . . 0.0 109.638 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -53.64 -30.91 45.24 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 126.363 1.865 . . . . 0.0 112.482 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -83.88 -51.93 6.77 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.0 mt -50.16 -40.1 45.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.812 0.845 . . . . 0.0 112.829 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.8 m -57.63 -39.34 69.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 CA-C-N 119.216 0.916 . . . . 0.0 110.375 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -66.19 -46.31 77.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 119.226 0.921 . . . . 0.0 108.71 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.6 m -52.64 -45.74 66.8 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.098 0.475 . . . . 0.0 110.079 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.6 m -67.84 -48.69 65.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.749 0.42 . . . . 0.0 110.761 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.79 -40.85 96.64 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.101 -0.999 . . . . 0.0 111.098 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.39 -32.43 60.78 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.0 111.357 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.81 167.58 37.77 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -160.52 112.54 1.96 Allowed 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.09 -111.25 2.69 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.75 -35.09 74.65 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.113 0.565 . . . . 0.0 111.066 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.01 118.3 47.78 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.063 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.16 156.43 55.49 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.551 2.167 . . . . 0.0 109.933 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 115.96 5.68 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.811 0.444 . . . . 0.0 109.833 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -77.98 -7.95 57.51 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -55.87 83.44 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.295 1.038 . . . . 0.0 112.644 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 135.16 -34.59 2.29 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.76 1.647 . . . . 0.0 111.043 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 mtm-85 -84.11 -38.88 20.19 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.184 0.994 . . . . 0.0 110.984 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.408 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -142.6 129.47 20.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 175.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -83.33 151.62 25.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 34.7 ttm105 -29.96 -49.99 0.11 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.69 1.996 . . . . 0.0 112.648 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.55 -35.84 81.21 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.363 0.983 . . . . 0.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -64.79 -59.01 4.71 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' A' ' 62' ' ' ALA . 56.6 mt -46.33 -57.91 4.19 Favored 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 127.218 2.207 . . . . 0.0 110.652 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -36.32 -56.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.533 1.533 . . . . 0.0 110.299 178.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -60.16 -42.4 94.86 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.554 0.342 . . . . 0.0 111.606 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.67 -48.49 69.17 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 122.764 0.426 . . . . 0.0 110.01 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.5 mt -56.72 -50.21 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 124.61 1.164 . . . . 0.0 109.203 177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -55.83 -52.01 65.51 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -54.05 -56.26 19.64 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 119.186 -0.435 . . . . 0.0 111.572 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.1 ptm -60.94 -45.14 95.9 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 118.869 0.759 . . . . 0.0 109.629 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.04 -36.84 70.96 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.45 -0.781 . . . . 0.0 110.974 177.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -63.34 -6.52 4.8 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.7 p -90.34 -8.7 50.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 120.221 1.373 . . . . 0.0 111.047 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.47 -1.729 . . . . 0.0 110.832 -176.645 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.51 47.0 3.77 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 68.49 -40.32 0.43 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.843 2.457 . . . . 0.0 113.159 -178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.6 m -45.16 -56.43 4.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.977 2.511 . . . . 0.0 113.671 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.59 -49.25 84.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.16 -48.51 78.14 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.903 0.481 . . . . 0.0 111.528 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.1 mt -73.47 -43.67 55.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 118.3 -0.857 . . . . 0.0 111.999 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.68 -8.24 0.49 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 115.747 1.758 . . . . 0.0 115.747 -173.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.75 -32.49 40.84 Favored Glycine 0 N--CA 1.47 0.91 0 CA-C-N 119.801 1.182 . . . . 0.0 111.321 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -73.47 155.45 39.23 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 117.449 0.624 . . . . 0.0 110.722 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.56 110.41 6.26 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 124.463 1.105 . . . . 0.0 108.966 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.93 153.28 16.95 Favored 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 120.323 1.151 . . . . 0.0 112.04 -11.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 p -70.24 114.35 8.3 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.625 1.57 . . . . 0.0 109.037 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.08 -48.4 22.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.662 0.785 . . . . 0.0 110.986 -176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 p -41.91 -50.57 4.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.608 1.963 . . . . 0.0 112.808 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 m -48.71 -32.47 8.48 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.316 0.647 . . . . 0.0 112.604 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -101.04 -54.99 2.67 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.903 0.481 . . . . 0.0 110.786 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -69.62 -32.79 71.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -67.04 -40.06 87.08 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -79.18 -28.58 42.69 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.573 0.749 . . . . 0.0 111.472 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.71 34.81 52.68 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.59 139.1 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.82 29.84 6.37 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.187 0.995 . . . . 0.0 111.593 -177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.62 24.25 76.5 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.495 -0.614 . . . . 0.0 112.764 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.76 135.31 82.99 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 118.554 1.177 . . . . 0.0 108.23 175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.44 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 37.8 Cg_endo -59.77 123.73 13.9 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.567 2.178 . . . . 0.0 110.006 -177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -91.65 179.03 5.76 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.774 0.797 . . . . 0.0 112.117 -174.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.94 161.84 30.38 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.17 54.16 0.74 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.125 1.77 . . . . 0.0 111.662 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.31 65.03 17.52 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.194 0.998 . . . . 0.0 110.124 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -40.06 -52.93 2.66 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 124.195 3.263 . . . . 0.0 114.381 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -49.48 -35.61 20.3 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.7 1.2 . . . . 0.0 112.615 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -65.45 -28.12 69.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.342 0.519 . . . . 0.0 111.245 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.44 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.3 m95 -102.32 -36.61 8.4 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.652 1.181 . . . . 0.0 112.43 -174.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.68 -52.02 1.23 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.093 1.757 . . . . 0.0 113.082 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.79 -24.92 56.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.55 150.94 79.96 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 121.525 -0.734 . . . . 0.0 110.202 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.23 87.13 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.883 2.389 . . . . 0.0 108.207 173.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -24.59 22.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 126.366 1.866 . . . . 0.0 113.252 -171.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.33 110.33 0.32 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.358 1.463 . . . . 0.0 110.46 177.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.2 t -47.93 -46.2 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.611 0.764 . . . . 0.0 110.118 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.91 -29.17 55.5 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.74 1.216 . . . . 0.0 113.095 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -85.67 -51.5 6.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 76.1 mt -49.79 -42.46 46.8 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.234 0.614 . . . . 0.0 112.188 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.25 -33.68 54.56 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.119 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.34 -49.06 70.83 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.895 1.225 . . . . 0.0 108.577 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -51.23 -46.47 62.29 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.57 0.748 . . . . 0.0 110.225 175.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.0 m -63.92 -49.94 70.64 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.988 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.4 mt -62.83 -42.56 99.78 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 120.852 -1.155 . . . . 0.0 111.157 -178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.71 -30.53 61.57 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.074 0.95 . . . . 0.0 111.865 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.62 157.11 30.37 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -155.08 115.51 3.85 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.131 -0.629 . . . . 0.0 109.506 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.67 -116.58 9.17 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.03 -24.88 58.4 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.923 0.489 . . . . 0.0 111.472 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.5 ttp -67.29 119.63 66.43 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-O 118.443 -0.789 . . . . 0.0 110.589 -177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.66 157.63 51.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.447 2.098 . . . . 0.0 110.276 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.76 120.18 11.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.333 0.653 . . . . 0.0 110.064 178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.05 -12.46 58.26 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -45.48 112.55 0.47 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.73 0.812 . . . . 0.0 111.146 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 105.02 -32.39 7.55 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.457 1.027 . . . . 0.0 112.599 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 77.2 mtm-85 -88.51 -49.99 6.57 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.404 1.102 . . . . 0.0 110.733 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.83 121.81 34.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -80.49 152.72 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.4 ttm-85 -26.65 -51.57 0.05 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.859 2.064 . . . . 0.0 111.564 168.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -63.01 -43.48 98.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.237 0.926 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -61.27 -56.67 17.92 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 122.339 1.066 . . . . 0.0 108.369 177.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.4 mt -47.8 -57.52 5.51 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 113.368 -1.742 . . . . 0.0 110.08 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -37.81 -55.86 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.537 1.535 . . . . 0.0 110.135 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.1 mttp -55.65 -42.75 75.48 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.331 0.394 . . . . 0.0 111.628 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.62 -47.23 64.14 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.5 mt -59.92 -48.5 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 122.729 0.411 . . . . 0.0 110.656 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.58 -37.49 84.07 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.638 1.108 . . . . 0.0 109.11 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -60.43 -47.38 86.34 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.055 0.843 . . . . 0.0 110.147 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 10.0 mtt -49.54 -65.65 0.53 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.1 mp -49.78 -40.56 41.84 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.308 -1.315 . . . . 0.0 112.067 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -61.24 -8.47 3.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.2 p -92.92 -11.53 33.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 120.521 1.51 . . . . 0.0 111.357 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.25 1.128 0 CA-C-O 117.543 -1.218 . . . . 0.0 110.679 -177.432 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 118.65 -0.691 . . . . 0.0 109.853 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -46.07 -41.82 11.43 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.134 0.873 . . . . 0.0 111.253 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -54.28 -62.48 1.63 Allowed 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.6 -49.25 14.29 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.083 0.953 . . . . 0.0 111.133 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.0 mt -57.86 -59.94 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 C-N-CA 123.786 0.834 . . . . 0.0 109.683 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -54.18 -47.42 72.06 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.286 0.634 . . . . 0.0 111.801 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.44 -47.55 76.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.421 0.688 . . . . 0.0 111.502 -173.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -148.61 -15.51 0.32 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.05 3.48 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 120.099 1.318 . . . . 0.0 111.288 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -133.69 149.95 51.53 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.562 1.545 . . . . 0.0 107.627 177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 108.26 6.08 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 124.421 1.088 . . . . 0.0 109.377 -178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.35 152.57 31.78 Favored 'Cis proline' 0 N--CA 1.456 -0.697 0 CA-C-N 120.204 1.109 . . . . 0.0 111.808 -8.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.67 126.28 29.21 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.487 1.115 . . . . 0.0 109.888 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.1 m -59.52 -50.17 74.97 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.239 0.542 . . . . 0.0 109.911 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.5 p -37.66 -61.04 0.65 Allowed 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 127.024 2.13 . . . . 0.0 113.101 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.72 -38.63 3.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.666 1.187 . . . . 0.0 112.3 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 43.6 m -91.11 -58.34 2.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 117.665 0.211 . . . . 0.0 110.985 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -67.54 -41.96 83.46 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -172.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -63.24 -34.6 78.02 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.654 -0.654 . . . . 0.0 110.607 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -93.15 -24.71 18.15 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.787 0.835 . . . . 0.0 112.678 -177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.77 35.12 13.8 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.101 0.858 . . . . 0.0 111.472 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.4 t -56.75 131.63 20.47 Favored 'Isoleucine or valine' 0 C--N 1.34 0.155 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.65 31.24 7.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.363 1.065 . . . . 0.0 111.451 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.48 26.06 74.72 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.56 -0.578 . . . . 0.0 112.632 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.5 134.08 77.06 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 118.418 1.109 . . . . 0.0 108.568 176.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -59.84 120.29 8.0 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.479 2.119 . . . . 0.0 109.493 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.1 mp0 -88.0 174.14 8.47 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.466 0.65 . . . . 0.0 111.923 -174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.94 165.56 24.91 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 45.82 41.23 7.42 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.549 1.14 . . . . 0.0 111.655 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.1 59.44 10.7 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.824 0.85 . . . . 0.0 109.988 -177.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -47.43 -34.41 19.3 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.421 3.414 . . . . 0.0 113.713 -175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -51.67 -38.87 56.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.186 0.994 . . . . 0.0 110.7 177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 15.7 4.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.453 0.701 . . . . 0.0 112.113 -178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -134.66 -40.28 0.79 Allowed 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 119.011 0.823 . . . . 0.0 111.485 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -40.41 -46.71 2.45 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.998 1.319 . . . . 0.0 112.505 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.58 -26.41 50.76 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.994 0.918 . . . . 0.0 113.195 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -75.28 159.33 82.5 Favored Pre-proline 0 CA--C 1.534 0.347 0 O-C-N 121.576 -0.703 . . . . 0.0 109.976 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.07 121.43 10.05 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.839 1.693 . . . . 0.0 109.677 175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -64.56 -39.16 93.24 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.211 0.529 . . . . 0.0 109.634 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.5 m -50.72 102.51 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.142 1.777 . . . . 0.0 112.036 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.7 -40.19 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.302 1.041 . . . . 0.0 109.964 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -55.73 -35.29 65.98 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.798 0.839 . . . . 0.0 112.253 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -77.74 -48.2 17.23 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.01 -43.6 70.19 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 122.879 0.472 . . . . 0.0 111.612 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.525 HG22 ' CD2' ' A' ' 49' ' ' LEU . 11.0 p -60.41 -44.29 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.911 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -56.15 -46.22 79.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 119.746 1.157 . . . . 0.0 109.652 178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.0 m -54.23 -37.77 64.99 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.042 0.383 . . . . 0.0 111.392 173.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.1 m -68.0 -50.39 55.87 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.614 0.766 . . . . 0.0 109.357 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.525 ' CD2' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -60.02 -42.42 94.34 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 120.158 1.345 . . . . 0.0 111.472 177.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.11 -38.49 78.93 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.044 0.538 . . . . 0.0 111.981 -177.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.98 155.32 29.67 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 -174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -155.48 135.17 12.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.66 -118.44 13.83 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.59 -3.32 46.59 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.694 0.798 . . . . 0.0 112.242 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 36.0 ttp -68.1 122.02 82.36 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 119.259 0.936 . . . . 0.0 110.595 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.468 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 50.6 Cg_exo -59.29 153.12 55.49 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.507 2.138 . . . . 0.0 111.034 176.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.32 112.62 6.0 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -71.32 -3.07 18.6 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.26 110.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.653 1.115 . . . . 0.0 111.072 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.82 -11.27 62.54 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.345 0.974 . . . . 0.0 114.596 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -76.1 -47.94 22.61 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.044 1.422 . . . . 0.0 109.906 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -139.64 156.23 46.96 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -82.56 140.47 33.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 45' ' ' VAL . 26.3 ttt180 -32.83 -44.21 0.1 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.577 1.951 . . . . 0.0 112.436 172.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.78 -47.8 83.52 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.811 1.187 . . . . 0.0 111.197 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -56.4 -56.77 16.96 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 122.902 1.334 . . . . 0.0 108.698 178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 62' ' ' ALA . 79.3 mt -48.08 -57.27 6.05 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 113.199 -1.819 . . . . 0.0 109.857 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -49.19 -53.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.892 1.277 . . . . 0.0 109.919 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.4 mmtm -57.87 -38.91 76.57 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.498 0.319 . . . . 0.0 111.258 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.17 -41.13 81.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.915 -0.49 . . . . 0.0 109.896 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.4 mt -66.7 -52.61 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 123.613 0.765 . . . . 0.0 109.991 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -57.29 -39.7 76.27 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.234 0.924 . . . . 0.0 109.086 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.14 -52.73 64.46 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.03 -0.51 . . . . 0.0 110.128 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.1 ptm -54.44 -43.35 71.54 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.611 0.641 . . . . 0.0 109.346 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.6 mt -65.15 -35.18 80.28 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 121.476 -0.765 . . . . 0.0 110.763 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.3 m -74.83 37.93 0.12 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.009 -1.057 . . . . 0.0 112.634 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.1 p -148.59 24.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.582 1.153 . . . . 0.0 109.918 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.252 1.232 0 CA-C-O 116.148 -1.882 . . . . 0.0 107.132 -177.439 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.468 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.56 -38.33 7.17 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.965 1.269 . . . . 0.0 112.586 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -66.54 -56.19 11.98 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -51.28 -51.63 52.4 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.947 1.299 . . . . 0.0 109.399 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -56.23 -57.91 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.838 1.655 . . . . 0.0 108.842 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -57.64 -52.15 66.61 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.888 0.475 . . . . 0.0 111.623 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.57 -46.34 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 118.463 -0.78 . . . . 0.0 111.557 -173.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.57 38.81 0.33 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.298 0.954 . . . . 0.0 113.04 -173.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.75 40.33 1.09 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.796 HG21 HBB1 ' A' ' 0' ' ' HEM . 1.1 p -137.25 156.94 47.68 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 126.436 1.895 . . . . 0.0 107.841 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 106.64 5.98 Favored Pre-proline 0 CA--C 1.533 0.295 0 C-N-CA 123.861 0.864 . . . . 0.0 108.904 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.83 152.85 24.35 Favored 'Cis proline' 0 N--CA 1.46 -0.467 0 CA-C-N 120.378 1.171 . . . . 0.0 112.142 -7.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.38 123.79 19.62 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HA ' ' HAB' ' A' ' 0' ' ' HEM . 0.5 OUTLIER -52.93 -51.0 62.88 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.912 0.885 . . . . 0.0 111.439 -176.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.9 p -40.88 -54.41 2.71 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.447 1.899 . . . . 0.0 111.872 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -41.91 -38.74 1.64 Allowed 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.61 1.164 . . . . 0.0 113.094 -177.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.4 m -98.43 -57.15 2.27 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.964 0.347 . . . . 0.0 111.49 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -73.71 -19.47 60.8 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 114.347 1.239 . . . . 0.0 114.347 -172.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.37 -53.57 18.8 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 119.535 1.061 . . . . 0.0 108.989 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -79.98 -31.13 39.83 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.467 0.307 . . . . 0.0 111.052 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.5 42.85 5.69 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -60.26 142.81 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.37 28.62 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.066 0.947 . . . . 0.0 111.502 -177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.96 25.95 73.64 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 119.444 -0.642 . . . . 0.0 112.715 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.05 134.14 87.54 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 118.738 1.269 . . . . 0.0 108.377 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.78 115.76 3.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.701 2.267 . . . . 0.0 108.258 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -86.16 179.08 7.01 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.901 0.857 . . . . 0.0 113.215 -171.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -65.23 159.94 22.6 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 170.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 34.61 52.38 0.55 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.545 1.538 . . . . 0.0 112.565 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.9 61.96 31.28 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 124.656 1.182 . . . . 0.0 110.317 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -41.73 -46.76 6.4 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.045 3.163 . . . . 0.0 114.683 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -49.88 -39.99 41.37 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.822 1.249 . . . . 0.0 111.533 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.67 -15.45 61.7 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.873 0.869 . . . . 0.0 112.463 -177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -110.94 -25.57 9.75 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.508 1.123 . . . . 0.0 112.294 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.05 -46.26 0.48 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.921 2.088 . . . . 0.0 114.433 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.39 -5.57 32.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -81.48 154.96 71.63 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 121.483 -0.761 . . . . 0.0 110.211 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -50.52 115.6 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.072 2.515 . . . . 0.0 111.462 177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -60.72 -34.03 73.77 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.403 -0.81 . . . . 0.0 110.209 177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.26 99.96 0.07 Allowed 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.754 2.022 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 65.2 t -53.33 -38.44 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.616 -0.677 . . . . 0.0 109.859 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -56.29 -26.2 51.12 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 112.415 176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -90.13 -50.81 5.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.4 mt -49.02 -41.01 33.23 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.694 0.798 . . . . 0.0 112.117 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.85 -30.4 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 121.533 -0.729 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.29 -49.62 68.82 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -50.99 -46.29 61.38 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 123.619 0.767 . . . . 0.0 109.796 174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.5 m -60.68 -51.9 67.42 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.75 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.5 mt -62.05 -45.46 93.46 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.245 -0.909 . . . . 0.0 111.456 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.86 -32.37 63.6 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.833 0.853 . . . . 0.0 112.369 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 161.01 27.8 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 108.366 -1.894 . . . . 0.0 108.366 -174.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.45 115.1 2.49 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.962 -0.728 . . . . 0.0 109.163 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.62 -116.95 9.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.25 -24.58 57.64 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.802 0.441 . . . . 0.0 111.371 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.0 ttp -66.38 121.18 75.57 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.599 -0.715 . . . . 0.0 109.946 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.523 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 90.8 Cg_endo -76.38 165.26 29.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.711 2.274 . . . . 0.0 109.781 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.78 134.03 48.1 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.79 -14.77 20.6 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.125 0.97 . . . . 0.0 112.326 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -47.77 101.02 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.269 1.028 . . . . 0.0 112.539 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 111.48 -37.28 3.77 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 125.009 1.29 . . . . 0.0 111.481 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.7 mtm-85 -77.02 -36.45 56.25 Favored 'General case' 0 CA--C 1.526 0.058 0 CA-C-N 117.756 0.778 . . . . 0.0 109.913 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.8 149.11 50.87 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 173.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -92.29 130.45 37.98 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -31.69 -44.37 0.08 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.029 2.132 . . . . 0.0 112.818 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.46 -48.95 75.55 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.684 1.129 . . . . 0.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.76 -47.93 81.4 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.012 0.925 . . . . 0.0 108.797 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.442 HD21 ' HB3' ' A' ' 62' ' ' ALA . 37.4 mt -51.86 -55.91 17.2 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.037 176.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 t -45.2 -57.81 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 124.211 1.004 . . . . 0.0 109.271 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -56.36 -39.8 73.47 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 118.483 0.583 . . . . 0.0 112.091 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.17 -40.97 95.01 Favored 'General case' 0 CA--C 1.528 0.098 0 O-C-N 121.722 -0.611 . . . . 0.0 110.073 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.4 mt -64.73 -47.76 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -53.47 -52.46 59.44 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -54.56 -52.15 63.01 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.671 -0.204 . . . . 0.0 110.56 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -53.19 -50.57 64.38 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 109.897 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.13 -30.12 71.2 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.945 -0.472 . . . . 0.0 110.997 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.1 m -74.25 40.59 0.13 Allowed 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.073 -1.017 . . . . 0.0 112.782 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.5 p -135.43 -10.92 2.16 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 109.827 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.4 mt . . . . . 0 C--O 1.251 1.134 0 CA-C-O 116.7 -1.619 . . . . 0.0 110.25 -177.839 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.796 HBB1 HG21 ' A' ' 10' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.467 0.401 0 CA-C-O 117.706 -1.14 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.89 11.93 84.31 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 68.53 -53.94 0.54 Allowed 'General case' 0 C--N 1.345 0.402 0 C-N-CA 129.068 2.947 . . . . 0.0 112.256 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.0 p -31.17 -56.75 0.24 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 127.728 2.411 . . . . 0.0 112.868 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.4 mt -55.29 -50.51 64.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 124.408 1.083 . . . . 0.0 110.483 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -68.29 -46.39 70.46 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.694 0.397 . . . . 0.0 110.398 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.0 mt -65.85 -42.11 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.958 -175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -161.55 32.47 0.13 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -174.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.75 -46.24 14.85 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 121.342 -0.849 . . . . 0.0 111.096 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.48 HG21 HBB1 ' A' ' 0' ' ' HEM . 81.3 p -97.89 168.8 10.08 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.644 0.778 . . . . 0.0 111.497 -175.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.5 115.53 25.18 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 125.0 1.32 . . . . 0.0 107.822 177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -64.51 169.66 35.43 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 CA-C-N 120.609 1.253 . . . . 0.0 110.057 -10.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.3 p -78.25 149.68 33.55 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.2 m -61.87 -44.54 96.6 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.9 p -50.56 -47.41 57.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.086 1.355 . . . . 0.0 111.651 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.4 m -42.64 -40.35 2.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.782 0.719 . . . . 0.0 112.167 -179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.8 m -98.29 -57.93 2.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.468 0.175 . . . . 0.0 111.188 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -62.2 -40.38 95.89 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.47 -29.77 64.52 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.138 0.426 . . . . 0.0 111.107 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -115.61 17.73 16.15 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.708 0.803 . . . . 0.0 111.681 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 48.09 40.23 20.55 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 123.899 0.761 . . . . 0.0 113.8 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.9 t -54.94 135.49 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 122.082 -0.658 . . . . 0.0 109.381 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 31.31 7.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.756 1.223 . . . . 0.0 111.806 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.55 23.38 77.09 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-O 119.667 -0.518 . . . . 0.0 112.628 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.73 140.77 75.01 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 118.222 1.011 . . . . 0.0 108.791 175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -58.27 119.44 6.69 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.489 2.126 . . . . 0.0 107.81 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -81.52 167.58 19.17 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 122.832 1.301 . . . . 0.0 111.26 -174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mp -77.01 162.26 27.68 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.061 -1.427 . . . . 0.0 107.873 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.23 53.56 1.71 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.939 1.296 . . . . 0.0 110.601 -176.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.92 64.93 11.75 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.006 1.723 . . . . 0.0 109.427 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -39.12 -55.46 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 124.588 3.525 . . . . 0.0 114.358 -174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -44.71 -45.44 9.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.01 1.324 . . . . 0.0 112.281 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -53.76 -39.16 65.12 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.463 0.705 . . . . 0.0 110.762 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -92.88 -29.9 15.69 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.846 0.859 . . . . 0.0 111.169 -175.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -41.19 98.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.504 0.722 . . . . 0.0 109.617 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -63.99 -41.75 97.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.095 0.474 . . . . 0.0 110.326 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -76.36 164.15 61.69 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.683 1.193 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -68.0 88.66 0.37 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 107.539 -1.754 . . . . 0.0 107.539 172.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -51.98 -22.2 3.75 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.293 1.437 . . . . 0.0 112.463 -176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -56.77 108.3 0.48 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.287 1.035 . . . . 0.0 110.453 176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.53 -46.33 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.736 1.214 . . . . 0.0 110.047 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.89 -36.83 3.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 127.201 2.2 . . . . 0.0 112.335 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -90.21 -52.74 4.79 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.298 1.039 . . . . 0.0 109.182 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 mt -44.72 -45.93 10.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.773 0.829 . . . . 0.0 112.634 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG12 ' HB3' ' A' ' 67' ' ' LEU . 19.2 m -61.35 -34.31 60.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.198 0 O-C-N 121.348 -0.845 . . . . 0.0 111.585 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.2 -47.18 71.68 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.5 m -53.5 -46.26 69.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.06 0.544 . . . . 0.0 110.051 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.8 m -62.17 -52.02 65.48 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.982 0.513 . . . . 0.0 111.345 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.67 -40.48 84.43 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 121.56 -0.713 . . . . 0.0 109.698 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.97 -35.43 76.73 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.145 0.578 . . . . 0.0 111.617 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.52 154.99 24.26 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 108.556 -1.817 . . . . 0.0 108.556 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -158.38 125.64 4.98 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.45 -137.67 49.15 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.06 -16.88 64.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.624 -0.788 . . . . 0.0 111.997 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.6 ttp -69.42 117.28 51.15 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.652 1.115 . . . . 0.0 109.801 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.32 155.06 64.91 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 122.441 2.094 . . . . 0.0 109.951 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.11 133.58 55.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -105.65 6.58 32.14 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.951 0.9 . . . . 0.0 110.447 175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -40.69 108.84 0.1 Allowed 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.243 1.817 . . . . 0.0 112.688 177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.28 -20.27 5.02 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.529 0.585 . . . . 0.0 113.021 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.3 mtm105 -76.37 -44.3 36.94 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.45 116.72 25.26 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 169.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.73 152.61 33.56 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -23.16 -52.55 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.219 2.208 . . . . 0.0 111.692 168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -60.54 -56.68 18.49 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.351 0.523 . . . . 0.0 111.811 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.67 -49.89 69.53 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.411 1.084 . . . . 0.0 109.687 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' HB3' HG12 ' A' ' 45' ' ' VAL . 71.0 mt -52.13 -58.6 6.09 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 125.291 1.436 . . . . 0.0 110.057 178.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.7 t -49.16 -58.28 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 123.753 0.821 . . . . 0.0 109.509 177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.08 -26.1 62.12 Favored 'General case' 0 N--CA 1.438 -1.057 0 C-N-CA 125.17 1.388 . . . . 0.0 113.068 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.32 -59.39 2.72 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.0 mt -51.17 -44.53 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.643 1.177 . . . . 0.0 111.459 -177.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -53.86 -37.85 64.09 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.865 0.757 . . . . 0.0 110.708 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -64.95 -44.21 90.16 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-N 118.996 0.816 . . . . 0.0 109.664 178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 70.7 mtp -53.55 -58.39 7.34 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.2 mp -55.3 -36.79 66.56 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.688 178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -62.49 -10.36 11.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.388 178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.9 p -89.01 -9.02 52.9 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 120.462 1.483 . . . . 0.0 111.158 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 116.554 -1.689 . . . . 0.0 111.033 -176.288 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.48 HBB1 HG21 ' A' ' 10' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -47.6 -42.13 19.65 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 119.328 0.967 . . . . 0.0 111.403 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 2.0 mp0 -49.9 -55.62 13.71 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.119 0.967 . . . . 0.0 108.751 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -57.19 -50.47 72.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.982 1.313 . . . . 0.0 110.387 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -50.65 -60.7 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.51 -52.56 63.29 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.241 1.416 . . . . 0.0 112.027 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.1 mt -67.84 -47.72 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 118.404 -0.808 . . . . 0.0 111.015 -173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -156.04 11.94 0.3 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -174.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.49 34.55 5.52 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 119.629 1.104 . . . . 0.0 111.591 -177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.21 157.64 45.57 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.486 1.514 . . . . 0.0 108.916 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.58 107.75 9.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 124.207 1.003 . . . . 0.0 110.088 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.16 159.17 68.99 Favored 'Cis proline' 0 N--CA 1.455 -0.746 0 CA-C-N 120.172 1.097 . . . . 0.0 110.053 -8.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -68.13 118.55 11.43 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.06 1.344 . . . . 0.0 110.429 -178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.5 m -46.49 -48.56 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.981 0.913 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -45.46 -44.73 12.53 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.979 1.712 . . . . 0.0 112.547 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -53.2 -26.16 16.54 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.016 0.526 . . . . 0.0 112.255 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.1 m -104.02 -58.26 1.91 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 118.097 0.408 . . . . 0.0 109.941 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -66.89 -35.52 80.2 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -173.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.67 -41.67 75.18 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.102 0.865 . . . . 0.0 109.834 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -80.57 -28.7 37.11 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.097 0.559 . . . . 0.0 111.513 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.27 38.71 7.64 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.4 t -56.04 125.53 11.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.158 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.51 32.77 9.3 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.031 0.932 . . . . 0.0 111.128 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.68 24.41 76.95 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.059 -0.856 . . . . 0.0 112.941 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -54.45 113.33 5.03 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 118.57 1.185 . . . . 0.0 108.591 176.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.541 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 66.0 Cg_exo -36.32 116.79 0.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 125.014 3.809 . . . . 0.0 114.493 -175.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.39 173.69 10.71 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.529 0.681 . . . . 0.0 111.701 -175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -73.58 159.52 32.99 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 172.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 14.0 m120 49.43 29.71 2.98 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.848 0.859 . . . . 0.0 112.119 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -125.07 61.53 33.43 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.989 0.916 . . . . 0.0 110.954 -174.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -45.35 -42.35 17.48 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 123.72 2.947 . . . . 0.0 112.799 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -49.36 -39.67 32.84 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.77 0.828 . . . . 0.0 112.198 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -67.97 -25.07 65.25 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.125 0.57 . . . . 0.0 111.801 -178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.541 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 86.3 m95 -105.52 -23.37 12.81 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.453 1.101 . . . . 0.0 112.893 -173.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -51.25 0.72 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.548 1.939 . . . . 0.0 113.582 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.71 -22.08 43.79 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -176.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -77.14 151.69 81.61 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 123.875 0.87 . . . . 0.0 110.206 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -65.3 125.28 14.25 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.675 1.583 . . . . 0.0 108.768 177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.0 p -62.58 -29.63 70.73 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.797 -0.565 . . . . 0.0 110.35 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -56.01 99.62 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 125.986 1.714 . . . . 0.0 111.945 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.09 -42.39 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 125.304 1.441 . . . . 0.0 109.411 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -47.41 -37.43 11.42 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.386 2.274 . . . . 0.0 112.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.42 -50.86 6.05 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.1 mt -47.71 -42.16 24.44 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.88 0.872 . . . . 0.0 112.401 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -62.94 -32.1 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 118.764 -0.636 . . . . 0.0 111.16 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -64.58 -50.03 68.86 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 m -51.26 -47.33 62.49 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 123.599 0.76 . . . . 0.0 109.908 175.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.1 m -61.73 -49.54 75.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.828 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.74 -45.52 93.59 Favored 'General case' 0 N--CA 1.458 -0.063 0 O-C-N 121.132 -0.98 . . . . 0.0 111.143 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.51 -31.16 65.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.944 0.897 . . . . 0.0 112.289 -177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.01 160.71 29.53 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 108.277 -1.929 . . . . 0.0 108.277 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -155.51 108.86 2.77 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.964 -0.727 . . . . 0.0 109.327 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.01 -113.95 5.88 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.69 -30.19 64.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.688 0.395 . . . . 0.0 111.0 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.1 ttp -63.62 120.35 62.12 Favored Pre-proline 0 C--O 1.234 0.257 0 CA-C-O 118.669 -0.682 . . . . 0.0 109.913 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.564 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 93.6 Cg_endo -74.57 156.66 44.94 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.843 2.362 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.71 135.1 56.44 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -100.46 -13.89 18.51 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.927 0.891 . . . . 0.0 113.329 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -48.97 102.79 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 112.148 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 112.38 -38.97 3.03 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.126 1.346 . . . . 0.0 111.537 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.8 mtm-85 -76.79 -39.74 50.47 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 117.68 0.74 . . . . 0.0 110.112 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.43 130.54 30.65 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -79.72 146.72 32.23 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -27.93 -53.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.377 170.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.69 -41.94 96.15 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.329 0.513 . . . . 0.0 112.134 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.49 -59.58 5.17 Favored 'General case' 0 C--O 1.227 -0.12 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.5 HD21 ' HB3' ' A' ' 62' ' ' ALA . 76.4 mt -46.07 -58.66 3.42 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.495 1.518 . . . . 0.0 111.004 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 t -39.34 -51.86 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.812 2.045 . . . . 0.0 111.149 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -58.06 -45.57 86.84 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 123.703 0.801 . . . . 0.0 111.057 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.43 -47.69 78.15 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.407 -0.808 . . . . 0.0 109.826 177.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 52.9 mt -56.98 -52.16 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 C-N-CA 123.052 0.541 . . . . 0.0 110.876 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.41 -39.98 92.72 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.984 -1.072 . . . . 0.0 109.28 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -57.08 -49.5 75.67 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.667 -0.682 . . . . 0.0 110.418 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 9.5 mtt -48.13 -63.62 1.02 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 122.17 0.986 . . . . 0.0 108.649 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.5 mp -49.83 -41.55 45.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 114.146 -1.388 . . . . 0.0 111.669 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.8 m -62.17 -10.94 11.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.4 p -90.1 -13.38 35.93 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.195 1.362 . . . . 0.0 111.207 177.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.6 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 117.79 -1.1 . . . . 0.0 111.566 -174.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.564 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.16 -39.8 65.05 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.72 -49.97 75.37 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -50.32 -52.72 34.32 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.865 0.757 . . . . 0.0 110.45 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.7 mt -58.14 -57.07 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.795 -179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -56.18 -50.46 71.13 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.307 1.043 . . . . 0.0 111.651 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.72 -46.9 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.859 -174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.11 36.38 0.29 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -172.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.92 33.17 2.28 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 118.845 0.748 . . . . 0.0 111.252 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.94 155.68 48.65 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.687 1.995 . . . . 0.0 107.189 177.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.01 108.23 18.13 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.705 0.802 . . . . 0.0 111.095 -176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -62.52 166.07 37.45 Favored 'Cis proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.216 1.113 . . . . 0.0 109.341 -11.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.1 p -67.54 136.09 53.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 m -49.7 -43.48 47.49 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 118.711 0.687 . . . . 0.0 109.426 178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.8 p -47.21 -41.44 18.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.066 1.347 . . . . 0.0 112.561 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.1 m -46.2 -39.16 9.31 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.3 0.64 . . . . 0.0 111.316 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.5 m -102.96 -52.33 3.07 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -72.0 -27.5 62.78 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -172.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.39 -47.08 62.54 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -68.17 -41.87 80.85 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.203 1.001 . . . . 0.0 110.367 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.42 34.81 13.08 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 -173.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.5 p -65.57 145.55 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.68 32.24 6.72 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.22 1.008 . . . . 0.0 111.576 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.58 24.43 73.9 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.322 -0.71 . . . . 0.0 113.098 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.34 126.62 75.01 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 118.818 1.309 . . . . 0.0 108.038 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -60.85 116.51 3.4 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.628 2.219 . . . . 0.0 108.294 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mp0 -74.68 -149.81 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.516 1.127 . . . . 0.0 111.433 -172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -130.63 145.78 51.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 125.496 1.518 . . . . 0.0 107.474 -176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' N ' ' OXT' ' A' ' 78' ' ' LEU . 0.2 OUTLIER 49.14 48.13 21.23 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 -168.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.42 51.78 1.41 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 127.341 2.257 . . . . 0.0 111.499 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -47.89 -34.97 23.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 124.336 3.358 . . . . 0.0 113.807 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -50.33 -40.13 48.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.917 1.287 . . . . 0.0 110.966 178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -78.22 -5.67 52.57 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 73.2 m95 -107.96 -44.99 4.07 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 50.58 46.03 26.05 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.913 0.863 . . . . 0.0 110.236 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 62.86 53.11 2.51 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 0.0 112.216 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -57.04 157.29 11.55 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 170.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -51.33 101.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.73 2.286 . . . . 0.0 111.073 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -59.05 -23.69 62.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.457 1.103 . . . . 0.0 111.989 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.0 m -55.07 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.71 1.604 . . . . 0.0 110.721 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 99.6 t -43.59 -41.47 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 125.279 1.431 . . . . 0.0 109.709 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -42.5 -38.02 1.81 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 127.345 2.258 . . . . 0.0 112.609 178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -91.13 -50.53 5.79 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.636 0.774 . . . . 0.0 110.17 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -51.09 -40.48 58.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 123.426 0.69 . . . . 0.0 111.844 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.02 -34.41 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 121.695 -0.628 . . . . 0.0 110.247 178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.09 -44.04 81.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.7 m -54.46 -44.99 73.04 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -67.01 -45.09 78.58 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.027 0.531 . . . . 0.0 110.889 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.8 mt -60.41 -50.45 73.54 Favored 'General case' 0 N--CA 1.457 -0.076 0 O-C-N 121.259 -0.9 . . . . 0.0 110.68 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.56 -28.39 51.79 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.416 1.086 . . . . 0.0 112.697 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 161.47 30.57 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -161.57 117.79 2.13 Favored 'General case' 0 CA--C 1.528 0.125 0 O-C-N 122.083 -0.657 . . . . 0.0 109.319 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.41 -118.06 13.51 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 108.517 -1.833 . . . . 0.0 108.517 -177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.34 -25.34 51.0 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 119.088 -0.482 . . . . 0.0 111.209 177.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 29.5 ttp -62.22 118.68 42.21 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.178 -176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 93.3 Cg_endo -72.46 160.52 46.58 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.509 2.139 . . . . 0.0 110.065 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.8 116.73 8.81 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -82.49 -7.46 59.64 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.676 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -55.9 88.78 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.931 0.892 . . . . 0.0 112.091 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.32 -41.9 1.44 Allowed Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.546 1.546 . . . . 0.0 110.572 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -75.55 -35.27 60.72 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 123.393 0.677 . . . . 0.0 110.384 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -143.72 130.72 20.54 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -78.57 149.66 32.96 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -32.04 -47.49 0.14 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.124 1.77 . . . . 0.0 111.494 171.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -61.68 -49.16 77.61 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.838 0.745 . . . . 0.0 111.66 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -56.43 -56.34 22.38 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-O 122.556 1.169 . . . . 0.0 108.791 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 80.5 mt -48.68 -60.71 2.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.391 -1.731 . . . . 0.0 110.085 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -43.29 -51.72 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 125.887 1.675 . . . . 0.0 110.851 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.6 mttp -59.21 -33.87 71.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.718 0.407 . . . . 0.0 111.395 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.37 -51.14 13.85 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.781 0.719 . . . . 0.0 109.39 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.4 mt -54.76 -45.77 73.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.121 0.968 . . . . 0.0 111.279 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -59.66 -41.39 90.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 120.036 1.289 . . . . 0.0 110.599 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -62.63 -54.14 43.97 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.6 ttm -45.75 -55.06 6.97 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.121 1.368 . . . . 0.0 109.782 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.7 mt -56.85 -26.62 58.86 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.239 0.615 . . . . 0.0 112.535 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.9 m -79.83 10.49 4.08 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.83 0.741 . . . . 0.0 112.372 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -177.05 54.48 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 176.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.736 ' OXT' HD12 ' A' ' 78' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.442 -0.875 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.592 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.91 -44.11 61.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 123.994 0.806 . . . . 0.0 111.134 176.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -57.63 -59.65 4.86 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 117.662 0.731 . . . . 0.0 109.448 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 p -54.5 -43.91 72.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.74 0.7 . . . . 0.0 111.438 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 77.9 mt -57.73 -55.46 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.24 -48.44 78.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.167 0.987 . . . . 0.0 111.872 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.3 mt -65.24 -51.73 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 118.654 -0.689 . . . . 0.0 110.538 -175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -153.85 8.69 0.37 Allowed 'General case' 0 C--N 1.34 0.163 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -173.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.42 36.39 4.42 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-N 119.795 1.18 . . . . 0.0 111.253 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -137.82 156.18 48.21 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.793 1.637 . . . . 0.0 108.155 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.0 110.79 10.94 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 123.761 0.825 . . . . 0.0 110.596 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -55.09 160.77 15.66 Favored 'Cis proline' 0 N--CA 1.456 -0.68 0 CA-C-N 119.915 1.005 . . . . 0.0 111.851 -15.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 p -70.34 114.9 8.92 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 124.355 1.062 . . . . 0.0 108.982 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -44.54 -48.27 10.23 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.19 0.996 . . . . 0.0 111.324 -176.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.1 p -43.76 -47.93 8.0 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 126.374 1.87 . . . . 0.0 112.184 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -49.46 -34.6 17.21 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.9 m -96.7 -58.03 2.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.63 0.252 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -67.4 -36.36 81.14 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -67.26 -41.37 85.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -177.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.64 -30.13 56.72 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.667 0.787 . . . . 0.0 110.572 177.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.73 35.47 40.29 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -60.4 136.95 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.02 28.21 5.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.119 0.968 . . . . 0.0 111.471 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.2 24.76 76.67 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.137 -0.813 . . . . 0.0 112.955 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.76 132.96 47.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 118.903 1.351 . . . . 0.0 108.422 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -49.48 104.38 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.958 3.106 . . . . 0.0 110.917 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.4 mp0 -75.24 176.23 7.57 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 122.514 1.149 . . . . 0.0 109.666 -177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.4 142.43 27.44 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.14 33.11 12.16 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.348 0.659 . . . . 0.0 109.461 -173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.66 55.87 17.72 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 118.125 -0.941 . . . . 0.0 112.641 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -37.09 -46.57 1.48 Allowed 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 124.486 3.457 . . . . 0.0 114.242 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -41.47 -45.36 3.17 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.046 1.338 . . . . 0.0 112.738 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -76.84 -25.05 52.73 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.679 0.672 . . . . 0.0 112.261 -176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -91.08 -23.49 20.3 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.411 0.684 . . . . 0.0 111.429 -177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.99 -47.39 0.53 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.32 2.248 . . . . 0.0 114.355 -177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -91.33 -14.37 30.87 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.428 0.691 . . . . 0.0 112.852 -175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -78.59 147.58 71.72 Favored Pre-proline 0 N--CA 1.451 -0.419 0 C-N-CA 123.839 0.856 . . . . 0.0 109.731 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.15 110.3 1.73 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.844 1.696 . . . . 0.0 108.573 177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.34 -27.47 47.4 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.135 0.574 . . . . 0.0 112.007 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.15 109.24 0.36 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.844 1.658 . . . . 0.0 111.482 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.3 t -51.95 -42.07 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -57.86 -20.96 40.32 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.75 1.22 . . . . 0.0 113.082 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -93.64 -53.85 3.88 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 174.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.8 mt -47.65 -41.72 22.91 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.62 0.768 . . . . 0.0 112.163 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.71 -37.1 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 121.688 -0.632 . . . . 0.0 110.41 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.7 -48.26 75.36 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -52.3 -46.04 65.78 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.811 0.845 . . . . 0.0 110.4 176.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.4 m -67.82 -40.97 83.76 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.058 0.543 . . . . 0.0 111.216 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.09 -56.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.49 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.37 61.72 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.567 1.147 . . . . 0.0 112.354 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.75 152.76 25.24 Favored Glycine 0 CA--C 1.531 1.044 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -151.76 142.75 23.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.88 -90.37 0.08 OUTLIER Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.216 -0.753 . . . . 0.0 111.216 -179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.98 16.0 2.65 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.365 1.466 . . . . 0.0 112.058 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 19.0 mtm -67.89 134.78 92.02 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 119.29 0.95 . . . . 0.0 110.847 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.57 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 92.9 Cg_endo -75.42 78.42 3.02 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.99 2.46 . . . . 0.0 108.784 177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -10.08 106.14 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 128.315 2.646 . . . . 0.0 112.403 178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -76.21 -6.65 52.3 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -47.29 114.83 0.94 Allowed 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.557 0.743 . . . . 0.0 111.272 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.12 -26.95 21.45 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.206 0.908 . . . . 0.0 112.717 178.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 49.7 mtm-85 -90.28 -52.44 4.93 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 118.514 1.157 . . . . 0.0 110.349 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -112.57 133.79 54.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -80.06 147.42 31.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -32.23 -45.71 0.11 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.38 1.872 . . . . 0.0 111.546 170.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -63.0 -47.18 84.21 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 119.211 0.914 . . . . 0.0 111.667 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -56.94 -58.65 7.23 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 122.577 1.179 . . . . 0.0 108.738 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.8 mt -47.14 -57.37 5.18 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 126.406 1.882 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.8 t -46.24 -57.23 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 124.844 1.257 . . . . 0.0 109.713 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -56.78 -43.65 81.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.802 0.274 . . . . 0.0 111.441 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.25 72.14 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 83.6 mt -57.75 -47.33 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.251 1.42 . . . . 0.0 109.463 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -55.26 -51.69 65.83 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -55.95 -50.8 69.77 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.361 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 79.0 mtp -51.84 -53.46 40.17 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.291 0.636 . . . . 0.0 109.987 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -57.78 -37.44 73.71 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.577 0.751 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.3 m -72.67 41.18 0.09 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.3 p -135.64 -16.35 1.78 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.36 1.864 . . . . 0.0 110.014 172.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 116.694 -1.622 . . . . 0.0 110.033 -178.126 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.57 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 117.87 -1.062 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -43.6 -49.85 7.1 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 119.397 0.999 . . . . 0.0 112.946 -177.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -56.12 -40.58 73.97 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.543 -0.386 . . . . 0.0 111.303 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -52.81 -42.09 64.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.553 0.615 . . . . 0.0 111.054 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 46.1 mt -59.33 -59.59 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.296 1.438 . . . . 0.0 109.197 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.32 -51.42 70.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.75 0.82 . . . . 0.0 111.349 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.1 mm -65.73 -46.02 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.816 0.446 . . . . 0.0 111.065 -173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -165.13 44.03 0.08 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -171.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.97 36.67 1.21 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.44 157.27 46.94 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.732 2.013 . . . . 0.0 107.47 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.92 113.49 6.41 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-O 118.278 -0.868 . . . . 0.0 108.802 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.73 152.5 19.71 Favored 'Cis proline' 0 N--CA 1.455 -0.792 0 CA-C-N 120.321 1.15 . . . . 0.0 111.065 -13.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.31 125.17 24.78 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.609 1.164 . . . . 0.0 109.775 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -54.74 -51.05 66.87 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.331 0.586 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -39.54 -61.06 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.509 1.923 . . . . 0.0 112.214 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.0 m -41.51 -39.62 1.6 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.441 1.497 . . . . 0.0 113.387 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -91.46 -56.82 2.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.045 0.45 . . . . 0.0 110.923 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -60.67 -41.18 94.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -173.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -48.31 -40.93 26.71 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.668 0.787 . . . . 0.0 112.109 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -116.43 26.08 10.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.991 0.516 . . . . 0.0 111.863 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 47.21 43.08 18.26 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.566 0.603 . . . . 0.0 113.54 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.25 136.89 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.69 30.36 8.69 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.549 1.14 . . . . 0.0 111.676 -178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.0 23.49 74.45 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.6 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.01 142.91 84.88 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 118.459 1.129 . . . . 0.0 109.323 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -59.78 121.53 9.98 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 N-CA-C 106.848 -2.02 . . . . 0.0 106.848 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.47 176.76 7.23 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 123.671 1.7 . . . . 0.0 110.849 -174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.5 tp -97.46 140.46 31.87 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.518 -2.128 . . . . 0.0 107.525 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 64.59 35.98 8.79 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.353 0.661 . . . . 0.0 109.459 -173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -131.62 71.26 81.14 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 124.467 1.107 . . . . 0.0 111.233 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -41.0 -57.99 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 124.344 3.363 . . . . 0.0 114.456 -174.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -43.53 -47.92 7.35 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.154 1.381 . . . . 0.0 112.164 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -53.26 -39.56 63.96 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.421 0.688 . . . . 0.0 110.972 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.1 m95 -91.03 -29.89 17.1 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.318 0.647 . . . . 0.0 111.073 -176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.11 -41.0 97.78 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.359 0.663 . . . . 0.0 109.396 177.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.56 -41.86 96.05 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -77.29 164.68 57.05 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 124.586 1.154 . . . . 0.0 111.085 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -67.82 89.8 0.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 N-CA-C 107.632 -1.719 . . . . 0.0 107.632 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -21.96 7.88 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.702 1.201 . . . . 0.0 112.322 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.94 109.5 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.434 1.893 . . . . 0.0 110.932 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 82.9 t -48.13 -44.01 11.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.251 1.02 . . . . 0.0 110.615 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.41 -29.09 61.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.009 1.724 . . . . 0.0 112.606 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -86.81 -55.35 3.89 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.4 mt -45.61 -44.36 13.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.833 1.253 . . . . 0.0 112.994 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.5 p -58.89 -37.33 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 O-C-N 121.722 -0.611 . . . . 0.0 110.607 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -65.58 -47.24 76.44 Favored 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 119.192 0.905 . . . . 0.0 108.905 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.4 m -53.04 -46.6 68.53 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 123.386 0.674 . . . . 0.0 110.259 175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -64.13 -46.45 84.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.002 0.521 . . . . 0.0 110.356 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -57.06 -54.41 47.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 121.791 -0.568 . . . . 0.0 109.951 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.48 64.25 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.22 1.008 . . . . 0.0 112.988 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.61 160.27 33.12 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -174.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -157.68 126.36 5.65 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 121.861 -0.787 . . . . 0.0 109.05 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.0 -120.68 22.89 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.92 -14.44 54.16 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.746 178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 39.2 ttp -71.69 118.23 64.67 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 119.166 0.894 . . . . 0.0 108.716 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -71.23 160.56 48.56 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.389 2.059 . . . . 0.0 110.611 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.2 133.14 53.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -101.65 -11.55 19.1 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.615 0.766 . . . . 0.0 111.363 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -46.37 117.53 1.62 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.364 1.065 . . . . 0.0 111.558 177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.52 -25.0 11.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.267 0.937 . . . . 0.0 112.34 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -86.35 -47.38 9.41 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 117.86 0.83 . . . . 0.0 108.865 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.481 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -110.08 142.24 41.82 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -80.36 131.03 35.56 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -28.35 -49.88 0.07 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.205 2.202 . . . . 0.0 112.659 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -61.28 -49.04 78.66 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.82 -0.55 . . . . 0.0 111.225 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -47.35 86.19 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 123.93 0.892 . . . . 0.0 109.141 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 62' ' ' ALA . 40.9 mt -51.63 -58.99 4.79 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.8 t -46.64 -54.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 C-N-CA 125.158 1.383 . . . . 0.0 110.484 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -56.72 -45.55 81.82 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.139 0.427 . . . . 0.0 111.333 179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.34 98.43 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.798 -0.564 . . . . 0.0 110.179 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 77.6 mt -65.2 -55.85 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 124.277 1.031 . . . . 0.0 109.268 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -59.26 -38.86 81.12 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.643 1.11 . . . . 0.0 109.773 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -59.53 -49.81 76.34 Favored 'General case' 0 C--N 1.341 0.237 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 ttp -53.52 -54.27 39.72 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.7 mt -56.36 -38.97 72.13 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 119.071 -0.49 . . . . 0.0 111.619 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -61.42 -6.5 2.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.882 1.219 . . . . 0.0 113.951 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 45.0 p -86.75 -5.28 59.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.725 1.148 . . . . 0.0 110.684 176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.224 -1.37 . . . . 0.0 110.688 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.0 t70 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 118.937 -0.554 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.29 -40.64 22.7 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -61.82 -47.33 85.58 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 117.883 0.841 . . . . 0.0 109.557 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.04 -48.39 76.09 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.238 0.615 . . . . 0.0 109.628 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.39 -55.95 20.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.151 0.98 . . . . 0.0 109.6 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -56.66 -50.48 71.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.914 0.886 . . . . 0.0 111.607 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 79.5 mt -71.46 -45.29 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.131 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.91 36.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.04 33.0 2.22 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -137.98 157.45 46.34 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.271 2.228 . . . . 0.0 106.408 176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.49 113.19 6.62 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 118.259 -0.877 . . . . 0.0 109.755 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -50.08 153.73 7.78 Favored 'Cis proline' 0 N--CA 1.457 -0.65 0 CA-C-N 120.522 1.222 . . . . 0.0 110.752 -15.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.2 p -67.01 144.16 56.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 22.7 m -56.25 -38.89 71.75 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.076 0.853 . . . . 0.0 108.906 177.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -56.28 -23.27 35.43 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.95 1.3 . . . . 0.0 112.8 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 71.0 m -57.48 -28.32 63.3 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.488 1.04 . . . . 0.0 110.628 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.2 m -122.54 -52.31 1.93 Allowed 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -70.09 -20.35 63.21 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.21 -52.12 65.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.818 0.735 . . . . 0.0 109.869 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.7 mtm-85 -91.47 -22.95 20.15 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.932 0.893 . . . . 0.0 111.339 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.34 42.15 8.09 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -61.35 146.6 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.51 30.17 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.081 0.952 . . . . 0.0 111.417 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.99 20.4 79.96 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.348 -0.696 . . . . 0.0 113.027 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.95 135.61 90.31 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.873 1.336 . . . . 0.0 108.272 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 39.3 Cg_endo -60.31 128.83 27.5 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.459 2.106 . . . . 0.0 109.915 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -89.02 171.44 9.85 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 122.264 1.031 . . . . 0.0 112.937 -174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.48 156.42 36.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.891 172.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 52.32 36.56 20.03 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.889 0.876 . . . . 0.0 111.265 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.37 65.52 68.29 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.842 -175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -39.74 -47.03 3.67 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 124.324 3.349 . . . . 0.0 114.428 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -51.11 -39.59 56.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.865 1.266 . . . . 0.0 111.487 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.49 -21.88 66.18 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.426 0.69 . . . . 0.0 111.733 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.402 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 88.1 m95 -108.58 -30.73 8.09 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.4 1.08 . . . . 0.0 112.903 -174.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.49 -50.79 1.12 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.728 1.611 . . . . 0.0 113.048 -178.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.49 -24.51 50.1 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -77.92 143.85 67.14 Favored Pre-proline 0 CA--C 1.535 0.381 0 O-C-N 121.529 -0.732 . . . . 0.0 110.276 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.79 96.43 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.675 2.25 . . . . 0.0 108.895 174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -55.78 -26.88 48.21 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.815 1.246 . . . . 0.0 112.943 -174.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.8 m -50.0 104.28 0.07 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.827 1.651 . . . . 0.0 111.48 178.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.7 t -46.14 -44.07 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.167 1.387 . . . . 0.0 111.54 -178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -58.18 -31.86 67.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.183 0.593 . . . . 0.0 112.045 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -81.63 -48.01 12.28 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.6 mt -51.67 -41.3 61.29 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 m -59.94 -34.18 55.32 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.347 0 CA-C-O 117.814 -1.088 . . . . 0.0 110.479 178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -60.87 -48.48 81.6 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 120.531 1.514 . . . . 0.0 109.057 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.69 -42.21 67.75 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.795 0.838 . . . . 0.0 111.205 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -70.39 -44.57 67.75 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.384 0.673 . . . . 0.0 110.334 -177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.1 mt -64.18 -50.66 67.25 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 124.795 1.238 . . . . 0.0 109.751 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.2 -29.12 61.59 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.201 1.001 . . . . 0.0 112.214 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.71 158.53 31.48 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -157.15 118.34 3.67 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.013 -0.698 . . . . 0.0 109.482 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.63 -117.77 12.28 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.39 -23.13 54.06 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 122.744 0.418 . . . . 0.0 111.461 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.4 ttp -66.41 118.49 54.04 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.466 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -72.34 154.38 56.13 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.481 2.121 . . . . 0.0 109.954 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.84 123.36 17.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.699 -0.667 . . . . 0.0 109.827 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -92.28 -11.9 33.99 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.967 0.803 . . . . 0.0 111.756 176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -44.26 116.01 0.94 Allowed 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.062 0.945 . . . . 0.0 112.037 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -26.36 9.73 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.154 0.883 . . . . 0.0 112.4 178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 -83.91 -44.75 13.93 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -111.23 146.39 37.04 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 172.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.55 132.58 34.91 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -31.96 -44.32 0.08 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.141 1.776 . . . . 0.0 112.64 174.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -57.02 -44.62 83.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.819 1.191 . . . . 0.0 111.645 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -54.03 -57.76 9.84 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-O 122.17 0.986 . . . . 0.0 108.531 177.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 62' ' ' ALA . 41.7 mt -50.34 -59.12 4.29 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.545 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.0 t -43.38 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 124.445 1.098 . . . . 0.0 109.687 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.36 -40.79 97.58 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 122.11 -0.369 . . . . 0.0 111.815 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.88 97.81 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.0 mt -65.22 -48.13 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 124.105 0.962 . . . . 0.0 109.111 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -51.27 -51.73 51.5 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -56.59 -53.73 54.22 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 119.218 -0.42 . . . . 0.0 111.107 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ptm -55.66 -47.34 76.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.507 0.594 . . . . 0.0 109.68 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.73 -38.52 90.83 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.832 -0.542 . . . . 0.0 110.449 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.2 m -61.71 -5.4 1.92 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.5 p -88.38 -16.31 33.26 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 120.207 1.367 . . . . 0.0 111.19 176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 116.657 -1.64 . . . . 0.0 110.601 -176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 118.601 -0.714 . . . . 0.0 109.09 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.62 -49.24 61.98 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -48.43 -49.75 33.95 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.274 1.029 . . . . 0.0 110.536 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -47.38 -40.3 17.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.385 1.074 . . . . 0.0 111.602 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.4 mt -58.23 -49.23 82.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -68.05 -44.72 75.75 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.967 0.907 . . . . 0.0 110.743 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 86.9 mt -69.32 -50.97 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.311 -174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -144.2 -9.75 0.67 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -171.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.2 -40.18 42.37 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-N 119.847 1.203 . . . . 0.0 111.131 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 p -72.57 158.59 35.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.131 0.491 . . . . 0.0 110.676 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.76 111.88 5.78 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.439 1.096 . . . . 0.0 109.792 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.06 151.34 12.04 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.249 1.125 . . . . 0.0 110.86 -13.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.4 p -66.3 134.35 52.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -51.4 -41.41 60.7 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.63 0.729 . . . . 0.0 109.334 178.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 p -50.93 -37.05 41.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.551 1.14 . . . . 0.0 112.814 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 75.0 m -44.75 -39.28 5.07 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 118.876 0.762 . . . . 0.0 111.407 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.7 m -107.04 -56.31 2.21 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.514 0.725 . . . . 0.0 110.439 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -62.7 -26.83 68.87 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.46 -1.52 53.75 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.69 0.677 . . . . 0.0 111.026 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -127.35 -17.69 4.64 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.925 0.89 . . . . 0.0 111.65 178.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.56 27.17 65.9 Favored Glycine 0 CA--C 1.526 0.769 0 O-C-N 121.597 -0.69 . . . . 0.0 111.488 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.9 p -60.87 141.64 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.38 27.76 5.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.973 0.909 . . . . 0.0 111.575 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.17 25.47 74.49 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.377 -0.68 . . . . 0.0 112.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.65 129.2 80.91 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 118.595 1.198 . . . . 0.0 108.311 176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -64.54 123.56 11.92 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.24 1.96 . . . . 0.0 109.269 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -93.29 -179.53 5.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.703 0.763 . . . . 0.0 113.053 -172.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.67 159.57 34.16 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 175.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.5 m120 48.06 32.34 2.89 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.281 1.032 . . . . 0.0 112.356 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.16 61.85 59.33 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-O 118.093 -0.956 . . . . 0.0 112.406 -175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -37.24 -49.11 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 124.456 3.437 . . . . 0.0 114.01 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.02 -43.78 9.52 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.245 1.418 . . . . 0.0 111.951 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -66.01 -27.0 67.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.747 0.819 . . . . 0.0 111.924 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -103.62 -18.55 14.69 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.689 1.195 . . . . 0.0 112.429 -175.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -47.05 0.64 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.407 1.883 . . . . 0.0 114.013 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -95.96 -9.84 30.16 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -81.27 131.57 58.54 Favored Pre-proline 0 CA--C 1.535 0.391 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -177.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -51.62 109.79 0.36 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.959 2.439 . . . . 0.0 110.888 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 m -56.59 -26.26 54.96 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.764 0.826 . . . . 0.0 112.446 -178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -49.43 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.31 1.844 . . . . 0.0 111.618 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.0 t -48.47 -38.56 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 123.67 0.788 . . . . 0.0 110.715 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.01 -44.01 82.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.844 0.458 . . . . 0.0 111.383 177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -68.71 -45.96 70.19 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.4 mt -56.51 -44.51 80.83 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 122.448 0.299 . . . . 0.0 111.553 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -65.12 -36.26 77.36 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -52.66 64.5 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.951 0.796 . . . . 0.0 109.798 175.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 m -51.17 -43.26 61.26 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 123.908 0.883 . . . . 0.0 111.106 176.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 m -69.12 -44.0 73.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.933 0.493 . . . . 0.0 111.042 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.9 mt -61.26 -52.5 64.47 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.337 -0.852 . . . . 0.0 109.947 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.5 77.91 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.677 0.791 . . . . 0.0 110.905 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.26 87.14 1.43 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.542 1.068 . . . . 0.0 110.867 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -77.79 146.58 35.73 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.652 1.181 . . . . 0.0 109.82 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.83 -110.85 3.07 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -108.24 9.49 28.01 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.684 1.193 . . . . 0.0 111.903 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 42.8 mtm -71.25 137.83 84.25 Favored Pre-proline 0 N--CA 1.455 -0.224 0 CA-C-N 119.172 0.896 . . . . 0.0 111.627 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 22.8 Cg_exo -63.52 139.37 69.98 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 N-CA-C 106.961 -1.977 . . . . 0.0 106.961 170.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.91 114.99 3.67 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -80.82 -8.74 59.78 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.83 -0.605 . . . . 0.0 111.846 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -51.7 112.15 0.72 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.94 0.791 . . . . 0.0 110.609 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.83 -26.14 10.25 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 123.945 0.783 . . . . 0.0 111.916 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.3 ttm-85 -74.6 -44.19 51.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.435 1.094 . . . . 0.0 108.696 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.512 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -126.99 157.11 40.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.79 1.236 . . . . 0.0 108.338 175.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -88.47 129.82 35.35 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.3 ttt85 -33.6 -43.81 0.13 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.532 1.933 . . . . 0.0 112.046 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -60.86 -48.82 80.05 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.401 1.0 . . . . 0.0 111.522 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.2 -48.81 78.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HB3' ' A' ' 62' ' ' ALA . 49.8 mt -50.8 -58.73 5.22 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.127 0.489 . . . . 0.0 109.693 176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.3 t -47.36 -56.9 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 124.796 1.239 . . . . 0.0 109.823 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.9 mttp -57.12 -40.38 76.97 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 122.873 0.469 . . . . 0.0 111.72 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.07 -42.62 93.98 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -63.36 -46.77 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -53.78 -51.42 63.48 Favored 'General case' 0 N--CA 1.457 -0.098 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -54.17 -54.11 44.27 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 119.102 -0.475 . . . . 0.0 110.306 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 39.3 mtp -49.33 -60.03 3.19 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.407 0.683 . . . . 0.0 109.394 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.4 mp -54.13 -39.15 66.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.54 0.736 . . . . 0.0 111.678 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.2 m -62.82 -9.01 8.0 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.159 -0.924 . . . . 0.0 113.321 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.8 p -88.8 -14.1 37.85 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.17 1.35 . . . . 0.0 110.932 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 116.457 -1.735 . . . . 0.0 111.122 -175.631 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.433 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.472 0.675 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.47 -37.36 19.02 Favored Glycine 0 C--N 1.339 0.699 0 C-N-CA 124.462 1.03 . . . . 0.0 111.698 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.93 -60.85 2.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -47.21 -46.12 23.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.679 1.192 . . . . 0.0 110.677 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.91 -53.37 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -59.52 -45.43 91.77 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.905 0.32 . . . . 0.0 111.67 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.76 -52.82 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.375 0.67 . . . . 0.0 112.035 -173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -133.23 -18.6 2.26 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -171.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.4 -32.34 43.03 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 119.916 1.235 . . . . 0.0 112.845 -176.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -71.36 150.45 45.05 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 117.583 0.692 . . . . 0.0 110.687 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.73 111.89 16.18 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.021 1.329 . . . . 0.0 109.46 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -62.46 159.14 59.07 Favored 'Cis proline' 0 N--CA 1.453 -0.877 0 CA-C-N 120.343 1.158 . . . . 0.0 109.402 -12.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -65.22 121.04 13.85 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.394 1.477 . . . . 0.0 110.31 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.6 m -51.17 -47.02 62.26 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.011 0.524 . . . . 0.0 110.552 -178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.8 p -41.44 -52.42 3.6 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 126.582 1.953 . . . . 0.0 112.226 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.4 m -47.62 -33.54 6.79 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.249 1.02 . . . . 0.0 112.552 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 24.4 m -99.28 -56.0 2.53 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.049 0.386 . . . . 0.0 110.838 178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -70.65 -38.81 73.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -172.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.36 -42.98 78.4 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.359 0.981 . . . . 0.0 108.994 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -38.91 79.36 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.212 1.005 . . . . 0.0 111.509 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.54 34.91 8.19 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.813 1.197 . . . . 0.0 110.362 -175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.5 t -55.98 129.46 17.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.55 30.96 6.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.481 1.112 . . . . 0.0 111.361 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.99 24.2 77.35 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 119.357 -0.69 . . . . 0.0 112.823 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.36 131.58 52.99 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 118.548 1.174 . . . . 0.0 108.33 175.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -60.09 116.95 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.077 2.518 . . . . 0.0 109.226 -176.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 mp0 -84.54 173.61 10.68 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.184 0.994 . . . . 0.0 112.631 -172.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.09 161.68 29.69 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 173.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 m120 49.36 32.03 4.25 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.549 0.74 . . . . 0.0 112.622 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 59.56 38.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.373 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -39.55 -45.89 3.37 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.055 3.17 . . . . 0.0 114.468 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.59 -44.48 18.17 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.663 1.185 . . . . 0.0 111.519 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -73.09 -18.15 61.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.171 0.989 . . . . 0.0 112.327 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -104.89 -18.22 14.28 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.32 1.048 . . . . 0.0 112.153 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.73 -46.2 0.59 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.391 1.876 . . . . 0.0 114.243 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -92.41 -14.91 27.9 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.616 0.767 . . . . 0.0 112.991 -176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -81.31 124.93 80.22 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 124.09 0.956 . . . . 0.0 109.373 -177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.31 120.99 8.17 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.571 2.181 . . . . 0.0 111.473 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -54.73 -31.05 57.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.827 0.851 . . . . 0.0 112.166 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -48.72 102.17 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.568 1.947 . . . . 0.0 112.855 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -50.1 -43.06 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.689 0.796 . . . . 0.0 109.404 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -58.24 -27.35 63.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.444 1.098 . . . . 0.0 112.769 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -85.85 -54.06 4.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.2 mt -52.92 -40.69 63.79 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.793 0.837 . . . . 0.0 112.521 -177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.97 -28.51 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.505 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -62.74 -47.39 83.77 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.681 1.128 . . . . 0.0 108.867 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.9 m -54.22 -48.22 71.3 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 123.926 0.89 . . . . 0.0 109.892 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.1 m -62.02 -45.24 94.46 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.921 -0.487 . . . . 0.0 111.066 178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.7 mt -62.14 -53.44 55.28 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.197 0.599 . . . . 0.0 110.98 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.89 -21.42 47.45 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.067 1.347 . . . . 0.0 112.976 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.4 162.63 35.32 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -177.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -159.91 114.33 2.29 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -115.33 7.14 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.94 -27.96 60.4 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.49 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 33.3 ttp -62.98 115.45 17.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-O 118.418 -0.801 . . . . 0.0 110.688 -176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.408 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 94.2 Cg_endo -77.21 130.27 10.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.032 2.488 . . . . 0.0 110.415 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -41.62 114.69 0.55 Allowed 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 125.434 1.494 . . . . 0.0 111.848 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -83.14 -13.63 55.18 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.483 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -48.99 112.85 0.68 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 118.89 0.768 . . . . 0.0 111.258 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.08 -32.92 6.56 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.278 0.942 . . . . 0.0 111.651 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.6 ttp-105 -79.15 -44.66 21.51 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.795 -0.816 . . . . 0.0 108.795 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.98 135.83 49.51 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 172.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.54 146.88 32.39 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 42.6 ttt85 -32.2 -47.89 0.16 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.234 1.814 . . . . 0.0 111.31 170.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.1 -46.02 92.31 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.673 0.67 . . . . 0.0 111.371 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -57.24 -58.15 9.51 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 122.08 0.943 . . . . 0.0 108.632 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 62' ' ' ALA . 72.5 mt -45.87 -58.03 3.85 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.543 1.537 . . . . 0.0 110.416 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.5 t -41.63 -51.67 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 125.158 1.383 . . . . 0.0 111.214 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -57.85 -38.84 76.4 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.572 0.169 . . . . 0.0 111.416 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -48.15 56.91 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 43.4 mt -58.1 -49.08 82.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.315 0.646 . . . . 0.0 111.114 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -61.5 -44.19 97.53 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.022 -1.049 . . . . 0.0 109.629 -179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -56.95 -53.51 57.21 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.286 0.494 . . . . 0.0 109.68 177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 28.3 ttm -48.2 -53.57 16.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.806 1.642 . . . . 0.0 109.907 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.34 -37.87 84.86 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.233 -0.292 . . . . 0.0 110.489 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.7 m -73.4 39.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.3 p -129.43 -12.93 4.41 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.932 1.693 . . . . 0.0 109.559 172.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.352 -1.308 . . . . 0.0 110.304 -176.282 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.408 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -45.32 -42.66 9.4 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.568 1.08 . . . . 0.0 111.77 179.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.0 mp0 -54.0 -61.99 1.94 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.542 1.137 . . . . 0.0 108.846 175.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.56 -53.21 24.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.75 1.22 . . . . 0.0 110.538 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.3 mt -52.7 -61.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.266 1.427 . . . . 0.0 110.0 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -56.77 -48.82 77.01 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.288 0.635 . . . . 0.0 112.035 -179.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 89.9 mt -67.69 -44.02 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 118.679 -0.676 . . . . 0.0 111.153 -173.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 6.14 0.19 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -174.249 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.04 40.04 2.65 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.827 1.194 . . . . 0.0 111.323 -177.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.84 155.94 49.56 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.527 1.531 . . . . 0.0 108.585 178.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.25 109.19 8.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 C-N-CA 123.738 0.815 . . . . 0.0 110.158 -177.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -57.73 156.69 32.27 Favored 'Cis proline' 0 N--CA 1.457 -0.664 0 CA-C-N 119.802 0.965 . . . . 0.0 111.462 -12.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.1 123.17 19.51 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.915 1.286 . . . . 0.0 109.72 179.581 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 m -55.79 -49.3 73.56 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.497 0.665 . . . . 0.0 111.011 -177.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 p -41.52 -51.1 3.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.282 1.833 . . . . 0.0 112.543 179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.7 m -44.44 -35.34 2.39 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.793 1.237 . . . . 0.0 113.345 -178.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.7 m -102.23 -52.73 3.07 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.747 0.419 . . . . 0.0 110.729 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -67.12 -25.63 66.29 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -61.39 -44.32 97.35 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.3 0.954 . . . . 0.0 110.249 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.93 -30.19 16.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.476 0.71 . . . . 0.0 111.152 178.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.94 40.1 5.01 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -176.181 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 89.4 t -53.7 136.22 15.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.411 0.685 . . . . 0.0 109.36 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.54 32.25 8.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.776 1.23 . . . . 0.0 112.097 -179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.31 14.76 81.18 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.267 -0.74 . . . . 0.0 113.278 178.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.23 130.38 68.7 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 118.529 1.165 . . . . 0.0 108.61 176.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -61.88 119.17 6.16 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.004 1.802 . . . . 0.0 109.402 -178.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.4 158.52 33.76 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.526 0.679 . . . . 0.0 110.323 -176.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.92 151.08 25.28 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 177.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 64.45 34.82 9.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.985 0.914 . . . . 0.0 109.363 -174.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.8 68.46 43.43 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.749 -0.643 . . . . 0.0 111.765 -176.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -38.65 -52.39 2.07 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 124.291 3.328 . . . . 0.0 114.275 -178.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.9 mp0 -48.52 -39.99 25.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.322 1.449 . . . . 0.0 111.812 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.04 -30.85 71.89 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.808 0.443 . . . . 0.0 111.339 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -101.25 -27.67 13.07 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 123.783 0.833 . . . . 0.0 112.359 -175.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.95 -51.55 0.92 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.05 1.74 . . . . 0.0 112.98 -178.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.54 -21.31 38.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -177.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.456 HH22 ' CGD' ' A' ' 0' ' ' HEM . 91.8 mtt-85 -81.36 156.5 71.24 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.872 0.869 . . . . 0.0 110.268 -177.369 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -53.89 109.85 0.43 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.008 2.472 . . . . 0.0 111.646 176.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.96 -31.52 72.64 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.031 -1.043 . . . . 0.0 110.423 177.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 105.17 0.17 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.425 2.29 . . . . 0.0 111.68 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.5 t -48.77 -39.7 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.001 0.92 . . . . 0.0 110.599 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -57.55 -39.67 77.19 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.841 1.256 . . . . 0.0 111.648 177.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -75.29 -44.18 47.0 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 41.1 mt -56.11 -49.73 73.06 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.8 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' O ' HD23 ' A' ' 49' ' ' LEU . 11.8 p -59.41 -44.69 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.291 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.64 -44.69 85.8 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.322 0.964 . . . . 0.0 109.596 177.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.6 m -59.58 -33.2 71.15 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.084 176.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.7 m -72.38 -45.31 60.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.5 0.72 . . . . 0.0 109.751 178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 45' ' ' VAL . 2.2 mm? -54.65 -52.31 62.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 119.86 1.209 . . . . 0.0 110.517 174.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.83 82.26 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.358 0.411 . . . . 0.0 111.762 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.21 124.21 3.65 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -174.816 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -101.12 139.87 36.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.133 1.373 . . . . 0.0 107.748 178.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.06 3.76 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.39 8.61 43.52 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.088 0.955 . . . . 0.0 112.723 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 37.1 mtm -68.06 148.25 98.37 Favored Pre-proline 0 C--N 1.338 0.091 0 CA-C-N 119.756 1.162 . . . . 0.0 112.261 -178.829 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.32 140.92 25.16 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 N-CA-C 106.345 -2.214 . . . . 0.0 106.345 171.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.85 117.66 6.17 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -77.0 4.07 10.86 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -175.071 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -50.67 104.75 0.08 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.057 0.943 . . . . 0.0 111.713 177.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.01 -8.43 63.33 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.186 0.898 . . . . 0.0 113.214 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -78.75 -42.21 28.68 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.858 1.329 . . . . 0.0 108.308 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.436 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -134.84 144.91 47.85 Favored 'General case' 0 CA--C 1.522 -0.123 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 174.05 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -81.47 143.21 32.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.58 -0.156 . . . . 0.0 110.58 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -27.72 -50.31 0.06 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.4 2.28 . . . . 0.0 112.295 169.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -63.77 -49.88 71.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.539 0.609 . . . . 0.0 111.095 -179.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.93 -50.65 72.93 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.35 1.06 . . . . 0.0 109.377 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 62' ' ' ALA . 44.2 mt -51.29 -56.84 10.87 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.251 1.42 . . . . 0.0 109.986 177.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.3 t -52.44 -53.95 17.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 123.175 0.59 . . . . 0.0 109.98 178.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -56.33 -36.83 69.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.672 0.789 . . . . 0.0 111.529 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.99 -50.72 38.87 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.5 mt -59.16 -48.72 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.467 1.107 . . . . 0.0 110.443 -176.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -59.28 -42.17 90.62 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.208 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -61.14 -48.85 79.71 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.557 0.617 . . . . 0.0 110.152 177.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 64.0 mtp -48.02 -58.05 4.96 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 122.016 0.912 . . . . 0.0 109.149 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.6 mt -56.28 -40.05 73.64 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.086 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.3 m -74.17 42.36 0.15 Allowed 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.122 -0.987 . . . . 0.0 113.583 -179.592 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 72.6 p -132.01 -15.62 2.95 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.441 1.496 . . . . 0.0 109.949 171.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.188 -1.386 . . . . 0.0 109.927 -177.33 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.456 ' CGD' HH22 ' A' ' 37' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.78 -40.37 41.33 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 176.486 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -58.36 -58.8 6.92 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -46.3 -47.98 18.25 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.905 0.775 . . . . 0.0 111.609 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -59.38 -57.11 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.162 0.985 . . . . 0.0 110.06 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -54.9 -44.68 74.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.105 0.962 . . . . 0.0 111.446 179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.6 mm -74.48 -51.71 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 118.597 -0.716 . . . . 0.0 111.956 -173.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.38 -16.55 1.83 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -171.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.47 -35.06 43.01 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.654 1.115 . . . . 0.0 112.112 -177.228 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -70.25 147.05 50.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.026 0.53 . . . . 0.0 110.791 -178.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.69 109.81 13.3 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.704 1.202 . . . . 0.0 109.349 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.35 161.25 58.86 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.257 1.128 . . . . 0.0 110.371 -8.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -70.73 125.48 26.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.26 1.424 . . . . 0.0 110.934 -177.609 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.0 m -56.18 -48.74 75.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.268 0.556 . . . . 0.0 110.389 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.7 p -38.44 -58.51 1.01 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.941 2.096 . . . . 0.0 111.888 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.7 m -41.1 -38.74 1.1 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.947 1.299 . . . . 0.0 113.113 -179.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.6 m -94.64 -56.07 2.91 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 117.828 0.285 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -65.65 -33.48 75.98 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -172.323 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.01 -39.88 83.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 119.752 1.16 . . . . 0.0 109.471 178.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 tpt85 -76.79 -29.99 56.25 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.174 0.99 . . . . 0.0 110.712 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.65 31.47 62.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -174.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -58.42 140.2 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -178.311 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.27 29.31 6.53 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.084 0.954 . . . . 0.0 111.414 -177.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 25.62 74.47 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.391 -0.672 . . . . 0.0 112.651 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.69 135.36 82.75 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.621 1.21 . . . . 0.0 108.622 176.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 57.7 Cg_endo -62.9 122.64 11.0 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.389 2.06 . . . . 0.0 109.178 -179.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -87.77 177.48 7.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.795 0.807 . . . . 0.0 111.955 -174.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -71.15 161.14 31.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 36.23 51.05 0.78 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.573 1.549 . . . . 0.0 111.786 177.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.41 63.13 27.17 Favored Pre-proline 0 CA--C 1.533 0.306 0 C-N-CA 124.8 1.24 . . . . 0.0 110.275 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -40.19 -46.42 4.14 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 124.245 3.297 . . . . 0.0 114.523 -176.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -49.31 -39.93 33.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.868 0.867 . . . . 0.0 111.92 179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -66.41 -24.45 66.47 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.53 0.732 . . . . 0.0 111.781 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 86.4 m95 -106.6 -22.3 12.8 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 124.69 1.196 . . . . 0.0 112.938 -174.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.33 -49.53 0.71 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.935 1.694 . . . . 0.0 113.484 -178.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -88.1 -15.27 36.67 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -81.63 153.36 70.59 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 118.944 0.793 . . . . 0.0 110.512 -177.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -53.24 125.92 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.727 2.285 . . . . 0.0 111.455 176.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -67.37 -40.18 85.74 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 174.04 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -49.42 101.15 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.006 2.522 . . . . 0.0 112.19 178.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.62 -40.1 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.025 0.93 . . . . 0.0 109.703 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -55.5 -25.39 36.81 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.324 1.85 . . . . 0.0 112.373 176.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -89.83 -51.23 5.6 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 175.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -51.35 -38.99 56.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.728 0.811 . . . . 0.0 112.158 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.76 -33.62 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.542 -0.724 . . . . 0.0 110.286 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -65.1 -49.45 69.92 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.598 1.09 . . . . 0.0 108.424 177.642 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -53.04 -43.69 66.81 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.047 0.539 . . . . 0.0 109.831 177.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 m -67.96 -46.23 72.0 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 122.028 -0.42 . . . . 0.0 110.716 179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.7 mt -56.18 -51.09 69.29 Favored 'General case' 0 N--CA 1.457 -0.116 0 O-C-N 121.673 -0.642 . . . . 0.0 110.083 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.79 -27.81 55.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.598 1.159 . . . . 0.0 113.134 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.49 163.3 32.92 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -175.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -157.42 119.63 3.82 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.916 -0.755 . . . . 0.0 109.499 -178.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.01 -118.06 12.98 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -178.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.8 -21.21 55.46 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 122.743 0.417 . . . . 0.0 111.588 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.6 ttp -68.54 118.66 62.19 Favored Pre-proline 0 C--O 1.234 0.279 0 CA-C-N 118.942 0.792 . . . . 0.0 110.075 -178.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.57 158.37 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.486 2.124 . . . . 0.0 109.798 178.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.24 148.01 38.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 175.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -114.92 -9.18 12.47 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.417 1.087 . . . . 0.0 113.14 178.199 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -48.13 110.24 0.31 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.084 0.856 . . . . 0.0 111.796 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.38 -31.33 7.55 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.084 0.849 . . . . 0.0 111.951 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -74.33 -46.46 40.72 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.479 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -128.01 129.02 46.05 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 173.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -76.84 145.16 38.56 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -30.69 -46.19 0.08 Allowed 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 127.113 2.165 . . . . 0.0 112.153 171.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -60.6 -54.51 44.49 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.475 1.034 . . . . 0.0 110.89 178.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.71 -51.06 71.09 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 124.433 1.093 . . . . 0.0 109.382 -179.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 62' ' ' ALA . 29.9 mt -50.4 -56.96 9.14 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.522 1.129 . . . . 0.0 110.103 177.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.6 t -50.42 -57.35 2.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 123.877 0.871 . . . . 0.0 109.395 179.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -54.2 -43.58 70.86 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 117.965 0.348 . . . . 0.0 111.525 -179.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.06 95.36 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 73.3 mt -66.07 -51.52 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 123.395 0.678 . . . . 0.0 109.886 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.45 -40.11 85.78 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 120.107 1.321 . . . . 0.0 108.878 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -57.2 -51.66 68.43 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.464 0.574 . . . . 0.0 109.945 175.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 ptm -56.55 -46.61 80.58 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.56 -35.12 79.45 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.658 -0.651 . . . . 0.0 111.204 179.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.8 m -62.81 -7.59 5.33 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.047 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 48.4 p -88.03 -12.19 45.07 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.867 1.212 . . . . 0.0 111.0 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 39.1 mt . . . . . 0 C--O 1.251 1.155 0 CA-C-O 116.486 -1.721 . . . . 0.0 111.095 -175.92 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 t70 . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -43.99 -39.93 5.34 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.569 1.557 . . . . 0.0 112.476 177.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -63.32 -44.34 95.22 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 117.851 0.825 . . . . 0.0 110.023 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.06 -53.48 57.73 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -54.21 -59.34 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.806 1.243 . . . . 0.0 110.292 -178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -58.29 -52.1 67.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.06 0.944 . . . . 0.0 111.893 -178.452 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.16 -44.21 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-O 119.112 -0.471 . . . . 0.0 111.292 -173.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -159.09 44.03 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.49 37.16 0.98 Allowed Glycine 0 CA--C 1.524 0.63 0 O-C-N 121.638 -0.664 . . . . 0.0 111.451 177.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -138.87 157.53 45.87 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.464 1.906 . . . . 0.0 107.587 177.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.39 107.92 8.64 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.562 0.745 . . . . 0.0 109.755 -178.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.25 158.2 27.59 Favored 'Cis proline' 0 N--CA 1.459 -0.526 0 CA-C-N 119.991 1.033 . . . . 0.0 112.314 -9.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.98 117.31 11.39 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.278 1.031 . . . . 0.0 109.116 178.004 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.2 m -46.43 -48.62 18.82 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.709 0.804 . . . . 0.0 111.194 -177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.6 p -44.45 -46.91 9.87 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.026 1.73 . . . . 0.0 112.586 178.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.7 m -50.91 -30.29 14.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.163 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 44.9 m -101.66 -56.37 2.3 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.895 0.316 . . . . 0.0 110.786 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -71.7 -23.14 61.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 -172.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.48 -50.78 62.17 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.52 1.054 . . . . 0.0 109.024 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.89 35.02 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.795 179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.6 44.53 9.3 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 -175.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.78 144.2 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 -178.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.28 29.91 7.31 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.965 0.906 . . . . 0.0 111.319 -177.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.87 20.41 79.83 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.109 179.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 137.61 84.49 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 118.931 1.365 . . . . 0.0 108.416 176.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -60.54 128.49 26.1 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.561 2.174 . . . . 0.0 109.842 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.9 174.73 7.1 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.291 1.043 . . . . 0.0 113.347 -173.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.08 166.71 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 113.497 -1.683 . . . . 0.0 106.853 169.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 48.03 34.77 4.44 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.558 0.743 . . . . 0.0 111.111 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.34 61.16 16.0 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.794 -173.541 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -40.09 -49.22 3.76 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.846 3.031 . . . . 0.0 113.729 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -45.83 -40.93 10.46 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.396 1.478 . . . . 0.0 112.264 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -63.41 -26.04 68.56 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.859 0.464 . . . . 0.0 111.661 -177.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -106.26 -28.68 10.27 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.257 1.423 . . . . 0.0 111.961 -175.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.24 -46.15 0.5 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.754 2.022 . . . . 0.0 112.86 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -107.63 30.64 6.11 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.215 1.006 . . . . 0.0 112.888 -175.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -134.69 159.36 72.46 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.549 1.14 . . . . 0.0 108.414 176.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -53.32 109.15 0.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 123.154 2.569 . . . . 0.0 112.77 -177.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -62.46 -32.4 73.27 Favored 'General case' 0 CA--C 1.536 0.417 0 O-C-N 121.211 -0.931 . . . . 0.0 110.276 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -55.92 103.94 0.12 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.479 1.912 . . . . 0.0 112.399 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.2 t -53.42 -39.43 36.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -56.72 -24.74 51.66 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.36 1.064 . . . . 0.0 112.569 178.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.21 -55.08 3.74 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.6 mt -47.82 -40.7 21.84 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.71 0.804 . . . . 0.0 112.472 -179.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.79 -35.02 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 118.725 -0.655 . . . . 0.0 110.933 -179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -64.45 -48.41 75.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.398 0.999 . . . . 0.0 108.846 177.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.0 m -54.98 -41.64 71.44 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.825 0.45 . . . . 0.0 109.799 176.397 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -67.64 -45.0 76.6 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.07 -0.394 . . . . 0.0 110.59 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.0 mt -58.09 -51.82 68.12 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.649 -0.657 . . . . 0.0 109.981 179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.08 -31.68 61.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.748 1.219 . . . . 0.0 113.432 -176.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.24 163.9 24.66 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -176.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -158.8 114.76 2.64 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.977 -0.719 . . . . 0.0 109.323 -177.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.42 -116.22 8.19 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.33 -26.17 60.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.88 0.472 . . . . 0.0 111.554 178.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.5 ttp -67.97 116.54 39.67 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.75 -177.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -67.57 166.2 24.76 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.23 1.953 . . . . 0.0 110.738 176.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.35 133.55 49.84 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 174.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -101.25 -10.43 20.36 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.835 0.854 . . . . 0.0 113.256 178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -49.25 110.09 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.549 0.613 . . . . 0.0 111.013 179.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 110.01 -37.44 3.77 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.725 1.155 . . . . 0.0 111.666 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -43.99 42.91 Favored 'General case' 0 C--O 1.228 -0.037 0 CA-C-N 117.994 0.897 . . . . 0.0 108.836 179.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -132.84 132.14 41.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 176.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -79.23 150.84 31.49 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.037 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -32.18 -46.65 0.13 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.328 1.851 . . . . 0.0 111.715 171.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -64.81 -44.92 88.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 119.434 1.015 . . . . 0.0 111.329 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -58.9 -56.31 23.83 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 122.459 1.123 . . . . 0.0 108.619 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.9 mt -47.63 -58.97 3.62 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.323 -1.762 . . . . 0.0 109.164 178.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 t -45.17 -57.39 0.78 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 C-N-CA 124.515 1.126 . . . . 0.0 109.636 177.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mmtm -58.68 -41.71 86.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.349 0.522 . . . . 0.0 111.955 -178.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.76 -44.31 93.84 Favored 'General case' 0 CA--C 1.528 0.105 0 O-C-N 121.718 -0.614 . . . . 0.0 110.02 -179.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.7 mt -63.41 -48.01 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -53.19 -51.47 61.98 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.091 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.7 -52.7 61.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.222 178.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 4.8 ttp -51.31 -56.52 12.61 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.6 mt -55.69 -37.6 68.55 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 121.837 -0.539 . . . . 0.0 111.107 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.8 m -67.92 -3.34 9.52 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 113.461 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.2 p -110.76 15.26 22.02 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 120.19 1.359 . . . . 0.0 111.242 177.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 116.748 -1.596 . . . . 0.0 109.62 179.613 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.457 -0.782 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -49.38 -38.75 27.65 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 124.275 0.941 . . . . 0.0 111.811 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.16 -60.97 3.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.33 -51.24 35.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.983 1.313 . . . . 0.0 110.53 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.6 mt -58.67 -57.23 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 124.041 0.937 . . . . 0.0 109.747 -177.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -58.03 -46.92 84.53 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.669 0.788 . . . . 0.0 111.72 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 93.8 mt -71.82 -49.07 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 118.855 -0.593 . . . . 0.0 111.787 -172.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -140.92 -13.74 0.93 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -170.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.33 -30.73 36.23 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 120.079 1.309 . . . . 0.0 112.66 -177.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -75.21 156.59 35.64 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.715 0.757 . . . . 0.0 111.161 -177.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.34 111.49 7.1 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.913 1.285 . . . . 0.0 108.954 -179.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.26 150.77 55.54 Favored 'Cis proline' 0 N--CA 1.453 -0.862 0 CA-C-N 120.435 1.191 . . . . 0.0 109.645 -11.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.93 118.62 7.49 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.053 1.741 . . . . 0.0 110.227 -179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 m -48.26 -47.04 36.37 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.476 0.655 . . . . 0.0 110.535 -178.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -45.09 -43.81 9.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.983 1.713 . . . . 0.0 112.557 178.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.7 m -51.13 -33.06 24.95 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.595 0.634 . . . . 0.0 112.025 -178.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.3 m -100.05 -53.93 3.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.424 0.289 . . . . 0.0 110.612 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -69.85 -29.3 66.51 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -173.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.73 -42.44 86.27 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 119.344 0.974 . . . . 0.0 108.855 178.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -81.76 -27.6 33.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.289 -178.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.55 33.84 46.42 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -175.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 p -61.45 144.69 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 O-C-N 122.09 -0.653 . . . . 0.0 109.289 -176.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.03 29.71 6.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.205 1.002 . . . . 0.0 111.534 -178.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.3 23.04 78.59 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 119.306 -0.719 . . . . 0.0 112.799 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.29 131.0 84.37 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 118.761 1.28 . . . . 0.0 108.028 176.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -61.65 121.72 9.97 Favored 'Trans proline' 0 N--CA 1.447 -1.241 0 C-N-CA 122.218 1.945 . . . . 0.0 109.041 -178.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.02 163.2 24.4 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 122.435 1.112 . . . . 0.0 111.121 -176.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 mp -70.79 161.97 29.98 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 171.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.18 55.0 2.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.838 1.255 . . . . 0.0 111.19 -178.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.71 64.66 7.2 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 123.759 0.824 . . . . 0.0 111.093 -178.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -36.86 -49.79 1.46 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 124.776 3.651 . . . . 0.0 114.523 -178.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.98 -43.01 13.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.128 1.371 . . . . 0.0 111.794 179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.7 -24.51 66.26 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.037 0.935 . . . . 0.0 112.008 -177.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 83.8 m95 -106.01 -19.39 13.74 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.443 1.097 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.43 -49.14 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.524 1.53 . . . . 0.0 113.342 -179.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.11 -14.75 33.05 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -177.141 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -82.03 131.63 56.16 Favored Pre-proline 0 CA--C 1.535 0.4 0 O-C-N 121.386 -0.821 . . . . 0.0 109.856 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -51.51 113.71 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.913 2.408 . . . . 0.0 111.198 177.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -58.05 -26.56 62.65 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.461 0.704 . . . . 0.0 112.395 -178.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -50.71 98.89 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.182 1.793 . . . . 0.0 111.662 178.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 66.8 t -41.36 -53.03 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 124.592 1.157 . . . . 0.0 110.619 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -53.89 -43.26 69.48 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.659 0.615 . . . . 0.0 112.659 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -61.52 -47.11 87.06 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 119.118 0.872 . . . . 0.0 108.782 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.6 -37.51 81.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.383 178.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.457 HG22 HD12 ' A' ' 71' ' ' ILE . 77.2 t -62.03 -43.57 97.81 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.201 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -60.81 -46.22 91.39 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.406 1.003 . . . . 0.0 109.724 177.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 15.8 m -54.3 -45.54 72.57 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.958 0.345 . . . . 0.0 110.454 176.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 22.0 m -67.37 -45.31 76.65 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.922 -0.486 . . . . 0.0 110.531 -178.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 37.1 mt -54.11 -54.93 32.73 Favored 'General case' 0 C--N 1.339 0.112 0 O-C-N 121.726 -0.609 . . . . 0.0 109.712 177.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.54 74.77 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.926 0.891 . . . . 0.0 112.613 -177.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.95 164.29 31.28 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 107.876 -2.089 . . . . 0.0 107.876 -174.481 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -157.58 108.79 2.28 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.761 -0.846 . . . . 0.0 109.569 -177.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.54 -115.08 6.93 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -178.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.47 -29.47 64.88 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.725 0.41 . . . . 0.0 111.052 178.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.4 ttp -65.16 120.05 64.06 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.421 -178.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.78 160.15 44.13 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.442 2.095 . . . . 0.0 110.354 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.41 135.68 52.11 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -106.6 -10.83 16.05 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.961 0.904 . . . . 0.0 111.019 177.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -49.0 123.81 7.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.363 1.065 . . . . 0.0 111.037 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.11 -16.36 33.64 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.186 0.898 . . . . 0.0 112.739 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.4 mtm105 -97.25 -48.84 5.19 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.225 1.013 . . . . 0.0 109.223 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.53 127.14 42.24 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 65' ' ' GLU . 13.5 m-20 -76.69 83.01 3.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 177.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 3.2 -47.91 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.516 1 C-N-CA 132.522 4.329 . . . . 0.0 117.221 -178.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 63' ' ' ASP . 42.9 mt-10 -50.07 -37.43 33.53 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.961 1.255 . . . . 0.0 109.265 173.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -51.02 -57.68 8.02 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.687 1.995 . . . . 0.0 109.818 173.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.3 mt -58.66 -56.41 22.54 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.749 -179.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.403 HG22 HG21 ' A' ' 45' ' ' VAL . 53.1 t -43.85 -57.14 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.199 1.0 . . . . 0.0 109.725 176.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -56.51 -48.9 76.22 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.242 1.017 . . . . 0.0 111.094 179.588 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -49.46 77.8 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.682 -0.636 . . . . 0.0 109.362 -178.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.457 HD12 HG22 ' A' ' 45' ' ' VAL . 73.2 mt -62.37 -46.78 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.546 1.138 . . . . 0.0 110.846 -176.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -59.57 -38.17 80.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.937 177.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -62.14 -51.35 68.22 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.173 176.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.0 mtp -44.45 -58.9 2.69 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-O 122.088 0.947 . . . . 0.0 109.632 177.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -58.3 -41.05 83.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.275 -179.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -74.58 42.55 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 65.4 p -136.46 -13.2 1.78 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.437 1.495 . . . . 0.0 110.096 171.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 C--O 1.251 1.168 0 CA-C-O 117.293 -1.337 . . . . 0.0 110.268 -178.408 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 118.349 -0.834 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -49.08 -43.73 32.41 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.493 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 mp0 -51.05 -61.65 2.1 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 124.351 1.06 . . . . 0.0 108.598 175.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -51.49 -48.99 62.71 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.76 1.224 . . . . 0.0 110.819 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.46 -55.04 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -177.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -59.28 -48.53 81.3 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.249 0.62 . . . . 0.0 111.843 179.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.95 -49.39 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-O 118.572 -0.728 . . . . 0.0 112.175 -172.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -135.06 -17.68 1.84 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -171.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.49 -34.52 35.58 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 119.978 1.263 . . . . 0.0 112.543 -176.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.8 p -70.25 151.18 45.62 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 117.361 0.58 . . . . 0.0 110.424 -178.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.09 111.22 7.89 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.645 1.178 . . . . 0.0 109.133 -179.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 151.97 24.81 Favored 'Cis proline' 0 N--CA 1.455 -0.757 0 CA-C-N 120.306 1.145 . . . . 0.0 111.449 -11.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.91 124.98 23.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.805 1.242 . . . . 0.0 109.309 178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.8 m -56.15 -45.36 79.65 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.393 0.616 . . . . 0.0 110.57 -178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.2 p -42.27 -50.51 4.95 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 126.567 1.947 . . . . 0.0 112.067 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.16 -37.35 2.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.292 1.037 . . . . 0.0 112.5 -179.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.0 m -102.14 -57.37 2.08 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 122.637 0.375 . . . . 0.0 111.046 -178.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -67.95 -20.96 65.11 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 -173.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -84.43 -2.65 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.164 0.893 . . . . 0.0 110.882 176.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.8 tpp85 -135.44 -9.6 2.19 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 113.485 0.921 . . . . 0.0 113.485 -177.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.45 35.5 51.88 Favored Glycine 0 CA--C 1.528 0.885 0 O-C-N 121.694 -0.629 . . . . 0.0 111.908 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.1 133.47 20.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.31 31.1 8.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.304 1.041 . . . . 0.0 111.462 -177.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.33 23.18 78.36 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.574 -0.57 . . . . 0.0 112.622 179.684 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.43 139.75 80.24 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 118.334 1.067 . . . . 0.0 109.251 177.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.8 Cg_endo -61.09 126.08 18.63 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.373 2.049 . . . . 0.0 109.308 179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -89.66 171.72 9.46 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.182 0.992 . . . . 0.0 112.491 -175.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.0 161.08 19.41 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.929 172.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 37.7 52.96 1.44 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.136 1.374 . . . . 0.0 112.009 176.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -145.04 65.41 11.94 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.796 0.838 . . . . 0.0 110.469 -177.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -37.67 -51.56 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.781 3.654 . . . . 0.0 114.695 -177.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -49.16 -39.34 28.64 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.136 0.974 . . . . 0.0 112.196 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -62.91 -26.8 68.97 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.155 0.582 . . . . 0.0 111.564 -179.035 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.436 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 80.5 m95 -104.24 -29.86 10.53 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.026 1.33 . . . . 0.0 112.269 -175.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -41.02 -41.51 1.69 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.957 1.703 . . . . 0.0 113.605 -178.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -86.59 -22.65 26.13 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.541 0.737 . . . . 0.0 112.317 -176.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -80.93 143.51 53.65 Favored Pre-proline 0 N--CA 1.45 -0.453 0 C-N-CA 124.022 0.929 . . . . 0.0 110.026 -176.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.93 85.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.063 2.509 . . . . 0.0 108.267 173.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.39 -23.86 26.87 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.728 2.011 . . . . 0.0 113.543 -170.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.6 m -51.18 112.69 0.77 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 124.649 1.18 . . . . 0.0 110.683 177.137 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -46.64 -44.58 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.524 1.13 . . . . 0.0 110.553 -179.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -50.79 -31.53 17.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.236 1.415 . . . . 0.0 113.001 179.328 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -91.44 -52.83 4.6 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.132 0.973 . . . . 0.0 109.046 177.009 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 mt -48.36 -41.32 28.31 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 122.824 0.449 . . . . 0.0 111.994 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.14 -37.71 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 121.747 -0.596 . . . . 0.0 110.903 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -65.85 -48.12 72.69 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.8 m -53.56 -42.28 67.38 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.708 0.29 . . . . 0.0 110.299 176.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.6 m -67.04 -48.83 67.12 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.282 0.633 . . . . 0.0 111.235 -179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.8 -43.02 69.53 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 109.528 -174.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.39 -35.7 73.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.538 0.735 . . . . 0.0 111.073 178.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 152.3 27.92 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 -177.623 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -153.5 149.52 27.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.27 -116.98 8.69 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 -177.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -110.29 14.21 22.78 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.453 1.101 . . . . 0.0 111.495 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 7.9 ttp -67.96 127.31 93.32 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.495 -0.753 . . . . 0.0 110.416 -178.621 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.685 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 72.7 Cg_endo -73.76 91.24 0.91 Allowed 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 122.492 2.128 . . . . 0.0 109.19 179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -25.55 123.29 0.06 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.178 2.191 . . . . 0.0 112.11 178.017 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.6 6.57 48.46 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.839 0.456 . . . . 0.0 112.096 -176.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -42.09 109.45 0.13 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 125.497 1.519 . . . . 0.0 112.695 178.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 -14.43 8.03 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 123.73 0.681 . . . . 0.0 113.449 178.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.2 mtm105 -82.05 -46.94 13.23 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.28 1.04 . . . . 0.0 108.507 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.05 126.27 45.95 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 172.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -78.22 150.26 33.51 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.3 ttm-85 -27.24 -49.89 0.05 OUTLIER 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 126.177 1.791 . . . . 0.0 112.102 170.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -60.67 -50.35 73.84 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.115 1.325 . . . . 0.0 111.56 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -54.29 -56.12 21.55 Favored 'General case' 0 N--CA 1.46 0.063 0 CA-C-O 122.662 1.22 . . . . 0.0 109.031 178.953 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.5 mt -50.38 -59.48 3.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 113.492 -1.686 . . . . 0.0 110.135 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.6 t -45.05 -53.81 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 125.394 1.478 . . . . 0.0 110.319 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -56.33 -33.94 66.1 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.048 0.539 . . . . 0.0 112.055 -179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.14 -46.68 27.52 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.747 0.703 . . . . 0.0 109.924 176.278 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.61 -49.92 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.825 . . . . 0.0 110.233 -176.371 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -54.65 -44.29 73.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.185 0.902 . . . . 0.0 109.777 -179.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -61.14 -50.51 72.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.1 ptm -54.5 -44.19 72.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.4 mt -67.53 -34.74 77.71 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.627 -0.671 . . . . 0.0 110.696 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -73.92 56.64 0.59 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.005 0.922 . . . . 0.0 111.793 179.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.6 p -150.81 -32.71 0.17 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.444 2.298 . . . . 0.0 109.598 177.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.251 1.137 0 C-N-CA 126.523 1.929 . . . . 0.0 110.413 178.885 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.685 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.89 -43.6 61.04 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 175.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -59.03 -56.73 18.51 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 m -48.71 -45.77 39.77 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.089 0.859 . . . . 0.0 111.709 179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.9 mt -62.14 -56.4 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 124.494 1.118 . . . . 0.0 109.826 -178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.47 -48.07 80.17 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.756 0.822 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.9 mm -70.42 -48.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.425 0.69 . . . . 0.0 111.146 -174.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.65 39.79 0.33 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -173.122 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.81 38.91 1.17 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -139.07 155.95 47.55 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 126.502 1.921 . . . . 0.0 107.587 177.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 105.29 16.85 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 123.715 0.806 . . . . 0.0 111.198 -176.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -65.54 164.47 61.49 Favored 'Cis proline' 0 N--CA 1.455 -0.749 0 CA-C-N 120.286 1.138 . . . . 0.0 110.113 -8.616 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -67.31 119.11 11.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.543 1.137 . . . . 0.0 109.806 -179.036 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.8 m -46.89 -45.46 20.5 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.895 0.878 . . . . 0.0 111.228 -176.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 p -46.02 -42.71 13.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.715 1.606 . . . . 0.0 112.311 177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -55.94 -16.27 4.53 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.716 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.3 m -115.27 -57.43 2.25 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.154 0.582 . . . . 0.0 109.788 175.566 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -71.14 -22.9 62.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -173.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.54 -48.6 66.51 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.751 1.16 . . . . 0.0 109.615 -178.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -86.54 -25.19 25.18 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.917 0.887 . . . . 0.0 111.1 178.652 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.38 41.97 8.85 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.2 p -59.51 140.27 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -178.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.41 28.58 5.97 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.993 0.917 . . . . 0.0 111.476 -177.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.46 79.62 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.009 179.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.69 121.25 43.14 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 118.823 1.311 . . . . 0.0 108.247 176.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 34' ' ' TRP . 74.1 Cg_exo -44.15 114.99 0.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.869 3.046 . . . . 0.0 113.636 -177.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.81 169.63 17.32 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.758 0.79 . . . . 0.0 111.759 -175.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.1 159.72 28.22 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 171.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.31 51.08 0.8 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.362 1.465 . . . . 0.0 111.733 178.053 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.96 62.04 31.33 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 123.919 0.888 . . . . 0.0 111.055 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -38.17 -45.85 2.15 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 124.33 3.353 . . . . 0.0 114.198 -178.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -45.42 -43.67 11.49 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.896 1.278 . . . . 0.0 111.957 178.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -69.3 -25.54 64.28 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.658 0.783 . . . . 0.0 112.074 -177.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.511 ' CZ2' ' HB2' ' A' ' 26' ' ' PRO . 88.5 m95 -104.26 -18.2 14.56 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.795 1.238 . . . . 0.0 112.754 -174.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.04 -48.4 0.59 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.937 2.095 . . . . 0.0 113.969 -178.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -98.65 -4.13 34.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -175.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -87.26 128.81 53.94 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.623 0.769 . . . . 0.0 109.486 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -51.95 123.87 13.42 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.525 2.15 . . . . 0.0 110.967 177.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -64.25 -23.57 67.35 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.295 0.638 . . . . 0.0 110.668 178.094 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -49.33 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.856 2.062 . . . . 0.0 112.264 178.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.1 t -49.44 -41.5 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 123.316 0.646 . . . . 0.0 109.43 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -50.61 -38.6 46.61 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.847 1.259 . . . . 0.0 112.262 177.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -79.57 -49.64 11.9 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 93.0 mt -52.29 -40.66 62.1 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.913 0.485 . . . . 0.0 111.915 -178.108 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.3 m -61.69 -35.05 65.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.298 177.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -65.9 -46.3 78.8 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 120.204 1.365 . . . . 0.0 108.698 178.292 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.7 m -52.89 -45.7 67.64 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.947 0.404 . . . . 0.0 110.162 175.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -69.5 -44.41 71.14 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.924 -0.485 . . . . 0.0 110.97 -178.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.4 mt -58.16 -51.14 70.96 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.283 -0.886 . . . . 0.0 110.347 179.525 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.78 -30.74 59.2 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.36 1.064 . . . . 0.0 112.376 -177.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.14 163.64 28.67 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -176.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -157.06 111.12 2.66 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 121.97 -0.723 . . . . 0.0 109.324 -177.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.15 -113.52 5.2 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.65 -30.67 63.07 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.945 0.498 . . . . 0.0 111.168 177.847 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 31.3 ttp -63.07 119.29 50.89 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.255 -176.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.84 160.46 47.79 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.365 2.044 . . . . 0.0 110.28 179.424 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.57 119.78 12.92 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -87.22 -4.45 59.1 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.523 -0.751 . . . . 0.0 112.785 178.61 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -57.83 89.36 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.108 0.867 . . . . 0.0 111.993 179.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 132.43 -34.2 2.54 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.889 1.709 . . . . 0.0 110.589 -178.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.2 mtm-85 -87.23 -37.27 17.39 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.258 1.023 . . . . 0.0 111.106 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -140.86 126.14 18.61 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.33 153.57 24.54 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.203 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 16.5 ttm-85 -29.17 -47.53 0.06 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.577 1.951 . . . . 0.0 112.047 171.724 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -62.81 -50.72 69.87 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.991 1.268 . . . . 0.0 111.665 179.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -54.96 -55.31 32.16 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-O 122.824 1.297 . . . . 0.0 108.955 178.498 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.4 mt -49.93 -60.46 2.9 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.151 179.093 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.4 t -42.09 -56.69 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.629 1.172 . . . . 0.0 109.765 177.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -56.99 -43.07 81.33 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.512 0.142 . . . . 0.0 111.22 -178.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -52.89 53.34 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.576 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.9 mt -54.66 -46.62 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.964 1.306 . . . . 0.0 110.135 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -53.51 -52.58 59.14 Favored 'General case' 0 N--CA 1.458 -0.072 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -55.94 -50.5 70.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.605 178.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.5 mtp -50.83 -58.16 6.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.377 0.671 . . . . 0.0 109.731 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.07 -36.73 73.22 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.884 0.874 . . . . 0.0 111.59 179.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.3 m -74.7 50.92 0.45 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.023 0.829 . . . . 0.0 112.659 -179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.7 p -149.24 -25.75 0.29 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.282 2.233 . . . . 0.0 110.035 174.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.62 -1.657 . . . . 0.0 110.421 179.528 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.7 t70 . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.5 54.46 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 124.524 1.059 . . . . 0.0 111.744 178.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -45.83 69.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.753 0.776 . . . . 0.0 109.882 178.312 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 m -56.72 -44.6 81.75 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 121.444 -0.785 . . . . 0.0 108.936 179.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.08 -53.92 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -57.47 -42.87 83.45 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.763 0.825 . . . . 0.0 112.738 -177.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -84.37 -39.93 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-O 118.791 -0.623 . . . . 0.0 111.709 -175.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -130.55 -34.73 1.54 Allowed 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -172.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.73 32.12 4.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-N 119.473 1.033 . . . . 0.0 113.343 -172.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.7 p -133.7 144.98 49.48 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 175.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.12 107.78 19.8 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.929 1.292 . . . . 0.0 110.388 -177.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -64.57 161.46 66.24 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.327 1.153 . . . . 0.0 109.718 -9.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.23 130.79 45.28 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.514 0.726 . . . . 0.0 110.145 -178.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.2 m -54.9 -41.92 71.52 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.023 0.829 . . . . 0.0 109.683 179.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.8 t -59.25 -8.71 1.75 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 178.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 m -67.08 -30.42 70.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 120.352 1.433 . . . . 0.0 109.898 175.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 88.0 m -113.95 -63.75 1.41 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.3 0.64 . . . . 0.0 112.407 -172.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -57.93 -23.36 53.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.006 1.322 . . . . 0.0 113.555 -174.224 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -69.18 -25.13 64.19 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.133 -0.355 . . . . 0.0 111.535 178.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 18.9 mtm-85 -121.11 -12.28 8.73 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.251 1.021 . . . . 0.0 112.218 179.151 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.3 35.89 51.6 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.3 p -61.87 145.47 13.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.242 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.19 28.09 6.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.898 0.879 . . . . 0.0 111.466 -177.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.53 21.37 79.56 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.318 -0.712 . . . . 0.0 113.032 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 132.55 87.25 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 118.855 1.327 . . . . 0.0 108.669 177.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.07 122.54 10.57 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.469 2.112 . . . . 0.0 108.769 -179.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -86.23 172.15 10.72 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -170.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.41 158.48 23.63 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.04 50.83 0.5 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 0.0 112.078 177.727 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.15 60.84 24.15 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.624 1.17 . . . . 0.0 110.885 -178.65 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.93 -48.46 1.5 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 124.599 3.533 . . . . 0.0 114.322 -178.715 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -44.39 -44.35 8.26 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.208 1.403 . . . . 0.0 111.838 178.45 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.69 -26.93 67.26 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.978 0.911 . . . . 0.0 112.014 -177.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -103.19 -15.96 15.86 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 124.826 1.25 . . . . 0.0 112.452 -175.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.68 -47.07 0.64 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.243 1.817 . . . . 0.0 113.709 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -99.72 -4.29 31.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.836 0.854 . . . . 0.0 113.27 -176.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -88.25 126.92 59.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 123.812 0.845 . . . . 0.0 109.405 -177.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.33 106.03 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.784 2.323 . . . . 0.0 110.529 177.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -57.7 -23.05 49.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.767 0.827 . . . . 0.0 112.509 -178.017 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -47.81 101.18 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.159 2.184 . . . . 0.0 111.031 178.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 90.3 t -49.69 -41.94 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.632 0.773 . . . . 0.0 110.001 179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -53.49 -34.97 60.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.986 1.714 . . . . 0.0 112.194 177.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.84 -52.12 7.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.8 mt -51.76 -37.82 52.86 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -177.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -58.88 -37.94 69.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-N 119.408 1.004 . . . . 0.0 110.149 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -65.38 -47.05 77.7 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 119.667 1.121 . . . . 0.0 108.814 179.32 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -52.61 -43.92 65.69 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.629 0.372 . . . . 0.0 110.329 176.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -71.97 -44.6 63.27 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.887 0.475 . . . . 0.0 111.066 -178.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 39.2 mt -57.69 -50.24 73.87 Favored 'General case' 0 N--CA 1.457 -0.096 0 O-C-N 121.442 -0.786 . . . . 0.0 109.898 179.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.35 -38.09 65.85 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.956 0.902 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.49 118.61 3.06 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -176.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -106.63 135.01 48.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.319 1.048 . . . . 0.0 108.456 -179.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.22 -121.48 26.88 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -89.12 -1.56 58.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.473 0.709 . . . . 0.0 112.32 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.0 ttp -65.19 127.59 93.01 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 119.016 0.825 . . . . 0.0 111.082 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 50.2 Cg_exo -59.41 144.44 99.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.108 1.872 . . . . 0.0 109.964 173.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.39 121.53 15.49 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -88.28 -4.93 58.62 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 118.143 -0.932 . . . . 0.0 113.432 -178.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -54.55 84.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.433 1.093 . . . . 0.0 113.538 179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 127.56 -36.86 2.46 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 126.982 2.229 . . . . 0.0 110.419 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -42.24 75.32 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.642 0.721 . . . . 0.0 109.202 177.128 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -141.24 129.2 21.9 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 176.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -84.06 154.2 23.37 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.219 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -29.85 -49.07 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.407 1.883 . . . . 0.0 112.011 171.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -63.01 -45.12 93.87 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.373 0.988 . . . . 0.0 111.784 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -59.52 -57.56 12.43 Favored 'General case' 0 CA--C 1.523 -0.076 0 CA-C-O 122.612 1.196 . . . . 0.0 108.77 177.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 62.8 mt -47.25 -57.9 4.69 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 126.906 2.082 . . . . 0.0 110.383 179.539 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 t -40.38 -54.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 0.0 110.459 178.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -60.34 -44.52 95.44 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.072 0.232 . . . . 0.0 111.394 -178.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.48 -51.25 63.97 Favored 'General case' 0 CA--C 1.53 0.173 0 O-C-N 121.515 -0.74 . . . . 0.0 109.919 -179.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 53.2 mt -56.64 -52.67 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.894 1.278 . . . . 0.0 110.373 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -60.6 -42.37 96.61 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.631 1.105 . . . . 0.0 109.616 -178.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -57.18 -51.96 67.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.644 0.656 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 7.3 ttp -54.16 -54.52 38.59 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.4 mt -56.3 -37.68 70.21 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.918 -0.489 . . . . 0.0 111.137 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.8 m -63.46 -7.45 6.8 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.084 -0.96 . . . . 0.0 113.493 -179.329 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.1 p -87.6 -11.75 47.67 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.289 1.404 . . . . 0.0 110.802 175.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.05 -176.067 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.657 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.51 -0.584 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.57 -38.29 1.04 Allowed Glycine 0 C--N 1.338 0.655 0 O-C-N 124.125 0.891 . . . . 0.0 112.907 174.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -56.92 6.95 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.417 0.687 . . . . 0.0 110.892 -177.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m -55.94 -43.97 77.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.501 0.721 . . . . 0.0 111.198 -177.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.3 mt -62.94 -57.82 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 126.106 1.762 . . . . 0.0 109.323 -176.598 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -58.47 -51.09 71.34 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.287 1.035 . . . . 0.0 110.854 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 mm -68.38 -48.32 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.926 -174.008 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.59 39.89 0.24 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -173.049 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -143.84 36.95 1.48 Allowed Glycine 0 CA--C 1.524 0.594 0 CA-C-N 118.867 0.758 . . . . 0.0 111.737 179.13 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 p -138.23 158.74 43.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.02 1.728 . . . . 0.0 108.01 178.025 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -140.12 107.59 6.81 Favored Pre-proline 0 CA--C 1.534 0.337 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.773 -178.159 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 154.39 29.51 Favored 'Cis proline' 0 N--CA 1.458 -0.611 0 CA-C-N 120.146 1.088 . . . . 0.0 111.732 -9.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.65 126.14 27.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.2 m -53.03 -48.35 67.66 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.848 0.749 . . . . 0.0 110.607 -178.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.0 p -42.6 -49.47 5.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 126.043 1.737 . . . . 0.0 112.454 178.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.03 -36.18 3.35 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.168 0.987 . . . . 0.0 112.766 -178.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.2 m -99.88 -54.4 2.92 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.317 0.247 . . . . 0.0 110.996 -178.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -69.65 -24.23 63.59 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -172.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.58 -42.42 82.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.864 0.756 . . . . 0.0 109.475 178.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 64.4 mtm180 -89.54 -24.9 21.63 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.207 1.003 . . . . 0.0 112.027 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.8 35.14 40.89 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -174.257 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.33 145.98 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -176.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.35 29.3 6.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 111.392 -177.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.84 24.21 76.95 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-O 119.286 -0.73 . . . . 0.0 112.868 179.778 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 132.9 87.68 Favored Pre-proline 0 CA--C 1.532 0.271 0 CA-C-N 118.852 1.326 . . . . 0.0 108.346 176.289 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.42 121.54 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.294 1.996 . . . . 0.0 107.954 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.24 159.89 19.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.159 0.981 . . . . 0.0 112.88 -172.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mp -73.52 142.67 46.71 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 172.272 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 69.28 27.08 5.21 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.079 1.352 . . . . 0.0 111.315 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.54 70.3 76.32 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 124.621 1.168 . . . . 0.0 111.121 -179.104 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -40.27 -52.05 3.08 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.667 3.578 . . . . 0.0 114.23 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 pm0 -50.46 -34.07 23.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.514 1.526 . . . . 0.0 112.518 -179.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -68.65 -27.49 66.04 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.282 0.492 . . . . 0.0 111.181 -179.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -101.05 -24.92 14.22 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.703 1.201 . . . . 0.0 111.864 -176.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.24 -43.73 0.54 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.793 1.637 . . . . 0.0 112.688 178.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -111.81 36.14 3.41 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.283 1.033 . . . . 0.0 112.08 -176.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -128.89 155.74 79.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.36 176.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -53.8 126.84 23.22 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.562 2.175 . . . . 0.0 111.367 178.693 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -70.22 -41.65 73.31 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 176.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.2 m -51.86 102.45 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.532 1.933 . . . . 0.0 112.893 -179.678 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 72.0 t -49.25 -43.17 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 123.848 0.859 . . . . 0.0 108.912 174.561 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -50.44 -34.96 26.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.557 1.943 . . . . 0.0 112.667 178.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -87.03 -49.68 7.16 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.046 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 mt -49.75 -40.59 41.54 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.777 0.431 . . . . 0.0 111.979 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.13 -32.45 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 O-C-N 121.378 -0.826 . . . . 0.0 110.76 179.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.72 -47.24 79.02 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.773 1.17 . . . . 0.0 108.457 177.116 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.0 m -53.87 -44.24 70.25 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -66.54 -45.56 79.03 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.878 0.37 . . . . 0.0 110.817 -179.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 32.1 mt -58.65 -49.41 77.64 Favored 'General case' 0 N--CA 1.456 -0.138 0 O-C-N 121.447 -0.783 . . . . 0.0 110.116 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.84 -31.16 61.59 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.483 1.113 . . . . 0.0 112.798 -177.864 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.17 164.47 29.81 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.871 -1.691 . . . . 0.0 108.871 -176.087 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -158.72 114.05 2.58 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.996 -0.708 . . . . 0.0 109.145 -178.003 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.98 -116.12 7.85 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.25 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.45 -26.42 60.93 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.968 0.507 . . . . 0.0 111.437 178.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.3 ttp -67.55 121.12 77.74 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-N 118.631 0.65 . . . . 0.0 109.847 -178.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -73.86 160.19 43.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.49 2.127 . . . . 0.0 110.131 -179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.85 122.59 17.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -89.15 -9.96 49.01 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 118.04 -0.981 . . . . 0.0 113.256 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -54.22 91.43 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.408 1.004 . . . . 0.0 113.056 -177.838 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 121.66 -42.2 1.72 Allowed Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.463 1.506 . . . . 0.0 110.361 -178.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -39.4 89.77 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 174.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -136.41 164.94 26.97 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -108.09 140.74 40.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.933 0.893 . . . . 0.0 108.961 177.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ttt-85 -29.24 -50.48 0.09 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.289 2.235 . . . . 0.0 113.234 173.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -65.14 -45.5 84.78 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.329 0.968 . . . . 0.0 111.366 -179.253 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -60.25 -54.5 45.07 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.881 0.848 . . . . 0.0 109.017 177.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 62' ' ' ALA . 35.6 mt -47.38 -57.84 4.83 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.371 1.468 . . . . 0.0 109.867 176.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.2 t -43.82 -55.41 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.622 1.169 . . . . 0.0 109.74 178.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.61 -43.16 89.5 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.35 179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.85 84.14 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.394 -0.816 . . . . 0.0 109.573 179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.2 mt -58.35 -42.52 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 124.902 1.281 . . . . 0.0 109.79 177.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.12 -52.52 64.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.305 0.957 . . . . 0.0 109.032 175.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -54.25 -54.02 45.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 27.4 ttm -47.1 -56.16 7.06 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.17 1.788 . . . . 0.0 110.079 176.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.15 -33.27 73.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 O-C-N 121.557 -0.714 . . . . 0.0 112.431 177.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 36.5 m -74.66 43.44 0.19 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.179 0.9 . . . . 0.0 112.367 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.1 p -135.81 -17.06 1.7 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.196 1.799 . . . . 0.0 109.819 173.805 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.445 -1.264 . . . . 0.0 109.569 178.547 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.62 -41.42 56.91 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 176.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -59.51 -52.57 65.0 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -50.67 -52.98 34.85 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.058 0.39 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.26 -58.98 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 125.12 1.368 . . . . 0.0 110.643 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -56.62 -52.41 64.97 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.394 0.678 . . . . 0.0 112.087 -178.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.8 mt -70.22 -44.94 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 CA-C-O 119.404 -0.331 . . . . 0.0 111.246 -174.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -160.82 44.66 0.19 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -171.276 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.57 38.14 0.95 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 176.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -139.33 159.5 42.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.845 2.058 . . . . 0.0 107.378 177.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.94 113.68 6.41 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-O 118.391 -0.814 . . . . 0.0 109.265 -178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.61 152.05 13.24 Favored 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 120.307 1.145 . . . . 0.0 111.33 -15.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.61 116.81 7.24 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.507 1.123 . . . . 0.0 108.6 177.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.3 m -46.68 -48.25 20.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.546 0.738 . . . . 0.0 110.788 -176.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.1 p -45.92 -46.35 16.0 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.212 1.805 . . . . 0.0 112.739 178.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 m -52.04 -29.66 22.11 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 118.143 0.429 . . . . 0.0 112.051 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.0 m -99.83 -56.97 2.24 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 117.777 0.262 . . . . 0.0 110.644 178.632 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -66.92 -32.76 74.23 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -173.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -68.81 -43.04 76.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 119.103 0.865 . . . . 0.0 109.139 179.394 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.12 -26.6 39.39 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.625 -177.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.55 50.47 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -176.29 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -60.97 141.01 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -178.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.61 29.17 5.29 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.108 0.963 . . . . 0.0 111.394 -177.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.61 28.41 71.03 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.754 179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.09 134.84 84.17 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 118.862 1.331 . . . . 0.0 108.368 175.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 73.9 Cg_endo -64.91 111.99 1.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 122.6 2.2 . . . . 0.0 107.984 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -84.87 175.82 8.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 121.978 0.894 . . . . 0.0 111.425 -174.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -67.48 154.34 41.61 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 106.93 -1.508 . . . . 0.0 106.93 171.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 48.28 32.96 3.42 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.312 1.845 . . . . 0.0 112.661 178.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -118.86 59.25 4.11 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 124.76 1.224 . . . . 0.0 109.666 178.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -47.62 -41.72 30.16 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.054 3.169 . . . . 0.0 113.053 -174.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -47.75 -37.67 13.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.903 0.881 . . . . 0.0 111.788 178.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -76.52 -27.71 56.08 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.198 0.454 . . . . 0.0 111.37 -178.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.532 ' CE2' ' HB3' ' A' ' 78' ' ' LEU . 81.5 m95 -92.09 -13.3 31.03 Favored 'General case' 0 CA--C 1.526 0.049 0 C-N-CA 123.57 0.748 . . . . 0.0 111.616 -177.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.72 -45.16 0.36 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.274 1.83 . . . . 0.0 112.899 177.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -113.74 28.6 8.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.121 0.968 . . . . 0.0 112.552 -177.418 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -115.13 119.61 38.38 Favored Pre-proline 0 CA--C 1.532 0.264 0 C-N-CA 124.459 1.104 . . . . 0.0 108.514 178.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.69 118.7 4.98 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.761 2.307 . . . . 0.0 110.786 177.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.9 p -64.74 -22.17 66.92 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.073 0.549 . . . . 0.0 111.343 179.151 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.04 103.65 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 127.087 2.155 . . . . 0.0 111.315 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 89.9 t -49.34 -44.23 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.638 0.775 . . . . 0.0 109.706 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -52.98 -34.0 54.0 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.172 1.789 . . . . 0.0 112.295 177.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -82.47 -51.16 8.08 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 176.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.1 mt -52.79 -38.81 61.68 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.702 0.801 . . . . 0.0 112.34 -178.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.1 m -59.61 -38.46 75.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.322 0 CA-C-N 119.243 0.928 . . . . 0.0 109.984 177.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.16 -45.52 80.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 119.708 1.14 . . . . 0.0 108.911 179.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.7 m -53.5 -44.97 69.49 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -70.76 -44.75 66.07 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 122.103 -0.373 . . . . 0.0 110.8 -178.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -57.53 -52.19 66.43 Favored 'General case' 0 C--N 1.338 0.104 0 O-C-N 121.393 -0.817 . . . . 0.0 109.999 179.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.81 -31.76 65.05 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.943 0.897 . . . . 0.0 111.817 -178.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.29 159.38 34.71 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -175.573 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -162.16 139.4 8.33 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.78 -138.57 48.24 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 108.284 -1.926 . . . . 0.0 108.284 -175.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.11 -21.03 66.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.689 -0.755 . . . . 0.0 111.835 176.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HB2' ' C1D' ' A' ' 0' ' ' HEM . 31.7 ttp -65.49 117.04 36.88 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 119.663 1.12 . . . . 0.0 110.888 -176.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -72.42 153.64 55.58 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.327 2.018 . . . . 0.0 110.021 178.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.5 123.46 16.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.333 0.653 . . . . 0.0 109.947 178.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -90.25 -4.44 57.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.844 0.747 . . . . 0.0 111.992 177.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -44.16 114.33 0.66 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.491 1.116 . . . . 0.0 111.893 176.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.71 -21.2 19.9 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.292 0.948 . . . . 0.0 112.898 178.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.3 mtm105 -87.71 -44.49 11.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.974 0.909 . . . . 0.0 109.298 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 126.93 45.9 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 172.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.64 152.37 28.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -30.55 -46.76 0.08 Allowed 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 126.07 1.748 . . . . 0.0 111.686 170.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.08 -50.49 73.51 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.583 1.083 . . . . 0.0 111.923 178.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -57.04 -54.93 41.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 125.096 1.358 . . . . 0.0 109.202 179.377 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.6 mt -50.33 -57.55 7.64 Favored 'General case' 0 N--CA 1.425 -1.684 0 C-N-CA 125.989 1.716 . . . . 0.0 109.711 178.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 t -47.64 -56.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.882 1.273 . . . . 0.0 109.668 177.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -57.94 -39.23 77.56 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.136 0.575 . . . . 0.0 111.634 -177.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.69 -48.12 64.7 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.539 -0.726 . . . . 0.0 109.777 177.9 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.6 mt -61.37 -46.56 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.084 1.353 . . . . 0.0 110.768 -176.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.37 -39.54 87.59 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.949 1.249 . . . . 0.0 109.763 179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.53 -59.54 5.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 175.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 85.9 mtp -41.33 -64.75 0.51 Allowed 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.619 1.168 . . . . 0.0 108.709 177.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 62.3 mt -46.64 -31.98 3.21 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.845 2.058 . . . . 0.0 113.371 -178.016 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.2 m -64.87 -4.86 4.9 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.512 1.051 . . . . 0.0 112.287 176.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.3 p -154.33 22.85 0.48 Allowed 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.685 3.994 . . . . 0.0 106.0 -179.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.532 ' HB3' ' CE2' ' A' ' 34' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.016 0 C-N-CA 128.257 2.623 . . . . 0.0 113.795 -170.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.405 ' C1D' ' HB2' ' A' ' 55' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.471 0.582 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -65.41 -41.53 96.4 Favored Glycine 0 C--N 1.335 0.494 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -57.22 -57.73 11.35 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.8 p -53.46 -45.53 69.56 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.542 0.61 . . . . 0.0 111.396 -179.039 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.0 mt -59.72 -56.48 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 0.0 109.889 -178.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -56.95 -47.19 81.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.992 0.917 . . . . 0.0 111.264 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.1 mt -68.92 -64.94 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.357 -175.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -141.5 43.81 1.74 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 118.77 0.714 . . . . 0.0 111.374 -173.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.69 36.89 1.22 Allowed Glycine 0 CA--C 1.525 0.665 0 O-C-N 121.225 -0.922 . . . . 0.0 112.304 177.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.97 155.43 48.88 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.31 1.844 . . . . 0.0 107.703 176.306 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.06 113.28 4.87 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.833 0.853 . . . . 0.0 109.572 -177.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.71 142.91 12.57 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 CA-C-N 120.045 1.052 . . . . 0.0 110.363 -14.352 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -67.83 128.66 37.33 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 123.221 0.608 . . . . 0.0 110.503 -178.096 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.2 m -54.38 -48.15 71.84 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.39 0.676 . . . . 0.0 111.149 -175.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -42.47 -54.65 3.78 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.184 1.793 . . . . 0.0 112.105 -179.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -42.7 -35.69 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.236 1.414 . . . . 0.0 112.878 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 53.0 m -100.78 -57.28 2.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 122.559 0.343 . . . . 0.0 111.414 -178.024 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -70.5 -35.12 73.05 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -172.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.47 -41.59 88.77 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -74.98 -31.33 61.41 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.291 1.436 . . . . 0.0 111.344 177.845 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.62 33.73 51.27 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -175.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.15 143.08 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 O-C-N 122.096 -0.649 . . . . 0.0 109.744 -176.638 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.47 32.61 6.73 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.361 1.064 . . . . 0.0 111.834 179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.0 22.3 77.12 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 119.443 -0.643 . . . . 0.0 113.095 179.6 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.83 136.23 83.27 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.689 1.245 . . . . 0.0 107.745 175.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -57.36 123.12 13.05 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.049 1.833 . . . . 0.0 109.969 -178.437 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.89 169.45 17.53 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 122.267 1.032 . . . . 0.0 110.172 -178.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mp -93.87 151.12 19.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.096 179.744 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 62.81 37.36 12.41 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -174.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.49 68.34 31.6 Favored Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 123.517 0.727 . . . . 0.0 111.915 -175.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -38.98 -51.42 2.43 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 124.653 3.569 . . . . 0.0 114.867 -177.403 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.98 -40.25 21.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.346 1.059 . . . . 0.0 111.988 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.21 -22.38 66.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.469 0.707 . . . . 0.0 111.884 -177.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -110.15 -30.21 7.85 Favored 'General case' 0 C--O 1.226 -0.174 0 C-N-CA 124.747 1.219 . . . . 0.0 112.607 -175.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.31 -51.03 1.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.68 1.592 . . . . 0.0 113.021 -178.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.22 -26.42 56.07 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -78.24 142.38 63.33 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.121 -177.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.48 89.74 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.179 2.586 . . . . 0.0 108.257 173.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -20.65 55.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.892 1.677 . . . . 0.0 113.639 -170.007 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -50.12 115.83 1.59 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.886 1.274 . . . . 0.0 110.651 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.3 t -48.18 -46.21 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.445 0.698 . . . . 0.0 110.343 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.95 -24.31 64.27 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.853 0.861 . . . . 0.0 113.02 -178.379 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.29 -54.56 4.13 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 mt -47.84 -43.32 28.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.408 1.083 . . . . 0.0 112.226 -179.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -59.91 -37.05 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 121.915 -0.491 . . . . 0.0 110.765 -179.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.3 -44.42 79.26 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.29 -47.32 72.5 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.162 0.506 . . . . 0.0 110.19 174.325 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 m -62.57 -45.99 90.4 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.588 0.755 . . . . 0.0 110.579 -179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.9 mt -58.26 -51.83 68.11 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.59 -0.694 . . . . 0.0 109.226 178.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.29 -35.06 79.63 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.093 0.557 . . . . 0.0 112.151 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.94 157.19 32.92 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 108.299 -1.921 . . . . 0.0 108.299 -174.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -156.38 129.48 7.99 Favored 'General case' 0 N--CA 1.462 0.138 0 O-C-N 121.816 -0.814 . . . . 0.0 109.034 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.9 -136.85 50.45 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.24 -23.62 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.484 -0.858 . . . . 0.0 111.811 176.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.9 ttp -65.88 115.5 23.49 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 119.334 0.97 . . . . 0.0 111.147 -177.278 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 38.9 Cg_exo -63.45 162.32 27.89 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.655 2.237 . . . . 0.0 111.255 177.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.09 136.66 43.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -104.83 -8.02 19.02 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.093 0.957 . . . . 0.0 110.684 175.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -43.42 115.89 0.85 Allowed 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.321 1.848 . . . . 0.0 111.714 177.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.67 -23.24 9.11 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 123.912 0.768 . . . . 0.0 112.559 177.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.2 mtm105 -83.92 -46.83 11.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.924 0.862 . . . . 0.0 108.746 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.29 138.1 37.83 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -77.58 25.93 0.18 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -173.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 62.19 -41.4 0.16 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.224 2.21 . . . . 0.0 111.979 -173.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 -64.81 -36.85 85.65 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.323 -1.485 . . . . 0.0 110.198 178.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -52.92 -58.36 7.21 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-O 123.229 1.49 . . . . 0.0 108.547 178.728 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.8 mt -55.08 -58.64 6.84 Favored 'General case' 0 N--CA 1.421 -1.917 0 C-N-CA 126.484 1.914 . . . . 0.0 110.022 178.346 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 24.5 t -41.94 -54.11 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.481 0.713 . . . . 0.0 110.451 176.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -61.71 -40.53 95.38 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.725 0.41 . . . . 0.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.77 71.56 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.554 -0.717 . . . . 0.0 110.082 179.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.21 -48.04 90.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.838 2.055 . . . . 0.0 110.38 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -58.74 -44.17 90.44 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.891 1.223 . . . . 0.0 109.655 -179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -61.77 -52.59 63.62 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 11.1 ttm -46.17 -50.26 15.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.069 1.347 . . . . 0.0 110.513 179.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -64.84 -35.39 80.95 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.124 -0.36 . . . . 0.0 110.823 178.131 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 m -74.8 59.14 0.86 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.588 0.755 . . . . 0.0 111.218 178.666 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -148.03 -40.57 0.17 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.739 2.016 . . . . 0.0 108.979 176.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.2 mp . . . . . 0 C--O 1.251 1.143 0 C-N-CA 128.344 2.657 . . . . 0.0 111.213 179.441 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.422 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 119.0 -0.524 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.19 -42.71 41.22 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 173.78 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -57.43 -53.25 60.31 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 117.956 0.878 . . . . 0.0 109.609 175.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.87 -49.36 59.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.865 0.466 . . . . 0.0 110.5 -179.691 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mt -70.68 -35.56 61.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -178.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -60.56 -45.02 95.47 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.346 -1.471 . . . . 0.0 109.989 176.448 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.9 mt -82.4 -28.82 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.548 -0.72 . . . . 0.0 111.545 -177.703 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -125.97 38.09 4.22 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.724 1.209 . . . . 0.0 110.707 -174.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.76 46.85 2.08 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 129.488 3.423 . . . . 0.0 112.041 -178.213 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . 0.259 3.1 p 69.73 -142.11 0.08 Allowed 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 126.414 1.885 . . . . 0.0 111.553 176.374 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.31 124.56 29.43 Favored Pre-proline 0 C--N 1.327 -0.395 0 C-N-CA 124.307 1.043 . . . . 0.0 110.863 -172.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -62.56 177.73 9.52 Favored 'Cis proline' 0 N--CA 1.458 -0.567 0 CA-C-N 119.541 0.872 . . . . 0.0 110.112 -18.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.45 136.85 33.27 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 174.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 m -54.62 -51.62 64.82 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.306 0.643 . . . . 0.0 110.222 -176.248 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -40.91 -61.34 0.99 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.518 1.927 . . . . 0.0 112.817 -179.442 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.72 -35.02 13.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.042 0.937 . . . . 0.0 112.55 -178.267 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.5 m -85.92 -59.9 2.17 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 118.594 0.634 . . . . 0.0 110.165 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -61.23 -50.81 71.56 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 123.643 0.777 . . . . 0.0 113.028 -173.6 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.86 -39.68 71.82 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 118.199 0.454 . . . . 0.0 110.994 -178.463 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -88.23 -2.07 58.39 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.951 0.9 . . . . 0.0 112.078 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 35.68 82.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 119.389 0.995 . . . . 0.0 112.443 -177.764 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.79 130.75 17.19 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 O-C-N 121.931 -0.746 . . . . 0.0 109.195 -179.242 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.92 31.41 8.44 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.456 1.102 . . . . 0.0 111.479 -178.642 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.98 22.67 78.95 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 119.355 -0.692 . . . . 0.0 112.568 179.749 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.43 137.9 68.71 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 118.578 1.189 . . . . 0.0 108.53 176.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -60.72 121.06 9.13 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.239 1.959 . . . . 0.0 109.098 -179.032 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -76.42 166.56 23.25 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 122.404 1.097 . . . . 0.0 112.359 -174.223 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.3 164.38 26.76 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 174.131 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 33.66 53.32 0.46 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.173 1.389 . . . . 0.0 111.735 -178.713 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.67 68.13 19.47 Favored Pre-proline 0 CA--C 1.532 0.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.702 -176.094 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -38.89 -48.59 2.78 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 124.453 3.435 . . . . 0.0 114.44 -177.351 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.2 mp0 -50.61 -40.53 52.97 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.957 1.303 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -66.05 -23.85 66.62 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.339 0.655 . . . . 0.0 111.535 -178.196 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -105.51 -30.71 9.37 Favored 'General case' 0 C--O 1.226 -0.163 0 C-N-CA 124.348 1.059 . . . . 0.0 112.749 -174.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.54 -50.51 1.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.784 1.634 . . . . 0.0 112.998 -178.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.9 -22.31 42.92 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -78.99 158.06 75.4 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 121.569 -0.707 . . . . 0.0 110.377 -177.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.52 108.91 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.886 2.391 . . . . 0.0 110.939 176.508 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.87 -37.02 75.6 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.7 m -59.69 107.97 0.67 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.752 1.621 . . . . 0.0 111.555 178.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.9 t -48.41 -41.92 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.494 1.118 . . . . 0.0 110.405 178.182 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.0 -27.16 17.89 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.231 1.412 . . . . 0.0 112.869 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.26 -49.57 7.17 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 176.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.8 mt -51.14 -39.44 56.28 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.875 0.87 . . . . 0.0 112.457 179.099 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -59.15 -33.16 49.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 117.851 -1.071 . . . . 0.0 110.652 177.571 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -64.17 -49.59 71.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 120.48 1.491 . . . . 0.0 108.974 179.798 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -51.83 -47.2 64.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 124.067 0.947 . . . . 0.0 110.114 175.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -66.87 -42.16 86.06 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.212 -179.541 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.99 -56.13 24.67 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.362 -0.836 . . . . 0.0 110.096 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.04 -27.92 57.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.233 1.013 . . . . 0.0 112.869 -176.378 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 164.69 29.11 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -175.263 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -157.96 112.15 2.57 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.97 -113.48 5.1 Favored Glycine 0 C--N 1.336 0.567 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -178.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.26 -31.33 65.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.969 0.508 . . . . 0.0 111.243 178.043 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 34.2 ttp -64.7 118.47 48.54 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.55 -176.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.5 157.5 40.63 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.742 2.295 . . . . 0.0 110.058 179.068 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.06 139.05 58.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.969 0.508 . . . . 0.0 110.685 178.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -114.53 -0.45 13.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.84 0.856 . . . . 0.0 111.63 175.436 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -46.67 117.86 1.8 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.232 1.013 . . . . 0.0 111.781 175.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.31 -19.62 21.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.1 0.857 . . . . 0.0 112.548 179.73 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 mtm105 -88.95 -45.18 9.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.489 1.115 . . . . 0.0 108.662 -179.034 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.483 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -120.5 123.09 42.09 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 171.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -71.95 146.05 48.03 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.7 tpt85 -25.65 -52.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.449 2.3 . . . . 0.0 112.01 168.058 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -65.1 -45.64 84.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.86 0.464 . . . . 0.0 111.788 -178.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.17 -48.51 79.77 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.733 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 62' ' ' ALA . 92.6 mt -52.34 -59.48 4.36 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.168 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.1 t -42.77 -59.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 124.288 1.035 . . . . 0.0 109.673 177.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -54.99 -42.69 72.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 118.37 0.532 . . . . 0.0 112.335 -178.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.65 -53.67 47.7 Favored 'General case' 0 N--CA 1.458 -0.071 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.4 mt -55.36 -44.14 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 124.609 1.163 . . . . 0.0 110.262 178.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -56.02 -55.59 31.01 Favored 'General case' 0 C--O 1.23 0.078 0 CA-C-N 118.784 0.72 . . . . 0.0 109.097 177.877 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -55.19 -51.28 67.05 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.297 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 19.5 ttm -48.58 -62.14 1.66 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.603 1.161 . . . . 0.0 109.326 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 mp -56.55 -35.58 68.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.485 0.714 . . . . 0.0 111.661 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 54.1 m -62.95 -5.54 3.01 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.472 179.832 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.4 p -87.9 -14.67 38.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 120.484 1.493 . . . . 0.0 111.004 175.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 116.718 -1.61 . . . . 0.0 110.401 -177.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.72 48.81 3.32 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 108.28 -1.928 . . . . 0.0 108.28 175.024 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 41.67 55.64 3.53 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.336 1.455 . . . . 0.0 110.89 178.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.1 p -149.3 -63.94 0.23 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.333 -176.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 68.0 mt -50.38 -55.93 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 118.843 0.747 . . . . 0.0 109.842 179.189 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -63.54 -43.01 98.33 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 -178.649 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.3 mm -70.75 -45.17 75.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 122.912 0.485 . . . . 0.0 112.091 -172.187 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -151.41 -10.9 0.21 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -173.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -96.06 36.78 3.68 Favored Glycine 0 N--CA 1.467 0.709 0 CA-C-N 120.026 1.285 . . . . 0.0 111.442 -176.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 p -136.08 147.16 47.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.256 1.822 . . . . 0.0 106.766 177.377 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.5 109.23 10.26 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.813 -178.228 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.24 159.87 30.44 Favored 'Cis proline' 0 N--CA 1.457 -0.64 0 CA-C-N 120.193 1.105 . . . . 0.0 111.85 -8.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.1 p -74.18 122.58 22.99 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.943 1.297 . . . . 0.0 110.117 -179.738 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.6 m -54.4 -51.6 64.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.548 0.69 . . . . 0.0 110.102 -178.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.5 p -39.68 -61.37 0.84 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 127.006 2.122 . . . . 0.0 112.419 179.654 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.2 m -42.92 -43.49 4.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.002 1.321 . . . . 0.0 113.068 -177.826 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.9 m -85.31 -55.61 3.94 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.463 0.305 . . . . 0.0 111.305 -177.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -64.75 -33.97 77.22 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 123.863 0.865 . . . . 0.0 113.172 -173.728 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -61.83 -48.02 82.47 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 118.544 0.611 . . . . 0.0 109.355 177.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -73.05 -30.58 63.82 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.229 0.612 . . . . 0.0 111.31 179.237 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.23 33.35 49.45 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -174.664 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.67 141.04 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.673 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.11 31.5 6.65 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.287 1.035 . . . . 0.0 111.668 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.87 24.61 76.38 Favored Glycine 0 CA--C 1.528 0.897 0 CA-C-O 119.547 -0.585 . . . . 0.0 112.993 178.873 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.25 87.58 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 118.564 1.182 . . . . 0.0 108.674 176.689 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -62.75 114.97 2.63 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.74 2.293 . . . . 0.0 108.764 -179.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -80.93 174.23 11.83 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.729 0.776 . . . . 0.0 112.667 -172.544 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -63.6 160.64 16.32 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 170.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 36.73 51.88 0.96 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.176 1.39 . . . . 0.0 112.419 176.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.33 59.01 19.09 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 123.807 0.843 . . . . 0.0 111.005 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -38.56 -47.61 2.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.558 3.505 . . . . 0.0 114.025 -177.753 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -47.66 -40.8 20.76 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.402 1.481 . . . . 0.0 112.059 -179.207 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -76.94 -26.09 53.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 117.921 0.328 . . . . 0.0 111.637 -177.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -91.6 -26.08 18.88 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 123.587 0.755 . . . . 0.0 111.736 -177.359 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.14 -46.33 0.5 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.159 2.184 . . . . 0.0 114.437 -178.129 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -91.91 -15.14 28.49 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 123.441 0.697 . . . . 0.0 112.816 -175.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 69.0 mtt-85 -81.08 148.78 64.92 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 123.489 0.716 . . . . 0.0 109.655 -177.496 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.34 129.41 28.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.58 2.186 . . . . 0.0 111.157 176.774 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.2 p -67.21 -40.84 86.51 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.415 0.626 . . . . 0.0 110.348 179.203 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.74 110.32 1.13 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.393 1.477 . . . . 0.0 111.425 -177.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.2 m -53.74 -36.78 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 C-N-CA 124.21 1.004 . . . . 0.0 109.891 177.075 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -55.48 -33.71 63.91 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.356 1.863 . . . . 0.0 111.343 177.49 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -83.4 -50.67 8.1 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -51.73 -38.12 53.91 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 68' ' ' VAL . 4.1 m -58.34 -36.87 60.32 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.419 0 C-N-CA 118.946 -1.101 . . . . 0.0 110.467 177.989 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -57.15 -44.9 83.86 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 120.734 1.606 . . . . 0.0 109.409 -179.418 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.7 m -58.04 -33.05 68.57 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.114 0.566 . . . . 0.0 110.468 174.312 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 m -75.73 -47.47 25.92 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.179 0.991 . . . . 0.0 110.007 -179.167 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.8 -48.06 73.24 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 120.598 -1.314 . . . . 0.0 110.099 174.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.58 -38.32 74.03 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.882 0.873 . . . . 0.0 112.692 -178.134 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.9 162.63 29.88 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -175.074 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -161.1 129.63 4.49 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 117.769 0.784 . . . . 0.0 109.083 -178.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.89 -120.28 21.78 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -177.696 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.2 -13.92 48.49 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 118.961 -0.542 . . . . 0.0 111.916 177.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.4 ' HB2' ' C1D' ' A' ' 0' ' ' HEM . 39.0 ttp -66.53 117.16 41.52 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 119.254 0.934 . . . . 0.0 110.38 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.27 159.72 38.21 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.346 2.031 . . . . 0.0 111.064 177.302 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.83 118.58 10.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.191 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -82.02 -4.22 56.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.467 1.031 . . . . 0.0 113.205 -179.092 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -56.57 86.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.292 1.037 . . . . 0.0 112.484 -179.656 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 128.02 -33.97 3.08 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.548 1.547 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.3 mtm-85 -78.33 -34.76 48.36 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 117.667 0.734 . . . . 0.0 110.936 -179.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.526 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -141.39 146.01 36.06 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 174.762 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -85.99 138.94 31.61 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.209 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 -30.59 -46.3 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 127.274 2.23 . . . . 0.0 113.028 173.111 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -60.17 -57.64 11.96 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.619 0.645 . . . . 0.0 110.441 177.808 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -53.49 -53.71 47.56 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.98 0.895 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 62' ' ' ALA . 28.5 mt -47.73 -55.27 9.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.85 1.66 . . . . 0.0 110.561 176.484 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.663 HG23 HG11 ' A' ' 45' ' ' VAL . 1.7 t -51.22 -58.67 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.181 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -54.51 -37.36 65.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.117 0.567 . . . . 0.0 111.842 -179.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.78 -44.1 82.23 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.36 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.413 HD12 HG13 ' A' ' 45' ' ' VAL . 54.3 mt -62.54 -47.38 93.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.507 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -45.25 -56.43 4.86 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.605 1.093 . . . . 0.0 109.751 176.56 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -55.66 -52.66 63.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.276 -1.329 . . . . 0.0 110.917 179.256 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 ptm -54.85 -43.62 73.21 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.533 0.606 . . . . 0.0 110.251 -178.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.3 mt -69.71 -29.78 67.26 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.625 -0.672 . . . . 0.0 111.057 178.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.7 m -73.96 43.06 0.15 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.036 0.834 . . . . 0.0 112.678 179.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.6 p -135.89 -13.83 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.783 2.033 . . . . 0.0 109.914 174.155 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--O 1.251 1.159 0 CA-C-O 117.417 -1.278 . . . . 0.0 110.035 -179.109 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.4 ' C1D' ' HB2' ' A' ' 55' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.617 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -57.16 -41.21 92.61 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 174.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -50.59 -42.97 56.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.251 1.02 . . . . 0.0 110.967 175.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -54.84 -39.19 68.32 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.546 -0.721 . . . . 0.0 110.984 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.81 -40.66 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.835 0.854 . . . . 0.0 110.586 -177.554 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' OH ' HD21 ' A' ' 28' ' ' LEU . 38.5 t80 -64.68 -41.66 95.9 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.962 0.801 . . . . 0.0 110.247 177.609 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 87.8 mt -69.35 -47.61 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 177.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.914 ' HB2' HG22 ' A' ' 13' ' ' THR . 30.5 m-80 110.74 88.1 0.0 OUTLIER 'General case' 0 C--N 1.345 0.411 0 C-N-CA 130.612 3.565 . . . . 0.0 114.009 162.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.41 -20.43 58.8 Favored Glycine 0 CA--C 1.551 2.301 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 156.192 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.29 163.92 3.57 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 129.214 3.006 . . . . 0.0 111.356 175.067 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.43 124.86 9.89 Favored Pre-proline 0 N--CA 1.452 -0.352 0 C-N-CA 125.248 1.419 . . . . 0.0 107.494 177.281 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -60.65 178.46 5.8 Favored 'Cis proline' 0 N--CA 1.46 -0.459 0 CA-C-N 120.525 1.223 . . . . 0.0 112.464 -8.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.914 HG22 ' HB2' ' A' ' 8' ' ' ASN . 1.0 OUTLIER -100.18 109.01 21.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.95 1.3 . . . . 0.0 110.295 179.598 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -41.54 -53.8 3.36 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.388 1.475 . . . . 0.0 109.943 176.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.7 p -44.1 -55.4 4.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.267 2.227 . . . . 0.0 111.513 -178.168 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -50.22 -37.46 35.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.492 0.717 . . . . 0.0 112.332 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 25.7 m -84.34 -59.45 2.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.35 0.595 . . . . 0.0 110.325 -179.496 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 -59.91 -42.49 93.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.956 1.302 . . . . 0.0 113.069 -174.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -62.63 -38.54 90.63 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.453 0.569 . . . . 0.0 110.015 179.566 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -25.3 41.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.43 0.692 . . . . 0.0 111.17 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 29.99 64.35 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -176.743 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.3 p -58.44 138.46 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.75 29.3 5.65 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.331 1.053 . . . . 0.0 111.72 -177.791 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.06 23.97 74.87 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.804 179.354 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.5 129.61 84.23 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 118.566 1.183 . . . . 0.0 108.362 176.423 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 34' ' ' TRP . 42.9 Cg_endo -61.22 122.04 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.256 1.971 . . . . 0.0 109.742 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -86.97 178.32 6.98 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.641 0.734 . . . . 0.0 111.805 -174.434 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.409 HD21 ' OH ' ' A' ' 6' ' ' TYR . 2.3 mm? -70.65 163.45 27.04 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 171.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 m120 48.07 34.39 4.21 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.681 0.792 . . . . 0.0 112.865 175.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.05 62.23 62.87 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 118.7 0.682 . . . . 0.0 112.384 -174.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -39.77 -51.55 2.92 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.151 3.234 . . . . 0.0 114.801 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -49.66 -40.95 41.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.776 0.831 . . . . 0.0 112.079 -179.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -68.8 -19.94 64.31 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.269 0.628 . . . . 0.0 112.015 -178.143 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.474 ' CE2' ' HB2' ' A' ' 26' ' ' PRO . 96.5 m95 -102.32 -35.88 8.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.269 1.028 . . . . 0.0 111.803 -178.58 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -37.27 -51.71 1.05 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.053 1.741 . . . . 0.0 113.131 -178.419 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.7 -24.44 53.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -177.047 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.6 mtt-85 -76.99 157.38 81.54 Favored Pre-proline 0 CA--C 1.537 0.474 0 O-C-N 121.621 -0.674 . . . . 0.0 110.117 -177.681 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -51.08 113.97 1.33 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.025 2.483 . . . . 0.0 111.583 178.172 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.6 m -59.46 -36.09 75.3 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.514 -0.741 . . . . 0.0 110.602 179.09 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.2 106.08 0.48 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.444 1.498 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.3 -36.03 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 O-C-N 121.844 -0.535 . . . . 0.0 109.563 176.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -57.99 -24.26 57.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.102 0.961 . . . . 0.0 112.528 177.655 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -89.34 -49.8 6.5 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.642 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.62 -40.99 41.08 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 179.158 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.32 -37.23 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 O-C-N 121.44 -0.787 . . . . 0.0 110.157 179.088 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -63.59 -47.77 80.11 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.436 1.016 . . . . 0.0 108.366 177.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.3 m -53.93 -37.62 64.02 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 122.124 0.17 . . . . 0.0 110.754 175.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 29.5 m -74.06 -48.7 28.12 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.911 -0.493 . . . . 0.0 110.713 -177.641 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD1' ' HA ' ' A' ' 59' ' ' ASP . 0.3 OUTLIER -66.68 -44.62 81.31 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.587 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.66 -35.04 60.5 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.38 0.672 . . . . 0.0 111.809 178.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 152.31 23.66 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -176.521 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' H ' ' HB3' ' A' ' 55' ' ' MET . 85.4 tttt -153.53 141.46 20.22 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -179.912 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.49 -119.93 18.71 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -177.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.07 3.48 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.839 0.855 . . . . 0.0 112.095 178.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.6 ttp -69.74 123.65 89.01 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 119.047 0.84 . . . . 0.0 110.144 -178.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.553 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 74.1 Cg_endo -69.26 145.15 59.12 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 121.568 1.512 . . . . 0.0 108.622 176.192 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.6 135.86 57.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.416 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -97.56 -36.82 10.17 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.109 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' HA ' ' CD1' ' A' ' 49' ' ' LEU . 9.2 t70 38.76 -144.52 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 127.228 2.211 . . . . 0.0 111.76 -179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.4 -20.4 5.19 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 126.999 2.238 . . . . 0.0 113.211 179.775 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.1 mtm-85 -61.84 -30.3 70.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.483 1.141 . . . . 0.0 109.614 176.594 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -121.15 106.91 11.97 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.123 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -63.11 86.84 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 126.432 1.893 . . . . 0.0 110.807 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 68.2 ttt-85 16.37 -64.63 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.516 3.526 . . . . 0.0 115.513 174.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -50.25 -35.79 28.42 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.046 -1.034 . . . . 0.0 111.065 178.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.27 -55.31 29.59 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.69 0.757 . . . . 0.0 109.588 178.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 42.4 mt -52.49 -53.56 44.18 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 124.738 1.215 . . . . 0.0 109.551 176.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.2 t -44.6 -58.33 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 124.453 1.101 . . . . 0.0 109.603 176.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -57.04 -39.76 75.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 118.891 0.768 . . . . 0.0 112.461 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.02 -44.28 96.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.4 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 80.0 mt -62.32 -47.14 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.862 0.865 . . . . 0.0 108.74 179.318 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -52.69 -51.81 58.7 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -55.37 -54.36 44.62 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.072 178.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.9 ttp -52.1 -47.96 64.99 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.096 0.559 . . . . 0.0 111.167 -179.745 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.1 mt -62.76 -35.62 80.4 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.861 -0.525 . . . . 0.0 110.312 177.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.5 m -73.5 39.08 0.1 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.391 -0.818 . . . . 0.0 113.2 179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.8 p -131.16 -14.32 3.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.979 1.711 . . . . 0.0 109.764 173.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.3 mp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.516 -1.707 . . . . 0.0 110.135 -178.446 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.553 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.38 -25.68 3.69 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.134 0.896 . . . . 0.0 110.925 176.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.73 -59.8 4.81 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.858 1.263 . . . . 0.0 110.599 -177.176 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -50.08 -47.04 53.9 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.086 0.554 . . . . 0.0 110.098 -179.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 mt -57.21 -57.99 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 124.607 1.163 . . . . 0.0 109.37 178.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -56.95 -48.26 78.75 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.125 0.57 . . . . 0.0 111.763 -178.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 78.6 mt -69.34 -48.49 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-O 118.765 -0.636 . . . . 0.0 111.231 -174.154 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -149.48 -5.29 0.38 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -172.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.23 37.46 3.51 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 120.072 1.306 . . . . 0.0 111.144 -176.061 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 p -136.6 151.46 49.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.422 1.489 . . . . 0.0 108.131 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.76 111.74 13.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 124.59 1.156 . . . . 0.0 109.695 -177.834 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -61.55 162.02 44.69 Favored 'Cis proline' 0 N--CA 1.455 -0.758 0 CA-C-N 120.266 1.131 . . . . 0.0 109.544 -13.163 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -67.97 129.1 38.88 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.776 0.83 . . . . 0.0 110.467 -177.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 m -57.48 -46.85 83.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.606 0.717 . . . . 0.0 110.531 -178.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 p -39.16 -55.19 1.68 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.709 2.004 . . . . 0.0 112.74 -179.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -43.09 -38.03 2.21 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.666 1.186 . . . . 0.0 112.916 -178.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.34 -57.14 2.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.15 -177.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -70.27 -24.23 63.02 Favored 'General case' 0 C--N 1.334 -0.091 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -172.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.47 -54.82 38.38 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.036 0.834 . . . . 0.0 109.89 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -16.28 28.02 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.442 -179.359 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 45.84 7.33 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.7 p -58.7 141.33 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.09 29.1 5.99 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.019 0.928 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.56 24.84 75.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 119.404 -0.664 . . . . 0.0 112.814 179.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 137.1 88.34 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 118.787 1.294 . . . . 0.0 108.208 175.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.42 117.34 4.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.552 2.168 . . . . 0.0 109.782 -178.484 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -76.31 175.87 8.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.943 0.877 . . . . 0.0 109.282 -179.838 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.0 mp -96.47 149.78 21.34 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 63.25 31.11 15.66 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.413 0.685 . . . . 0.0 109.506 -173.713 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.58 57.77 27.19 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 124.04 0.936 . . . . 0.0 112.618 -177.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -34.36 -48.14 0.59 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 125.06 3.84 . . . . 0.0 114.267 -179.464 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -39.65 -46.79 1.88 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.006 1.722 . . . . 0.0 112.68 178.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -76.55 -29.54 56.71 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.146 0.43 . . . . 0.0 111.522 -177.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -85.36 -20.69 29.53 Favored 'General case' 0 C--O 1.225 -0.233 0 C-N-CA 123.403 0.681 . . . . 0.0 111.43 -177.034 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -36.58 -45.46 0.51 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.448 1.899 . . . . 0.0 113.758 179.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -94.08 -14.96 25.2 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.795 0.838 . . . . 0.0 112.825 -177.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -79.88 127.24 78.07 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 123.945 0.898 . . . . 0.0 109.093 -177.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.44 126.35 19.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.602 2.202 . . . . 0.0 111.558 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.8 p -65.68 -27.07 68.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.314 0.646 . . . . 0.0 111.126 179.568 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.0 102.68 0.05 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.658 1.583 . . . . 0.0 111.243 179.396 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 45' ' ' VAL . 44.6 t -42.52 -51.17 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 124.211 1.004 . . . . 0.0 110.195 179.492 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -51.7 -44.54 63.2 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -62.98 -47.59 82.5 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.2 mt -61.16 -38.65 87.23 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 110.649 179.04 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG22 HD12 ' A' ' 71' ' ' ILE . 86.6 t -64.26 -40.3 88.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.326 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -60.39 -48.92 79.67 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.282 0.946 . . . . 0.0 109.547 174.868 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 m -54.06 -43.87 70.62 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.499 0.59 . . . . 0.0 111.158 177.459 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 m -69.04 -44.71 72.11 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.91 -0.494 . . . . 0.0 110.011 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 28.9 mt -55.4 -53.29 58.12 Favored 'General case' 0 C--N 1.339 0.122 0 O-C-N 121.369 -0.832 . . . . 0.0 110.601 177.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.05 -26.01 43.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.72 1.208 . . . . 0.0 113.342 -176.006 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.86 160.66 31.87 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 108.976 -1.65 . . . . 0.0 108.976 -176.145 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -158.21 119.98 3.59 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -178.633 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.91 -119.34 17.44 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -178.443 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.6 -21.46 55.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.761 0.424 . . . . 0.0 111.598 178.194 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 35.0 ttp -69.0 121.96 83.51 Favored Pre-proline 0 N--CA 1.454 -0.228 0 CA-C-N 118.795 0.725 . . . . 0.0 110.236 -177.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.7 157.28 39.91 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.57 2.18 . . . . 0.0 110.179 179.769 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.49 123.0 16.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.324 177.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -89.72 -10.21 46.53 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 119.223 0.92 . . . . 0.0 112.71 178.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -50.01 111.8 0.57 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.927 0.491 . . . . 0.0 110.436 178.735 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.81 -36.96 4.0 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 124.477 1.037 . . . . 0.0 111.72 -179.814 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.2 mtm-85 -85.41 -47.62 9.8 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-N 118.13 0.965 . . . . 0.0 110.052 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.45 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -116.75 126.91 53.83 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 175.404 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -80.25 149.93 30.22 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.34 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -25.92 -52.13 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.181 2.192 . . . . 0.0 112.074 170.342 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -60.28 -49.86 75.92 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.433 0.56 . . . . 0.0 111.576 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -55.47 -55.61 29.78 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 122.139 0.971 . . . . 0.0 109.024 178.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 62' ' ' ALA . 75.7 mt -49.7 -58.92 4.37 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 113.675 -1.602 . . . . 0.0 109.946 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.67 -55.49 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.672 1.589 . . . . 0.0 110.587 178.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -58.54 -44.16 89.5 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.224 0.61 . . . . 0.0 111.199 -178.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.67 -45.08 88.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.695 -0.628 . . . . 0.0 109.938 179.437 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.435 HD12 HG22 ' A' ' 45' ' ' VAL . 60.1 mt -67.59 -46.61 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 124.614 1.166 . . . . 0.0 111.303 -175.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.28 -42.06 90.38 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.28 1.4 . . . . 0.0 109.402 178.28 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -62.29 -50.04 73.25 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 176.881 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.6 ttm -48.89 -52.95 21.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.846 0.858 . . . . 0.0 109.264 178.587 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.1 mt -61.53 -39.12 89.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.106 0.562 . . . . 0.0 111.745 178.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 53.2 p -62.4 -8.61 6.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 119.45 1.023 . . . . 0.0 113.536 -177.06 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.3 p -79.26 -14.75 58.84 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.519 1.054 . . . . 0.0 111.007 176.115 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 116.603 -1.665 . . . . 0.0 111.03 -174.888 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -36.4 -49.04 1.25 Allowed Glycine 0 C--N 1.34 0.757 0 C-N-CA 125.767 1.651 . . . . 0.0 113.46 -177.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 55.9 mp0 -59.38 -63.86 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.455 0.702 . . . . 0.0 109.765 178.124 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -49.45 15.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.503 1.121 . . . . 0.0 110.33 -179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.72 -54.98 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 124.888 1.275 . . . . 0.0 108.873 -178.331 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -60.3 -47.15 87.25 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.217 0.462 . . . . 0.0 111.495 -177.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mm -70.78 -46.66 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 118.719 -0.657 . . . . 0.0 111.558 -172.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -149.95 -11.71 0.27 Allowed 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.098 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.11 35.37 4.29 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 120.114 1.324 . . . . 0.0 111.773 -174.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.6 p -135.56 152.39 51.23 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.956 1.303 . . . . 0.0 108.051 177.634 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.46 108.61 9.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.73 1.212 . . . . 0.0 109.744 -178.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.18 158.92 26.32 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 CA-C-N 119.941 1.015 . . . . 0.0 111.853 -10.6 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.11 122.0 19.32 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.338 1.055 . . . . 0.0 109.712 179.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 m -52.26 -50.52 61.91 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 0.0 110.379 -178.145 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.1 p -40.28 -55.83 2.1 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.445 1.898 . . . . 0.0 112.695 178.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.1 m -46.04 -32.48 2.85 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.285 1.034 . . . . 0.0 113.01 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.5 m -99.05 -57.04 2.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.044 0.384 . . . . 0.0 111.026 179.444 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -68.44 -32.27 72.18 Favored 'General case' 0 C--N 1.334 -0.075 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -66.65 -42.7 86.27 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 118.828 0.74 . . . . 0.0 109.126 179.271 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -80.94 -27.96 35.89 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.313 -178.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.75 37.09 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.98 139.9 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -178.141 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.21 28.56 5.66 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.088 0.955 . . . . 0.0 111.546 -177.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.44 24.11 76.82 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.365 -0.686 . . . . 0.0 112.857 179.597 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.57 131.78 77.36 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 118.767 1.283 . . . . 0.0 108.498 175.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -60.47 117.56 4.33 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 109.28 -178.41 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -89.21 178.86 6.25 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.749 0.785 . . . . 0.0 112.771 -171.213 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.99 159.21 23.55 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 171.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.16 53.87 0.73 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.685 1.594 . . . . 0.0 112.541 177.053 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.57 59.34 24.53 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.171 0.989 . . . . 0.0 110.461 179.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -39.66 -52.45 2.59 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 124.455 3.437 . . . . 0.0 114.489 -175.815 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -49.87 -35.08 22.1 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.246 1.018 . . . . 0.0 112.765 -179.26 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -74.43 -28.17 60.94 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.783 0.72 . . . . 0.0 110.915 -179.376 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -91.86 -30.2 16.3 Favored 'General case' 0 C--O 1.226 -0.171 0 C-N-CA 123.568 0.747 . . . . 0.0 111.981 -177.154 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.89 -51.14 0.69 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.647 1.979 . . . . 0.0 113.484 -178.003 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.44 -25.28 54.26 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.764 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -76.98 152.65 82.56 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 110.033 -177.167 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -64.73 110.64 1.49 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.538 1.492 . . . . 0.0 108.482 176.038 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.7 m -55.52 -28.96 57.85 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.249 0.477 . . . . 0.0 111.414 179.227 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.6 m -53.48 103.85 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.884 1.674 . . . . 0.0 111.444 178.402 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.6 t -51.14 -39.64 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 123.555 0.742 . . . . 0.0 110.337 178.409 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -56.97 -23.46 45.97 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.383 1.073 . . . . 0.0 112.679 179.768 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -90.55 -53.04 4.6 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 175.374 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 72.3 mt -49.84 -39.81 40.19 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.114 0.966 . . . . 0.0 112.506 179.747 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -33.81 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 O-C-N 121.664 -0.648 . . . . 0.0 110.266 179.103 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -65.45 -46.87 78.18 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.453 1.024 . . . . 0.0 108.735 176.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.0 m -53.54 -44.45 69.2 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.7 m -65.95 -47.61 74.07 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.078 0.551 . . . . 0.0 110.684 -179.5 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.1 mt -59.24 -49.1 79.12 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.359 -0.838 . . . . 0.0 110.619 -179.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.09 -30.79 61.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.394 1.078 . . . . 0.0 112.572 -177.588 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.36 161.32 31.45 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -175.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -159.62 114.4 2.37 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.581 0.69 . . . . 0.0 109.725 -177.216 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.67 -117.76 12.61 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -178.108 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.17 -25.12 59.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.302 -0.38 . . . . 0.0 111.201 177.828 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 32.8 ttp -65.63 119.2 58.31 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 118.463 -0.78 . . . . 0.0 110.33 -177.469 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -72.02 160.78 46.67 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 122.29 1.994 . . . . 0.0 110.154 178.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.19 117.35 9.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -82.16 -7.77 59.63 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 118.646 0.657 . . . . 0.0 112.368 178.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -49.88 113.64 0.89 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.821 0.737 . . . . 0.0 110.321 176.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.7 -28.95 9.82 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.061 0.838 . . . . 0.0 112.121 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -76.07 -43.91 41.46 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.646 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -131.02 152.9 49.83 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 123.831 0.852 . . . . 0.0 108.73 176.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -88.95 132.89 34.51 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 176.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 46.2 ttt-85 -29.65 -47.4 0.07 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.402 2.281 . . . . 0.0 113.391 173.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -69.01 -41.7 77.42 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.417 1.008 . . . . 0.0 111.312 -178.125 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 -46.5 83.0 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 176.737 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 62' ' ' ALA . 55.3 mt -51.99 -61.12 2.46 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 175.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 t -41.12 -56.23 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 125.348 1.459 . . . . 0.0 109.594 177.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -54.8 -44.01 73.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.926 0.49 . . . . 0.0 111.512 179.658 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -48.2 75.67 Favored 'General case' 0 C--O 1.228 -0.061 0 O-C-N 121.707 -0.62 . . . . 0.0 109.852 -179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.5 mt -57.52 -50.42 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 123.871 0.868 . . . . 0.0 110.602 178.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.85 -40.76 96.46 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 120.253 1.388 . . . . 0.0 109.294 -179.526 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -57.76 -50.62 72.62 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.724 0.693 . . . . 0.0 109.561 176.885 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.4 ttp -52.66 -52.82 54.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.328 0.651 . . . . 0.0 109.272 178.385 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.4 mp -57.81 -33.8 68.98 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.745 -0.597 . . . . 0.0 111.839 176.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.5 m -73.01 38.0 0.08 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.402 1.001 . . . . 0.0 113.423 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 57.9 p -132.01 -15.77 2.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.314 1.845 . . . . 0.0 109.479 171.681 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.311 -1.328 . . . . 0.0 109.724 179.96 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 CA--C 1.516 -0.353 0 CA-C-O 117.426 -1.274 . . . . 0.0 108.067 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.49 19.24 57.2 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 -171.301 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 66.87 -62.07 0.31 Allowed 'General case' 0 C--N 1.35 0.588 0 C-N-CA 129.802 3.241 . . . . 0.0 111.76 175.073 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 p -26.28 -64.78 0.07 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.479 3.112 . . . . 0.0 112.806 179.392 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.5 mt -44.94 -57.39 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.293 1.037 . . . . 0.0 110.508 -178.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -66.74 -47.21 72.97 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.919 0.487 . . . . 0.0 111.721 -178.35 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.8 mt -69.55 -46.79 74.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -172.686 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -145.22 -5.06 0.69 Allowed 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -170.608 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.43 33.95 6.17 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 120.168 1.349 . . . . 0.0 112.042 -176.644 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.64 150.52 51.58 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.119 1.768 . . . . 0.0 107.403 177.525 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.58 109.62 14.69 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.248 1.019 . . . . 0.0 110.272 -177.172 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -63.01 163.07 50.14 Favored 'Cis proline' 0 N--CA 1.455 -0.79 0 CA-C-N 120.292 1.14 . . . . 0.0 110.065 -10.725 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -69.17 129.42 39.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.327 1.051 . . . . 0.0 110.177 -178.341 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -59.19 -46.51 88.22 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.443 0.639 . . . . 0.0 111.044 -177.687 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.3 p -37.27 -57.19 0.9 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 127.207 2.203 . . . . 0.0 112.168 179.24 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -39.15 -34.52 0.18 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 126.512 1.925 . . . . 0.0 113.677 -178.417 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.8 m -104.55 -57.89 1.96 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.497 0.719 . . . . 0.0 110.625 -179.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -64.27 -24.07 67.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -172.212 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -73.59 -22.0 60.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 119.986 1.266 . . . . 0.0 111.052 177.231 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.4 mtm105 -107.5 -24.76 11.68 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.91 0.884 . . . . 0.0 111.683 -178.304 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.35 32.62 51.13 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.133 -1.187 . . . . 0.0 110.133 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.4 p -57.78 140.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.57 28.8 6.42 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -177.192 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.21 22.98 77.0 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.319 -0.712 . . . . 0.0 112.892 179.39 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.91 130.76 82.88 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-N 118.798 1.299 . . . . 0.0 108.644 176.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -64.14 121.73 9.49 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.601 2.201 . . . . 0.0 108.648 -179.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -89.28 178.67 6.28 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.954 0.883 . . . . 0.0 113.277 -171.335 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.9 160.92 29.8 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.729 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 35.78 52.9 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.769 1.628 . . . . 0.0 111.674 177.165 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.23 64.34 19.71 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 123.975 0.91 . . . . 0.0 110.456 -177.518 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -38.68 -50.55 2.43 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 124.302 3.335 . . . . 0.0 114.099 -177.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -49.22 -39.98 31.92 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.179 0.992 . . . . 0.0 112.27 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -64.16 -28.65 69.9 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.259 0.624 . . . . 0.0 111.337 -179.15 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -100.83 -27.01 13.56 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.712 1.205 . . . . 0.0 112.384 -174.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -38.84 -43.88 0.98 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.061 1.744 . . . . 0.0 113.744 -178.884 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -92.8 -15.89 25.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.586 0.754 . . . . 0.0 112.771 -176.373 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.7 mtt-85 -84.3 133.93 44.01 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 123.631 0.772 . . . . 0.0 109.597 -177.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.19 105.32 0.12 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.991 2.461 . . . . 0.0 110.302 176.938 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.98 -24.87 63.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.876 0.87 . . . . 0.0 113.038 -175.56 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.5 m -52.48 102.24 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.441 1.497 . . . . 0.0 111.424 179.781 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 83.0 t -47.6 -45.02 10.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.293 1.037 . . . . 0.0 110.255 179.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -55.35 -29.32 58.14 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.915 1.286 . . . . 0.0 112.168 -179.014 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -86.19 -50.73 6.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.431 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.3 mt -50.46 -40.94 52.17 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.062 0.545 . . . . 0.0 112.21 -179.778 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.7 m -59.6 -30.8 45.5 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.317 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.984 178.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.7 -50.04 68.54 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.224 1.375 . . . . 0.0 108.471 177.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -53.81 -42.67 68.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.173 0.589 . . . . 0.0 110.128 176.238 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.9 m -68.22 -44.36 75.9 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.813 0.34 . . . . 0.0 110.681 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 35.2 mt -61.66 -47.24 86.23 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.262 -0.899 . . . . 0.0 110.366 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.83 -31.19 51.48 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.173 0.989 . . . . 0.0 112.716 -177.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.82 159.0 28.58 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 -175.075 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.495 ' H ' ' HB3' ' A' ' 55' ' ' MET . 53.9 tttp -156.77 124.55 5.48 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -177.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.86 -114.89 6.51 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.3 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.67 -18.86 33.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.738 0.815 . . . . 0.0 112.028 178.243 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.495 ' HB3' ' H ' ' A' ' 52' ' ' LYS . 12.4 ttp -62.25 124.57 82.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 118.948 0.795 . . . . 0.0 110.439 -176.994 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.433 ' HD3' HBC2 ' A' ' 0' ' ' HEM . 98.1 Cg_endo -72.49 158.24 51.44 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.082 1.854 . . . . 0.0 109.31 178.017 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.97 114.5 6.57 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -79.78 -7.41 58.64 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.306 179.473 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.74 113.18 0.66 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.842 0.747 . . . . 0.0 110.936 177.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.88 -27.18 11.55 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.164 0.887 . . . . 0.0 112.331 179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -77.73 -49.73 13.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -130.71 134.56 47.02 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.183 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -77.69 149.0 34.68 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.472 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -27.72 -50.16 0.06 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.144 1.777 . . . . 0.0 112.402 168.641 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -69.02 -39.63 79.13 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.638 -0.664 . . . . 0.0 112.21 -178.637 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.38 -53.27 60.15 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 119.618 1.099 . . . . 0.0 108.208 175.595 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.419 HD21 ' HB3' ' A' ' 62' ' ' ALA . 54.7 mt -49.61 -59.4 3.82 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 125.802 1.641 . . . . 0.0 109.155 177.158 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.4 t -43.19 -57.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.167 0.987 . . . . 0.0 109.077 176.243 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -58.63 -31.96 68.59 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.545 -0.74 . . . . 0.0 112.106 -176.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.87 -52.63 14.02 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.222 0.919 . . . . 0.0 109.262 176.93 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.7 mt -53.03 -39.71 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.468 1.107 . . . . 0.0 110.073 178.782 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -52.31 -56.61 13.69 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.092 0.86 . . . . 0.0 109.637 176.226 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -55.83 -53.88 51.37 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.691 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 33.3 ttm -47.22 -61.07 2.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.101 0.96 . . . . 0.0 110.331 -179.076 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.0 mt -61.45 -35.74 78.45 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.042 -0.411 . . . . 0.0 111.137 -178.862 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.7 m -62.53 -5.0 2.22 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -179.787 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -88.97 -13.83 38.02 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 120.393 1.451 . . . . 0.0 111.265 176.399 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.638 -176.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . 0.433 HBC2 ' HD3' ' A' ' 56' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 117.045 -1.455 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.4 -75.63 0.28 Allowed Glycine 0 C--N 1.339 0.705 0 C-N-CA 125.453 1.501 . . . . 0.0 110.798 175.062 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -108.04 -34.29 6.93 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.979 -2.61 . . . . 0.0 109.535 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.6 m 70.59 -62.78 0.43 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 127.163 2.185 . . . . 0.0 107.395 -176.9 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.28 -55.26 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 119.431 1.014 . . . . 0.0 108.759 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -69.56 -50.46 44.55 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -178.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.38 -50.53 72.32 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 C-N-CA 118.149 -1.42 . . . . 0.0 112.531 -174.425 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -158.73 51.86 0.4 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -169.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -158.38 35.7 0.52 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.71 -0.556 . . . . 0.0 111.71 -179.408 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.23 154.41 50.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.228 1.811 . . . . 0.0 106.586 175.48 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.58 105.34 10.89 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 118.473 -0.775 . . . . 0.0 110.091 -176.187 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.21 155.97 77.1 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 120.208 1.11 . . . . 0.0 110.417 -7.038 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 129.9 42.42 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.615 1.166 . . . . 0.0 110.719 -178.304 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 m -52.47 -48.51 65.84 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.409 1.1 . . . . 0.0 110.143 178.721 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -49.29 -39.57 31.38 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.334 1.853 . . . . 0.0 112.207 179.205 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.5 m -47.0 -40.39 14.44 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.893 -178.42 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 67.1 m -99.37 -51.29 3.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.954 0.783 . . . . 0.0 110.929 -177.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -69.27 -22.97 63.78 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -173.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.7 -42.9 90.61 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.469 1.031 . . . . 0.0 110.127 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.01 -25.32 17.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.701 0.8 . . . . 0.0 111.569 179.181 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.53 37.83 13.47 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 -175.027 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.18 149.09 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -176.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 52.29 30.11 7.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.136 0.974 . . . . 0.0 111.291 -178.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.75 23.16 78.39 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.948 179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.63 132.57 91.3 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 118.908 1.354 . . . . 0.0 108.132 176.382 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.63 118.08 5.03 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.181 1.92 . . . . 0.0 107.778 179.387 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -75.72 162.72 27.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.834 0.825 . . . . 0.0 111.52 -174.343 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.95 159.47 34.64 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 170.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 40.57 56.8 2.71 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.599 1.159 . . . . 0.0 111.191 -177.356 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 63.3 5.45 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 124.57 1.148 . . . . 0.0 109.65 -177.679 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -45.35 -44.5 16.26 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 124.063 3.175 . . . . 0.0 113.43 -175.116 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -50.0 -34.59 21.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.904 0.881 . . . . 0.0 112.335 178.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.11 -28.61 64.44 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.025 0.53 . . . . 0.0 111.455 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -99.09 -15.68 18.92 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 124.417 1.087 . . . . 0.0 111.958 -176.162 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -35.36 -45.77 0.34 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.236 1.814 . . . . 0.0 112.935 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -112.33 30.47 7.05 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.042 0.937 . . . . 0.0 112.638 -176.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -121.1 124.42 27.39 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.603 1.161 . . . . 0.0 108.074 177.604 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -50.88 108.71 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.417 2.745 . . . . 0.0 110.826 178.121 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.5 m -58.01 -24.78 59.67 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -176.589 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m -49.1 105.54 0.08 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.016 1.727 . . . . 0.0 112.4 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 95.1 t -49.45 -45.25 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 123.484 0.714 . . . . 0.0 109.442 177.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -57.44 -23.4 49.38 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.858 1.263 . . . . 0.0 113.145 -179.122 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -90.58 -55.05 3.73 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.1 mt -50.82 -39.49 53.35 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.733 1.213 . . . . 0.0 112.444 -178.589 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.39 -35.41 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 O-C-N 121.623 -0.673 . . . . 0.0 109.949 179.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.95 -48.8 75.08 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 119.173 0.897 . . . . 0.0 108.69 177.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.3 m -53.16 -37.35 61.78 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.696 0.798 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 m -75.15 -47.53 28.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.109 0.564 . . . . 0.0 109.996 -178.792 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.58 -48.8 80.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 124.441 1.097 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -73.02 -33.63 65.85 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.889 0.876 . . . . 0.0 110.921 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.32 86.85 1.19 Allowed Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.255 0.919 . . . . 0.0 111.272 -179.768 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -77.72 144.99 36.82 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.915 1.286 . . . . 0.0 109.97 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.41 -114.91 5.99 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.018 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.69 -0.26 51.8 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.028 0.931 . . . . 0.0 112.424 -179.352 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.5 mtm -71.57 139.51 83.79 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 119.413 1.006 . . . . 0.0 111.179 -178.402 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -71.91 153.54 58.3 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 171.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.53 113.91 5.1 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -78.4 -16.16 57.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.533 -179.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -49.6 113.3 0.8 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.51 1.05 . . . . 0.0 110.511 175.285 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.41 -32.55 7.04 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.38 0.99 . . . . 0.0 111.493 -179.002 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -76.27 -46.21 29.0 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.397 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 67' ' ' LEU . . . -137.51 138.26 39.49 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.488 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -79.1 147.65 32.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.15 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 68' ' ' VAL . 67.1 ttt-85 -30.53 -51.27 0.14 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.489 1.915 . . . . 0.0 111.782 169.412 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.32 -29.43 65.01 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.543 -0.723 . . . . 0.0 112.168 -176.991 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -66.31 -58.98 4.17 Favored 'General case' 0 N--CA 1.459 0.021 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 173.18 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 62' ' ' ALA . 74.5 mt -44.18 -55.85 4.52 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.097 1.759 . . . . 0.0 110.18 179.544 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 64' ' ' ARG . 3.3 t -38.5 -51.66 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.692 1.597 . . . . 0.0 111.266 178.306 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -59.0 -47.0 86.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.451 0.643 . . . . 0.0 110.791 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.44 94.14 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 121.929 -0.482 . . . . 0.0 109.775 -179.664 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.41 -49.47 82.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.501 1.12 . . . . 0.0 110.405 -178.649 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -63.1 -41.12 99.3 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.155 -0.966 . . . . 0.0 109.243 -179.334 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -58.17 -55.7 31.54 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.838 0.745 . . . . 0.0 109.299 176.66 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.8 ttm -43.34 -53.29 5.37 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.201 1.8 . . . . 0.0 109.997 176.492 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.5 mt -64.52 -38.51 91.27 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.995 -0.44 . . . . 0.0 111.348 178.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.9 m -75.25 45.55 0.29 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.861 0.864 . . . . 0.0 113.024 -178.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 67.2 p -138.77 -18.96 1.04 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.091 1.756 . . . . 0.0 110.398 173.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.13 0 CA-C-O 116.492 -1.718 . . . . 0.0 110.922 -177.478 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 0' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_